[{"symbol": "PFE", "publishedDate": "2021-03-29 18:55:20", "title": "Pfizer (PFE) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/y/q/drugs2-743967.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $36.62, marking a +1.02% move from the previous day.", "url": "https://www.zacks.com/stock/news/1315128/pfizer-pfe-gains-as-market-dips-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-03-29 13:28:00", "title": "CDC: Pfizer And Moderna Vaccines Could Significantly Cut Down On Coronavirus Transmission", "image": "https://cdn.snapi.dev/images/v1/w/5/cdc-pfizer-and-moderna-vaccines-could-significantly-cut-down-on-coronavirus-transmission-743508.jpg", "site": "Forbes", "text": "The study shows the vaccines prevent all coronavirus infections, not just symptomatic ones.", "url": "https://www.forbes.com/sites/carlieporterfield/2021/03/29/cdc-pfizer-and-moderna-vaccines-could-significantly-cut-down-on-coronavirus-transmission/"}, {"symbol": "PFE", "publishedDate": "2021-03-29 11:49:05", "title": "CDC New Study Shows Pfizer, Moderna COVID-19 Shots 90% Effective Against Infection In Real-World Setting", "image": "https://cdn.snapi.dev/images/v1/v/c/biotech28-743313.jpg", "site": "Benzinga", "text": "The two-dose COVID-19 vaccines from\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) -\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) and\u00a0Moderna Inc\u00a0(NASDAQ:\u00a0MRNA) lower the risk for infection by up to 90%,\u00a0according to data released\u00a0by the U.S. Centers for Disease Control and Prevention. The study was released in Morbidity and Mortality Weekly Report, an online journal published by the Centers for Disease Control and Prevention.", "url": "https://www.benzinga.com/general/biotech/21/03/20385632/cdc-new-study-shows-pfizer-moderna-covid-19-shots-90-effective-against-infection-in-real-world-se"}, {"symbol": "PFE", "publishedDate": "2021-03-29 11:00:01", "title": "One dose of Pfizer or Moderna vaccines was 80% effective in preventing Covid in CDC study of health workers", "image": "https://cdn.snapi.dev/images/v1/h/w/106828724-1611340171521-gettyimages-1230600321-virus-vaccine-us-743215.jpg", "site": "CNBC", "text": "", "url": "https://www.cnbc.com/2021/03/29/cdc-study-shows-single-dose-of-pfizer-or-moderna-covid-vaccines-was-80percent-effective.html"}, {"symbol": "PFE", "publishedDate": "2021-03-29 07:12:00", "title": "This Stalwart's Growth Story Isn't Over Yet", "image": "https://cdn.snapi.dev/images/v1/1/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6186452flab-worker-woman-science-researchjpgw700opresize-742567.jpg", "site": "The Motley Fool", "text": "It's a big-name pharma with a storied history, but Eli Lilly still has plenty of room left to run.", "url": "https://www.fool.com/investing/2021/03/29/this-stalwarts-growth-story-isnt-over-yet/"}, {"symbol": "PFE", "publishedDate": "2021-03-28 06:08:00", "title": "3 High-Yield Dividend Stocks With Solid Growth Prospects", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938142fgettyimages-1194732144jpgw700opresize-742148.jpg", "site": "The Motley Fool", "text": "You don't have to sacrifice growth for great dividend yields with these stocks.", "url": "https://www.fool.com/investing/2021/03/28/3-high-yield-dividend-stocks-with-solid-growth-pro/"}, {"symbol": "PFE", "publishedDate": "2021-03-27 06:00:00", "title": "This COVID Giant's Shares Are Lagging Behind Rivals -- Here's Why", "image": "https://cdn.snapi.dev/images/v1/j/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6193362fgettyimages-1294009031jpgw700opresize-741826.jpg", "site": "The Motley Fool", "text": "It's all about the pace of gains.", "url": "https://www.fool.com/investing/2021/03/27/this-covid-giants-shares-are-lagging-behind-rivals/"}, {"symbol": "PFE", "publishedDate": "2021-03-26 10:36:42", "title": "Pfizer (PFE) Gets Unfavorable Votes from FDA Panel for Tanezumab", "image": "https://cdn.snapi.dev/images/v1/s/t/drugs14-741076.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and Eli Lilly receive FDA Joint Advisory Committee's vote results for tanezumab being developed for treating osteoarthritis pain. The committee voted 1 in favor and 19 against tanezumab.", "url": "https://www.zacks.com/stock/news/1299156/pfizer-pfe-gets-unfavorable-votes-from-fda-panel-for-tanezumab"}, {"symbol": "PFE", "publishedDate": "2021-03-26 07:31:00", "title": "The Promises Behind Terns' Multi-Pronged Pipeline", "image": "https://cdn.snapi.dev/images/v1/k/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6194032fmedicalteam580-spnmjxjpgw700opresize-740673.jpg", "site": "The Motley Fool", "text": "This pharma may be a newcomer to the stock market, but it has several innovative drugs in development for a common condition with no current treatments approved.", "url": "https://www.fool.com/investing/2021/03/26/the-promises-behind-terns-multi-pronged-pipeline/"}, {"symbol": "PFE", "publishedDate": "2021-03-26 00:07:15", "title": "Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky", "image": "https://cdn.snapi.dev/images/v1/t/m/xray-elbowosteoarthritis-rl-ap-740503.jpeg", "site": "Benzinga", "text": "An expert panel of the\u00a0U.S. Food and Drug Administration\u00a0has rejected Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company's (NYSE: LLY) application to approve their experimental drug for the treatment of osteoarthritis pain, citing safety risks and an inadequate plan to manage them. What Happened: The FDA's Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 19-1 that the drug Tanezumab's risks outweigh its benefits for patients with moderate-to-severe osteoarthritis pain, Pfizer and Eli Lilly said in a statement Thursday.", "url": "https://www.benzinga.com/general/biotech/21/03/20352896/pfizer-and-eli-lillys-osteoarthritis-drug-rejected-by-fda-panel-as-too-risky"}, {"symbol": "PFE", "publishedDate": "2021-03-25 22:10:56", "title": "In Key Milestone, Pfizer Begins Testing COVID-19 Vaccine In Children", "image": "https://cdn.snapi.dev/images/v1/e/4/dimitri-houtteman-qbhppxw3ess-unsplash-6-0-740473.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) and\u00a0BioNTech SE (NASDAQ: BNTX) have started clinical trials of their jointly-developed COVID-19 vaccine with children, the companies said in a statement Thursday. What Happened: The vaccine trials involve healthy participants aged 6 months to 11-years and the first participants have already received the shots.", "url": "https://www.benzinga.com/general/biotech/21/03/20352545/in-key-milestone-pfizer-begins-testing-covid-19-vaccine-in-children"}, {"symbol": "PFE", "publishedDate": "2021-03-25 16:12:43", "title": "Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag", "image": "https://cdn.snapi.dev/images/v1/3/u/drugs8-740109.jpg", "site": "Market Watch", "text": "Pfizer Inc. and Eli Lilly and Co. said Thursday that a joint advisory committee of the U.S. Food and Drug Administration has voted against their investigational tanezumab drug for the treatment of certain types of arthritis in adults when use of other drugs aren't possible. \"While we are disappointed with today's outcome, we continue to believe that tanezumab has a positive benefit-risk profile for patients with moderate-to-severe osteoarthritis pain for whom current treatments are ineffective or not appropriate,\" Ken Verburg, tanezumab development team leader at Pfizer, said in a statement.", "url": "https://www.marketwatch.com/story/pfizer-eli-lilly-say-experimental-arthritis-drug-tanezumab-hits-fda-snag-2021-03-25"}, {"symbol": "PFE", "publishedDate": "2021-03-25 15:50:00", "title": "Joint FDA Advisory Committee Votes on Application for Tanezumab for the Treatment of Osteoarthritis Pain", "image": "https://cdn.snapi.dev/images/v1/p/r/press2-740030.jpg", "site": "Business Wire", "text": "NEW YORK & INDIANAPOLIS--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on tanezumab. There was a single voting question focused on whether the proposed risk evaluation and mitigation strategy (REMS) for tanezumab will ensure its benefits outweigh its risks, and the Committee voted 1 in favor and 19 aga", "url": "https://www.businesswire.com/news/home/20210325005905/en/Joint-FDA-Advisory-Committee-Votes-on-Application-for-Tanezumab-for-the-Treatment-of-Osteoarthritis-Pain/"}, {"symbol": "PFE", "publishedDate": "2021-03-25 13:40:56", "title": "Pfizer now administering Covid vaccine does to children under age 12 in trial", "image": "https://cdn.snapi.dev/images/v1/x/0/pfizer-now-administering-covid-vaccine-does-to-children-under-age-12-in-trial-739857.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on latest news from Pfizer, which has started to give the Covid vaccine to children under the age of 12 as part of a new trial.", "url": "https://www.youtube.com/watch?v=jQeeyBXrByk"}, {"symbol": "PFE", "publishedDate": "2021-03-25 13:06:00", "title": "Pfizer Starts Testing Covid-19 Vaccine On Children Ages 6 Months To 11 Years Old", "image": "https://cdn.snapi.dev/images/v1/h/w/pfizer-starts-testing-covid-19-vaccine-on-children-ages-6-months-to-11-years-old-739822.jpg", "site": "Forbes", "text": "In its plan to test the efficacy of its coronavirus vaccine on children as young as six months old, Pfizer joined other drugmakers in a race toward what would mark a major step in the effort to combat the pandemic.", "url": "https://www.forbes.com/sites/ginaheeb/2021/03/25/pfizer-starts-testing-covid-19-vaccine-on-children-ages-6-months-to-11-years-old/"}, {"symbol": "PFE", "publishedDate": "2021-03-25 12:30:01", "title": "Pfizer begins Covid vaccine trial on infants and young kids", "image": "https://cdn.snapi.dev/images/v1/i/q/106821037-16100620952021-01-07t224902z-12704091-rc2a3l9u1pzs-rtrmadp-0-health-coronavirus-usa-739712.jpeg", "site": "CNBC", "text": "The U.S. is unlikely to achieve herd immunity until children can get vaccinated, public health officials and infectious disease experts say.", "url": "https://www.cnbc.com/2021/03/25/covid-vaccine-pfizer-begins-trial-on-infants-and-young-kids.html"}, {"symbol": "PFE", "publishedDate": "2021-03-25 10:37:25", "title": "4 Stocks That Continue to Gain From Telehealth Offerings", "image": "https://cdn.snapi.dev/images/v1/k/r/health12-739406.jpg", "site": "Zacks Investment Research", "text": "We take a sneak peek into four telehealth stocks that are well-poised for growth on their robust digital services suite.", "url": "https://www.zacks.com/stock/news/1293881/4-stocks-that-continue-to-gain-from-telehealth-offerings"}, {"symbol": "PFE", "publishedDate": "2021-03-25 07:32:39", "title": "Pfizer says Ibrance gives more survival time to some breast-cancer patients", "image": "https://cdn.snapi.dev/images/v1/n/z/drugs47-738737.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. gained 0.2% in premarket trading on Thursday after the company said peer-reviewed research shows that Ibrance improved survival among about 1,400 breast-cancer patients when used as a first-line therapy in combination with aromatase inhibitor letrozole. Patients who had taken the combination therapy reported 20 months of real-world progression-free survival compared to the roughly 12 months reported by patients taking only letrozole.", "url": "https://www.marketwatch.com/story/pfizer-says-ibrance-gives-more-survival-time-to-some-breast-cancer-patients-2021-03-25"}, {"symbol": "PFE", "publishedDate": "2021-03-25 06:45:00", "title": "Real-World Evidence Supports Effectiveness of First-line IBRANCE\u00ae (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer", "image": "https://cdn.snapi.dev/images/v1/a/b/press7-738627.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced the peer-reviewed publication of real-world evidence (RWE) demonstrating that first-line therapy with IBRANCE\u00ae (palbociclib) in combination with letrozole was associated with improved real-world progression-free survival (rwPFS) and overall survival (OS) in women with hormone receptor-positive (HR+), human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (mBC) compared with letrozole alone. These findings repre", "url": "https://www.businesswire.com/news/home/20210325005221/en/Real-World-Evidence-Supports-Effectiveness-of-First-line-IBRANCE%C2%AE-palbociclib-Combination-Therapy-in-HR-HER2--Metastatic-Breast-Cancer/"}, {"symbol": "PFE", "publishedDate": "2021-03-24 09:12:06", "title": "Pfizer (PFE) Begins Clinical Study on COVID-19 Antiviral Pill", "image": "https://cdn.snapi.dev/images/v1/m/u/drugs35-737254.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) starts an early-stage U.S. study on an oral COVID-19 antiviral candidate.", "url": "https://www.zacks.com/stock/news/1288385/pfizer-pfe-begins-clinical-study-on-covid-19-antiviral-pill"}, {"symbol": "PFE", "publishedDate": "2021-03-24 06:41:35", "title": "Hong Kong Suspends Pfizer/BioNTech COVID-19 Shots On Loose Caps, Minor Dirt: Report", "image": "https://cdn.snapi.dev/images/v1/w/e/biotech38-736830.jpg", "site": "Benzinga", "text": "Hong Kong and Macau have\u00a0temporarily suspended COVID-19 vaccines\u00a0manufactured by\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE)/BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) due to packaging defects in a batch of vials. Vials with lot number 210102 were\u00a0found to have defective\u00a0packaging, authorities said.", "url": "https://www.benzinga.com/general/biotech/21/03/20314022/hong-kong-suspends-pfizerbiontech-covid-19-shots-on-loose-caps-minor-dirt-report"}, {"symbol": "PFE", "publishedDate": "2021-03-24 06:05:00", "title": "Which COVID Vaccine Stock Is the Best Pick?", "image": "https://cdn.snapi.dev/images/v1/a/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6188032fcoronavirus-vaccine-bottlesjpgw700opresize-736788.jpg", "site": "The Motley Fool", "text": "This question has multiple right answers.", "url": "https://www.fool.com/investing/2021/03/24/which-covid-vaccine-stock-is-the-best-pick/"}, {"symbol": "PFE", "publishedDate": "2021-03-24 02:13:58", "title": "Hong Kong Suspends Use Of Pfizer-BioNTech Vaccine Due To Defective Bottle Lids", "image": "https://cdn.snapi.dev/images/v1/f/4/hong-kong-suspends-use-of-pfizer-biontech-vaccine-due-to-defective-bottle-lids-736684.jpg", "site": "Forbes", "text": "Vaccine maker BioNTech and its Chinese partner Fosun Pharma say they have found no reason to believe the defect may have caused a safety issue.", "url": "https://www.forbes.com/sites/siladityaray/2021/03/24/hong-kong-suspends-use-of-pfizer-biontech-vaccine-due-to-defective-bottle-lids/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 17:48:56", "title": "Edgewise Therapeutics Proposes Terms For $150 Million IPO", "image": "https://cdn.snapi.dev/images/v1/f/z/biotech30-736425.jpg", "site": "Seeking Alpha", "text": "Edgewise Therapeutics has filed to raise $150 million in an IPO.", "url": "https://seekingalpha.com/article/4415693-edgewise-therapeutics-proposes-terms-for-150-million-ipo"}, {"symbol": "PFE", "publishedDate": "2021-03-23 14:02:00", "title": "Pfizer to Develop mRNA Vaccines Without BioNTech", "image": "https://cdn.snapi.dev/images/v1/b/7/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6190532fscientist-lab-pipette-gettyjpgw700opresize-736007.jpg", "site": "The Motley Fool", "text": "The pharmaceutical heavyweight thinks it won't need any more help to whip up new mRNA-based vaccines.", "url": "https://www.fool.com/investing/2021/03/23/pfizer-to-develop-mrna-vaccines-without-biontech/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 13:05:42", "title": "Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug", "image": "https://cdn.snapi.dev/images/v1/x/a/drugs22-735917.jpg", "site": "Benzinga", "text": "Pfizer Inc\u00a0(NYSE:\u00a0PFE)\u00a0has started an early-stage U.S. trial\u00a0of an oral COVID-19 antiviral therapy, dubbed as PF-07321332. The drugmaker, which developed the first authorized COVID-19 vaccine in the U.S. with Germany's\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX), said the antiviral candidate showed potent activity against SARS-CoV-2 in lab studies.", "url": "https://www.benzinga.com/general/biotech/21/03/20302811/pfizer-starts-early-stage-study-of-oral-antiviral-covid-19-drug"}, {"symbol": "PFE", "publishedDate": "2021-03-23 12:30:22", "title": "Pfizer starts early-stage study of oral COVID-19 treatment", "image": "https://cdn.snapi.dev/images/v1/g/j/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p-735815.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. were down 1.1% in trading on Tuesday after the drug maker said it initiated a Phase 1 clinical trial testing its experimental oral antiviral as a COVID-19 treatment. The early-stage study, which is being conducted in the U.S., will evaluate the safety and tolerability of the drug.", "url": "https://www.marketwatch.com/story/pfizer-starts-early-stage-study-of-oral-covid-19-treatment-2021-03-23"}, {"symbol": "PFE", "publishedDate": "2021-03-23 12:28:16", "title": "Pfizer Testing Oral Covid Treatment \u2014 Would Be First To Market", "image": "https://cdn.snapi.dev/images/v1/0/g/pfizer-testing-oral-covid-treatment-would-be-first-to-market-735813.jpg", "site": "Forbes", "text": "After bringing the first vaccine to market, Pfizer hopes for next breakthrough.", "url": "https://www.forbes.com/sites/melissaholzberg/2021/03/23/pfizer-testing-oral-covid-treatment---would-be-first-to-market/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 11:51:19", "title": "Pfizer Plans To Develop New mRNA-Based Vaccines By Itself, Says CEO: WSJ", "image": "https://cdn.snapi.dev/images/v1/t/w/drugs19-735728.jpg", "site": "Benzinga", "text": "Pfizer Inc's\u00a0(NYSE: PFE) chief executive Albert Bourla said that the company\u00a0now aims to expand its vaccine business\u00a0by developing new shots using the mRNA technology to target other viruses and pathogens beyond the coronavirus, reports the Wall Street Journal. The mRNA technology was used in working on the COVID-19 vaccine with its German partner\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX).", "url": "https://www.benzinga.com/general/biotech/21/03/20301634/pfizer-plans-to-develop-new-mrna-based-vaccines-by-itself-says-ceo-wsj"}, {"symbol": "PFE", "publishedDate": "2021-03-23 11:42:44", "title": "2 Dirt-Cheap Value Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6188312fgettyimages-1262577719jpgw700opresize-735734.jpg", "site": "The Motley Fool", "text": "Pfizer and Philip Morris offer excellent bang for your buck.", "url": "https://www.fool.com/investing/2021/03/23/2-dirt-cheap-value-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 11:00:01", "title": "Pfizer begins early stage clinical trial testing oral antiviral drug for Covid", "image": "https://cdn.snapi.dev/images/v1/n/h/106848079-16147199552021-03-02t211201z-528892790-rc293m9mucv5-rtrmadp-0-usa-business-735621.jpeg", "site": "CNBC", "text": "The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.", "url": "https://www.cnbc.com/2021/03/23/covid-pfizer-begins-early-stage-clinical-trial-testing-oral-antiviral-drug.html"}, {"symbol": "PFE", "publishedDate": "2021-03-23 11:00:00", "title": "Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2", "image": "https://cdn.snapi.dev/images/v1/l/f/press18-735639.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the safety and tolerability of an investigational, novel oral antiviral therapeutic for SARS-CoV-2, the virus that causes COVID-19. This Phase 1 trial is being conducted in the United States. The oral antiviral clinical candidate PF-07321332, a SARS-CoV2-3CL protease inhibitor,", "url": "https://www.businesswire.com/news/home/20210323005644/en/Pfizer-Initiates-Phase-1-Study-of-Novel-Oral-Antiviral-Therapeutic-Agent-Against-SARS-CoV-2/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 10:00:00", "title": "Pfizer Invites Public to View and Listen to Webcast of Pfizer May 4 Conference Call with Analysts", "image": "https://cdn.snapi.dev/images/v1/5/s/conf17-735482.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 4, 2021. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's First Quarter 2021 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Informati", "url": "https://www.businesswire.com/news/home/20210323005043/en/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-Pfizer-May-4-Conference-Call-with-Analysts/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 09:32:30", "title": "Why You Should Avoid Pfizer Stock Despite Its Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/w/v/biotech17-735396.jpg", "site": "InvestorPlace", "text": "While Pfizer has a Covid-19 vaccine out for the public, PFE stock isn't getting much love from Wall Street. Let's avoid it for now.", "url": "https://investorplace.com/moneywire/2021/03/why-you-should-avoid-pfe-stock-despite-its-covid-19-vaccine/"}, {"symbol": "PFE", "publishedDate": "2021-03-23 09:05:17", "title": "Will the Fourth COVID-19 Vaccine in U.S. Get FDA Nod Soon?", "image": "https://cdn.snapi.dev/images/v1/c/h/drugs10-735300.jpg", "site": "Zacks Investment Research", "text": "Interim data from a U.S. late-stage study on AstraZeneca's (AZN) COVID-19 vaccine shows that the candidate was, on average, about 79% effective in preventing COVID-19.", "url": "https://www.zacks.com/stock/news/1284053/will-the-fourth-covid-19-vaccine-in-us-get-fda-nod-soon"}, {"symbol": "PFE", "publishedDate": "2021-03-23 07:03:38", "title": "Pfizer: Ultra-Cold Storage Of COVID-19 Vaccine No Longer Required", "image": "https://cdn.snapi.dev/images/v1/7/v/biotech1-734865.jpg", "site": "Seeking Alpha", "text": "The FDA no longer requires PFE to transport vaccines at ultra-low temperatures.", "url": "https://seekingalpha.com/article/4415526-pfizer-ultra-cold-storage-of-covidminus-19-vaccine-no-longer-required"}, {"symbol": "PFE", "publishedDate": "2021-03-23 05:52:00", "title": "These 15 Words From Pfizer's CFO Could Translate to Billions in Sales for Its COVID Vaccine", "image": "https://cdn.snapi.dev/images/v1/u/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6187982fword-bubble-with-money-bagjpgw700opresize-734753.jpg", "site": "The Motley Fool", "text": "Just how many billions, though, remains to be seen.", "url": "https://www.fool.com/investing/2021/03/23/these-15-words-from-pfizers-cfo-could-translate-to/"}, {"symbol": "PFE", "publishedDate": "2021-03-22 18:55:23", "title": "Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/g/y/drugs5-734531.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $36, moving +1.32% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1283803/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-03-22 15:21:51", "title": "Pfizer Stock Is a Good Value Given Its Valuation History", "image": "https://cdn.snapi.dev/images/v1/g/l/drugs3-734173.jpg", "site": "InvestorPlace", "text": "Pfizer stock is good value here given its valuation history. PFE stock is worth at least 18% more based on its historical yield and forward P/E ratio.", "url": "https://investorplace.com/2021/03/pfe-stock-is-worth-18-percent-more-based-on-its-historical-pe-ratio-dividend-yield/"}, {"symbol": "PFE", "publishedDate": "2021-03-22 13:09:35", "title": "Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 Trials", "image": "https://cdn.snapi.dev/images/v1/m/a/hand-cream-5359396-1280-734005.jpg", "site": "Benzinga", "text": "Ahead of an advisory committee meeting scheduled for later this week, the FDA released its in-depth review of\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) and\u00a0Eli Lilly And Co's\u00a0(NYSE:\u00a0LLY) tanezumab, an anti-NGF osteoarthritis drug. What Happened:\u00a0Potential FDA approval for tanezumab still looked rocky as the regulator casts doubt over its safety.", "url": "https://www.benzinga.com/general/biotech/21/03/20281330/pfizereli-lillys-tanezumab-safety-profile-fails-to-impress-fda-even-after-15-years-of-development"}, {"symbol": "PFE", "publishedDate": "2021-03-22 10:21:54", "title": "3 Reasons Pfizer Stock Is Worth a Shot", "image": "https://cdn.snapi.dev/images/v1/1/h/heres-why-pfizer-stock-looks-inviting-at-39-levels-733657.jpg", "site": "InvestorPlace", "text": "PFE stock is worth a shot because shares of Pfizer are fairly priced and the company offers growth and a solid dividend. The post 3 Reasons Pfizer Stock Is Worth a Shot appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/03/3-reasons-pfizer-pfe-stock-is-worth-a-shot/"}, {"symbol": "PFE", "publishedDate": "2021-03-22 06:36:00", "title": "Why I Didn't Jump on the Coronavirus Vaccine Stock Bandwagon", "image": "https://cdn.snapi.dev/images/v1/o/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6187552fwoman-in-mask-and-gloves-holding-tray-of-vials-labeled-covid-19-vaccine-gettyimages-1254511513jpgw700opresize-732943.jpg", "site": "The Motley Fool", "text": "Many people have rushed to invest in vaccine markers. Here's why this Fool didn't.", "url": "https://www.fool.com/investing/2021/03/22/why-i-didnt-jump-on-the-coronavirus-vaccine-stock/"}, {"symbol": "PFE", "publishedDate": "2021-03-21 09:03:00", "title": "The Multibillion-Dollar Question: How Long Do COVID Vaccines Last?", "image": "https://cdn.snapi.dev/images/v1/y/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6180162fdoctor-with-vaccine-syringe-and-question-markjpgw700opresize-732571.jpg", "site": "The Motley Fool", "text": "Some stocks could be big winners and losers depending on what the answer to this question is.", "url": "https://www.fool.com/investing/2021/03/21/the-multibillion-dollar-question-how-long-do-covid/"}, {"symbol": "PFE", "publishedDate": "2021-03-21 07:37:00", "title": "This Company Will Fix the Hidden COVID Danger to Come", "image": "https://cdn.snapi.dev/images/v1/i/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6188202fgetty-woman-w-surgical-maskjpgw700opresize-732535.jpg", "site": "The Motley Fool", "text": "There are long-term implications to the coronavirus pandemic that the market is not appreciating.", "url": "https://www.fool.com/investing/2021/03/21/this-company-will-fix-the-hidden-covid-danger-to-c/"}, {"symbol": "PFE", "publishedDate": "2021-03-21 06:01:00", "title": "3 Embarrassingly Cheap Dividend Stocks", "image": "https://cdn.snapi.dev/images/v1/s/2/s2kwedff-23-732532.jpg", "site": "The Motley Fool", "text": "Income-seeking investors will love these stocks with great dividends and attractive valuations.", "url": "https://www.fool.com/investing/2021/03/21/3-embarrassingly-cheap-dividend-stocks/"}, {"symbol": "PFE", "publishedDate": "2021-03-20 09:52:31", "title": "FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings", "image": "https://cdn.snapi.dev/images/v1/k/i/653-732387.jpg", "site": "Benzinga", "text": "Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the biggest gainers of the week after the biopharma reported positive Phase 1/2 data for its RTX-240 in solid tumors.", "url": "https://www.benzinga.com/general/biotech/21/03/20261034/fda-decisions-for-pfizer-eli-lilly-and-bluebird-bio-bristol-meyers-squibb-plus-new-data-and-earni"}, {"symbol": "PFE", "publishedDate": "2021-03-19 15:38:37", "title": "7 Dividend Stocks You Can Trust Your Retirement To", "image": "https://cdn.snapi.dev/images/v1/a/s/reit11-732027.jpg", "site": "InvestorPlace", "text": "Dividend stocks remain one of the most stable segments to pour your capital into. Here are seven companies will put your mind at ease.", "url": "https://investorplace.com/2021/03/7-dividend-stocks-you-can-trust-your-retirement-to/"}, {"symbol": "PFE", "publishedDate": "2021-03-19 06:04:00", "title": "Could a Supply Glut Sink COVID Vaccine Stocks?", "image": "https://cdn.snapi.dev/images/v1/m/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6180122fcovid-19-vaccine-vialsjpgw700opresize-730993.jpg", "site": "The Motley Fool", "text": "Here's why a supply glut could be on the way --and what the impact could be.", "url": "https://www.fool.com/investing/2021/03/19/could-a-supply-glut-sink-covid-vaccine-stocks/"}, {"symbol": "PFE", "publishedDate": "2021-03-18 11:44:07", "title": "1-Year Tour From Market Crash to Boom: 5 Top ETFs", "image": "https://cdn.snapi.dev/images/v1/t/x/semi22-729857.jpg", "site": "Zacks Investment Research", "text": "The stock market staged a strong rebound from the lows and is currently hitting new highs with the major bourses crossing new milestones.", "url": "https://www.zacks.com/stock/news/1282049/1-year-tour-from-market-crash-to-boom-5-top-etfs"}, {"symbol": "PFE", "publishedDate": "2021-03-18 10:00:00", "title": "Will AstraZeneca's Covid-19 Troubles Help Pfizer Stock?", "image": "https://cdn.snapi.dev/images/v1/1/a/will-astrazenecas-covid-19-troubles-help-pfizer-stock-729618.jpg", "site": "Forbes", "text": "AstraZeneca's Covid-19 vaccine was seen as key to fighting the pandemic globally, given its low cost and easy distribution, but its roll-out and uptake haven't exactly been smooth. The shot was recently suspended from use in multiple countries including Germany, Denmark, Norway, and France due.", "url": "https://www.forbes.com/sites/greatspeculations/2021/03/18/will-astrazenecas-covid-19-troubles-help-pfizer-stock/"}, {"symbol": "PFE", "publishedDate": "2021-03-18 06:10:00", "title": "Which COVID Stocks Are the Best Picks if Coronavirus Variants Spread?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc2-729000.jpg", "site": "The Motley Fool", "text": "Some vaccine makers are better positioned than others.", "url": "https://www.fool.com/investing/2021/03/18/which-covid-stocks-are-the-best-picks-if-coronavir/"}, {"symbol": "PFE", "publishedDate": "2021-03-18 05:00:40", "title": "Building A Dividend Growth Portfolio From Scratch In Today's Expensive Market", "image": "https://cdn.snapi.dev/images/v1/m/i/value-paper-pen-arrow-768x432-728923.jpg", "site": "Seeking Alpha", "text": "The current valuation suggests that investors purchasing the index today could suffer through negative returns for the next 2 to 3 years or longer. Low interest rates have generated strong demand for dividend growth stocks.", "url": "https://seekingalpha.com/article/4414701-building-dividend-growth-portfolio-from-scratch-in-today-s-expensive-market"}, {"symbol": "PFE", "publishedDate": "2021-03-17 12:04:48", "title": "Did Pfizer Just Trip Up AbbVie's Chances For A New Arthritis Drug?", "image": "https://cdn.snapi.dev/images/v1/x/k/drugs7-727978.jpg", "site": "Investors Business Daily", "text": "AbbVie stock plunged Wednesday after the Food and Drug Administration requested additional information to assess the benefit of potential blockbuster drug Rinvoq in psoriatic arthritis. The post Did Pfizer Just Trip Up AbbVie's Chances For A New Arthritis Drug?", "url": "https://www.investors.com/news/technology/abbvie-stock-plunges-fda-delays-review-rinvoq-psoriatic-arthritis/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 10:12:17", "title": "The Great Air Travel Boom of 2021 Is Only One \u2018Generation' Away", "image": "https://cdn.snapi.dev/images/v1/l/8/drugs4-727710.jpg", "site": "InvestorPlace", "text": "Airline stocks should take off as vaccines are more widely dispersed and all that cabin fever can finally be addressed. The post The Great Air Travel Boom of 2021 Is Only One \u2018Generation' Away appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/03/the-great-air-travel-boom-of-2021-is-only-one-generation-away/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 07:32:24", "title": "3 Pharma Dividend Growth Stocks Yielding 4.5%", "image": "https://cdn.snapi.dev/images/v1/w/q/drugs7-727217.jpg", "site": "Seeking Alpha", "text": "I discuss 3 large cap pharma stocks that are yielding about 4.5% or more and are undervalued based on P/E ratio.", "url": "https://seekingalpha.com/article/4414476-3-pharma-dividend-growth-stocks-yielding-4_5-percent"}, {"symbol": "PFE", "publishedDate": "2021-03-17 07:00:00", "title": "Mediar Therapeutics Adds New Investors As It Advances Anti-Fibrotic Treatments", "image": "https://cdn.snapi.dev/images/v1/l/6/press19-727141.jpg", "site": "Business Wire", "text": "CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $PFE #MassGeneralBrigham--Mediar Therapeutics completes seed extension funding round with participation from Pfizer Ventures and Ono Venture Investment.", "url": "https://www.businesswire.com/news/home/20210317005237/en/Mediar-Therapeutics-Adds-New-Investors-As-It-Advances-Anti-Fibrotic-Treatments/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 06:09:00", "title": "These COVID Stocks Could Be Hurt by a Global Raw Material Shortage", "image": "https://cdn.snapi.dev/images/v1/p/o/podc7-727047.jpg", "site": "The Motley Fool", "text": "Two stocks especially stand out.", "url": "https://www.fool.com/investing/2021/03/17/these-covid-stocks-could-be-hurt-by-a-global-raw-m/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 06:04:00", "title": "4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package", "image": "https://cdn.snapi.dev/images/v1/p/o/podc5-727045.jpg", "site": "The Motley Fool", "text": "An easily overlooked provision in the legislation could be bad news for four drugmakers, in particular.", "url": "https://www.fool.com/investing/2021/03/17/4-pharma-stocks-that-could-be-losers-with-the-19-t/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 06:01:00", "title": "Better COVID Stock: Moderna vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/v/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6180082fgloved-hands-holding-2-covid-vaccine-bottlesjpgw700opresize-727039.jpg", "site": "The Motley Fool", "text": "They both have plenty to offer investors.", "url": "https://www.fool.com/investing/2021/03/17/better-covid-stock-moderna-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2021-03-17 00:24:00", "title": "Pfizer to halt biosimilar output in China, sell assets to WuXi Biologics", "image": "https://cdn.snapi.dev/images/v1/u/4/m02d20210317t2i1555153107w940fhfwllplsqrlynxmpeh2g08s-726947.jpg", "site": "Reuters", "text": "Pfizer Inc has decided to stop producing biosimilar products in China and sell a unit in the eastern city of Hangzhou to WuXi Biologics Inc, the U.S. drugmaker said on Wednesday.", "url": "https://www.reuters.com/article/us-pfizer-m-a-wuxi-bio-cay/pfizer-to-halt-biosimilar-output-in-china-sell-assets-to-wuxi-biologics-idUSKBN2B90CI"}, {"symbol": "PFE", "publishedDate": "2021-03-16 18:56:16", "title": "Pfizer (PFE) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/h/p/drugs5-726773.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $35.83, marking a +1.19% move from the previous day.", "url": "https://www.zacks.com/stock/news/1280939/pfizer-pfe-gains-as-market-dips-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-03-16 07:32:00", "title": "Why Zoetis Is the Pfizer of Animal Healthcare", "image": "https://cdn.snapi.dev/images/v1/a/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6175862fcat-looking-at-pills-on-a-tablejpgw700opresize-725161.jpg", "site": "The Motley Fool", "text": "Zoetis has proven to investors that the pharmaceutical apple doesn't fall far from the tree.", "url": "https://www.fool.com/investing/2021/03/16/why-zoetis-is-the-pfizer-of-animal-healthcare/"}, {"symbol": "PFE", "publishedDate": "2021-03-16 02:46:37", "title": "Pfizer: Forget About Momentum And Start Buying Value", "image": "https://cdn.snapi.dev/images/v1/2/l/drugs49-724875.jpg", "site": "Seeking Alpha", "text": "Pfizer: Forget About Momentum And Start Buying Value", "url": "https://seekingalpha.com/article/4414168-pfizer-forget-momentum-and-start-buying-value"}, {"symbol": "PFE", "publishedDate": "2021-03-15 16:33:14", "title": "Jefferies' Yee favors Pfizer and Moderna for Covid-19 vaccines long-term", "image": "https://cdn.snapi.dev/images/v1/r/f/jefferies-yee-favors-pfizer-and-moderna-for-covid-19-vaccines-long-term-724533.jpg", "site": "CNBC Television", "text": "Germany is the latest country to suspend the Oxford-AstraZeneca vaccine over blood clot fears. Michael Yee, Jefferies managing director, Pfizer and Moderna will be in the lead for Covid-19 vaccines in the long term.", "url": "https://www.youtube.com/watch?v=AUOnKLM9y14"}, {"symbol": "PFE", "publishedDate": "2021-03-15 16:12:07", "title": "What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.", "image": "https://cdn.snapi.dev/images/v1/p/f/5000jpgwidth460quality85autoformatfitmaxs1a7319fc0b0a0919b5efebc7790723bc-711584-724442.jpg", "site": "InvestorPlace", "text": "What did the stock market do today? Investors focused on speculative vaccine plays, cannabis stocks and reopening rallies.", "url": "https://investorplace.com/2021/03/what-did-the-stock-market-do-today-3-big-stories-ocgn-stock-sndl-ccl-aal-tlry-amc-stock/"}, {"symbol": "PFE", "publishedDate": "2021-03-15 12:29:24", "title": "7 High-Yield Stocks for Your Retirement Nest Egg", "image": "https://cdn.snapi.dev/images/v1/q/s/asset-management24-3-724037.jpg", "site": "InvestorPlace", "text": "High-dividend names are some of the best retirement stocks and can be a good way to achieve strong long-term growth for your portfolio. The post 7 High-Yield Stocks for Your Retirement Nest Egg appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/03/seven-high-yield-retirement-stocks-for-your-nest-egg/"}, {"symbol": "PFE", "publishedDate": "2021-03-15 11:43:07", "title": "Air Travel Demand Nears 1-Year High: ETFs to Fly High", "image": "https://cdn.snapi.dev/images/v1/1/2/etf12-723908.jpg", "site": "Zacks Investment Research", "text": "According to the latest data from Transportation Security Administration (TSA), about 1.357 million travelers checked in at American airports on Mar 12 - the highest number since Mar 15, 2020.", "url": "https://www.zacks.com/stock/news/1279336/air-travel-demand-nears-1-year-high-etfs-to-fly-high"}, {"symbol": "PFE", "publishedDate": "2021-03-14 06:01:00", "title": "3 High-Yield Dividend Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/w/h/what-will-the-stock-market-return-in-2020-722523.jpg", "site": "The Motley Fool", "text": "Great dividends. Great businesses.", "url": "https://www.fool.com/investing/2021/03/14/3-high-yield-dividend-stocks-to-buy-now/"}, {"symbol": "PFE", "publishedDate": "2021-03-13 08:32:00", "title": "Why the Growth Isn't Over for This Best-in-Breed Biotech Stock", "image": "https://cdn.snapi.dev/images/v1/i/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6172152fgetty-lab-tech-vialsjpgw700opresize-722321.jpg", "site": "The Motley Fool", "text": "It's not getting much attention lately, but the future for Amgen looks strong.", "url": "https://www.fool.com/investing/2021/03/13/why-the-growth-isnt-over-for-this-best-in-breed-bi/"}, {"symbol": "PFE", "publishedDate": "2021-03-13 07:33:00", "title": "Should Pfizer's and Mylan's Shareholders Sell Their Shares of Viatris?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc14-722337.jpg", "site": "The Motley Fool", "text": "It's been a rough start for the combined generic drug company.", "url": "https://www.fool.com/investing/2021/03/13/should-pfizers-and-mylans-shareholders-sell-their/"}, {"symbol": "PFE", "publishedDate": "2021-03-13 06:08:00", "title": "Is Johnson & Johnson's COVID Vaccine Actually Better Than Pfizer's and Moderna's Vaccines?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc2-722294.jpg", "site": "The Motley Fool", "text": "Don't jump to any conclusions based on the different vaccines' advisory committee votes.", "url": "https://www.fool.com/investing/2021/03/13/is-johnson-johnsons-covid-vaccine-actually-better/"}, {"symbol": "PFE", "publishedDate": "2021-03-13 06:00:00", "title": "Should You Buy These Vaccine Stocks After the Sell-Off?", "image": "https://cdn.snapi.dev/images/v1/w/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6178432fgettyimages-1148621172jpgw700opresize-722262.jpg", "site": "The Motley Fool", "text": "Each of these players has dropped about 40% or more in recent weeks.", "url": "https://www.fool.com/investing/2021/03/13/should-you-buy-these-vaccine-stocks-after-the-sell/"}, {"symbol": "PFE", "publishedDate": "2021-03-12 17:06:30", "title": "What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.", "image": "https://cdn.snapi.dev/images/v1/e/w/biotech29-722071.jpg", "site": "InvestorPlace", "text": "What did the stock market do today? All eyes were on the Covid-19 vaccine rollout and on bad news for EV stocks.", "url": "https://investorplace.com/2021/03/what-did-the-stock-market-do-today-3-big-stories-vaccines-nvax-wkhs-ride-stock-chpt-stock-nfts/"}, {"symbol": "PFE", "publishedDate": "2021-03-12 14:31:29", "title": "Pfizer CEO compensation jumped 17% in 2020, as COVID-19 vaccine was developed but stock fell", "image": "https://cdn.snapi.dev/images/v1/b/o/biotech22-721892.jpg", "site": "Market Watch", "text": "Pfizer Inc.'s stock may have lost ground last year, and so far this year, while its peer group gained ground, but 2020 could still be considered a good year for the health care company, as it developed, along with its partner BioNTech SE , one of the three COVID-19 vaccines in use in the U.S. It was certainly a good year for Chief Executive Albert Bourla, whose total compensation increased 17.3% to $21,033,570, from $17,928,963 in 2019, according to a proxy filing on Friday. His 2020 compensation included a salary of $1,650,000, was well as option award, non-equity incentive plan compensation and stock awards.", "url": "https://www.marketwatch.com/story/pfizer-ceo-compensation-jumped-17-in-2020-as-covid-19-vaccine-was-developed-but-stock-fell-2021-03-12"}, {"symbol": "PFE", "publishedDate": "2021-03-12 11:43:05", "title": "7 Healthcare Stocks to Buy and Hold for the Long Term", "image": "https://cdn.snapi.dev/images/v1/9/t/biotech8-721564.jpg", "site": "InvestorPlace", "text": "These steady, strong healthcare stocks are great picks for investors to buy and hold onto for at least the next five years. The post 7 Healthcare Stocks to Buy and Hold for the Long Term appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/03/7-healthcare-stocks-to-buy-and-hold-for-the-long-term/"}, {"symbol": "PFE", "publishedDate": "2021-03-11 18:16:59", "title": "Pfizer says COVID-19 vaccine blocks 94% of asymptomatic infections", "image": "https://cdn.snapi.dev/images/v1/5/3/pfizer-says-covid-19-vaccine-blocks-94-of-asymptomatic-infections-720451.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the news of the Pfizer vaccine blocking 94% of asymptomatic infections plus the latest announcements from President Biden on the COVID-19 vaccine supply.", "url": "https://www.youtube.com/watch?v=dbh698cCApQ"}, {"symbol": "PFE", "publishedDate": "2021-03-11 17:26:08", "title": "Pfizer Inc. (PFE) Management Presents at Barclays Global Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/h/0/transcript20-720391.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) Management Presents at Barclays Global Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4413308-pfizer-inc-pfe-management-presents-barclays-global-healthcare-conference-transcript"}, {"symbol": "PFE", "publishedDate": "2021-03-11 12:24:17", "title": "Pfizer's Vaccine 97% Effective at Preventing COVID-19 in Real-World Study", "image": "https://cdn.snapi.dev/images/v1/d/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6176442fsmart-scientist-in-the-lab-gettyjpgw700opresize-719699.jpg", "site": "The Motley Fool", "text": "Results from Israel suggest the Pfizer-BioNTech vaccine works even better than its phase 3 trial results indicated.", "url": "https://www.fool.com/investing/2021/03/11/pfizers-vaccine-97-effective-at-preventing-covid-1/"}, {"symbol": "PFE", "publishedDate": "2021-03-11 10:45:11", "title": "Pfizer/BioNTech's COVID-19 Vaccine Can Prevent Asymptomatic Infection, Study Shows", "image": "https://cdn.snapi.dev/images/v1/g/n/biotech38-719475.jpg", "site": "Benzinga", "text": "Pfizer Inc\u00a0(NYSE:\u00a0PFE) and\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) said that real-world data from Israel suggests that their COVID-19 vaccine is 94% effective in preventing asymptomatic infections, thus having the potential to reduce transmission significantly. The companies also said the latest analysis of the Israeli data showed the vaccine was\u00a097% effective in preventing\u00a0symptomatic disease, severe disease, and death, in line with the 95% efficacy reported in December.", "url": "https://www.benzinga.com/general/biotech/21/03/20123467/pfizerbiontechs-covid-19-vaccine-can-prevent-asymptomatic-infection-study-shows"}, {"symbol": "PFE", "publishedDate": "2021-03-11 09:03:10", "title": "Pfizer Covid vaccine blocks 94% of asymptomatic infections and 97% of symptomatic cases in Israeli study", "image": "https://cdn.snapi.dev/images/v1/q/p/106852520-1615468225991-gettyimages-1231323486-afp-93k34w-719010.jpeg", "site": "CNBC", "text": "Pfizer said its Covid-19 vaccine blocked 94% of asymptomatic infections in an Israeli study \u2013 a result CEO Albert Bourla called \"extremely important.\"", "url": "https://www.cnbc.com/2021/03/11/pfizer-covid-vaccine-blocks-94percent-of-asymptomatic-infections-and-97percent-of-symptomatic-cases-in-israeli-study.html"}, {"symbol": "PFE", "publishedDate": "2021-03-10 13:35:41", "title": "600 Adolescents Inoculated With Pfizer/BioNtech COVID-19 Shot In Israel Witness No Serious Side-Effects: Guardian", "image": "https://cdn.snapi.dev/images/v1/m/p/biotech33-717618.jpg", "site": "Benzinga", "text": "Around 600 children between the ages of 12 and 16 who have been given the\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) /\u00a0BioNtech SE\u00a0(NASDAQ:\u00a0BNTX) COVID-19 vaccination in Israel did not experience any severe side-effects,\u00a0the Guardian reports. Israel's health ministry has recommended vaccinating some teenagers if they suffer from underlying conditions.", "url": "https://www.benzinga.com/general/biotech/21/03/20103850/600-adolescents-inoculated-with-pfizerbiontech-covid-19-shot-in-israel-witness-no-serious-side-ef"}, {"symbol": "PFE", "publishedDate": "2021-03-10 13:32:22", "title": "Pfizer/BioNTech To Supply Additional 4M COVID-19 Shots To Europe: Reuters", "image": "https://cdn.snapi.dev/images/v1/k/m/biotech34-717620.jpg", "site": "Benzinga", "text": "The European Commission has\u00a0reportedly reached a deal\u00a0with\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) and\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) to supply an additional four million COVID-19 vaccine doses be delivered in March.\u00a0 According to Reuters, this additional supply deal is expected to ease border movement and tackle virus hotspots.", "url": "https://www.benzinga.com/general/biotech/21/03/20102371/pfizerbiontech-to-supply-additional-4m-covid-19-shots-to-europe-reuters"}, {"symbol": "PFE", "publishedDate": "2021-03-10 11:45:00", "title": "Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers", "image": "https://cdn.snapi.dev/images/v1/m/n/press20-717435.jpg", "site": "Business Wire", "text": "STRASBOURG, France--(BUSINESS WIRE)-- #TG4001--Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the expansion of a randomized, controlled study with TG4001 in combination with avelumab versus avelumab monotherapy in patients with HPV16-positive anogenital tumors (NCT: 03260023). Transgene has amended the initial Phase Ib/II trial protocol to enable a more rapid start of this important P", "url": "https://www.businesswire.com/news/home/20210310005694/en/Transgene-Expands-Phase-II-Clinical-Trial-of-Therapeutic-Vaccine-TG4001-in-Combination-With-Avelumab-Versus-Avelumab-Monotherapy-in-Patients-With-HPV16-positive-Anogenital-Cancers/"}, {"symbol": "PFE", "publishedDate": "2021-03-10 10:35:19", "title": "Pfizer To Make COVID-19 Jab In India On Faster Clearance Assurance, Export Freedom: Reuters", "image": "https://cdn.snapi.dev/images/v1/7/s/drugs35-717182.jpg", "site": "Benzinga", "text": "Pfizer Inc\u00a0(NYSE:\u00a0PFE) has told the Indian government it wants to produce its COVID-19 vaccine locally if assured of faster regulatory clearance and freedom on pricing and exports,\u00a0reports Reuters. Last month, the company\u00a0pulled out its marketing application\u00a0seeking emergency approval for its COVID-19 shot in India after failing to adhere to the drug regulator's request for a small local study.", "url": "https://www.benzinga.com/general/biotech/21/03/20099658/pfizer-to-make-covid-19-jab-in-india-on-faster-clearance-assurance-export-freedom-reuters"}, {"symbol": "PFE", "publishedDate": "2021-03-10 07:29:00", "title": "Europe's Lagging in Vaccination. Pfizer and BioNTech Agree to Provide 4 Million More Doses.", "image": "https://cdn.snapi.dev/images/v1/f/u/im-285655-716593.jpg", "site": "Barrons", "text": "Trailing other leading economies in Covid-19 vaccination, the European Commission said Pfizer and BioNTech have agreed to provide 4 million extra doses.", "url": "https://www.barrons.com/articles/pfizer-and-biontech-agree-to-provide-4-million-more-vaccine-doses-to-europe-51615379348"}, {"symbol": "PFE", "publishedDate": "2021-03-10 05:47:22", "title": "Pfizer, BioNTech Predict Increase In Capacity To 3B COVID-19 Vaccine Shots In 2022: Bloomberg", "image": "https://cdn.snapi.dev/images/v1/f/w/covid-19-vaccine-1-image-by-torstensimon-from-pixabay-6-716394.jpg", "site": "Benzinga", "text": "BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) says it could have the capacity to make 3 billion doses of the COVID-19 vaccine it developed with\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) in 2022,\u00a0Bloomberg reports. BioNTech's CEO Ugur Sahin said that the increased manufacturing depends on demand and factors such as the requirement of the additional boost to vaccinations.", "url": "https://www.benzinga.com/general/biotech/21/03/20093638/pfizer-biontech-predict-increase-in-capacity-to-3b-covid-19-vaccine-shots-in-2022-bloomberg"}, {"symbol": "PFE", "publishedDate": "2021-03-10 04:57:44", "title": "European Commission says Pfizer and BioNTech to supply 4 million more coronavirus vaccine doses", "image": "https://cdn.snapi.dev/images/v1/6/y/biotech39-716363.jpg", "site": "Market Watch", "text": "The European Commission said Wednesday that Pfizer and BioNTech will provide 4 million more doses of their coronavirus vaccine in the next two weeks. European Commission President Ursula von der Leyen said the doses are on top of planned dose deliveries.", "url": "https://www.marketwatch.com/story/european-commission-says-pfizer-and-biontech-to-supply-4-million-more-coronavirus-vaccine-doses-2021-03-10"}, {"symbol": "PFE", "publishedDate": "2021-03-09 18:27:32", "title": "Tech Stocks Lead a Market Rebound Tuesday", "image": "https://cdn.snapi.dev/images/v1/d/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6048012ffinancial-newspaper-dollar-sign-stock-quotes-invest-gettyjpgw700opresize-710556-716060.jpg", "site": "GuruFocus", "text": "The Dow Jones Industrial Average closed at 31,832.74 on Tuesday with a gain of 30.30 points or 0.10%. The S&P 500 closed at 3,875.44 for a gain of 54.09 points or 1.42%.", "url": "https://www.gurufocus.com/news/1381818/tech-stocks-lead-a-market-rebound-tuesday"}, {"symbol": "PFE", "publishedDate": "2021-03-09 17:00:00", "title": "Study: Pfizer and BioNTech Vaccine Neutralizes Brazil Coronavirus Variant", "image": "https://cdn.snapi.dev/images/v1/2/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6173322fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize-715988.jpg", "site": "The Motley Fool", "text": "The two companies' BNT162b2 seems to protect patients against the fast-spreading variant.", "url": "https://www.fool.com/investing/2021/03/09/study-pfizer-and-biontech-vaccine-neutralizes-braz/"}, {"symbol": "PFE", "publishedDate": "2021-03-09 07:22:10", "title": "FDA Ok's Roche's Companion Diagnostic For Pfizer's Lorbrena In Lung Cancer", "image": "https://cdn.snapi.dev/images/v1/g/d/drugs14-714362.jpg", "site": "Benzinga", "text": "The\u00a0FDA has approved\u00a0Roche Holdings AG's\u00a0(OTCMKT: RHHBY) Ventana ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer patients eligible for treatment with\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) Lorbrena (lorlatinib). The assay is intended for the qualitative detection of the anaplastic lymphoma kinase (ALK) protein in formalin-fixed, paraffin-embedded non-small cell lung cancer tissue.", "url": "https://www.benzinga.com/general/biotech/21/03/20072283/fda-oks-roches-companion-diagnostic-for-pfizers-lorbrena-in-lung-cancer"}, {"symbol": "PFE", "publishedDate": "2021-03-09 07:11:48", "title": "Coronavirus: Pfizer/BioNTech vaccine works on Brazil variant, study shows", "image": "https://cdn.snapi.dev/images/v1/w/c/1615291761-2021-03-09-12-09-21-1efdef26733671c3867a265e5595ab39-714329.jpg", "site": "Proactive Investors", "text": "The COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) works on the Brazil variant, according to a new study. Scientists took blood samples from people who had already received the jab and analysed it against a lab-made reconstruction of the virus.", "url": "https://www.proactiveinvestors.co.uk//companies/news/943353/coronavirus-pfizerbiontech-vaccine-works-on-brazil-variant-study-shows-943353.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-03-09 06:07:55", "title": "Pfizer/BioNTech COVID-19 Jab Neutralizes Virus Variant In Brazil: Reuters", "image": "https://cdn.snapi.dev/images/v1/g/x/virus-4937553-1280-0-714185.jpg", "site": "Benzinga", "text": "According to a lab study published in the New England Journal of Medicine,\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE)/BioNTech SE's\u00a0(NASDAQ:\u00a0BNTX) COVID-19 vaccine can neutralize a new variant of the coronavirus in Brazil,\u00a0reported Reuters. The scientists said the neutralizing ability was roughly equivalent to the vaccine's effect on a previous version of the virus from last year.", "url": "https://www.benzinga.com/general/biotech/21/03/20071173/pfizerbiontech-covid-19-jab-neutralizes-virus-variant-in-brazil-reuters"}, {"symbol": "PFE", "publishedDate": "2021-03-09 06:00:00", "title": "Here's Why the Novavax CEO is Shrugging Off Moderna's and Pfizer's Market Dominance", "image": "https://cdn.snapi.dev/images/v1/o/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6170362fgettyimages-1304095884jpgw700opresize-714151.jpg", "site": "The Motley Fool", "text": "There are two reasons not to worry.", "url": "https://www.fool.com/investing/2021/03/09/heres-why-the-novavax-ceo-is-shrugging-off-moderna/"}, {"symbol": "PFE", "publishedDate": "2021-03-09 02:19:00", "title": "The New York Post: Pfizer-BioNTech vaccine neutralizes Brazil COVID-19 variant, study shows", "image": "https://cdn.snapi.dev/images/v1/9/h/im-308750width620size15023474178403755-714040.jpg", "site": "Market Watch", "text": "Researchers developed an engineered version of the COVID-19 mutation and found that blood samples taken from people who received the vaccine were able to neutralize the variant, according to the study published in the New England Journal of Medicine on Monday.", "url": "https://www.marketwatch.com/story/pfizer-biontech-vaccine-neutralizes-brazil-covid-19-variant-study-shows-11615274364"}, {"symbol": "PFE", "publishedDate": "2021-03-08 01:00:00", "title": "Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate", "image": "https://cdn.snapi.dev/images/v1/b/t/press16-711956.jpg", "site": "GlobeNewsWire", "text": "Saint-Herblain (France) and New York, NY , March 8, 2021 \u2013 Valneva SE (\u201cValneva\u201d), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. (NYSE: PFE) today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is anticipated to be the final Phase 2 study readout before a decision to progress into pivotal Phase 3 studies.", "url": "https://www.globenewswire.com/news-release/2021/03/08/2188310/0/en/Valneva-and-Pfizer-Announce-Initiation-of-Phase-2-Study-for-Lyme-Disease-Vaccine-Candidate.html"}, {"symbol": "PFE", "publishedDate": "2021-03-07 10:49:19", "title": "Russian intelligence has reportedly launched a disinformation campaign attacking the Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-vaccine-updates-possibly-easier-storage-efficacy-against-south-african-strain-711770.jpg", "site": "Business Insider", "text": "Russian intelligence officials are attempting to cast doubt on the Pfizer coronavirus vaccine, according to a new report from the Wall Street Journal.\u00a0 Four publications acting as fronts for Russian intelligence are disseminating information that questions the efficacy and safety of the Pfizer vaccine, State Department officials told the Journal.", "url": "https://www.businessinsider.com/russia-trying-to-sow-public-doubt-about-pfizer-covid19-vaccine-2021-3"}, {"symbol": "PFE", "publishedDate": "2021-03-07 10:38:00", "title": "Are Pregnant Women a Big Market for Pfizer and BioNTech's Vaccine?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc10-711769.jpg", "site": "The Motley Fool", "text": "The opportunity is bigger than it might at first appear.", "url": "https://www.fool.com/investing/2021/03/07/are-pregnant-women-a-big-market-for-pfizer-and-bio/"}, {"symbol": "PFE", "publishedDate": "2021-03-06 10:03:00", "title": "How Worried Should Investors Be About the South African Coronavirus Variant?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc12-711577.jpg", "site": "The Motley Fool", "text": "Vaccine makers may have a solution.", "url": "https://www.fool.com/investing/2021/03/06/how-worried-should-investors-be-about-the-south-af/"}, {"symbol": "PFE", "publishedDate": "2021-03-06 06:47:00", "title": "2 Green Flags for Pfizer in 2021 and 1 Yellow Flag", "image": "https://cdn.snapi.dev/images/v1/p/o/podc2-711501.jpg", "site": "The Motley Fool", "text": "A clue: They have to do with revenue.", "url": "https://www.fool.com/investing/2021/03/06/2-green-flags-for-pfizer-in-2021-and-1-yellow-flag/"}, {"symbol": "PFE", "publishedDate": "2021-03-05 11:50:37", "title": "7 Mega-Cap Stocks Standing Above the Fray", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks232-710686.jpg", "site": "InvestorPlace", "text": "The remote economy has served as a tailwind for numerous mega-cap stocks that show a lot of future growth potential. Here are 7 stocks worth buying this year.", "url": "https://investorplace.com/2021/03/7-mega-cap-stocks-standing-above-the-fray/"}, {"symbol": "PFE", "publishedDate": "2021-03-05 08:33:00", "title": "Why Pfizer Is Still a Top Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/i/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6166342fgetty-long-term-goalsjpgw700opresize-710236.jpg", "site": "The Motley Fool", "text": "Adding some of this pharma giant to your portfolio makes sense for the long run.", "url": "https://www.fool.com/investing/2021/03/05/why-pfizer-is-still-a-top-stock-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-03-05 06:08:00", "title": "Why the FDA's Coronavirus Variant Guidance Is Great News for Pfizer, Moderna, and Johnson & Johnson", "image": "https://cdn.snapi.dev/images/v1/p/o/podc15-709963.jpg", "site": "The Motley Fool", "text": "Testing vaccines against new variants will be much easier than it might otherwise have been.", "url": "https://www.fool.com/investing/2021/03/05/why-the-fdas-coronavirus-variant-guidance-is-great/"}, {"symbol": "PFE", "publishedDate": "2021-03-04 18:58:13", "title": "Pfizer (PFE) Stock Moves -0.55%: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/o/i/drugs27-709642.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $34.20, moving -0.55% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1273694/pfizer-pfe-stock-moves-055-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-03-04 11:34:26", "title": "Pfizer Has A Unique Portfolio Outside Of Its Vaccine", "image": "https://cdn.snapi.dev/images/v1/b/z/pfizer-vaccine-updates-possibly-easier-storage-efficacy-against-south-african-strain-708539.jpg", "site": "Seeking Alpha", "text": "Pfizer has a unique portfolio of assets outside of its vaccine which will help drive strong shareholder rewards. Additionally, the company is continuing to generate incredibly strong earnings from its COVID-19 vaccine over the next several years.", "url": "https://seekingalpha.com/article/4411363-pfizer-unique-portfolio-outside-of-vaccine"}, {"symbol": "PFE", "publishedDate": "2021-03-04 10:00:00", "title": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/o/e/conf11-708236.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Frank D'Amelio, Chief Financial Officer, Executive Vice President, Global Supply, at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 1:15 p.m. Eastern Standard Time. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/inves", "url": "https://www.businesswire.com/news/home/20210304005012/en/Pfizer-Invites-Public-to-Listen-to-Webcast-of-Pfizer-Discussion-at-Healthcare-Conference/"}, {"symbol": "PFE", "publishedDate": "2021-03-04 09:53:21", "title": "Pfizer's (PFE) Lorbrena Gets FDA Nod for First-Line Lung Cancer", "image": "https://cdn.snapi.dev/images/v1/q/z/drugs14-708212.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) label expansion application for Lorbrena as first-line treatment for metastatic lung cancer gets approval in the United States.", "url": "https://www.zacks.com/stock/news/1273165/pfizers-pfe-lorbrena-gets-fda-nod-for-first-line-lung-cancer"}, {"symbol": "PFE", "publishedDate": "2021-03-04 08:31:00", "title": "Should You Be Concerned About mRNA COVID Vaccines?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc1-707934.jpg", "site": "The Motley Fool", "text": "The short answer: No.", "url": "https://www.fool.com/investing/2021/03/04/should-you-be-concerned-about-mrna-covid-vaccines/"}, {"symbol": "PFE", "publishedDate": "2021-03-04 06:23:29", "title": "Pfizer's Lorbrena Wins Full FDA Approval As First Line Treatment Of ALK-Positive Lung Cancer", "image": "https://cdn.snapi.dev/images/v1/n/j/drugs11-707488.jpg", "site": "Benzinga", "text": "The\u00a0FDA has approved\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) supplemental application seeking approval for Lorbrena (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). The FDA action also converts 2018 accelerated approval to full approval.", "url": "https://www.benzinga.com/general/biotech/21/03/20003039/pfizers-lorbrena-wins-full-fda-approval-as-first-line-treatment-of-alk-positive-lung-cancer"}, {"symbol": "PFE", "publishedDate": "2021-03-03 19:03:00", "title": "U.S. FDA Expands Approval of Pfizer's LORBRENA\u00ae as First-Line Treatment for ALK-Positive Metastatic Lung Cancer", "image": "https://cdn.snapi.dev/images/v1/f/h/press10-707183.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.'s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA\u00ae (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). LORBRENA is now indicated for adults with metastatic NSCLC whose tumors are ALK-positive as detected by an FDA-approved test. The FDA action also converts the 2018 accelerate", "url": "https://www.businesswire.com/news/home/20210303006042/en/U.S.-FDA-Expands-Approval-of-Pfizer%E2%80%99s-LORBRENA%C2%AE-as-First-Line-Treatment-for-ALK-Positive-Metastatic-Lung-Cancer/"}, {"symbol": "PFE", "publishedDate": "2021-03-03 13:56:56", "title": "Merck, Bristol Myers and Pfizer...which one is most attractive?", "image": "https://cdn.snapi.dev/images/v1/5/x/merck-bristol-myers-and-pfizerwhich-one-is-most-attractive-706528.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions in #AskHalftime.", "url": "https://www.youtube.com/watch?v=C0G6HP9zU8c"}, {"symbol": "PFE", "publishedDate": "2021-03-03 12:15:49", "title": "Pfizer will see vaccine sales last longer than people realize: Mizuho's Divan", "image": "https://cdn.snapi.dev/images/v1/d/v/pfizer-will-see-vaccine-sales-last-longer-than-people-realize-mizuhos-divan-706272.jpg", "site": "CNBC Television", "text": "Louise Chen of Cantor Fitzgerald and Dr. Vamil Divan of Mizuho join \"Squawk on the Street\" to discuss vaccine stocks and their outlook.", "url": "https://www.youtube.com/watch?v=7PtVBC9yea8"}, {"symbol": "PFE", "publishedDate": "2021-03-02 09:53:34", "title": "Real-world data shows Pfizer's Covid vaccine is giving 'very strong' results after one dose", "image": "https://cdn.snapi.dev/images/v1/y/u/106826050-1611056643269-gettyimages-1230011324-health-coronavirus-14280653-703598.jpeg", "site": "CNBC", "text": "Figures in a research paper from Public Health England showed how vaccines can significantly reduce hospitalizations in the elderly.", "url": "https://www.cnbc.com/2021/03/02/coronavirus-uk-charts-show-how-pfizers-vaccine-is-working.html"}, {"symbol": "PFE", "publishedDate": "2021-03-02 07:42:00", "title": "Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by up to 80%, study shows", "image": "https://cdn.snapi.dev/images/v1/u/b/im-305966width620size15005861664712778-703052.jpg", "site": "Market Watch", "text": "France revises its stance and approves the AstraZeneca\u2013Oxford vaccine for the over-65s.", "url": "https://www.marketwatch.com/story/single-dose-of-astrazeneca-or-pfizer-covid-19-vaccine-cuts-hospitalization-risk-by-up-to-80-study-shows-11614688951"}, {"symbol": "PFE", "publishedDate": "2021-03-02 06:05:00", "title": "Could Coronavirus Variants Boost Pfizer's Vaccine Sales By 50%?", "image": "https://cdn.snapi.dev/images/v1/k/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6158382fcovid-vaccine-with-dollar-signjpgw700opresize-702794.jpg", "site": "The Motley Fool", "text": "Probably not in the way some might think.", "url": "https://www.fool.com/investing/2021/03/02/could-coronavirus-variants-boost-pfizers-vaccine-s/"}, {"symbol": "PFE", "publishedDate": "2021-03-02 05:01:13", "title": "7 Blue-Chip Stocks That Look a Little Pale", "image": "https://cdn.snapi.dev/images/v1/4/3/430alsmf-1-702726.jpg", "site": "InvestorPlace", "text": "Several tried and true blue-chip stocks that performed well during the past year are starting to look a little pale lately. Is this a temporary downturn or the start of worsening trend?", "url": "https://investorplace.com/2021/03/7-blue-chip-stocks-that-look-a-little-pale/"}, {"symbol": "PFE", "publishedDate": "2021-03-02 01:46:57", "title": "Dr. Fauci Insists U.S. Will Stick To Two Dose Strategy For Pfizer, Moderna Vaccines", "image": "https://cdn.snapi.dev/images/v1/r/i/dr-fauci-insists-us-will-stick-to-two-dose-strategy-for-pfizer-moderna-vaccines-702646.jpg", "site": "Forbes", "text": "Fauci's statement comes amid rising calls to prioritize the first dose to ensure more people are vaccinated faster.", "url": "https://www.forbes.com/sites/siladityaray/2021/03/02/dr-fauci-insists-us-will-stick-to-two-dose-strategy-for-pfizer-moderna-vaccines/"}, {"symbol": "PFE", "publishedDate": "2021-03-01 19:17:10", "title": "Pfizer Inc. (PFE) Management Presents at Cowen 41st Annual Health Care Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/y/a/transcript20-702436.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) Management Presents at Cowen 41st Annual Health Care Conference (Transcript)", "url": "https://seekingalpha.com/article/4410537-pfizer-inc-pfe-management-presents-cowen-41st-annual-health-care-conference-transcript"}, {"symbol": "PFE", "publishedDate": "2021-03-01 07:57:00", "title": "Flowserve supplying pumps, valves for Pfizer vaccine production", "image": "https://cdn.snapi.dev/images/v1/q/j/m02d20210301t2i1553319932w940fhfwllplsqrlynxmpeh201f1-700529.jpg", "site": "Reuters", "text": "Flowserve Corp, an American supplier of industrial machinery, said on Monday it was providing pumps, valves and seals to Pfizer Inc to support the production of its COVID-19 vaccine.", "url": "https://www.reuters.com/article/us-health-coronavirus-flowserve-pfizer/flowserve-supplying-pumps-valves-for-pfizer-vaccine-production-idUSKBN2AT2EA"}, {"symbol": "PFE", "publishedDate": "2021-02-28 06:01:00", "title": "3 Reasons to Buy Pfizer and 1 Reason to Sell", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6143572fbuy-and-sell-in-front-of-man-with-hands-on-his-hipsjpgw700opresize-699909.jpg", "site": "The Motley Fool", "text": "You'll probably be able to guess the top reason to buy this pharma stock.", "url": "https://www.fool.com/investing/2021/02/28/3-reasons-to-buy-pfizer-and-1-reason-to-sell/"}, {"symbol": "PFE", "publishedDate": "2021-02-26 14:43:11", "title": "122 Dividend Growers Include 18 Ideal Dogs For February", "image": "https://cdn.snapi.dev/images/v1/e/t/etf18-42-698965.jpg", "site": "Seeking Alpha", "text": "YCharts US Stock Dividend Growers measure performance of US exchange-traded companies that have increased dividends every year for 10 consecutive years with profitable annual returns.", "url": "https://seekingalpha.com/article/4409569-dividend-growers-include-ideal-dogs-for-february"}, {"symbol": "PFE", "publishedDate": "2021-02-26 12:27:47", "title": "Top 5 4th-Quarter Trades of Chris Davis' Firm", "image": "https://cdn.snapi.dev/images/v1/t/o/insurance3-698675.jpg", "site": "GuruFocus", "text": "Davis Select Advisors recently released its fourth-quarter 2020 portfolio update. Among the changes made during the quarter, the firm disclosed a new position in Viatris Inc. (NASDAQ:VTRS), a position boost in Cigna Corp. (NYSE:CI) and reductions in its holdings in Facebook Inc. (NASDAQ:FB), Quest Diagnostics Inc. (NYSE:DGX) and Alphabet Inc. (NASDAQ:GOOGL)(NASDAQ:GOOG).", "url": "https://www.gurufocus.com/news/1371215/top-5-4thquarter-trades-of-chris-davis-firm"}, {"symbol": "PFE", "publishedDate": "2021-02-26 07:25:33", "title": "Pfizer's 20-Valent Pneumococcal Vaccine Application Accepted EU Review", "image": "https://cdn.snapi.dev/images/v1/l/g/biotech20-697868.jpg", "site": "Benzinga", "text": "The European Medicines Agency has\u00a0accepted for review\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) marketing application seeking approval for the 20-valent pneumococcal conjugate vaccine (20vPnC). The vaccine candidate is for preventing invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in adults ages 18 years and older.", "url": "https://www.benzinga.com/general/biotech/21/02/19876409/pfizers-20-valent-pneumococcal-vaccine-application-accepted-eu-review"}, {"symbol": "PFE", "publishedDate": "2021-02-26 07:00:09", "title": "Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning", "image": "https://cdn.snapi.dev/images/v1/m/k/drugs33-697798.jpg", "site": "Investors Business Daily", "text": "The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/DTgryJepqns/"}, {"symbol": "PFE", "publishedDate": "2021-02-26 06:45:00", "title": "European Medicines Agency Accepts Pfizer's Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older", "image": "https://cdn.snapi.dev/images/v1/x/n/press7-697771.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, as submitted for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults ages 18 years and older. With the MAA acceptance, the formal review process by the EMA's Committee for Medicinal Products", "url": "https://www.businesswire.com/news/home/20210226005036/en/European-Medicines-Agency-Accepts-Pfizer%E2%80%99s-Marketing-Authorization-Application-for-Its-Investigational-20-valent-Pneumococcal-Conjugate-Vaccine-for-Adults-18-Years-of-Age-or-Older/"}, {"symbol": "PFE", "publishedDate": "2021-02-26 06:43:00", "title": "Pfizer vaccine can reduce transmission after 1 dose, new study finds", "image": "https://cdn.snapi.dev/images/v1/h/q/im-304743width620size15005861664712778-697765.jpg", "site": "Market Watch", "text": "A single dose of the COVID-19 vaccine made by Pfizer and BioNTech reduces infections and lowers the risk of transmission, according to a new study.", "url": "https://www.marketwatch.com/story/pfizer-vaccine-can-reduce-transmission-after-1-dose-new-study-finds-11614339785"}, {"symbol": "PFE", "publishedDate": "2021-02-26 06:30:00", "title": "EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency", "image": "https://cdn.snapi.dev/images/v1/y/j/press7-697754.jpg", "site": "Business Wire", "text": "NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon, a long-acting recombinant human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD). Pfizer expects a decision from the European Commission in 2022. \u201cToday's announcement is", "url": "https://www.businesswire.com/news/home/20210226005102/en/EMA-Accepts-Marketing-Application-for-Somatrogon-to-Treat-Pediatric-Patients-with-Growth-Hormone-Deficiency/"}, {"symbol": "PFE", "publishedDate": "2021-02-26 06:06:00", "title": "3 Popular Stocks Billionaires Can't Stop Selling", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6148182finvestor-pressing-sell-button-gettyjpgw700opresize-697753.jpg", "site": "The Motley Fool", "text": "These widely held stocks were on the chopping block during the fourth quarter.", "url": "https://www.fool.com/investing/2021/02/26/3-popular-stocks-billionaires-cant-stop-selling/"}, {"symbol": "PFE", "publishedDate": "2021-02-26 04:52:45", "title": "\"Real world\" test of Pfizer COVID-19 vaccine in Israel determines effectiveness in preventing illness", "image": "https://cdn.snapi.dev/images/v1/o/w/1614333014-elbow-bump-697651.jpg", "site": "Proactive Investors", "text": "Your free daily email from Fuller Treacy Money Comments of the Day 26 February 2021 \u00a0 Video commentary for February 25th 2021 \u00a0 Eoin Treacy's view A link to today's video commentary is posted in the Subscriber's Area.\u00a0 Some of the topics discussed include: Treasury yields spike higher, stcocks and bonds pause, oil eases, gold weak, bitcoin steady yield curve steepening.", "url": "https://www.proactiveinvestors.co.uk//companies/news/942421/-real-world--test-of-pfizer-covid-19-vaccine-in-israel-determines-effectiveness-in-preventing-illness-942421.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-02-25 19:44:36", "title": "Pfizer gets FDA approval to store vaccine at more normal temperatures", "image": "https://cdn.snapi.dev/images/v1/o/j/pfizer-gets-fda-approval-to-store-vaccine-at-more-normal-temperatures-697382.jpg", "site": "CNBC Television", "text": "Pfizer and Moderna are developing Covid-19 booster shots to combat variants. Pfizer also got FDA approval to store the vaccine at more normal temperatures, rather than the ultra-cold temps previously recommended.", "url": "https://www.youtube.com/watch?v=CSBu4Yf4lhc"}, {"symbol": "PFE", "publishedDate": "2021-02-25 18:17:26", "title": "Pfizer's Covid Vaccine Doesn't Need Ultra-Cold Storage, FDA Says", "image": "https://cdn.snapi.dev/images/v1/a/b/pfizers-covid-vaccine-doesnt-need-ultra-cold-storage-fda-says-697250.jpg", "site": "Forbes", "text": "This change could make handling the vaccine easier for small clinics with few resources.", "url": "https://www.forbes.com/sites/joewalsh/2021/02/25/pfizers-covid-vaccine-doesnt-need-ultra-cold-storage-fda-says/"}, {"symbol": "PFE", "publishedDate": "2021-02-25 17:41:17", "title": "FDA allows Pfizer to store Covid vaccine at normal freezer temperatures for 2 weeks", "image": "https://cdn.snapi.dev/images/v1/d/9/fda-allows-pfizer-to-store-covid-vaccine-at-normal-freezer-temperatures-for-2-weeks-697209.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports the FDA has allowed Pfizer to store its Covid vaccines at normal freezer temperatures for two weeks. This will allow for easier storage for Pfizer vaccines, which previously had to be stored in ultra-cold conditions.", "url": "https://www.youtube.com/watch?v=bboCs3OMPgE"}, {"symbol": "PFE", "publishedDate": "2021-02-25 16:53:43", "title": "Prometheus Biosciences Starts $125 Million IPO Plan", "image": "https://cdn.snapi.dev/images/v1/0/c/drugs24-697042.jpg", "site": "Seeking Alpha", "text": "Prometheus Biosciences Starts $125 Million IPO Plan", "url": "https://seekingalpha.com/article/4409134-prometheus-biosciences-starts-125-million-ipo-plan"}, {"symbol": "PFE", "publishedDate": "2021-02-25 14:03:25", "title": "10 Dividend Growth Stocks For February 2021", "image": "https://cdn.snapi.dev/images/v1/a/v/asset-management49.jpg", "site": "Seeking Alpha", "text": "This monthly series ranks a selection of dividend growth stocks in Dividend Radar, presenting the 10 top-ranked stocks for consideration.", "url": "https://seekingalpha.com/article/4409019-10-dividend-growth-stocks-february-2021"}, {"symbol": "PFE", "publishedDate": "2021-02-25 13:26:31", "title": "Forget Pfizer Stock, Buy Historically Cheap Call Options", "image": "https://cdn.snapi.dev/images/v1/i/d/drugs17.jpg", "site": "Seeking Alpha", "text": "Forget Pfizer Stock, Buy Historically Cheap Call Options", "url": "https://seekingalpha.com/article/4408976-pfizer-stock-buy-historically-cheap-call-options"}, {"symbol": "PFE", "publishedDate": "2021-02-25 12:04:06", "title": "Pfizer director Dr. Scott Gottlieb explains how a third Covid shot may protect against variants", "image": "https://cdn.snapi.dev/images/v1/s/n/106833945-1612277367966-gettyimages-1230596336-afp-8yt9wz.jpeg", "site": "CNBC", "text": "Pfizer is exploring two paths with its vaccine to try providing more protection against new Covid strains, according to board member Dr. Scott Gottlieb.", "url": "https://www.cnbc.com/2021/02/25/dr-scott-gottlieb-on-pfizers-efforts-on-a-third-covid-vaccine-shot.html"}, {"symbol": "PFE", "publishedDate": "2021-02-25 10:08:56", "title": "Pfizer board member Scott Gottlieb on variant-specific Covid vaccine", "image": "https://cdn.snapi.dev/images/v1/z/y/pfizer-board-member-scott-gottlieb-on-variant-specific-covid-vaccine.jpg", "site": "CNBC Television", "text": "Pfizer and BioNTech said on Thursday they are testing a third dose of their Covid-19 vaccine to better understand the immune response against new variants of the virus. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined \"Squawk Box\" on Thursday to discuss.", "url": "https://www.youtube.com/watch?v=TC8z75UCYNo"}, {"symbol": "PFE", "publishedDate": "2021-02-25 09:19:29", "title": "Coronavirus: Pfizer vaccine proves highly effective in real-world study, Moderna eyes 2,000% rise in revenue", "image": "https://cdn.snapi.dev/images/v1/w/u/1614257446-shutterstock-1852480339.jpg", "site": "Proactive Investors", "text": "Moderna, Inc. (NASDAQ:MRNA) said it expects to make US$18.4bn (\u00a313bn) in revenue this year as governments worldwide have booked millions of doses of its COVID-19 vaccine. In 2020, total revenue rocketed 93% to US$803mln, mostly due to grants by the US government to speed up the development of the jab.", "url": "https://www.proactiveinvestors.co.uk//companies/news/942317/coronavirus-pfizer-vaccine-proves-highly-effective-in-real-world-study-moderna-eyes-2000-rise-in-revenue-942317.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-02-25 07:52:53", "title": "Coronavirus: Moderna forecasts US$18.4bn sales this year, Pfizer/BioNTech vaccine proved highly effective by study on 1.2mln people", "image": "https://cdn.snapi.dev/images/v1/g/h/1614257446-shutterstock-1852480339.jpg", "site": "Proactive Investors", "text": "Moderna, Inc. (NASDAQ:MRNA) said it expects to make US$18.4bn (\u00a313bn) in revenue this year as governments worldwide have booked millions of doses of its COVID-19 vaccine. In 2020, total revenue rocketed 93% to US$803mln, mostly due to grants by the US government to speed up the development of the jab.", "url": "https://www.proactiveinvestors.co.uk//companies/news/942317/coronavirus-moderna-forecasts-us184bn-sales-this-year-pfizerbiontech-vaccine-proved-highly-effective-by-study-on-12mln-people-942317.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-02-25 07:03:48", "title": "Pfizer, BioNTech to test a COVID-19 vaccine booster against new SARS-CoV-2 variants", "image": "https://cdn.snapi.dev/images/v1/t/9/biotech10.jpg", "site": "Market Watch", "text": "Pfizer Inc. and BioNTech SE said Thursday they have initiated the evaluation of a third dose of their COVID-19 vaccine, to study the effect of a booster on new SARS-CoV-2 variants. The study will draw on participants of its Phase 1 study in the U.S., who will be offered the opportunity to receive a booster of the current vaccine six to 12 months after receiving their initial two doses.", "url": "https://www.marketwatch.com/story/pfizer-biontech-to-test-a-covid-19-vaccine-booster-against-new-sars-cov-2-variants-2021-02-25"}, {"symbol": "PFE", "publishedDate": "2021-02-25 07:03:43", "title": "Pfizer-BioNTech Vaccine 94% Effective In Real World: Study", "image": "https://cdn.snapi.dev/images/v1/p/a/vaccine-5.jpeg", "site": "Benzinga", "text": "A real-world study of the coronavirus vaccine developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) showed the drug to be 94 percent effective at preventing COVID-19. What Happened:\u00a0The large-scale study conducted in Israel found the two-dose vaccine reduced symptomatic cases by 94 percent one week after the second dose and also reduced the severity of the disease by 92 percent, Nikkei Asia reported on Thursday.", "url": "https://www.benzinga.com/news/21/02/19849206/pfizer-biontech-vaccine-94-effective-in-real-world-study"}, {"symbol": "PFE", "publishedDate": "2021-02-25 06:45:00", "title": "Pfizer Will Test Third Dose of Vaccine to Protect Against Variants", "image": "https://cdn.snapi.dev/images/v1/c/w/im-303774.jpg", "site": "Barrons", "text": "The FDA has signaled an eagerness in recent days for progress on vaccines that can offer protection from the emerging variants.", "url": "https://www.barrons.com/articles/pfizer-will-test-third-dose-of-vaccine-to-protect-against-variants-51614206560"}, {"symbol": "PFE", "publishedDate": "2021-02-25 00:47:43", "title": "COVID-19 Continues, But Good Times For mRNA Vaccine Developers Pfizer/BioNTech And Moderna", "image": "https://cdn.snapi.dev/images/v1/4/k/biotech9.jpg", "site": "Seeking Alpha", "text": "Pfizer sees $15 billion revenue from the Pfizer/BioNTech COVID vaccine in 2021 and it could completely change Pfizer's revenue and earnings trajectory. Think about what this will do for BioNTech. The above revenues are for the \u201cpandemic phase.\u201d Pfizer/BioNTech may be considering a 3-4x price increase for their COVID-19 vaccine(s) after this phase. Read this sentence again.", "url": "https://seekingalpha.com/article/4408827-covid-19-continues-but-good-times-for-mrna-vaccine-developers-pfizer-biontech-moderna"}, {"symbol": "PFE", "publishedDate": "2021-02-24 18:06:00", "title": "How Pfizer Plans to Combat Covid-19 Variants", "image": "https://cdn.snapi.dev/images/v1/o/c/im-303798.jpg", "site": "Barrons", "text": "Pfizer's chief scientist said it was imperative for countries to work together to identify Covid-19 variants taking hold in vaccinated people.", "url": "https://www.barrons.com/articles/how-pfizer-plans-to-combat-covid-19-variants-51614207972"}, {"symbol": "PFE", "publishedDate": "2021-02-24 13:05:55", "title": "12 Reasons Novavax Beats Pfizer For Titles Of Best Covid Vaccine And Best Covid Vaccine Stock", "image": "https://cdn.snapi.dev/images/v1/o/h/biotech6.jpg", "site": "Seeking Alpha", "text": "12 Reasons Novavax Beats Pfizer For Titles Of Best Covid Vaccine And Best Covid Vaccine Stock", "url": "https://seekingalpha.com/article/4408574-12-reasons-novavax-beats-pfizer-for-titles-of-best-covid-vaccine-and-best-covid-vaccine-stock"}, {"symbol": "PFE", "publishedDate": "2021-02-24 13:00:00", "title": "ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Expanded Use of Cabenuva (cabotegravir, rilpivirine) as an HIV Treatment for Use Every 2-Months", "image": "https://cdn.snapi.dev/images/v1/m/e/press17---n0td5uawii.jpg", "site": "Business Wire", "text": "RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (\u201cGSK\u201d), with Pfizer Inc. and Shionogi Limited as shareholders, announced today the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration (FDA) for the expanded use of Cabenuva (cabotegravir, rilpivirine). The sNDA seeks to expand Cabenuva's label to include every 2-months dosing for the treatment of HIV-1 infection in", "url": "https://www.businesswire.com/news/home/20210224005862/en/%C2%A0ViiV-Healthcare-Submits-Supplemental-New-Drug-Application-to-US-FDA-for-Expanded-Use-of-Cabenuva-cabotegravir-rilpivirine-as-an-HIV-Treatment-for-Use-Every-2-Months/"}, {"symbol": "PFE", "publishedDate": "2021-02-24 06:31:01", "title": "Pfizer's Tick-Borne Encephalitis Vaccine Gets Priority Review Tag In US", "image": "https://cdn.snapi.dev/images/v1/f/7/biotech35.jpg", "site": "Benzinga", "text": "The FDA has accepted \u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) marketing application seeking approval for TicoVac under priority review status. TicoVac is the tick-borne encephalitis (TBE) vaccine for active immunization in individuals aged one and older.", "url": "https://www.benzinga.com/general/biotech/21/02/19816025/pfizers-tick-borne-encephalitis-vaccine-gets-priority-review-tag-in-us"}, {"symbol": "PFE", "publishedDate": "2021-02-24 03:52:04", "title": "Pfizer, Moderna, J&J Pledge To Make 240M COVID-19 Vaccine Doses Available In US By March-End", "image": "https://cdn.snapi.dev/images/v1/o/q/diana-polekhina-bufafc4l8v0-unsplash.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE), Moderna Inc. (Nasdaq: MRNA) and Johnson & Johnson (NYSE: JNJ) said they are committed to making a total of 240 million doses of COVID-19 vaccines available in the U.S. by the end of March. What Happened: The drug makers told a House subcommittee on Tuesday they are working on ramping up production of their vaccines to meet demand.", "url": "https://www.benzinga.com/general/biotech/21/02/19815317/pfizer-moderna-j-j-pledge-to-make-240m-covid-19-vaccine-doses-available-in-us-by-march-end"}, {"symbol": "PFE", "publishedDate": "2021-02-23 17:18:36", "title": "Big Pharma Short Percentage Is Below Overall Market", "image": "https://cdn.snapi.dev/images/v1/v/b/bank4-9clxwkzuer.jpg", "site": "GuruFocus", "text": "Even investors that don't own the stocks must have had their interest piqued about the goings-on with GameStop Corp. (NYSE:GME), AMC Entertainment Holdings Inc. (NYSE:AMC) and Express Inc. (NYSE:EXPR). The companies were involved in a \"short squeeze\" that saw the shares of all three struggling companies gyrating wildly.", "url": "https://www.gurufocus.com/news/1367823/big-pharma-short-percentage-is-below-overall-market-"}, {"symbol": "PFE", "publishedDate": "2021-02-23 14:57:32", "title": "Pfizer And Moderna To Dramatically Increase Covid-19 Vaccine Production This Spring", "image": "https://cdn.snapi.dev/images/v1/m/l/pfizer-and-moderna-to-dramatically-increase-covid-19-vaccine-production-this-spring.jpg", "site": "Forbes", "text": "Pfizer and Moderna said Tuesday they're making improvements that will allow them to deliver more vaccines in the coming months.", "url": "https://www.forbes.com/sites/alisondurkee/2021/02/23/pfizer-and-moderna-to-dramatically-increase-covid-19-vaccine-production-this-spring/"}, {"symbol": "PFE", "publishedDate": "2021-02-23 10:59:15", "title": "Why Turning Point Is Turning Heads", "image": "https://cdn.snapi.dev/images/v1/i/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6146302fgetty-lung-cancerjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This oncology biotech is up over 450% since its April 2019 IPO. Are there still gains to come, or should investors turn away?", "url": "https://www.fool.com/investing/2021/02/23/why-turning-point-is-turning-heads/"}, {"symbol": "PFE", "publishedDate": "2021-02-23 10:00:00", "title": "Pfizer Vaccine Updates: Possibly Easier Storage, Efficacy Against South African Strain", "image": "https://cdn.snapi.dev/images/v1/a/f/pfizer-vaccine-updates-possibly-easier-storage-efficacy-against-south-african-strain.jpg", "site": "Forbes", "text": "Last week, there were two positive developments relating to Pfizer and its German partner BioNTech's Covid-19 vaccine, and one possible negative development. Firstly, Pfizer says based on internal testing that its vaccine can tolerate warmer temperatures than initially specified, possibly making.", "url": "https://www.forbes.com/sites/greatspeculations/2021/02/23/pfizer-vaccine-updates-possibly-easier-storage-efficacy-against-south-african-strain/"}, {"symbol": "PFE", "publishedDate": "2021-02-23 09:06:39", "title": "FDA Issues New Guidelines for COVID-19 Vaccines, Tests, Drugs", "image": "https://cdn.snapi.dev/images/v1/c/9/biotech36.jpg", "site": "Zacks Investment Research", "text": "The FDA encourages companies to evaluate the impact of COVID-19 virus variants on the efficacy or performance of their COVID-19 vaccines, tests and medicines.", "url": "https://www.zacks.com/stock/news/1267903/fda-issues-new-guidelines-for-covid-19-vaccines-tests-drugs"}, {"symbol": "PFE", "publishedDate": "2021-02-23 05:11:49", "title": "7 of the Best Stocks To Buy as a New Investor", "image": "https://cdn.snapi.dev/images/v1/z/n/bank36.jpg", "site": "InvestorPlace", "text": "When starting out, it's probably best to look at quality. Here are seven familiar names for new investors to consider.", "url": "https://investorplace.com/2021/02/7-of-the-best-stocks-to-buy-as-a-new-investor/"}, {"symbol": "PFE", "publishedDate": "2021-02-22 14:54:28", "title": "Pfizer-Biontech Shot Stops COVID-19 Spread, Israeli Study Shows", "image": "https://cdn.snapi.dev/images/v1/b/a/pfizer-biontech-shot-stops-covid-19-spread-israeli-study-shows.jpg", "site": "Bloomberg Markets and Finance", "text": "Feb.22 -- Sheba Medical Center Deputy Director General Arnon Afek speaks with Bloomberg's Alix Steel and Guy Johnson about the effectiveness of the Pfizer-Biontech vaccine on \"Bloomberg Markets: European Close\".", "url": "https://www.youtube.com/watch?v=mXCJAy0B2Jg"}, {"symbol": "PFE", "publishedDate": "2021-02-22 14:19:19", "title": "Pfizer-Biontech Shot Stops COVID-19 Spread, Israeli Study Shows", "image": "https://cdn.snapi.dev/images/v1/h/n/pfizer-biontech-shot-stops-covid-19-spread-israeli-study-shows.jpg", "site": "Bloomberg Markets and Finance", "text": "Feb.22 -- Sheba Medical Center Deputy Director General Arnon Afek speaks with Bloomberg's Alix Steel and Guy Johnson about the effectiveness of the Pfizer-Biontech vaccine on \"Bloomberg Markets: European Close\".", "url": "https://www.youtube.com/watch?v=74Cw6FiAsu4"}, {"symbol": "PFE", "publishedDate": "2021-02-22 13:58:21", "title": "Pfizer Vaccine Highly Effective After Just One Dose, U.K. Early Data Suggest", "image": "https://cdn.snapi.dev/images/v1/g/q/pfizer-vaccine-highly-effective-after-just-one-dose-uk-early-data-suggest.jpg", "site": "Forbes", "text": "\u201cWe should be very encouraged by these initial findings,\u201d said the head of Public Health England.", "url": "https://www.forbes.com/sites/jemimamcevoy/2021/02/22/pfizer-vaccine-highly-effective-after-just-one-dose-uk-early-data-suggest/"}, {"symbol": "PFE", "publishedDate": "2021-02-22 13:01:47", "title": "Pfizer Inc: An Undervalued Dividend Growth Stock", "image": "https://cdn.snapi.dev/images/v1/w/w/drugs16.jpg", "site": "GuruFocus", "text": "Investing in dividend growth stocks is one of the most famous strategies today, but unfortunately, finding lucrative opportunities has become increasingly difficult as a result of the record bull run. Stock prices of many renowned dividend-paying companies have appreciated double or triple digits since last March, and this calls for extreme caution from investors whose objective is to generate a safe and steady income stream by investing in stocks.", "url": "https://www.gurufocus.com/news/1366007/pfizer-inc-an-undervalued-dividend-growth-stock"}, {"symbol": "PFE", "publishedDate": "2021-02-22 10:59:00", "title": "Pfizer vaccine reduces coronavirus-infection risk, Public Health England says", "image": "https://cdn.snapi.dev/images/v1/0/1/im-302323width620size14797687861271676.jpg", "site": "Market Watch", "text": "An initial dose of the vaccine made by Pfizer and BioNTech cuts the risk of coronavirus infection, Public Health England announced on Monday as U.K. Prime Minister Boris Johnson confirmed plans to relax lockdown rules.", "url": "https://www.marketwatch.com/story/pfizer-vaccine-reduces-coronavirus-infection-risk-public-health-england-says-11614009545"}, {"symbol": "PFE", "publishedDate": "2021-02-22 07:09:22", "title": "Pfizer/BioNtech's COVID-19 Shot Staved Off Illness, Death For Over 95% Of Israeli patients", "image": "https://cdn.snapi.dev/images/v1/y/m/biotech21.jpg", "site": "Benzinga", "text": "The Israel health ministry said that\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) and\u00a0BioNtech SE's\u00a0(NASDAQ:\u00a0BNTX) COVID-19 vaccine had proved\u00a095.8% effective\u00a0in preventing coronavirus infection among those vaccinated two weeks after receiving their second shot, compared to unvaccinated people, according to data compiled up to February 13. The shot\u00a0appeared to stop the vast majority\u00a0of vaccine recipients in Israel from COVID-19 infection, providing the first real-world indication that the immunization will curb transmission of the coronavirus, the health ministry reported.", "url": "https://www.benzinga.com/general/biotech/21/02/19768272/pfizerbiontechs-covid-19-shot-staved-off-illness-death-for-over-95-of-israeli-patients"}, {"symbol": "PFE", "publishedDate": "2021-02-22 05:28:58", "title": "Pfizer Expands Production For COVID-19 Doses After Meeting With President: Bloomberg", "image": "https://cdn.snapi.dev/images/v1/1/r/diana-polekhina-r6u-fhltche-unsplash.jpg", "site": "Benzinga", "text": "The U.S. President Joe Biden met with\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) CEO Albert Bourla on Friday to discuss its COVID-19 vaccine stockpile estimated to be ready by Summer 2021,\u00a0Bloomberg reports. The meeting took place at Pfizer's manufacturing facility in Michigan.", "url": "https://www.benzinga.com/general/biotech/21/02/19767473/pfizer-expands-production-for-covid-19-doses-after-meeting-with-president-bloomberg"}, {"symbol": "PFE", "publishedDate": "2021-02-21 11:11:58", "title": "ETY Could Perform Better In 2020 Without Written Options Strategy", "image": "https://cdn.snapi.dev/images/v1/c/g/computer-electronic36.jpg", "site": "Seeking Alpha", "text": "ETY Could Perform Better In 2020 Without Written Options Strategy", "url": "https://seekingalpha.com/article/4407736-ety-could-perform-better-in-2020-without-written-options-strategy"}, {"symbol": "PFE", "publishedDate": "2021-02-21 06:09:00", "title": "Warren Buffett Just Sold His Pfizer Stock. Should You?", "image": "https://cdn.snapi.dev/images/v1/i/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6136812fwarren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You should definitely follow Buffett in one way.", "url": "https://www.fool.com/investing/2021/02/21/warren-buffett-just-sold-his-pfizer-stock-should-y/"}, {"symbol": "PFE", "publishedDate": "2021-02-21 05:45:00", "title": "Successful Investors Share 3 Investments That Won't Keep You Awake at Night", "image": "https://cdn.snapi.dev/images/v1/y/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6137932fbuffett-copy-2jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't stress out over your stocks -- here are three that guarantee sweet dreams and healthy returns.", "url": "https://www.fool.com/investing/2021/02/21/successful-investors-share-3-investments-that-wont/"}, {"symbol": "PFE", "publishedDate": "2021-02-20 16:52:24", "title": "Pfizer's Covid Vaccine Over 95% Effective In Israel, New Study Reportedly Shows", "image": "https://cdn.snapi.dev/images/v1/5/7/pfizers-covid-vaccine-over-95-effective-in-israel-new-study-reportedly-shows.jpg", "site": "Forbes", "text": "That's good news for the rest of the world.", "url": "https://www.forbes.com/sites/joewalsh/2021/02/20/pfizers-covid-vaccine-over-95-effective-in-israel-new-study-reportedly-shows/"}, {"symbol": "PFE", "publishedDate": "2021-02-20 11:27:30", "title": "Pfizer commits to doubling vaccine supply in response to President Biden's call for a quicker rollout", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-south-africajpgquality90stripall.jpg", "site": "Business Insider", "text": "On Friday, President Joe Biden secured a commitment from US pharmaceutical company Pfizer to double its COVID-19 vaccine supply to the nation, Reuters reported. Biden has set a target to fill the country's vaccine stockpile by summer, a situation that Pfizer may have just made a reality. Pfizer's chief executive, Albert Bourla, announced that he expects to more than double the approximately 5 million doses per week that the company provides to the US government. Per Reuters, he made the comments when the president visited one of its biggest manufacturing facilities.", "url": "https://www.businessinsider.com/pfizer-commits-to-double-vaccine-supply-response-biden-quicker-rollout-2021-2"}, {"symbol": "PFE", "publishedDate": "2021-02-19 19:45:00", "title": "Pfizer and BioNTech Coronavirus Vaccine Effective After 1 Dose, Can Last 2 Weeks in Standard Freezer, Separate Research Shows", "image": "https://cdn.snapi.dev/images/v1/m/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6143142fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg", "site": "The Motley Fool", "text": "The new findings promise simpler transport, storage, and administration for BNT162b2.", "url": "https://www.fool.com/investing/2021/02/19/pfizer-and-biontech-coronavirus-vaccine-effective/"}, {"symbol": "PFE", "publishedDate": "2021-02-19 16:23:13", "title": "Michael Burry's Top 5 Holdings: Pfizer, CitiGroup, Kraft Heinz, More", "image": "https://cdn.snapi.dev/images/v1/4/w/new-york-city-pfizer-world-headquarters-01-1.jpg", "site": "Benzinga", "text": "On Tuesday, Feb. 16, the SEC released filings from many high-profile investors such as Warren Buffett, Cathie Wood and Michael Burry. Burry, of \"The Big Short\" fame, had GameStop as his biggest holding in June when the stock was at only $4.", "url": "https://www.benzinga.com/news/21/02/19755853/michael-burrys-top-5-holdings-pfizer-citigroup-kraft-heinz-more"}, {"symbol": "PFE", "publishedDate": "2021-02-19 15:28:36", "title": "Promising new data shows Pfizer's vaccine can overcome its ultra-cold storage requirements, as new research hints at just how effective the shot is (PFE)", "image": "https://cdn.snapi.dev/images/v1/p/r/promising-new-data-shows-pfizers-vaccine-can-overcome-its-ultra-cold-storage-requirements-as-new-research-hints-at-just-how-effective-the-shot-is.jpg", "site": "Business Insider", "text": "Pfizer and BioNTech announced Friday that they are seeking approval from the US Food and Drug Administration to store their COVID-19 vaccine at higher temperatures. New data from Pfizer shows the shots can be stored at temperatures between minus 13 degrees and 5 degrees Fahrenheit for up to two weeks as an \"alternative or complement to storage in an ultra-low temperature freezer.\" Pfizer CEO Albert Bourla in a press release said, \"We appreciate our ongoing collaboration with the FDA and CDC as we work to ensure our vaccine can be shipped and stored under increasingly flexible conditions. If approved, this new storage option would offer pharmacies and vaccination centers greater flexibility in how they manage their vaccine supply.\"", "url": "https://www.businessinsider.com/pfizers-vaccine-stored-at-higher-temperatures-highly-effective-one-dose-2021-2"}, {"symbol": "PFE", "publishedDate": "2021-02-19 14:38:34", "title": "Pfizer: Vaccine can be stored for two weeks at freezer temperatures", "image": "https://cdn.snapi.dev/images/v1/j/e/pfizer-vaccine-can-be-stored-for-two-weeks-at-freezer-temperatures.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on the current state of Covid vaccines, including Pfizer's remarks on its vaccine storage requirements.", "url": "https://www.youtube.com/watch?v=r50YmuKCzqo"}, {"symbol": "PFE", "publishedDate": "2021-02-19 14:00:55", "title": "Massive Growth Bubble: 5 Attractive Stocks To Buy Now", "image": "https://cdn.snapi.dev/images/v1/5/b/oil9.jpg", "site": "Seeking Alpha", "text": "Massive Growth Bubble: 5 Attractive Stocks To Buy Now", "url": "https://seekingalpha.com/article/4407491-massive-growth-bubble-5-attractive-stocks-to-buy-now"}, {"symbol": "PFE", "publishedDate": "2021-02-19 13:58:22", "title": "Fauci says U.S. is sticking to two doses of the BioNTech/Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/u/u/biotech9.jpg", "site": "Market Watch", "text": "Federal health officials on Friday downplayed the real-world application of preliminary research in Israel that said one dose of BioNTech SE and Pfizer Inc.'s COVID-19 vaccine was 85% effective. Their vaccine, which requires two doses spaced several weeks apart, had an efficacy rate of 95% in clinical trials.", "url": "https://www.marketwatch.com/story/fauci-says-us-is-sticking-to-two-doses-of-the-biontechpfizer-vaccine-2021-02-19"}, {"symbol": "PFE", "publishedDate": "2021-02-19 12:14:37", "title": "A Closer Look At The Numbers: Pfizer Administers A Dose Of Neutrality", "image": "https://cdn.snapi.dev/images/v1/r/f/a-closer-look-at-the-numbers-pfizer-administers-a-dose-of-neutrality.jpg", "site": "Forbes", "text": "Pfizer's numbers alone can be deceptive. That's why we took a deep dive into the company's trends and insights into its future.", "url": "https://www.forbes.com/sites/qai/2021/02/19/a-closer-look-at-the-numbers-pfizer-administers-a-dose-of-neutrality/"}, {"symbol": "PFE", "publishedDate": "2021-02-19 12:07:30", "title": "Pfizer (PFE), BioNTech Test COVID-19 Vaccine in Pregnant Women", "image": "https://cdn.snapi.dev/images/v1/c/v/biotech40.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech begin dosing in a mid-to-late-stage study on their COVID-19 vaccine in healthy pregnant women.", "url": "https://www.zacks.com/stock/news/1266323/pfizer-pfe-biontech-test-covid-19-vaccine-in-pregnant-women"}, {"symbol": "PFE", "publishedDate": "2021-02-19 10:48:41", "title": "Pfizer-BioNTech's COVID-19 vaccine just got a lot easier to transport and distribute", "image": "https://cdn.snapi.dev/images/v1/8/s/gettyimages-1229305401jpgw600.jpg", "site": "TechCrunch", "text": "The COVID-19 vaccine developed by Pfizer and BioNTech now has less stringent and extreme transportation requirements than it debuted with. Originally, the mRNA-based vaccine had to be maintained at ultra-low temperatures throughout the transportation chain in order to remain viable \u2013 between -76\u00b0F and -112\u00b0F.", "url": "https://techcrunch.com/2021/02/19/pfizer-biontechs-covid-19-vaccine-just-got-a-lot-easier-to-transport-and-distribute/"}, {"symbol": "PFE", "publishedDate": "2021-02-19 07:28:07", "title": "BioNTech, Pfizer say their COVID-19 vaccine can be stored at higher temperatures than previously thought", "image": "https://cdn.snapi.dev/images/v1/j/n/biotech24.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. gained 0.1% in premarket trading on Friday after the drugmaker said it is requesting a regulatory change to the storage requirements for the COVID-19 vaccine it developed with BioNTech SE . BioNTech's stock was down 0.8%.", "url": "https://www.marketwatch.com/story/biontech-pfizer-say-their-covid-19-vaccine-can-be-stored-at-higher-temperatures-than-previously-thought-2021-02-19"}, {"symbol": "PFE", "publishedDate": "2021-02-19 06:09:48", "title": "Single Shot Of Pfizer-BioNTech Covid-19 Vaccine Is 85% Effective, Study Finds", "image": "https://cdn.snapi.dev/images/v1/f/1/single-shot-of-pfizer-biontech-covid-19-vaccine-is-85-effective-study-finds.jpg", "site": "Forbes", "text": "The researchers said the findings support policies delaying the second shot in efforts to stretch supplies and speed up immunizations.", "url": "https://www.forbes.com/sites/roberthart/2021/02/19/single-shot-of-pfizer-biontech-covid-19-vaccine-is-85-effective-study-finds/"}, {"symbol": "PFE", "publishedDate": "2021-02-19 06:06:00", "title": "Wow! Warren Buffett Sold These 37 Stocks in 2020", "image": "https://cdn.snapi.dev/images/v1/o/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6136182finvestor-pressing-sell-button-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This is highly unusual behavior from a historically passive investor -- but there is an explanation.", "url": "https://www.fool.com/investing/2021/02/19/wow-warren-buffett-sold-these-37-stocks-in-2020/"}, {"symbol": "PFE", "publishedDate": "2021-02-19 01:07:47", "title": "Delay Pfizer COVID-19 Vaccine's 2nd Inoculation To Boost Supply? Here's What Research Is Saying", "image": "https://cdn.snapi.dev/images/v1/5/i/diana-polekhina-r6u-fhltche-unsplash.jpg", "site": "Benzinga", "text": "The first dose of Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) vaccine could be highly efficacious against COVID-19, a study has found \u2014\u00a0fueling debate over delaying the second dose to stretch supplies, Reuters reported Thursday. What Happened: The first dose of the Pfizer vaccine could be 85% effective, according to a study of healthcare workers at Israel's Sheba Medical Center, Reuters noted.", "url": "https://www.benzinga.com/general/biotech/21/02/19742790/delay-pfizer-covid-19-vaccines-2nd-inoculation-to-boost-supply-heres-what-research-is-saying"}, {"symbol": "PFE", "publishedDate": "2021-02-18 17:27:43", "title": "Prem Watsa's Top 5 Trades of the 4th Quarter", "image": "https://cdn.snapi.dev/images/v1/p/7/stm8-1.jpg", "site": "GuruFocus", "text": "Prem Watsa (Trades, Portfolio), the founder and chairman of Fairfax Financial Ltd. (TSX:FFH), disclosed this week that his insurance company's top five trades during the fourth quarter featured new positions in Pfizer Inc. (NYSE:PFE) and Merck & Co. (NYSE:MRK) and the closure of his holdings in Fitbit Inc. (NYSE:FIT), Gildan Activewear Inc. (NYSE:GIL) and NetEase Inc. (NASDAQ:NTES).", "url": "https://www.gurufocus.com/news/1363880/prem-watsas-top-5-trades-of-the-4th-quarter"}, {"symbol": "PFE", "publishedDate": "2021-02-18 14:55:46", "title": "NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19", "image": "https://cdn.snapi.dev/images/v1/m/l/3500jpgwidth460quality85autoformatfitmaxsc09d0d72308b748658bc8721c20668a9.jpg", "site": "InvestorPlace", "text": "As Covid-19 becomes endemic, rich governments will turn to Novavax to vaccinate people in developing economies. NVAX stock will benefit.", "url": "https://investorplace.com/2021/02/nvax-stock-most-undervalued-vaccine-maker-endemic-covid-19/"}, {"symbol": "PFE", "publishedDate": "2021-02-18 13:45:06", "title": "Pfizer, BioNTech have started trial to evaluate their COVID-19 vaccine in pregnant women", "image": "https://cdn.snapi.dev/images/v1/6/j/biotech9---y5lkmccdiq.jpg", "site": "Market Watch", "text": "Pfizer Inc. and partner BioNTech SE said Thursday that they have commenced a clinical trial to evaluate their COVID-19 vaccine in pregnant women. The companies said the Phase 2/3 trial will enroll 4,000 health pregnant women in the U.S., Canada, Argentina, Brazil, Chile, Mozambique, South Africa, the United Kindom and Spain, with the first participants dosed in the U.S. \"We are proud to start this study in pregnant women and continue to gather the evidence on safety and efficacy to potentially support the use of the vaccine by important subpopulations,\" said William Gruber, senior vice president of vaccine clinical research and development at Pfizer.", "url": "https://www.marketwatch.com/story/pfizer-biontech-have-started-trial-to-evaluate-their-covid-19-vaccine-in-pregnant-women-2021-02-18"}, {"symbol": "PFE", "publishedDate": "2021-02-18 09:51:37", "title": "Pfizer/BioNTech to Sell More COVID-19 Vaccine Doses to EU", "image": "https://cdn.snapi.dev/images/v1/e/r/biotech34.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE)/BioNTech (BNTX) win a deal for 200 million more doses of its COVID-19 vaccine in Europe.", "url": "https://www.zacks.com/stock/news/1265358/pfizer-biontech-to-sell-more-covid-19-vaccine-doses-to-eu"}, {"symbol": "PFE", "publishedDate": "2021-02-17 20:39:28", "title": "What to make of Pfizer, Moderna insiders dumping stock?", "image": "https://cdn.snapi.dev/images/v1/j/j/astrazeneca-740x416.jpg", "site": "Invezz", "text": "Insiders at Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) and other COVID-19 vaccine makers collectively sold nearly half a billion dollars worth of their stock but one pro isn't alarmed by the trend, The Wall Street Journal reported. What are insider trades?", "url": "https://invezz.com/news/2021/02/18/what-to-make-of-pfizer-moderna-insiders-dumping-stock/"}, {"symbol": "PFE", "publishedDate": "2021-02-17 19:33:33", "title": "Pfizer: South African variant could significantly reduce vaccine protection", "image": "https://cdn.snapi.dev/images/v1/q/u/pfizer-south-african-variant-could-significantly-reduce-vaccine-protection.jpg", "site": "CNBC Television", "text": "A new study shows the neutralization levels against the South African covid variant were two-thirds lower when compared to the older variants of the Covid-19. It's unclear what this would look like in a real-world scenario.", "url": "https://www.youtube.com/watch?v=8oaQkLuiYcE"}, {"symbol": "PFE", "publishedDate": "2021-02-17 17:34:42", "title": "Pfizer, BioNTech COVID-19 vaccine likely to protect against South Africa strain", "image": "https://cdn.snapi.dev/images/v1/6/j/biotech8.jpg", "site": "Market Watch", "text": "Pfizer Inc. and BioNTech SE said late Wednesday its COVID-19 vaccine provided protection against the South African variant of the novel coranovirus in a lab study. The study, conducted by Pfizer and the University of Texas Medical Branch and not done in humans, investigated the full set of South African variant spike mutations.", "url": "https://www.marketwatch.com/story/pfizer-biontech-covid-19-vaccine-likely-to-protect-against-south-africa-strain-2021-02-17"}, {"symbol": "PFE", "publishedDate": "2021-02-17 08:32:20", "title": "Pfizer-BioNTech to supply 200 million additional COVID-19 vaccine doses to EU", "image": "https://cdn.snapi.dev/images/v1/j/c/im-300108width620size14988290398126465.jpg", "site": "Market Watch", "text": "Pfizer-BioNTech to supply 200 million additional COVID-19 vaccine doses to EU", "url": "https://www.marketwatch.com/story/pfizer-biontech-to-get-eu-200-million-more-covid-19-shots-01613555951"}, {"symbol": "PFE", "publishedDate": "2021-02-17 06:50:00", "title": "Exclusive: Pfizer's COVID-19 vaccine supply to the EU 30% below plans, sources say", "image": "https://cdn.snapi.dev/images/v1/l/g/m02d20210217t2i1551842527w940fhfwllplsqrlynxmpeh1g0t4.jpg", "site": "Reuters", "text": "Pfizer has not yet delivered to the European Union about 10 million COVID-19 vaccine doses that were due in December, EU officials said, leaving it about one-third short of the supplies it had expected by now from the U.S. company.", "url": "https://www.reuters.com/article/us-health-coronavirus-eu-pfizer-exclusiv/exclusive-pfizers-covid-19-vaccine-supply-to-the-eu-30-below-plans-sources-say-idUSKBN2AH1E3"}, {"symbol": "PFE", "publishedDate": "2021-02-17 06:45:00", "title": "Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma", "image": "https://cdn.snapi.dev/images/v1/j/s/press6---0g9wsk4laa.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359) of elranatamab (PF-06863135), an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody, in patients with relapsed/refractory multiple myeloma. The study evaluates the efficacy and safety of elranatamab, administered subcutaneously, in patients with disease that is refractory to at least one a", "url": "https://www.businesswire.com/news/home/20210217005121/en/Pfizer-Initiates-Pivotal-Phase-2-MagnetisMM-3-Trial-of-BCMA-CD3-Bispecific-Antibody-Elranatamab-PF-06863135-in-Multiple-Myeloma/"}, {"symbol": "PFE", "publishedDate": "2021-02-17 06:20:24", "title": "Europe Calls On Pfizer/BioNtech For 200M More COVID-19 Vaccine Doses", "image": "https://cdn.snapi.dev/images/v1/v/e/biotech9.jpg", "site": "Benzinga", "text": "The European Commission has\u00a0announced an agreement\u00a0with\u00a0Pfizer Inc\u00a0(NYSE:\u00a0PFE) and\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) for 200 million more doses of its COVID-19 vaccine in\u00a0addition to the 300 million doses\u00a0committed to the EU through this year.\u00a0 The EC has the option to request a supply of an additional 100 million doses.", "url": "https://www.benzinga.com/general/biotech/21/02/19698482/europe-calls-on-pfizerbiontech-for-200m-more-covid-19-vaccine-doses"}, {"symbol": "PFE", "publishedDate": "2021-02-17 04:00:00", "title": "Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY\u00ae", "image": "https://cdn.snapi.dev/images/v1/i/x/press11---5hczdsc61p.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY\u00ae, the companies' COVID-19 Vaccine, to the 27 European Union (EU) member states. The EC has the option to request supply of an additional 100 million doses. This new agreement is in addition to the 300 million doses that have already been committed to the EU through 2021 under the f", "url": "https://www.businesswire.com/news/home/20210217005348/en/Pfizer-and-BioNTech-to-Supply-the-European-Union-with-200-Million-Additional-Doses-of-COMIRNATY%C2%AE/"}, {"symbol": "PFE", "publishedDate": "2021-02-17 03:04:09", "title": "Taiwan Says Deal To Buy 5 Million Pfizer-BioNTech Covid-19 Vaccines On Hold, Hints At Pressure From China", "image": "https://cdn.snapi.dev/images/v1/2/v/taiwan-says-deal-to-buy-5-million-pfizer-biontech-covid-19-vaccines-on-hold-hints-at-pressure-from-china.jpg", "site": "Forbes", "text": "Tensions between Taiwan and China have risen sharply during the Covid-19 pandemic as the island has accused the Chinese government of aggravating the pandemic.", "url": "https://www.forbes.com/sites/siladityaray/2021/02/17/taiwan-says-deal-to-buy-5-million-pfizer-biontech-covid-19-vaccines-on-hold-hints-at-pressure-from-china/"}, {"symbol": "PFE", "publishedDate": "2021-02-16 20:08:44", "title": "Protagenic Therapeutics Files For $17.5 Million IPO", "image": "https://cdn.snapi.dev/images/v1/g/w/drugs31.jpg", "site": "Seeking Alpha", "text": "Protagenic Therapeutics Files For $17.5 Million IPO", "url": "https://seekingalpha.com/article/4406503-protagenic-therapeutics-files-for-17_5-million-ipo"}, {"symbol": "PFE", "publishedDate": "2021-02-16 09:01:37", "title": "Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer", "image": "https://cdn.snapi.dev/images/v1/u/q/biotech2---2vao5mwoum.jpg", "site": "Benzinga", "text": "Exelixis Inc\u00a0(NASDAQ:\u00a0EXEL) has\u00a0reported new data\u00a0from the\u00a0Phase 2 (PAPMET) study\u00a0evaluating CABOMETYX (cabozantinib) compared with\u00a0Pfizer Inc's\u00a0(NYSE: PFE) Sutent (sunitinib) in patients with metastatic papillary renal cell carcinoma (PRCC), a form of kidney cancer. Exelixis\u00a0presented the data at the American Society of Clinical Oncology's Genitourinary Cancers Symposium.", "url": "https://www.benzinga.com/general/biotech/21/02/19670150/exelixis-cabozantinib-data-shows-clinically-significant-benefit-versus-pfizers-sutent-in-a-type-o"}, {"symbol": "PFE", "publishedDate": "2021-02-16 08:48:18", "title": "Pfizer's PANZYGA Wins FDA Approval For Rare Peripheral Nerves Disorder", "image": "https://cdn.snapi.dev/images/v1/e/i/drugs19.jpg", "site": "Benzinga", "text": "The FDA has\u00a0approved\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) supplemental marketing application seeking approval for PANZYGA (immune globulin intravenous, human - ifas) for chronic inflammatory demyelinating polyneuropathy (CIDP), caused by damage to the covering of the nerves, called myelin, and is characterized by motor and sensory loss and weakness associated with loss of deep tendon reflexes. According to the company, PANZYGA is the only intravenous immunoglobulin (IVIg) with two FDA-approved maintenance dosing options for CIDP.", "url": "https://www.benzinga.com/general/biotech/21/02/19668498/pfizers-panzyga-wins-fda-approval-for-rare-peripheral-nerves-disorder"}, {"symbol": "PFE", "publishedDate": "2021-02-16 06:17:20", "title": "Report: North Korean Hackers Tried To Steal Covid-19 Vaccine Tech From Pfizer", "image": "https://cdn.snapi.dev/images/v1/d/a/report-north-korean-hackers-tried-to-steal-covid-19-vaccine-tech-from-pfizer.jpg", "site": "Forbes", "text": "The isolated country has previously been accused of targeting researchers and pharma companies for sensitive information on the pandemic.", "url": "https://www.forbes.com/sites/roberthart/2021/02/16/report-north-korean-hackers-tried-to-steal-covid-19-vaccine-tech-from-pfizer/"}, {"symbol": "PFE", "publishedDate": "2021-02-16 06:04:00", "title": "Pfizer Could Be an Even Bigger Winner After These 2 Fantastic Findings", "image": "https://cdn.snapi.dev/images/v1/u/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6133062fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's more good news for Pfizer's COVID-19 vaccine.", "url": "https://www.fool.com/investing/2021/02/16/pfizer-could-be-an-even-bigger-winner-after-these/"}, {"symbol": "PFE", "publishedDate": "2021-02-15 16:05:50", "title": "Pfizer (PFE) Gets FDA Nod for New Indication of Immunoglobulin", "image": "https://cdn.snapi.dev/images/v1/n/v/drugs12.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) Panzyga gets FDA approval to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a rare neurological disease.", "url": "https://www.zacks.com/stock/news/1263210/pfizer-pfe-gets-fda-nod-for-new-indication-of-immunoglobulin"}, {"symbol": "PFE", "publishedDate": "2021-02-15 13:15:42", "title": "Market Lessons From a Year of Pandemic", "image": "https://cdn.snapi.dev/images/v1/3/2/employerstudentloanrepaymentextended-9f8b9322926447bf97fc862170684c41.jpg", "site": "Investopedia", "text": "One of the most important takeaways for investors is that timing the market is, and always has been, a near impossible task.", "url": "https://www.investopedia.com/market-lessons-from-a-year-of-pandemic-5112623"}, {"symbol": "PFE", "publishedDate": "2021-02-14 06:01:00", "title": "What's the Outlook for Pfizer Stock?", "image": "https://cdn.snapi.dev/images/v1/d/l/drugs9.jpg", "site": "The Motley Fool", "text": "The pharmaceutical giant's future should be much brighter than its recent past.", "url": "https://www.fool.com/investing/2021/02/14/whats-the-outlook-for-pfizer-stock/"}, {"symbol": "PFE", "publishedDate": "2021-02-14 05:55:00", "title": "7 Stocks That Cost the Same as a Dozen Roses", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks-5---9ljmygbhgs.jpg", "site": "The Motley Fool", "text": "Move over, roses. These stock prices will give you another reason to fall in love.", "url": "https://www.fool.com/investing/2021/02/14/7-stocks-that-cost-the-same-as-a-dozen-roses/"}, {"symbol": "PFE", "publishedDate": "2021-02-13 10:00:00", "title": "Should You Be Concerned About COVID Vaccine Efficacy Against the South African Variant?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc3---xbfscdsdvo.jpg", "site": "The Motley Fool", "text": "Be concerned? Maybe. Worried?", "url": "https://www.fool.com/investing/2021/02/13/should-you-be-concerned-about-covid-vaccine-effica/"}, {"symbol": "PFE", "publishedDate": "2021-02-13 07:03:00", "title": "Here's Why You Can't Compare Vaccine Results Between Johnson & Johnson, Pfizer, and Moderna", "image": "https://cdn.snapi.dev/images/v1/p/o/podc11---rzahurrgnd.jpg", "site": "The Motley Fool", "text": "It's simply not an apples-to-apples comparison.", "url": "https://www.fool.com/investing/2021/02/13/heres-why-you-cant-compare-vaccine-results-between/"}, {"symbol": "PFE", "publishedDate": "2021-02-13 07:00:00", "title": "A Top Pension Bought More GE, Zoom, and Pfizer Stock. Here's What It Sold.", "image": "https://cdn.snapi.dev/images/v1/g/0/im-298585.jpg", "site": "Barrons", "text": "The State of Wisconsin Investment Board oversees one of the best-run pensions in America, in terms of its funding.", "url": "https://www.barrons.com/articles/pension-bought-ge-zoom-pfizer-stock-sold-intel-51612984339"}, {"symbol": "PFE", "publishedDate": "2021-02-12 17:10:00", "title": "U.S. FDA Approves PANZYGA\u00ae for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "image": "https://cdn.snapi.dev/images/v1/y/k/press18---idnx3izsik.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for PANZYGA\u00ae (Immune Globulin Intravenous [Human] \u2013 ifas 10% Liquid Preparation) to treat adult patients with a rare neurological disease of the peripheral nerves called chronic inflammatory demyelinating polyneuropathy (CIDP). PANZYGA is the only intravenous immunoglobulin (IVIg) with two FDA-approved maintenance", "url": "https://www.businesswire.com/news/home/20210212005537/en/U.S.-FDA-Approves-PANZYGA%C2%AE-for-the-Treatment-of-Adults-with-Chronic-Inflammatory-Demyelinating-Polyneuropathy-CIDP/"}, {"symbol": "PFE", "publishedDate": "2021-02-12 11:27:43", "title": "COVID-19 Vaccine Updates: US Strikes 100M-Dose Supply Deals With Moderna, Pfizer, EU Starts Rolling Review Of CureVac Vaccine", "image": "https://cdn.snapi.dev/images/v1/c/j/syringe-1884779-1920-26.jpg", "site": "Benzinga", "text": "Coronavirus vaccine news supply deals and a regulatory filing are in the headlines in Friday's trading session.\u00a0 US\u00a0Secures More Vaccine Doses: Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE), the two companies that\u00a0have received\u00a0 emergency use authorization\u00a0for vaccine candidates in the U.S., confirmed supply deals with the federal\u00a0government.", "url": "https://www.benzinga.com/general/biotech/21/02/19637918/covid-19-vaccine-updates-us-strikes-100m-dose-supply-deals-with-moderna-pfizer-eu-starts-rolling-"}, {"symbol": "PFE", "publishedDate": "2021-02-12 08:56:22", "title": "U.S. orders another 100 million doses of the BioNTech/Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/q/o/biotech11.jpg", "site": "Market Watch", "text": "BioNTech SE's stock was down 0.3% and shares of Pfizer Inc. were up 0.1% in premarket trading on Friday after the companies said the U.S. now plans to purchase an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. This brings the total number of vaccine doses supplied in the U.S. by BioNTech and Pfizer to 300 million.", "url": "https://www.marketwatch.com/story/us-orders-another-100-million-doses-of-the-biontechpfizer-covid-19-vaccine-2021-02-12"}, {"symbol": "PFE", "publishedDate": "2021-02-12 07:09:11", "title": "The Pfizer vaccine could be effective against the 2 most dangerous COVID-19 variants, according to new data", "image": "https://cdn.snapi.dev/images/v1/t/h/the-pfizer-vaccine-could-be-effective-against-the-2-most-dangerous-covid-19-variants-according-to-new-data.jpg", "site": "Business Insider", "text": "The Pfizer vaccine could protect against the new variants of the coronavirus, according to data from a new study cited by the Guardian. The vaccine led to promising results when tested against two variants widely feared by health experts, one first found in the UK, and another first found in South Africa.", "url": "https://www.businessinsider.com/pfizer-vaccine-promising-against-2-covid-19-variants-study-2021-2"}, {"symbol": "PFE", "publishedDate": "2021-02-12 07:00:00", "title": "How Long Until We Reach Herd Immunity? Expert Timelines Vary", "image": "https://cdn.snapi.dev/images/v1/p/o/podc6---s0dvsvfalv.jpg", "site": "The Motley Fool", "text": "When will things get back to normal?", "url": "https://www.fool.com/investing/2021/02/12/how-long-until-we-reach-herd-immunity-expert-timel/"}, {"symbol": "PFE", "publishedDate": "2021-02-12 06:20:00", "title": "Here's What Investors Need to Know About the Sputnik V Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/c/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6126352fgettyimages-1267049788jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It could have a major impact on the competitive international vaccine market.", "url": "https://www.fool.com/investing/2021/02/12/heres-what-investors-need-to-know-about-sputnik-v-/"}, {"symbol": "PFE", "publishedDate": "2021-02-11 15:28:51", "title": "Pfizer is Yahoo Finance Premium's investment idea of the day", "image": "https://cdn.snapi.dev/images/v1/s/e/pfizer-is-yahoo-finance-premiums-investment-idea-of-the-day.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Kristin Myers and Jared Blikre discuss Yahoo Finance Premium's investment idea of the day. Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=ZWTpZiqc9LE"}, {"symbol": "PFE", "publishedDate": "2021-02-11 09:31:00", "title": "Pfizer: Buy It For A Safe 4% Plus Dividend Yield", "image": "https://cdn.snapi.dev/images/v1/p/d/drugs16.jpg", "site": "Seeking Alpha", "text": "Pfizer offers an attractive dividend yield and a conservative P/E ratio. The safety and quantum of Pfizer's dividend likely outweighs the potential for relatively slow dividend growth.", "url": "https://seekingalpha.com/article/4404303-pfizer-buy-for-safe-4-plus-dividend-yield"}, {"symbol": "PFE", "publishedDate": "2021-02-10 17:19:15", "title": "The Vanguard Health Care Fund's Top 5 Trades of the 4th Quarter", "image": "https://cdn.snapi.dev/images/v1/p/f/drugs7.jpg", "site": "GuruFocus", "text": "The Vanguard Health Care Fund (Trades, Portfolio) has released its portfolio for the fourth quarter. Major trades include selling out of Medtronic PLC (NYSE:MDT), Merck & Co Inc. (NYSE:MRK) and Roche Holding AG (XSWX:ROG).", "url": "https://www.gurufocus.com/news/1356112/the-vanguard-health-care-funds-top-5-trades-of-the-4th-quarter"}, {"symbol": "PFE", "publishedDate": "2021-02-10 12:40:17", "title": "Look For A Bounce In Pfizer After 2-Month Pullback", "image": "https://cdn.snapi.dev/images/v1/b/q/pfizerbiontechlab.png", "site": "Seeking Alpha", "text": "Pfizer stock fell after the earnings report fell short of estimates. Revenue has declined in the past several years but is now rising. Additionally, Pfizer has a low P/E ratio. Pfizer's 50-week moving average is just below the trend line at $34.01, giving the stock two layers of support in the same area.", "url": "https://seekingalpha.com/article/4404923-pfizer-look-for-bounce-after-two-month-pullback"}, {"symbol": "PFE", "publishedDate": "2021-02-10 06:36:00", "title": "The Warren Buffett News You Won't Want to Miss Is 5 Days Away", "image": "https://cdn.snapi.dev/images/v1/b/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6123672f17171920167-b5afce5167-kjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's why Wall Street has Feb. 15 circled on its calendar.", "url": "https://www.fool.com/investing/2021/02/10/warren-buffett-news-wont-want-to-miss-5-days-away/"}, {"symbol": "PFE", "publishedDate": "2021-02-10 06:10:00", "title": "What Are Pfizer's Prospects in 2021 and Beyond?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc13---sxnl94vmlw.jpg", "site": "The Motley Fool", "text": "Hint: Better than the company's recent Q4 results might make you think.", "url": "https://www.fool.com/investing/2021/02/10/what-are-pfizers-prospects-in-2021-and-beyond/"}, {"symbol": "PFE", "publishedDate": "2021-02-08 13:22:15", "title": "Pfizer COVID-19 vaccine should ward off South Africa strain, study shows", "image": "https://cdn.snapi.dev/images/v1/f/i/pfizer-south-africajpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer's COVID-19 vaccine provides protection against the highly contagious variant of the virus that emerged in South Africa, a new study shows. People who received the Pfizer shots had higher levels of antibodies capable of neutralizing the strain than those found in patients who contracted the bug, New York University researchers found.", "url": "https://nypost.com/2021/02/08/pfizer-covid-vaccine-works-on-south-africa-variant-study/"}, {"symbol": "PFE", "publishedDate": "2021-02-08 10:32:22", "title": "Pfizer: Fundamentals Point To Higher Prices", "image": "https://cdn.snapi.dev/images/v1/r/b/drugs39.jpg", "site": "Seeking Alpha", "text": "Pfizer: Fundamentals Point To Higher Prices", "url": "https://seekingalpha.com/article/4404278-pfizer-fundamentals-point-to-higher-prices"}, {"symbol": "PFE", "publishedDate": "2021-02-08 09:41:10", "title": "3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions", "image": "https://cdn.snapi.dev/images/v1/s/w/drugs36.jpg", "site": "InvestorPlace", "text": "Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.", "url": "https://investorplace.com/2021/02/3-under-the-radar-biotech-stocks-to-buy-after-earnings/"}, {"symbol": "PFE", "publishedDate": "2021-02-08 04:22:47", "title": "4D pharma inks clinical trial collaboration and supply agreement with Merck and Pfizer", "image": "https://cdn.snapi.dev/images/v1/6/r/1612772355-2021-02-08-08-19-15-d66de205ad80b0e872cb48c82022a1f6.jpg", "site": "Proactive Investors", "text": "4D pharma PLC (LON:DDDD) has signed a clinical trial collaboration and supply agreement with Merck KGaA, and Pfizer Inc. As part of the tie-up, 4D pharma will start a clinical trial this year with BAVENCIO, a drug for advanced or metastatic urothelial carcinoma developed by Merck and Pfizer, in combination with UK group's MRx0518. \"With this second clinical trial collaboration for MRx0518 with a leading immune checkpoint inhibitor, 4D is able to evaluate MRx0518 in a new combination and earlier treatment setting,\u201d said 4D chief executive Duncan Peyton.", "url": "https://www.proactiveinvestors.co.uk//companies/news/940622/4d-pharma-inks-clinical-trial-collaboration-and-supply-agreement-with-merck-and-pfizer-940622.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-02-08 03:31:49", "title": "4D pharma PLC inks clinical trial collaboration and supply agreement with Merck KGaA, and Pfizer Inc", "image": "https://cdn.snapi.dev/images/v1/f/d/1612772355-2021-02-08-08-19-15-d66de205ad80b0e872cb48c82022a1f6.jpg", "site": "Proactive Investors", "text": "4D pharma PLC (LON:DDDD) has signed a clinical trial collaboration and supply agreement with Merck KGaA, and Pfizer Inc. As part of the tie-up, 4D pharma will start a clinical trial this year with BAVENCIO, a drug for advanced or metastatic urothelial carcinoma developed by Merck and Pfizer, in combination with UK group's MRx0518. \"With this second clinical trial collaboration for MRx0518 with a leading immune checkpoint inhibitor, 4D is able to evaluate MRx0518 in a new combination and earlier treatment setting,\u201d said 4D chief executive Duncan Peyton.", "url": "https://www.proactiveinvestors.co.uk//companies/news/940622/4d-pharma-plc-inks-clinical-trial-collaboration-and-supply-agreement-with-merck-kgaa-and-pfizer-inc-940622.html?SNAPI"}, {"symbol": "PFE", "publishedDate": "2021-02-06 06:45:00", "title": "Short-Sellers Just Won Their Bet on This Vaccine Stock", "image": "https://cdn.snapi.dev/images/v1/m/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6118372fgettyimages-89348585jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The stock lost more than half its value in one trading session.", "url": "https://www.fool.com/investing/2021/02/06/short-sellers-just-won-their-bet-on-this-vaccine-s/"}, {"symbol": "PFE", "publishedDate": "2021-02-06 06:40:00", "title": "1 Green Flag and 1 Red Flag From Pfizer's Earnings", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6110162fgettyimages-1266490076jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Updates on the COVID-19 vaccine and plans for a more focused structure dominated the release.", "url": "https://www.fool.com/investing/2021/02/06/1-green-flag-and-1-red-flag-from-pfizers-earnings/"}, {"symbol": "PFE", "publishedDate": "2021-02-05 13:38:16", "title": "Pharma ETFs in Focus Post Q4 Earnings", "image": "https://cdn.snapi.dev/images/v1/i/4/drugs23.jpg", "site": "Zacks Investment Research", "text": "Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.", "url": "https://www.zacks.com/stock/news/1258521/pharma-etfs-in-focus-post-q4-earnings"}, {"symbol": "PFE", "publishedDate": "2021-02-05 06:45:00", "title": "Pfizer Confirms U.S. Patent Term Extension for IBRANCE\u00ae (palbociclib) Until March 2027", "image": "https://cdn.snapi.dev/images/v1/l/s/press1---zxatpp1ijb.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Patent and Trademark Office (USPTO) recently issued a U.S. Patent Term Extension (PTE) certificate for IBRANCE\u00ae (palbociclib). The certificate extends the term of U.S. Patent No. RE47,739 (\u2018739) by more than four years until March 5, 2027. The PTE certificate was granted under the patent restoration provisions of the Drug Price Competition and Patent Term Restoration Act of 1984. This PTE will be listed in Approved", "url": "https://www.businesswire.com/news/home/20210205005079/en/Pfizer-Confirms-U.S.-Patent-Term-Extension-for-IBRANCE%C2%AE-palbociclib-Until-March-2027/"}, {"symbol": "PFE", "publishedDate": "2021-02-05 05:34:48", "title": "Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - Reuters", "image": "https://cdn.snapi.dev/images/v1/g/a/biotech40.jpg", "site": "Benzinga", "text": "According to Reuters,\u00a0Pfizer Inc\u00a0((NYSE:\u00a0PFE) and its German partner\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) have\u00a0reportedly withdrawn their application\u00a0for the emergency-use nod of its COVID-19 vaccine in India, as the Company failed to meet drug regulator's (Central Drugs Standard Control Organization) demand for small local trial on the vaccine's safety and immunogenicity for Indians. Unlike other companies conducting small studies in India for foreign-developed vaccines, Pfizer had sought an exception citing approvals it had received elsewhere based on trials in countries such as the U.S. and Germany.", "url": "https://www.benzinga.com/general/biotech/21/02/19506620/pfizer-drops-india-vaccine-application-after-regulator-seeks-local-trial-reuters"}, {"symbol": "PFE", "publishedDate": "2021-02-04 21:03:00", "title": "3 Top Stocks You Can Buy and Hold for the Next Decade", "image": "https://cdn.snapi.dev/images/v1/s/t/stocks1600-300x169---j2clpudl3q.jpg", "site": "The Motley Fool", "text": "Frequent trading can hurt your portfolio's performance, so find some great companies to hang on to for the long haul.", "url": "https://www.fool.com/investing/2021/02/04/3-top-stocks-you-can-buy-and-hold-for-the-next-dec/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 17:13:47", "title": "Adagene Readies Plan For $132 Million U.S. IPO", "image": "https://cdn.snapi.dev/images/v1/c/o/drug1.jpg", "site": "Seeking Alpha", "text": "Adagene Readies Plan For $132 Million U.S. IPO", "url": "https://seekingalpha.com/article/4403569-adagene-readies-plan-for-132-million-u-s-ipo"}, {"symbol": "PFE", "publishedDate": "2021-02-04 13:42:30", "title": "More Than One In Three People In U.K. Study Report Side Effects From Pfizer Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/t/b/more-than-one-in-three-people-in-uk-study-report-side-effects-from-pfizer-coronavirus-vaccine.jpg", "site": "Forbes", "text": "People who were previously infected with coronavirus were more likely to report having full-body reactions.", "url": "https://www.forbes.com/sites/carlieporterfield/2021/02/04/more-than-one-in-three-people-in-uk-study-report-side-effects-from-pfizer-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 08:35:57", "title": "5 Very Safe High-Dividend Stocks to Buy Now for Worried Investors", "image": "https://cdn.snapi.dev/images/v1/w/8/14dow.jpg", "site": "24/7 Wall Street", "text": "The song remains the same, and it will for the foreseeable future. The Federal Reserve probably will not be raising rates until 2023, so we remain in a setting with coupons on government securities still close to generational lows.", "url": "https://247wallst.com/investing/2021/02/04/5-very-safe-high-dividend-stocks-to-buy-now-for-worried-investors/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 07:50:00", "title": "Here's Why These 2 Vaccine Makers Are Most Likely to Beat New COVID Strains", "image": "https://cdn.snapi.dev/images/v1/1/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6109732fgettyimages-1296010642jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both have a plan to tackle emerging coronavirus variants.", "url": "https://www.fool.com/investing/2021/02/04/heres-why-these-2-vaccine-makers-are-most-likely-t/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 06:50:00", "title": "Here's How Novavax's Vaccine Stacks Up Against Moderna's and Pfizer's", "image": "https://cdn.snapi.dev/images/v1/x/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6108162fgettyimages-1227230187jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Can Novavax handle new coronavirus strains better than its rivals?", "url": "https://www.fool.com/investing/2021/02/04/heres-how-novavaxs-vaccine-stacks-against-modernas/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 06:42:00", "title": "Can This Maverick Biotech Become the Frontrunner in the Fight Against Alzheimer's?", "image": "https://cdn.snapi.dev/images/v1/r/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6113112fgettyimages-1176326346jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors are betting this underdog will succeed where even the most reputable of biotech firms have failed.", "url": "https://www.fool.com/investing/2021/02/04/can-this-maverick-biotech-become-the-frontrunner-i/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 06:38:00", "title": "Here's Why Pfizer's a Great Stock to Buy and Hold Now", "image": "https://cdn.snapi.dev/images/v1/6/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6109892fscientist-looking-at-stuff-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Around $15 billion from coronavirus vaccine sales this year will be just the beginning.", "url": "https://www.fool.com/investing/2021/02/04/heres-why-pfizers-a-great-stock-to-buy-and-hold-no/"}, {"symbol": "PFE", "publishedDate": "2021-02-04 06:10:00", "title": "Should Investors Worry About New Coronavirus Variants?", "image": "https://cdn.snapi.dev/images/v1/s/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6107202fcoronavirus-globe-stock-chartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Yes and no.", "url": "https://www.fool.com/investing/2021/02/04/should-investors-worry-about-new-coronavirus-varia/"}, {"symbol": "PFE", "publishedDate": "2021-02-03 14:06:36", "title": "Pfizer Is Ready, Even For COVID-19 Variants", "image": "https://cdn.snapi.dev/images/v1/z/8/hakan-nural-z2n-r7pg6km-unsplash.jpg", "site": "Benzinga", "text": "This week is all about healthcare with Pfizer Inc. (NYSE: PFE), Sanofi SA (NASDAQ: SNY), Regeneron Pharmaceticals Inc (NASDAQ: REGN), and Bristol-Myers Squibb Co (NYSE: BMY) reporting earnings. But, what is under the spotlight is the effort pharmaceutical and biotech companies are making to combat COVID-19 or more precisely, the vaccine.", "url": "https://www.benzinga.com/general/biotech/21/02/19472493/pfizer-is-ready-even-for-covid-19-variants"}, {"symbol": "PFE", "publishedDate": "2021-02-03 06:30:00", "title": "Is It Too Late to Buy Pfizer Stock?", "image": "https://cdn.snapi.dev/images/v1/y/f/m02d20210202t2i1549981239w940fhfwllplsqrlynxmpeh110rn.jpg", "site": "The Motley Fool", "text": "Time to buy the drugmaker is running out.", "url": "https://www.fool.com/investing/2021/02/03/is-it-too-late-to-buy-pfizer-stock/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 19:35:47", "title": "Pfizer and Moderna test Covid-19 booster shots", "image": "https://cdn.snapi.dev/images/v1/4/n/pfizer-and-moderna-test-covid-19-booster-shots.jpg", "site": "CNBC Television", "text": "CNBC's senior health and science reporter Meg Tirell on what Pfizer is doing to combat Covid variants. She also reports Russia's Sputnik V Vaccine appears to be 90 percent effective against symptomatic Covid-19.", "url": "https://www.youtube.com/watch?v=tRA-bdTgKdY"}, {"symbol": "PFE", "publishedDate": "2021-02-02 16:58:55", "title": "Pfizer Posts Strong Revenue and Big Expectations for 2021", "image": "https://cdn.snapi.dev/images/v1/i/n/drugs44.jpg", "site": "GuruFocus", "text": "Leading pharmaceutical research development company Pfizer Inc. (NYSE:PFE) has released solid revenue for the fourth quarter alongside some lofty expectations for 2021.", "url": "https://www.gurufocus.com/news/1347664/pfizer-posts-strong-revenue-and-big-expectations-for-2021"}, {"symbol": "PFE", "publishedDate": "2021-02-02 16:51:21", "title": "Coronavirus Vaccine Maker Pfizer Posts a Mixed Q4", "image": "https://cdn.snapi.dev/images/v1/i/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6111012fgloved-hands-holding-a-vial-of-medicinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors weren't impressed with the results, despite double-digit percentage increases on both the top and bottom lines.", "url": "https://www.fool.com/investing/2021/02/02/coronavirus-vaccine-maker-pfizer-posts-a-mixed-q4/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 16:41:06", "title": "Pfizer, Inc. (PFE) CEO Dr. Albert Bourla on Q4 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/v/q/transcript39.jpg", "site": "Seeking Alpha", "text": "Pfizer, Inc. (PFE) CEO Dr. Albert Bourla on Q4 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4402872-pfizer-inc-pfe-ceo-dr-albert-bourla-on-q4-2020-results-earnings-call-transcript"}, {"symbol": "PFE", "publishedDate": "2021-02-02 14:49:00", "title": "Pfizer Increased Vaccine Sales Estimate After AstraZeneca and J&J Stumbles", "image": "https://cdn.snapi.dev/images/v1/b/d/im-293581.jpg", "site": "Barrons", "text": "Pfizer CEO Albert Bourla says he has grown more confident about the outlook for the vaccine.", "url": "https://www.barrons.com/articles/pfizer-increased-vaccine-sales-estimate-after-astrazeneca-and-j-j-stumbles-51612295394"}, {"symbol": "PFE", "publishedDate": "2021-02-02 13:55:14", "title": "Options Bulls Blast Pfizer Stock After Earnings", "image": "https://cdn.snapi.dev/images/v1/4/k/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p.jpg", "site": "Schaeffers Research", "text": "The shares of Pfizer Inc (NYSE:PFE) are down 3.1% at $34.69 at last check, after the drugmaker reported\u00a0 an earnings miss alongside better-than-expected revenue.", "url": "https://www.schaeffersresearch.com/content/options/2021/02/02/options-bulls-blast-pfizer-stock-after-earnings"}, {"symbol": "PFE", "publishedDate": "2021-02-02 13:53:38", "title": "Bolt Biotherapeutics Aims For $150 Million U.S. IPO", "image": "https://cdn.snapi.dev/images/v1/e/g/drugs40---cng5gy0w3e.jpg", "site": "Seeking Alpha", "text": "Bolt Biotherapeutics has filed proposed terms for a $150 million IPO. The firm is developing antibody conjugate treatments for various cancers.", "url": "https://seekingalpha.com/article/4402758-bolt-biotherapeutics-aims-for-150-million-u-s-ipo"}, {"symbol": "PFE", "publishedDate": "2021-02-02 12:54:19", "title": "Is Pfizer Stock A Buy On Guidance For $15 Billion In Covid Vaccine Sales?", "image": "https://cdn.snapi.dev/images/v1/t/b/biotech2---xvdctey3xb.jpg", "site": "Investors Business Daily", "text": "Pfizer stock took a hit in early February on a disappointing fourth-quarter report, though the company called for $15 billion in full-year Covid vaccine sales. So, is Pfizer stock a buy now?", "url": "https://www.investors.com/news/technology/pfizer-stock-buy-now/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 12:27:06", "title": "Pfizer evaluating Covid vaccine boosters in case needed for variants", "image": "https://cdn.snapi.dev/images/v1/6/q/pfizer-evaluating-covid-vaccine-boosters-in-case-needed-for-variants.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Pfizer's evaluation of its Covid vaccine against variants of the virus.", "url": "https://www.youtube.com/watch?v=-_EpS_vwG74"}, {"symbol": "PFE", "publishedDate": "2021-02-02 11:22:08", "title": "Pfizer (PFE) Q4 Earnings Miss, Sales Beat, 2021 View Upbeat", "image": "https://cdn.snapi.dev/images/v1/l/y/drugs37.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) misses estimates for earnings while beating the same for sales. It provides an upbeat financial outlook for 2021.", "url": "https://www.zacks.com/stock/news/1255985/pfizer-pfe-q4-earnings-miss-sales-beat-2021-view-upbeat"}, {"symbol": "PFE", "publishedDate": "2021-02-02 11:22:05", "title": "Groundhog Day, But Nothing's the Same: Q4 for PFE, UPS", "image": "https://cdn.snapi.dev/images/v1/5/f/interest-ratesjpgquality90stripall.jpg", "site": "Zacks Investment Research", "text": "We can also take a look at GameStop (GME), AMC Entertainment (AMC) and the silver commodity and recognize that it's not \"deja vu all over again\" (to quote Yogi Berra); it is a return to valuation normalcy.", "url": "https://www.zacks.com/stock/news/1256004/groundhog-day-but-nothings-the-same-q4-for-pfe-ups"}, {"symbol": "PFE", "publishedDate": "2021-02-02 11:22:03", "title": "Markets Return to Normalcy", "image": "https://cdn.snapi.dev/images/v1/s/l/entertainment-diversified3.jpg", "site": "Zacks Investment Research", "text": "Markets Return to Normalcy", "url": "https://www.zacks.com/stock/news/1256029/markets-return-to-normalcy"}, {"symbol": "PFE", "publishedDate": "2021-02-02 11:16:19", "title": "Pfizer Expects COVID-19 Vaccine To Bring $15B In Revenue This Year", "image": "https://cdn.snapi.dev/images/v1/i/1/syringe-1884779-1920-25.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE), the first company to\u00a0obtain emergency use authorization for a\u00a0coronavirus vaccine, offered a preview Tuesday into the vaccine's revenue potential in the current fiscal year. Pfizer's COVID-19 vaccine was co-developed with German partner BioNTech SE \u2013 ADR (NASDAQ: BNTX).", "url": "https://www.benzinga.com/general/biotech/21/02/19441482/pfizer-expects-covid-19-vaccine-to-bring-15b-in-revenue-this-year"}, {"symbol": "PFE", "publishedDate": "2021-02-02 11:00:00", "title": "Why Pfizer's Q4 Results Simply Don't Matter Very Much", "image": "https://cdn.snapi.dev/images/v1/3/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6109872fsyringe-and-vial-of-medicine-in-gloved-handsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "It's why the market shrugged off the big drugmaker's fourth-quarter earnings miss.", "url": "https://www.fool.com/investing/2021/02/02/why-pfizers-q4-results-simply-dont-matter-very-muc/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 10:19:41", "title": "Pfizer expects to rake in sales of $15 billion from its Covid-19 vaccine this year", "image": "https://cdn.snapi.dev/images/v1/t/w/210202093707-restricted-pfizer-biontech-covid-19-vaccine-super-169.jpg", "site": "CNN Business", "text": "Pfizer expects to earn approximately $15 billion in revenue from its Covid-19 vaccine this year, the company said Tuesday.", "url": "https://www.cnn.com/2021/02/02/investing/pfizer-earnings-covid-vaccine/index.html"}, {"symbol": "PFE", "publishedDate": "2021-02-02 10:19:30", "title": "Jim Cramer on Pfizer's fourth-quarter earnings and full-year guidance", "image": "https://cdn.snapi.dev/images/v1/2/c/jim-cramer-on-pfizers-fourth-quarter-earnings-and-full-year-guidance.jpg", "site": "CNBC Television", "text": "Pfizer earned 42 cents per share for the fourth quarter, 6 cents a share below estimates. Pfizer's revenue was above forecasts, however, and the company raised its full-year guidance amid the positive impact of the Covid-19 vaccine developed in conjunction with partner BioNTech.", "url": "https://www.youtube.com/watch?v=gROX4_fpxZE"}, {"symbol": "PFE", "publishedDate": "2021-02-02 09:53:52", "title": "Pfizer plans to deliver 200 million doses of Covid vaccine to U.S. by May, sooner than expected", "image": "https://cdn.snapi.dev/images/v1/e/2/106833942-1612277204369-gettyimages-1230597509-20090101210115-99-41058.jpeg", "site": "CNBC", "text": "", "url": "https://www.cnbc.com/2021/02/02/covid-vaccine-pfizer-plans-to-deliver-200-million-doses-to-us-by-may-sooner-than-expected.html"}, {"symbol": "PFE", "publishedDate": "2021-02-02 09:38:24", "title": "Pfizer's profit comes in weaker than expected in the fourth quarter", "image": "https://cdn.snapi.dev/images/v1/5/z/56848336-s-740x416.jpg", "site": "Invezz", "text": "Pfizer Inc. (NYSE: PFE) said on Tuesday that its profit in the fiscal fourth quarter came in weaker than expected. Revenue, on the other hand, topped analysts' estimates in Q4.", "url": "https://invezz.com/news/2021/02/02/pfizers-profit-comes-in-weaker-than-expected-in-the-fourth-quarter/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 09:06:16", "title": "Pfizer (PFE) Misses Q4 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/y/b/drugs27.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) delivered earnings and revenue surprises of -8.70% and 6.11%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/1255750/pfizer-pfe-misses-q4-earnings-estimates"}, {"symbol": "PFE", "publishedDate": "2021-02-02 08:08:04", "title": "Pfizer expects its COVID-19 vaccine to bring in about $15 billion in revenue this year", "image": "https://cdn.snapi.dev/images/v1/i/u/biotech16.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. were up 0.1% in premarket trading on Tuesday after the drugmaker said the COVID-19 vaccine it developed with BioNTech SE is expected to generate about $15 billion in sales in 2021. BioNTech's shares gained 0.6% in the premarket on Tuesday.", "url": "https://www.marketwatch.com/story/pfizer-expects-its-covid-19-vaccine-to-bring-in-about-15-billion-in-revenue-this-year-2021-02-02"}, {"symbol": "PFE", "publishedDate": "2021-02-02 07:13:16", "title": "Pfizer: Q4 Earnings Insights", "image": "https://cdn.snapi.dev/images/v1/l/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056782fvaccine-vials-with-stacks-of-cashjpgw700opresize.jpg", "site": "Benzinga", "text": "Shares of Pfizer (NYSE:PFE) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 23.64% over the past year to $0.42, which missed the estimate of $0.48.", "url": "https://www.benzinga.com/news/earnings/21/02/19438195/pfizer-q4-earnings-insights"}, {"symbol": "PFE", "publishedDate": "2021-02-02 07:05:34", "title": "Pfizer forecasts $15 billion in revenue from Covid vaccine in 2021", "image": "https://cdn.snapi.dev/images/v1/f/w/pfizer-forecasts-15-billion-in-revenue-from-covid-vaccine-in-2021.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell breaks down Pfizer's fourth-quarter earnings results and adjusted full-year guidance.", "url": "https://www.youtube.com/watch?v=Cc3j2Vtt-Ig"}, {"symbol": "PFE", "publishedDate": "2021-02-02 07:00:58", "title": "Pfizer stock slips after profit misses expectations, while revenue beats", "image": "https://cdn.snapi.dev/images/v1/8/a/drugs17.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. slipped 0.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that missed expectations, but revenue that beat forecasts and provided an upbeat full-year outlook. The company swung to net income of $594 million, or 10 cents a share, from a net loss of $337 million, or 6 cents a share, in the year-ago period.", "url": "https://www.marketwatch.com/story/pfizer-stock-slips-after-profit-misses-expectations-while-revenue-beats-2021-02-02"}, {"symbol": "PFE", "publishedDate": "2021-02-02 06:55:00", "title": "Pfizer sees about $15 billion in 2021 sales from COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/n/r/m02d20210202t2i1549981239w940fhfwllplsqrlynxmpeh110rn.jpg", "site": "Reuters", "text": "Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.", "url": "https://www.reuters.com/article/us-pfizer-results/pfizer-sees-about-15-billion-in-2021-sales-from-covid-19-vaccine-idUSKBN2A21EO"}, {"symbol": "PFE", "publishedDate": "2021-02-02 06:45:00", "title": "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS", "image": "https://cdn.snapi.dev/images/v1/j/q/press8---0ykjjaqvxl.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance(4) for Adjusted diluted EPS(2) and provided 2021 financial guidance(4) for other Adjusted(2) income statement line items, including details regarding the expected contributions to 2021 performance from BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine. EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: \u201c2020", "url": "https://www.businesswire.com/news/home/20210202005425/en/PFIZER-REPORTS-FOURTH-QUARTER-AND-FULL-YEAR-2020-RESULTS-AND-RELEASES-5-YEAR-PIPELINE-METRICS/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 06:02:00", "title": "Will Pfizer's Latest Bad News Wipe Out a Big Chunk of Its COVID Vaccine Profits?", "image": "https://cdn.snapi.dev/images/v1/1/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6107142fdollar-sign-blowing-awayjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's no need to panic at this point.", "url": "https://www.fool.com/investing/2021/02/02/will-pfizers-latest-bad-news-wipe-out-a-big-chunk/"}, {"symbol": "PFE", "publishedDate": "2021-02-02 05:01:15", "title": "7 Pharmaceutical Stocks\u00a0With\u00a0Compelling Pipelines", "image": "https://cdn.snapi.dev/images/v1/i/o/drugs16---a9qjqt4zsq.jpg", "site": "InvestorPlace", "text": "Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead. The post 7 Pharmaceutical Stocks\u00a0With\u00a0Compelling Pipelines appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/02/7-pharmaceutical-stocks-with-compelling-pipelines/"}, {"symbol": "PFE", "publishedDate": "2021-02-01 15:08:03", "title": "3 Reasons Pfizer Stock Will Have a Solid 2021", "image": "https://cdn.snapi.dev/images/v1/w/p/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg", "site": "InvestorPlace", "text": "The vaccine will be a key. But there are other growth drivers for Pfizer stock.", "url": "https://investorplace.com/2021/02/3-reasons-pfizer-stock-will-have-a-solid-2021/"}, {"symbol": "PFE", "publishedDate": "2021-02-01 13:15:35", "title": "Pfizer Earnings: What to Look For", "image": "https://cdn.snapi.dev/images/v1/v/8/pfizer-5bfc478746e0fb00512003ff.jpg", "site": "Investopedia", "text": "Pfizer (PFE) reports Q4 earnings on February 2. Can it reverse falling profits and revenue as it ramps up COVID-19 vaccine production?", "url": "https://www.investopedia.com/pfizer-q4-2020-earnings-5101080"}, {"symbol": "PFE", "publishedDate": "2021-02-01 12:27:00", "title": "BioNTech-Pfizer partnership pledges 75 million more vaccine doses to help ease the EU bloc's shortage", "image": "https://cdn.snapi.dev/images/v1/a/t/im-293084width620size15005861664712778.jpg", "site": "Market Watch", "text": "German chancellor Angela Merkel set to hold crisis talks on Monday to boost faltering vaccination program", "url": "https://www.marketwatch.com/story/biontech-pfizer-partnership-pledges-75-million-more-vaccine-doses-to-help-ease-the-eu-blocs-shortage-11612200465"}, {"symbol": "PFE", "publishedDate": "2021-02-01 12:07:32", "title": "Markets Await Economic and Earnings Data", "image": "https://cdn.snapi.dev/images/v1/q/t/catalog-mail6.jpg", "site": "Zacks Investment Research", "text": "Markets Await Economic and Earnings Data", "url": "https://www.zacks.com/stock/news/1255284/markets-await-economic-and-earnings-data"}, {"symbol": "PFE", "publishedDate": "2021-02-01 11:22:07", "title": "Another Big Week for Q4 Earnings, Econ News; ON Semi Beats", "image": "https://cdn.snapi.dev/images/v1/j/y/sp222.jpg", "site": "Zacks Investment Research", "text": "Q4 earnings season keeps going full-throttle this week, with lots of household names reporting quarterly earnings.", "url": "https://www.zacks.com/stock/news/1255258/another-big-week-for-q4-earnings-econ-news-on-semi-beats"}, {"symbol": "PFE", "publishedDate": "2021-02-01 11:22:05", "title": "Drug/Biotech Stock Earnings on Feb 2: AMGN, PFE & CTLT", "image": "https://cdn.snapi.dev/images/v1/o/q/drugs6---ph4uw7nsfg.jpg", "site": "Zacks Investment Research", "text": "Let us take a look at three drug/biotech companies, AMGN, PFE, CTLT, which are gearing up for their earnings release.", "url": "https://www.zacks.com/stock/news/1255266/drug-biotech-stock-earnings-on-feb-2-amgn-pfe-ctlt"}, {"symbol": "PFE", "publishedDate": "2021-02-01 10:06:38", "title": "Pfizer Earnings Preview", "image": "https://cdn.snapi.dev/images/v1/n/0/bp-ab837-pfizer-gr-20201130094221.jpg", "site": "Benzinga", "text": "Pfizer (NYSE:PFE) announces its next round of earnings this Tuesday, February 02. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement.", "url": "https://www.benzinga.com/news/earnings/21/02/19421365/pfizer-earnings-preview"}, {"symbol": "PFE", "publishedDate": "2021-02-01 06:15:00", "title": "3 Mega-Trends Healthcare Investors Should Watch Right Now", "image": "https://cdn.snapi.dev/images/v1/p/o/podc12---e9tn5vozmv.jpg", "site": "The Motley Fool", "text": "Companies working to bring us to the other side of the pandemic might be the biggest winners.", "url": "https://www.fool.com/investing/2021/02/01/3-mega-trends-healthcare-investors-should-watch-ri/"}, {"symbol": "PFE", "publishedDate": "2021-01-31 15:00:00", "title": "Amazon, Exxon Mobil, Pfizer, Alphabet, and Other Stocks to Watch This Week", "image": "https://cdn.snapi.dev/images/v1/n/q/im-289564.jpg", "site": "Barrons", "text": "It's another busy week for earnings, with results from Alphabet, Amazon, Alibaba, Electronic Arts, Exxon Mobil, Pfizer, T-Mobile, Ford, and many more. Plus, the January jobs report.", "url": "https://www.barrons.com/articles/amazon-exxon-mobil-pfizer-alphabet-and-other-stocks-for-investors-to-watch-this-week-51612123248"}, {"symbol": "PFE", "publishedDate": "2021-01-31 06:10:00", "title": "Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?", "image": "https://cdn.snapi.dev/images/v1/l/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6095432fvaccine-vials-with-stacks-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: It's complicated.", "url": "https://www.fool.com/investing/2021/01/31/can-johnson-johnson-beat-pfizer-and-moderna-in-the/"}, {"symbol": "PFE", "publishedDate": "2021-01-30 12:18:00", "title": "Sanofi Will Make Pfizer's Covid-19 Vaccine. Are More Partnerships Coming?", "image": "https://cdn.snapi.dev/images/v1/x/d/im-292828.jpg", "site": "Barrons", "text": "Other big firms with no Covid-19 vaccine of their own may plan on helping manufacture competitors' vaccines, analysts say.", "url": "https://www.barrons.com/articles/sanofi-will-make-pfizers-covid-19-vaccine-are-more-manufacturing-partnerships-coming-51612027097"}, {"symbol": "PFE", "publishedDate": "2021-01-30 06:55:00", "title": "Biden's Latest Move Just Handed the Vaccine Market to These 2 Companies", "image": "https://cdn.snapi.dev/images/v1/t/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6102532fgettyimages-1266401360jpgw700opresize.jpg", "site": "The Motley Fool", "text": "They can't vaccinate the whole world against COVID-19 -- but they may vaccinate all of the U.S.", "url": "https://www.fool.com/investing/2021/01/30/bidens-latest-move-just-handed-the-vaccine-market/"}, {"symbol": "PFE", "publishedDate": "2021-01-29 13:19:47", "title": "Now More Than Ever Why Pfizer Stock Is a Buy", "image": "https://cdn.snapi.dev/images/v1/h/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063592fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg", "site": "InvestorPlace", "text": "With 2020's proof in hand, it won't razzle dazzle Wall Street, but make no mistake, Pfizer stock can breathe life into investors portfolios The post Now More Than Ever Why Pfizer Stock Is a Buy appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner It doesn't matter if you have $500 in savings or $5 million.", "url": "https://investorplace.com/2021/01/now-more-than-ever-why-pfizer-stock-is-a-buy/"}, {"symbol": "PFE", "publishedDate": "2021-01-29 11:17:08", "title": "Personal Income Increased in December", "image": "https://cdn.snapi.dev/images/v1/j/2/biotech16.jpg", "site": "Zacks Investment Research", "text": "Personal Income Increased in December", "url": "https://www.zacks.com/stock/news/1254275/personal-income-increased-in-december"}, {"symbol": "PFE", "publishedDate": "2021-01-29 11:17:04", "title": "Pfizer's (PFE) Key Brands Likely to Drive Its Q4 Earnings", "image": "https://cdn.snapi.dev/images/v1/p/y/drugs37.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) Biopharma unit becomes the \"New Pfizer\" following the separation of the Upjohn unit. The Q4 announcement will the first quarterly result for the \"New Pfizer\".", "url": "https://www.zacks.com/stock/news/1254282/pfizers-pfe-key-brands-likely-to-drive-its-q4-earnings"}, {"symbol": "PFE", "publishedDate": "2021-01-29 07:23:00", "title": "Better Coronavirus Stock: Johnson & Johnson vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/w/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6100852fhypodermic-needles-syringe-drug-pharma-fmjsn7fjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Pfizer already is putting its COVID-19 vaccine into people's arms, while Johnson & Johnson's is waiting to be approved.", "url": "https://www.fool.com/investing/2021/01/29/better-coronavirus-stock-johnson-johnson-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2021-01-29 07:10:00", "title": "Here's What Investors Need to Know About Medical Diligence", "image": "https://cdn.snapi.dev/images/v1/p/o/podc11---rzremsdisv.jpg", "site": "The Motley Fool", "text": "In the healthcare industry, diligence is a matter of life and death. We're looking at you, Theranos.", "url": "https://www.fool.com/investing/2021/01/29/heres-what-investors-need-to-know-about-medical-di/"}, {"symbol": "PFE", "publishedDate": "2021-01-29 06:01:00", "title": "Look Out, Pfizer and Moderna: Here Comes Novavax", "image": "https://cdn.snapi.dev/images/v1/y/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6103912fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The small biotech just reported terrific news for its COVID-19 vaccine candidate.", "url": "https://www.fool.com/investing/2021/01/29/look-out-pfizer-and-moderna-here-comes-novavax/"}, {"symbol": "PFE", "publishedDate": "2021-01-28 07:16:04", "title": "Pfizer says its vaccine works against key mutations on the coronavirus variants found in South Africa and the UK", "image": "https://cdn.snapi.dev/images/v1/1/0/104685035-s-740x416.jpg", "site": "Business Insider", "text": "The COVID-19 vaccine co-developed by Pfizer and BioNTech works against lab-made coronaviruses that are similar to the variants found in the UK and South Africa, the drugmakers announced Wednesday. Studies conducted by Pfizer and the University of Texas showed \"small differences\" in how well antibodies produced by Pfizer's vaccine bound to and killed the lab-made viruses, compared to how well they worked against the original virus.", "url": "https://www.businessinsider.com/coronavirus-variants-vaccines-pfizer-mutations-south-africa-uk-study-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-28 06:28:27", "title": "Preliminary Study Finds Pfizer's COVID-19 Vaccine Effective Against UK, South Africa Variants", "image": "https://cdn.snapi.dev/images/v1/8/o/biotech5.jpg", "site": "Benzinga", "text": "Pfizer Inc PFE , in a preliminary lab study, found that its COVID-19 vaccine co-developed by BioNTech SE BNTX is effective against the new mutation variants found in the U.K. and South Africa, the Wall Street Journal reported.", "url": "https://www.benzinga.com/general/biotech/21/01/19363996/preliminary-study-finds-pfizers-covid-19-vaccine-effective-against-uk-south-africa-variants-wsj"}, {"symbol": "PFE", "publishedDate": "2021-01-28 06:10:00", "title": "Better Buy: Pfizer vs. BioNTech", "image": "https://cdn.snapi.dev/images/v1/l/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6095352fvaccine-vials-with-shopping-cartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock will be the bigger winner between these two COVID-19 vaccine partners?", "url": "https://www.fool.com/investing/2021/01/28/better-buy-pfizer-vs-biontech/"}, {"symbol": "PFE", "publishedDate": "2021-01-28 05:36:00", "title": "4 Stocks Warren Buffett Is Likely to Add to in 2021", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6095842fbuy-low-sell-high-stock-market-chart-investing-retirement-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Oracle of Omaha (and his investing team) might do a bit of shopping in the new year.", "url": "https://www.fool.com/investing/2021/01/28/4-stocks-warren-buffett-likely-to-add-to-in-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-28 02:24:00", "title": "Pfizer to continue vaccine supply to Italy even if Rome files lawsuit: CEO to paper", "image": "https://cdn.snapi.dev/images/v1/9/y/m02d20210128t2i1549350630w940fhfwllplsqrlynxmpeh0r0f4.jpg", "site": "Reuters", "text": "Pfizer will continue to supply its COVID-19 vaccine to Italy, respecting its agreement with the European Commission, even if Rome sues the company, the chief executive of the group's Italian unit said on Thursday.", "url": "https://www.reuters.com/article/us-health-coronavirus-italy-pfizer/pfizer-to-continue-vaccine-supply-to-italy-even-if-rome-files-lawsuit-ceo-to-paper-idUSKBN29X0PZ"}, {"symbol": "PFE", "publishedDate": "2021-01-27 09:47:11", "title": "Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?", "image": "https://cdn.snapi.dev/images/v1/0/r/drugs9.jpg", "site": "Zacks Investment Research", "text": "Higher sales of Pfizer's (PFE) key brands, Eliquis, Ibrance and Inlyta, and revenues from COVID-19 vaccine are likely to have driven sales in the fourth quarter.", "url": "https://www.zacks.com/stock/news/1252405/pfizer-pfe-to-report-q4-earnings-whats-in-the-cards"}, {"symbol": "PFE", "publishedDate": "2021-01-27 09:03:37", "title": "Sanofi to help produce doses of Pfizer-BioNTech Covid vaccine", "image": "https://cdn.snapi.dev/images/v1/m/z/sanofi-to-help-produce-doses-of-pfizer-biontech-covid-vaccine.jpg", "site": "CNBC International TV", "text": "CNBC's Charlotte Reed reports on Sanofi lending a hand to produce 125 million doses of the Pfizer-BioNTech Covid-19 vaccine after it suffered a setback in the development of its own vaccine.", "url": "https://www.youtube.com/watch?v=ZJSkQkhl5yc"}, {"symbol": "PFE", "publishedDate": "2021-01-27 08:21:28", "title": "The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF", "image": "https://cdn.snapi.dev/images/v1/v/l/medical4.jpg", "site": "InvestorPlace", "text": "One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.", "url": "https://investorplace.com/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf/"}, {"symbol": "PFE", "publishedDate": "2021-01-27 07:05:00", "title": "Is It Too Late to Get In On This Millionaire-Making Stock?", "image": "https://cdn.snapi.dev/images/v1/n/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6087402fgettyimages-506712124jpgw700opresize.jpg", "site": "The Motley Fool", "text": "While it's already made some people rich, Axsome Therapeutics is just getting started.", "url": "https://www.fool.com/investing/2021/01/27/is-it-too-late-to-get-in-on-this-millionaire-makin/"}, {"symbol": "PFE", "publishedDate": "2021-01-27 07:00:00", "title": "Sanofi teams up with BioNTech and Pfizer to help fix Europe's vaccine shortage", "image": "https://cdn.snapi.dev/images/v1/v/x/im-290958width620size15005861664712778.jpg", "site": "Market Watch", "text": "Unusual collaboration will see Sanofi supply more than 125 million doses of Pfizer\u2013BioNTech COVID shot from the summer.", "url": "https://www.marketwatch.com/story/sanofi-teams-up-with-biontech-and-pfizer-to-help-fix-europes-vaccine-shortage-11611748820"}, {"symbol": "PFE", "publishedDate": "2021-01-27 06:45:00", "title": "Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ\u00ae (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)", "image": "https://cdn.snapi.dev/images/v1/v/1/press14.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467). The primary objective of this study was to evaluate the safety of tofacitinib at two doses (5 mg twice daily and 10 mg twice daily) versus a TNF inhibitor (TNFi) in subjects with rheumatoid arthritis (RA) who were 50 years of age or older and had at least one additional cardiovascular (CV) risk f", "url": "https://www.businesswire.com/news/home/20210127005184/en/Pfizer-Shares-Co-Primary-Endpoint-Results-from-Post-Marketing-Required-Safety-Study-of-XELJANZ%C2%AE-tofacitinib-in-Subjects-with-Rheumatoid-Arthritis-RA/"}, {"symbol": "PFE", "publishedDate": "2021-01-27 05:43:13", "title": "Sweden is withholding vaccine payments to Pfizer as it suspects it is being overcharged", "image": "https://cdn.snapi.dev/images/v1/s/w/sweden-is-withholding-vaccine-payments-to-pfizer-as-it-suspects-it-is-being-overcharged.jpg", "site": "Business Insider", "text": "Sweden has said that it is withholding payment to the pharma giant Pfizer while it figures out if it is being overcharged for coronavirus vaccine doses. On Tuesday, the Dagens Nyheter newspaper reported that Sweden's health agency asked the European Union to ask Pfizer why it was being charged for six doses per vial of the Pfizer-BioNTech vaccine, despite only agreeing to pay for five.", "url": "https://www.businessinsider.com/sweden-suspends-pfizer-vaccine-payments-suspects-overcharged-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-26 18:49:23", "title": "Pfizer (PFE) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/q/o/drugs5.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $37.31, marking a +0.08% move from the previous day.", "url": "https://www.zacks.com/stock/news/1252075/pfizer-pfe-gains-as-market-dips-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-26 16:53:26", "title": "U.S. plans to buy 200 million Covid vaccine doses from Moderna and Pfizer", "image": "https://cdn.snapi.dev/images/v1/a/1/us-plans-to-buy-200-million-covid-vaccine-doses-from-moderna-and-pfizer.jpg", "site": "CNBC Television", "text": "Kayla Tausche reports the HHS will boost its vaccine supply to states from 8.6 million to a minimum of 10 million doses per week. States will now get a 3-week look ahead.", "url": "https://www.youtube.com/watch?v=xGibNpJCvCI"}, {"symbol": "PFE", "publishedDate": "2021-01-26 14:52:58", "title": "Pfizer Will Deliver Covid-19 Vaccines Much Sooner Than Expected", "image": "https://cdn.snapi.dev/images/v1/b/m/pfizer-will-deliver-covid-19-vaccines-much-sooner-than-expected.jpg", "site": "Forbes", "text": "But one syringe supplier said there may not be enough equipment to keep up with the pace of vaccines.", "url": "https://www.forbes.com/sites/roberthart/2021/01/26/pfizer-will-deliver-covid-19-vaccines-much-sooner-than-expected/"}, {"symbol": "PFE", "publishedDate": "2021-01-26 12:26:48", "title": "Pfizer will supply the US with 200 million COVID-19 vaccine doses 2 months sooner than expected due to 'extra' doses extracted from vials (PFE)", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-will-supply-the-us-with-200-million-covid-19-vaccine-doses-2-months-sooner-than-expected-due-to-extra-doses-extracted-from-vials.jpg", "site": "Business Insider", "text": "Pfizer will supply the US with 200 million doses of its coronavirus vaccine two months sooner than expected, according to the firm's chief executive. Pfizer CEO Albert Bourla said the US, which bought 200 million initial vaccine doses from the firm last year, will get the shipment two months earlier than expected after the FDA changed changed labels to account for \"extra doses\" in vials.", "url": "https://www.businessinsider.com/pfizer-to-supply-us-200-million-vaccines-months-sooner-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-26 11:25:04", "title": "Hold Your Pfizer Shares Despite Hiccups in Vaccine Rollout", "image": "https://cdn.snapi.dev/images/v1/m/p/biotech16.jpg", "site": "InvestorPlace", "text": "No need to let Covid-19 vaccine distribution issues deter you from owning Pfizer stock as the company still stands to earn massive revenues. The post Hold Your Pfizer Shares Despite Hiccups in Vaccine Rollout appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/hold-your-pfizer-stock-shares-despite-hiccups-in-vaccine-rollout/"}, {"symbol": "PFE", "publishedDate": "2021-01-26 10:32:04", "title": "Pfizer's (PFE) Bavencio Gets EU Nod for First-Line Bladder Cancer", "image": "https://cdn.snapi.dev/images/v1/x/g/drugs33.jpg", "site": "Zacks Investment Research", "text": "The European Commission approves Pfizer (PFE) and Merck KGaA's Bavencio as a monotherapy for first-line maintenance treatment in advanced/metastatic urothelial carcinoma.", "url": "https://www.zacks.com/stock/news/1251873/pfizers-pfe-bavencio-gets-eu-nod-for-first-line-bladder-cancer"}, {"symbol": "PFE", "publishedDate": "2021-01-26 08:45:00", "title": "Vaccine nationalism: Germany suggests EU should restrict the export of Pfizer's vaccine", "image": "https://cdn.snapi.dev/images/v1/5/5/im-290424width620size15005861664712778.jpg", "site": "Market Watch", "text": "With vaccination campaigns hindered by logistical blunders and industrial shortages, the blame game has started among European governments and industrialists.", "url": "https://www.marketwatch.com/story/vaccine-nationalism-germany-suggests-eu-should-restrict-the-export-of-pfizers-vaccine-11611668745"}, {"symbol": "PFE", "publishedDate": "2021-01-26 08:25:00", "title": "Are REITs Still A Good Investment?", "image": "https://cdn.snapi.dev/images/v1/e/7/reit23.jpg", "site": "Seeking Alpha", "text": "Are REITs Still A Good Investment?", "url": "https://seekingalpha.com/article/4400683-are-reits-still-good-investment"}, {"symbol": "PFE", "publishedDate": "2021-01-26 08:05:36", "title": "Pfizer and AstraZeneca take heat as vaccine delays threaten Europe's recovery", "image": "https://cdn.snapi.dev/images/v1/m/n/210126044405-astrazeneca-vials-0121-restricted-super-169.jpg", "site": "CNN Business", "text": "The European Union is calling out vaccine makers AstraZeneca and Pfizer over delivery delays that could slow its recovery from the pandemic. Officials are even threatening to introduce export controls on doses produced in the bloc as anger mounts.", "url": "https://www.cnn.com/2021/01/26/business/astrazeneca-pfizer-vaccine-delays-europe/index.html"}, {"symbol": "PFE", "publishedDate": "2021-01-26 07:30:15", "title": "Pfizer Faces a New Perception Risk You Shouldn't Ignore", "image": "https://cdn.snapi.dev/images/v1/i/f/drugs29.jpg", "site": "InvestorPlace", "text": "Pfizer stock was earlier a key benefactor from the coronavirus vaccine race, but a new perceptional risk is weighing on shares. The post Pfizer Faces a New Perception Risk You Shouldn't Ignore appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/pfizer-stock-faces-perception-risks/"}, {"symbol": "PFE", "publishedDate": "2021-01-26 06:45:00", "title": "Could Pfizer Be a Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/h/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6093872fgettyimages-956437954jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Recent guidance from the CEO suggests this stock will beat the market over the next decade.", "url": "https://www.fool.com/investing/2021/01/26/could-pfizer-be-a-millionaire-maker-stock/"}, {"symbol": "PFE", "publishedDate": "2021-01-26 06:12:00", "title": "3 Stocks Warren Buffett Would Love", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038332fsmiling-warren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "He's a stickler for predictable and recurring revenue.", "url": "https://www.fool.com/investing/2021/01/26/3-stocks-warren-buffett-would-love/"}, {"symbol": "PFE", "publishedDate": "2021-01-26 06:04:00", "title": "Why Pfizer Will Make More Money Than Originally Expected in 2021", "image": "https://cdn.snapi.dev/images/v1/u/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6095302fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The big drugmaker's coronavirus vaccine could deliver extra revenue.", "url": "https://www.fool.com/investing/2021/01/26/why-pfizer-will-make-more-money-than-originally-ex/"}, {"symbol": "PFE", "publishedDate": "2021-01-25 17:29:58", "title": "When the Travel Sector Is Set to Take Off", "image": "https://cdn.snapi.dev/images/v1/c/k/biotech38.jpg", "site": "InvestorPlace", "text": "The travel and hospitality industry is a sector that should thrive in 2021. In fact, travel is one of Eric Fry's four \"Power Trends\" in the new year.", "url": "https://investorplace.com/2021/01/the-travel-sector-is-set-to-take-off-once-vaccine-pessimism-goes-away/"}, {"symbol": "PFE", "publishedDate": "2021-01-25 13:32:36", "title": "Pfizer (PFE) to Supply 40M Doses of Coronavirus Vaccine to COVAX", "image": "https://cdn.snapi.dev/images/v1/a/l/biotech35---2ndysujmtu.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech inks an agreement with COVAX to supply up to 40 million doses of their COVID-19 vaccine, BNT162b2.", "url": "https://www.zacks.com/stock/news/1251482/pfizer-pfe-to-supply-40m-doses-of-coronavirus-vaccine-to-covax"}, {"symbol": "PFE", "publishedDate": "2021-01-25 11:46:15", "title": "Pfizer board member Gottlieb defends change to ship fewer Covid vaccine vials", "image": "https://cdn.snapi.dev/images/v1/u/9/105846845-1555007976919img-8995.jpg", "site": "CNBC", "text": "\"The bottom line here is that this is a very scarce resource. We need to make sure every dose gets used,\" Dr. Scott Gottlieb, who sits on the board of Pfizer, said.", "url": "https://www.cnbc.com/2021/01/25/pfizer-board-member-gottlieb-defends-move-to-ship-fewer-covid-vaccine-vials.html"}, {"symbol": "PFE", "publishedDate": "2021-01-25 09:30:15", "title": "Pfizer knew in summer Covid vaccine vials held six doses but filed as five doses to speed release, b", "image": "https://cdn.snapi.dev/images/v1/q/9/pfizer-knew-in-summer-covid-vaccine-vials-held-six-doses-but-filed-as-five-doses-to-speed-release-b.jpg", "site": "CNBC Television", "text": "Pfizer will now ship fewer vials of its coronavirus vaccine because it had previously shipped more doses than anticipated in its first traunche of distribution. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined \"Squawk Box\" on Monday to discuss.", "url": "https://www.youtube.com/watch?v=ph9DD-Z3Ygk"}, {"symbol": "PFE", "publishedDate": "2021-01-25 04:55:49", "title": "Dividend Stock Purchase: Lanny's December 2020 Summary", "image": "https://cdn.snapi.dev/images/v1/k/1/dividends-payment-768x432.jpg", "site": "Seeking Alpha", "text": "My dividend stock portfolio was burnt by dividend cuts in 2020 and lost over $800+ in forward dividend income. Therefore, I was ready to get back to basics and acquire more shares in the best quality dividend stocks out there. I make a weekly purchase of 3 shares into the Vanguard High Dividend Yield ETF. There were no special opportunities/large drops in the market, therefore I only bought on Mondays throughout December.", "url": "https://seekingalpha.com/article/4400721-dividend-stock-purchase-lannys-december-2020-summary"}, {"symbol": "PFE", "publishedDate": "2021-01-25 02:00:00", "title": "European Commission Approves BAVENCIO\u00ae (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma", "image": "https://cdn.snapi.dev/images/v1/d/f/press9---qvmuwgyjhd.jpg", "site": "PRNewsWire", "text": "ROCKLAND, Mass. and NEW YORK, Jan. 25, 2021 /PRNewswire/ -- EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved BAVENCIO\u00ae (avelumab) as monotherapy for...", "url": "https://www.prnewswire.com/news-releases/european-commission-approves-bavencio-avelumab-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301213683.html"}, {"symbol": "PFE", "publishedDate": "2021-01-25 01:57:43", "title": "Pfizer COVID-19 Vaccine Gets Approved In Australia", "image": "https://cdn.snapi.dev/images/v1/y/m/markus-spiske-dnbtfbnqlrc-unsplash-3.jpg", "site": "Benzinga", "text": "The COVID-19 vaccine made by Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) has been approved by Australia's Therapeutic Goods Administration, Reuters reported Monday (Sydney Time). What Happened: Inoculation of Pfizer's vaccine is likely to commence in late February at 80,000 doses per week, Australia's Health Minister Greg Hunt told reporters.", "url": "https://www.benzinga.com/general/biotech/21/01/19290633/pfizer-covid-19-vaccine-gets-approved-in-australia"}, {"symbol": "PFE", "publishedDate": "2021-01-24 14:30:00", "title": "Why Pfizer's Future Looks Better in 2021", "image": "https://cdn.snapi.dev/images/v1/p/o/podc4---hu5hhmjiv6.jpg", "site": "The Motley Fool", "text": "Several factors should work in the big drugmaker's favor this year.", "url": "https://www.fool.com/investing/2021/01/24/why-pfizers-future-looks-better-in-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-24 11:32:42", "title": "White House says U.S. states can't directly purchase Covid vaccine under emergency use authorization", "image": "https://cdn.snapi.dev/images/v1/1/0/106810418-1607785676560-ap20347485617712.jpg", "site": "CNBC", "text": "White House chief of staff Ron Klain said Sunday that he didn't think it was possible for states to purchase Covid-19 vaccines directly from manufacturers.", "url": "https://www.cnbc.com/2021/01/24/white-house-says-states-cant-purchase-covid-vaccine-directly.html"}, {"symbol": "PFE", "publishedDate": "2021-01-24 06:10:00", "title": "What Kind of Deals Is Pfizer Planning for the Next Few Years?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc7---7xdpkzksij.jpg", "site": "The Motley Fool", "text": "Pfizer CEO Albert Bourla knows what he wants.", "url": "https://www.fool.com/investing/2021/01/24/what-kind-of-deals-is-pfizer-planning-for-the-next/"}, {"symbol": "PFE", "publishedDate": "2021-01-23 06:08:00", "title": "Better Buy: Gilead Sciences vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/g/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6087782ftwo-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "One has a top COVID-19 treatment, the other has a top COVID-19 vaccine. Which stock will come out on top.", "url": "https://www.fool.com/investing/2021/01/23/better-buy-gilead-sciences-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2021-01-22 17:31:58", "title": "Pfizer says its Covid vaccine trial for kids ages 12 to 15 is fully enrolled", "image": "https://cdn.snapi.dev/images/v1/p/q/106807147-16073506982020-12-07t140913z-50319633-rc2eik99et8o-rtrmadp-0-health-coronavirus-usa-new-york-schools.jpeg", "site": "CNBC", "text": "Pfizer's Covid-19 vaccine is authorized for people age 16 and older. The company's trial in kids 12-15 is now fully enrolled, a key step for use in kids.", "url": "https://www.cnbc.com/2021/01/22/pfizer-says-its-covid-vaccine-trial-for-kids-ages-12-to-15-is-fully-enrolled.html"}, {"symbol": "PFE", "publishedDate": "2021-01-22 16:08:00", "title": "Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6094612fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg", "site": "The Motley Fool", "text": "Moderna and Pfizer/BioNTech should rake in similar levels of revenue for their vaccines.", "url": "https://www.fool.com/investing/2021/01/22/top-coronavirus-vaccine-makers-will-earn-up-to-23/"}, {"symbol": "PFE", "publishedDate": "2021-01-22 14:49:51", "title": "CDC quietly changes Covid vaccine guidance to OK mixing Pfizer and Moderna shots in 'exceptional situations'", "image": "https://cdn.snapi.dev/images/v1/5/8/106828724-1611340171521-gettyimages-1230600321-virus-vaccine-us.jpg", "site": "CNBC", "text": "The CDC says the two products are not interchangeable, but it added in updated guidance posted Thursday that it's OK to mix the shots in rare circumstances.", "url": "https://www.cnbc.com/2021/01/22/cdc-changes-covid-vaccine-guidance-to-ok-mixing-pfizer-and-moderna-shots-in-exceptional-si.html"}, {"symbol": "PFE", "publishedDate": "2021-01-22 14:05:55", "title": "Pfizer to supply up to 40 million doses of Covid vaccine to Covax global immunization program", "image": "https://cdn.snapi.dev/images/v1/x/s/106822051-1610357596966-gettyimages-1230517677-afp-8yh3ec.jpeg", "site": "CNBC", "text": "The Covax program aims to provide 2 billion doses of Covid-19 vaccines to participating countries, including poorer nations, by the end of this year.", "url": "https://www.cnbc.com/2021/01/22/pfizer-to-supply-40-million-covid-vaccine-doses-to-covax-global-immunization-program.html"}, {"symbol": "PFE", "publishedDate": "2021-01-22 13:01:55", "title": "Pfizer to supply up to 40 million doses to WHO-backed global Covid vaccine program", "image": "https://cdn.snapi.dev/images/v1/k/6/106822051-1610357596966-gettyimages-1230517677-afp-8yh3ec.jpeg", "site": "CNBC", "text": "", "url": "https://www.cnbc.com/2021/01/22/pfizer-to-supply-40-million-covid-v.html"}, {"symbol": "PFE", "publishedDate": "2021-01-22 12:15:58", "title": "BioNTech, Pfizer to sell 40 million doses to lower-income countries", "image": "https://cdn.snapi.dev/images/v1/r/x/biotech3.jpg", "site": "Market Watch", "text": "BioNTech SE and Pfizer Inc. said Friday that they plan to sell 40 million doses of their COVID-19 vaccine this year to Covax, a group that aims to ensure 92 lower-income countries have access to coronavirus vaccines. BioNTech's stock gained 1.2% in trading on Friday, while shares of Pfizer were up 0.3%.", "url": "https://www.marketwatch.com/story/biontech-pfizer-to-sell-40-million-doses-to-lower-income-countries-2021-01-22"}, {"symbol": "PFE", "publishedDate": "2021-01-22 08:16:00", "title": "Bill Ackman Pushes 3 Retailers to Get Directly Involved in U.S. Coronavirus Vaccine Drive", "image": "https://cdn.snapi.dev/images/v1/3/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6093832fmedical-professional-conferring-with-patient-located-in-the-drivers-seat-of-a-carjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The high-profile hedge fund manager feels that Target, Walmart, and Kroger could be a big help in getting Americans inoculated.", "url": "https://www.fool.com/investing/2021/01/22/bill-ackman-pushes-3-retailers-to-get-involved-in/"}, {"symbol": "PFE", "publishedDate": "2021-01-22 06:47:32", "title": "WHO Says Pfizer-BioNTech Covid-19 Vaccine Is Safe For The Elderly After Norway Questioned Its Role In Numerous Deaths", "image": "https://cdn.snapi.dev/images/v1/p/x/who-says-pfizer-biontech-covid-19-vaccine-is-safe-for-the-elderly-after-norway-questioned-its-role-in-numerous-deaths.jpg", "site": "Forbes", "text": "Norway's medicines authority said there might be a link between vaccination and the deaths of several elderly people.", "url": "https://www.forbes.com/sites/roberthart/2021/01/22/who-says-pfizer-biontech-covid-19-vaccine-is-safe-for-the-elderly-after-norway-questioned-its-role-in-numerous-deaths/"}, {"symbol": "PFE", "publishedDate": "2021-01-22 06:10:00", "title": "3 Warren Buffett Stocks That Should Be Surefire Winners in 2021", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6087742fsmiling-warren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The billionaire investor seems likely to add to his already impressive net worth with these stocks.", "url": "https://www.fool.com/investing/2021/01/22/3-warren-buffett-stocks-that-should-be-surefire-wi/"}, {"symbol": "PFE", "publishedDate": "2021-01-22 05:29:09", "title": "Pfizer and BioNTech will reportedly supply COVID-19 shots to COVAX, the WHO's vaccine scheme for poorer countries, following Biden's commitment to the program", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-and-biontech-will-reportedly-supply-covid-19-shots-to-covax-the-whos-vaccine-scheme-for-poorer-countries-following-bidens-commitment-to-the-program.jpg", "site": "Business Insider", "text": "Pfizer and BioNTech will supply COVID-19 vaccines to COVAX, the World Health Organization (WHO) scheme designed to share doses with poorer countries, two sources with knowledge of the matter told Reuters. The number of doses Pfizer and BioNTech share with the scheme would likely be relatively small, the sources said. One said the doses were mainly intended for healthcare workers.", "url": "https://www.businessinsider.com/pfizer-biontech-covid-19-vaccine-covax-who-world-health-organization-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-22 00:19:35", "title": "Pfizer, GSK-Backed ViiV First To Get FDA Approval For Injectable Drug To Treat HIV", "image": "https://cdn.snapi.dev/images/v1/1/b/diana-polekhina-epcfsdrgbsw-unsplash.jpg", "site": "Benzinga", "text": "In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has received the approval of the United States Food and Drug Administration. What Happened: The injectable \u2014 Cabenuva \u2014 is designed to replace the current treatment of HIV in adults which is based on taking daily pills.", "url": "https://www.benzinga.com/general/biotech/21/01/19268509/pfizer-gsk-backed-viiv-first-to-get-fda-approval-for-injectable-drug-to-treat-hiv"}, {"symbol": "PFE", "publishedDate": "2021-01-21 19:15:00", "title": "Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program", "image": "https://cdn.snapi.dev/images/v1/0/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6093372fbiotech-laboratory-work-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The partners could supply the WHO with coronavirus vaccine doses for lower-income countries.", "url": "https://www.fool.com/investing/2021/01/21/pfizer-and-biontech-to-supply-whos-covid-19-vaccin/"}, {"symbol": "PFE", "publishedDate": "2021-01-21 16:50:52", "title": "For Pfizer, the Covid-19 Vaccine \u2018Honeymoon' Is Over", "image": "https://cdn.snapi.dev/images/v1/r/5/104685035-s-740x416.jpg", "site": "InvestorPlace", "text": "PFE stock never enjoyed the same run-up in the Covid-19 vaccine race as its competitors, even though it crossed the finish line first. The post For Pfizer, the Covid-19 Vaccine \u2018Honeymoon' Is Over appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/pfe-stock-for-pfizer-the-covid-19-vaccine-honeymoon-is-over/"}, {"symbol": "PFE", "publishedDate": "2021-01-21 12:09:12", "title": "Ignore the Bears and Invest in Pfizer", "image": "https://cdn.snapi.dev/images/v1/i/c/drugs42.jpg", "site": "InvestorPlace", "text": "Pfizer stock has been struggling mainly due to misapprehensions surrounding the company's Covid-19 vaccine and the depth of its portfolio. The post Ignore the Bears and Invest in Pfizer appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/ignore-the-bears-and-invest-in-pfizer-stock/"}, {"symbol": "PFE", "publishedDate": "2021-01-21 11:18:26", "title": "Pfizer (PFE) COVID-19 Vaccine Seems Potent Against UK Strain", "image": "https://cdn.snapi.dev/images/v1/j/t/biotech27.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and partner BioNTech announce data from an in-vitro study showing that their coronavirus vaccine holds potential for neutralization of the new strain of coronavirus that was found in the United Kingdom.", "url": "https://www.zacks.com/stock/news/1249841/pfizer-pfe-covid-19-vaccine-seems-potent-against-uk-strain"}, {"symbol": "PFE", "publishedDate": "2021-01-21 06:09:00", "title": "3 COVID Stocks to Buy if You're Not a Big Risk-Taker", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079162fsticky-note-showing-coronavirus-with-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These stocks won't keep you up at night.", "url": "https://www.fool.com/investing/2021/01/21/3-covid-stocks-to-buy-if-youre-not-a-big-risk-take/"}, {"symbol": "PFE", "publishedDate": "2021-01-20 18:48:16", "title": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/g/p/drugs33---7nt6foacms.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed at $36.50 in the latest trading session, marking a -0.63% move from the prior day.", "url": "https://www.zacks.com/stock/news/1249444/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-20 16:22:00", "title": "Pfizer and BioNTech Report Evidence That Their Vaccine Is Effective Against COVID-19 Variant", "image": "https://cdn.snapi.dev/images/v1/9/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6091252fgettyimages-1267929704jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A new study bolsters confidence in the mRNA vaccine.", "url": "https://www.fool.com/investing/2021/01/20/pfizer-and-biontech-report-evidence-that-vaccine-i/"}, {"symbol": "PFE", "publishedDate": "2021-01-20 11:52:55", "title": "Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today", "image": "https://cdn.snapi.dev/images/v1/p/s/drugs25.jpg", "site": "InvestorPlace", "text": "Covid-19 pharma stocks like NVAX stock and BNTX stock are making headlines as Joe Biden promises to vaccinate 100 million Americans. The post Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock/"}, {"symbol": "PFE", "publishedDate": "2021-01-20 10:46:20", "title": "Pfizer-BioNTech Vaccine Found Effective Against New Coronavirus Strain In Lab Study", "image": "https://cdn.snapi.dev/images/v1/e/f/pfizerbiontechlab.png", "site": "Benzinga", "text": "The coronavirus vaccine developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE \u2013 ADR (NASDAQ: BNTX) works against a\u00a0new strain of coronavirus that appeared in the U.K., according to a preprint made available before publication. What Happened: The B.1.1.7 strain\u00a0is unlikely to escape BNT162b2-mediated protection, according to the preprint.", "url": "https://www.benzinga.com/general/biotech/21/01/19233661/pfizer-biontech-vaccine-found-effective-against-new-coronavirus-strain-in-lab-study"}, {"symbol": "PFE", "publishedDate": "2021-01-20 09:00:43", "title": "10 Dividend Growth Stocks For January 2021", "image": "https://cdn.snapi.dev/images/v1/l/q/utilities15.jpg", "site": "Seeking Alpha", "text": "10 Dividend Growth Stocks For January 2021", "url": "https://seekingalpha.com/article/4399843-10-dividend-growth-stocks-for-january-2021"}, {"symbol": "PFE", "publishedDate": "2021-01-20 08:33:00", "title": "My Best SaaS Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/q/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6085882fgettyimages-1185375168jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Veeva Systems could double its annual revenue over the next four years.", "url": "https://www.fool.com/investing/2021/01/20/my-best-saas-stock-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-20 07:38:00", "title": "Is It Too Late for Oil Stocks?", "image": "https://cdn.snapi.dev/images/v1/w/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6083662frigjpgw700opresize.jpg", "site": "The Motley Fool", "text": "High dividend yields backed by low debt is the best way to approach this risky sector.", "url": "https://www.fool.com/investing/2021/01/20/is-it-too-late-for-oil-stocks/"}, {"symbol": "PFE", "publishedDate": "2021-01-20 05:30:56", "title": "Pfizer-BioNTech vaccine found to be effective against Covid variant discovered in the UK", "image": "https://cdn.snapi.dev/images/v1/8/t/106825225-1610724539531-gettyimages-1230596211-afp-8yt9je.jpeg", "site": "CNBC", "text": "The Covid vaccine developed by Pfizer-BioNTech is likely to be effective against a mutant strain of the virus that was first discovered in the U.K.", "url": "https://www.cnbc.com/2021/01/20/covid-pfizer-biontech-vaccine-likely-to-be-effective-against-uk-variant.html"}, {"symbol": "PFE", "publishedDate": "2021-01-19 09:05:12", "title": "Invest Like A Billionaire With High Yield: THW", "image": "https://cdn.snapi.dev/images/v1/m/g/drugs10---qzacpqqvmc.jpg", "site": "Seeking Alpha", "text": "Invest Like A Billionaire With High Yield: THW", "url": "https://seekingalpha.com/article/4399114-invest-like-billionaire-high-yield-thw"}, {"symbol": "PFE", "publishedDate": "2021-01-19 08:53:00", "title": "Where Will Pfizer Be in 5 Years?", "image": "https://cdn.snapi.dev/images/v1/w/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6087352flife-science-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "What's in store for America's biggest pharmaceutical company and its shareholders?", "url": "https://www.fool.com/investing/2021/01/19/where-will-pfizer-be-in-5-years/"}, {"symbol": "PFE", "publishedDate": "2021-01-18 23:02:59", "title": "Cuomo Asks Pfizer To Let New York Purchase COVID-19 Vaccine Directly", "image": "https://cdn.snapi.dev/images/v1/4/7/daniel-schludi-magznecmcug-unsplash-2.jpg", "site": "Benzinga", "text": "New York Governor Andrew Cuomo asked Pfizer Inc (NYSE: PFE) to sell its COVID-19 vaccine directly to New York in a letter on Monday. What Happened: The governor wrote to the New York-based pharmaceutical giant's CEO Albert Bourla as Pfizer is not bound by supply commitments that rival Moderna Inc (NASDAQ: MRNA) has made under Operation Warp Speed \u2014 the federal government's vaccine initiative.", "url": "https://www.benzinga.com/general/biotech/21/01/19207572/cuomo-asks-pfizer-to-let-new-york-purchase-covid-19-vaccine-directly"}, {"symbol": "PFE", "publishedDate": "2021-01-18 21:40:16", "title": "Biden Covid advisor challenges Cuomo's letter to buy vaccine directly from Pfizer", "image": "https://cdn.snapi.dev/images/v1/p/o/106436592-1583931388419gounder.jpg", "site": "CNBC", "text": "Biden's Covid Advisory Board member Dr. Celine Gounder said that Cuomo's request to buy the Pfizer vaccine directly, could cause more problems than it solves.", "url": "https://www.cnbc.com/2021/01/19/biden-covid-advisor-challenges-cuomos-letter-to-buy-vaccine-directly.html"}, {"symbol": "PFE", "publishedDate": "2021-01-18 20:41:18", "title": "Cuomo asked Pfizer to sell its COVID-19 vaccine directly to New York, just as the head of the WHO warns of mounting inequities in vaccine distribution", "image": "https://cdn.snapi.dev/images/v1/c/u/cuomo-asked-pfizer-to-sell-its-covid-19-vaccine-directly-to-new-york-just-as-the-head-of-the-who-warns-of-mounting-inequities-in-vaccine-distribution.jpg", "site": "Business Insider", "text": "New York Gov. Andrew Cuomo called on pharmaceutical company Pfizer to sell doses of its coronavirus vaccine directly to New York state, in the hopes of accelerating a process that has languished in recent weeks. The request would require Pfizer to circumvent the federal government's Operation Warp Speed \u2014 a campaign to produce and distribute some 300 million doses to Americans in an effort to end the pandemic \u2014 and deal directly with Cuomo's state administration.", "url": "https://www.businessinsider.com/new-york-gov-cuomo-asks-pfizer-sell-vaccine-to-ny-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-18 13:41:18", "title": "New York Gov. Cuomo asks to buy Covid vaccine directly from Pfizer amid dose shortages", "image": "https://cdn.snapi.dev/images/v1/i/3/106797280-16055309142020-11-15t165030z-2065037913-rc2s3k9fkiis-rtrmadp-0-health-coronavirus-usa-new-york.jpeg", "site": "CNBC", "text": "The request comes after an alarmingly slow start to the national vaccine rollout, with the country millions of injections short of initial projections.", "url": "https://www.cnbc.com/2021/01/18/covid-vaccine-new-york-gov-cuomo-asks-to-buy-directly-from-pfizer.html"}, {"symbol": "PFE", "publishedDate": "2021-01-16 07:56:00", "title": "Can the Pfizer and Moderna Vaccines Beat the New Coronavirus Strains?", "image": "https://cdn.snapi.dev/images/v1/t/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6085962fgettyimages-1293882481jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Two mRNA COVID vaccines aced clinical trials. Now new virus variants are putting them to the test.", "url": "https://www.fool.com/investing/2021/01/16/can-the-pfizer-and-moderna-vaccines-beat-the-new-c/"}, {"symbol": "PFE", "publishedDate": "2021-01-16 06:09:00", "title": "3 Fantastic Coronavirus Vaccine Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079112flight-bulb-with-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Each has more to offer than just a COVID-19 vaccine.", "url": "https://www.fool.com/investing/2021/01/16/3-fantastic-coronavirus-vaccine-stocks-to-buy-righ/"}, {"symbol": "PFE", "publishedDate": "2021-01-15 13:46:52", "title": "Why Pfizer Is a Long-Term Investor's Friend", "image": "https://cdn.snapi.dev/images/v1/o/q/drugs2.jpg", "site": "InvestorPlace", "text": "Pfizer stock has a lot to offer, including a nifty dividend and focus on the future that give confidence to many conservative investors. The post Why Pfizer Is a Long-Term Investor's Friend appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/pfe-pfizer-stock-long-term-investors-friend/"}, {"symbol": "PFE", "publishedDate": "2021-01-15 13:43:59", "title": "Final Trades: Pfizer, Devon Energy, Zimmer & more", "image": "https://cdn.snapi.dev/images/v1/9/f/final-trades-pfizer-devon-energy-zimmer-more.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top picks to watch for the second half.", "url": "https://www.youtube.com/watch?v=gj9q6pjiSrE"}, {"symbol": "PFE", "publishedDate": "2021-01-15 09:02:03", "title": "Pfizer's (PFE) Xalkori Gets FDA Nod for Rare Lymphoma in Kids", "image": "https://cdn.snapi.dev/images/v1/a/h/drugs47.jpg", "site": "Zacks Investment Research", "text": "FDA approves Pfizer's (PFE) Xalkori for relapsed or refractory ALK-positive anaplastic large cell lymphoma, a rare form of non-Hodgkin lymphoma (NHL), in pediatric patients and young adults.", "url": "https://www.zacks.com/stock/news/1247198/pfizers-pfe-xalkori-gets-fda-nod-for-rare-lymphoma-in-kids"}, {"symbol": "PFE", "publishedDate": "2021-01-15 08:16:54", "title": "Pfizer to temporarily reduce Covid vaccine deliveries to Europe", "image": "https://cdn.snapi.dev/images/v1/v/q/106814129-1608533111793-gettyimages-1292266587-l1060455.jpeg", "site": "CNBC", "text": "Pfizer will temporarily reduce the number of doses of its coronavirus vaccine being delivered to Europe, according to the Norwegian Institute of Public Health.", "url": "https://www.cnbc.com/2021/01/15/pfizer-to-temporarily-reduce-covid-vaccine-deliveries-to-europe.html"}, {"symbol": "PFE", "publishedDate": "2021-01-15 06:08:00", "title": "Is Pfizer Stock a Buy?", "image": "https://cdn.snapi.dev/images/v1/n/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079102fquestion-mark-with-stock-chartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't focus on the big drugmaker's past. Look to the future.", "url": "https://www.fool.com/investing/2021/01/15/is-pfizer-stock-a-buy/"}, {"symbol": "PFE", "publishedDate": "2021-01-14 16:30:00", "title": "Pfizer's XALKORI\u00ae (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults", "image": "https://cdn.snapi.dev/images/v1/8/l/press18---oxtafj0ey0.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI\u00ae (crizotinib) for the treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is anaplastic lymphoma kinase (ALK)-positive. The safety and efficacy of XALKORI have not been established in older adults with relapsed or re", "url": "https://www.businesswire.com/news/home/20210114006005/en/Pfizer%E2%80%99s-XALKORI%C2%AE-crizotinib-Approved-by-FDA-for-ALK-positive-Anaplastic-Large-Cell-Lymphoma-in-Children-and-Young-Adults/"}, {"symbol": "PFE", "publishedDate": "2021-01-14 10:39:28", "title": "A Dividend Investor's Guide To 2021: The Cure To Uncertain Times", "image": "https://cdn.snapi.dev/images/v1/x/z/etf33-21.jpg", "site": "Seeking Alpha", "text": "Year 2020 was wild, and left many important threats for 2021. I will summarize the key threats I see, and offer my approach to the markets.", "url": "https://seekingalpha.com/article/4398925-dividend-investors-guide-to-2021-cure-to-uncertain-times"}, {"symbol": "PFE", "publishedDate": "2021-01-13 18:48:20", "title": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/a/5/drugs32.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $36.86, marking a -0.86% move from the previous day.", "url": "https://www.zacks.com/stock/news/1246288/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-13 14:51:59", "title": "7 Pharmaceutical Stocks With Exciting Plans for 2021", "image": "https://cdn.snapi.dev/images/v1/o/f/drugs28.jpg", "site": "InvestorPlace", "text": "Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.", "url": "https://investorplace.com/2021/01/7-pharmaceutical-stocks-with-exciting-plans-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-12 18:48:18", "title": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/b/9/drugs20.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $37.18, moving -1.56% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1245459/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-12 16:19:04", "title": "Pfizer Inc. (PFE) CEO Albert Bourla Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/g/0/transcript43---rbwn0z4d7j.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4398621-pfizer-inc-pfe-ceo-albert-bourla-presents-39th-annual-jpmorgan-healthcare-conference"}, {"symbol": "PFE", "publishedDate": "2021-01-12 14:18:11", "title": "A Guide to Biotech ETF Investing Amid the Coronavirus Crisis", "image": "https://cdn.snapi.dev/images/v1/y/3/etf42.jpg", "site": "Zacks Investment Research", "text": "The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.", "url": "https://www.zacks.com/stock/news/1245417/a-guide-to-biotech-etf-investing-amid-the-coronavirus-crisis"}, {"symbol": "PFE", "publishedDate": "2021-01-12 12:39:26", "title": "Pfizer, BioNTech Boost Vaccine Production Goal To 2 Billion Doses In 2021", "image": "https://cdn.snapi.dev/images/v1/l/q/pfizer-biontech-boost-vaccine-production-goal-to-2-billion-doses-in-2021.jpg", "site": "Forbes", "text": "The companies also expect to apply their mRNA vaccine technology to other diseases, such as flu.", "url": "https://www.forbes.com/sites/katiejennings/2021/01/12/pfizer-biontech-boost-vaccine-production-goal-to-2-billion-doses-in-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-12 11:32:16", "title": "Even In This Market, There Are Better Choices Than Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/d/o/drugs11.jpg", "site": "InvestorPlace", "text": "A smaller, nimbler, Pfizer is supposed to drive growth. But there are real strategic questions, leaving PFE stock cheap for good reason.", "url": "https://investorplace.com/2021/01/better-choices-than-pfe-stock/"}, {"symbol": "PFE", "publishedDate": "2021-01-12 11:28:44", "title": "Pfizer's earnings outlook for 2021 tops expectations, but stock falls", "image": "https://cdn.snapi.dev/images/v1/b/a/104685035-s-740x416.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. dropped 2.1% in morning trading Tuesday, even after the drug maker provided an upbeat earnings outlook for this year. Speaking at the J.P.", "url": "https://www.marketwatch.com/story/pfizers-earnings-outlook-for-2021-tops-expectations-but-stock-falls-2021-01-12"}, {"symbol": "PFE", "publishedDate": "2021-01-12 11:17:17", "title": "Covid-19 Vaccinations Promise to Ramp Up", "image": "https://cdn.snapi.dev/images/v1/0/n/biotech29.jpg", "site": "Zacks Investment Research", "text": "Guidance for the end of 2020 was to have 20 million Americans with the first half of the two-injection immunization treatment; as of now, only around 9 million Americans have received the first dose.", "url": "https://www.zacks.com/stock/news/1245166/covid-19-vaccinations-promise-to-ramp-up"}, {"symbol": "PFE", "publishedDate": "2021-01-12 11:17:11", "title": "COVID-19 Vaccine Production to Ramp Up", "image": "https://cdn.snapi.dev/images/v1/s/j/eu-drug-regulator-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use.jpg", "site": "Zacks Investment Research", "text": "COVID-19 Vaccine Production to Ramp Up", "url": "https://www.zacks.com/stock/news/1245186/covid-19-vaccine-production-to-ramp-up"}, {"symbol": "PFE", "publishedDate": "2021-01-12 11:01:46", "title": "Pfizer CEO supports expanding Covid vaccine eligibility, describes supply of doses as adequate", "image": "https://cdn.snapi.dev/images/v1/u/9/106635982-1604927371759-106635982-1595948992117-gettyimages-1132313750-wm2-7799-20190226114402859.jpg", "site": "CNBC", "text": "\"I think the main bottleneck right now is to make sure we ramp up our prioritization so we can administer more vaccines,\" Pfizer CEO Albert Bourla told CNBC.", "url": "https://www.cnbc.com/2021/01/12/pfizer-ceo-albert-bourla-supports-expanding-covid-vaccine-eligibility.html"}, {"symbol": "PFE", "publishedDate": "2021-01-12 10:44:00", "title": "Pfizer forecasts 2021 earnings of $3 to $3.10 per share", "image": "https://cdn.snapi.dev/images/v1/1/n/m02d20210112t2i1547507217w940fhfwllplsqrlynxmpeh0b13n.jpg", "site": "Reuters", "text": "Pfizer Inc expects 2021 earnings of between $3 and $3.10 per share, Chief Executive Officer Albert Bourla said at a J.P. Morgan healthcare conference on Tuesday.", "url": "https://www.reuters.com/article/us-pfizer-outlook/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share-idUSKBN29H248"}, {"symbol": "PFE", "publishedDate": "2021-01-12 09:37:42", "title": "Pfizer CEO Albert Bourla on Covid vaccine manufacturing outlook", "image": "https://cdn.snapi.dev/images/v1/v/w/pfizer-ceo-albert-bourla-on-covid-vaccine-manufacturing-outlook.jpg", "site": "CNBC Television", "text": "Pfizer CEO Albert Bourla told CNBC's \"Squawk Box\" Tuesday that the company plans to increase coronavirus vaccine production this year, with a goal of manufacturing up to two billion doses.", "url": "https://www.youtube.com/watch?v=ixHzHhM3qDE"}, {"symbol": "PFE", "publishedDate": "2021-01-12 09:31:00", "title": "Should You Really Invest in Pfizer Stock in 2021?", "image": "https://cdn.snapi.dev/images/v1/v/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6079642fcovid-19-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Why chasing trends may not always be a good idea.", "url": "https://www.fool.com/investing/2021/01/12/should-you-really-invest-in-pfizer-stock-in-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-12 06:45:00", "title": "Pfizer Invests $120 Million in Biotechnology Innovation Through the Pfizer Breakthrough Growth Initiative", "image": "https://cdn.snapi.dev/images/v1/h/2/press4---frqodvysqn.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the Pfizer Breakthrough Growth Initiative (PBGI). Through PBGI, Pfizer is investing up to $500 million in biotechnology companies, providing funding and access to Pfizer's scientific expertise to help ensure the continuity of promising clinical development programs of potential future strategic interest t", "url": "https://www.businesswire.com/news/home/20210112005304/en/Pfizer-Invests-120-Million-in-Biotechnology-Innovation-Through-the-Pfizer-Breakthrough-Growth-Initiative/"}, {"symbol": "PFE", "publishedDate": "2021-01-12 05:21:18", "title": "7 Blue-Chip Stocks For A Steady-Eddie 2021", "image": "https://cdn.snapi.dev/images/v1/z/d/aero3.jpg", "site": "InvestorPlace", "text": "For those looking for a steady ride in 2021, today's selection suggests seven blue-chip stocks for consideration in long-term portfolios. The post 7 Blue-Chip Stocks For A Steady-Eddie 2021 appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/7-blue-chip-stocks-for-a-steady-eddie-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-11 19:35:28", "title": "Biden gets second dose of Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/b/a/biden-gets-second-dose-of-pfizer-vaccine.jpg", "site": "CNBC Television", "text": "President-elect Joe Biden got his second shot of the Pfizer Covid-19 vaccine today.", "url": "https://www.youtube.com/watch?v=OK0ZDrJFZhs"}, {"symbol": "PFE", "publishedDate": "2021-01-11 18:48:14", "title": "Pfizer (PFE) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/a/t/drugs3.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $37.77, moving +1.72% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1244744/pfizer-pfe-gains-as-market-dips-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-11 18:05:52", "title": "Apple And Nvidia Among Trending Stocks Rated Top Buy This Week", "image": "https://cdn.snapi.dev/images/v1/4/9/apple-and-nvidia-among-trending-stocks-rated-top-buy-this-week.jpg", "site": "Forbes", "text": "We have a very interesting week ahead full of earnings reports and news. But time will tell what will happen.", "url": "https://www.forbes.com/sites/qai/2021/01/11/apple-and-nvidia-among-trending-stocks-rated-top-buy-this-week/"}, {"symbol": "PFE", "publishedDate": "2021-01-11 17:05:31", "title": "Healthcare Stocks: How AI Is Helping in the Fight Against COVID-19", "image": "https://cdn.snapi.dev/images/v1/z/r/drug1.jpg", "site": "InvestorPlace", "text": "There's a lot of potential in the healthcare space thanks to new technologies, and we believe that we have found the best high-quality stocks to play the massive upside. The post Healthcare Stocks: How AI Is Helping in the Fight Against COVID-19 appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/healthcare-stocks-how-ai-is-helping-fight-covid-19/"}, {"symbol": "PFE", "publishedDate": "2021-01-11 15:02:06", "title": "4 Reasons for Bank ETFs to Win in 2021", "image": "https://cdn.snapi.dev/images/v1/z/d/drugs48.jpg", "site": "Zacks Investment Research", "text": "Bank ETFs should stay strong in the coming days on the back of cheaper valuation, Fed's signal for buybacks, Democrat's control over Senate and spike in bond yields.", "url": "https://www.zacks.com/stock/news/1244700/4-reasons-for-bank-etfs-to-win-in-2021"}, {"symbol": "PFE", "publishedDate": "2021-01-11 12:29:00", "title": "BioNTech CEO Says a Version of Its Covid Vaccine With Less Stringent Storage Requirements Could Come This Year", "image": "https://cdn.snapi.dev/images/v1/f/g/im-283485.jpg", "site": "Barrons", "text": "Success would help Pfizer and BioNTech compete longer term with J&J and Novavax, whose vaccines don't have the same temperature restrictions.", "url": "https://www.barrons.com/articles/biontech-ceo-says-a-version-of-its-covid-vaccine-with-less-stringent-storage-requirements-could-come-this-year-51610386171"}, {"symbol": "PFE", "publishedDate": "2021-01-11 12:02:11", "title": "Futures Down as Investors Weigh Covid-19 Cases Against Vaccines", "image": "https://cdn.snapi.dev/images/v1/6/s/drugs43.jpg", "site": "Zacks Investment Research", "text": "Futures Down as Investors Weigh Covid-19 Cases Against Vaccines", "url": "https://www.zacks.com/stock/news/1244486/futures-down-as-investors-weigh-covid-19-cases-against-vaccines"}, {"symbol": "PFE", "publishedDate": "2021-01-11 11:17:06", "title": "Racing Against Time: Covid-19 vs. Vaccines", "image": "https://cdn.snapi.dev/images/v1/o/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047732fgloved-hands-holding-2-covid-vaccine-bottlesjpgw700opresize.jpg", "site": "Zacks Investment Research", "text": "This past Friday brought the U.S. its largest single-day amount of Covid-19 cases since the pandemic began in earnest back in March of last year: 310K in a single 24-hour period.", "url": "https://www.zacks.com/stock/news/1244459/racing-against-time-covid-19-vs-vaccines"}, {"symbol": "PFE", "publishedDate": "2021-01-11 10:32:35", "title": "NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening", "image": "https://cdn.snapi.dev/images/v1/a/t/drugs38.jpg", "site": "InvestorPlace", "text": "Phase 3 trial delays are pushing NVAX stock down, but the biotech still has a reliable vaccine candidate expected to generate $3.9 billion. The post NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/nvax-stock-is-worth-a-small-position-but-vaccine-race-is-tightening/"}, {"symbol": "PFE", "publishedDate": "2021-01-11 09:16:01", "title": "BioNTech says Covid vaccine is effective against key new strains; to publish more data in days", "image": "https://cdn.snapi.dev/images/v1/u/d/106822175-1610372170765-gettyimages-1230257842-20090101201222-99-783760.jpeg", "site": "CNBC", "text": "Public health experts have expressed concern the new mutant strains could pose a threat to inoculation efforts.", "url": "https://www.cnbc.com/2021/01/11/covid-biontech-ceo-says-vaccine-is-effective-against-new-strains.html"}, {"symbol": "PFE", "publishedDate": "2021-01-11 07:31:26", "title": "BioNTech CEO: Pfizer-BioNTech vaccine effective against strains in UK, South Africa", "image": "https://cdn.snapi.dev/images/v1/n/j/biontech-ceo-pfizer-biontech-vaccine-effective-against-strains-in-uk-south-africa.jpg", "site": "CNBC Television", "text": "BioNTech CEO Ugur Sahin joined \"Squawk Box\" on Monday to discuss how effective the Pfizer-BioNTech's coronavirus vaccine is at protecting against the variants of the virus researchers have documented in South Africa and the United Kingdom.", "url": "https://www.youtube.com/watch?v=w64kyMP6y8k"}, {"symbol": "PFE", "publishedDate": "2021-01-11 06:08:00", "title": "Your 3 Best Profit Opportunities in 2021", "image": "https://cdn.snapi.dev/images/v1/j/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063052fgettyimages-1184416505jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Add these top growth stocks to your portfolio before it's too late.", "url": "https://www.fool.com/investing/2021/01/11/your-3-best-profit-opportunities-in-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-10 10:50:58", "title": "Got $600? Investors Are Buying Stock In Tesla, Nio And Pfizer With Stimulus Checks", "image": "https://cdn.snapi.dev/images/v1/2/b/tesla-made-in-china-model-3-1-1.jpg", "site": "Benzinga", "text": "Every week, Benzinga conducts a survey to collect sentiment on what traders are most excited about,\u00a0interested in\u00a0or thinking about when they are managing and building their personal portfolios. This week we posed the following question related to how traders and investors plan to use their stimulus money:", "url": "https://www.benzinga.com/trading-ideas/long-ideas/21/01/19091666/got-600-investors-are-buying-stock-in-tesla-nio-and-pfizer-with-stimulus-checks"}, {"symbol": "PFE", "publishedDate": "2021-01-10 07:06:00", "title": "My Best Coronavirus Vaccine Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/l/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6075312fgettyimages-1251442245jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Can this winner keep on succeeding?", "url": "https://www.fool.com/investing/2021/01/10/my-best-coronavirus-vaccine-stock-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-09 08:29:00", "title": "These Were the 5 Best Diagnostics Stocks of 2020", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6077462flaboratory-e2rkdkhjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These winners are positioned for gains even after COVID.", "url": "https://www.fool.com/investing/2021/01/09/these-were-the-5-best-diagnostics-stocks-of-2020/"}, {"symbol": "PFE", "publishedDate": "2021-01-09 06:04:00", "title": "Better Coronavirus Stock: AstraZeneca vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/a/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6069132f2-covid-vaccines-in-front-of-100jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's how these two huge COVID-19 vaccine makers compare.", "url": "https://www.fool.com/investing/2021/01/09/better-coronavirus-stock-astrazeneca-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 13:38:20", "title": "EU looks to buy another 300 million doses of Pfizer COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/q/g/vaccine-eu-43jpgquality90stripall.jpg", "site": "New York Post", "text": "The European Union is planning to double its supply of Pfizer's coronavirus vaccine by purchasing up to 300 million additional doses, officials said Friday. The deal would add to the EU's existing 300 million-dose order \u2014 potentially giving the 27-nation bloc nearly half of the 1.3 billion doses that Pfizer and German partner BioNTech plan.", "url": "https://nypost.com/2021/01/08/eu-looks-to-buy-another-300m-doses-of-pfizer-covid-vaccine/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 12:57:00", "title": "CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy", "image": "https://cdn.snapi.dev/images/v1/q/b/press2---40u7ilieek.jpg", "site": "Business Wire", "text": "NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- #cureduchenne--CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD), celebrates Pfizer Inc's (NYSE: PFE) announcement surrounding the first dosing of a patient with Duchenne in their Phase III gene therapy clinical trial. Pfizer has showcased tremendous progress over the past year in pushing forward PF-06939926, its rAAV9 mini-dystrophin gene therapy for DMD. PF-06939926 was initially developed by Jude Sa", "url": "https://www.businesswire.com/news/home/20210108005505/en/CureDuchenne-Congratulates-Pfizer-on-Dosing-First-Patient-in-Phase-III-Clinical-Trial-for-Duchenne-Muscular-Dystrophy/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 12:27:05", "title": "Pfizer's Covid vaccine appears to stop variants found in U.K., South Africa", "image": "https://cdn.snapi.dev/images/v1/c/g/pfizers-covid-vaccine-appears-to-stop-variants-found-in-uk-south-africa.jpg", "site": "CNBC Television", "text": "Pfizer's vaccine appears to neutralize the Covid variants found in the U.K. and South Africa. The study was conducted by Pfizer and has not been peer reviewed.", "url": "https://www.youtube.com/watch?v=XHd3CUYEO9o"}, {"symbol": "PFE", "publishedDate": "2021-01-08 10:28:10", "title": "Dividend Income Summary: Lanny's December 2020 Summary", "image": "https://cdn.snapi.dev/images/v1/o/x/insurance1.jpg", "site": "Seeking Alpha", "text": "Dividend Income Summary: Lanny's December 2020 Summary", "url": "https://seekingalpha.com/article/4397912-dividend-income-summary-lannys-december-2020-summary"}, {"symbol": "PFE", "publishedDate": "2021-01-08 09:04:32", "title": "Former FDA chief Scott Gottlieb on Pfizer vaccine's ability to neutralize Covid variants", "image": "https://cdn.snapi.dev/images/v1/g/l/former-fda-chief-scott-gottlieb-on-pfizer-vaccines-ability-to-neutralize-covid-variants.jpg", "site": "CNBC Television", "text": "A coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious variants of the virus discovered in the U.K. and South Africa, according to a study conducted by the U.S. pharmaceutical giant. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined \"Squawk Box\" on Friday to discuss the findings.", "url": "https://www.youtube.com/watch?v=UBhLiK7H1mI"}, {"symbol": "PFE", "publishedDate": "2021-01-08 08:28:19", "title": "Europe's drug regulator says there is an extra dose in BioNTech/Pfizer's COVID-19 vaccine vials", "image": "https://cdn.snapi.dev/images/v1/r/i/56848336-s-740x416.jpg", "site": "Market Watch", "text": "The European Medicines Agency said Friday that the product information for BioNTech SE and Pfizer Inc.'s COVID-19 vaccine should be updated to say there are six doses in each vial. The authorization granted to the vaccine, which is referred to as Comirnaty in Europe, on Dec. 21 in the European Union says there are five doses in each vial.", "url": "https://www.marketwatch.com/story/europes-drug-regulator-says-there-is-an-extra-dose-in-biontechpfizers-covid-19-vaccine-vials-2021-01-08"}, {"symbol": "PFE", "publishedDate": "2021-01-08 08:24:24", "title": "The EU has secured access to up to 300 million extra Pfizer doses, following criticism for its slow COVID-19 vaccine rollout", "image": "https://cdn.snapi.dev/images/v1/t/h/the-eu-has-secured-access-to-up-to-300-million-extra-pfizer-doses-following-criticism-for-its-slow-covid-19-vaccine-rollout.jpg", "site": "Business Insider", "text": "The EU has secured access to 300 million more doses of Pfizer and BioNTech's COVID-19 vaccine, the president of the European Commission, Ursula von der Leyen, said during a press conference Friday morning. This would double the EU's total supply of Pfizer-BioNTech's vaccine, but is unlikely to solve problems with the trade bloc's slow rollout of vaccines.", "url": "https://www.businessinsider.com/eu-secures-access-300-million-pfizer-covid-19-vaccines-europe-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-08 08:23:00", "title": "Pfizer Research Suggests Covid-19 Vaccine Will Protect Against New Variants", "image": "https://cdn.snapi.dev/images/v1/t/t/im-248560.jpg", "site": "Barrons", "text": "The exuberance around the rapid availability of Covid-19 vaccines has been in limbo in recent days. The latest news could offer reassurance.", "url": "https://www.barrons.com/articles/pfizer-research-suggests-covid-19-vaccine-will-protect-vs-variants-51610112221"}, {"symbol": "PFE", "publishedDate": "2021-01-08 08:01:26", "title": "Pfizer's Covid-19 Vaccine Delay Isn't Welcome News for Shareholders", "image": "https://cdn.snapi.dev/images/v1/w/y/biotech26.jpg", "site": "InvestorPlace", "text": "The UK's chief medical officers want to delay second doses of the Pfizer/BioNTech vaccine. Is this much ado about nothing for PFE stock?", "url": "https://investorplace.com/2021/01/pfizers-vaccine-delay-not-good-news-for-pfe-stock/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 07:42:00", "title": "Pfizer-BioNTech Vaccine Effective Against Mutation in New Covid-19 Variants, Study Finds", "image": "https://cdn.snapi.dev/images/v1/8/q/bp-ab837-pfizer-gr-20201130094221.jpg", "site": "Barrons", "text": "The Covid-19 vaccine developed by Pfizer and BioNTech appears to provide protection against the new highly contagious U.K. and South African variants, according to a preliminary study.", "url": "https://www.barrons.com/articles/pfizer-biontech-vaccine-effective-against-mutation-in-new-covid-19-variants-study-finds-51610109726"}, {"symbol": "PFE", "publishedDate": "2021-01-08 07:22:00", "title": "Pfizer\u2013BioNTech vaccine appears to protect against U.K. and South African COVID-19 strains, study finds", "image": "https://cdn.snapi.dev/images/v1/0/7/im-282552width620size16431322207958923.jpg", "site": "Market Watch", "text": "BioNTech said that the company would be able to adjust the vaccine developed with Pfizer to address new mutations of a coronavirus if necessary.", "url": "https://www.marketwatch.com/story/pfizerbiontech-vaccine-appears-to-protect-against-u-k-and-south-african-covid-19-strains-study-finds-11610108542"}, {"symbol": "PFE", "publishedDate": "2021-01-08 07:04:50", "title": "Pfizer-BioNTech Vaccine Appears Resistant To New Covid Variant, Study Finds, As U.S. Records Deadliest Day", "image": "https://cdn.snapi.dev/images/v1/0/p/pfizer-biontech-vaccine-appears-resistant-to-new-covid-variant-study-finds-as-us-records-deadliest-day.jpg", "site": "Forbes", "text": "The American pharma giant tested its mRNA Covid-19 vaccine against the coronavirus mutants spreading rapidly through the U.K. and South Africa.", "url": "https://www.forbes.com/sites/roberthart/2021/01/08/pfizer-biontech-vaccine-appears-resistant-to-new-covid-variant-study-finds-as-us-records-deadliest-day/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 06:56:00", "title": "My Best Biotech Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/b/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6072782fscientist-microscope-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's why the biggest biotech IPO of 2019 outshines all its peers.", "url": "https://www.fool.com/investing/2021/01/08/my-best-biotech-stock-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 06:45:16", "title": "Pfizer and BioNTech say COVID-19 vaccine neutralizes mutation found in new U.K., South Africa variants", "image": "https://cdn.snapi.dev/images/v1/z/5/biotech24.jpg", "site": "Market Watch", "text": "Pfizer Inc. and German partner BioNTech SE said Friday an in vitro study found that their COVID-19 vaccine neutralizes the two new highly infectious variants that have emerged in the U.K. and South Africa. The results were published on the preprint service bioRxiv and have not yet been peer-reviewed.", "url": "https://www.marketwatch.com/story/pfizer-and-biontech-say-covid-19-vaccine-neutralizes-mutation-found-in-new-uk-south-africa-variants-2021-01-08"}, {"symbol": "PFE", "publishedDate": "2021-01-08 06:18:37", "title": "Pfizer vaccine appears to neutralize a key mutation of Covid variants found in UK, South Africa", "image": "https://cdn.snapi.dev/images/v1/9/a/106821138-1610081333688-gettyimages-1230473469-20090101210108-99-939413.jpeg", "site": "CNBC", "text": "The research, which has not yet been peer-reviewed, suggested the Pfizer-BioNTech vaccine worked to neutralize the so-called N501Y mutation.", "url": "https://www.cnbc.com/2021/01/08/pfizer-biontech-vaccine-appears-effective-against-mutation-in-new-strains.html"}, {"symbol": "PFE", "publishedDate": "2021-01-08 06:05:00", "title": "Why Pfizer Was a Surprising Loser in 2020 but Could Win Big Time in 2021", "image": "https://cdn.snapi.dev/images/v1/p/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6069122f1-bill-folded-into-arrow-trending-upjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Better days appear to be ahead for the big drugmaker.", "url": "https://www.fool.com/investing/2021/01/08/why-pfizer-was-a-surprising-loser-in-2020-but-coul/"}, {"symbol": "PFE", "publishedDate": "2021-01-08 05:54:33", "title": "EU agrees new Pfizer Covid vaccine deal and secures nearly half its annual output", "image": "https://cdn.snapi.dev/images/v1/t/8/106813100-16082362882020-12-13t121713z-772785253-rc2cmk9bg2al-rtrmadp-0-britain-eu.jpeg", "site": "CNBC", "text": "The EU is doubling its purchases of the Pfizer-BioNTech coronavirus vaccine at a time of growing concern over its rollout.", "url": "https://www.cnbc.com/2021/01/08/eu-announces-300-million-more-doses-of-pfizer-biontech-covid-vaccine.html"}, {"symbol": "PFE", "publishedDate": "2021-01-08 05:45:00", "title": "An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission", "image": "https://cdn.snapi.dev/images/v1/7/x/press11---egszyzqlxt.jpg", "site": "GlobeNewsWire", "text": "New York and Mainz, Germany, January 8, 2021 \u2014 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv and are available here.", "url": "https://www.globenewswire.com/news-release/2021/01/08/2155442/0/en/An-In-Vitro-Study-Shows-Pfizer-BioNTech-COVID-19-Vaccine-Elicits-Antibodies-that-Neutralize-SARS-CoV-2-with-a-Mutation-Associated-with-Rapid-Transmission.html"}, {"symbol": "PFE", "publishedDate": "2021-01-08 02:50:59", "title": "Pfizer study suggests vaccine works against virus variant", "image": "https://cdn.snapi.dev/images/v1/n/w/biotech23.jpg", "site": "Fox Business", "text": "The study is preliminary and has not yet been reviewed by experts, a key step for medical research.", "url": "https://www.foxbusiness.com/markets/pfizer-study-suggests-vaccine-works-against-virus-variant"}, {"symbol": "PFE", "publishedDate": "2021-01-08 02:20:08", "title": "Pfizer Study Shows Vaccine Efficacious Against COVID-19 Variant", "image": "https://cdn.snapi.dev/images/v1/n/9/dimitri-houtteman-qbhppxw3ess-unsplash-6.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE)/BionNTech SE (NASDAQ: BNTX) COVID-19 showed signs of working against a mutation found in\u00a0two highly-contagious\u00a0COVID-19 virus\u00a0variants detected in the U.K. and South Africa in a laboratory study conducted by Pfizer. What Happened: These positive findings were spotted during the\u00a0study, conducted in collaboration with\u00a0the University of Texas\u00a0Medical Branch, reports Reuters.", "url": "https://www.benzinga.com/general/biotech/21/01/19072015/pfizer-study-shows-vaccine-efficacious-against-covid-19-variant"}, {"symbol": "PFE", "publishedDate": "2021-01-08 00:43:07", "title": "Early study suggests Pfizer vaccine effective against COVID-19 mutations", "image": "https://cdn.snapi.dev/images/v1/e/a/early-study-suggests-pfizer-vaccine-effective-against-covid-19-mutations.jpg", "site": "Business Insider", "text": "The COVID-19 vaccine from pharmaceutical companies Pfizer and BioNTech looks to be effective against 16 different mutations of the coronavirus, according to a study that has not yet undergone peer review. As Reuters reported, the study, by researchers at Pfizer and the University of Texas Medical Branch, suggests the vaccine will not need to be tweaked in order to work against a seemingly more contagious variant of the coronavirus that arose in the UK.", "url": "https://www.businessinsider.com/study-suggests-pfizer-vaccine-effective-against-covid-19-mutations-2021-1"}, {"symbol": "PFE", "publishedDate": "2021-01-08 00:15:00", "title": "Pfizer vaccine appears effective against rapidly spreading coronavirus variants", "image": "https://cdn.snapi.dev/images/v1/i/i/gettyimages-1230470376.jpg", "site": "CNET", "text": "Preliminary data shows Pfizer's mRNA vaccine can effectively neutralize coronavirus variants in lab tests.", "url": "https://www.cnet.com/news/pfizer-vaccine-appears-effective-against-rapidly-spreading-coronavirus-variants/"}, {"symbol": "PFE", "publishedDate": "2021-01-07 19:45:00", "title": "Pfizer Stock: A Top Bet for 2021?", "image": "https://cdn.snapi.dev/images/v1/d/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063332faccurate-pipette-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A new coronavirus vaccine isn't the only reason to buy this big pharma stock right now.", "url": "https://www.fool.com/investing/2021/01/07/pfizer-stock-a-top-bet-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-07 10:32:19", "title": "The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better", "image": "https://cdn.snapi.dev/images/v1/w/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5915492fnyse-wall-street-trading-new-york-financial-stock-market-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This not-so-old strategy of identifying undervalued blue chip stocks has had its moments -- but not enough of them.", "url": "https://www.fool.com/investing/2021/01/07/dogs-of-the-dow-didnt-hunt-2020-2021-no-better/"}, {"symbol": "PFE", "publishedDate": "2021-01-07 09:48:31", "title": "While It's Price Won't Soar, Pfizer Stock Is a Fantastic Long-Term Buy", "image": "https://cdn.snapi.dev/images/v1/j/l/vaccine-4.jpeg", "site": "InvestorPlace", "text": "Pfizer has a strong pipeline and an attractive dividend yield, making PFe stock attractive for certain types of investors. The post While It's Price Won't Soar, Pfizer Stock Is a Fantastic Long-Term Buy appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/pfe-stock-is-a-fantastic-long-term-buy/"}, {"symbol": "PFE", "publishedDate": "2021-01-07 09:47:19", "title": "3 Biotech Technological Developments to Watch Out For in 2021", "image": "https://cdn.snapi.dev/images/v1/f/d/drugs11.jpg", "site": "Zacks Investment Research", "text": "Here we discuss three booming technological developments in the biotech sector, which can capture investor attention in 2021", "url": "https://www.zacks.com/stock/news/1242420/3-biotech-technological-developments-to-watch-out-for-in-2021"}, {"symbol": "PFE", "publishedDate": "2021-01-06 21:12:28", "title": "Pfizer: Mr. Market Vs. The Analysts", "image": "https://cdn.snapi.dev/images/v1/o/q/im-268289width620size14988290398126465.jpg", "site": "Seeking Alpha", "text": "Pfizer is trading at a remarkable 4.19% dividend yield. The analyst consensus is for a 12.48% price gain over the next twelve months.", "url": "https://seekingalpha.com/article/4397671-pfizer-mr-market-vs-analysts"}, {"symbol": "PFE", "publishedDate": "2021-01-06 12:50:46", "title": "4 Health Care Stocks to Consider as Covid-19 Vaccine Distribution Continues", "image": "https://cdn.snapi.dev/images/v1/f/o/biotech32.jpg", "site": "GuruFocus", "text": "As the Covid-19 vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) continue to be distributed throughout the U.S. and internationally to doctors, nurses, the elderly and other vulnerable populations, investors are looking to the health care industry to find value.", "url": "https://www.gurufocus.com/news/1325071/4-health-care-stocks-to-consider-as-covid19-vaccine-distribution-continues"}, {"symbol": "PFE", "publishedDate": "2021-01-06 10:32:15", "title": "FDA Opposes Dilution of COVID-19 Vaccine Doses: Here's Why", "image": "https://cdn.snapi.dev/images/v1/k/h/drugs46.jpg", "site": "Zacks Investment Research", "text": "The FDA is against any changes to the approved dosing regimens for Pfizer (PFE)/BioNTech (BNTX) and Moderna's (MRNA) coronavirus vaccines as demanded by some experts.", "url": "https://www.zacks.com/stock/news/1241842/fda-opposes-dilution-of-covid-19-vaccine-doses-heres-why"}, {"symbol": "PFE", "publishedDate": "2021-01-06 07:00:40", "title": "Pfizer unveils its first major logo redesign in 70 years", "image": "https://cdn.snapi.dev/images/v1/i/x/p-1-90591119-pfizer-rebrand.jpg", "site": "Fast Company", "text": "A new brand identity aims to embody the pharma giant's shift from pills like Advil and Viagra to the science of vaccines. Pharmaceutical giant Pfizer has unveiled its most significant brand refresh in about 70 years.", "url": "https://www.fastcompany.com/90591119/pfizer-unveils-its-first-major-logo-redesign-in-70-years"}, {"symbol": "PFE", "publishedDate": "2021-01-06 06:14:00", "title": "Is Pfizer Stock a Buy?", "image": "https://cdn.snapi.dev/images/v1/n/v/pfizerjpgquality90stripall.jpg", "site": "The Motley Fool", "text": "The company is poised to begin delivering on its promise of growth and innovation.", "url": "https://www.fool.com/investing/2021/01/06/is-pfizer-stock-a-buy/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 18:59:38", "title": "Many Covid stocks are not sustainable in a post-Covid world, Jim Cramer says", "image": "https://cdn.snapi.dev/images/v1/d/t/many-covid-stocks-are-not-sustainable-in-a-post-covid-world-jim-cramer-says.jpg", "site": "CNBC Television", "text": "Once we get this vaccination program under control, then the sustainable stocks should keep climbing, but the unsustainable ones will face trouble, the \"Mad Money\" host said.", "url": "https://www.youtube.com/watch?v=yywzjDazKgQ"}, {"symbol": "PFE", "publishedDate": "2021-01-05 18:48:16", "title": "Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/b/3/drugs40.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed at $37.19 in the latest trading session, marking a +1.03% move from the prior day.", "url": "https://www.zacks.com/stock/news/1241537/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2021-01-05 17:27:00", "title": "Pfizer Launches First Major Rebranding in Over 70 Years", "image": "https://cdn.snapi.dev/images/v1/w/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6073252fim-280725jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company \"unlocks\" its famous little blue pill in a symbolic move.", "url": "https://www.fool.com/investing/2021/01/05/pfizer-launches-first-major-rebranding-in-over-70/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 14:36:32", "title": "7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible", "image": "https://cdn.snapi.dev/images/v1/d/d/ddhciry2.", "site": "InvestorPlace", "text": "The Covid-19 vaccine rally isn't just limited to biotech firms. Here are the top coronavirus stocks that are making mass vaccination possible.", "url": "https://investorplace.com/2021/01/7-coronavirus-stocks-to-buy-to-make-mass-vaccination-possible/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 12:16:00", "title": "FDA Opposes Diluting Coronavirus Vaccine Doses From Moderna and Pfizer to Boost Supply", "image": "https://cdn.snapi.dev/images/v1/u/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6072312fbiohazard-suit-stop-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The recent suggestion from the Operation Warp Speed task force has been rejected due to a lack of clinical evidence.", "url": "https://www.fool.com/investing/2021/01/05/fda-opposes-diluting-coronavirus-vaccine-doses-fro/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 12:02:10", "title": "U.S. Dollar Sees First Drop Since 2017: ETFs & Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/a/y/semi20.jpg", "site": "Zacks Investment Research", "text": "The super-easy policies by the Fed and the central government as well as a series of vaccine development have pushed the U.S. dollar down.", "url": "https://www.zacks.com/stock/news/1241286/us-dollar-sees-first-drop-since-2017-etfs-stocks-to-buy"}, {"symbol": "PFE", "publishedDate": "2021-01-05 11:37:09", "title": "EU In Talks To Buy Up To 300M More Coronavirus Vaccine Doses From Pfizer-BioNTech", "image": "https://cdn.snapi.dev/images/v1/q/p/medicine-5103043-1920-29.jpg", "site": "Benzinga", "text": "With the U.K. entering a third nationwide lockdown and the COVID-19 pandemic raging through the rest of Europe,\u00a0vaccines approved for emergency use are\u00a0in high demand.\u00a0 What Happened: The European Union is negotiating with Pfizer Inc. (NYSE: PFE)-BioNTech SE \u2013 ADR (NASDAQ: BNTX) to procure\u00a0an additional 100 million doses of the pair's\u00a0coronavirus vaccine candidate, with an option to buy 200 million more doses, according to a Bloomberg report.", "url": "https://www.benzinga.com/general/biotech/21/01/19018211/eu-in-talks-to-buy-up-to-300m-more-coronavirus-vaccine-doses-from-pfizer-biontech"}, {"symbol": "PFE", "publishedDate": "2021-01-05 10:00:00", "title": "Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/n/2/press10---l8lzjdnljx.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer leadership at the 39th Annual J.P. Morgan Healthcare Conference to be held virtually. Albert Bourla, Chairman and Chief Executive Officer, will participate in a fireside chat presentation on Tuesday, January 12, 2021 at 10:00 a.m. EST. Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, will participate in a COVID-19 Vaccines Keynote Panel", "url": "https://www.businesswire.com/news/home/20210105005119/en/Pfizer-Invites-Public-to-Listen-to-Two-Webcasts-of-Pfizer-Discussions-at-Healthcare-Conference/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 08:17:06", "title": "Pfizer's (PFE) BLA for Somatrogon Gets FDA's Acceptance", "image": "https://cdn.snapi.dev/images/v1/r/l/drugs30.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) BLA for growth hormone deficiency (GHD) gets accepted by the FDA for standard review. FDA's decision expected in October 2021.", "url": "https://www.zacks.com/stock/news/1240970/pfizers-pfe-bla-for-somatrogon-gets-fdas-acceptance"}, {"symbol": "PFE", "publishedDate": "2021-01-05 07:50:00", "title": "2 Undervalued Stocks for 2021", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040462fgettyimages-1279583057jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Johnson & Johnson and Pfizer are dependable stocks with good dividends, but they get little love from the market, making them bargains this year.", "url": "https://www.fool.com/investing/2021/01/05/2-undervalued-stocks-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 07:07:00", "title": "Meet the 2021 Dogs of the Dow", "image": "https://cdn.snapi.dev/images/v1/s/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6070662fdogs-getty-smilingjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here are the newest stocks to join the portfolio for those using this easy-to-follow strategy.", "url": "https://www.fool.com/investing/2021/01/05/meet-the-2021-dogs-of-the-dow/"}, {"symbol": "PFE", "publishedDate": "2021-01-05 04:08:33", "title": "FDA Warns Against Tinkering With Pfizer, Moderna Vaccine Regimens After White House Advisor's Comments", "image": "https://cdn.snapi.dev/images/v1/f/t/daniel-schludi-magznecmcug-unsplash-1.jpg", "site": "Benzinga", "text": "The United States Food and Drug Administration has warned against changing the dosing regimen, interval, or mixing of COVID-19 vaccines in a statement issued Monday. What Happened: The health agency recognized that available data indicates the use of two specified doses of the COVID-19 vaccines \u2014 made by Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) \u2014\u00a0at specified intervals.", "url": "https://www.benzinga.com/general/biotech/21/01/19012616/fda-warns-against-tinkering-with-pfizer-moderna-vaccine-regimens-after-white-house-advisors-comme"}, {"symbol": "PFE", "publishedDate": "2021-01-04 13:15:41", "title": "3 Bank Stocks To Buy for the New Year", "image": "https://cdn.snapi.dev/images/v1/h/9/bank25.jpg", "site": "InvestorPlace", "text": "The financial sector is powering higher and the price action is healthy. That said, here are the top three bank stocks to buy now.", "url": "https://investorplace.com/2021/01/3-bank-stocks-to-buy-for-the-new-year/"}, {"symbol": "PFE", "publishedDate": "2021-01-04 11:26:03", "title": "Tech Finishes as the Strongest Sector in 2020", "image": "https://cdn.snapi.dev/images/v1/j/s/asset-management13-8.jpg", "site": "Zacks Investment Research", "text": "Tech Finishes as the Strongest Sector in 2020", "url": "https://www.zacks.com/stock/news/1240698/tech-finishes-as-the-strongest-sector-in-2020"}, {"symbol": "PFE", "publishedDate": "2021-01-04 10:00:00", "title": "My Favorite Biotech Stock for 2021", "image": "https://cdn.snapi.dev/images/v1/a/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6070292fgenetic-researchjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This clinical-stage biotech stock could be a top buyout candidate in 2021.", "url": "https://www.fool.com/investing/2021/01/04/my-favorite-biotech-stock-for-2021/"}, {"symbol": "PFE", "publishedDate": "2021-01-04 09:11:13", "title": "5 Momentum Stocks Bargain Hunters Would Love Chasing", "image": "https://cdn.snapi.dev/images/v1/h/t/biotech24.jpg", "site": "Zacks Investment Research", "text": "To tap the market's rally, it will be prudent to invest in momentum stocks that are still cheap. Our choices are Winnebago Industries (WGO), Fiat Chrysler (FCAU), FedEx (FDX), Williams-Sonoma (WSM) and Lennar (LEN).", "url": "https://www.zacks.com/stock/news/1240466/5-momentum-stocks-bargain-hunters-would-love-chasing"}, {"symbol": "PFE", "publishedDate": "2021-01-04 06:45:00", "title": "US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency", "image": "https://cdn.snapi.dev/images/v1/1/n/press18---zxnr3dhcif.jpg", "site": "Business Wire", "text": "NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the US Food and Drug Administration (FDA) has accepted for filing the initial Biologics License Application (BLA) for somatrogon, a long-acting human growth hormone that is intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency (GHD). The target Prescription Drug User Fee Act (PDUFA) action date for decision by the FDA is in O", "url": "https://www.businesswire.com/news/home/20210104005200/en/US-FDA-Accepts-Regulatory-Submission-from-Pfizer-and-OPKO-for-Review-of-Somatrogon-to-Treat-Pediatric-Patients-with-Growth-Hormone-Deficiency/"}, {"symbol": "PFE", "publishedDate": "2021-01-04 05:11:21", "title": "Latest Pivot Does Little To Bolster Case for IDEX Stock Charging Higher", "image": "https://cdn.snapi.dev/images/v1/h/t/computer-electronic21.jpg", "site": "InvestorPlace", "text": "A pivot or reinvention into the hot EV market has made some inroads with investors in 2020, but don't ignore IDEX stock's history of poorly repeating itself. The post Latest Pivot Does Little To Bolster Case for IDEX Stock Charging Higher appeared first on InvestorPlace.", "url": "https://investorplace.com/2021/01/latest-pivot-does-little-to-bolster-case-for-idex-stock-charging-higher/"}, {"symbol": "PFE", "publishedDate": "2021-01-04 04:15:00", "title": "ICON Supports Pfizer and BioNTech on the Investigational COVID-19 Vaccine Trial", "image": "https://cdn.snapi.dev/images/v1/b/j/press4---ifdt8pi5jt.jpg", "site": "Business Wire", "text": "DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries and government and public health organisations, today announced it provided clinical trial services to the Pfizer (NYSE:PFE) and BioNTech SE (Nasdaq: BNTX) investigational COVID-19 vaccine programme. Pfizer and BioNTech were the first to announce positive efficacy results from a Phase 3, la", "url": "https://www.businesswire.com/news/home/20210104005272/en/ICON-Supports-Pfizer-and-BioNTech-on-the-Investigational-COVID-19-Vaccine-Trial/"}, {"symbol": "PFE", "publishedDate": "2021-01-02 06:05:00", "title": "Pfizer's Next Multibillion-Dollar COVID Vaccine Move", "image": "https://cdn.snapi.dev/images/v1/r/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063592fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A lot of money could ride on a planned second version of Pfizer's coronavirus vaccine.", "url": "https://www.fool.com/investing/2021/01/02/pfizers-next-multibillion-dollar-covid-vaccine-mov/"}, {"symbol": "PFE", "publishedDate": "2021-01-01 08:30:00", "title": "3 No-Brainer Stocks to Buy in Healthcare", "image": "https://cdn.snapi.dev/images/v1/3/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6064922fgettyimages-1224454909jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you're worried about another market crash, don't pass up these three unstoppable healthcare stocks.", "url": "https://www.fool.com/investing/2021/01/01/3-no-brainer-stocks-to-buy-in-healthcare/"}, {"symbol": "PFE", "publishedDate": "2021-01-01 06:30:00", "title": "3 Dividend Stocks Ideal for Retirees", "image": "https://cdn.snapi.dev/images/v1/k/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6064902fgettyimages-1202331183jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't miss out on buying these incredible stocks in the new year.", "url": "https://www.fool.com/investing/2021/01/01/3-dividend-stocks-ideal-for-retirees/"}, {"symbol": "PFE", "publishedDate": "2020-12-31 19:37:00", "title": "Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.", "image": "https://cdn.snapi.dev/images/v1/b/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6068172fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company sounded alarm bells about the widening gap between the initial shot and booster of BNT162b2.", "url": "https://www.fool.com/investing/2020/12/31/pfizer-criticizes-sudden-change-in-coronavirus-dos/"}, {"symbol": "PFE", "publishedDate": "2020-12-31 14:19:38", "title": "Why Pfizer is the Cheapest Coronavirus Vaccine Play", "image": "https://cdn.snapi.dev/images/v1/u/p/biotech3---j2lywpuo13.jpg", "site": "InvestorPlace", "text": "PFE stock does not include any value to the Pfizer-BioNTech partnership and the developments of a game-changing Covid-19 vaccine. The post Why Pfizer is the Cheapest Coronavirus Vaccine Play appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-31 13:33:04", "title": "Top ETF Stories of Fourth-Quarter 2020", "image": "https://cdn.snapi.dev/images/v1/f/q/drugs7.jpg", "site": "Zacks Investment Research", "text": "The year 2020 as a whole could easily be attributed to the COVID-19 outbreak.", "url": "https://www.zacks.com/stock/news/1239976/top-etf-stories-of-fourth-quarter-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-31 11:17:04", "title": "5 Big ETF Stories of 2020 Worth Watching in 2021", "image": "https://cdn.snapi.dev/images/v1/2/e/computer-electronic4.jpg", "site": "Zacks Investment Research", "text": "We discuss some of the events that dominated the headlines in 2020 and are worth watching in 2021.", "url": "https://www.zacks.com/stock/news/1239830/5-big-etf-stories-of-2020-worth-watching-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-31 09:16:00", "title": "U.K. health service pushes back interval for delivering second Pfizer coronavirus vaccine to a duration company says is untested", "image": "https://cdn.snapi.dev/images/v1/o/d/im-279638width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K. National Health Service has pushed back the window for people to receive the second dose of the coronavirus vaccine made by Pfizer and BioNTech \u2014 to a duration the companies tested on only a small percentage of patients.", "url": "https://www.marketwatch.com/story/u-k-health-service-pushes-back-interval-for-delivering-second-pfizer-coronavirus-vaccine-to-a-duration-company-says-is-untested-11609424175"}, {"symbol": "PFE", "publishedDate": "2020-12-30 12:02:09", "title": "4 Best Performing Sector ETFs of December", "image": "https://cdn.snapi.dev/images/v1/8/o/etf5.jpg", "site": "Zacks Investment Research", "text": "Despite the surge in coronavirus cases, December has been kind for the U.S. stock market with the major indices enjoying a historic rally.", "url": "https://www.zacks.com/stock/news/1235929/4-best-performing-sector-etfs-of-december"}, {"symbol": "PFE", "publishedDate": "2020-12-30 10:27:28", "title": "Why the New Covid-19 Strain Matters for Pfizer Stakeholders", "image": "https://cdn.snapi.dev/images/v1/m/h/201209123827-pfizer-biontech-coronavirus-vaccine-wales-1208-super-169.jpg", "site": "InvestorPlace", "text": "With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic's winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some pressure.", "url": "https://investorplace.com/2020/12/pfe-stock-why-new-coronavirus-strain-matters/"}, {"symbol": "PFE", "publishedDate": "2020-12-30 09:47:23", "title": "Wall Street Stories That Hit Headlines in 2020", "image": "https://cdn.snapi.dev/images/v1/w/m/computer-electronic31.jpg", "site": "Zacks Investment Research", "text": "With super-easy policies and vaccination, small-cap stocks like Liquidity Services (LQDT) and cyclical stocks like Nexstar Media (NXST), Deere & Company (DE) and BHP Billiton (BBL) are expected to benefit the most.", "url": "https://www.zacks.com/stock/news/1235105/wall-street-stories-that-hit-headlines-in-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-30 09:47:07", "title": "5 Factors Indicating That Oil is Poised for a Run-Up in 2021", "image": "https://cdn.snapi.dev/images/v1/x/h/oil5.jpg", "site": "Zacks Investment Research", "text": "As a proof of the improving energy environment, refining biggies like Marathon Petroleum (MPC) and Phillips 66 (PSX) experienced sequential increase in utilization during the third quarter.", "url": "https://www.zacks.com/stock/news/1235183/5-factors-indicating-that-oil-is-poised-for-a-run-up-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-30 07:26:00", "title": "The 3 Safest Stocks to Buy With Your Stimulus Money", "image": "https://cdn.snapi.dev/images/v1/p/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938142fgettyimages-1194732144jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies are heavyweights, and they're only getting stronger.", "url": "https://www.fool.com/investing/2020/12/30/the-3-safest-stocks-to-buy-with-600-in-stimulus-mo/"}, {"symbol": "PFE", "publishedDate": "2020-12-30 06:12:43", "title": "2 Top Picks - Safe High Dividend Biotechs For 2021", "image": "https://cdn.snapi.dev/images/v1/i/d/drugs8.jpg", "site": "Seeking Alpha", "text": "2 Top Picks - Safe High Dividend Biotechs For 2021", "url": "https://seekingalpha.com/article/4396693-2-top-picks-safe-high-dividend-biotechs-for-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-29 22:11:00", "title": "Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union", "image": "https://cdn.snapi.dev/images/v1/9/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6066262fgettyimages-1266494637jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The EU's total order now stands at 300 million.", "url": "https://www.fool.com/investing/2020/12/29/pfizer-and-biontech-supplying-100-million-addition/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 19:19:16", "title": "Undervalued Pharmaceutical Dividends For The New Year", "image": "https://cdn.snapi.dev/images/v1/w/1/euh22.jpg", "site": "Seeking Alpha", "text": "AbbVie and Bristol-Myers Squibb are major pharmaceuticals that have recently made large acquisitions that have significantly increased their total debt. However, both AbbVie and Bristol-Myers Squibb have robust drug pipelines and are actively expanding indications of key therapeutics to drive strong growth going forward.", "url": "https://seekingalpha.com/article/4396667-undervalued-pharmaceutical-dividends-for-new-year"}, {"symbol": "PFE", "publishedDate": "2020-12-29 18:48:19", "title": "Pfizer (PFE) Gains As Market Dips: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/p/f/drugs2.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $37.05, marking a +0.62% move from the previous day.", "url": "https://www.zacks.com/stock/news/1232103/pfizer-pfe-gains-as-market-dips-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2020-12-29 16:33:00", "title": "Arcturus Reports Results From Early-Stage Testing of Its Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/w/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6065922fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors obviously considered these to be underwhelming, however.", "url": "https://www.fool.com/investing/2020/12/29/arcturus-reports-results-from-early-stage-testing/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 16:26:58", "title": "European Union Set To Purchase 100M More Doses Of Pfizer COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/l/q/medicine-5103043-1920-28.jpg", "site": "Benzinga", "text": "European Commission\u00a0President Ursula von der Leyen took to Twitter to announce Tuesday that the European Union will purchase an additional 100 million doses of the Pfizer (NYSE: PFE)-BioNTech\u00a0(NASDAQ: BNTX) coronavirus vaccine.\u00a0 We decided to take an additional 100 million doses of the #BioNTech /@Pfizer vaccine, which is already being used to vaccinate people across the EU.", "url": "https://www.benzinga.com/general/biotech/20/12/18954761/european-union-set-to-purchase-100m-more-doses-of-pfizer-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-29 13:31:13", "title": "Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021", "image": "https://cdn.snapi.dev/images/v1/w/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg", "site": "Market Watch", "text": "Pfizer Inc. and its German partner BioNTech SE will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes after the European Commission exercised an option to purchase the extra doses that was granted as part of an agreement signed in November.", "url": "https://www.marketwatch.com/story/pfizer-and-biontech-to-supply-additional-100-million-covid-vaccine-doses-to-eu-in-2021-2020-12-29"}, {"symbol": "PFE", "publishedDate": "2020-12-29 13:11:00", "title": "Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY\u00ae", "image": "https://cdn.snapi.dev/images/v1/c/c/press7---sg6hddejwr.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY\u00ae, the companies' COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission's decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total", "url": "https://www.businesswire.com/news/home/20201229005380/en/Pfizer-and-BioNTech-to-Supply-the-European-Union-with-100-Million-Additional-Doses-of-COMIRNATY%C2%AE/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 11:17:09", "title": "Myovant (MYOV) Up on Collaboration With Pfizer for Relugolix", "image": "https://cdn.snapi.dev/images/v1/d/u/biotech35---evzqrysgbv.jpg", "site": "Zacks Investment Research", "text": "Myovant Sciences (MYOV) and Pfizer enter collaboration agreement to develop and commercialize relugolix monotherapy and combination regimen for prostate cancer and uterine fibroids, respectively.", "url": "https://www.zacks.com/stock/news/1230385/myovant-myov-up-on-collaboration-with-pfizer-for-relugolix"}, {"symbol": "PFE", "publishedDate": "2020-12-29 11:07:41", "title": "Why Betting Against the S&P 500 Makes Little Sense in 2021", "image": "https://cdn.snapi.dev/images/v1/v/m/computer-electronic19.jpg", "site": "InvestorPlace", "text": "It has defied the odds -- or at least Covid-19's wrath -- in 2020, and conditions continue to shape up for a strong year ahead in SPY stock. The post Why Betting Against the S&P 500 Makes Little Sense in 2021 appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/why-betting-against-the-sp-500-makes-little-sense-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 11:03:14", "title": "Pfizer Stock Is Too Hot but It's Definitely Safe to Handle Here", "image": "https://cdn.snapi.dev/images/v1/g/0/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg", "site": "InvestorPlace", "text": "PFE stock has had 2 recent mega rallies and it could have another one. But it's best asset is the support below and the dividend yield.", "url": "https://investorplace.com/2020/12/pfe-stock-is-too-hot-but-its-definitely-safe-to-handle-here/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 10:32:06", "title": "Pfizer (PFE) Lorbrena First-Line sNDA Gets FDA Priority Review", "image": "https://cdn.snapi.dev/images/v1/v/g/drugs45.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) label expansion application for Lorbrena as first-line treatment for metastatic lung cancer gets priority review from the FDA.", "url": "https://www.zacks.com/stock/news/1230258/pfizer-pfe-lorbrena-first-line-snda-gets-fda-priority-review"}, {"symbol": "PFE", "publishedDate": "2020-12-29 10:14:25", "title": "My Favorite Stocks for 2021: Pfizer, Disney, 8 Others", "image": "https://cdn.snapi.dev/images/v1/y/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5790832fwall-street-signjpgw700opresize.jpg", "site": "GuruFocus", "text": "Pfizer (NYSE:PFE), Walt Disney (NYSE:DIS) and D.R. Horton (NYSE:DHI) are among my favorite stocks for the coming year.", "url": "https://www.gurufocus.com/news/1319877/my-favorite-stocks-for-2021-pfizer-disney-8-others"}, {"symbol": "PFE", "publishedDate": "2020-12-29 08:55:47", "title": "3 Stocks Set for Huge Returns In 2021", "image": "https://cdn.snapi.dev/images/v1/m/8/aaai22.jpg", "site": "InvestorPlace", "text": "A new year comes with new opportunities and challenges for investors looking to make a smart bet. Here are the top stocks set for huge returns in 2021.", "url": "https://investorplace.com/2020/12/3-stocks-set-for-huge-returns-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 06:08:00", "title": "Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes", "image": "https://cdn.snapi.dev/images/v1/2/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063542fman-looking-at-coronavirus-and-chart-imagesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Mutations could mean more money for the two drugmakers.", "url": "https://www.fool.com/investing/2020/12/29/why-new-coronavirus-strains-could-boost-pfizer-and/"}, {"symbol": "PFE", "publishedDate": "2020-12-29 05:11:06", "title": "Pfizer's All-in Costs Show Vaccine Probably Won't Move the Needle Much", "image": "https://cdn.snapi.dev/images/v1/d/m/biotech29.jpg", "site": "InvestorPlace", "text": "For all the hoopla, PFE stock has already seen the benefit of the Covid-19 vaccine and needs new catalysts. Still, long-term investors may want it's healthy dividend.", "url": "https://investorplace.com/2020/12/vaccine-probably-wont-move-the-pfe-stock-needle-much/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 18:00:32", "title": "Shares of Startup Biotechs Soar on Cancer Study Results", "image": "https://cdn.snapi.dev/images/v1/e/g/drugs40---xmaegx6y3t.jpg", "site": "GuruFocus", "text": "Breast cancer is the second leading cause of death of women in the U.S. alone. Given the prevalence of the disease, it's no surprise that numerous pharmaceutical and biotech companies are searching for effective treatments.", "url": "https://www.gurufocus.com/news/1319538/shares-of-startup-biotechs-soar-on-cancer-study-results"}, {"symbol": "PFE", "publishedDate": "2020-12-28 16:30:00", "title": "LORBRENA\u00ae (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA", "image": "https://cdn.snapi.dev/images/v1/v/j/press7---x5mh08thog.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA \u00ae (lorlatinib) as a first-line treatment for people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). The sNDA is based on data from the pivotal CROWN study and is being reviewed by the FDA under its Real-Time Oncology Review (RTOR) pilot program. T", "url": "https://www.businesswire.com/news/home/20201228005232/en/LORBRENA%C2%AE-lorlatinib-sNDA-in-Previously-Untreated-ALK-Positive-Lung-Cancer-Accepted-for-Priority-Review-by-U.S.-FDA/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 14:06:36", "title": "7 Hot Stocks That Are Cheering on Vaccine Approvals", "image": "https://cdn.snapi.dev/images/v1/j/7/biotech26.jpg", "site": "InvestorPlace", "text": "The recent vaccine approvals could turn these names into hot stocks to buy now, despite them hailing from some of this year's most beleaguered sectors. The post 7 Hot Stocks That Are Cheering on Vaccine Approvals appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/7-hot-stocks-to-buy-now-that-are-cheering-vaccine-approvals/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 13:32:09", "title": "4 Transportation Stocks Likely to Keep Flying High in 2021", "image": "https://cdn.snapi.dev/images/v1/j/k/air5---vadzkwo0x1.jpg", "site": "Zacks Investment Research", "text": "Robust advancement in e-commerce and an uptick in freight conditions make transportation stocks attractive investment bets. Evidently, the likes of UPS, Knight-Swift (KNX), Atlas Air (AAWW) and ArcBest (ARCB) should grace one's portfolio.", "url": "https://www.zacks.com/stock/news/1225865/4-transportation-stocks-likely-to-keep-flying-high-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-28 12:07:02", "title": "Myovant leaps 35% on Pfizer partnership for development of prostate-cancer drug", "image": "https://cdn.snapi.dev/images/v1/m/y/myovant-leaps-35-on-pfizer-partnership-for-development-of-prostate-cancer-drug.jpg", "site": "Business Insider", "text": "Shares of Myovant surged as much as 35% to $30 on Monday after the biopharmaceutical company announced a partnership with Pfizer to develop and commercialize a drug for the treatment of prostate cancer patients. The drug, called Orgovyx, was approved by the FDA on December 18 for the treatment of adult patients with advanced prostate cancer. Myovant is also working on a relugolix combination tablet that could treat patients with endometriosis and uterine fibroids. That tablet is still awaiting FDA approval. \"We are thrilled to partner with Pfizer to unlock the full potential of ORGOVYX in advanced prostate cancer and relugolix combination tablet in uterine fibroids and endometriosis, advancing our mission to redefine care for women and for men,\" said Lynn Seely, Myovant CEO, in an announcement. \"This transformative collaboration will significantly strengthen the upcoming launch of ORGOVYX and the potential launches of relugolix combination tablet in women's health, while substantially enhancing our financial position and enabling us to expand our pipeline of potential new medicines.\" Read more: Wall Street's biggest firms are warning that these 8 things could crash the stock market's party in 2021", "url": "https://www.businessinsider.com/myovant-stock-price-pfizer-partnership-develop-prostate-cancer-drug-endrometriosis-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-28 12:01:37", "title": "Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion", "image": "https://cdn.snapi.dev/images/v1/j/2/biotech24.jpg", "site": "Market Watch", "text": "Shares of Myovant Sciences soared 27% Monday, after its parent Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly develop a treatment for prostate cancer and women's health in a deal worth up to $4.2 billion in upfront and potential milestone payments.", "url": "https://www.marketwatch.com/story/myovant-shares-soar-27-on-news-of-pfizer-prostate-cancer-drug-collaboration-worth-up-to-42-billion-2020-12-28"}, {"symbol": "PFE", "publishedDate": "2020-12-28 11:17:10", "title": "5 Sector ETFs That Beat the Market in 2020", "image": "https://cdn.snapi.dev/images/v1/q/k/etf8.jpg", "site": "Zacks Investment Research", "text": "With historic twists and turns, 2020 has turned out to be a banner year.", "url": "https://www.zacks.com/stock/news/1225238/5-sector-etfs-that-beat-the-market-in-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-28 11:00:00", "title": "Coronavirus vaccine: Moderna, Pfizer trials were the \u2018highest of quality,' expert explains", "image": "https://cdn.snapi.dev/images/v1/b/y/coronavirus-vaccine-moderna-pfizer-trials-were-the-highest-of-quality-expert-explains.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Julie Hyman, Brian Sozzi, and Myles Udland discuss the COVID-19 vaccine rollout with Dr. Reynold Panettieri, Robert Wood Johnson Medical School Professor of Medicine and advisor to the GERM ETF. Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=KMG5JoWMd6w"}, {"symbol": "PFE", "publishedDate": "2020-12-28 10:59:47", "title": "Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant", "image": "https://cdn.snapi.dev/images/v1/b/p/biotech21.jpg", "site": "24/7 Wall Street", "text": "Myovant Sciences Ltd. (NYSE: MYOV) shares shot up on Monday after the company announced a new collaboration with the pharmaceutical giant Pfizer Inc.", "url": "https://247wallst.com/healthcare-business/2020/12/28/why-this-recently-approved-prostate-cancer-treatment-could-be-huge-for-myovant/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 10:50:15", "title": "Deal With Pfizer Sends Myovant Shares Higher: What Investors Need To Know", "image": "https://cdn.snapi.dev/images/v1/v/g/pill-1884775-1920-62.jpg", "site": "Benzinga", "text": "Myovant Sciences Ltd (NYSE: MYOV) stock\u00a0is adding about one-fourth of its market capitalization Monday following a licensing deal with Pfizer Inc. (NYSE: PFE). What Happened: Myovant announced a collaboration with Pfizer to develop and commercialize relugolix for oncology indications and women's health in the U.S. and Canada.", "url": "https://www.benzinga.com/general/biotech/20/12/18938649/deal-with-pfizer-sends-myovant-shares-higher-what-investors-need-to-know"}, {"symbol": "PFE", "publishedDate": "2020-12-28 10:40:26", "title": "Biopharmaceutical Stock Surges Thanks to Pfizer Partnership", "image": "https://cdn.snapi.dev/images/v1/e/o/drugs37.jpg", "site": "Schaeffers Research", "text": "The shares of\u00a0Myovant Sciences Ltd (NYSE:MYOV) are up 27.2% at $29.08 at last check, gapping to record highs, after the biopharmaceutical concern announced a collaboration with Pfizer (PFE) to develop and commercialize cancer treatment relugolix in both the U.S. and Canada.", "url": "https://www.schaeffersresearch.com/content/news/2020/12/28/biopharmaceutical-stock-surges-thanks-to-pfizer-partnership"}, {"symbol": "PFE", "publishedDate": "2020-12-28 10:32:03", "title": "3 Restaurant Stocks to Gain Big With the Vaccine Rollout", "image": "https://cdn.snapi.dev/images/v1/p/d/drugs35.jpg", "site": "Zacks Investment Research", "text": "Restaurant industry is likely to benefit from the vaccine rollout. Following the vaccine rollout, dine-in option should become safe and traffic is likely to increase.", "url": "https://www.zacks.com/stock/news/1225207/3-restaurant-stocks-to-gain-big-with-the-vaccine-rollout"}, {"symbol": "PFE", "publishedDate": "2020-12-28 09:37:00", "title": "UPDATE - Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health", "image": "https://cdn.snapi.dev/images/v1/p/r/press10---dr7pd6i9ac.jpg", "site": "GlobeNewsWire", "text": "Myovant and Pfizer to jointly develop and commercialize ORGOVYX\u2122 (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and Canada", "url": "https://www.globenewswire.com/news-release/2020/12/28/2150911/0/en/UPDATE-Sumitovant-Biopharma-Announces-Myovant-Sciences-and-Pfizer-Enter-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html"}, {"symbol": "PFE", "publishedDate": "2020-12-28 09:02:10", "title": "5 Stocks That Could Directly Gain From Pfizer's Vaccine Success", "image": "https://cdn.snapi.dev/images/v1/g/p/biotech11.jpg", "site": "Zacks Investment Research", "text": "As vaccine rollout picks up in the United States, companies directly involved in the distribution process stand to benefit, making it wise to keep an eye on names like FedEx (FDX) and Linde (LIN)", "url": "https://www.zacks.com/stock/news/1224655/5-stocks-that-could-directly-gain-from-pfizers-vaccine-success"}, {"symbol": "PFE", "publishedDate": "2020-12-28 08:35:38", "title": "Dividend Bumps and Buybacks Give Pfizer Stock 20% Upside", "image": "https://cdn.snapi.dev/images/v1/v/q/drugs34.jpg", "site": "InvestorPlace", "text": "Pfizer's dividend yield and other value metrics imply good upside for PFE stock. PFE stock is still at least 22% undervalued based on its dividend yield and other valuation metrics.", "url": "https://investorplace.com/2020/12/dividend-bumps-and-buybacks-give-pfizer-stock-20-upside/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 07:28:12", "title": "Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion", "image": "https://cdn.snapi.dev/images/v1/m/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5489222fdrugs-and-pills-on-top-of-hundred-dollar-billsjpgw700opresize.jpg", "site": "Market Watch", "text": "Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc. to jointly develop a treatment for men's and women's cancer in a deal worth up to $4.2 billion in upfront and potential milestone payments. Myovant will receive an upfront payment of $650 million to develop relugolix, a once-daily, oral gonadotropin-releasing hormone receptor antagonist for use in oncology and women's health in the U.S. and Canada.", "url": "https://www.marketwatch.com/story/myovant-shares-soar-16-premarket-on-news-of-pfizer-cancer-drug-deal-worth-up-to-42-billion-2020-12-28"}, {"symbol": "PFE", "publishedDate": "2020-12-28 06:55:00", "title": "Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health", "image": "https://cdn.snapi.dev/images/v1/p/r/press20---0byqjdmsgi.jpg", "site": "GlobeNewsWire", "text": "Myovant and Pfizer to jointly develop and commercialize ORGOVYXTM (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and CanadaMyovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total payment of up to $4.2 billionORGOVYX(relugolix) is the first approved therapy in the Sumitovant Biopharma family of companies Myovant and Pfizer to jointly develop and commercialize ORGOVYXTM (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and CanadaMyovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total payment of up to $4.2 billionORGOVYX(relugolix) is the first approved therapy in the Sumitovant Biopharma family of companies", "url": "https://www.globenewswire.com/news-release/2020/12/28/2150827/0/en/Sumitovant-Biopharma-Announces-Myovant-Sciences-and-Pfizer-Enter-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html"}, {"symbol": "PFE", "publishedDate": "2020-12-28 06:35:55", "title": "As Vaccine Excitement Fades, Buy the Pullback in Pfizer", "image": "https://cdn.snapi.dev/images/v1/u/c/biotech5.jpg", "site": "InvestorPlace", "text": "With its solid dividend yield and reasonable valuation, there's more to like about PFE stock than just Pfizer's pandemic catalyst. The post As Vaccine Excitement Fades, Buy the Pullback in Pfizer appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-28 06:30:00", "title": "Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health", "image": "https://cdn.snapi.dev/images/v1/1/k/press20---0ab9ktfyt2.jpg", "site": "GlobeNewsWire", "text": "BASEL, Switzerland and NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced a collaboration to develop and commercialize relugolix \u2013 a once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist \u2013 in oncology and women's health in the U.S. and Canada. Pfizer will also receive an exclusive option to commercialize relugolix in oncology outside the U.S. and Canada, excluding certain Asian countries.", "url": "https://www.globenewswire.com/news-release/2020/12/28/2150813/0/en/Myovant-Sciences-and-Pfizer-Announce-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html"}, {"symbol": "PFE", "publishedDate": "2020-12-27 11:30:00", "title": "Moderna or Pfizer? Which Company Stands to Gain the Most From Vaccine Rollout", "image": "https://cdn.snapi.dev/images/v1/g/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6059132fgettyimages-1215824553jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Cost and logistics will determine the ultimate winner.", "url": "https://www.fool.com/investing/2020/12/27/moderna-or-pfizer-which-company-stands-to-gain-the/"}, {"symbol": "PFE", "publishedDate": "2020-12-27 07:21:00", "title": "4 Reasons the Stock Market Could Crash in January", "image": "https://cdn.snapi.dev/images/v1/8/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6062052fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The New Year might begin on a sour note if one of more of these events comes to fruition.", "url": "https://www.fool.com/investing/2020/12/27/4-reasons-the-stock-market-could-crash-in-january/"}, {"symbol": "PFE", "publishedDate": "2020-12-27 06:35:00", "title": "Should Investors Be Stashing Cash for 2021?", "image": "https://cdn.snapi.dev/images/v1/i/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056432f2021-and-moneyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "As effective coronavirus vaccines pave the way for an economic recovery, cash-rich investors will be at an advantage.", "url": "https://www.fool.com/investing/2020/12/27/should-investors-be-stashing-cash-for-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-27 06:11:00", "title": "3 COVID Vaccine Stocks Smart Investors Are Buying for 2021", "image": "https://cdn.snapi.dev/images/v1/i/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056812f2021-with-syringejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Should you consider these stocks, too?", "url": "https://www.fool.com/investing/2020/12/27/3-covid-vaccine-stocks-smart-investors-are-buying/"}, {"symbol": "PFE", "publishedDate": "2020-12-26 08:15:00", "title": "What's Behind the Vaccine Feud Between Pfizer and the Feds?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc3---fcfyzwqwaw.jpg", "site": "The Motley Fool", "text": "There's more bark than bite.", "url": "https://www.fool.com/investing/2020/12/26/whats-behind-the-vaccine-feud-between-pfizer-and-t/"}, {"symbol": "PFE", "publishedDate": "2020-12-26 06:09:00", "title": "Pfizer's Pipeline Candidate That Could Be a Bigger Winner Than Its COVID Vaccine", "image": "https://cdn.snapi.dev/images/v1/n/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056782fvaccine-vials-with-stacks-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The drugmaker has another experimental vaccine that should generate billions of dollars in sales annually.", "url": "https://www.fool.com/investing/2020/12/26/pfizers-pipeline-candidate-that-could-be-a-bigger/"}, {"symbol": "PFE", "publishedDate": "2020-12-25 02:30:06", "title": "3 Undervalued Dividend Stocks For Christmas: Lanny's Christmas List", "image": "https://cdn.snapi.dev/images/v1/s/k/stocks1234-epfiv9fteo.jpg", "site": "Seeking Alpha", "text": "Intel is going to be the dominant player in the industry, as many other industries and companies in and outside of technology rely on its chips.", "url": "https://seekingalpha.com/article/4396177-3-undervalued-dividend-stocks-for-christmas-lannys-christmas-list"}, {"symbol": "PFE", "publishedDate": "2020-12-24 11:18:15", "title": "Evergreen Tree of ETFs to Lighten Your Christmas", "image": "https://cdn.snapi.dev/images/v1/5/x/etf43.jpg", "site": "Zacks Investment Research", "text": "The Christmas tree of top-ranked ETFs to brighten 2021 is now ready for investors. May it spread cheer!", "url": "https://www.zacks.com/stock/news/1205906/evergreen-tree-of-etfs-to-lighten-your-christmas"}, {"symbol": "PFE", "publishedDate": "2020-12-24 11:18:05", "title": "Pfizer/BioNTech to Sell More COVID-19 Vaccine Doses to U.S.", "image": "https://cdn.snapi.dev/images/v1/g/d/biotech25---3rjhevqkvj.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE)/BioNTech(BNTX) won a deal for 100 million more doses of its COVID-19 vaccine in the United States.", "url": "https://www.zacks.com/stock/news/1206080/pfizer-biontech-to-sell-more-covid-19-vaccine-doses-to-us"}, {"symbol": "PFE", "publishedDate": "2020-12-24 10:00:00", "title": "2 Must-Own Stocks in 2021", "image": "https://cdn.snapi.dev/images/v1/m/o/us-market-movers-as-economic-data-outweighs-the-pandemic.jpg", "site": "The Motley Fool", "text": "American Airlines and Pfizer should both perform far better than expected in 2021.", "url": "https://www.fool.com/investing/2020/12/24/2-must-own-stocks-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-24 09:47:21", "title": "5 Bank Stocks Set to Rebound With Vaccine-Driven Economic Recovery", "image": "https://cdn.snapi.dev/images/v1/k/k/biotech22.jpg", "site": "Zacks Investment Research", "text": "Improving lending scenarios and restoration of normal activities in 2021, with the help of coronavirus vaccines rollout, will likely help banks like JPMorgan (JPM), Bank of Hawaii (BOH), Bank OZK (OZK), UMB Financial (UMBF) and Synovus (SNV) witness a rebound.", "url": "https://www.zacks.com/stock/news/1205586/5-bank-stocks-set-to-rebound-with-vaccine-driven-economic-recovery"}, {"symbol": "PFE", "publishedDate": "2020-12-24 06:57:00", "title": "Better Coronavirus Stock: Moderna or Pfizer?", "image": "https://cdn.snapi.dev/images/v1/e/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6057862fcoronavirus-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both biotech companies' vaccines have received approval for emergency use in the U.S. -- but which is a better coronavirus stock?", "url": "https://www.fool.com/investing/2020/12/24/better-coronavirus-stock-moderna-or-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-12-24 06:30:00", "title": "3 Red-Hot Stocks to Buy With Just $1,000", "image": "https://cdn.snapi.dev/images/v1/0/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6058872fgettyimages-1273207450jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investing doesn't have to be complicated. These three stocks are premium buys for the new year and beyond.", "url": "https://www.fool.com/investing/2020/12/24/3-red-hot-stocks-to-buy-with-just-1000/"}, {"symbol": "PFE", "publishedDate": "2020-12-24 06:00:00", "title": "10 Dividend Growth Stocks For December 2020", "image": "https://cdn.snapi.dev/images/v1/i/q/the-mirage-within-the-market-a-current-snapshot.jpg", "site": "Seeking Alpha", "text": "In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to get quality scores and sort them in descending order, breaking ties with additional metrics.", "url": "https://seekingalpha.com/article/4396091-10-dividend-growth-stocks-for-december-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-23 18:49:18", "title": "Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/r/q/drugs21.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $37.44, moving +1.91% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1202463/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2020-12-23 17:34:43", "title": "More than 1M Americans have been vaccinated; U.S. to buy 100M more vaccines from Pfizer", "image": "https://cdn.snapi.dev/images/v1/x/9/more-than-1m-americans-have-been-vaccinated-us-to-buy-100m-more-vaccines-from-pfizer.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports the latest news on the coronavirus vaccine distribution, and the new strain of COVID-19. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=milJbnGw0AQ"}, {"symbol": "PFE", "publishedDate": "2020-12-23 16:33:03", "title": "ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe", "image": "https://cdn.snapi.dev/images/v1/m/n/biotech16---mqykzixgjr.jpg", "site": "Zacks Investment Research", "text": "Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.", "url": "https://www.zacks.com/stock/news/1201995/etfs-to-shine-as-pfizers-covid-19-vaccine-gets-a-nod-in-europe"}, {"symbol": "PFE", "publishedDate": "2020-12-23 16:18:30", "title": "Vaccine Stocks Rebound On Pfizer's U.S. Deal, Moderna OK In Canada", "image": "https://cdn.snapi.dev/images/v1/w/h/biotech28.jpg", "site": "Investors Business Daily", "text": "Coronavirus vaccine stocks yo-yoed Wednesday as\u00a0Pfizer won a deal for 100 million more doses in the U.S. and Moderna snagged authorization in Canada for people ages 18 and older. The post Vaccine Stocks Rebound On Pfizer's U.S. Deal, Moderna OK In Canada appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/coronavirus-vaccine-stocks-rebound-pfizer-us-deal-moderna-ok-canada/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 16:08:00", "title": "Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/y/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6061712fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg", "site": "The Motley Fool", "text": "The government still holds an option to get as many as 400 million more.", "url": "https://www.fool.com/investing/2020/12/23/pfizer-and-biontech-to-supply-feds-with-100-millio/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 15:58:00", "title": "Here's Why Wells Fargo Was Rising on Wednesday", "image": "https://cdn.snapi.dev/images/v1/l/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6061792fwfc-mediajpgw700opresize.jpg", "site": "The Motley Fool", "text": "The financial sector was performing well, but Wells Fargo was a big standout.", "url": "https://www.fool.com/investing/2020/12/23/heres-why-wells-fargo-was-rising-on-wednesday/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 15:36:50", "title": "U.S. government, Pfizer reach deal for more vaccine doses", "image": "https://cdn.snapi.dev/images/v1/d/l/us-government-pfizer-reach-deal-for-more-vaccine-doses.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports that Pfizer and the U.S. government have reached a deal to supply more doses of the coronavirus vaccine.", "url": "https://www.youtube.com/watch?v=yOivzBNQvAk"}, {"symbol": "PFE", "publishedDate": "2020-12-23 15:28:44", "title": "Pfizer to deliver 100 million additional doses of its COVID-19 vaccine to the U.S. government", "image": "https://cdn.snapi.dev/images/v1/f/o/104685035-s-740x416.jpg", "site": "Invezz", "text": "Pfizer Inc. (NYSE: PFE) said on Wednesday that it struck a \u00a31.48 billion deal with the U.S. government under which it will now deliver an additional 100 million doses of its COVID-19 vaccine by the end of July. The ongoing pandemic has so far infected more than 18 million people in the United States and caused over 332 thousand deaths.", "url": "https://invezz.com/news/2020/12/23/pfizer-to-deliver-100-million-additional-doses-of-its-covid-19-vaccine-to-the-u-s-government/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 14:03:57", "title": "Why Pfizer Stock Deserves a Spot In Your Portfolio", "image": "https://cdn.snapi.dev/images/v1/n/c/vaccine-4.jpeg", "site": "InvestorPlace", "text": "Pfizer has received its share of \"no respect\" treatment in 2020, but investors should be able to use that to their advantage going forward The post Why Pfizer Stock Deserves a Spot In Your Portfolio appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets", "url": "https://investorplace.com/2020/12/why-pfizer-stock-deserves-a-spot-in-your-portfolio/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 13:53:08", "title": "COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test", "image": "https://cdn.snapi.dev/images/v1/b/f/lab-217041-1280-38.jpg", "site": "Benzinga", "text": "COVID-19-related developments headlined biotech news flow on Wednesday, with announcements of a couple of federal deals and a filing for emergency use authorization. Pfizer-BioNTech to Supply U.S. 100M Incremental Doses: Pfizer Inc. (NYSE: PFE)-BioNTech SE\u00a0(NASDAQ: BNTX) announced\u00a0the U.S. government has firmed up commitment to purchase an incremental 100 million doses of the companies' investigational vaccine \u2013 BNT162b2, confirming earlier reports.", "url": "https://www.benzinga.com/general/biotech/20/12/18912070/covid-news-flow-pfizer-biontechs-us-vaccine-supply-deal-merck-strikes-356m-contract-sorrento-file"}, {"symbol": "PFE", "publishedDate": "2020-12-23 13:43:42", "title": "Coronavirus vaccine: US to secure an additional 100 million doses of COVID-19 vaccine from Pfizer", "image": "https://cdn.snapi.dev/images/v1/h/n/106809695-1607644402725-vac.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the United States purchasing an additional 100 million doses of the coronavirus vaccine with a delivery date of July 2021. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=VvgaGGLrHeQ"}, {"symbol": "PFE", "publishedDate": "2020-12-23 11:46:26", "title": "Top Stocks To Buy Today As Markets Trade Higher Despite Stimulus Criticism", "image": "https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-trade-higher-despite-stimulus-criticism.jpg", "site": "Forbes", "text": "Markets rose slightly despite President Donald Trump slamming the stimulus package in a late night video. For investors looking to make the most of this market, our deep learning algorithms have crunched the data to give you a set of Top Buys.", "url": "https://www.forbes.com/sites/qai/2020/12/23/top-stocks-to-buy-today-as-markets-trade-higher-despite-stimulus-criticism/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 11:41:15", "title": "Coronavirus vaccine: US to purchase additional 100 million doses of COVID-19 vaccines", "image": "https://cdn.snapi.dev/images/v1/m/q/coronavirus-vaccine-us-to-purchase-additional-100-million-doses-of-covid-19-vaccines.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the United States purchasing an additional 100 million doses of the COVID-19 Pfizer- Biontech vaccine. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=79ELBUAiT6U"}, {"symbol": "PFE", "publishedDate": "2020-12-23 11:09:48", "title": "Pfizer Stock Surges After Vaccine Deal with U.S. Government", "image": "https://cdn.snapi.dev/images/v1/a/m/biotech1---5ubqvpavxx.jpg", "site": "Schaeffers Research", "text": "The shares of\u00a0Pfizer Inc. (NYSE:PFE) are up 1.9% at $37.48 at last check, after the pharmaceutical company announced a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion.", "url": "https://www.schaeffersresearch.com/content/news/2020/12/23/pfizer-stock-surges-after-vaccine-deal-with-us-government"}, {"symbol": "PFE", "publishedDate": "2020-12-23 11:06:09", "title": "Dubai is offering the Pfizer vaccine to residents for free in addition to China's Sinopharm shot", "image": "https://cdn.snapi.dev/images/v1/u/b/106551552-1590481334887gettyimages-1048780340.jpeg", "site": "CNBC", "text": "The emirate's first batch of the Pfizer vaccines landed at Dubai International Airport late Tuesday night from Brussels.", "url": "https://www.cnbc.com/2020/12/23/dubai-offering-pfizer-sinopharm-covid-vaccines-to-residents-for-free.html"}, {"symbol": "PFE", "publishedDate": "2020-12-23 10:32:23", "title": "How Effective Will Vaccines be Against New Coronavirus Strain?", "image": "https://cdn.snapi.dev/images/v1/j/u/drugs16.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and Moderna (MRNA), the companies whose coronavirus vaccines have been approved for emergency use, are evaluating their vaccines against the fast-spreading new strain of coronavirus found in the United Kingdom.", "url": "https://www.zacks.com/stock/news/1200531/how-effective-will-vaccines-be-against-new-coronavirus-strain"}, {"symbol": "PFE", "publishedDate": "2020-12-23 10:20:54", "title": "Pfizer Stock Just Can't Seem to Find a Cure for Investor Apathy", "image": "https://cdn.snapi.dev/images/v1/5/0/drugs15.jpg", "site": "InvestorPlace", "text": "Here's my investor math: Huge medical breakthrough, plus huge PR and reputation breakthrough, plus insatiable demand for new product equals (or should equal) ... something.", "url": "https://investorplace.com/2020/12/pfizer-stock-just-cant-seem-to-find-a-cure-for-investor-apathy/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 10:19:00", "title": "Pfizer to Supply an Additional 100 Million Doses of Covid-19 Vaccine to U.S.", "image": "https://cdn.snapi.dev/images/v1/w/s/im-277327.jpg", "site": "Barrons", "text": "Here's what you need to know about the impact of Covid-19 to navigate the markets today.", "url": "https://www.barrons.com/articles/news-updates-51608736667"}, {"symbol": "PFE", "publishedDate": "2020-12-23 10:09:53", "title": "Trump Administration Reaches Deal For 100 Million Additional Doses Of Pfizer's Vaccine", "image": "https://cdn.snapi.dev/images/v1/b/9/trump-administration-reaches-deal-for-100-million-additional-doses-of-pfizers-vaccine.jpg", "site": "Forbes", "text": "The deal doubles the nation's Pfizer vaccine doses.", "url": "https://www.forbes.com/sites/elanagross/2020/12/23/trump-administration-reaches-deal-for-100-million-additional-doses-of-pfizers-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:58:53", "title": "Pfizer Stock Was a Long-Term Place Before Covid and Will Stay One After", "image": "https://cdn.snapi.dev/images/v1/g/6/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p.jpg", "site": "InvestorPlace", "text": "The Covid-19 vaccine isn't a game-changer for Pfizer's valuation. That said, PFE stock was already cheap, and remains a strong buy.", "url": "https://investorplace.com/2020/12/pfizer-stock-long-term-before-covid-stay-one/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:55:00", "title": "3 High-Yield Dividend Stocks I'd Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/q/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5745282fbank-account-1-gettyimages-841087530jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you're looking for a top notch payout, look no further than these stocks.", "url": "https://www.fool.com/investing/2020/12/23/3-high-yield-dividend-stocks-id-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:44:35", "title": "White House and Pfizer strike deal for 100 million more vaccine doses", "image": "https://cdn.snapi.dev/images/v1/c/r/white-house-and-pfizer-strike-deal-for-100-million-more-vaccine-doses.jpg", "site": "CNBC Television", "text": "Pfizer will supply the United States with 100 million additional doses of its Covid-19 vaccine by July next year, the U.S. drugmaker said on Wednesday. CNBC's Becky Quick and Joe Kernen discuss.", "url": "https://www.youtube.com/watch?v=2PvC9zaKsSA"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:16:45", "title": "Pfizer, BioNTech to supply U.S. with an additional 100 million doses of COVID-19 vaccine for about $2 billion", "image": "https://cdn.snapi.dev/images/v1/t/j/pfizer-covid-19-vaccines-five-big-unknowns.jpg", "site": "Market Watch", "text": "Pfizer Inc. and BioNTech SE announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to 200 million.", "url": "https://www.marketwatch.com/story/pfizer-biontech-to-supply-us-with-an-additional-100-million-doses-of-covid-19-vaccine-for-about-2-billion-2020-12-23"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:15:00", "title": "Pfizer to supply U.S. with 100 million more COVID-19 shots by July", "image": "https://cdn.snapi.dev/images/v1/2/l/m02d20201223t2i1545553758w940fhfwllplsqrlynxmpegbm0sx.jpg", "site": "Reuters", "text": "Pfizer Inc will supply the United States with 100 million additional doses of its COVID-19 vaccine by July next year, the U.S. drugmaker said on Wednesday.", "url": "https://www.reuters.com/article/us-health-coronavirus-usa-pfizer/pfizer-to-supply-u-s-with-100-million-more-covid-19-shots-by-july-idUSKBN28X1GC"}, {"symbol": "PFE", "publishedDate": "2020-12-23 07:00:00", "title": "Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/u/i/press3---ne6mfgpa1l.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies' COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the origi", "url": "https://www.businesswire.com/news/home/20201223005185/en/Pfizer-and-BioNTech-to-Supply-the-U.S.-with-100-Million-Additional-Doses-of-COVID-19-Vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 06:26:37", "title": "Pfizer and the Trump administration are reportedly close to agreeing 70 million extra vaccine doses for next year to plug a potentially massive shortfall in the US", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-and-the-trump-administration-are-reportedly-close-to-agreeing-70-million-extra-vaccine-doses-for-next-year-to-plug-a-potentially-massive-shortfall-in-the-us.jpg", "site": "Business Insider", "text": "Pfizer is reportedly close to striking a deal with the Trump administration to supply tens of million more doses of its COVID-19 vaccine to the US in 2021, people familiar with the discussions told The New York Times Tuesday. The US government wants 100 million additional doses of Pfizer and its German partner BioNTech's vaccine between April to June, the Times reported. The drugmaker has said it could supply 70 million doses, the people said, provided it gets better access to manufacturing supplies through the Defense Production Act.", "url": "https://www.businessinsider.com/pfizer-vaccine-trump-administration-extra-doses-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-23 06:10:00", "title": "Should You Worry About This Side Effect to Moderna's and Pfizer's COVID Vaccines?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc1---ajbypxgi8m.jpg", "site": "The Motley Fool", "text": "The short answer is \"no.\"", "url": "https://www.fool.com/investing/2020/12/23/should-you-worry-about-this-side-effect-to-moderna/"}, {"symbol": "PFE", "publishedDate": "2020-12-23 05:11:08", "title": "Throw Growth Aside and See Pfizer Stock as Top Dividend and Cash Flow Play", "image": "https://cdn.snapi.dev/images/v1/u/v/drugs7.jpg", "site": "InvestorPlace", "text": "Forget growth. Pfizer is an income play.", "url": "https://investorplace.com/2020/12/pfe-stock-is-a-top-dividend-and-cash-flow-play/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 23:43:25", "title": "US close on deal with Pfizer for millions more vaccine doses", "image": "https://cdn.snapi.dev/images/v1/j/c/biotech26---yw0adtdmps.jpg", "site": "Fox Business", "text": "Another deal with Pfizer would move the nation closer to the goal of vaccinating all Americans.", "url": "https://www.foxbusiness.com/markets/us-close-on-deal-with-pfizer-for-millions-more-vaccine-doses"}, {"symbol": "PFE", "publishedDate": "2020-12-22 23:42:00", "title": "BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc.", "image": "https://cdn.snapi.dev/images/v1/v/k/press2---j3dufz2358.jpg", "site": "PRNewsWire", "text": "LUND, Sweden, Dec. 23, 2020 /PRNewswire/ -- BioInvent International AB (OMXS: BINV ), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that Pfizer Inc. (\"Pfizer\") (NYSE: PFE) has...", "url": "https://www.prnewswire.com/news-releases/bioinvent-receives-3-million-payment-related-to-selection-of-antibodies-under-collaboration-with-pfizer-inc-301197924.html"}, {"symbol": "PFE", "publishedDate": "2020-12-22 22:49:44", "title": "Pfizer Nears Deal To Supply Another 100M COVID-19 Vaccine Doses To US By July", "image": "https://cdn.snapi.dev/images/v1/i/n/cdc-9mvmgp2zhgs-unsplash.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) is nearing a deal with the outgoing President Donald\u00a0Trump's administration to supply 100 million\u00a0doses of its coronavirus vaccine to the United States, the Wall Street Journal reported Tuesday. What Happened: The U.S. government would pay Pfizer $2 billion as per the terms of the deal, under consideration, and the drugmaker would provide the vaccine doses by July, people familiar with the matter told the Journal.", "url": "https://www.benzinga.com/general/biotech/20/12/18904942/pfizer-nears-deal-to-supply-another-100m-covid-19-vaccine-doses-to-us-by-july"}, {"symbol": "PFE", "publishedDate": "2020-12-22 20:36:00", "title": "Las Vegas: COVID Winter", "image": "https://cdn.snapi.dev/images/v1/u/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6059782fvegas-strip-during-winter-editjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Amidst an unchecked surge that has left Nevada with the highest per capita COVID hospitalizations in the nation, Governor Steve Sisolak (D) has chosen a novel approach to containing the spread of the virus: Do absolutely nothing.", "url": "https://www.fool.com/investing/2020/12/22/las-vegas-covid-winter/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 19:19:27", "title": "Pfizer and the U.S. is nearing deal to deliver 100M more vaccines", "image": "https://cdn.snapi.dev/images/v1/u/c/pfizer-and-the-us-is-nearing-deal-to-deliver-100m-more-vaccines.jpg", "site": "CNBC Television", "text": "CNBC's senior health and science reporter Meg Tirrell reports the U.S. is nearing a deal with Pfizer to deliver an additional 100 million doses of the coronavirus vaccine. The first 70 million will be split across April, May and June.", "url": "https://www.youtube.com/watch?v=8B98NGnvmwA"}, {"symbol": "PFE", "publishedDate": "2020-12-22 18:52:45", "title": "Report: Trump Administration Nears Deal For Additional Pfizer Vaccine Doses", "image": "https://cdn.snapi.dev/images/v1/w/9/report-trump-administration-nears-deal-for-additional-pfizer-vaccine-doses.jpg", "site": "Forbes", "text": "The government had the opportunity to secure 600 million doses under an agreement signed in July.", "url": "https://www.forbes.com/sites/elanagross/2020/12/22/report-trump-administration-nears-deal-for-additional-pfizer-vaccine-doses/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 17:56:57", "title": "Pfizer nears deal with U.S. government for more Covid vaccine doses, source says", "image": "https://cdn.snapi.dev/images/v1/b/s/106814531-16085762092020-12-21t182006z-1140774493-rc2urk9pi75l-rtrmadp-0-health-coronavirus-vaccines.jpeg", "site": "CNBC", "text": "The U.S. government is close to a deal with Pfizer for up to an additional 100 million doses of its coronavirus vaccine, a source told CNBC's Meg Tirrell on Tuesday.", "url": "https://www.cnbc.com/2020/12/22/covid-vaccine-pfizer-nears-deal-with-us-government-for-more-doses-.html"}, {"symbol": "PFE", "publishedDate": "2020-12-22 12:10:32", "title": "Top Stocks To Buy Today As Markets Trade Mixed After Yesterday's Session", "image": "https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-trade-mixed-after-yesterdays-session.jpg", "site": "Forbes", "text": "Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.", "url": "https://www.forbes.com/sites/qai/2020/12/22/top-stocks-to-buy-today-as-markets-trade-mixed-after-yesterdays-session/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 12:02:14", "title": "5 High Beta & Momentum ETFs to Tap the Santa Rally", "image": "https://cdn.snapi.dev/images/v1/h/e/bank43---ekca46iumh.jpg", "site": "Zacks Investment Research", "text": "These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.", "url": "https://www.zacks.com/stock/news/1196100/5-high-beta-momentum-etfs-to-tap-the-santa-rally"}, {"symbol": "PFE", "publishedDate": "2020-12-22 11:19:27", "title": "Moderna, Pfizer Testing Coronavirus Vaccine Against New Strain", "image": "https://cdn.snapi.dev/images/v1/9/l/syringe-1884758-1920-80.jpg", "site": "Benzinga", "text": "Even with the relief brought by the conditional approval of two coronavirus vaccines,\u00a0a more virulent and contagious variant of the virus in the U.K. has emerged.\u00a0 Pfizer Inc. (NYSE: PFE), with its German partner BioNTech SE \u2013 ADR (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) are the two companies that have received approval for emergency use of their respective investigational vaccines.", "url": "https://www.benzinga.com/general/biotech/20/12/18895061/moderna-pfizer-testing-coronavirus-vaccine-against-new-strain"}, {"symbol": "PFE", "publishedDate": "2020-12-22 11:17:19", "title": "3 Large Drugmakers Set to Rule the Sector in 2021", "image": "https://cdn.snapi.dev/images/v1/w/h/drugs48.jpg", "site": "Zacks Investment Research", "text": "3 Large Drugmakers Set to Rule the Sector in 2021", "url": "https://www.zacks.com/commentary/1194839/3-large-drugmakers-set-to-rule-the-sector-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-22 10:00:00", "title": "Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts", "image": "https://cdn.snapi.dev/images/v1/e/h/conf8---wldmcx8qsv.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/", "url": "https://www.businesswire.com/news/home/20201222005012/en/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-February-2-Conference-Call-with-Analysts/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 09:02:07", "title": "4 Restaurant Stocks to Play a Likely Turnaround in 2021", "image": "https://cdn.snapi.dev/images/v1/l/a/drugs44.jpg", "site": "Zacks Investment Research", "text": "Although the restaurant industry is grappling with the coronavirus outbreak, restaurant stocks like JACK, RUTH, FAT and STKS have impressive 2021 earnings growth projections.", "url": "https://www.zacks.com/stock/news/1195324/4-restaurant-stocks-to-play-a-likely-turnaround-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-22 07:55:00", "title": "Do These Coronavirus Vaccine Companies Have a Place in an ESG Portfolio?", "image": "https://cdn.snapi.dev/images/v1/7/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6053342fgettyimages-1218143963jpgw700opresize.jpg", "site": "The Motley Fool", "text": "They might, especially if you consider vaccines to be good for society.", "url": "https://www.fool.com/investing/2020/12/22/do-these-coronavirus-vaccine-companies-have-place-/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 07:32:05", "title": "Pfizer/BioNTech COVID-19 Vaccine Gets Authorization in Europe", "image": "https://cdn.snapi.dev/images/v1/a/w/biotech34.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate is the first COVID-19 vaccine to be granted conditional authorization in Europe.", "url": "https://www.zacks.com/stock/news/1195067/pfizer-biontech-covid-19-vaccine-gets-authorization-in-europe"}, {"symbol": "PFE", "publishedDate": "2020-12-22 07:09:41", "title": "Pfizer-BioNTech, Moderna Test Vaccines Against New Covid-19 Variant Spreading Across U.K.", "image": "https://cdn.snapi.dev/images/v1/y/q/pfizer-biontech-moderna-test-vaccines-against-new-covid-19-variant-spreading-across-uk.jpg", "site": "Forbes", "text": "BioNTech's CEO said on Tuesday that while it is currently unclear whether the vaccine can protect against the new U.K. strain, it is \u201chighly likely\u201d the shot can protect against new variants.", "url": "https://www.forbes.com/sites/roberthart/2020/12/22/pfizer-biontech-moderna-test-vaccines-against-new-covid-19-variant-spreading-across-uk/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 06:30:00", "title": "5 Huge Investing Lessons We All Re-Learned in 2020", "image": "https://cdn.snapi.dev/images/v1/b/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056632fgettyimages-1063612540jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It was a crazy year that reinforced time-tested investing principles.", "url": "https://www.fool.com/investing/2020/12/22/5-huge-investing-lessons-we-all-re-learned-in-2020/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 06:10:00", "title": "Is Pfizer's COVID Vaccine Growth Story Already Over?", "image": "https://cdn.snapi.dev/images/v1/s/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056732fend-of-story-typewriterjpgw700opresize.jpg", "site": "The Motley Fool", "text": "It might seem like it, based on the stock's recent performance.", "url": "https://www.fool.com/investing/2020/12/22/is-pfizers-covid-vaccine-growth-story-already-over/"}, {"symbol": "PFE", "publishedDate": "2020-12-22 06:08:17", "title": "Dividend Stock Purchase: Lanny's November 2020 Summary", "image": "https://cdn.snapi.dev/images/v1/j/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5219362ftd-ameritrade-apps-and-web-sites.jpg", "site": "Seeking Alpha", "text": "My dividend stock portfolio was burnt by dividend cuts and lost over $800+ in forward dividend income. Therefore, I was ready to get back to basics and acquire more shares in the best quality dividend stocks out there. My dividend stock purchases of VYM totaled $1,307.79, acquiring 15 total shares. This added $41.10 in forward dividend income. I will continue this going forward, 3 shares per week.", "url": "https://seekingalpha.com/article/4395776-dividend-stock-purchase-lannys-november-2020-summary"}, {"symbol": "PFE", "publishedDate": "2020-12-22 02:13:00", "title": "Singapore is first Asian country to receive batch of Pfizer's Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/8/y/006-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg", "site": "CNET", "text": "The Pfizer-BioNTech vaccine has landed in the tiny-island nation after it was approved for distribution last week.", "url": "https://www.cnet.com/health/singapore-becomes-first-asian-country-to-receive-batches-of-pfizer-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 21:59:49", "title": "Pfizer Partner BioNTech Confident Vaccine Effective Against UK Mutant COVID-19 Strain", "image": "https://cdn.snapi.dev/images/v1/q/b/satheesh-sankaran-yxtna6yccls-unsplash-1.jpg", "site": "Benzinga", "text": "Ugur Sahin, CEO of BioNTech SE (NASDAQ: BNTX) \u2014 the German partner of Pfizer Inc (NYSE: PFE) \u2014 expressed confidence that two companies' jointly-developed vaccine is effective against a new mutation of COVID-19, Reuters reported Monday.\u00a0 What Happened: Sahin told Germany's Bild TV that BioNTech would look into the mutation that has emerged out of the United Kingdom in the coming days and viewed the matter \u201cwith a degree of soberness,\u201d as per Reuters.", "url": "https://www.benzinga.com/general/biotech/20/12/18887340/pfizer-partner-biontech-confident-vaccine-effective-against-uk-mutant-covid-19-strain"}, {"symbol": "PFE", "publishedDate": "2020-12-21 19:31:00", "title": "Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe", "image": "https://cdn.snapi.dev/images/v1/b/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6058702fgloved-hands-holding-a-vial-of-medicinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "BNT162b2 gets another green light from a top healthcare regulator.", "url": "https://www.fool.com/investing/2020/12/21/pfizer-and-biontechs-coronavirus-vaccine-approved/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 17:19:38", "title": "U.S. plans to study allergic reactions from Pfizer's Covid vaccine", "image": "https://cdn.snapi.dev/images/v1/p/d/106814522-16085755612020-12-18t013420z-1275281663-rc2dpk9hqxno-rtrmadp-0-health-coronavirus-usa.jpeg", "site": "CNBC", "text": "The U.S. is planning a study to find out why some people have suffered from allergic reactions after receiving a Covid vaccine, an NIAID official told CNBC.", "url": "https://www.cnbc.com/2020/12/21/covid-vaccine-us-plans-to-study-allergic-reactions-from-pfizer-shots.html"}, {"symbol": "PFE", "publishedDate": "2020-12-21 14:37:51", "title": "E.U. committee recommends authorization of BioNTech and Pfizer's coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/a/x/004-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. were down 1.1% and BioNTech SE shares were up 1.2% in trading on Monday after the companies said their COVID-19 vaccine has been recommended for authorization in the European Union. The Committee for Medicinal Products for Human Use made the recommendation, and the European Commission is expected to review it and make a final decision in the \"near future.", "url": "https://www.marketwatch.com/story/eu-committee-recommends-authorization-of-biontech-and-pfizers-coronavirus-vaccine-2020-12-21"}, {"symbol": "PFE", "publishedDate": "2020-12-21 14:33:16", "title": "Trending Stocks For This Week As Markets Remain Sensitive To News", "image": "https://cdn.snapi.dev/images/v1/t/r/trending-stocks-for-this-week-as-markets-remain-sensitive-to-news.jpg", "site": "Forbes", "text": "Mixed sentiment is once again the theme. On one hand, a stimulus package finally passed and a second coronavirus vaccine is on its way.", "url": "https://www.forbes.com/sites/qai/2020/12/21/trending-stocks-for-this-week-as-markets-remain-sensitive-to-news/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 14:09:00", "title": "Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/i/2/press11---j2glzpg5p9.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY\u00ae (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. This follows the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) positive op", "url": "https://www.businesswire.com/news/home/20201221005672/en/Pfizer-and-BioNTech-Receive-Authorization-in-the-European-Union-for-COVID-19-Vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 13:36:40", "title": "Trump Covid vaccine czar says 'extremely low' chance Pfizer and Moderna shots won't work against new strain", "image": "https://cdn.snapi.dev/images/v1/j/n/106811374-1608036473344-gettyimages-1291313833-tdp-l-covid19-vaccines-1408.jpeg", "site": "CNBC", "text": "resident Donald Trump's coronavirus vaccine czar said Monday that he expects Pfizer's and Moderna's Covid-19 shots will be effective against a new mutation of the virus found in the U.K.", "url": "https://www.cnbc.com/2020/12/21/trump-covid-vaccine-czar-says-extremely-low-chance-pfizer-and-moderna-shots-wont-work-against-new-strain.html"}, {"symbol": "PFE", "publishedDate": "2020-12-21 12:48:00", "title": "European Commission gives final approval to Pfizer/BioNTech vaccine", "image": "https://cdn.snapi.dev/images/v1/p/m/m02d20201221t2i1545335695w940fhfwllplsqrlynxmpegbk1cq.jpg", "site": "Reuters", "text": "The European Commission gave approval on Monday for the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech, the final step to allowing Europe to start inoculations within a week.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccine-eu/european-commission-gives-final-approval-to-pfizer-biontech-vaccine-idUSKBN28V2ED"}, {"symbol": "PFE", "publishedDate": "2020-12-21 12:34:50", "title": "Pfizer/BioNTech Covid vaccine approved by European regulator", "image": "https://cdn.snapi.dev/images/v1/0/h/4660jpgwidth460quality85autoformatfitmaxs13aede3c6ff836eab80a61758ff31a36.jpg", "site": "The Guardian", "text": "EMA's move paves way for inoculations to begin across Europe within next few days", "url": "https://www.theguardian.com/society/2020/dec/21/pfizer-biontech-covid-vaccine-approved-by-european-regulator"}, {"symbol": "PFE", "publishedDate": "2020-12-21 12:03:04", "title": "5 Small-Cap ETFs Set to Explode on COVID-19 Vaccines", "image": "https://cdn.snapi.dev/images/v1/q/u/biotech20.jpg", "site": "Zacks Investment Research", "text": "As the economy seems on track for strong growth, a small-cap rally is expected to strengthen in the New Year.", "url": "https://www.zacks.com/stock/news/1191922/5-small-cap-etfs-set-to-explode-on-covid-19-vaccines"}, {"symbol": "PFE", "publishedDate": "2020-12-21 11:18:10", "title": "Top 5 S&P 500 Stocks That Helped the Index Gain in 2020", "image": "https://cdn.snapi.dev/images/v1/c/p/computer-electronic28.jpg", "site": "Zacks Investment Research", "text": "Here we pick five S&P 500 stocks -- NVDA, ETSY, AAPL, MSFT & AMZN -- that have helped the index deliver solid returns this year.", "url": "https://www.zacks.com/stock/news/1191709/top-5-sp-500-stocks-that-helped-the-index-gain-in-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-21 11:18:08", "title": "Pre-Markets Down to Start Christmas Week", "image": "https://cdn.snapi.dev/images/v1/m/x/aero3.jpg", "site": "Zacks Investment Research", "text": "Though already off the lows we saw a couple hours before today's opening bell, the Dow is down 400 points, the S&P 500 -55 and the Nasdaq -140.", "url": "https://www.zacks.com/stock/news/1191729/pre-markets-down-to-start-christmas-week"}, {"symbol": "PFE", "publishedDate": "2020-12-21 11:18:06", "title": "Christmas Week Begins With Pre-market Sell-off", "image": "https://cdn.snapi.dev/images/v1/e/w/aero2.jpg", "site": "Zacks Investment Research", "text": "Christmas Week Begins With Pre-market Sell-off", "url": "https://www.zacks.com/stock/news/1191805/christmas-week-begins-with-pre-market-sell-off"}, {"symbol": "PFE", "publishedDate": "2020-12-21 11:10:56", "title": "EMA Committee Recommends Conditional Approval Of Pfizer-BioNTech Vaccine In Europe", "image": "https://cdn.snapi.dev/images/v1/f/q/vaccine-4892017-1920-8.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE)-BioNTech SE's \u2013 ADR (NASDAQ: BNTX) coronavirus vaccine candidate \u2013 BNT162b2 \u2013 is inching closer to getting conditional approval in European Union, after similar approvals in the U.S., U.K., Bahrain Saudi Arabia, Canada, Mexico and Switzerland. What Happened: Following a rigorous evaluation of BNT162b2, which is to go by the trade name Comirnaty in Europe, the European Medicines Agency's Committee For Medicinal Products For Human Use concluded by consensus that sufficiently robust data on the safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorization.", "url": "https://www.benzinga.com/general/biotech/20/12/18877575/ema-committee-recommends-conditional-approval-of-pfizer-biontech-vaccine-in-europe"}, {"symbol": "PFE", "publishedDate": "2020-12-21 10:53:01", "title": "7 Healthcare Stocks to Buy With the Sector Under Scrutiny", "image": "https://cdn.snapi.dev/images/v1/w/b/reit9.jpg", "site": "InvestorPlace", "text": "True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.", "url": "https://investorplace.com/2020/12/7-healthcare-stocks-to-buy-with-the-sector-under-scrutiny/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 10:50:00", "title": "European Union Approves Pfizer-BioNTech Covid Vaccine", "image": "https://cdn.snapi.dev/images/v1/v/a/im-276070.jpg", "site": "Barrons", "text": "The European Union has authorized its first vaccine against Covid-19, joining the U.S. and the U.K. in allowing the shots developed by Pfizer and BioNTech.", "url": "https://www.barrons.com/articles/european-union-approves-pfizer-biontech-covid-vaccine-51608565816"}, {"symbol": "PFE", "publishedDate": "2020-12-21 10:17:04", "title": "EU Drug Regulator Approves Pfizer-BioNTech Covid-19 Vaccine For Emergency Use", "image": "https://cdn.snapi.dev/images/v1/n/w/eu-drug-regulator-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use.jpg", "site": "Forbes", "text": "The European Union has so far managed to secure 2 billion doses of various Covid-19 vaccines.", "url": "https://www.forbes.com/sites/siladityaray/2020/12/21/eu-drug-regulator-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 10:10:00", "title": "European Regulators Clear Pfizer's Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/6/t/im-276103.jpg", "site": "Barrons", "text": "Here's what you need to know about the impact of Covid-19 to navigate the markets today.", "url": "https://www.barrons.com/articles/news-updates-51608563362"}, {"symbol": "PFE", "publishedDate": "2020-12-21 10:08:00", "title": "EU drug regulator: Pfizer-BioNTech vaccine should be on case by case for pregnant women", "image": "https://cdn.snapi.dev/images/v1/m/r/m02d20201221t2i1545315607w940fhfwllplsqrlynxmpegbk12x.jpg", "site": "Reuters", "text": "The European drug regulator said on Monday the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech on pregnant women should be done on a case by case basis.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccine-ema-pregna/eu-drug-regulator-pfizer-biontech-vaccine-should-be-on-case-by-case-for-pregnant-women-idUSKBN28V1VV"}, {"symbol": "PFE", "publishedDate": "2020-12-21 09:40:26", "title": "European Medicines Agency just recommended the Pfizer and BioNtech COVID-19 vaccine for use in EU", "image": "https://cdn.snapi.dev/images/v1/e/u/european-medicines-agency-just-recommended-the-pfizer-and-biontech-covid-19-vaccine-for-use-in-eu.jpg", "site": "Business Insider", "text": "The European Union drug regulator recommended the EU authorize the Pfizer and BioNtech COVID-19 vaccine on Monday. Experts on the European Medicines Agency's human medicines committee concluded the Pfizer vaccine was safe and effective for people 16-years-old and older using available data. The decision will lead the way for a EU-wide authorization of the vaccine.", "url": "https://www.businessinsider.com/pfizer-covid-vaccine-use-european-medicines-agency-eu-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-21 09:24:54", "title": "European Medicines Agency authorizes Pfizer vaccine for use in the EU", "image": "https://cdn.snapi.dev/images/v1/h/h/106801456-1606219164685-gettyimages-1229640665-boy2020.jpeg", "site": "CNBC", "text": "The European Medicines Agency said it had recommended granting conditional marketing authorization for the vaccine in people aged 16 and over.", "url": "https://www.cnbc.com/2020/12/21/european-medicines-agency-authorizes-pfizer-vaccine-for-use-in-the-eu.html"}, {"symbol": "PFE", "publishedDate": "2020-12-21 09:21:00", "title": "Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/h/s/press19---ikxkcpxpjn.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. The purpose of a", "url": "https://www.businesswire.com/news/home/20201221005471/en/Pfizer-and-BioNTech-Receive-CHMP-Positive-Opinion-for-their-COVID-19-Vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 09:02:13", "title": "Vaccines to Fuel Santa Claus Rally: 5 Stock Picks", "image": "https://cdn.snapi.dev/images/v1/i/0/steel21.jpg", "site": "Zacks Investment Research", "text": "With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.", "url": "https://www.zacks.com/stock/news/1191264/vaccines-to-fuel-santa-claus-rally-5-stock-picks"}, {"symbol": "PFE", "publishedDate": "2020-12-21 09:02:08", "title": "4 Restaurant Stocks to Watch as Vaccine Rollout Begins", "image": "https://cdn.snapi.dev/images/v1/f/f/biotech6.jpg", "site": "Zacks Investment Research", "text": "Vaccine rollout should allow dine-in to resume in restaurants with online delivery expected to sustain, making it prudent to keep an eye on names like Brinker International (EAT) and McDonald's (MCD)", "url": "https://www.zacks.com/stock/news/1191291/4-restaurant-stocks-to-watch-as-vaccine-rollout-begins"}, {"symbol": "PFE", "publishedDate": "2020-12-21 08:58:30", "title": "3 Mega-Cap Stocks for Safe Dividends", "image": "https://cdn.snapi.dev/images/v1/s/t/stcu22---ndweqtz8d7.jpg", "site": "InvestorPlace", "text": "Thanks to their safe dividends, you can rely on these mega-cap stocks to not only survive tough times, but pay you while you wait. The post 3 Mega-Cap Stocks for Safe Dividends appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/3-mega-cap-stocks-for-safe-dividends/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 07:38:01", "title": "Shippers prepare to move both Pfizer and Moderna vaccines simultaneously", "image": "https://cdn.snapi.dev/images/v1/n/n/shippers-prepare-to-move-both-pfizer-and-moderna-vaccines-simultaneously.jpg", "site": "CNBC Television", "text": "The first doses of Moderna's coronavirus vaccine are being shipped around the U.S. after the FDA approved it for emergency use late Friday. CNBC's Frank Holland reports how this rollout will be much different than that of Pfizer's vaccine and how FedEx is playing a key role in its distribution.", "url": "https://www.youtube.com/watch?v=2e6FP8iydXo"}, {"symbol": "PFE", "publishedDate": "2020-12-21 06:59:34", "title": "Stocks Set to Confront the Virus in 2021 (NASDAQ: MRNA) (OTC: HALB) (NYSE: PFE)", "image": "https://cdn.snapi.dev/images/v1/d/p/biotech3.jpg", "site": "OTC PR Wire", "text": "Stocks Set to Confront the Virus in 2021 (NASDAQ: MRNA) (OTC: HALB) (NYSE: PFE)", "url": "https://otcprwire.com/stocks-set-to-confront-the-virus-in-2021-nasdaq-mrna-otc-halb-nyse-pfe/"}, {"symbol": "PFE", "publishedDate": "2020-12-21 02:39:14", "title": "CDC Says Over 556,208 Pfizer/BioNTech COVID-19 Shots Administered In Week 1 Of Inoculation Drive", "image": "https://cdn.snapi.dev/images/v1/w/b/dimitri-houtteman-qbhppxw3ess-unsplash-4-0.jpg", "site": "Benzinga", "text": "A week into the COVID-19 mass vaccination efforts, the U.S. Centers For Disease Control and Prevention\u00a0reports that \u2014 of the 2,838,225\u00a0doses\u00a0distributed around the country \u2014 over 556,208 doses had been administered as of Sunday. What Happened: The U.S.\u00a0Food and Drug Administration has approved two vaccine candidates so far.", "url": "https://www.benzinga.com/general/biotech/20/12/18869562/cdc-says-over-556-208-pfizerbiontech-covid-19-shots-administered-in-week-1-of-inoculation-drive"}, {"symbol": "PFE", "publishedDate": "2020-12-20 14:30:00", "title": "3 Top Breakout Stocks to Watch in 2021", "image": "https://cdn.snapi.dev/images/v1/k/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6045752fgettyimages-851045746jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies have already delivered handsome profits to their shareholders in 2020, but their growth prospects mean they remain solid buys.", "url": "https://www.fool.com/investing/2020/12/20/3-top-breakout-stocks-to-watch-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-20 08:51:00", "title": "4 Reasons You Should Buy Pfizer Stock Right Now", "image": "https://cdn.snapi.dev/images/v1/w/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6052752fsciency-scientists-with-lab-equipment-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You're not the only one wondering if this dividend-paying pharma stock deserves a place in a portfolio.", "url": "https://www.fool.com/investing/2020/12/20/reasons-to-buy-pfizer-stock-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-20 07:31:00", "title": "$40 Billion Per Year for COVID Vaccine Makers Hinges on This 1 Unanswered Question", "image": "https://cdn.snapi.dev/images/v1/6/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047842fquestion-mark-made-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "And it could be a long time before we know the answer.", "url": "https://www.fool.com/investing/2020/12/20/40-billion-per-year-for-covid-vaccine-makers-hinge/"}, {"symbol": "PFE", "publishedDate": "2020-12-19 15:21:04", "title": "Pfizer-BioNTech And Moderna Covid-19 Vaccines: Here Are 5 Differences", "image": "https://cdn.snapi.dev/images/v1/d/c/pfizer-biontech-and-moderna-covid-19-vaccines-here-are-5-differences.jpg", "site": "Forbes", "text": "Now there are two. The Moderna Covid-19 coronavirus vaccine received emergency use authorization from the U.S. FDA to join the Pfizer/BioNTech vaccine.", "url": "https://www.forbes.com/sites/brucelee/2020/12/19/pfizer-biontech-and-moderna-covid-19-vaccines-here-are-5-differences/"}, {"symbol": "PFE", "publishedDate": "2020-12-19 12:33:00", "title": "Here's What Investors Need to Know About Pfizer and BioNTech's Vaccine Launch", "image": "https://cdn.snapi.dev/images/v1/p/o/podc11---a7lalanm24.jpg", "site": "The Motley Fool", "text": "Manufacturing is a black box for investors.", "url": "https://www.fool.com/investing/2020/12/19/heres-what-investors-need-to-know-about-pfizer-and/"}, {"symbol": "PFE", "publishedDate": "2020-12-19 09:15:00", "title": "Here's Why Pfizer's Vaccine Is So Important", "image": "https://cdn.snapi.dev/images/v1/p/o/podc8---eoytkzmqaf.jpg", "site": "The Motley Fool", "text": "It could be the beginning of the end for the pandemic.", "url": "https://www.fool.com/investing/2020/12/19/heres-why-pfizers-vaccine-is-so-important/"}, {"symbol": "PFE", "publishedDate": "2020-12-19 07:45:00", "title": "Better Coronavirus Stock: Pfizer vs. BioNTech", "image": "https://cdn.snapi.dev/images/v1/6/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6050762fgettyimages-1219401083jpgw700opresize.jpg", "site": "The Motley Fool", "text": "One healthcare company is confident about its future while the other tries to recapture its former glory.", "url": "https://www.fool.com/investing/2020/12/19/better-coronavirus-stock-pfizer-vs-biontech/"}, {"symbol": "PFE", "publishedDate": "2020-12-19 06:44:01", "title": "Moderna Finishes The Vaccine Race Close Behind Pfizer as FDA Authorizes Its Coronavirus Vaccine For Emergency Use", "image": "https://cdn.snapi.dev/images/v1/b/c/virus-4030721-1920-1-1.jpg", "site": "Benzinga", "text": "A week after Pfizer Inc. (NYSE: PFE) received the greenlight for its vaccine against the coronavirus, the Food and Drug Administration cleared a similar vaccine candidate, mRNA-1273, from Moderna Inc (NASDAQ: MRNA). What Happened: The\u00a0FDA authorized the emergency use of mRNA-1273 against COVID-19 in individuals 18 years and older, the Cambridge, Massachusetts-based biopharma said in a late Friday statement.", "url": "https://www.benzinga.com/general/biotech/20/12/18864205/moderna-finishes-the-vaccine-race-close-behind-pfizer-as-fda-authorizes-its-coronavirus-vaccine-f"}, {"symbol": "PFE", "publishedDate": "2020-12-19 06:17:00", "title": "Is Pfizer Stock a Good Bet on Coronavirus Vaccines?", "image": "https://cdn.snapi.dev/images/v1/3/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6048762fvaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "The FDA gave this pharmaceutical company's COVID-19 vaccine the green light for emergency use, but does that make it a sound investment?", "url": "https://www.fool.com/investing/2020/12/19/is-pfizer-stock-a-good-bet-on-coronavirus-vaccines/"}, {"symbol": "PFE", "publishedDate": "2020-12-18 16:57:01", "title": "Dr. Scott Gottlieb on the Pfizer, Moderna vaccine rollouts", "image": "https://cdn.snapi.dev/images/v1/i/c/dr-scott-gottlieb-on-the-pfizer-moderna-vaccine-rollouts.jpg", "site": "CNBC Television", "text": "The FDA advisory panel recommended Moderna vaccine for emergency use authorization. The Pfizer vaccine has been distributed across the U.S. and delivered to health-care workers, but some states said they haven't received enough vaccines.", "url": "https://www.youtube.com/watch?v=QRiE_aAQXoQ"}, {"symbol": "PFE", "publishedDate": "2020-12-18 14:25:00", "title": "Pfizer Stock and the Modern-Day Apollo Program", "image": "https://cdn.snapi.dev/images/v1/a/x/drugs25.jpg", "site": "InvestorPlace", "text": "Much like the effort to put a man on the moon, the Covid-19 vaccine is historic. But there are other drivers for Pfizer stock as well.", "url": "https://investorplace.com/2020/12/pfizer-stock-and-the-modern-day-apollo-program/"}, {"symbol": "PFE", "publishedDate": "2020-12-18 11:17:05", "title": "Markets, Covid Deaths at New All-Time Highs", "image": "https://cdn.snapi.dev/images/v1/u/j/biotech25.jpg", "site": "Zacks Investment Research", "text": "The coronavirus posted a new one-day high in both cases -- 241,620 -- and fatalities -- 3,438 -- on Thursday.", "url": "https://www.zacks.com/stock/news/1180622/markets-covid-deaths-at-new-all-time-highs"}, {"symbol": "PFE", "publishedDate": "2020-12-18 08:17:09", "title": "4 Small COVID-19 Vaccine Makers to Look Out for in 2021", "image": "https://cdn.snapi.dev/images/v1/s/l/biotech16.jpg", "site": "Zacks Investment Research", "text": "Here we discuss four small biotech companies, NVAX, CVAC, VXRT and ARCT, that are making COVID-19 vaccine candidates, which may be approved in 2021, if successfully developed, and bring profits.", "url": "https://www.zacks.com/stock/news/1179956/4-small-covid-19-vaccine-makers-to-look-out-for-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-18 07:19:24", "title": "A leading vaccine researcher on the key differences between the Moderna and Pfizer vaccines", "image": "https://cdn.snapi.dev/images/v1/z/7/a-leading-vaccine-researcher-on-the-key-differences-between-the-moderna-and-pfizer-vaccines.jpg", "site": "CNBC Television", "text": "Padmini Pillai, an immunoengineer at MIT, discusses the main issues with both the Moderna and Pfizer-BioNTech COVID vaccines, including why one must be stored at much colder temperatures than the other.", "url": "https://www.youtube.com/watch?v=OtQdRNY22UM"}, {"symbol": "PFE", "publishedDate": "2020-12-18 06:10:16", "title": "Pfizer said it has millions of doses of vaccine sitting in a warehouse because the federal government hasn't told it where to send them", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-said-it-has-millions-of-doses-of-vaccine-sitting-in-a-warehouse-because-the-federal-government-hasnt-told-it-where-to-send-them.jpg", "site": "Business Insider", "text": "Pfizer said Thursday that millions of COVID-19 vaccines are sitting in storage because the US government hasn't given it directions on where to send them yet.\u00a0 The statement was released a day after Health and Human Services Secretary Alex Azar suggested at a press conference that the drug company was having \"manufacturing challenges,\" The Hill reported.\u00a0", "url": "https://www.businessinsider.com/pfizer-waiting-on-government-to-ship-millions-of-coronavirus-shots-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-18 06:10:00", "title": "Should You Sell Pfizer Stock Now?", "image": "https://cdn.snapi.dev/images/v1/8/4/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg", "site": "The Motley Fool", "text": "Think long and hard about it first.", "url": "https://www.fool.com/investing/2020/12/18/should-you-sell-pfizer-stock-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-17 18:48:18", "title": "Pfizer (PFE) Gains But Lags Market: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/g/q/drugs16.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) closed the most recent trading day at $38.03, moving +0.5% from the previous trading session.", "url": "https://www.zacks.com/stock/news/1177828/pfizer-pfe-gains-but-lags-market-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2020-12-17 15:03:04", "title": "TIPS ETFs to Buy for 2021 on Inflation Trade", "image": "https://cdn.snapi.dev/images/v1/r/y/drugs12.jpg", "site": "Zacks Investment Research", "text": "The COVID-19 vaccines and their availability have raised the prospect of inflation as we move ahead into the next year.", "url": "https://www.zacks.com/stock/news/1177239/tips-etfs-to-buy-for-2021-on-inflation-trade"}, {"symbol": "PFE", "publishedDate": "2020-12-17 14:31:14", "title": "PreMarket Prep Stock Of The Day: Pfizer", "image": "https://cdn.snapi.dev/images/v1/2/z/new-york-city-pfizer-world-headquarters-01-2.jpg", "site": "Benzinga", "text": "Benzinga's\u00a0PreMarket Prep\u00a0airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.", "url": "https://www.benzinga.com/general/health-care/20/12/18841503/premarket-prep-stock-of-the-day-pfizer"}, {"symbol": "PFE", "publishedDate": "2020-12-17 12:47:39", "title": "Pfizer says it's not having problems with vaccine distribution", "image": "https://cdn.snapi.dev/images/v1/2/p/pfizer-says-its-not-having-problems-with-vaccine-distribution.jpg", "site": "CNBC Television", "text": "CNBC's senior health and science reporter Meg Tirrell reports Pfizer says it doesn't have any problems with vaccine distribution. However, there are also millions of doses that are currently awaiting further instruction for distribution.", "url": "https://www.youtube.com/watch?v=BDPSzkr5GF4"}, {"symbol": "PFE", "publishedDate": "2020-12-17 12:02:09", "title": "10 Best Performing Leveraged ETFs of 2020", "image": "https://cdn.snapi.dev/images/v1/n/q/biotech8.jpg", "site": "Zacks Investment Research", "text": "This year has witnessed historic twists and turns with the largest bull market turning into a bear market in March on the coronavirus outbreak, and then marking the fastest-ever recovery.", "url": "https://www.zacks.com/stock/news/1176737/10-best-performing-leveraged-etfs-of-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-17 10:48:31", "title": "HHS Secretary Azar says Pfizer keeps government at 'arm's length' on Covid vaccine manufacturing", "image": "https://cdn.snapi.dev/images/v1/u/m/106812877-1608217991766-gettyimages-1230127960-hhs-vaccination.jpeg", "site": "CNBC", "text": "Health and Human Services Secretary Alex Azar said Thursday he'd like \u201cmore visibility\u201d into Pfizer's Covid vaccine manufacturing, adding Pfizer has kept the federal government at \u201carm's length.\u201d", "url": "https://www.cnbc.com/2020/12/17/covid-vaccine-hhs-secretary-azar-says-pfizer-keeps-us-at-arms-length-on-manufacturing.html"}, {"symbol": "PFE", "publishedDate": "2020-12-17 10:15:00", "title": "Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc5---evhg8sfxei.jpg", "site": "The Motley Fool", "text": "The failure to launch really isn't all that surprising.", "url": "https://www.fool.com/investing/2020/12/17/why-didnt-pfizer-stock-jump-more-after-winning-aut/"}, {"symbol": "PFE", "publishedDate": "2020-12-17 09:47:07", "title": "These Stocks Could Be Your Secret Santa This Christmas", "image": "https://cdn.snapi.dev/images/v1/t/f/specialty14.jpg", "site": "Zacks Investment Research", "text": "Looking for a surprise this Christmas? Bet on these stocks - BJs Wholesale (BJ), Gogo (GOGO), TRI Pointe (TPH), Penske Automotive (PAG), and Santander Consumer (SC) - for big returns.", "url": "https://www.zacks.com/stock/news/1176251/these-stocks-could-be-your-secret-santa-this-christmas"}, {"symbol": "PFE", "publishedDate": "2020-12-17 08:56:06", "title": "HHS Sec. Azar says he'd like more visibility into Pfizer's manufacturing", "image": "https://cdn.snapi.dev/images/v1/g/f/hhs-sec-azar-says-hed-like-more-visibility-into-pfizers-manufacturing.jpg", "site": "CNBC Television", "text": "\"Pfizer has got a different relationship with us. They're part of Operation Warp Speed.", "url": "https://www.youtube.com/watch?v=iJdeK5HaAYQ"}, {"symbol": "PFE", "publishedDate": "2020-12-17 08:41:03", "title": "You can't sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won't compensate you for damages either", "image": "https://cdn.snapi.dev/images/v1/g/o/106811150-1607984220234-2020-12-14t213737z-738443905-rc29nk9yvgvs-rtrmadp-3-health-coronavirus-usa.jpg", "site": "CNBC", "text": "Companies like Pfizer and Moderna have total immunity from legal liability if something unintentionally goes wrong with their Covid vaccines.", "url": "https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html"}, {"symbol": "PFE", "publishedDate": "2020-12-17 06:36:00", "title": "The Coronavirus Vaccine Number No One Is Talking About (but Should Be)", "image": "https://cdn.snapi.dev/images/v1/m/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6049532fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: It has nothing to do with efficacy.", "url": "https://www.fool.com/investing/2020/12/17/the-coronavirus-vaccine-number-no-one-is-talking-a/"}, {"symbol": "PFE", "publishedDate": "2020-12-17 00:36:21", "title": "Pfizer COVID-19 Vaccine US Supply Could Rise 40% As FDA Clears Use Of Extra Doses In Vials", "image": "https://cdn.snapi.dev/images/v1/y/t/national-cancer-institute-kmvohcb-w5g-unsplash-0.jpg", "site": "Benzinga", "text": "Extra doses contained in the vials of Pfizer Inc's (NYSE: PFE) COVID-19 vaccine do not need to be discarded, according to the United States Food and Drug Administration, Reuters reported Wednesday.\u00a0 What Happened: Labeling confusion had led to hospital pharmacists discarding one in every six doses of the vaccine made jointly by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX), Stat News had reported earlier.", "url": "https://www.benzinga.com/general/biotech/20/12/18828445/pfizer-covid-19-vaccine-us-supply-could-rise-40-as-fda-clears-use-of-extra-doses-in-vials"}, {"symbol": "PFE", "publishedDate": "2020-12-16 21:40:00", "title": "Pfizer vaccine doses thrown away in US after labelling confusion", "image": "https://cdn.snapi.dev/images/v1/v/w/2372012150224604507-5208056jpg20201215140859.jpg", "site": "Skynews", "text": "Hospital pharmacists in the US have been throwing out extra COVID-19 vaccine doses as the country battles with record numbers of infections and deaths.", "url": "https://news.sky.com/story/covid-19-fda-says-extra-doses-of-pfizer-vaccine-can-be-used-after-labelling-confusion-12165102"}, {"symbol": "PFE", "publishedDate": "2020-12-16 19:57:44", "title": "Could Trillium Fall Below $10 in 2021?", "image": "https://cdn.snapi.dev/images/v1/g/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6052342fgettyimages-949947192jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A decline in the stock price plus positive clinical data equals opportunity.", "url": "https://www.fool.com/investing/2020/12/16/could-trillium-fall-below-10-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 19:27:50", "title": "New report shows label confusion led to wasted doses of Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/y/x/new-report-shows-label-confusion-led-to-wasted-doses-of-pfizer-vaccine.jpg", "site": "CNBC Television", "text": "CNBC's senior health and science correspondent Meg Tirrell joins Shep Smith to report hospitals found that once the Covid vaccine was diluted there might be more doses than were previously calculated, leading to some waste. She also reports Dr. Anthony Fauci expects everyone to receive the vaccine by early spring of 2021 if the current speed of distributing vaccines continues.", "url": "https://www.youtube.com/watch?v=DH5ps_D2L8A"}, {"symbol": "PFE", "publishedDate": "2020-12-16 19:06:52", "title": "Report: Pfizer Vaccine Vials Hold Extra Doses\u2014Increasing U.S. Supply By Up To 40%", "image": "https://cdn.snapi.dev/images/v1/u/u/report-pfizer-vaccine-vials-hold-extra-dosesincreasing-us-supply-by-up-to-40.jpg", "site": "Forbes", "text": "But some doses may have already been thrown away.", "url": "https://www.forbes.com/sites/nicholasreimann/2020/12/16/report-pfizer-vaccine-vials-hold-extra-doses-increasing-us-supply-by-up-to-40/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 16:45:48", "title": "Delta Air Lines moves Pfizer vaccine on passenger flights (with video)", "image": "https://cdn.snapi.dev/images/v1/u/f/delta-air-canada-vaccine-shipments-2.jpg", "site": "FreightWaves", "text": "Delta Air Lines (NYSE: DAL) said it has delivered two shipments of Pfizer Inc.'s COVID-19 vaccine, joining American Airlines (NASDQ: AAL) and United Airlines in supporting distribution of the initial wave of doses to the American public. Delta said it transported the shipments from Detroit to Atlanta and San Francisco on regularly scheduled passenger flights.", "url": "https://www.freightwaves.com/news/delta-air-lines-moves-pfizer-vaccine-on-passenger-flights-with-video"}, {"symbol": "PFE", "publishedDate": "2020-12-16 13:13:52", "title": "Alaska health worker has serious allergic reaction to Pfizer vaccine: NYT", "image": "https://cdn.snapi.dev/images/v1/d/y/alaska-health-worker-has-serious-allergic-reaction-to-pfizer-vaccine-nyt.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell breaks down The New York Times report about a health worker in Alaska who suffered an allergic reaction to the Pfizer vaccine. The patient is now in stable condition and it is not known if the person has a history of allergic reactions to vaccines.", "url": "https://www.youtube.com/watch?v=fJ0ImR-K-hU"}, {"symbol": "PFE", "publishedDate": "2020-12-16 12:27:35", "title": "Top Stocks To Buy Today As Markets Respond To Mixed Sentiment", "image": "https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-respond-to-mixed-sentiment.jpg", "site": "Forbes", "text": "Although stocks surged yesterday on stimulus hopes, the indices showed some signs of weakness this morning reflecting the mixed bag of news being thrown at investors on a daily basis. For investors looking to make the most of this market, our AI has crunched the data to give you a set of Top Buys.", "url": "https://www.forbes.com/sites/qai/2020/12/16/top-stocks-to-buy-today-markets-respond-to-mixed-sentiment/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 11:32:41", "title": "U.S. quarantines Pfizer vaccine shipments in California and Alabama after transit 'anomaly' left vials too cold", "image": "https://cdn.snapi.dev/images/v1/f/a/106812050-1608123664721-gettyimages-1230147221-afp-8x88h6.jpeg", "site": "CNBC", "text": "Doses of Pfizer's vaccine were quarantined in California and Alabama after an \u201canomaly\u201d in the transportation process caused the storage temperature to get too cold.", "url": "https://www.cnbc.com/2020/12/16/covid-vaccine-us-quarantines-pfizer-shipments-in-california-alabama-after-transit-anomaly.html"}, {"symbol": "PFE", "publishedDate": "2020-12-16 09:50:00", "title": "Pfizer And Moderna's Vaccines Could Be More Profitable Than You Think", "image": "https://cdn.snapi.dev/images/v1/j/b/pfizer-and-modernas-vaccines-could-be-more-profitable-than-you-think.jpg", "site": "Forbes", "text": "Moderna and Pfizer have quickly developed highly effective vaccines that should help to end the Covid-19 pandemic. With Pfizer's vaccine already rolling out in the U.K, and the U.S. in limited quantities, and Moderna's likely to follow suit in the coming weeks, investors are likely trying to.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/16/pfizer-and-modernas-vaccines-could-be-more-profitable-than-you-think/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 09:02:09", "title": "Earn 7% Plus Yield With These ETFs", "image": "https://cdn.snapi.dev/images/v1/c/3/etf25---3pad5ag8gm.jpg", "site": "Zacks Investment Research", "text": "These ETFs offer at least 7% in annual yield.", "url": "https://www.zacks.com/stock/news/1172044/earn-7-plus-yield-with-these-etfs"}, {"symbol": "PFE", "publishedDate": "2020-12-16 08:30:00", "title": "2 REITs To Buy Before The Vaccine Changes Everything", "image": "https://cdn.snapi.dev/images/v1/z/q/entertainment-diversified13.jpg", "site": "Seeking Alpha", "text": "The vaccine is now approved and we have a clear end in sight to this crisis. This is very good news for the most covid-sensitive businesses.", "url": "https://seekingalpha.com/article/4394487-2-reits-to-buy-vaccine-changes-everything"}, {"symbol": "PFE", "publishedDate": "2020-12-16 06:14:00", "title": "3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic World", "image": "https://cdn.snapi.dev/images/v1/x/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047752fthrowing-mask-into-a-trash-canjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They each have a key competitive edge that could set them apart.", "url": "https://www.fool.com/investing/2020/12/16/3-covid-19-vaccine-stocks-that-could-be-the-bigges/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 06:10:00", "title": "What Pfizer's Vaccine Authorization Means for Moderna", "image": "https://cdn.snapi.dev/images/v1/p/o/podc3---wakaxmh6nr.jpg", "site": "The Motley Fool", "text": "The Moderna and Pfizer vaccines have one key similarity.", "url": "https://www.fool.com/investing/2020/12/16/what-pfizers-vaccine-authorization-means-for-moder/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 06:03:00", "title": "Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna", "image": "https://cdn.snapi.dev/images/v1/d/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047732fgloved-hands-holding-2-covid-vaccine-bottlesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The challenges for two big drugmakers could translate to opportunities for their rivals in the COVID-19 vaccine race.", "url": "https://www.fool.com/investing/2020/12/16/why-astrazenecas-and-sanofis-bad-news-could-be-gre/"}, {"symbol": "PFE", "publishedDate": "2020-12-16 02:41:55", "title": "China Secures 100M Doses Of Pfizer-BioNTech COVID-19 Vaccine For 2021", "image": "https://cdn.snapi.dev/images/v1/1/z/dimitri-houtteman-qbhppxw3ess-unsplash-3-0.jpg", "site": "Benzinga", "text": "Millions of doses of Pfizer Inc (NYSE: PFE) and BioNTech SE's\u00a0 (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg reported Tuesday. What Happened: Local pharmaceutical firm Shanghai Fosun Pharmaceutical (Group) Co, Ltd (OTC: SFOSF) \u2014\u00a0 which signed an agreement with BioNTech in March \u2014 will pay the German company $300 million (EUR 250 million) for an initial 50 million doses, according to Bloomberg.", "url": "https://www.benzinga.com/general/biotech/20/12/18809547/china-secures-100m-doses-of-pfizer-biontech-covid-19-vaccine-for-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-15 16:34:14", "title": "Piper Sandler analyst discusses Pfizer and Moderna's respective vaccine rollouts", "image": "https://cdn.snapi.dev/images/v1/x/e/piper-sandler-analyst-discusses-pfizer-and-modernas-respective-vaccine-rollouts.jpg", "site": "CNBC Television", "text": "Ted Tenthoff, Piper Sandler Senior Analyst, says Moderna has risen to the challenge by creating its own Covid-19 vaccine. He joins 'Closing Bell' to discuss the vaccine rollouts by Pfizer and Moderna.", "url": "https://www.youtube.com/watch?v=fJwBMs5fB_I"}, {"symbol": "PFE", "publishedDate": "2020-12-15 16:27:48", "title": "The 8 Best Long-Term Stocks with Plenty of Potential", "image": "https://cdn.snapi.dev/images/v1/x/k/d22edfff-hfr4nxtl0b.jpg", "site": "InvestorPlace", "text": "These best long-term stocks can help boost any diversified portfolio. Here are eight picks with particularly strong potential for the years to come.", "url": "https://investorplace.com/2020/12/the-8-best-long-term-stocks-with-plenty-of-potential/"}, {"symbol": "PFE", "publishedDate": "2020-12-15 16:18:37", "title": "One health-care stock looks like a buy as Pfizer begins Covid vaccine rollout, market analyst says", "image": "https://cdn.snapi.dev/images/v1/e/f/106811524-1608047971885-gettyimages-1230137377-afp-8x77pk.jpeg", "site": "CNBC", "text": "Health-care stocks are in focus after Pfizer began shipments in the U.S. of its Covid vaccine and the first vaccinations were given this week.", "url": "https://www.cnbc.com/2020/12/15/health-care-stocks-on-watch-as-pfizer-begins-covid-vaccine-rollout.html"}, {"symbol": "PFE", "publishedDate": "2020-12-15 12:47:04", "title": "5 Small-Cap Sector ETFs Beating the Russell 2000", "image": "https://cdn.snapi.dev/images/v1/2/x/biotech5.jpg", "site": "Zacks Investment Research", "text": "We have presented five ETFs that have easily crushed the Russell 2000 Index over the past three months.", "url": "https://www.zacks.com/stock/news/1168817/5-small-cap-sector-etfs-beating-the-russell-2000"}, {"symbol": "PFE", "publishedDate": "2020-12-15 12:02:09", "title": "Sector ETFs to Gain the Most on COVID-19 Vaccine Rollout", "image": "https://cdn.snapi.dev/images/v1/q/g/etf6.jpg", "site": "Zacks Investment Research", "text": "The United States has geared up for the largest-ever immunization with the rollout of the COVID-19 vaccine.", "url": "https://www.zacks.com/stock/news/1168617/sector-etfs-to-gain-the-most-on-covid-19-vaccine-rollout"}, {"symbol": "PFE", "publishedDate": "2020-12-15 11:21:14", "title": "Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock", "image": "https://cdn.snapi.dev/images/v1/x/5/biotech40---u5rsqmuvj8.jpg", "site": "24/7 Wall Street", "text": "BioNTech S.E. (NASDAQ: BNTX) was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.", "url": "https://247wallst.com/healthcare-business/2020/12/15/why-one-analyst-sees-big-upside-in-this-covid-19-vaccine-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-15 11:05:11", "title": "Pfizer coronavirus vaccine arrives in Louisiana", "image": "https://cdn.snapi.dev/images/v1/f/a/pfizer-coronavirus-vaccine-arrives-in-louisiana.jpg", "site": "CNBC Television", "text": "CNBC's Brian Sullivan reports on the arrival of the Pfizer vaccine in Louisiana as workers prepare the coronavirus vaccine for distribution.", "url": "https://www.youtube.com/watch?v=jv_pXC5FqrU"}, {"symbol": "PFE", "publishedDate": "2020-12-15 10:58:50", "title": "Here's How To Bull Trade The Dip In Pfizer Stock With Finesse", "image": "https://cdn.snapi.dev/images/v1/e/p/im-270120width620size15005861664712778.jpg", "site": "InvestorPlace", "text": "Sellers are striking Pfizer stock , even as it rolls out its novel coronavirus vaccine. Ignore the weakness, and buy with short puts.", "url": "https://investorplace.com/2020/12/heres-how-to-bull-trade-the-dip-in-pfizer-stock-with-finesse/"}, {"symbol": "PFE", "publishedDate": "2020-12-15 09:56:19", "title": "FDA staff recommends watching for Bell's palsy in Moderna and Pfizer vaccine recipients", "image": "https://cdn.snapi.dev/images/v1/z/j/106799008-1605725497031-gettyimages-1229670584-afp-8vf9bn.jpeg", "site": "CNBC", "text": "The FDA said that there were four reported cases of Bell's palsy among Moderna's 30,000 trial participants, including three who got the vaccine.", "url": "https://www.cnbc.com/2020/12/15/fda-staff-recommends-watching-for-bells-palsy-in-moderna-and-pfizer-vaccine-recipients.html"}, {"symbol": "PFE", "publishedDate": "2020-12-15 09:02:24", "title": "US Starts COVID-19 Vaccine Drive: 5 Consumer Discretionary Picks", "image": "https://cdn.snapi.dev/images/v1/t/c/biotech27.jpg", "site": "Zacks Investment Research", "text": "The COVID-19 vaccine comes as a relief, indicating that the economy might bounce back in the coming days helping stocks like WilliamsSonoma (WSM), Reynolds Consumer Products (REYN) and Spectrum Brands Holdings (SPB).", "url": "https://www.zacks.com/stock/news/1167917/us-starts-covid-19-vaccine-drive-5-consumer-discretionary-picks"}, {"symbol": "PFE", "publishedDate": "2020-12-15 09:02:08", "title": "5 Stocks to Win Big as Coronavirus Vaccine Rollout Begins", "image": "https://cdn.snapi.dev/images/v1/m/a/us-market-movers-as-economic-data-outweighs-the-pandemic.jpg", "site": "Zacks Investment Research", "text": "Emergency approval of COVID-19 vaccines is a boon for stocks such as Trane Technologies (TT), United Parcel Service (UPS), FedEx (FDX), Pfizer (PFE) and Moderna (MRNA). Here's why -", "url": "https://www.zacks.com/stock/news/1167984/5-stocks-to-win-big-as-coronavirus-vaccine-rollout-begins"}, {"symbol": "PFE", "publishedDate": "2020-12-15 08:24:02", "title": "Pfizer vaccine expected to land in 425 locations across the U.S.", "image": "https://cdn.snapi.dev/images/v1/1/f/pfizer-vaccine-expected-to-land-in-425-locations-across-the-us.jpg", "site": "CNBC Television", "text": "The first shots of Pfizer-BioNTech's Covid-19 vaccine are being administered to healthcare workers, marking a pivotal moment in the country's long march to bring the virus under control. CNBC's Meg Tirrell reports the latest on the operation to distribute the vaccine around the country.", "url": "https://www.youtube.com/watch?v=6kBWL6KoT1Q"}, {"symbol": "PFE", "publishedDate": "2020-12-15 07:21:00", "title": "Could the S&P 500 Hit 4,000 in 2021?", "image": "https://cdn.snapi.dev/images/v1/v/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047552fstock-market-ticker-symbol-digital-quote-board-nyse-sp-500-nasdaq-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A handful of catalysts will dictate how the benchmark stock index performs next year.", "url": "https://www.fool.com/investing/2020/12/15/could-the-sp-500-hit-4000-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-15 07:04:00", "title": "WHO sees \"strong commitment\" from Pfizer on affordable COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/f/p/m02d20201215t2i1544617194w940fhfwllplsqrlynxmpegbe0qh.jpg", "site": "Reuters", "text": "A World Health Organization senior official said on Tuesday that the agency was in talks with Pfizer to include its COVID-19 vaccine as part of an early global roll out.", "url": "https://www.reuters.com/article/health-coronavirus-who-pfizer/who-sees-strong-commitment-from-pfizer-on-affordable-covid-vaccine-idUSKBN28P1AT"}, {"symbol": "PFE", "publishedDate": "2020-12-15 06:04:00", "title": "Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc10---z8oxfgrl8k.jpg", "site": "The Motley Fool", "text": "Hint: There isn't just one answer.", "url": "https://www.fool.com/investing/2020/12/15/which-is-the-best-covid-vaccine-stock-now-pfizer-b/"}, {"symbol": "PFE", "publishedDate": "2020-12-15 05:16:46", "title": "7 Christmas Stocks to Buy for 2020's Atypical Holidays", "image": "https://cdn.snapi.dev/images/v1/k/i/asset-management42.jpg", "site": "InvestorPlace", "text": "This year's holiday season is anything but typical due to Covid-19. Here are seven Christmas stocks to buy that are atypical from past years.", "url": "https://investorplace.com/2020/12/7-christmas-stocks-to-buy-for-2020s-atypical-holidays/"}, {"symbol": "PFE", "publishedDate": "2020-12-14 21:59:34", "title": "After Pfizer, Moderna's COVID-19 Vaccine Data Comprised In Cyberattack", "image": "https://cdn.snapi.dev/images/v1/7/g/markus-spiske-iar-afb0qqw-unsplash-1.jpg", "site": "Benzinga", "text": "Moderna Inc (NASDAQ: MRNA) said documents related to its COVID-19 vaccine were targeted by hackers in an attack on the European Medicines Agency (EMA), Reuters reported Monday. What Happened: The Cambridge, Massachusetts-based vaccine maker said its submissions to the EMA didn't contain any information pertaining to the identity of its vaccine study participants.", "url": "https://www.benzinga.com/general/biotech/20/12/18787354/after-pfizer-modernas-covid-19-vaccine-data-comprised-in-cyberattack"}, {"symbol": "PFE", "publishedDate": "2020-12-14 20:33:51", "title": "Warren Buffett's Berkshire Hathaway has new stakes in AbbVie, Pfizer, Merck, Bristol-Myers Squibb", "image": "https://cdn.snapi.dev/images/v1/y/e/warren-buffetts-berkshire-hathaway-has-new-stakes-in-abbvie-pfizer-merck-bristol-myers-squibb.jpg", "site": "Yahoo Finance", "text": "Warren Buffett's Berkshire Hathaway released its newest holdings worth more than $1.8 billion with notable investments in some big pharma stocks like Merck and Pfizer. Yahoo Finance's Jared Blikre breaks it all down.", "url": "https://www.youtube.com/watch?v=2YDnF3BMX7w"}, {"symbol": "PFE", "publishedDate": "2020-12-14 18:51:20", "title": "Vaccine distribution, peak-season climax spawn parcel delivery storm", "image": "https://cdn.snapi.dev/images/v1/w/d/will-vaccine-distribution-1.jpg", "site": "FreightWaves", "text": "A tumultuous year for the parcel-delivery business has been taken to another level as parcel shippers find themselves competing with the most precious of cargoes for peak holiday season air and surface capacity.\u00a0 To the amazement of many, the first of what are expected to be several vaccines to crush the novel coronavirus has been approved by federal regulators and shipped out before the end of 2020.", "url": "https://www.freightwaves.com/news/vaccine-distribution-peak-season-climax-spawn-parcel-delivery-storm"}, {"symbol": "PFE", "publishedDate": "2020-12-14 15:51:48", "title": "Coronavirus vaccine: First doses of COVID-19 Pfizer vaccine are administered on the East Coast", "image": "https://cdn.snapi.dev/images/v1/b/j/coronavirus-vaccine-first-doses-of-covid-19-pfizer-vaccine-are-administered-on-the-east-coast.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the distribution of the first COVID-19 vaccine. #coronavirusvaccine #COVID19vaccine #Pfizer For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=blDQfY0kP5M"}, {"symbol": "PFE", "publishedDate": "2020-12-14 15:13:28", "title": "The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF", "image": "https://cdn.snapi.dev/images/v1/n/h/medical14.jpg", "site": "InvestorPlace", "text": "One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.", "url": "https://investorplace.com/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf/"}, {"symbol": "PFE", "publishedDate": "2020-12-14 14:42:52", "title": "Pfizer Rated Top Buy This Week As Vaccine Distribution Kicks Off", "image": "https://cdn.snapi.dev/images/v1/w/e/pfizer-rated-top-buy-this-week-as-vaccine-distribution-kicks-off.jpg", "site": "Forbes", "text": "Although December has largely kept November's election and vaccine rally moving, markets fell for the first week in three last week. Among all the news and data spurring on the markets, our deep learning algorithms have used AI technology to rate the Top Trending Stocks for this week.", "url": "https://www.forbes.com/sites/qai/2020/12/14/pfizer-rated-top-buy-this-week-as-vaccine-distribution-kicks-off/"}, {"symbol": "PFE", "publishedDate": "2020-12-14 14:38:46", "title": "3 Health Care Companies That Recently Raised Dividends", "image": "https://cdn.snapi.dev/images/v1/h/k/drugs14.jpg", "site": "GuruFocus", "text": "Dividend increase announcements continue to pile up as 2020 draws to a close. The health care sector remains one of my favorite places to find stocks offering solid yields and lengthy track records of dividend growth.", "url": "https://www.gurufocus.com/news/1310730/3-health-care-companies-that-recently-raised-dividends"}, {"symbol": "PFE", "publishedDate": "2020-12-14 13:35:07", "title": "U.S. administers first shots of Pfizer's Covid vaccine, launching a historic rollout", "image": "https://cdn.snapi.dev/images/v1/k/o/106810931-1607968510591-gettyimages-1230125351-virus-vaccine-us.jpeg", "site": "CNBC", "text": "\"There is not one part of this country that's not being touched today through Wednesday,\" Gen. Gustave Perna, who's in charge of logistics for Operation Warp Speed,\u00a0said.", "url": "https://www.cnbc.com/2020/12/14/us-administers-first-shots-of-pfizers-covid-vaccine-launching-a-historic-rollout.html"}, {"symbol": "PFE", "publishedDate": "2020-12-14 13:01:50", "title": "Pfizer and Biontech have a significant commercial opportunity: Analyst", "image": "https://cdn.snapi.dev/images/v1/x/f/pfizer-and-biontech-have-a-significant-commercial-opportunity-analyst.jpg", "site": "Yahoo Finance", "text": "Senior research analyst for healthcare at ClearBridge Investments Marshall Gordon, joins Yahoo Finance Live to discuss the commercial opportunity COVID-19 vaccine developers such as Pfizer and BioNTech have over the next couple of months, and the genera\u2026 #Pfizer #Biontech #ClearBridgeinvestments For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. About Yahoo Finance Premium: With a subscription to Yahoo Finance Premium, get the tools you need to invest with confidence.", "url": "https://www.youtube.com/watch?v=_u2sdpP2Xic"}, {"symbol": "PFE", "publishedDate": "2020-12-14 12:35:43", "title": "Pfizer negotiating with U.S. to provide additional 100 million Covid vaccine doses, CEO says", "image": "https://cdn.snapi.dev/images/v1/y/5/pfizer-negotiating-with-us-to-provide-additional-100-million-covid-vaccine-doses-ceo-says.jpg", "site": "CNBC Television", "text": "Pfizer CEO Dr. Albert Bourla said the company is negotiating with the federal government to provide an additional 100 million Covid-19 vaccine doses next year as Americans will receive some of the first shots Monday.", "url": "https://www.youtube.com/watch?v=Dm0xnZEaVD0"}, {"symbol": "PFE", "publishedDate": "2020-12-14 12:33:47", "title": "The Margin: WATCH: Relieved Americans applaud as the Pfizer-BioNTech COVID-19 vaccine rolls out across the country", "image": "https://cdn.snapi.dev/images/v1/5/e/mw-iw132-pfizer-20201214105526-zqjpguuidc86fdc14-3e24-11eb-8b79-9c8e992d421e.jpg", "site": "Market Watch", "text": "Queens, N.Y., nurse Sandra Lindsay received the first COVID-19 vaccine in the U.S. on Monday morning", "url": "https://www.marketwatch.com/story/watch-relieved-americans-applaud-as-the-pfizer-biontech-covid-19-vaccine-rolls-out-across-the-country-2020-12-14"}, {"symbol": "PFE", "publishedDate": "2020-12-14 11:48:16", "title": "5 Potential Thematic Rotations That I Expect To Take Place In 2021", "image": "https://cdn.snapi.dev/images/v1/a/y/sdw212w-2.jpg", "site": "Seeking Alpha", "text": "2020 has already featured a number of short-term leadership shifts. I expect that trend to continue in 2021.", "url": "https://seekingalpha.com/article/4394610-5-potential-thematic-rotations-i-expect-to-take-place-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-12-14 11:07:00", "title": "Historic Day for Pfizer (PFE), Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/v/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955382fsyringe-and-needle-on-top-of-calendarjpgw700opresize.jpg", "site": "Zacks Investment Research", "text": "With more than 180K daily reported cases as of yesterday, with more than 109K hospitalizations and nearly 1500 deaths on Sunday alone, this vaccine availability is not just historic, it's momentous.", "url": "https://www.zacks.com/stock/news/1164542/historic-day-for-pfizer-pfe-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-14 10:45:34", "title": "Jim Cramer on the Pfizer vaccine rollout: 'This is a historic moment'", "image": "https://cdn.snapi.dev/images/v1/z/e/jim-cramer-on-the-pfizer-vaccine-rollout-this-is-a-historic-moment.jpg", "site": "CNBC Television", "text": "After months of research and clinical trials, the Pfizer-BioNTech vaccine delivery is underway, with millions of doses being distributed across the country. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss what the vaccine means for the country.", "url": "https://www.youtube.com/watch?v=B6dDCmUFw64"}, {"symbol": "PFE", "publishedDate": "2020-12-14 10:43:06", "title": "TPG's Jim Coulter on the business impact of Pfizer's vaccine rollout", "image": "https://cdn.snapi.dev/images/v1/l/w/tpgs-jim-coulter-on-the-business-impact-of-pfizers-vaccine-rollout.jpg", "site": "CNBC Television", "text": "Jim Coulter, co-founder and co-CEO of TPG, which oversees $85 billion in assets under management, joined \"Squawk Box\" on Monday to discuss what he thinks a working vaccine could mean for the markets and investors.", "url": "https://www.youtube.com/watch?v=jaP0TE3ggUo"}, {"symbol": "PFE", "publishedDate": "2020-12-14 10:18:52", "title": "Pfizer in talks to supply US with another 100 million vaccine doses", "image": "https://cdn.snapi.dev/images/v1/9/r/health-coronavirus-usa-pfizerjpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer is in talks to supply the US government with another 100 million doses of the company's coronavirus vaccine, CEO Albert Bourla said Monday. That would add to the 100 million doses Pfizer plans to deliver by the end of March under an order the Trump administration placed in July, Bourla told CNN.", "url": "https://nypost.com/2020/12/14/pfizer-in-talks-to-give-us-another-100-million-vaccine-doses/"}, {"symbol": "PFE", "publishedDate": "2020-12-14 10:15:18", "title": "Contingency planning guides Pfizer vaccine distribution flow", "image": "https://cdn.snapi.dev/images/v1/b/q/operation-warp-speed-timeline-1.jpg", "site": "FreightWaves", "text": "With lifesaving COVID-19 vaccines finally en route to state administration sites, the guiding principles for officials in charge of managing the supply chain are adaptability and maintaining a consistent flow of doses to health care facilities.\u00a0\u00a0 Army Gen.", "url": "https://www.freightwaves.com/news/contingency-planning-guides-pfizer-vaccine-distribution-flow"}, {"symbol": "PFE", "publishedDate": "2020-12-14 10:02:21", "title": "Pfizer's CEO hasn't gotten his Covid vaccine yet, saying he doesn't want to cut in line", "image": "https://cdn.snapi.dev/images/v1/t/a/105687507-1547831143627bourla.jpg", "site": "CNBC", "text": "\"This is a vaccine that was developed without cutting corners from a company with 171 years of credentials,\" Pfizer CEO Albert Bourla said.", "url": "https://www.cnbc.com/2020/12/14/pfizers-ceo-hasnt-gotten-his-covid-vaccine-yet-saying-he-doesnt-want-to-cut-in-line.html"}, {"symbol": "PFE", "publishedDate": "2020-12-14 09:24:24", "title": "Pfizer negotiating with U.S. to provide an additional 100 million Covid vaccine doses, CEO says", "image": "https://cdn.snapi.dev/images/v1/e/s/106810481-1607869242560-106810481-1607868621351-gettyimages-1230101981-afp-8x2884.jpg", "site": "CNBC", "text": "Pfizer and the U.S. are working out details on timing, CEO Albert Bourla told CNBC's \"Squawk Box\" in an interview.", "url": "https://www.cnbc.com/2020/12/14/covid-vaccine-pfizer-negotiating-with-us-to-provide-an-additional-100-million-doses-ceo-says.html"}, {"symbol": "PFE", "publishedDate": "2020-12-14 09:21:49", "title": "U.S. could have bought additional Pfizer vaccines in November but passed, says Pfizer board member", "image": "https://cdn.snapi.dev/images/v1/6/i/105764881-1551816622419scott.jpg", "site": "CNBC", "text": "\"This has been a challenging process because there have been multiple conversations happening as recently as November,\" Dr. Scott Gottlieb told CNBC.", "url": "https://www.cnbc.com/2020/12/14/covid-vaccine-us-passed-on-more-pfizer-doses-in-november-says-board-member-gottlieb.html"}, {"symbol": "PFE", "publishedDate": "2020-12-14 08:59:19", "title": "Pfizer CEO Albert Bourla on vaccine hesitancy: 'Trust science'", "image": "https://cdn.snapi.dev/images/v1/4/8/pfizer-ceo-albert-bourla-on-vaccine-hesitancy-trust-science.jpg", "site": "CNBC Television", "text": "\"The decision not to vaccinate will not affect only your health or your life,\" Pfizer Chairman and CEO Albert Bourla told CNBC's \"Squawk Box\" Monday when asked about individuals who may be hesitant to take the vaccine. \"Unfortunately it will affect the lives of others, and likely the lives of the people you love the most, which are the people that usually you are in contact with.", "url": "https://www.youtube.com/watch?v=P6O6FqYYImk"}, {"symbol": "PFE", "publishedDate": "2020-12-14 08:35:01", "title": "U.S. turned down more Covid vaccines as recently as Nov. 2020: Pfizer board member", "image": "https://cdn.snapi.dev/images/v1/2/b/us-turned-down-more-covid-vaccines-as-recently-as-nov-2020-pfizer-board-member.jpg", "site": "CNBC Television", "text": "Pfizer board member and former FDA Commissioner Dr. Scott Gottlieb told CNBC's \"Squawk Box\" that the U.S. government turned down additional doses of Pfizer's vaccine as recently as November 2020.", "url": "https://www.youtube.com/watch?v=lOmzpR8JCx8"}, {"symbol": "PFE", "publishedDate": "2020-12-14 08:19:00", "title": "COVID-19 Vaccine Race Heats Up as Pfizer Gets Emergency Nod", "image": "https://cdn.snapi.dev/images/v1/q/v/biotech23.jpg", "site": "Zacks Investment Research", "text": "FDA grants emergency use approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate.", "url": "https://www.zacks.com/stock/news/1163938/covid-19-vaccine-race-heats-up-as-pfizer-gets-emergency-nod"}, {"symbol": "PFE", "publishedDate": "2020-12-14 08:09:59", "title": "How UPS is shipping the Pfizer Covid vaccine around the U.S.", "image": "https://cdn.snapi.dev/images/v1/w/n/how-ups-is-shipping-the-pfizer-covid-vaccine-around-the-us.jpg", "site": "CNBC Television", "text": "Months of planning and investment to update cold chain capabilities has all lead up to this: the first shipments of Pfizer's Covid vaccine across the country. CNBC's Frank Holland reports from the heart of UPS's World Port air operations.", "url": "https://www.youtube.com/watch?v=VzK3ZDUWLRA"}, {"symbol": "PFE", "publishedDate": "2020-12-14 08:07:59", "title": "Pfizer and Moderna could earn $32 billion in revenues from their COVID-19 vaccines in 2021", "image": "https://cdn.snapi.dev/images/v1/p/o/poster-moderna-fda-application-emergency-use.jpg", "site": "Business Insider", "text": "US drugmakers Pfizer and Moderna could rake in around $32 billion in revenues from their COVID-19 vaccines in 2021, according to Wall Street estimates. Pfizer and its German partner BioNTech will bring in roughly $19 billion from global sales of its COVID-19 vaccine in 2021, according to Morgan Stanley estimates first reported by CNN on Friday.", "url": "https://www.businessinsider.com/pfizer-moderna-biontech-vaccine-sales-revenue-covid-19-shot-2021-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-14 07:36:13", "title": "Pfizer-BioNTech Covid vaccine distribution begins around the United States", "image": "https://cdn.snapi.dev/images/v1/k/6/pfizer-biontech-covid-vaccine-distribution-begins-around-the-united-states.jpg", "site": "CNBC Television", "text": "After months of research and clinical trials, the Pfizer-BioNTech vaccine delivery is underway, with millions of doses being distributed across the country. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=2U5KEGw6pg4"}, {"symbol": "PFE", "publishedDate": "2020-12-14 07:36:04", "title": "Head of trucking company transporting Pfizer vaccine discusses the first day of distribution", "image": "https://cdn.snapi.dev/images/v1/9/m/head-of-trucking-company-transporting-pfizer-vaccine-discusses-the-first-day-of-distribution.jpg", "site": "CNBC Television", "text": "Andrew Boyle, Co-President of Boyle Transportation which is working with UPS to distribute the Pfizer/Biontech Covid-19 vaccine, joins Worldwide Exchange with an inside look at the rollout process.", "url": "https://www.youtube.com/watch?v=ZnE4KXsTE_U"}, {"symbol": "PFE", "publishedDate": "2020-12-14 07:24:00", "title": "Pfizer CEO says still negotiating with U.S. on more coronavirus vaccines", "image": "https://cdn.snapi.dev/images/v1/x/i/m02d20201214t2i1544495089w940fhfwllplsqrlynxmpegbd0sx.jpg", "site": "Reuters", "text": "Pfizer CEO Albert Bourla on Monday said the company has not signed an agreement yet with the United States on providing 100 million more coronavirus vaccine doses in 2021, telling CNN it is still negotiating whether to deliver the drug in the second or third quarter of the year.", "url": "https://www.reuters.com/article/health-coronavirus-usa-pfizer/pfizer-ceo-says-still-negotiating-with-u-s-on-more-coronavirus-vaccines-idUSKBN28O1GI"}, {"symbol": "PFE", "publishedDate": "2020-12-14 06:12:59", "title": "Pfizer, BioNTech COVID-19 vaccine candidate study in Germany support safety profile", "image": "https://cdn.snapi.dev/images/v1/g/s/biotech20---k0hzq4jhpu.jpg", "site": "Market Watch", "text": "Pfizer Inc. and its Germany-based partner BioNTech SE said overall results of a Phase 1/2 study in Germany of its COVID-19 vaccine candidate, BNT162b2, mirrored those from the U.S. study. The companies said the results supported \"the favorable safety profile and robust induction of virus-specific antibody responses.", "url": "https://www.marketwatch.com/story/pfizer-biontech-covid-19-vaccine-candidate-study-in-germany-support-safety-profile-2020-12-14"}, {"symbol": "PFE", "publishedDate": "2020-12-14 06:04:00", "title": "3 COVID Stocks That Are Screaming Buys", "image": "https://cdn.snapi.dev/images/v1/y/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038422fdollar-sign-in-the-midst-of-coronavirusjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These coronavirus leaders are great picks for different reasons.", "url": "https://www.fool.com/investing/2020/12/14/3-covid-stocks-that-are-screaming-buys/"}, {"symbol": "PFE", "publishedDate": "2020-12-14 03:11:50", "title": "Pfizer Plans To Offer COVID-19 Vaccine To Placebo Group Trial Volunteers: Report", "image": "https://cdn.snapi.dev/images/v1/i/o/syringe-417786-1920-11.jpg", "site": "Benzinga", "text": "Pfizer Inc\u00a0(NYSE: PFE) and\u00a0BioNTech SE\u00a0(NASDAQ: BNTX) plan to allow the participants in the COVID-19 vaccine trials to learn if they were part of the placebo group and offer them free shots,\u00a0Bloomberg reports. What Happened:\u00a0Pfizer, in an emailed statement to Bloomberg, said that both companies are providing voluntary options to COVID-19 vaccine clinical trial volunteers, who were part of the placebo group, to receive the vaccine at scheduled time points.", "url": "https://www.benzinga.com/general/biotech/20/12/18767922/pfizer-plans-to-offer-covid-19-vaccine-to-placebo-group-trial-volunteers-report"}, {"symbol": "PFE", "publishedDate": "2020-12-14 02:51:02", "title": "Former FDA director says Pfizer's coronavirus vaccine approval was speedy but thorough", "image": "https://cdn.snapi.dev/images/v1/v/g/former-fda-director-says-pfizers-coronavirus-vaccine-approval-was-speedy-but-thorough.jpg", "site": "CNBC International TV", "text": "Norman Baylor of Biologics Consulting and former U.S. FDA Director says the agency took no shortcuts in approving Pfizer's vaccine, despite political pressure.", "url": "https://www.youtube.com/watch?v=XGXPAIvbbj4"}, {"symbol": "PFE", "publishedDate": "2020-12-13 17:45:30", "title": "Michigan airports support airlift of Pfizer vaccine (with video)", "image": "https://cdn.snapi.dev/images/v1/6/d/gerald-ford-airport-1.jpg", "site": "FreightWaves", "text": "Gerald R. Ford International Airport in Grand Rapids, Michigan, could play an active role in the U.S. and worldwide distribution of COVID-19 vaccine because it is the closest commercial airport to Pfizer Inc.'s Kalamazoo manufacturing plant. On Sunday, an Airbus A300 cargo jet operated by FedEx Express (NYSE: F D X) left Ford airport for the 90- minute flight to FedEx's global air hub in Memphis, Tennessee, carrying the first air shipment of the life-saving vaccine.", "url": "https://www.freightwaves.com/news/michigan-airports-support-airlift-of-pfizer-vaccine-with-video"}, {"symbol": "PFE", "publishedDate": "2020-12-13 16:24:00", "title": "Boyle Transportation helps UPS air network move COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/2/u/121320-boyle-transportation-vaccines.jpg", "site": "FreightWaves", "text": "Heavy-duty Freightliner Cascadias operated by Billerica, Massachusetts-based Boyle Transportation rumbled from a Pfizer (NYSE: PFE) plant in Michigan on Sunday, hauling the first doses of a vaccine critical to ending the coronavirus pandemic. Boyle is an experienced transporter of vaccines.", "url": "https://www.freightwaves.com/news/boyle-transportion-helps-ups-air-network-move-covid-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-13 16:05:00", "title": "How Many COVID Vaccine Doses Will Pfizer and Moderna Distribute by Year-End?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc11---imo4wulepw.jpg", "site": "The Motley Fool", "text": "Hint: It's a big number -- but not nearly big enough.", "url": "https://www.fool.com/investing/2020/12/13/how-many-covid-vaccine-doses-will-pfizer-and-moder/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 14:26:07", "title": "CDC's Redfield officially recommends Pfizer coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/8/f/biotech15.jpg", "site": "Fox Business", "text": "Centers for Disease Control and Prevention\u00a0Director Dr. Robert Redfield said Sunday that he signed the CDC's official recommendation for Americans 16 and older to use the Pfizer-BioNTech coronavirus vaccine and applauded the vaccine as a step to \"help restore some normalcy to our lives and our country.\".", "url": "https://www.foxbusiness.com/markets/cdc-redfield-pfizer-biontech-coronavirus-vaccine-recommendation"}, {"symbol": "PFE", "publishedDate": "2020-12-13 14:25:44", "title": "FedEX, UPS trucks depart with first Pfizer COVID vaccines", "image": "https://cdn.snapi.dev/images/v1/m/g/interview-with-ait-1-1.jpg", "site": "FreightWaves", "text": "FedEx Express (NYSE: FDX)\u00a0 and UPS (NYSE: UPS) trucks departed Pfizer Inc.'s (NYSE: PFE) sprawling manufacturing facility in Portage, Michigan, on Sunday morning loaded with COVID-19 vaccines packed in dry ice to maintain them at ultra-cold temperatures. The express delivery companies have roughly divided the nation in two, with FedEx supplying the western states and UPS those in the east, based on plans developed in coordination with the federal government's Operation Warp Speed.", "url": "https://www.freightwaves.com/news/fedex-ups-trucks-depart-with-first-pfizer-covid-vaccines"}, {"symbol": "PFE", "publishedDate": "2020-12-13 14:02:00", "title": "These 2 Early-Stage COVID Vaccines Could Be Game-Changers", "image": "https://cdn.snapi.dev/images/v1/p/o/podc9---ahhpxguzjt.jpg", "site": "The Motley Fool", "text": "The first to market won't necessarily dominate the market over the long run.", "url": "https://www.fool.com/investing/2020/12/13/these-2-early-stage-covid-vaccines-could-be-game-c/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 10:35:00", "title": "COVID Vaccine Stock Ideas for Different Investors", "image": "https://cdn.snapi.dev/images/v1/p/o/podc5---6e5g2cfdua.jpg", "site": "The Motley Fool", "text": "Whether you're aggressive, risk-averse, or somewhere in between, here are some coronavirus vaccine stocks you might want to consider.", "url": "https://www.fool.com/investing/2020/12/13/covid-vaccine-stock-ideas-for-different-investor/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 08:32:00", "title": "How Soon Will COVID Vaccines Be Available After FDA Authorization?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc4---eh9z719kph.jpg", "site": "The Motley Fool", "text": "Faster than you might think.", "url": "https://www.fool.com/investing/2020/12/13/how-soon-will-covid-vaccines-be-available-after-fd/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 08:26:50", "title": "Pfizer begins packing coronavirus vaccine shipments at Michigan facility", "image": "https://cdn.snapi.dev/images/v1/z/e/biotech13.jpg", "site": "Fox Business", "text": "The first trucks carrying a COVID-19 vaccine for widespread use in the United States are set to pull out of a Michigan manufacturing plant Sunday.", "url": "https://www.foxbusiness.com/markets/pfizer-biontech-coronavirus-vaccine-ships-to-states"}, {"symbol": "PFE", "publishedDate": "2020-12-13 07:07:00", "title": "3 Easy Retirement Investing Resolutions for 2021", "image": "https://cdn.snapi.dev/images/v1/h/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6043182fyounger-man-holding-money-laptopjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Start the year off right with these easy, money-making resolutions.", "url": "https://www.fool.com/retirement/2020/12/13/3-easy-retirement-investing-resolutions-for-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 06:35:00", "title": "The Most Popular Coronavirus Stock May Lose Half Its Value by 2023", "image": "https://cdn.snapi.dev/images/v1/w/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6044342fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.", "url": "https://www.fool.com/investing/2020/12/13/the-most-popular-coronavirus-stock-may-lose-half-i/"}, {"symbol": "PFE", "publishedDate": "2020-12-13 06:05:00", "title": "3 Top Coronavirus Stocks to Buy in December", "image": "https://cdn.snapi.dev/images/v1/v/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038402fgift-box-with-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's something for every kind of investor with this list.", "url": "https://www.fool.com/investing/2020/12/13/3-top-coronavirus-stocks-to-buy-in-december/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 23:13:37", "title": "Coronavirus vaccine: This is one of the safest vaccines we've seen: Physician on Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/3/g/coronavirus-vaccine-this-is-one-of-the-safest-vaccines-weve-seen-physician-on-pfizer-vaccine.jpg", "site": "Yahoo Finance", "text": "Dr. Heather Yeo, SurvivorNet Medical Advisor & Associate Professor of Surgery and Population Health Sciences at Weill Cornell Medical College joins Yahoo Finance's Kristin Myers to break down the latest coronavirus developments. #Pfizer #coronavirus #COVID-19vaccine #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=PyLE3K7wuLU"}, {"symbol": "PFE", "publishedDate": "2020-12-12 17:04:41", "title": "FAA clears pilots to receive Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/j/v/faa-issues-pilot-1.jpg", "site": "FreightWaves", "text": "The Federal Aviation Administration on Saturday determined that commercial pilots and air traffic controllers subject to FAA medical clearance may receive Pfizer Inc.'s (NYSE: PFE) newly approved COVID-19 vaccine. The Food and Drug Administration Friday night authorized the vaccine's public use on an emergency basis after an extensive review of its safety and ability to protect against the virus, which has claimed nearly 300,000 lives in the U.S. The Air Line Pilots Association earlier this week urged the FAA to quickly approve the vaccine for pilots so they don't violate medical certifications by taking the drug.", "url": "https://www.freightwaves.com/news/faa-clears-pilots-to-receive-pfizer-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-12 16:58:00", "title": "U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older", "image": "https://cdn.snapi.dev/images/v1/e/l/press1---l0frnjdhbb.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). This ACIP vote follows the December 1, 2020, ACIP recommend", "url": "https://www.businesswire.com/news/home/20201212005026/en/U.S.-CDC-Committee-of-Independent-Health-Experts-Recommends-Vaccination-with-Pfizer-and-BioNTech-COVID-19-Vaccine-for-Persons-Ages-16-Years-and-Older/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 16:30:25", "title": "Trucks to play key role in vaccine distribution", "image": "https://cdn.snapi.dev/images/v1/p/r/interview-with-ait-1.jpg", "site": "FreightWaves", "text": "The biggest and most important civilian logistics project in American history is under way, and trucks are likely to be at the center of it. Trucks operated by UPS Inc. (NYSE:UPS) and FedEx Express, the air express unit of FedEx Corp. (NYSE:FDX) hit the road Saturday to begin distributing hundreds of millions of COVID-19 vaccine shipments designed to end the scourge that has claimed more than 290,000 American lives, just hours after the Food and Drug Administration authorized the emergency use of a vaccine from U.S. drug giant Pfizer Inc. (NYSE:PFE) and its German partner BioNTech.", "url": "https://www.freightwaves.com/news/trucks-to-play-key-role-in-vaccine-distribution"}, {"symbol": "PFE", "publishedDate": "2020-12-12 16:25:36", "title": "A CDC panel just voted to recommend Pfizer's COVID-19 shot for people 16 years and older", "image": "https://cdn.snapi.dev/images/v1/a/-/a-cdc-panel-just-voted-to-recommend-pfizers-covid-19-shot-for-people-16-years-and-older.jpg", "site": "Business Insider", "text": "The Advisory Committee on Immunization Practices, part of the Centers for Disease Control and Prevention, just voted to recommend Pfizer's coronavirus vaccine for everyone over age 16. The move further paves the way for the shots to be rolled out in the US, although CDC Director Robert Redfield still must accept the panel's recommendation.", "url": "https://www.businessinsider.com/cdc-acip-recommend-coronavirus-vaccine-paving-way-to-be-covered-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-12 15:47:30", "title": "Pfizer's Covid vaccine ships within hours. Here's how the U.S. plans to get it to everyone", "image": "https://cdn.snapi.dev/images/v1/o/1/106810439-1607797641738-assets-img-media-freezer-13.jpg", "site": "CNBC", "text": "The FDA just cleared the first Covid vaccine for emergency use. Within hours, FedEx and UPS will begin shipping 2.9 million doses across the country.", "url": "https://www.cnbc.com/2020/12/12/how-fedex-ups-plan-to-distribute-fda-approved-covid-vaccine-when-will-you-get-the-coronavirus-vaccine.html"}, {"symbol": "PFE", "publishedDate": "2020-12-12 14:53:43", "title": "CDC panel clears Pfizer Covid vaccine for people 16 years and older, clearing another pivotal hurdle", "image": "https://cdn.snapi.dev/images/v1/k/x/106544019-1589903717399gettyimages-1207345881.jpeg", "site": "CNBC", "text": "A key U.S. Centers for Disease Control and Prevention panel voted unanimously to recommend Pfizer-BioNTech's Covid-19 vaccine for people 16 years and older on Saturday.", "url": "https://www.cnbc.com/2020/12/12/cdc-panel-clears-pfizer-covid-vaccine-for-people-over-age-of-16.html"}, {"symbol": "PFE", "publishedDate": "2020-12-12 14:09:57", "title": "Pfizer Covid Vaccine Expected To Arrive In All 50 States By Monday", "image": "https://cdn.snapi.dev/images/v1/i/r/pfizer-covid-vaccine-expected-to-arrive-in-all-50-states-by-monday.jpg", "site": "Forbes", "text": "The vaccines are already being packaged, an official said.", "url": "https://www.forbes.com/sites/nicholasreimann/2020/12/12/pfizer-covid-vaccine-expected-to-arrive-in-all-50-states-by-monday/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 14:04:00", "title": "Why the U.K. Beat the U.S. in Authorizing a COVID Vaccine", "image": "https://cdn.snapi.dev/images/v1/p/o/podc13---xohicasui1.jpg", "site": "The Motley Fool", "text": "Hint: It's all about the process.", "url": "https://www.fool.com/investing/2020/12/12/why-the-uk-beat-the-us-in-authorizing-a-covid-vacc/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 12:56:40", "title": "FedEx, UPS activate delivery networks after FDA approves Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/q/m/fedex-and-ups-1.jpg", "site": "FreightWaves", "text": "FedEx (NYSE: FDX) and UPS (NYSE: UPS) refrigerated trucks are expected to roll out of Pfizer's (NYSE: PFE) pharmaceutical facilities Saturday, carrying the first 3.2 million-dose batch of COVID-19 vaccines to designated drop facilities in each state and to airports for longer trips. The Food and Drug Administration on Friday night gave the go-ahead for the drug's emergency public use.", "url": "https://www.freightwaves.com/news/fedex-ups-activate-delivery-networks-after-fda-approves-pfizer-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-12 12:09:08", "title": "Most people with allergies should get Pfizer's coronavirus shot, according to the FDA", "image": "https://cdn.snapi.dev/images/v1/m/o/most-people-with-allergies-should-get-pfizers-coronavirus-shot-according-to-the-fda.jpg", "site": "Business Insider", "text": "People with common allergies to foods or to things in the environment like pollen or dust probably don't have to worry about having a serious reaction to the just-authorized Pfizer coronavirus vaccine, the US Food and Drug Administration said during a press conference on Saturday.\u00a0 Even people who've had a severe allergic reaction to food or to something in the environment\u00a0in the past should be OK to get the shot, Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said during the briefing. FDA said that people who are allergic to the shot itself or to one of its ingredients shouldn't get it.", "url": "https://www.businessinsider.com/fda-people-allergies-can-take-pfizer-coronavirus-vaccine-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-12 11:13:28", "title": "FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/7/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047292fvaccination-5jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't call it an approval -- yet.", "url": "https://www.fool.com/investing/2020/12/12/fda-authorizes-pfizer-and-biontechs-coronavirus-va/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 07:56:48", "title": "Pfizer's COVID-19 vaccine wins emergency use authorisation from the U.S. FDA", "image": "https://cdn.snapi.dev/images/v1/t/o/56848336-s-740x416.jpg", "site": "Invezz", "text": "Pfizer Inc. (NYSE: PFE) received emergency use authorisation from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine that it developed in collaboration with Germany's BioNTech on Friday. The first round of vaccination comprising 2.9 million doses will begin in the upcoming week and focus primarily on elderly patients and healthcare workers this month.", "url": "https://invezz.com/news/2020/12/12/pfizers-covid-19-vaccine-wins-emergency-use-authorisation-from-the-u-s-fda/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 07:48:48", "title": "Pfizer-BioNTech Gets FDA Nod For Emergency Use Of Coronavirus Vaccine; Deliveries To Begin Immediately", "image": "https://cdn.snapi.dev/images/v1/c/o/virus-4937553-1920-1-1.jpg", "site": "Benzinga", "text": "The U.S. became the fifth nation behind the U.K., Bahrain, Canada and Saudi Arabia to approve a coronavirus vaccine candidate for emergency use. The verdict from the drug regulator came swifter than even the rapid timeline expected by many.", "url": "https://www.benzinga.com/general/biotech/20/12/18762366/pfizer-biontech-gets-fda-nod-for-emergency-use-of-coronavirus-vaccine-deliveries-to-begin-immedia"}, {"symbol": "PFE", "publishedDate": "2020-12-12 07:26:55", "title": "How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO", "image": "https://cdn.snapi.dev/images/v1/b/c/biotech11---dojm3irmqj.jpg", "site": "Fox Business", "text": "Albert Bourla and his team overcame unproven science and manufacturing bottlenecks; \u2018you're asking for too much.'.", "url": "https://www.foxbusiness.com/markets/behind-pfizer-record-covid-vaccine-effort"}, {"symbol": "PFE", "publishedDate": "2020-12-12 07:03:00", "title": "Is It Too Late to Get in on This Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/u/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6037722fgettyimages-1209372918jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A biotech that no one has heard of has been making a few investors rich for much of 2020.", "url": "https://www.fool.com/investing/2020/12/12/is-it-too-late-to-get-in-on-this-millionaire-maker/"}, {"symbol": "PFE", "publishedDate": "2020-12-12 06:14:00", "title": "Better Coronavirus Stock: Johnson & Johnson vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/k/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038382f2-scientists-in-lab-standing-side-by-sidejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Their COVID-19 vaccine programs are important, but both of these healthcare giants have other growth drivers.", "url": "https://www.fool.com/investing/2020/12/12/better-coronavirus-stock-johnson-johnson-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 23:45:43", "title": "White House pressured FDA to approve Pfizer vaccine: Report", "image": "https://cdn.snapi.dev/images/v1/7/z/white-house-pressured-fda-to-approve-pfizer-vaccine-report.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the latest vaccine news and the Washington Post article that stated the White House Chief of Staff Mark Meadows pressured Food and Drug Administration Commissioner Stephen Hahn to approve the coronavirus vaccine.", "url": "https://www.youtube.com/watch?v=O0ULBNlxKIY"}, {"symbol": "PFE", "publishedDate": "2020-12-11 23:12:00", "title": "Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19", "image": "https://cdn.snapi.dev/images/v1/m/w/press3---croinkg44k.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possib", "url": "https://www.businesswire.com/news/home/20201211005640/en/Pfizer-and-BioNTech-Celebrate-Historic-First-Authorization-in-the-U.S.-of-Vaccine-to-Prevent-COVID-19/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 22:06:00", "title": "FDA authorizes Pfizer's COVID-19 vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/2/w/005-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg", "site": "CNET", "text": "Vaccinations could start as soon as next week.", "url": "https://www.cnet.com/news/fda-authorizes-pfizers-covid-19-vaccine-for-emergency-use/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 22:01:00", "title": "First COVID-19 vaccine receives emergency approval in U.S.", "image": "https://cdn.snapi.dev/images/v1/i/m/im-271342width620size15005861664712778.jpg", "site": "Market Watch", "text": "The Food and Drug Administration authorized BioNTech and Pfizer Inc.'s COVID-19 vaccine Friday evening, which will make it the first vaccine for the coronavirus to reach Americans during the public-health crisis.", "url": "https://www.marketwatch.com/story/first-covid-19-vaccine-receives-emergency-approval-in-u-s-11607742063"}, {"symbol": "PFE", "publishedDate": "2020-12-11 21:49:44", "title": "FDA Authorizes Emergency Use Of Pfizer's Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/c/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017202fgettyimages-1210736764jpgw700opresize.jpg", "site": "Deadline", "text": "The Food and Drug Administration gave emergency use authorization for the first time to a coronavirus vaccine, a milestone in the fight against the pandemic that has resulted in the deaths of almost 100,000 Americans. \u201cToday's action follows an open and transparent review process that included input from independent scientific and public health experts and...", "url": "https://deadline.com/2020/12/coronavirus-vaccine-fda-1234655445/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 21:40:44", "title": "FDA grants emergency use authorization for Pfizer's COVID-19 vaccine, distribution to begin within days", "image": "https://cdn.snapi.dev/images/v1/b/5/gettyimages-1229654222jpgw600.jpg", "site": "TechCrunch", "text": "The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner BioNTech, the New York Times first reported on Friday night, and later\u00a0supported by The Wall Street Journal. This EUA follows a recommendation by an independent panel of experts commissioned by the [\u2026]", "url": "https://techcrunch.com/2020/12/11/fda-grants-emergency-use-authorization-for-pfizers-covid-19-vaccine-distribution-to-begin-within-days/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 21:31:28", "title": "FDA approves Pfizer's Covid vaccine for emergency use as U.S. reaches pivotal moment in the pandemic", "image": "https://cdn.snapi.dev/images/v1/i/e/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg", "site": "CNBC", "text": "The FDA has approved Pfizer and BioNTech's coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic.", "url": "https://www.cnbc.com/2020/12/11/pfizer-covid-vaccine-approved-fda-emergency-use.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 21:26:55", "title": "PFIZER SHOT GETS OK: US regulators greenlight first coronavirus vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/u/k/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so.jpg", "site": "Business Insider", "text": "US regulators have authorized the first coronavirus vaccine for emergency use, marking an inflection point in the pandemic and kicking off what's set to be the largest vaccination campaign in US history. The US Food and Drug Administration OK'd a highly effective COVID-19 vaccine developed by the drugmakers Pfizer and BioNTech, FDA said in a letter on its website. The decision followed an endorsement from an independent expert panel that reviewed data on the shot.", "url": "https://www.businessinsider.com/fda-authorizes-pfizer-biontech-coronavirus-vaccine-for-us-emergency-use-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-11 20:43:23", "title": "FDA advisor who voted against recommending Pfizer's Covid vaccine explains why she would \u2018be first in line' to get it", "image": "https://cdn.snapi.dev/images/v1/g/y/106809695-1607644402725-vac.jpg", "site": "CNBC", "text": "Dr. Archana Chatterjee, dean of the Chicago Medical School, who was one of the four FDA panel \u201cno\u201d votes, explains her decision.", "url": "https://www.cnbc.com/2020/12/11/fda-advisor-who-voted-against-recommending-pfizers-covid-vaccine-explains-why-she-would-be-first-in-line-to-get-it.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 19:20:39", "title": "Pfizer factory prepares to ship vaccine nationwide", "image": "https://cdn.snapi.dev/images/v1/x/n/pfizer-factory-prepares-to-ship-vaccine-nationwide.jpg", "site": "CNBC Television", "text": "NBC's Gabe Gutierrez reports on a Pfizer factory in the U.S. that's preparing to ship out the Covid vaccine nationwide.", "url": "https://www.youtube.com/watch?v=Li0oCFCiRTg"}, {"symbol": "PFE", "publishedDate": "2020-12-11 18:19:50", "title": "CDC will monitor for Bell's palsy among Pfizer vaccine recipients, but sees no causal relationship", "image": "https://cdn.snapi.dev/images/v1/o/f/106807760-1607433123297-gettyimages-1230009194-afp-8wp4z2.jpeg", "site": "CNBC", "text": "There is \"no known or expected causal relationship between the vaccine and Bell's palsy,\" the Centers for Disease Control and Prevention said Friday.", "url": "https://www.cnbc.com/2020/12/11/cdc-monitors-for-bells-palsy-among-pfizer-vaccine-recipients-sees-no-causal-relationship.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 15:32:43", "title": "Institutional Interest In Volatile Bitcoin Could Bring Record Highs In 2021", "image": "https://cdn.snapi.dev/images/v1/x/e/etf19.jpg", "site": "InvestorPlace", "text": "Although short-term profit-taking will likely put pressure on Bitcoin, long-term investors could consider investing in digital assets. The post Institutional Interest In Volatile Bitcoin Could Bring Record Highs In 2021 appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/institutional-interest-in-volatile-bitcoin-could-bring-record-highs-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 15:27:00", "title": "US closer to approving Pfizer coronavirus vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/9/v/skynews-pfizer-coronavirus-5167467jpg20201110092122.jpg", "site": "Skynews", "text": "The US government is expected to approve the Pfizer COVID-19 vaccine for emergency use within hours, according to reports.", "url": "https://news.sky.com/story/covid-19-us-closer-to-approving-pfizer-coronavirus-vaccine-for-emergency-use-12158491"}, {"symbol": "PFE", "publishedDate": "2020-12-11 14:45:24", "title": "Pfizer Analyst Breaks Down The FDA Process For Coronavirus Vaccine Candidate", "image": "https://cdn.snapi.dev/images/v1/m/q/medicine-5103043-1920-27.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) and\u00a0BioNTech SE's \u2013 ADR (NASDAQ: BNTX) coronavirus vaccine candidate passed the Adcom test, with the FDA panel voting 17-4 in favor of its risk-benefit profile in individuals 16 and older.\u00a0 Here's SVB Leerink analyst Geoffrey Porges' take on the dynamics of the Adcom vote.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/12/18754175/pfizer-analyst-breaks-down-the-fda-process-for-coronavirus-vaccine-candidate"}, {"symbol": "PFE", "publishedDate": "2020-12-11 14:37:23", "title": "White House threatens to fire FDA chief unless Pfizer Covid vaccine approved Friday, report says", "image": "https://cdn.snapi.dev/images/v1/7/d/106256485-1574272467663gettyimages-1183636908r.jpg", "site": "CNBC", "text": "White House chief of staff Mark Meadows told the head of the FDA to submit his resignation if the agency doesn't clear Pfizer's vaccine for emergency use by day's end, according to reports.", "url": "https://www.cnbc.com/2020/12/11/white-house-threatens-to-fire-fda-chief-unless-covid-vaccine-oked-friday-report.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 14:29:54", "title": "FDA vaccine committee member explains why he voted yes on Pfizer's vaccine", "image": "https://cdn.snapi.dev/images/v1/9/l/fda-vaccine-committee-member-explains-why-he-voted-yes-on-pfizers-vaccine.jpg", "site": "CNBC Television", "text": "Dr. Paul Offit, Director of The Vaccine Center at Children's Hospital of Philadelphia, joins 'Power Lunch' to discuss why he voted to authorize Pfizer's vaccine and the concerns of those who voted against the vaccine.", "url": "https://www.youtube.com/watch?v=ALqHbPnsYuU"}, {"symbol": "PFE", "publishedDate": "2020-12-11 14:15:52", "title": "Coronavirus vaccine distribution in the US: Emergency use authorization expected this weekend", "image": "https://cdn.snapi.dev/images/v1/m/q/coronavirus-vaccine-distribution-in-the-us-emergency-use-authorization-expected-this-weekend.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports the latest news on vaccine distribution.", "url": "https://www.youtube.com/watch?v=2v5jaDYdwNg"}, {"symbol": "PFE", "publishedDate": "2020-12-11 12:35:56", "title": "FDA's Pfizer COVID vaccine approval means Moderna's just days away", "image": "https://cdn.snapi.dev/images/v1/t/1/biotech40.jpg", "site": "Fox Business", "text": "Moderna is next in line to win FDA approval for its COVID-19 vaccine.", "url": "https://www.foxbusiness.com/markets/pfizers-coronavirus-fdamoderna-vaccine-approval-days-away"}, {"symbol": "PFE", "publishedDate": "2020-12-11 11:48:07", "title": "The FDA is preparing to authorize Pfizer's vaccine", "image": "https://cdn.snapi.dev/images/v1/t/h/the-fda-is-preparing-to-authorize-pfizers-vaccine.jpg", "site": "Business Insider", "text": "Hello, What a week it's been. If you had any doubts this month could be one long marathon of vaccine news, this week certainly proved the case.", "url": "https://www.businessinsider.com/business-insiders-biggest-healthcare-stories-week-ending-december-11-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-11 11:09:16", "title": "FDA's review of Pfizer vaccine is encouraging: Caret Group's Hassan", "image": "https://cdn.snapi.dev/images/v1/p/i/fdas-review-of-pfizer-vaccine-is-encouraging-caret-groups-hassan.jpg", "site": "CNBC Television", "text": "CNBC's \"Squawk on the Street\" team discusses the FDA's review of the Pfizer vaccine for emergency use authorization with Fred Hassan, Caret Group chairman.", "url": "https://www.youtube.com/watch?v=QglO19BHmxY"}, {"symbol": "PFE", "publishedDate": "2020-12-11 11:06:57", "title": "California to begin vaccine rollout of 327,000 Pfizer doses", "image": "https://cdn.snapi.dev/images/v1/h/p/california-to-begin-vaccine-rollout-of-327000-pfizer-doses.jpg", "site": "CNBC Television", "text": "CNBC's Kate Rogers reports on how California is preparing to rollout vaccines.", "url": "https://www.youtube.com/watch?v=r5qdyJs97NA"}, {"symbol": "PFE", "publishedDate": "2020-12-11 11:03:39", "title": "Pfizer board member Gottlieb on FDA's move toward emergency approval", "image": "https://cdn.snapi.dev/images/v1/j/4/pfizer-board-member-gottlieb-on-fdas-move-toward-emergency-approval.jpg", "site": "CNBC Television", "text": "An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins \"Squawk Box\" to discuss.", "url": "https://www.youtube.com/watch?v=i-spW_vk3ac"}, {"symbol": "PFE", "publishedDate": "2020-12-11 10:51:58", "title": "Coronavirus vaccine: Pfizer COVID-19 vaccine shots expected to start in a few days: Azar US Sec HHS", "image": "https://cdn.snapi.dev/images/v1/6/1/coronavirus-vaccine-pfizer-covid-19-vaccine-shots-expected-to-start-in-a-few-days-azar-us-sec-hhs.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the latest news on coronavirus Pfizer vaccine approval and distribution. #coronavirusvaccine #COVID-19vaccine #Pfizervaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=ohZU152lUv0"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:56:45", "title": "FDA Says It Will 'Rapidly' Authorize Pfizer's Covid Vaccine; But Shares Fall", "image": "https://cdn.snapi.dev/images/v1/l/k/biotech33.jpg", "site": "Investors Business Daily", "text": "Food and Drug Administration Commissioner Stephen Hahn said the agency would \"rapidly\" authorize Pfizer and BioNTech's coronavirus vaccine \u2014 but Pfizer stock fell early Friday. The post FDA Says It Will 'Rapidly' Authorize Pfizer's Covid Vaccine; But Shares Fall appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pfizer-stock-jumps-fda-rapidly-authorize-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:47:44", "title": "LIVE | Pfizer, Disney, Costco: Jim Cramer's Stock Market Breakdown - Dec. 11", "image": "https://cdn.snapi.dev/images/v1/k/i/live-pfizer-disney-costco-jim-cramers-stock-market-breakdown-dec-11.jpg", "site": "The Street", "text": "In Friday's stock market breakdown, Jim Cramer talks Costco, Disney, Lululemon, Pfizer, bitcoin and more.", "url": "https://www.youtube.com/watch?v=qBS1iW5KIj4"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:44:00", "title": "Pfizer/BioNTech COVID-19 Vaccine Gets FDA Panel's Backing", "image": "https://cdn.snapi.dev/images/v1/n/c/biotech31.jpg", "site": "Zacks Investment Research", "text": "An FDA panel recommends granting approval for emergency use of Pfizer's (PFE)/BioNTech's (BNTX) COVID-19 vaccine", "url": "https://www.zacks.com/stock/news/1154123/pfizer-biontech-covid-19-vaccine-gets-fda-panels-backing"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:36:53", "title": "Pfizer and Moderna could score $32 billion in Covid-19 vaccine sales -- in 2021 alone", "image": "https://cdn.snapi.dev/images/v1/w/r/201209123827-pfizer-biontech-coronavirus-vaccine-wales-1208-super-169.jpg", "site": "CNN Business", "text": "The imminent authorization of Pfizer's Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. The milestone is also a major moneymaker for the companies that developed the vaccines.", "url": "https://www.cnn.com/2020/12/11/business/pfizer-vaccine-covid-moderna-revenue/index.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:20:26", "title": "Covid-19 Vaccinations Could Start \u2018Monday Or Tuesday' As FDA Set To Approve Pfizer Vaccine, HHS Chief Says", "image": "https://cdn.snapi.dev/images/v1/q/w/covid-19-vaccinations-could-start-monday-or-tuesday-as-fda-set-to-approve-pfizer-vaccine-hhs-chief-says.jpg", "site": "Forbes", "text": "Alex Azar said the government is on \u201cjust the last dotting of i's and crossing of t's\u201d before it approves the first vaccine.", "url": "https://www.forbes.com/sites/alisondurkee/2020/12/11/covid-19-vaccinations-could-start-monday-or-tuesday-as-fda-set-to-approve-pfizer-vaccine-hhs-chief-says/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 09:12:29", "title": "FDA 'Rapidly Working' On Emergency Use Authorization For Pfizer, BioNTech's Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/x/i/syringe-1884758-1920-79.jpg", "site": "Benzinga", "text": "In a historic development, an FDA committee overwhelmingly voted in favor Thursday of the agency approving BNT162b2, an mRNA vaccine being developed by Pfizer Inc. (NYSE: PFE) and\u00a0BioNTech SE \u2013 ADR (NASDAQ: BNTX) against the coronavirus.\u00a0 What Happened: FDA has informed Pfizer that the agency is rapidly working toward finalization and issuance of an emergency use authorization for its co-developed investigational vaccine, FDA Commissioner Stephen Hahn said in a Friday statement.", "url": "https://www.benzinga.com/general/biotech/20/12/18751042/fda-rapidly-working-on-emergency-use-authorization-for-pfizer-biontechs-coronavirus-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:55:54", "title": "Azar credits 'Trump's personal leadership' for speed of Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/w/l/azar-credits-trumps-personal-leadership-for-speed-of-pfizer-vaccine.jpg", "site": "Fox Business", "text": "Health and Human Services Secretary Alex Azar gives update on Pfizer coronavirus vaccine emergency approval. Subscribe to Fox Business!", "url": "https://www.youtube.com/watch?v=tvxc88xmrtE"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:53:28", "title": "Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-climbs-2-as-fda-nears-final-authorization-of-its-covid-19-vaccine.jpg", "site": "Business Insider", "text": "Pfizer gained as much as 2.2% in early Friday trading after a panel of experts recommended that the US Food and Drug Administration approve its coronavirus vaccine for emergency use. The group, which included infectious disease experts, statisticians, and public health scientists, voted 17 to 4 on Thursday in favor of authorizing the shot for people at least 16 years old. One member abstained.", "url": "https://markets.businessinsider.com/news/stocks/pfizer-stock-price-fda-hahn-emergency-coronavirus-vaccine-authorization-pfe-2020-12-1029885460"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:52:00", "title": "Pfizer's Vaccine Will Be Authorized for Emergency Use, Azar Says", "image": "https://cdn.snapi.dev/images/v1/r/e/regulator-says-yes-to-pfizer-and-biontech-uk-becomes-first-western-country-to-have-a-coronavirus-vaccine---gw4huskkzi.jpg", "site": "Barrons", "text": "Here's what you need to know about the impact of Covid-19 to navigate the markets today.", "url": "https://www.barrons.com/articles/news-updates-51607694694"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:34:53", "title": "Physician on FDA advisory board explains her decision to vote against Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/5/z/physician-on-fda-advisory-board-explains-her-decision-to-vote-against-pfizer-vaccine.jpg", "site": "CNBC Television", "text": "Not every member of the FDA advisory panel voted in favor of emergency use authorization for the Pfizer-BioNTech's Covid vaccine. Dr. Archana Chatterjee, Dean of the Chicago Medical School, was a member of the FDA committee.", "url": "https://www.youtube.com/watch?v=vPTFb2Ebr0k"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:33:52", "title": "Pfizer coronavirus vaccine to receive FDA emergency-use authorization: Alex Azar", "image": "https://cdn.snapi.dev/images/v1/n/3/biotech21.jpg", "site": "Fox Business", "text": "The\u00a0Food and Drug Administration\u00a0will grant emergency-use authorization for the COVID-19\u00a0vaccine\u00a0developed by Pfizer and BioNTech, Health and Human Services Secretary Alex Azar said Friday.", "url": "https://www.foxbusiness.com/markets/pfizer-to-recieve-fda-emergency-use-authorization-alex-azar"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:26:52", "title": "FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/d/w/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg", "site": "CNBC", "text": "Dr. Archana Chatterjee told CNBC on Friday she's \"fully supportive\" of emergency use authorization for people who are 18 years and older.", "url": "https://www.cnbc.com/2020/12/11/dr-archana-chatterjee-explains-her-fda-panel-no-vote-on-pfizer-covid-vaccine.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:09:46", "title": "The FDA says it will authorize Pfizer's COVID-19 vaccine, which could be rolled out as early as Monday", "image": "https://cdn.snapi.dev/images/v1/t/h/the-fda-says-it-will-authorize-pfizers-covid-19-vaccine-which-could-be-rolled-out-as-early-as-monday.jpg", "site": "Business Insider", "text": "The US Food and Drug Administration (FDA) has said it intends to authorize\u00a0Pfizer and BioNTech's COVID-19 vaccine. It \"will rapidly work toward finalization and issuance of an emergency use authorization\" for Pfizer's shot, it said Friday morning. The vaccine would be the first to be authorized for use in the US.", "url": "https://www.businessinsider.com/fda-authorize-pfizer-covid-vaccine-biontech-alex-azar-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-11 08:00:00", "title": "BAVENCIO\u00ae (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma", "image": "https://cdn.snapi.dev/images/v1/p/o/press1---qpmj33rnju.jpg", "site": "PRNewsWire", "text": "ROCKLAND, Mass. and NEW YORK, Dec. 11, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...", "url": "https://www.prnewswire.com/news-releases/bavencio-avelumab-receives-positive-chmp-opinion-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301191189.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 07:52:44", "title": "FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/s/s/fda-chief-says-agency-will-quickly-approve-pfizers-covid-vaccine-for-emergency-use.jpg", "site": "CNBC Television", "text": "The U.S. Food and Drug Administration is \"rapidly\" working toward clearing Pfizer's Covid-19 vaccine for emergency use after a key panel overwhelmingly endorsed the shots Thursday evening, Commissioner Stephen Hahn said in a statement on Friday. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=7pz4FiH0t88"}, {"symbol": "PFE", "publishedDate": "2020-12-11 07:31:48", "title": "FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use.", "image": "https://cdn.snapi.dev/images/v1/w/u/106809694-16076441102020-12-10t133915z-162623677-rc2dkk9lddra-rtrmadp-0-health-coronavirus-pfizer-vaccine.jpeg", "site": "CNBC", "text": "A key FDA advisory panel overwhelmingly endorsed the Pfizer's Covid-19 vaccine Thursday evening.", "url": "https://www.cnbc.com/2020/12/11/fda-chief-says-agency-will-quickly-approve-pfizers-covid-vaccine-for-emergency-use.html"}, {"symbol": "PFE", "publishedDate": "2020-12-11 07:30:24", "title": "FDA said it plans to issue emergency authorization to BioNTech/Pfizer's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/u/w/biotech20.jpg", "site": "Market Watch", "text": "The Food and Drug Administration plans to finalize and issue an emergency use authorization to BioNTech and Pfizer Inc.'s experimental COVID-19 vaccine, the regulator said Friday. Shares of BioNTech gained 1.5% in premarket trading on Friday, while Pfizer's stock was up 2.1%.", "url": "https://www.marketwatch.com/story/fda-said-it-plans-to-issue-emergency-authorization-to-biontechpfizers-covid-19-vaccine-2020-12-11"}, {"symbol": "PFE", "publishedDate": "2020-12-11 07:11:16", "title": "FDA advisory panel member Dr. Ofer Levy on voting to approve the Pfizer vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/u/k/fda-advisory-panel-member-dr-ofer-levy-on-voting-to-approve-the-pfizer-vaccine-for-emergency-use.jpg", "site": "CNBC Television", "text": "Dr. Ofer Levy, Director of the Precision Vaccines Program at Boston Children's Hospital, and a member of the FDA advisory committee evaluating the Pfizer and Moderna vaccines, joins Worldwide Exchange after the panel voted in favor of emergency use authorization for Pfizer's Covid-19 vaccine.", "url": "https://www.youtube.com/watch?v=M53BsTjQins"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:58:45", "title": "How hospitals are prepping to administer the Pfizer-BioNtech Covid vaccine", "image": "https://cdn.snapi.dev/images/v1/z/w/how-hospitals-are-prepping-to-administer-the-pfizer-biontech-covid-vaccine.jpg", "site": "CNBC Television", "text": "Once the Covid vaccine is delivered, what happens inside the hospital? CNBC's Frank Holland got a look at how one hospital in Newark, New Jersey is preparing to administer hundreds of vaccinations daily.", "url": "https://www.youtube.com/watch?v=ckocLOMMkQs"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:53:49", "title": "Pfizer raises quarterly cash dividend to 39 cents a share vs. 38 cents", "image": "https://cdn.snapi.dev/images/v1/8/w/drugs36.jpg", "site": "Market Watch", "text": "Pfizer Inc. said Friday's its board has raised its quarterly cash dividend to 39 cents a share from 38 cents in the year-earlier period. The new dividend will be payable March 5 to shareholders of record as of Jan. 29.", "url": "https://www.marketwatch.com/story/pfizer-raises-quarterly-cash-dividend-to-39-cents-a-share-vs-38-cents-2020-12-11"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:51:13", "title": "Why two members of the FDA advisory panel on the Pfizer-BioNTech vaccine voted against approval", "image": "https://cdn.snapi.dev/images/v1/a/f/why-two-members-of-the-fda-advisory-panel-on-the-pfizer-biontech-vaccine-voted-against-approval.jpg", "site": "CNBC Television", "text": "An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=2EtAzVy89ZU"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:50:00", "title": "2 Best Coronavirus Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/v/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6041482fgettyimages-1221650152jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies haven't even started to report revenue from their COVID-19 projects yet.", "url": "https://www.fool.com/investing/2020/12/11/2-best-coronavirus-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:45:00", "title": "These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020", "image": "https://cdn.snapi.dev/images/v1/n/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038852fgettyimages-1169477832jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.", "url": "https://www.fool.com/investing/2020/12/11/these-5-mid-cap-healthcare-stocks-had-the-best-gai/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:12:00", "title": "This COVID Vaccine Stock Is the Safest Bet of All", "image": "https://cdn.snapi.dev/images/v1/a/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038372frisk-and-rewardjpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you don't like taking on too big of a risk, here's the coronavirus vaccine stock that's likely right up your alley.", "url": "https://www.fool.com/investing/2020/12/11/this-covid-vaccine-stock-is-the-safest-bet-of-all/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 06:05:00", "title": "FDA Committee Gives Thumbs Up for Pfizer's COVID Vaccine: 3 Most Important Things to Know", "image": "https://cdn.snapi.dev/images/v1/6/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038432fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's what really matters from the FDA advisory committee's historic vote on Thursday.", "url": "https://www.fool.com/investing/2020/12/11/fda-committee-gives-thumbs-up-for-pfizers-covid-va/"}, {"symbol": "PFE", "publishedDate": "2020-12-11 05:56:00", "title": "Here's What Investors Need To Know Before Buying Pfizer Stock For Its Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/l/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5948752fcovid-19-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "With all eyes on its COVID vaccine candidate, another drug may have more impact on the company's fate -- and its stock price.", "url": "https://www.fool.com/investing/2020/12/11/heres-what-investors-need-to-know-before-buying-pf/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 21:38:19", "title": "Pfizer-BioNTech COVID-19 Vaccine Gets FDA Advisors' Nod", "image": "https://cdn.snapi.dev/images/v1/q/t/cdc-hxhpw1v7-ze-unsplash-3-0.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE\u00a0and BioNTech SE (NASDAQ: BNTX)\u00a0have got the green light on their COVID-19 vaccine from an external panel of experts that advise the United States Food and Drug Administration. What Happened: The Vaccines and Related Biological Products Advisory Committee (VRBPAC)\u00a0 voted by a large majority of 17 to 4 in favor of giving emergency use authorization (EUA) to the companies' coronavirus vaccine.", "url": "https://www.benzinga.com/general/biotech/20/12/18745799/pfizer-biontech-covid-19-vaccine-gets-fda-advisors-nod"}, {"symbol": "PFE", "publishedDate": "2020-12-10 20:00:59", "title": "Michigan prepares for a vaccine rollout as soon as the FDA approves Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/2/7/michigan-prepares-for-a-vaccine-rollout-as-soon-as-the-fda-approves-pfizer-vaccine.jpg", "site": "CNBC Television", "text": "NBC's Gabe Guiterrez joins Shep Smith to report Michigan healthcare workers are already preparing for a vaccine rollout as soon as the FDA approves the Pfizer vaccine for emergency use authorization. Big states will receive 320,000 vaccines, medium states 50,000 and small states about 5,000 vaccines.", "url": "https://www.youtube.com/watch?v=rq0J8LXjpzw"}, {"symbol": "PFE", "publishedDate": "2020-12-10 19:05:02", "title": "Pfizer-BioNTech Covid Vaccine Gets Nod From FDA Advisers", "image": "https://cdn.snapi.dev/images/v1/q/r/pfizer-biontech-covid-vaccine-gets-nod-from-fda-advisers.jpg", "site": "Bloomberg Markets and Finance", "text": "Dec.10 -- A Food and Drug Administration advisory panel voted 17 to 4, with one abstention, that the benefits of the vaccine from\u00a0Pfizer Inc.\u00a0and\u00a0BioNTech SE outweigh the risks for use in people ages 16 and older.\u00a0Robert Langreth reports on \"Bloomberg Daybreak: Asia.", "url": "https://www.youtube.com/watch?v=sKcjU5l0cwI"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:55:44", "title": "Pfizer Vaccine Gets FDA Nod", "image": "https://cdn.snapi.dev/images/v1/x/f/pfizer-vaccine-gets-fda-nod.jpg", "site": "Bloomberg Technology", "text": "Dec.10 -- The first\u00a0Covid-19 vaccine\u00a0expected to be deployed in the U.S. won the backing of a panel of government advisers. Bloomberg's Michelle Cortez reports on \"Bloomberg Technology.", "url": "https://www.youtube.com/watch?v=iSBnx6teFNo"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:51:00", "title": "Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.", "image": "https://cdn.snapi.dev/images/v1/1/q/press12---3drcmqs0d9.jpg", "site": "GlobeNewsWire", "text": "NEW YORK and MAINZ, GERMANY, December 10, 2020 \u2014 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted (17 to 4) in support of the FDA granting Emergency Use Authorization (EUA) for the companies' COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision.", "url": "https://www.globenewswire.com/news-release/2020/12/10/2143492/0/en/Pfizer-and-BioNTech-Receive-FDA-Advisory-Committee-Vote-Supporting-Potential-First-Emergency-Use-Authorization-for-Vaccine-to-Combat-COVID-19-in-the-U-S.html"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:50:00", "title": "Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.", "image": "https://cdn.snapi.dev/images/v1/i/a/press14---l0emak0jrr.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 4 in support of the FDA granting Emergency Use Authorization (EUA) for the companies' COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision. VRBPAC based its recommendation on the", "url": "https://www.businesswire.com/news/home/20201210006182/en/Pfizer-and-BioNTech-Receive-FDA-Advisory-Committee-Vote-Supporting-Potential-First-Emergency-Use-Authorization-for-Vaccine-to-Combat-COVID-19-in-the-U.S./"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:38:33", "title": "FDA advisory council signals support for Pfizer's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/q/7/p-1-fda-vaccine-advisory-councils-signals-support-for-pfizer-vaccine.jpg", "site": "Fast Company", "text": "Pfizer's vaccine now has the blessing of the FDA's advisory council, an important step in moving toward approval. A panel of vaccine and infectious disease experts advising the Food and Drug Administration voted to approve Pfizer's COVID-19 vaccine for anyone 16 years and above.", "url": "https://www.fastcompany.com/90584895/fda-advisory-council-signals-support-for-pfizers-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:17:00", "title": "FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine", "image": "https://cdn.snapi.dev/images/v1/x/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6045612fphysician-holding-a-vaccine-shotjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The final green light decision now rests in the FDA's hands.", "url": "https://www.fool.com/investing/2020/12/10/fda-advisory-committee-recommends-emergency-author/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:15:00", "title": "FDA Advisory Committee Recommends Authorization of Pfizer's Covid Vaccine", "image": "https://cdn.snapi.dev/images/v1/m/0/m02d20201110t2i1540707780w940fhfwllplsqrlynxmpega90pz.jpg", "site": "Barrons", "text": "The vote is the final step needed before the FDA makes it's approval decision, which could happen as soon as Friday.", "url": "https://www.barrons.com/articles/fda-advisory-committee-recommends-authorizing-pfizer-covid-vaccine-51607642145"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:05:48", "title": "FDA panel recommends approval of Pfizer's Covid vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/f/q/fda-panel-recommends-approval-of-pfizers-covid-vaccine-for-emergency-use.jpg", "site": "CNBC Television", "text": "A key Food and Drug Administration advisory panel on Thursday recommended the approval of Pfizer and BioNTech's coronavirus vaccine for emergency use in people over 16 years old, the last step before the FDA gives the final OK to broadly distribute the first doses throughout the United States. If the FDA accepts the nonbinding recommendation from the Vaccines and Related Biological Products Advisory Committee \u2014 which is expected \u2014 it would mark a pivotal moment in the Covid-19 pandemic, which has infected more than 15.4 million people and killed roughly 290,000 in the U.S. in less than a year.", "url": "https://www.youtube.com/watch?v=oBoW6K8XZ9c"}, {"symbol": "PFE", "publishedDate": "2020-12-10 18:02:00", "title": "FDA panel backs Pfizer's COVID-19 vaccine for emergency use in US", "image": "https://cdn.snapi.dev/images/v1/t/q/004-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg", "site": "CNET", "text": "Now it's up to the FDA to decide whether to accept that recommendation. Pfizer says the vaccine has shown 95% effectiveness in clinical trials.", "url": "https://www.cnet.com/news/fda-panel-backs-pfizers-covid-19-vaccine-for-emergency-use-in-us/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 17:55:00", "title": "Medical experts vote in favor of FDA authorization of BioNTech/Pfizer COVID-19 vaccine candidate", "image": "https://cdn.snapi.dev/images/v1/1/a/im-271706width620size14988290398126465.jpg", "site": "Market Watch", "text": "The Food and Drug Administration will now make the final decision on whether to authorize the experimental vaccine.", "url": "https://www.marketwatch.com/story/medical-experts-vote-in-favor-of-fda-authorization-of-biontech-pfizer-covid-19-vaccine-candidate-11607640908"}, {"symbol": "PFE", "publishedDate": "2020-12-10 17:53:08", "title": "FDA panel recommends approving Pfizer's COVID-19 vaccine emergency use authorization", "image": "https://cdn.snapi.dev/images/v1/p/s/gettyimages-1230032451jpgw603.jpg", "site": "TechCrunch", "text": "An independent panel of experts has recommended Food and Drug Administration (FDA) has now voted to approve an official Emergency Use Authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine. This means that it's one step closer to beginning to be administered to people in special circumstances \u2013 including for front-line healthcare workers dealing with healthcare facilities [\u2026]", "url": "https://techcrunch.com/2020/12/10/fda-panel-recommends-approving-pfizers-covid-19-vaccine-emergency-use-authorization/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 17:47:53", "title": "An influential expert panel just gave its blessing to Pfizer's 2-dose coronavirus shot, teeing up the FDA to imminently authorize the US' first COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/a/n/an-influential-expert-panel-just-gave-its-blessing-to-pfizers-2-dose-coronavirus-shot-teeing-up-the-fda-to-imminently-authorize-the-us-first-covid-19-vaccine.jpg", "site": "Business Insider", "text": "A committee of 22 leading scientists and doctors just voted 17 to 4, with one abstention, encouraging the US Food and Drug Administration to grant emergency use authorization for Pfizer's COVID-19 vaccine in the US. Their vote is not a final verdict, it's really just advice.", "url": "https://www.businessinsider.com/fda-advisory-committee-endorses-pfizers-covid-19-vaccine-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-10 17:42:00", "title": "Pfizer COVID-19 vaccine recommended for approval by US government advisory panel", "image": "https://cdn.snapi.dev/images/v1/n/u/skynews-brexit-breaking-news-5177180jpg20201123152327.jpg", "site": "Skynews", "text": "The US government advisory panel has recommended the Pfizer COVID-19 be approved for use.", "url": "https://news.sky.com/story/covid-19-pfizer-vaccine-recommended-for-approval-by-us-government-advisory-panel-12157588"}, {"symbol": "PFE", "publishedDate": "2020-12-10 17:37:28", "title": "FDA panel recommends approval of Pfizer's Covid vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/h/e/106807762-16074332352020-12-08t113336z-1247632997-rc2zik92aws9-rtrmadp-0-health-coronavirus-britain-rollout.jpeg", "site": "CNBC", "text": "If the FDA adopts the recommendation it would mark a pivotal moment in the Covid-19 pandemic, which has killed roughly 290,000 in the U.S. in less than a year.", "url": "https://www.cnbc.com/2020/12/10/pfizer-covid-vaccine-fda-panel-recommends-approval-for-emergency-use.html"}, {"symbol": "PFE", "publishedDate": "2020-12-10 16:56:06", "title": "The Question to Ask About COVID-19 Vaccine Stocks", "image": "https://cdn.snapi.dev/images/v1/r/j/drugs30---wemrfr2b6z.jpg", "site": "InvestorPlace", "text": "The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started.", "url": "https://investorplace.com/2020/12/the-question-to-ask-about-covid-19-vaccine-stocks/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 16:47:15", "title": "Merck CEO: Pfizer and Moderna vaccines look fantastic", "image": "https://cdn.snapi.dev/images/v1/t/t/merck-ceo-pfizer-and-moderna-vaccines-look-fantastic.jpg", "site": "CNBC Television", "text": "Ken Frazier, Merck Chairman and CEO, joins 'Closing Bell' to discuss Merck's coronavirus vaccines and his thoughts on the other coronavirus vaccines being worked on by other companies.", "url": "https://www.youtube.com/watch?v=MdmPtkYB6ko"}, {"symbol": "PFE", "publishedDate": "2020-12-10 14:22:55", "title": "How Safe Is Pfizer's Covid-19 Vaccine? Here's What You Should Know About Reports Of Allergic Reactions In Britain", "image": "https://cdn.snapi.dev/images/v1/e/0/how-safe-is-pfizers-covid-19-vaccine-heres-what-you-should-know-about-reports-of-allergic-reactions-in-britain.jpg", "site": "Forbes", "text": "Two people reported severe allergic reactions to Pfizer and BioNTech's Covid-19 vaccine when it was rolled out in the U.K.", "url": "https://www.forbes.com/sites/roberthart/2020/12/10/how-safe-is-pfizers-covid-19-vaccine-heres-what-you-should-know-about-reports-of-allergic-reactions-in-britain/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 13:25:37", "title": "No, there isn't evidence that Pfizer's vaccine causes infertility.", "image": "https://cdn.snapi.dev/images/v1/j/5/09distortions-brief-infertility-articlelarge-v2jpgquality75autowebpdisableupscale.jpg", "site": "NYTimes", "text": "A flurry of rumors online has prompted concern. But scientists assert the claims are baseless.", "url": "https://www.nytimes.com/2020/12/10/technology/no-there-isnt-evidence-that-pfizers-vaccine-causes-infertility.html"}, {"symbol": "PFE", "publishedDate": "2020-12-10 11:03:00", "title": "Pfizer/BioNTech COVID-19 Vaccine Raises New Safety Concerns", "image": "https://cdn.snapi.dev/images/v1/w/d/biotech8.jpg", "site": "Zacks Investment Research", "text": "The Bell's palsy related side-effects are not alarming enough to preclude FDA from granting emergency approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine.", "url": "https://www.zacks.com/stock/news/1150644/pfizer-biontech-covid-19-vaccine-raises-new-safety-concerns"}, {"symbol": "PFE", "publishedDate": "2020-12-10 10:29:24", "title": "Jim Cramer: I'm confused why U.S. seems to be taking longer to approve Pfizer's Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/w/a/jim-cramer-im-confused-why-us-seems-to-be-taking-longer-to-approve-pfizers-covid-19-vaccine.jpg", "site": "CNBC Television", "text": "CNBC's Jim Cramer asks CNBC's Meg Tirrell why it might be that Canada and the United Kingdom ended up approving the Pfizer-BioNTech coronavirus vaccine for emergency use before the United States.", "url": "https://www.youtube.com/watch?v=_CHMs4jBd5s"}, {"symbol": "PFE", "publishedDate": "2020-12-10 10:21:00", "title": "Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine", "image": "https://cdn.snapi.dev/images/v1/v/2/press20---du0wihpeqi.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate. In the trial of 43,448 participants, who were 16 years and older, 21,720 of whom received BNT162b2 and 21,728 placebo, the two-dose regimen of 30 \u03bcg BNT162b2, which was given 21 days apart, was well-tolerat", "url": "https://www.businesswire.com/news/home/20201210005703/en/Pfizer-and-BioNTech-Announce-Publication-of-Results-from-Landmark-Phase-3-Trial-of-BNT162b2-COVID-19-Vaccine-Candidate-in-The-New-England-Journal-of-Medicine/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 09:50:15", "title": "5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return", "image": "https://cdn.snapi.dev/images/v1/7/y/drugs21.jpg", "site": "24/7 Wall Street", "text": "Many prognosticators across Wall Street feel that interest rates will start to rise in 2021 Deutsche Bank is negative on duration and sees the 10-year Treasury bond yield rising to 1.5% in the second quarter of 2021 from the current yield of 0.95%.", "url": "https://247wallst.com/healthcare-business/2020/12/10/5-dividend-paying-pharmaceutical-stocks-to-buy-for-solid-2021-total-return/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 09:42:12", "title": "FDA director: The agency expects to approve Pfizer's vaccine after today's crucial hearing", "image": "https://cdn.snapi.dev/images/v1/f/d/fda-director-the-agency-expects-to-approve-pfizers-vaccine-after-todays-crucial-hearing.jpg", "site": "Business Insider", "text": "A panel of independent experts is meeting today to evaluate Pfizer's coronavirus vaccine. By day's end, they're expected to come to a vote that will advise the US Food and Drug Administration (FDA) to approve or deny the shot for emergency use.\u00a0 But FDA Commissioner Dr. Stephen Hahn said the outcome is already predictable, and that the agency intends to act on the advisory panel's advice immediately.\u00a0", "url": "https://www.businessinsider.com/fda-director-we-expect-to-approve-pfizers-vaccine-after-hearing-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-10 09:35:26", "title": "Live | Airbnb, Facebook, Pfizer: Jim Cramer's Stock Market Breakdown - Dec. 10", "image": "https://cdn.snapi.dev/images/v1/a/8/live-airbnb-facebook-pfizer-jim-cramers-stock-market-breakdown-dec-10.jpg", "site": "The Street", "text": "In Thursday's market breakdown, Jim Cramer talks Airbnb, Facebook, Pfizer, jobless claims and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet", "url": "https://www.youtube.com/watch?v=k6tBHdGNLG0"}, {"symbol": "PFE", "publishedDate": "2020-12-10 08:35:53", "title": "FDA likely to weigh allergic reactions of Pfizer's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/l/3/pfizer-covid-vaccinejpgquality90stripall.jpg", "site": "New York Post", "text": "The feds will likely scrutinize recent allergic reactions to Pfizer's coronavirus vaccine before clearing it for emergency use, the government's top vaccine adviser said. Two people who received the groundbreaking COVID-19 shot in the UK suffered severe allergic reactions to it, leading British health officials to warn that individuals with \u201csignificant\u201d allergic reactions may not.", "url": "https://nypost.com/2020/12/10/fda-may-weigh-allergic-reactions-to-pfizer-covid-19-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 08:13:00", "title": "Vaccine Euphoria Aids Oil in the Face of Huge Supply Build", "image": "https://cdn.snapi.dev/images/v1/a/w/oil27.jpg", "site": "Zacks Investment Research", "text": "The top gainers of the S&P 500 during the past month are all energy firms - Occidental Petroleum (OXY), Apache (APA), Diamondback Energy (FANG), Marathon Oil (MRO) and Devon Energy (DVN).", "url": "https://www.zacks.com/stock/news/1150044/vaccine-euphoria-aids-oil-in-the-face-of-huge-supply-build"}, {"symbol": "PFE", "publishedDate": "2020-12-10 07:14:44", "title": "FDA advisory committee meets Thursday to discuss Pfizer vaccine data", "image": "https://cdn.snapi.dev/images/v1/w/d/fda-advisory-committee-meets-thursday-to-discuss-pfizer-vaccine-data.jpg", "site": "CNBC Television", "text": "The FDA will kick off a meeting Thursday morning made up of a group of independent medical experts who will discuss the risks and benefits of the Pfizer-BioNTech coronavirus vaccine. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=8YTdcGZB5CU"}, {"symbol": "PFE", "publishedDate": "2020-12-10 07:14:42", "title": "6 things to know before FDA panel votes on Pfizer's Covid vaccine today", "image": "https://cdn.snapi.dev/images/v1/z/m/106808683-1607532026099-2020-12-08t183156z-1175983302-rc26jk9j1u2v-rtrmadp-3-health-coronavirus-vaccines-cdc.jpg", "site": "CNBC", "text": "A FDA panel is scheduled to vote Thursday on whether to recommend the approval of Pfizer and BioNTech's coronavirus vaccine for emergency use.", "url": "https://www.cnbc.com/2020/12/09/pfizer-covid-vaccine-6-things-to-know-before-fda-panel-votes-today.html"}, {"symbol": "PFE", "publishedDate": "2020-12-10 07:00:52", "title": "Pfizer Stock Faces Its Next Big Covid Challenge: An FDA Committee", "image": "https://cdn.snapi.dev/images/v1/j/1/drugs24.jpg", "site": "Investors Business Daily", "text": "A Food and Drug Administration panel will meet Thursday to discuss Pfizer's BioNTech-partnered coronavirus vaccine. The results could spark Pfizer stock and BioNTech stock.", "url": "https://www.investors.com/news/technology/pfizer-stock-fda-panel-slated-weigh-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 06:52:00", "title": "3 Best Biotech Stocks of 2020: Are They Buys Now?", "image": "https://cdn.snapi.dev/images/v1/o/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038932fgettyimages-1236338088jpgw700opresize.jpg", "site": "The Motley Fool", "text": "There are plenty of catalysts on the horizon for these investments -- and a healthy dose of risk.", "url": "https://www.fool.com/investing/2020/12/10/3-best-biotech-stocks-of-2020-are-they-buys-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 06:07:00", "title": "3 Reasons to Buy Pfizer Stock Now", "image": "https://cdn.snapi.dev/images/v1/b/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040872fgettyimages-1206825409jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company has a lot more going for it than just a coronavirus vaccine.", "url": "https://www.fool.com/investing/2020/12/10/3-reasons-to-buy-pfizer-stock-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 06:05:00", "title": "3 Warren Buffett Dividend Stocks You Can Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/t/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038332fsmiling-warren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Solid dividends and solid businesses. Buffett likes these stocks -- and you might, too.", "url": "https://www.fool.com/investing/2020/12/10/3-warren-buffett-dividend-stocks-you-can-buy-right/"}, {"symbol": "PFE", "publishedDate": "2020-12-10 05:30:34", "title": "Americans with severe allergies may need to avoid Pfizer's COVID-19 shot until the risks are better understood, Trump's vaccine chief said", "image": "https://cdn.snapi.dev/images/v1/a/m/americans-with-severe-allergies-may-need-to-avoid-pfizers-covid-19-shot-until-the-risks-are-better-understood-trumps-vaccine-chief-said.jpg", "site": "Business Insider", "text": "The Food and Drug Administration (FDA) could advise Americans with severe allergies to take Pfizer's COVID-19 vaccine until more information is known about two allergic reactions to the shot in the UK, Trump's vaccine chief said. The FDA is meeting Thursday to review the vaccine for emergency use, and the first shots could be given out as early as Friday.", "url": "https://www.businessinsider.com/slaoui-fda-allergic-reactions-pfizer-covid-19-vaccine-authorization-us-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-10 05:15:51", "title": "Pfizer-BioNTech vaccine documents were \u2018unlawfully accessed' in a cyberattack on Europe's medicines agency", "image": "https://cdn.snapi.dev/images/v1/w/9/106807760-1607433123297-gettyimages-1230009194-afp-8wp4z2.jpeg", "site": "CNBC", "text": "Documents for the Pfizer-BioNTech Covid-19 vaccine were 'unlawfully accessed' in a cyberattack on the European Medicines Agency.", "url": "https://www.cnbc.com/2020/12/10/pfizer-biontech-vaccine-documents-unlawfully-accessed-in-ema-hack.html"}, {"symbol": "PFE", "publishedDate": "2020-12-10 00:46:26", "title": "Pfizer, BioNTech Say Hackers Accessed COVID-19 Vaccine Development Data", "image": "https://cdn.snapi.dev/images/v1/a/s/kaitlyn-baker-vzjdyl5jvxy-unsplash.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said on Wednesday that hackers illegally accessed documents related to their COVID-19 vaccine in an attack on the European Medicines Agency (EMA). What Happened: The two companies said in a statement\u00a0they believe the personal data of trial participants were not compromised and that the EMA had assured them that the incident would not impact the timeline of the vaccine's review.", "url": "https://www.benzinga.com/general/biotech/20/12/18726861/pfizer-biontech-say-hackers-accessed-covid-19-vaccine-development-data"}, {"symbol": "PFE", "publishedDate": "2020-12-09 21:53:21", "title": "Canada becomes the latest to authorize Pfizer vaccine, US emergency use expected by end of week", "image": "https://cdn.snapi.dev/images/v1/c/m/canada-becomes-the-latest-to-authorize-pfizer-vaccine-us-emergency-use-expected-by-end-of-week.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the latest news on COVID-19 vaccine approval in Canada and the United States. #coronavirusvaccine #COVID19vaccine #coronavirus For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=84AP-7r5uzw"}, {"symbol": "PFE", "publishedDate": "2020-12-09 19:39:29", "title": "2.9M Pfizer vaccines can be shipped within 24 hours of FDA clearance", "image": "https://cdn.snapi.dev/images/v1/p/u/29m-pfizer-vaccines-can-be-shipped-within-24-hours-of-fda-clearance.jpg", "site": "CNBC Television", "text": "Two people with a history of severe allergies experienced an allergic reaction after receiving the Pfizer vaccine. This is currently under investigation.", "url": "https://www.youtube.com/watch?v=OHYw1VK2DHc"}, {"symbol": "PFE", "publishedDate": "2020-12-09 17:45:09", "title": "Pfizer (PFE) Dips More Than Broader Markets: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/m/t/drugs16.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $41.85, marking a -1.67% move from the previous day.", "url": "https://www.zacks.com/stock/news/1147953/pfizer-pfe-dips-more-than-broader-markets-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2020-12-09 17:29:05", "title": "FDA will likely scrutinize allergic reactions to Pfizer's Covid vaccine in UK before clearing use in U.S., Trump vaccine chief says", "image": "https://cdn.snapi.dev/images/v1/m/y/106807763-16074332922020-12-08t123316z-1123259786-rc20jk91l78u-rtrmadp-0-health-coronavirus-britain-rollout.jpeg", "site": "CNBC", "text": "The allergic reactions reported by U.K. health-care workers vaccinated against Covid-19 shouldn't be a surprise, some medical experts said on Wednesday.", "url": "https://www.cnbc.com/2020/12/09/covid-vaccine-fda-will-likely-scrutinize-allergic-reactions-to-pfizers-vaccine-in-uk-before-clearing-use-in-us.html"}, {"symbol": "PFE", "publishedDate": "2020-12-09 15:02:00", "title": "Pfizer and BioNTech's Coronavirus Vaccine Approved in Canada", "image": "https://cdn.snapi.dev/images/v1/l/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6043572fgettyimages-1168877430jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It was the third authorization of BNT162b2 by a national healthcare regulator in the space of a week.", "url": "https://www.fool.com/investing/2020/12/09/pfizer-and-biontech-coronavirus-vaccine-approved-i/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 12:37:40", "title": "Canada authorizes BioNTech/Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/w/f/biotech17.jpg", "site": "Market Watch", "text": "Shares of BioNTech were down 0.6% and Pfizer Inc.'s stock fell 1.1% in trading on Wednesday after the companies announced that their COVID-19 vaccine candidate had received emergency authorization in Canada. This is the third country, after Bahrain and the United Kingdom, to authorize their coronavirus vaccine.", "url": "https://www.marketwatch.com/story/canada-authorizes-biontechpfizer-covid-19-vaccine-2020-12-09"}, {"symbol": "PFE", "publishedDate": "2020-12-09 12:35:49", "title": "Canada beats the US to approving Pfizer and BioNTech's coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/s/y/syringe-1884758-1920-36---xxgsgzmghw.jpg", "site": "Business Insider", "text": "Canada approved Pfizer and BioNTech's coronavirus vaccine for use, the country's health department announced on Wednesday. The UK made a similar decision earlier this month, but the vaccine is still awaiting authorization for emergency use in the US.\u00a0 The vaccine, made by US drugmaker Pfizer and German biotech firm BioNTech, is 95% effective at preventing COVID-19, according to the company's Phase 3 trials. Pfizer predicts it will produce up to 50 million vaccine doses for global distribution by the end of 2020, and up to 1.3 billion doses in 2021.", "url": "https://www.businessinsider.com/canada-beats-us-approves-pfizer-biontech-coronavirus-covid-vaccine-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-09 12:12:01", "title": "Pfizer Stock Trips After U.K. Notes Possible Allergic Reactions To Covid Vaccine", "image": "https://cdn.snapi.dev/images/v1/l/y/drugs14.jpg", "site": "Investors Business Daily", "text": "Pfizer stock toppled Wednesday on reports of two allergic reactions after the U.K. began its widespread coronavirus vaccine campaign. Both were staff members of the National Health Service.", "url": "https://www.investors.com/news/technology/pfizer-stock-dips-possible-allergic-reactions-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 12:00:28", "title": "Canada Approves Pfizer's Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/t/i/canada-approves-pfizers-coronavirus-vaccine.jpg", "site": "Forbes", "text": "Both Canada and the U.K. have now approved the vaccine for emergency use. It's still under review in the U.S.", "url": "https://www.forbes.com/sites/jemimamcevoy/2020/12/09/canada-approves-pfizers-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 11:48:32", "title": "Pentagon reveals plans to distribute first 44,000 doses of Pfizer vaccine as early as next week", "image": "https://cdn.snapi.dev/images/v1/v/m/106808596-1607526062815-5257556-1.jpg", "site": "CNBC", "text": "As early as next week, the Department of Defense is slated to receive nearly 44,000 of the first dose of Pfizer's coronavirus vaccine.", "url": "https://www.cnbc.com/2020/12/09/pentagon-to-distribute-44000-doses-of-pfizer-vaccine-by-next-week.html"}, {"symbol": "PFE", "publishedDate": "2020-12-09 09:30:00", "title": "Artificial Intelligence Just Revealed a Potential Concern for COVID Vaccine Makers", "image": "https://cdn.snapi.dev/images/v1/r/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6036512fcovid-19-vaccine-vialsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Vaccines are another part of the COVID-19 story related to demographics and race.", "url": "https://www.fool.com/investing/2020/12/09/artificial-intelligence-just-revealed-a-potential/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 09:24:20", "title": "7 Undervalued Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/i/m/computer-electronic38.jpg", "site": "InvestorPlace", "text": "Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued.", "url": "https://investorplace.com/2020/12/7-undervalued-stocks-to-buy-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 08:29:00", "title": "Pfizer (PFE) Pneumococcal Vaccine BLA Gets FDA's Priority Tag", "image": "https://cdn.snapi.dev/images/v1/g/w/drugs4.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine candidate helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia.", "url": "https://www.zacks.com/stock/news/1146393/pfizer-pfe-pneumococcal-vaccine-bla-gets-fdas-priority-tag"}, {"symbol": "PFE", "publishedDate": "2020-12-09 08:18:00", "title": "U.K. Warns That People With Severe Allergic Reactions Should Not Get Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-covid-19-vaccines-five-big-unknowns.jpg", "site": "Barrons", "text": "Tuesday, the U.K. became the first country in the West to roll out a Covid-19 vaccine, administering Pfizer's vaccine less than a week after British regulators gave the go-ahead to begin mass inoculations.", "url": "https://www.barrons.com/articles/u-k-warns-that-people-with-severe-allergic-reactions-should-not-get-covid-19-vaccine-51607519895"}, {"symbol": "PFE", "publishedDate": "2020-12-09 08:07:12", "title": "U.K. Regulator Warns People With \u2018Significant' Allergies To Avoid Pfizer-BioNTech Vaccine", "image": "https://cdn.snapi.dev/images/v1/g/u/uk-regulator-warns-people-with-significant-allergies-to-avoid-pfizer-biontech-vaccine.jpg", "site": "Forbes", "text": "The U.K. began widespread vaccination Tuesday after becoming the first western country to authorize the vaccine.", "url": "https://www.forbes.com/sites/roberthart/2020/12/09/uk-regulator-warns-people-with-significant-allergies-to-avoid-pfizer-biontech-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 07:45:59", "title": "UK investigates possible allergic reactions to Pfizer coronavirus shot", "image": "https://cdn.snapi.dev/images/v1/q/l/m02d20201118t2i1541636034w940fhfwllplsqrlynxmpegah137.jpg", "site": "Fox Business", "text": "U.K. regulators said Wednesday that people who have a \"significant history'' of allergic reactions shouldn't receive the new Pfizer-BioNTech vaccine.", "url": "https://www.foxbusiness.com/markets/uk-prizer-coronavirus-vaccine-allergic-reactions"}, {"symbol": "PFE", "publishedDate": "2020-12-09 07:41:48", "title": "He got the Pfizer vaccine in the UK, and says everyone else should do the same", "image": "https://cdn.snapi.dev/images/v1/q/g/he-got-the-pfizer-vaccine-in-the-uk-and-says-everyone-else-should-do-the-same.jpg", "site": "CNBC Television", "text": "Paul Johnston, manager of the Palmerston Residential Home in Northern Ireland, discusses how the long-term facility was the first to receive the Pfizer COVID-19 vaccine.", "url": "https://www.youtube.com/watch?v=NZON_MZI1lM"}, {"symbol": "PFE", "publishedDate": "2020-12-09 07:30:00", "title": "Could Pfizer Be a Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/t/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032942fgettyimages-1271178839jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This pharma company has a wildly popular coronavirus vaccine. Will it be enough to lift its stock to record levels?", "url": "https://www.fool.com/investing/2020/12/09/could-pfizer-be-a-millionaire-maker-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 06:54:00", "title": "U.K. regulators warn people with history of \u2018significant' allergic reactions not to have Pfizer\u2013BioNTech COVID-19 vaccine, after two adverse reactions", "image": "https://cdn.snapi.dev/images/v1/i/q/im-270482width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K. regulator has warned people with a history of \u201csignificant allergic reactions\u201d not to have the Pfizer\u2013BioNTech COVID-19 vaccine after two health-care workers had adverse reactions on the first day of the rollout.", "url": "https://www.marketwatch.com/story/u-k-regulators-warn-people-with-history-of-significant-allergic-reactions-not-to-have-pfizerbiontech-covid-19-vaccine-after-two-adverse-reactions-11607514857"}, {"symbol": "PFE", "publishedDate": "2020-12-09 06:50:00", "title": "2 Solid Coronavirus Testing Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/n/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035662fcovid-imagejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Although vaccine makers are dominating headlines, these diagnostic companies will remain relevant in the fight against COVID-19.", "url": "https://www.fool.com/investing/2020/12/09/2-solid-coronavirus-testing-stocks-to-buy-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 06:40:00", "title": "After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?", "image": "https://cdn.snapi.dev/images/v1/1/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040452fgettyimages-1287178632jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't expect just one or two winners in the coronavirus vaccine race. Be prepared for several.", "url": "https://www.fool.com/investing/2020/12/09/after-moderna-and-pfizer-which-vaccine-makers-may/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 06:27:40", "title": "People with a history of 'significant' allergic reactions shouldn't have Pfizer jab, UK regulator warns", "image": "https://cdn.snapi.dev/images/v1/r/y/106807763-16074332922020-12-08t123316z-1123259786-rc20jk91l78u-rtrmadp-0-health-coronavirus-britain-rollout.jpeg", "site": "CNBC", "text": "People who have a history of \"significant\" allergic reactions should not currently receive the coronavirus vaccine developed by Pfizer and BioNTech, the U.K. drug regulator said on Wednesday.", "url": "https://www.cnbc.com/2020/12/09/pfizer-jab-warning-for-people-with-history-of-significant-allergic-reactions.html"}, {"symbol": "PFE", "publishedDate": "2020-12-09 06:08:00", "title": "Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's", "image": "https://cdn.snapi.dev/images/v1/g/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038312f2-covid-vaccines-in-front-of-100jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Two factors could give Moderna an edge.", "url": "https://www.fool.com/investing/2020/12/09/heres-what-could-make-modernas-covid-vaccine-a-big/"}, {"symbol": "PFE", "publishedDate": "2020-12-09 03:08:41", "title": "Pfizer Is Worth The Risk For A Vaccine Payoff", "image": "https://cdn.snapi.dev/images/v1/f/5/drugs1.jpg", "site": "Seeking Alpha", "text": "Pfizer, Inc. recently made headlines as the first pharmaceutical company to produce a successful COVID-19 vaccine. The company, along with its German partner BioNTech SE, filed for emergency-use authorization in late November.", "url": "https://seekingalpha.com/article/4393755-pfizer-is-worth-risk-for-vaccine-payoff"}, {"symbol": "PFE", "publishedDate": "2020-12-08 19:30:45", "title": "FDA report finds Pfizer Covid vaccine safe and effective", "image": "https://cdn.snapi.dev/images/v1/b/5/fda-report-finds-pfizer-covid-vaccine-safe-and-effective.jpg", "site": "CNBC Television", "text": "The FDA advisory committee will meet on Dec. 10 to review the Pfizer BioNTech COVID-19 vaccine. CNBC's senior health and science reporter joins Shep Smith with the details.", "url": "https://www.youtube.com/watch?v=OriYCbbNAJ4"}, {"symbol": "PFE", "publishedDate": "2020-12-08 17:17:00", "title": "Why Despegar Soared 62% in November", "image": "https://cdn.snapi.dev/images/v1/3/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6037822fa-woman-walks-through-the-airport-with-a-rolling-suitcasejpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company's been in the eye of the storm, but things may be looking up.", "url": "https://www.fool.com/investing/2020/12/08/why-despegar-soared-62-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 16:52:33", "title": "The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure", "image": "https://cdn.snapi.dev/images/v1/m/c/drugs48.jpg", "site": "InvestorPlace", "text": "Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021. The post The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/the-7-best-coronavirus-vaccine-stocks-still-in-the-race-for-a-cure/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 16:48:51", "title": "Pfizer's pneumonia vaccine candidate gets FDA review", "image": "https://cdn.snapi.dev/images/v1/3/q/drugs49.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumonia and other illnesses in adults. The vaccine candidate would cover more strains of the bacteria than other vaccines in the market and in late-stage trials, the company said.", "url": "https://www.marketwatch.com/story/pfizers-pneumonia-vaccine-candidate-gets-fda-review-2020-12-08"}, {"symbol": "PFE", "publishedDate": "2020-12-08 16:30:00", "title": "U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older", "image": "https://cdn.snapi.dev/images/v1/v/k/press9---on1rhnglwr.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, as submitted for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults ages 18 years and older. The Prescription Drug User Fee Act (PDUFA) goal date for a decision by the FDA on the 2", "url": "https://www.businesswire.com/news/home/20201208006015/en/U.S.-FDA-Accepts-for-Priority-Review-the-Biologics-License-Application-for-Pfizer%E2%80%99s-Investigational-20-valent-Pneumococcal-Conjugate-Vaccine-for-Adults-18-Years-of-Age-and-Older/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 15:31:06", "title": "The FDA says Pfizer's Covid vaccine is safe and effective. But brace yourself for the second shot, trial participants warn", "image": "https://cdn.snapi.dev/images/v1/e/q/106791886-1605096960804-gettyimages-1229031575.jpg", "site": "CNBC", "text": "The FDA says the Pfizer Covid vaccine is both safe and effective. CNBC spoke with Pfizer and Moderna trial participants about what side effects you can expect.", "url": "https://www.cnbc.com/2020/12/08/pfizer-moderna-covid-vaccine-side-effects-trials.html"}, {"symbol": "PFE", "publishedDate": "2020-12-08 14:55:26", "title": "4 Undervalued Bargain Stocks to Buy Before They Bounce", "image": "https://cdn.snapi.dev/images/v1/g/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5305732fimage-4-internet-connections-across-a-smart-cityjpgw700opresize.jpg", "site": "InvestorPlace", "text": "These bargain stocks could potentially outperform in the coming year. They have strong fundamentals and are worth holding long-term as well.", "url": "https://investorplace.com/2020/12/four-undervalued-bargain-stocks-to-buy-before-they-bounce/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 14:54:00", "title": "U.S. inches closer to FDA authorization of first COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/i/m/im-270120width620size15005861664712778.jpg", "site": "Market Watch", "text": "An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S.", "url": "https://www.marketwatch.com/story/u-s-inches-closer-to-fda-authorization-of-first-covid-19-vaccine-11607457278"}, {"symbol": "PFE", "publishedDate": "2020-12-08 13:42:51", "title": "Stock ETFs Rally Amid Pfizer Vaccine Rollout Enthusiasm", "image": "https://cdn.snapi.dev/images/v1/z/u/stock-etfs-rally-amid-pfizer-vaccine-rollout-enthusiasm-440x250.jpg", "site": "ETF Trends", "text": "Stocks and index ETFs are breaking new ground again on Tuesday, scrambling back from posting losses earlier in the day, as enthusiasm around the Pfizer vaccine rollout is spurring investors. The S&P 500 gained 0.3% to reach a record high, where it breached the 3,700 level for the first time.", "url": "https://www.etftrends.com/stock-etfs-rally-amid-pfizer-vaccine-rollout-enthusiasm/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 12:54:56", "title": "White House claims Pfizer 'negotiating in public' on coronavirus vaccine allocation", "image": "https://cdn.snapi.dev/images/v1/h/b/pfizer-22jpgquality90stripall.jpg", "site": "Fox Business", "text": "The White House on Tuesday claimed that Pfizer is \u201cnegotiating in public\u201d on the allocation of the forthcoming coronavirus vaccine and trying to embarrass the U.S. government in an effort to gain market share over its vaccine competitors.", "url": "https://www.foxbusiness.com/markets/white-house-pfizer-negotiating-in-public-coronavirus-vaccine-allocation"}, {"symbol": "PFE", "publishedDate": "2020-12-08 12:36:54", "title": "Pfizer Board Member Gottlieb Confirms Trump Administration Rejected \u2018Multiple' Offers For More Vaccine Doses", "image": "https://cdn.snapi.dev/images/v1/8/p/pfizer-board-member-gottlieb-confirms-trump-administration-rejected-multiple-offers-for-more-vaccine-doses.jpg", "site": "Forbes", "text": "The U.S. will have to wait until summer 2021 to acquire additional doses of the vaccine.", "url": "https://www.forbes.com/sites/roberthart/2020/12/08/pfizer-board-member-gottlieb-confirms-trump-administration-rejected-multiple-offers-for-more-vaccine-doses/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 12:00:12", "title": "The U.K. Has Begun Its BioNTech-Pfizer Vaccine Rollout. Here's How | WSJ", "image": "https://cdn.snapi.dev/images/v1/i/n/the-uk-has-begun-its-biontech-pfizer-vaccine-rollout-heres-how-wsj.jpg", "site": "Wall Street Journal", "text": "The U.K. became the first Western nation to vaccinate patients against Covid-19. WSJ explains how the country is planning to roll out the BioNTech-Pfizer vaccine at record speed, making it a test case for the rest of the world.", "url": "https://www.youtube.com/watch?v=nlA2eT_Ieto"}, {"symbol": "PFE", "publishedDate": "2020-12-08 11:25:13", "title": "Pfizer Stock Rallies As FDA Appears To Support Covid Vaccine Approval", "image": "https://cdn.snapi.dev/images/v1/8/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5819542fvaccination-syringejpgw700opresize.jpg", "site": "Investors Business Daily", "text": "Pfizer stock eked out a small gain Tuesday after Food and Drug Administration documents appeared to support authorizing its coronavirus vaccine. An advisory committee will meet Thursday.", "url": "https://www.investors.com/news/technology/pfizer-stock-rises-fda-documents-appear-support-coronavirus-vaccine-ok/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:46:55", "title": "FDA says Pfizer's vaccine meets prescribed success criteria", "image": "https://cdn.snapi.dev/images/v1/x/e/fda-says-pfizers-vaccine-meets-prescribed-success-criteria.jpg", "site": "CNBC Television", "text": "The FDA has announced that the Pfizer vaccine meets its prescribed success criteria. CNBC's Meg Tirrell reports on the announcement and how the FDA is thinking about the vaccine ahead of its Thursday meeting with outside advisors.", "url": "https://www.youtube.com/watch?v=L0wAwmEMaeY"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:30:00", "title": "BNTX Stock: Buy at the High?", "image": "https://cdn.snapi.dev/images/v1/y/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6039992fstock-chartjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company's development of a gene-based vaccine should help investors get over a high stock price", "url": "https://www.fool.com/investing/2020/12/08/bntx-stock-buy-at-the-high/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:28:00", "title": "Pfizer CEO confident of getting U.S. advisory panel nod for COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/4/m/m02d20201208t2i1543839336w940fhfwllplsqrlynxmpegb7198.jpg", "site": "Reuters", "text": "Pfizer Chief Executive Albert Bourla said on Tuesday he expects a \"very intense\" meeting with a U.S. vaccine advisory panel this week but is counting on the panel of outside experts to sign off on his company's COVID-19 vaccine candidate.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines/pfizer-ceo-confident-of-getting-u-s-advisory-panel-nod-for-covid-19-vaccine-idUSKBN28I26X"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:25:23", "title": "UK begins rollout of Pfizer's coronavirus vaccine: Here's what you need to know", "image": "https://cdn.snapi.dev/images/v1/z/v/106807771-16074335942020-12-08t090448z-722051655-rc2xik975sm5-rtrmadp-0-health-coronavirus-britain-rollout.jpeg", "site": "CNBC", "text": "Ninety-year-old Margaret Keenan on Tuesday became the first person in the world to receive the Pfizer-BioNTech vaccine outside of trial conditions.", "url": "https://www.cnbc.com/2020/12/08/uk-rolls-out-pfizer-coronavirus-vaccine-heres-what-you-need-to-know.html"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:23:53", "title": "Cramer on the White House declining Pfizer's offer for additional vaccine doses", "image": "https://cdn.snapi.dev/images/v1/w/y/cramer-on-the-white-house-declining-pfizers-offer-for-additional-vaccine-doses.jpg", "site": "CNBC Television", "text": "Dr. Scott Gottlieb, a member of Pfizer's board, told CNBC on Tuesday the company's offers to provide the U.S. additional doses of its coronavirus vaccine in 2021 was declined by the Trump administration. CNBC's Jim Cramer and David Faber discuss.", "url": "https://www.youtube.com/watch?v=ucD-R6BuQVc"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:07:28", "title": "LIVE | Apple, Pfizer, Tesla: Jim Cramer's Stock Market Breakdown - Dec. 8", "image": "https://cdn.snapi.dev/images/v1/h/q/live-apple-pfizer-tesla-jim-cramers-stock-market-breakdown-dec-8.jpg", "site": "The Street", "text": "In Tuesday's market breakdown, Jim Cramer talks Apple, Pfizer, Tesla, Toll Brothers, and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet", "url": "https://www.youtube.com/watch?v=x6UyyaNHACU"}, {"symbol": "PFE", "publishedDate": "2020-12-08 10:06:00", "title": "Pfizer's Coronavirus Vaccine Is 52.4% Effective After First Dose", "image": "https://cdn.snapi.dev/images/v1/9/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040682finjecting-vaccine-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "That conclusion is based on a new, unfiltered look at clinical trial data from the BNT162b2 program.", "url": "https://www.fool.com/investing/2020/12/08/pfizers-coronavirus-vaccine-is-524-effective-after/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:32:02", "title": "FDA highlights safety profile of BioNTech/Pfizer vaccine in advance of advisory committee meeting", "image": "https://cdn.snapi.dev/images/v1/y/e/biotech4---z0wiunsy5v.jpg", "site": "Market Watch", "text": "The COVID-19 vaccine candidate developed by BioNTech and Pfizer Inc. likely has a \"favorable safety profile,\" according to documents published Tuesday by the Food and Drug Administration. In premarket trading on Tuesday, BioNTech's stock was up 1.3%, and shares of Pfizer gained 0.9%.", "url": "https://www.marketwatch.com/story/fda-highlights-safety-profile-of-biontechpfizer-vaccine-in-advance-of-advisory-committee-meeting-2020-12-08"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:31:09", "title": "Pfizer's COVID-19 vaccine data gets positive FDA review", "image": "https://cdn.snapi.dev/images/v1/o/f/drugs32.jpg", "site": "Fox Business", "text": "WASHINGTON (AP) \u2014 Documents released by U.S. regulators Tuesday confirmed that Pfizer and BioNTech's COVID-19 vaccine was strongly protective against COVID-19 -- offering the world's first detailed look at the evidence behind the shots.", "url": "https://www.foxbusiness.com/markets/pfizers-covid-19-vaccine-data-gets-positive-fda-review"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:29:00", "title": "3 Stay-at-Home Stocks That Could Make You Rich -- Even After the Pandemic Is Over", "image": "https://cdn.snapi.dev/images/v1/j/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035782fgettyimages-1258140616jpgw700opresize.jpg", "site": "The Motley Fool", "text": "People will eventually return to pre-coronavirus routines. But that doesn't mean they'll abandon the goods and services of these companies.", "url": "https://www.fool.com/investing/2020/12/08/3-stay-at-home-stocks-that-may-make-you-rich-even/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:18:00", "title": "FDA Analysis Confirms Safety of Pfizer Vaccine", "image": "https://cdn.snapi.dev/images/v1/1/0/106788079-16049431642020-11-05t095723z-1430031187-rc2xwj91w57a-rtrmadp-0-china-trade-expo.jpeg", "site": "Barrons", "text": "Here's what you need to know about the impact of Covid-19 to navigate the markets today.", "url": "https://www.barrons.com/articles/news-updates-51607437051"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:14:54", "title": "FDA likely to approve Pfizer-BioNTech vaccine, research head says", "image": "https://cdn.snapi.dev/images/v1/4/n/fda-likely-to-approve-pfizer-biontech-vaccine-research-head-says.jpg", "site": "CNBC International TV", "text": "Andrew Baum, global head of health care research at Citi, says the U.S. Food and Drug Administration (FDA) is very likely to approve the Pfizer-BioNTech vaccine soon.", "url": "https://www.youtube.com/watch?v=sZoXA_NuVFs"}, {"symbol": "PFE", "publishedDate": "2020-12-08 09:12:07", "title": "Here's what goes into shipping Pfizer's Covid vaccine", "image": "https://cdn.snapi.dev/images/v1/g/l/heres-what-goes-into-shipping-pfizers-covid-vaccine.jpg", "site": "CNBC Television", "text": "Delivering the Covid vaccine is being called the biggest logistical challenge in a generation. It's a global public health event that involves a complex web of shipping and technology where every step matters.", "url": "https://www.youtube.com/watch?v=GXyVzY9Xv9E"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:53:00", "title": "These 5 Large-Cap Healthcare Stocks Had the Best Gains in 2020", "image": "https://cdn.snapi.dev/images/v1/q/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6034192ftelemedicine-visit-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's how these big businesses became enormous during a year most of us would rather forget.", "url": "https://www.fool.com/investing/2020/12/08/these-5-large-cap-healthcare-stocks-had-the-best-g/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:46:00", "title": "Pfizer (PFE) Up 14% in 3 Months on COVID-19 Vaccine Progress", "image": "https://cdn.snapi.dev/images/v1/x/n/drugs33.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is now approved for emergency use in United Kingdom and Bahrain.", "url": "https://www.zacks.com/stock/news/1142654/pfizer-pfe-up-14-in-3-months-on-covid-19-vaccine-progress"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:37:49", "title": "White House declined Pfizer's offer to secure more Covid vaccine doses: Board member Gottlieb", "image": "https://cdn.snapi.dev/images/v1/4/m/white-house-declined-pfizers-offer-to-secure-more-covid-vaccine-doses-board-member-gottlieb.jpg", "site": "CNBC Television", "text": "Dr. Scott Gottlieb, board member at Pfizer and biotech company Illumina as well as former FDA commissioner, told CNBC's \"Squawk Box\" on Tuesday that Pfizer offered its second quarter allotment of Covid-19 vaccine to the Trump administration multiple times, but the government declined to strike an additional agreement on the option to purchase, relying instead on multiple other vaccine agreements.", "url": "https://www.youtube.com/watch?v=1ZvwqAC_Zdo"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:36:40", "title": "U.S. declined Pfizer offer for additional Covid vaccine doses, says board member Dr. Scott Gottlieb", "image": "https://cdn.snapi.dev/images/v1/r/p/106804951-1606914066901-gettyimages-1229766595-afp-8vt2pc.jpeg", "site": "CNBC", "text": "\"Pfizer did offer up an additional allotment ... to the United States government multiple times,\" Dr. Scott Gottlieb told CNBC.", "url": "https://www.cnbc.com/2020/12/08/covid-vaccine-us-declined-pfizer-offer-for-more-doses-says-scott-gottlieb-.html"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:27:58", "title": "FDA says Pfizer Covid vaccine data did not raise safety concerns", "image": "https://cdn.snapi.dev/images/v1/a/3/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.jpg", "site": "CNBC Television", "text": "The Food and Drug Administration said Tuesday data from Pfizer's coronavirus vaccine trials did not raise any specific safety concerns. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=avqDyCdxNj8"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:17:00", "title": "Looking for a Dependable Stock? Buy This Industrial Behemoth", "image": "https://cdn.snapi.dev/images/v1/i/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035412fgettyimages-1277731016jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This dividend stock is using its internally developed IP to become a leader in SaaS for the industrial sector.", "url": "https://www.fool.com/investing/2020/12/08/looking-for-a-dependable-stock-buy-this-industrial/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 08:10:21", "title": "FDA says Pfizer Covid vaccine data did not raise safety concerns.", "image": "https://cdn.snapi.dev/images/v1/e/j/106807754-1607432767035-gettyimages-1230009248-britain-health-virus.jpeg", "site": "CNBC", "text": "The Food and Drug Administration said Tuesday data from Pfizer's coronavirus vaccine trials did not raise any specific safety concerns.", "url": "https://www.cnbc.com/2020/12/08/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.html"}, {"symbol": "PFE", "publishedDate": "2020-12-08 07:32:51", "title": "FDA to release detailed data on Pfizer's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/n/k/pfizer-covidjpgquality90stripall.jpg", "site": "New York Post", "text": "The Food and Drug Administration is reportedly expected to release detailed data about Pfizer's coronavirus vaccine on Tuesday as regulators consider whether to clear it for emergency use. The data will give the public an in-depth look at how well the vaccine works before the FDA's vaccine committee meets Thursday to consider Pfizer's application for.", "url": "https://nypost.com/2020/12/08/fda-to-release-detailed-data-on-pfizer-covid-19-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 07:04:00", "title": "Did You Miss Out on a 5000% Gain With Trillium Stock?", "image": "https://cdn.snapi.dev/images/v1/7/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6039882fgettyimages-1181608651jpgw700opresize.jpg", "site": "The Motley Fool", "text": "A new CEO and prioritization of research could have more big gains in store for the company", "url": "https://www.fool.com/investing/2020/12/08/did-you-miss-out-on-5000-gain-with-trillium-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 07:03:00", "title": "When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action", "image": "https://cdn.snapi.dev/images/v1/p/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018072fhospital-supply-roomjpgw700opresize.jpg", "site": "The Motley Fool", "text": "One medical distribution company has been through this before.", "url": "https://www.fool.com/investing/2020/12/08/when-a-covid-19-vaccine-is-ready-this-company-is-p/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 07:00:28", "title": "Pfizer, Moderna Face Public-Relations Hurdle For Covid Vaccines: IBD/TIPP Poll", "image": "https://cdn.snapi.dev/images/v1/y/f/biotech18.jpg", "site": "Investors Business Daily", "text": "The latest IBD/TIPP Poll shows just 52% of Americans are likely to get a coronavirus vaccine \u2014 a fact that could hamstring Pfizer and Moderna, the makers of the two front-running drugs. The post Pfizer, Moderna Face Public-Relations Hurdle For Covid Vaccines: IBD/TIPP Poll appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/moderna-stock-pfizer-stock-hurdle-public-relations-challenge-coronavirus-vaccines/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 07:00:06", "title": "No, the Pfizer and Moderna vaccine development has not been \u2018reckless.'", "image": "https://cdn.snapi.dev/images/v1/q/p/merlin-180945753-1366f93c-246a-49d0-9b9b-8bbf36d6949a-articlelargejpgquality75autowebpdisableupscale.jpg", "site": "NYTimes", "text": "Experts maintain that widespread rollout of these vaccines, which have undergone rigorous testing, is very likely to be safe.", "url": "https://www.nytimes.com/2020/12/08/technology/covid-vaccines-senate-hearing.html"}, {"symbol": "PFE", "publishedDate": "2020-12-08 06:49:11", "title": "U.K. becomes first to administer Pfizer-BioNTech Covid vaccine outside of trials", "image": "https://cdn.snapi.dev/images/v1/d/d/uk-becomes-first-to-administer-pfizer-biontech-covid-vaccine-outside-of-trials.jpg", "site": "CNBC Television", "text": "Tuesday has been dubbed \"V-Day\" in the U.K. as the first doses of the coronavirus vaccine are being injected into patients. CNBC's Julianna Tatelbaum reports.", "url": "https://www.youtube.com/watch?v=sQIwWMYVOLk"}, {"symbol": "PFE", "publishedDate": "2020-12-08 06:20:00", "title": "World watches as first person receives Pfizer-BioNTech COVID shot", "image": "https://cdn.snapi.dev/images/v1/x/y/im-269823width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K. will receive just 4 million doses of the vaccine being developed by AstraZeneca and the University of Oxford \u2014 by year-end \u2014 short of the 30 million doses hoped for.", "url": "https://www.marketwatch.com/story/world-watches-as-first-person-receives-pfizer-biontech-covid-shot-11607426453"}, {"symbol": "PFE", "publishedDate": "2020-12-08 06:11:00", "title": "$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest Winners", "image": "https://cdn.snapi.dev/images/v1/o/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038292fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The companies with the biggest gains won't necessarily be those with the highest sales of coronavirus vaccines.", "url": "https://www.fool.com/investing/2020/12/08/40-billion-covid-vaccine-market-in-2021-these-3-st/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 06:04:44", "title": "COVID-19 vaccine: 90-year-old woman becomes first to receive Pfizer vaccine in UK", "image": "https://cdn.snapi.dev/images/v1/c/h/gettyimages-1230005171.jpg", "site": "CNET", "text": "The UK is the first country to approve Pfizer's vaccine and is beginning its rollout on Tuesday.", "url": "https://www.cnet.com/news/covid-19-vaccine-90-year-old-woman-becomes-first-to-receive-pfizer-vaccine-in-uk/"}, {"symbol": "PFE", "publishedDate": "2020-12-08 04:38:01", "title": "Pfizer Vs. Merck Vs. AbbVie Vs.", "image": "https://cdn.snapi.dev/images/v1/z/l/drugs26.jpg", "site": "Seeking Alpha", "text": "Healthcare stocks are a staple of every portfolio. With an ageing population, healthcare stocks are here to stay.", "url": "https://seekingalpha.com/article/4393529-pfizer-vs-merck-vs-abbvie-vs-bristol-myers-vs-johnson-johnson-vs-amgen"}, {"symbol": "PFE", "publishedDate": "2020-12-08 02:47:14", "title": "Pfizer, AstraZeneca Vaccine Combination To Be Tested Against COVID-19 In UK", "image": "https://cdn.snapi.dev/images/v1/s/c/cdc-v-nbumdfzm-unsplash.jpg", "site": "Benzinga", "text": "The United Kingdom will administer one shot each of COVID-19 vaccines\u00a0made by Pfizer Inc (NYSE: PFE) and AstraZeneca plc (NASDAQ: AZN) to test whether the approach would result in increased immunity, Bloomberg reported Monday. What Happened: The studies planned for the next year, will be \u201crelatively small\u201d as per Clive Dix, Deputy Chair of U.K. Vaccine Taskforce, who added \u2014 \u201cThey'll only be with the approved vaccines.", "url": "https://www.benzinga.com/general/biotech/20/12/18688604/pfizer-astrazeneca-vaccine-combination-to-be-tested-against-covid-19-in-uk"}, {"symbol": "PFE", "publishedDate": "2020-12-08 00:02:13", "title": "Pfizer Tells US It Can't Provide Substantial Extra Doses Before June As Other Countries Have Already Secured Supply: WaPo", "image": "https://cdn.snapi.dev/images/v1/d/6/kristine-wook-gwuhbsrzovo-unsplash.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) has told the outgoing Donald Trump administration that it cannot supply a considerable amount of additional doses of its COVID-19 vaccine to the United States until late June because other countries have hastened to secure the supply, the Washington Post reported Monday. What Happened: The development means that the U.S. government may have difficulty in procurement beyond the 100 million doses it has already secured earlier this year, according to the Post.", "url": "https://www.benzinga.com/general/biotech/20/12/18687865/pfizer-tells-us-it-cant-provide-substantial-extra-doses-before-june-as-other-countries-have-alrea"}, {"symbol": "PFE", "publishedDate": "2020-12-07 21:11:07", "title": "Pfizer COVID-19 Vaccine Could Get Emergency Approval By Friday, FDA Advisor Says", "image": "https://cdn.snapi.dev/images/v1/h/o/dimitri-houtteman-qbhppxw3ess-unsplash-1-0.jpg", "site": "Benzinga", "text": "A member of a United States Food and Drug Administration committee on vaccines said that the agency could issue an emergency authorization for Pfizer Inc's (NYSE: PFE) COVID-19 vaccine as early as Friday. What Happened: James Hildreth, a member of the Vaccines and Related Biological Products Advisory Committee, said on NBC's \u201cWeekend Today\u201d show that the body would meet on Thursday to review the COVID-19 vaccine developed by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX).", "url": "https://www.benzinga.com/general/biotech/20/12/18687083/pfizer-covid-19-vaccine-could-get-emergency-approval-by-friday-fda-advisor-says"}, {"symbol": "PFE", "publishedDate": "2020-12-07 21:03:12", "title": "Trump is hosting a 'vaccine summit' to discuss the 'success' of Operation Warp Speed. The governors of Florida and Texas will join, Moderna and Pfizer declined the invite.", "image": "https://cdn.snapi.dev/images/v1/t/r/trump-is-hosting-a-vaccine-summit-to-discuss-the-success-of-operation-warp-speed-the-governors-of-florida-and-texas-will-join-moderna-and-pfizer-declined-the-invite.jpg", "site": "Business Insider", "text": "President Donald Trump will host a \"vaccine summit\" Tuesday night to \"congratulate\" his administration's vaccine effort. The White House released details of President Donald Trump's summit, an event where the president will sign an executive order stating the US would provide vaccines to Americans before aiding other nations. STAT News first reported on the summit and Fox News first reported on the executive order.\u00a0", "url": "https://www.businessinsider.com/trump-to-host-vaccine-summit-with-governors-fdas-peter-marks-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-07 19:40:37", "title": "President Trump will hold vaccine summit Tuesday, as Pfizer and Moderna decline to attend", "image": "https://cdn.snapi.dev/images/v1/n/a/president-trump-will-hold-vaccine-summit-tuesday-as-pfizer-and-moderna-decline-to-attend.jpg", "site": "CNBC Television", "text": "NBC's Hallie Jackson joins Shep Smith to report details on President Trump's vaccine summit. HHS Secretary Alex Azar told Lester Holt President Trump is not concerned about the shortage of vaccines, but that he wants to reinforce his 'America first vaccine' strategy, Jackson reports.", "url": "https://www.youtube.com/watch?v=7hx-2QpU7-8"}, {"symbol": "PFE", "publishedDate": "2020-12-07 18:13:00", "title": "Capitol Report: White House denies report saying it passed when Pfizer offered additional vaccine doses", "image": "https://cdn.snapi.dev/images/v1/t/b/im-268289width620size14988290398126465.jpg", "site": "Market Watch", "text": "Trump administration officials on Monday deny a New York Times report that says they passed when Pfizer offered in late summer to sell the U.S. government additional doses. They also play down news that Moderna and Pfizer won't take part in Trump's vaccine summit.", "url": "https://www.marketwatch.com/story/white-house-denies-report-saying-it-passed-when-pfizer-offered-additional-vaccine-doses-11607382780"}, {"symbol": "PFE", "publishedDate": "2020-12-07 17:22:33", "title": "Pfizer And Moderna Steer Clear Of White House Vaccine Summit", "image": "https://cdn.snapi.dev/images/v1/n/v/pfizer-and-moderna-steer-clear-of-white-house-vaccine-summit.jpg", "site": "Forbes", "text": "The two companies will be conspicuous by their absence at an event some administration sources are viewing as a publicity stunt for President Donald Trump.", "url": "https://www.forbes.com/sites/joewalsh/2020/12/07/pfizer-and-moderna-steer-clear-of-white-house-vaccine-summit/"}, {"symbol": "PFE", "publishedDate": "2020-12-07 17:19:52", "title": "The Trump administration reportedly rejected an offer from Pfizer for more COVID-19 vaccine doses, and now other countries might get them", "image": "https://cdn.snapi.dev/images/v1/t/h/the-trump-administration-reportedly-rejected-an-offer-from-pfizer-for-more-covid-19-vaccine-doses-and-now-other-countries-might-get-them.jpg", "site": "Business Insider", "text": "The Trump administration declined an offer from Pfizer in late summer for additional COVID-19 vaccine doses, the New York Times reported on Monday, citing people familiar with the matter.\u00a0 This means that Americans may struggle to get more doses of Pfizer's COVID-19 vaccine given commitments it's made to other countries, the Times said.\u00a0", "url": "https://www.businessinsider.com/trump-administration-rejected-pfizer-offer-more-covid-19-vaccine-doses-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-07 14:34:15", "title": "FDA could authorize Pfizer's Covid vaccine this week as U.S. deaths surge", "image": "https://cdn.snapi.dev/images/v1/s/g/106807115-1607348018052-gettyimages-1229988084-htum30010.jpeg", "site": "CNBC", "text": "The move would be a pivotal moment in the pandemic as public health officials say the U.S. is likely to face its worst health crisis in history this winter.", "url": "https://www.cnbc.com/2020/12/07/covid-vaccine-fda-may-authorize-pfizers-this-week.html"}, {"symbol": "PFE", "publishedDate": "2020-12-07 09:50:00", "title": "Buy Pfizer Stock Or JNJ For Vaccine Run?", "image": "https://cdn.snapi.dev/images/v1/q/j/buy-pfizer-stock-or-jnj-for-vaccine-run.jpg", "site": "Forbes", "text": "Pfizer or JNJ for vaccine run? While Pfizer's stock and Johnson & Johnson's stock look hot with vaccines, data suggests Merck stock is better than both!", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/07/buy-pfizer-stock-or-jnj-for-vaccine-run/"}, {"symbol": "PFE", "publishedDate": "2020-12-07 07:15:00", "title": "Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma", "image": "https://cdn.snapi.dev/images/v1/h/k/press12---4qtp0yiy6t.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced safety and clinical response results from the ongoing Phase 1 study (NCT03269136) for PF-06863135, an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody. Data from 30 patients with relapsed or refractory multiple myeloma showed manageable safety across all subcutaneous dose levels with no dose-limiting toxicities observed, and 83% of patients achieved a clinical response at the highest dose level. T", "url": "https://www.businesswire.com/news/home/20201207005166/en/Pfizer-Reports-Positive-Clinical-Data-for-BCMA-CD3-Bispecific-Antibody-PF-06863135-in-Multiple-Myeloma/"}, {"symbol": "PFE", "publishedDate": "2020-12-07 07:00:00", "title": "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy", "image": "https://cdn.snapi.dev/images/v1/e/y/press20---vrjs5bifzw.jpg", "site": "Business Wire", "text": "NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or PF-07055480), an investigational gene therapy for patients with severe hemophilia A. These data are being presented today at the 62nd American Society for Hematology Annual meeting taking place virtually from December 5th - 8th. The oral pres", "url": "https://www.businesswire.com/news/home/20201207005251/en/Pfizer-and-Sangamo-Announce-Updated-Phase-12-Results-Showing-Sustained-Factor-VIII-Activity-Levels-in-3x1013-VGKG-Cohort-Through-One-Year-Following-Hemophilia-A-Gene-Therapy/"}, {"symbol": "PFE", "publishedDate": "2020-12-06 23:05:40", "title": "AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/m/p/cdc-p5auv6sk1xc-unsplash-2.jpg", "site": "Benzinga", "text": "AstraZeneca Plc's\u00a0 (NASDAQ: AZN) partner,\u00a0the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday,\u00a0as per the Press Trust Of India. What Happened: The SII is conducting the phase-3 clinical trial of the Oxford-AstraZeneca vaccine \u2014 dubbed Covishield \u2014 in India, which is co-sponsored by the Indian Council of Medical Research, as per PTI.", "url": "https://www.benzinga.com/general/biotech/20/12/18666832/astrazeneca-follows-pfizer-in-seeking-india-emergency-use-approval-for-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-06 21:31:14", "title": "PFE Stock Price Increased 6.3% This Past Week: Why It Happened", "image": "https://cdn.snapi.dev/images/v1/w/j/drugs14.jpg", "site": "Pulse2", "text": "The stock price of Pfizer Inc. (NYSE:PFE) increased 6.3% this past week as it went from $37.95 per share on November 30 morning to a closing price of $40.34 on Friday, December 4. These are some of the reasons why it happened.", "url": "https://pulse2.com/pfe-stock-price-increased-nyse-pfizer-6-3-this-past-week-why-it-happened/"}, {"symbol": "PFE", "publishedDate": "2020-12-06 15:04:54", "title": "Week In Review: CANbridge Closes $43 Million E Round For Rare Disease Drugs", "image": "https://cdn.snapi.dev/images/v1/s/t/drugs13.jpg", "site": "Seeking Alpha", "text": "CANbridge Pharma completed a $43 million Series E financing that is a follow-on to its $98 million Series D round, announced in February. Pfizer and Germany's BioNTech announced their partnered mRNA COVID-19 vaccine has been approved for use in the UK, the first acceptance of a coronavirus vaccine in the west.", "url": "https://seekingalpha.com/article/4393252-week-in-review-canbridge-closes-43-million-e-round-for-rare-disease-drugs"}, {"symbol": "PFE", "publishedDate": "2020-12-06 10:03:20", "title": "Pfizer Applies For Emergency Approval For COVID-19 Vaccine In India: Media Reports", "image": "https://cdn.snapi.dev/images/v1/b/h/vaccine-4.jpeg", "site": "Benzinga", "text": "Pfizer Inc.\u00a0(NYSE: PFE) is seeking emergency approval for its COVID-19 vaccine in India,\u00a0according to media sources in the country. What Happened:\u00a0The vaccine developed together with\u00a0BioNTech SE - ADR\u00a0(NASDAQ: BNTX) was approved in the U.K. last week.", "url": "https://www.benzinga.com/news/20/12/18664716/pfizer-applies-for-emergency-approval-for-covid-19-vaccine-in-india-media-reports"}, {"symbol": "PFE", "publishedDate": "2020-12-06 06:36:00", "title": "The 5 Biggest Threats to the Stock Market in 2021", "image": "https://cdn.snapi.dev/images/v1/e/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035302fnyse-wall-street-trading-new-york-financial-stock-market-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Is another big crash on the horizon?", "url": "https://www.fool.com/investing/2020/12/06/the-5-biggest-threats-to-the-stock-market-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-12-06 06:24:00", "title": "3 Top Healthcare Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/v/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030792fgettyimages-1166581794jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These companies have growth opportunities that will last long after the COVID vaccine gets life back to normal.", "url": "https://www.fool.com/investing/2020/12/06/3-top-healthcare-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-06 06:12:00", "title": "3 Value Stocks Warren Buffett Owns That You Should Consider Buying Too", "image": "https://cdn.snapi.dev/images/v1/6/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026562fwarren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Oracle of Omaha knows a good bargain when he sees one.", "url": "https://www.fool.com/investing/2020/12/06/3-value-stocks-warren-buffett-owns-that-you-should/"}, {"symbol": "PFE", "publishedDate": "2020-12-06 06:09:00", "title": "This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far", "image": "https://cdn.snapi.dev/images/v1/n/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026572fgolden-dollar-signsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You'll probably be surprised at just great the returns from investing in this stock have been.", "url": "https://www.fool.com/investing/2020/12/06/this-covid-vaccine-stock-has-been-the-biggest-mill/"}, {"symbol": "PFE", "publishedDate": "2020-12-05 11:00:00", "title": "Is Pfizer a Great Dividend Stock?", "image": "https://cdn.snapi.dev/images/v1/r/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032582fstack-of-100-dollar-billsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's a lot more to the company besides its vaccine.", "url": "https://www.fool.com/investing/2020/12/05/is-pfizer-a-great-dividend-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-05 09:06:00", "title": "5 Safe And Cheap Dividend Stocks To Invest In (December 2020)", "image": "https://cdn.snapi.dev/images/v1/i/w/semi15.jpg", "site": "Seeking Alpha", "text": "This article is part of our monthly series where we highlight five companies that are large cap, relatively safe, dividend paying, and are offering large discounts to their historical norms. It's always a good idea to keep your wish list ready by separating the wheat from the chaff.", "url": "https://seekingalpha.com/article/4392796-5-safe-and-cheap-dividend-stocks-to-invest-in-december-2020"}, {"symbol": "PFE", "publishedDate": "2020-12-05 09:00:00", "title": "Pfizer: Coronavirus Vaccine Playing Out, Still Inexpensive And Offering A High Yield", "image": "https://cdn.snapi.dev/images/v1/t/z/drugs4.jpg", "site": "Seeking Alpha", "text": "Pfizer's vaccine for COVID looks promising and should boost revenues substantially. The company is trading at an inexpensive valuation and offers an above-average dividend yield.", "url": "https://seekingalpha.com/article/4393119-pfizer-coronavirus-vaccine-playing-out-still-inexpensive-and-offering-high-yield"}, {"symbol": "PFE", "publishedDate": "2020-12-05 06:12:00", "title": "Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch", "image": "https://cdn.snapi.dev/images/v1/i/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026542fglass-vial-and-ampulejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Don't be surprised if this small biotech takes off in 2021.", "url": "https://www.fool.com/investing/2020/12/05/heres-the-dark-horse-in-the-covid-vaccine-race-tha/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 23:04:30", "title": "Bahrain joins U.K. in authorizing emergency use of Pfizer\u2013BioNTech vaccine", "image": "https://cdn.snapi.dev/images/v1/e/y/im-268900width620size15005861664712778.jpg", "site": "Market Watch", "text": "Bahrain joins U.K. in authorizing emergency use of Pfizer\u2013BioNTech vaccine", "url": "https://www.marketwatch.com/story/bahrain-becomes-second-country-to-grant-the-pfizer-biontech-vaccine-emergency-use-authorization-01607140898"}, {"symbol": "PFE", "publishedDate": "2020-12-04 18:17:42", "title": "Why You Shouldn't Yet Bet on the \u201cValue Rally\u201d", "image": "https://cdn.snapi.dev/images/v1/w/q/software5.jpg", "site": "InvestorPlace", "text": "You'd have to take a \u201cbrave pill\u201d to follow the \"value rally\" trend right now. Here's why and what you need to be focusing on instead.", "url": "https://investorplace.com/2020/12/why-you-shouldnt-yet-bet-on-the-value-rally/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 13:45:58", "title": "Pfizer's Scaled-Down COVID-19 Vaccine Manufacturing Plan Is Old News: BofA", "image": "https://cdn.snapi.dev/images/v1/e/m/new-york-city-pfizer-world-headquarters-01-1.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE)-BioNTech SE \u2013 ADR (NASDAQ: BNTX) is first among coronavirus vaccine developers to secure authorization for emergency use of candidate BNT162b2, with the first approval granted by U.K. regulators. Scale-Down Previously Disclosed: An analyst at BofA Securities shrugged off a Thursday report in The Wall Street Journal that hinted at manufacturing constraints, resulting in a modest pullback in Pfizer shares.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/12/18653755/pfizers-scaled-down-covid-19-vaccine-manufacturing-plan-is-old-news-bofa"}, {"symbol": "PFE", "publishedDate": "2020-12-04 13:35:37", "title": "FDA Expected to Approve Use of Pfizer Vaccine: Johns Hopkins", "image": "https://cdn.snapi.dev/images/v1/q/b/fda-expected-to-approve-use-of-pfizer-vaccine-johns-hopkins.jpg", "site": "Bloomberg Markets and Finance", "text": "Dec.04 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses he timeline for a rollout of a Covid-19 vaccine in the U.S. and adjusting coronavirus self-isolation guidelines. He speaks with Bloomberg's Francine Lacqua on \u201cBloomberg Surveillance.", "url": "https://www.youtube.com/watch?v=oT_mL1oPIM4"}, {"symbol": "PFE", "publishedDate": "2020-12-04 10:03:38", "title": "LIVE | Jobs, Stimulus, Pfizer: Jim Cramer's Stock Market Breakdown 12/4", "image": "https://cdn.snapi.dev/images/v1/e/o/live-jobs-stimulus-pfizer-jim-cramers-stock-market-breakdown-124.jpg", "site": "The Street", "text": "In Friday's market breakdown, Jim Cramer talks jobs, stimulus. Pfizer, theater stocks and more.", "url": "https://www.youtube.com/watch?v=Ozg4cuBHii0"}, {"symbol": "PFE", "publishedDate": "2020-12-04 09:00:00", "title": "What The Approval Of The Covid Vaccine In The U.K Means For Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/9/w/what-the-approval-of-the-covid-vaccine-in-the-uk-means-for-pfizer-stock.jpg", "site": "Forbes", "text": "Pfizer's Covid-19 vaccine has been approved for emergency use in the United Kingdom, with initial shots likely to be given as soon as next week. The U.K is the first western country to ratify the shot and the country is expected to be allotted between four million to five million doses of the.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/04/what-the-approval-of-the-covid-vaccine-in-the-uk-means-for-pfizer-stock/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 07:48:00", "title": "Dow Jones 30,000: Here's Why It's Still Underperforming the S&P 500 and the Nasdaq", "image": "https://cdn.snapi.dev/images/v1/h/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6024962fgettyimages-177320725jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Coronavirus vaccine news and a Biden presidency are pushing the stock market higher, but certain sectors are contributing most of the gains.", "url": "https://www.fool.com/investing/2020/12/04/dow-jones-30000-heres-why-it-still-underperforming/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 07:05:14", "title": "Wells Fargo Finally Sees Light At the End of the Tunnel", "image": "https://cdn.snapi.dev/images/v1/i/p/bank7.jpg", "site": "InvestorPlace", "text": "After a rough couple of years, 2021 may finally be the year Wells Fargo returns to its glory days. WFC stock sees a lot of upside ahead.", "url": "https://investorplace.com/2020/12/wfc-stock-finally-sees-the-light-at-the-end-of-the-tunnel/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 06:52:00", "title": "2 Stocks to Buy With Multiple COVID-19 Vaccines in Sight", "image": "https://cdn.snapi.dev/images/v1/y/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6028712fmask-showing-map-of-the-worldjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The demand for cold storage and transportation could make these stocks scorching-hot buys.", "url": "https://www.fool.com/investing/2020/12/04/2-stocks-to-buy-with-multiple-covid-19-vaccines-in/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 06:41:23", "title": "Pfizer details how supply chain constraints impacted vaccine forecast", "image": "https://cdn.snapi.dev/images/v1/q/a/pfizer-details-how-supply-chain-constraints-impacted-vaccine-forecast.jpg", "site": "CNBC Television", "text": "Pfizer shares came under pressure late in Thursday's trading session after a Wall Street Journal report shed light on the company's shifting vaccine forecast. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=MbODRZ-dOWA"}, {"symbol": "PFE", "publishedDate": "2020-12-04 06:20:00", "title": "3 Top Coronavirus Stocks to Watch in December", "image": "https://cdn.snapi.dev/images/v1/x/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5940292fgettyimages-1215388990jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Vaccine makers of all sizes and development stages face crucial news this month.", "url": "https://www.fool.com/investing/2020/12/04/3-top-coronavirus-stocks-to-watch-in-december/"}, {"symbol": "PFE", "publishedDate": "2020-12-04 06:11:00", "title": "3 COVID Vaccine Stocks to Invest in for the Long Run", "image": "https://cdn.snapi.dev/images/v1/w/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026532fhand-holding-hourglass-with-dollar-signsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These aren't just temporary sensations.", "url": "https://www.fool.com/investing/2020/12/04/3-covid-vaccine-stocks-to-invest-in-for-the-long-r/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 20:50:00", "title": "Pfizer Cuts 2020 Vaccine Rollout Target", "image": "https://cdn.snapi.dev/images/v1/c/u/pfizer-cuts-2020-vaccine-rollout-target.jpg", "site": "Bloomberg Markets and Finance", "text": "Dec.03 -- Moderna says its shot has the potential for \u201cdurable immunity\u201d and Pfizer has scaled back production targets for its dose. Bloomberg's Michelle Cortez reports on \u201cBloomberg Daybreak: Asia.", "url": "https://www.youtube.com/watch?v=2F-8Ks2E5Wk"}, {"symbol": "PFE", "publishedDate": "2020-12-03 19:23:02", "title": "I'm hopeful we'll have enough Covid-19 supply in 2021: Dr. Scott Gottlieb on Pfizer vaccine rollout", "image": "https://cdn.snapi.dev/images/v1/j/w/im-hopeful-well-have-enough-covid-19-supply-in-2021-dr-scott-gottlieb-on-pfizer-vaccine-rollout.jpg", "site": "CNBC Television", "text": "Pfizer's shares dropped after a report said the U.S. drugmaker expects to ship half of the Covid-19 vaccines it originally planned for this year due to supply-chain problems. Pfizer is now planning to ship 50 million vaccines by the end of the year, down from the original 100 million it hoped to send out initially.", "url": "https://www.youtube.com/watch?v=uOyZwZbKahI"}, {"symbol": "PFE", "publishedDate": "2020-12-03 18:36:44", "title": "Supply chain delays marred Pfizer's initial vaccine rollout plans, but the company says it will still deliver on the supply it promised the US", "image": "https://cdn.snapi.dev/images/v1/s/u/supply-chain-delays-marred-pfizers-initial-vaccine-rollout-plans-but-the-company-says-it-will-still-deliver-on-the-supply-it-promised-the-us.jpg", "site": "Business Insider", "text": "Supply chain problems reportedly caused Pfizer to cut projections for its COVID-19 vaccine rollout.\u00a0 Sources close to the Pfizer vaccine development told The Wall Street Journal delays scaling up raw materials, coupled with an \"unprecedented\" effort to deliver millions of vaccines within a year, led the company to miss target shipments.", "url": "https://www.businessinsider.com/pfizer-vaccine-rollout-supply-chain-problems-hinder-distribution-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-03 18:36:29", "title": "Pfizer Scales Back Covid Vaccine Production Targets", "image": "https://cdn.snapi.dev/images/v1/q/a/pfizer-scales-back-covid-vaccine-production-targets.jpg", "site": "Bloomberg Markets and Finance", "text": "Dec.03 -- Pfizer Inc.\u00a0scaled back its Covid-19 production targets earlier this year after the drugmaker ran into difficulties securing all the materials it needs to produce the shots at a large scale. Roberg Langreth reports on \"Bloomberg Markets: The Close.", "url": "https://www.youtube.com/watch?v=X3v5JBk6ck0"}, {"symbol": "PFE", "publishedDate": "2020-12-03 18:01:42", "title": "Pfizer slashes Covid vaccine rollout", "image": "https://cdn.snapi.dev/images/v1/e/k/pfizer-slashes-covid-vaccine-rollout.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on what's behind Pfizer's announcement it would be slashing its Covid vaccine rollout. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Steve Grasso and Dan Nathan.", "url": "https://www.youtube.com/watch?v=xer2OJNMSx8"}, {"symbol": "PFE", "publishedDate": "2020-12-03 17:54:41", "title": "As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally", "image": "https://cdn.snapi.dev/images/v1/x/t/biotech-etfs-continue-rally-as-uk-authorizes-pfizer-vaccine-440x250.jpg", "site": "ETF Trends", "text": "Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K. became the first country to authorize Pfizer's coronavirus vaccine for emergency use, which is likely to increase pressure on the U.S. Food and Drug [.", "url": "https://www.etftrends.com/u-k-authorizes-pfizer-vaccine-biotech-etfs-rally/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 17:47:00", "title": "Pfizer to Ship Half as Many Coronavirus Vaccine Doses as Originally Planned in Initial Phase", "image": "https://cdn.snapi.dev/images/v1/3/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6034632fgloved-hand-filling-a-syringe-from-a-vialjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company puts the blame on difficulties with raw materials, among other challenges.", "url": "https://www.fool.com/investing/2020/12/03/pfizer-to-ship-half-as-many-coronavirus-vaccine-do/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 17:11:10", "title": "Pfizer Stock Trips As Supply-Chain Issues Hamper Covid Vaccine Delivery", "image": "https://cdn.snapi.dev/images/v1/3/i/drugs20.jpg", "site": "Investors Business Daily", "text": "Pfizer stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. The post Pfizer Stock Trips As Supply-Chain Issues Hamper Covid Vaccine Delivery appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pfizer-stock-dives-drugmaker-reportedly-cuts-coronavirus-vaccine-deliveries-2020/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 16:36:13", "title": "Pfizer shares fall on report company cut its Covid vaccine rollout target", "image": "https://cdn.snapi.dev/images/v1/q/x/106806046-1607028491927-gettyimages-1229921016-belgium-pfizer.jpeg", "site": "CNBC", "text": "The Wall Street Journal, citing a person directly involved in the development, said some early batches of the raw materials needed for the vaccine failed to meet standards.", "url": "https://www.cnbc.com/2020/12/03/pfizer-shares-fall-on-report-company-cut-its-covid-vaccine-rollout-target.html"}, {"symbol": "PFE", "publishedDate": "2020-12-03 16:33:35", "title": "Gold Prices Are Torn Between the Bulls and the Bears", "image": "https://cdn.snapi.dev/images/v1/e/7/biotech19.jpg", "site": "InvestorPlace", "text": "Some think that positive vaccine news will be bad for the gold price, while others point to continuing uncertainty and a weak dollar. The post Gold Prices Are Torn Between the Bulls and the Bears appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/gold-prices-are-torn-between-the-bulls-and-the-bears/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 16:21:14", "title": "Supply Chain Issues Cause Pfizer To Cut Initial COVID-19 Vaccine Shipments In Half", "image": "https://cdn.snapi.dev/images/v1/5/h/vaccine-5074670-1920-20.jpg", "site": "Benzinga", "text": "Pfizer (NYSE: PFE) shares fell after reports emerged the company expects to ship half of the COVID-19 vaccines it originally planned for this year due to supply-chain issues, according to\u00a0The Wall Street Journal. What To Know:\u00a0In November,\u00a0Pfizer and BioNTech's (NASDAQ: BNTX) vaccine candidate showed a 95% efficacy rate.", "url": "https://www.benzinga.com/news/20/12/18643855/supply-chain-issues-cause-pfizer-to-cut-initial-covid-19-vaccine-shipments-in-half"}, {"symbol": "PFE", "publishedDate": "2020-12-03 16:05:25", "title": "Dr. Fauci says UK's Pfizer Covid vaccine review 'much less deep' than U.S.", "image": "https://cdn.snapi.dev/images/v1/r/2/106799890-16058235172020-11-19t220406z-593852167-rc2m6k9wi6x1-rtrmadp-0-health-coronavirus-usa.jpeg", "site": "CNBC", "text": "\"The U.K. has decided to do it a little bit differently, they've gone over it very quickly,\" Fauci told Sky News.", "url": "https://www.cnbc.com/2020/12/03/pfizer-covid-vaccine-dr-fauci-says-uks-review-less-deep-than-us.html"}, {"symbol": "PFE", "publishedDate": "2020-12-03 16:03:40", "title": "Pfizer CEO Is \u2018Confident' In Covid-19 Vaccine Rollout And Looking Beyond The Pandemic", "image": "https://cdn.snapi.dev/images/v1/7/t/pfizer-ceo-is-confident-in-covid-19-vaccine-rollout-and-looking-beyond-the-pandemic.jpg", "site": "Forbes", "text": "At the 2020 Forbes Healthcare Summit, Albert Bourla is already looking beyond his company's vaccine success and into a post-pandemic world.", "url": "https://www.forbes.com/sites/katiejennings/2020/12/03/pfizer-ceo-is-confident-in-covid-19-vaccine-rollout-and-looking-beyond-the-pandemic/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 12:14:02", "title": "Pfizer gears up for mass rollout of Covid vaccine as the U.K. approves emergency use", "image": "https://cdn.snapi.dev/images/v1/9/p/pfizer-gears-up-for-mass-rollout-of-covid-vaccine-as-the-uk-approves-emergency-use.jpg", "site": "CNBC Television", "text": "Pfizer workers are gearing up for a mass rollout of the company's Covid-19 vaccine. The United Kingdom became the first country to approve Pfizer's vaccine.", "url": "https://www.youtube.com/watch?v=zqLXuO4gVX8"}, {"symbol": "PFE", "publishedDate": "2020-12-03 11:32:36", "title": "Why Pfizer's Covid vaccine has been authorized in the U.K. but not the U.S. yet", "image": "https://cdn.snapi.dev/images/v1/8/x/106804951-1606914066901-gettyimages-1229766595-afp-8vt2pc.jpeg", "site": "CNBC", "text": "Pfizer had been submitting data on its vaccine on a \"rolling basis\" to the U.K., meaning regulators there were able to review the data in real-time.", "url": "https://www.cnbc.com/2020/12/03/pfizers-covid-vaccine-why-uk-approved-but-not-the-us-yet.html"}, {"symbol": "PFE", "publishedDate": "2020-12-03 09:42:00", "title": "What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates", "image": "https://cdn.snapi.dev/images/v1/m/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6028692fgettyimages-1173258771jpgw700opresize.jpg", "site": "The Motley Fool", "text": "With FDA meetings near, Moderna and Pfizer enter a new phase of the vaccine race.", "url": "https://www.fool.com/investing/2020/12/03/what-happens-next-for-modernas-and-pfizers-coronav/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 09:28:00", "title": "Stocks to Track in December as Markets Peak", "image": "https://cdn.snapi.dev/images/v1/a/d/adasads2---mhwboynbly.jpg", "site": "Zacks Investment Research", "text": "December is likely to be filled with events or stock/sector specific news that could provide a boost to the stocks.", "url": "https://www.zacks.com/stock/news/1126014/stocks-to-track-in-december-as-markets-peak"}, {"symbol": "PFE", "publishedDate": "2020-12-03 08:30:00", "title": "Oil Ends Higher on Vaccine News Despite EIA's Bearish Report", "image": "https://cdn.snapi.dev/images/v1/a/g/oil17.jpg", "site": "Zacks Investment Research", "text": "The top five gainers of the S&P 500 in November were all energy firms - Occidental Petroleum (OXY), Devon Energy (DVN), Apache (APA), Diamondback Energy (FANG) and TechnipFMC (FTI).", "url": "https://www.zacks.com/stock/news/1125776/oil-ends-higher-on-vaccine-news-despite-eias-bearish-report"}, {"symbol": "PFE", "publishedDate": "2020-12-03 08:00:00", "title": "Here's Why Pfizer Stock Looks Inviting At $39 Levels", "image": "https://cdn.snapi.dev/images/v1/d/k/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg", "site": "Forbes", "text": "Pfizer's stock is up just 3% since the start of the year and it has gained around 45% from its March lows. Despite the recent rally, Pfizer could offer an upside in the near term, as the company's revenues and earnings are expected to see strong gains going forward.", "url": "https://www.forbes.com/sites/greatspeculations/2020/12/03/heres-why-pfizer-stock-looks-inviting-at-39-levels/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 07:41:00", "title": "Should Investors Buy Pfizer Stock for Its Coronavirus Vaccine?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc4---viooyvdwvl.jpg", "site": "The Motley Fool", "text": "Consider the outlook for the rest of the company's units before investing.", "url": "https://www.fool.com/investing/2020/12/03/should-investors-buy-pfizer-stock-for-its-coronavi/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 06:52:47", "title": "Why vaccine-maker stocks didn't move as much as expected during the pandemic", "image": "https://cdn.snapi.dev/images/v1/m/q/why-vaccine-maker-stocks-didnt-move-as-much-as-expected-during-the-pandemic.jpg", "site": "CNBC Television", "text": "Sel Hardy, analyst at CFRA, joins \"Squawk Box\" to discuss the performance of the drug maker stocks as the race for the vaccine is nearing the finish line.", "url": "https://www.youtube.com/watch?v=WNzGLv4nTZA"}, {"symbol": "PFE", "publishedDate": "2020-12-03 06:40:00", "title": "2 Surprising Coronavirus Vaccine Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/b/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010762fgettyimages-1251020606jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If we judge by return on investment, these two mid-cap biotechs may be the ultimate winners of the coronavirus vaccine race.", "url": "https://www.fool.com/investing/2020/12/03/2-surprising-coronavirus-vaccine-stocks-buy-right-/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 06:27:00", "title": "Got $5,000 and 5 Years to Wait? Buy This Under-the-Radar Biotech Stock Now", "image": "https://cdn.snapi.dev/images/v1/d/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6029482fscientists-examining-flask-in-pharmaceutical-laboratory-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "This company's about to begin delivering a stream of new drugs that target genetic diseases, and hardly anyone's heard about it.", "url": "https://www.fool.com/investing/2020/12/03/got-5000-and-5-years-to-wait-buy-this-under-the-ra/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 05:16:13", "title": "7 Undervalued Stocks to Snap Up Today", "image": "https://cdn.snapi.dev/images/v1/u/t/stocks111-20.jpg", "site": "InvestorPlace", "text": "There aren't many undervalued stocks out there, but some familiar, quality names fit the bill. We've pulled that list together for you.", "url": "https://investorplace.com/2020/12/undervalued-stocks-are-out-there-including-some-familiar-names/"}, {"symbol": "PFE", "publishedDate": "2020-12-03 05:02:57", "title": "'This is going to be challenging:' How the UK will roll out Pfizer's coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/5/s/106492459-1587069194538london.jpg", "site": "CNBC", "text": "The U.K. was the first country in the world to approve Pfizer and BioNTech's coronavirus vaccine for widespread use. In a way, that was the easy part.", "url": "https://www.cnbc.com/2020/12/03/how-the-uk-will-roll-out-the-covid-vaccine.html"}, {"symbol": "PFE", "publishedDate": "2020-12-03 00:55:23", "title": "Dividend Stock Watch List: Lanny's December 2020 Edition", "image": "https://cdn.snapi.dev/images/v1/h/r/semi17.jpg", "site": "Seeking Alpha", "text": "As a dividend stock investor, for the first time, I feel a little uncertain of what the future may hold. We have three completely different industries here with Pharmaceutical/healthcare, Technology/IT and consumer-goods.", "url": "https://seekingalpha.com/article/4392698-dividend-stock-watch-list-lannys-december-2020-edition"}, {"symbol": "PFE", "publishedDate": "2020-12-02 17:43:00", "title": "Pfizer's Coronavirus Vaccine Gets a Nod in UK: ETFs to Shine", "image": "https://cdn.snapi.dev/images/v1/a/e/drugs49.jpg", "site": "Zacks Investment Research", "text": "Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.", "url": "https://www.zacks.com/stock/news/1123973/pfizers-coronavirus-vaccine-gets-a-nod-in-uk-etfs-to-shine"}, {"symbol": "PFE", "publishedDate": "2020-12-02 16:56:00", "title": "5 Top Stock Trades for Thursday: SNAP, PFE, WKHS, BOX, SPOT", "image": "https://cdn.snapi.dev/images/v1/t/m/data-internet21.jpg", "site": "InvestorPlace", "text": "Snap, Pfizer, Workhorse, Box and Spotify were our top stock trades for Thursday. With that in mind, let's have a look at the charts.", "url": "https://investorplace.com/2020/12/5-top-stock-trades-for-thursday-snap-pfe-wkhs-box-spot/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 15:33:25", "title": "European officials say UK rushed approval of Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/p/y/pfizerjpgquality90stripall.jpg", "site": "New York Post", "text": "European Union officials slammed the UK on Wednesday for rushing its landmark approval of Pfizer's coronavirus vaccine, saying health authorities shouldn't put speed ahead of safety. The British government cleared the COVID-19 shot early Wednesday, just 10 days after it started examining data from large-scale clinical trials run by Pfizer and its German partner, BioNTech.", "url": "https://nypost.com/2020/12/02/eu-officials-say-uk-approved-pfizer-covid-vaccine-too-fast/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 15:24:00", "title": "Why Pfizer and BioNTech Stocks Popped Today", "image": "https://cdn.snapi.dev/images/v1/1/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032222fcoronavirus-vaccine-gettyimages-1219401083jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.", "url": "https://www.fool.com/investing/2020/12/02/why-pfizer-and-biontech-stocks-popped-today/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 15:04:36", "title": "What we still don't know about COVID vaccines after the U.K.'s emergency-use authorization of the Pfizer-BioNTech candidate", "image": "https://cdn.snapi.dev/images/v1/u/x/mw-iv178-covidv-20201202141635-zqjpguuide517a956-34d2-11eb-a8b3-9c8e992d421e.jpg", "site": "Market Watch", "text": "The U.K. government granted emergency use authorization to the COVID-19 vaccine being developed by Pfizer Inc. and German partner BioNTech SE with some fanfare on Wednesday, but experts cautioned that the news does not mean the pandemic is close to being over.", "url": "https://www.marketwatch.com/story/what-we-still-dont-know-about-covid-vaccines-after-the-uks-emergency-use-authorization-of-the-pfizer-biontech-candidate-2020-12-02"}, {"symbol": "PFE", "publishedDate": "2020-12-02 14:22:42", "title": "Blue-Chip Pharmaceutical Stock Surges Following Vaccine Update", "image": "https://cdn.snapi.dev/images/v1/s/s/ss222ff.", "site": "Schaeffers Research", "text": "Blue-chip pharmaceutical giant Pfizer Inc.\u00a0(NYSE:PFE)\u00a0is making waves, as the company's coronavirus vaccine -- which was developed with BioNTech (BNTX) -- was granted emergency use approval in the U.K, after it was shown to be 95% effective in preventing COVID-19 infections.", "url": "https://www.schaeffersresearch.com/content/options/2020/12/02/blue-chip-pharmaceutical-stock-surges-following-vaccine-update"}, {"symbol": "PFE", "publishedDate": "2020-12-02 13:57:45", "title": "What Pfizer, BioNTech Investors Need To Know About COVID-19 Vaccine With Conditional UK Approval", "image": "https://cdn.snapi.dev/images/v1/c/p/virus-4933201-1280-8.png", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE)-BioNTech SE \u2013 ADR (NASDAQ: BNTX) earned the distinction of being the first companies to receive regulatory authorization for emergency use of their investigational coronavirus vaccine candidate BNT162b2 following a positive verdict from the United Kingdom's drug regulator. Here's what investors should know about the combo's vaccine candidate:", "url": "https://www.benzinga.com/general/biotech/20/12/18619579/what-pfizer-biontech-investors-need-to-know-about-covid-19-vaccine-with-conditional-uk-approval"}, {"symbol": "PFE", "publishedDate": "2020-12-02 13:30:10", "title": "United Kingdom approves Pfizer, BioNTech's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/y/6/united-kingdom-approves-pfizer-biontechs-covid-19-vaccine.jpg", "site": "Fox Business", "text": "The United Kingdom has approved Pfizer and BioNTech's COVID-19 vaccine and plans to begin vaccinations next week, FOX Business' Edward Lawrence reports. #FoxBusiness Subscribe to Fox Business!", "url": "https://www.youtube.com/watch?v=e4f4bxxGF0k"}, {"symbol": "PFE", "publishedDate": "2020-12-02 12:54:16", "title": "Here's what U.K. approval of Pfizer's Covid vaccine could mean for the U.S.", "image": "https://cdn.snapi.dev/images/v1/h/w/heres-what-uk-approval-of-pfizers-covid-vaccine-could-mean-for-the-us.jpg", "site": "CNBC Television", "text": "The U.K. on Wednesday became the first country to authorize the Pfizer-BioNTech vaccine for emergency use. The development has many hopeful the vaccine could soon be approved in the U.S. Here's how a vaccine rollout could work in the U.S., and what it means for businesses.", "url": "https://www.youtube.com/watch?v=lnqLS8Y25OI"}, {"symbol": "PFE", "publishedDate": "2020-12-02 11:55:20", "title": "COVID-19 Vaccines Are on the Way and Major Players Are Cashing In", "image": "https://cdn.snapi.dev/images/v1/e/u/biotech4.jpg", "site": "24/7 Wall Street", "text": "COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.", "url": "https://247wallst.com/healthcare-business/2020/12/02/covid-19-vaccines-are-on-the-way-and-major-players-are-cashing-in/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 11:45:49", "title": "Pfizer team evaluates higher shipping temperature for COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/r/v/operation-warp-speed-1.jpg", "site": "FreightWaves", "text": "The drugmakers behind the COVID-19 vaccine approved Wednesday by United Kingdom authorities are studying whether it can be transported at higher temperatures than minus 94 degrees Fahrenheit (minus 70 Celsius), which would ease logistics challenges for getting people immunized, BioNTech CEO Ugar Sahin said.\u00a0 In an interview on CNN shortly after the U.K. became the first Western nation to approve public use of the vaccine from U.S. pharmaceutical giant Pfizer (NYSE: PFE) and German partner BioNTech, Sahin said people in the U.K. could begin getting vaccinations by early next week.", "url": "https://www.freightwaves.com/news/pfizer-team-evaluates-higher-shipping-temperature-for-covid-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-02 11:06:15", "title": "Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/3/9/pfizer-ceo-speaks-at-virtual-roundtable-event-after-uk-approves-emergency-use-of-coronavirus-vaccine.jpg", "site": "Yahoo Finance", "text": "Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. About Yahoo Finance Premium: With a subscription to Yahoo Finance Premium, get the tools you need to invest with confidence.", "url": "https://www.youtube.com/watch?v=d0VHQEE-78M"}, {"symbol": "PFE", "publishedDate": "2020-12-02 11:03:00", "title": "Pfizer and BioNTech's Coronavirus Vaccine Approved for Use in the U.K.", "image": "https://cdn.snapi.dev/images/v1/y/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030662fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg", "site": "The Motley Fool", "text": "The vaccine will begin to be available to the public next week, says the government.", "url": "https://www.fool.com/investing/2020/12/02/pfizer-and-biontechs-coronavirus-vaccine-approved/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 10:47:00", "title": "Pfizer/BioNTech's COVID-19 Vaccine Gets Approval in U.K.", "image": "https://cdn.snapi.dev/images/v1/m/f/biotech3---gptomp0aia.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate becomes the first-ever vaccine to get authorization.", "url": "https://www.zacks.com/stock/news/1123061/pfizer-biontechs-covid-19-vaccine-gets-approval-in-uk"}, {"symbol": "PFE", "publishedDate": "2020-12-02 10:44:00", "title": "Encouraging News on COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/o/y/laboratory-3827745-1920-7.jpg", "site": "Zacks Investment Research", "text": "Encouraging News on COVID-19 Vaccine", "url": "https://www.zacks.com/stock/news/1123037/encouraging-news-on-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-12-02 10:35:00", "title": "CDC Panel Recommends Which Groups Should Get Coronavirus Vaccines First", "image": "https://cdn.snapi.dev/images/v1/l/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030632fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The recommendation for early inoculation against COVID-19 covers around 24 million people.", "url": "https://www.fool.com/investing/2020/12/02/cdc-panel-recommends-which-groups-should-get-coron/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 10:11:55", "title": "UK approves Pfizer, BioNTech COVID-19 vaccine for use next week", "image": "https://cdn.snapi.dev/images/v1/t/h/uk-approves-pfizer-biontech-covid-19-vaccine-for-use-next-week.jpg", "site": "Yahoo Finance", "text": "The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, becoming the first country to do so for widespread use. Yahoo Finance's Anjalee Khemlani breaks down the details.", "url": "https://www.youtube.com/watch?v=fxA_pEvCXok"}, {"symbol": "PFE", "publishedDate": "2020-12-02 10:01:32", "title": "'This is monumental'\u2014Cramer on the U.K. approving Pfizer's Covid vaccine for general use", "image": "https://cdn.snapi.dev/images/v1/a/7/this-is-monumentalcramer-on-the-uk-approving-pfizers-covid-vaccine-for-general-use.jpg", "site": "CNBC Television", "text": "The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the country next week, with elderly people in care homes and medical workers first in line.", "url": "https://www.youtube.com/watch?v=qOkr7ATl7gc"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:58:41", "title": "Pfizer/BioNTech COVID-19 Vaccine Approved in the U.K.", "image": "https://cdn.snapi.dev/images/v1/q/n/adobestock-199783080-8d5f276111e4444784eef4133c18583f.jpeg", "site": "Investopedia", "text": "Vaccine hopes are starting to be fulfilled as the first COVID-19 vaccine gets authorized.", "url": "https://www.investopedia.com/pfizer-biontech-covid-19-vaccine-approved-in-the-u-k-5089614"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:52:47", "title": "Pfizer Jumps After Nabbing First-Ever Coronavirus Vaccine Approval", "image": "https://cdn.snapi.dev/images/v1/g/d/drugs43---ijddi2kwj2.jpg", "site": "Investors Business Daily", "text": "Pfizer stock jumped early Wednesday after the pharmaceutical company's BioNTech-partnered coronavirus vaccine gained authorization in the U.K. Also, Merck sold its investment in Moderna. The post Pfizer Jumps After Nabbing First-Ever Coronavirus Vaccine Approval appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pfizer-stock-jumps-gains-coronavirus-vaccine-approval-uk/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:42:57", "title": "LIVE | Pfizer, Salesforce, Slack: Jim Cramer's Stock Market Breakdown 12/2", "image": "https://cdn.snapi.dev/images/v1/e/f/live-pfizer-salesforce-slack-jim-cramers-stock-market-breakdown-122.jpg", "site": "The Street", "text": "In Wednesday's market breakdown, Jim Cramer talks Pfizer's U.K. vaccine approval, Salesforce buying Slack, President-elect Biden's economic team and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet", "url": "https://www.youtube.com/watch?v=yKUyN1J7Y2s"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:20:00", "title": "Pfizer/BioNTech Seek Marketing Nod for COVID-19 Vaccine in EU", "image": "https://cdn.snapi.dev/images/v1/e/g/biotech35---gr1wiiv9tc.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is 95% effective in final analysis.", "url": "https://www.zacks.com/stock/news/1122924/pfizer-biontech-seek-marketing-nod-for-covid-19-vaccine-in-eu"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:19:00", "title": "Pfizer-BioNTech seeks full marketing approval from UK for COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/p/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5757652fcoronavirus-vaccine-bottlesjpgw700opresize.jpg", "site": "Reuters", "text": "Pfizer is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to deliver by the weekend the first shots following approval for emergency use in the country.", "url": "https://www.reuters.com/article/us-health-coronavirus-britain-pfizer/pfizer-biontech-seeks-full-marketing-approval-from-uk-for-covid-19-vaccine-idUSKBN28C22V"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:08:00", "title": "Will Americans Get COVID-19 Vaccine Sooner Than Europeans?", "image": "https://cdn.snapi.dev/images/v1/2/f/gettyimages-1227406908.jpg", "site": "Zacks Investment Research", "text": "Moderna (MRNA), and Pfizer (PFE)/BioNTech (BNTX) file for emergency use authorization of their COVID-19 vaccine candidates in Europe", "url": "https://www.zacks.com/stock/news/1122868/will-americans-get-covid-19-vaccine-sooner-than-europeans"}, {"symbol": "PFE", "publishedDate": "2020-12-02 09:00:43", "title": "Pfizer surges 5% on emergency UK approval for COVID-19 vaccine (PFE)", "image": "https://cdn.snapi.dev/images/v1/m/0/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg", "site": "Business Insider", "text": "The UK became the first country in the world on Tuesday to grant emergency use authorization to Pfizer and BioNTech's COVID-19 vaccine. The vaccine, which demonstrated an efficacy rate of 95% in preventing COVID-19 among patients, will be made available to the country next week for a rollout to hospitals and vaccination centers across the country.", "url": "https://www.businessinsider.com/pfizer-stock-price-emergency-uk-approval-for-covid19-vaccine-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-02 08:52:53", "title": "UK approves its first vaccine", "image": "https://cdn.snapi.dev/images/v1/u/k/uk-approves-its-first-vaccine.jpg", "site": "Business Insider", "text": "Hi, The UK has approved Pfizer and BioNTech's coronavirus vaccine, becoming the first Western country to give a vaccine an OK. The plan is to make the vaccine available next week.\u00a0", "url": "https://www.businessinsider.com/business-insiders-biggest-healthcare-stories-for-december-2-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-02 08:12:00", "title": "Who will be first in line for the Pfizer-BioNTech COVID-19 vaccine?", "image": "https://cdn.snapi.dev/images/v1/v/z/im-267048width620size15744157441574416.jpg", "site": "Market Watch", "text": "Care home residents and people over the age of 80 will be among the first to receive the Pfizer-BioNTech COVID-19 vaccine, when the U.K. rollout starts next week.", "url": "https://www.marketwatch.com/story/who-will-be-first-in-line-for-the-pfizer-biontech-covid-19-vaccine-11606914711"}, {"symbol": "PFE", "publishedDate": "2020-12-02 08:02:39", "title": "Pfizer Covid-19 vaccine approved for use in UK", "image": "https://cdn.snapi.dev/images/v1/n/q/gettyimages-1229904522.jpg", "site": "CNET", "text": "Senior citizens will be first in line as the UK is the first country to approve Pfizer's vaccine.", "url": "https://www.cnet.com/health/pfizer-covid-19-coronavirus-vaccine-approved-for-use-in-uk/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 07:34:00", "title": "How the U.K. became first to approve the Pfizer-BioNTech vaccine, and are there dangers authorizing so fast?", "image": "https://cdn.snapi.dev/images/v1/z/a/im-267040width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K.'s regulator had been delegated much of the work to authorize Europe's medicines, and seemed better prepared than most to approve the vaccine.", "url": "https://www.marketwatch.com/story/how-the-u-k-became-first-to-approve-the-pfizer-biontech-vaccine-and-are-there-dangers-authorizing-so-fast-11606912465"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:52:00", "title": "Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic", "image": "https://cdn.snapi.dev/images/v1/s/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026872fgettyimages-1216778258jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It's time to count how many vaccine doses leading companies can provide -- and how many may be needed.", "url": "https://www.fool.com/investing/2020/12/02/why-we-need-all-5-of-these-coronavirus-vaccine-com/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:31:46", "title": "The UK has approved Pfizer and BioNTech's COVID-19 vaccine, but the US is still waiting. Here's why.", "image": "https://cdn.snapi.dev/images/v1/t/h/the-uk-has-approved-pfizer-and-biontechs-covid-19-vaccine-but-the-us-is-still-waiting-heres-why.jpg", "site": "Business Insider", "text": "The UK has approved Pfizer and its German partner BioNTech's COVID-19 vaccine \u2014 but regulators in the US are yet to make a decision on authorization. The UK's vaccine regulator approved the shot Wednesday morning, making it the first western country to authorize a COVID-19 vaccine. Vaccinations will start next week, the government said.", "url": "https://www.businessinsider.com/us-fda-approve-pfizer-vaccine-biontech-covid-uk-mhra-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:26:34", "title": "UK approves Pfizer-BioNTech coronavirus vaccine to begin rolling out next week", "image": "https://cdn.snapi.dev/images/v1/g/x/uk-approves-pfizer-biontech-coronavirus-vaccine-to-begin-rolling-out-next-week.jpg", "site": "CNBC Television", "text": "The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the country next week, with elderly people in care homes and medical workers first in line.", "url": "https://www.youtube.com/watch?v=_gTCGoMnWI8"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:26:07", "title": "7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge", "image": "https://cdn.snapi.dev/images/v1/v/7/biotech25.jpg", "site": "InvestorPlace", "text": "These seven long-term stocks are likely to bring stable returns to any tech portfolio. The post 7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/7-long-term-tech-stocks-cibr-ogig-pypl-roku-qcom-xsd-twtr/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:18:00", "title": "U.K. Becomes First Country to Approve Pfizer's Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/w/h/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock.jpg", "site": "Barrons", "text": "The U.K. has become the first country to approve the Pfizer-BioNTech Covid-19 vaccine, with preparations under way to begin the rollout next week.", "url": "https://www.barrons.com/articles/u-k-becomes-first-country-to-approve-pfizers-covid-19-vaccine-the-rollout-will-start-next-week-51606907329"}, {"symbol": "PFE", "publishedDate": "2020-12-02 06:08:00", "title": "COVID Vaccine Stocks Update: Where Things Stand Now", "image": "https://cdn.snapi.dev/images/v1/u/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026442fcovid-vaccine-with-dollar-signjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's what you need to know about all of the leaders in the coronavirus vaccine race.", "url": "https://www.fool.com/investing/2020/12/02/covid-vaccine-stocks-update-where-things-stand-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 05:18:11", "title": "U.K. Approves Pfizer-BioNTech's Covid-19 Vaccine, The First Country To Do So", "image": "https://cdn.snapi.dev/images/v1/b/b/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so.jpg", "site": "Forbes", "text": "The vaccine will be available across the U.K. starting next week with the elderly and frontline healthcare workers being the first to receive a shot.", "url": "https://www.forbes.com/sites/siladityaray/2020/12/02/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 05:02:00", "title": "Pfizer and BioNTech's COVID-19 vaccine wins U.K. approval \u2014 rollout to begin next week", "image": "https://cdn.snapi.dev/images/v1/5/p/im-267020width620size15005861664712778.jpg", "site": "Market Watch", "text": "U.K. becomes first country to approve a coronavirus vaccine, with immunisations to start within days for those most at risk", "url": "https://www.marketwatch.com/story/pfizer-and-biontechs-covid-19-vaccine-wins-u-k-approval-rollout-to-begin-next-week-11606903369"}, {"symbol": "PFE", "publishedDate": "2020-12-02 04:24:00", "title": "Vaccine approval is a historic moment for the UK", "image": "https://cdn.snapi.dev/images/v1/s/k/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg", "site": "Skynews", "text": "This is an historic moment. The beginning of the end of the pandemic.", "url": "https://news.sky.com/story/covid-19-approval-of-pfizer-vaccine-is-a-historic-moment-for-the-uk-12148876"}, {"symbol": "PFE", "publishedDate": "2020-12-02 04:20:52", "title": "The UK approves the BioNTech/Pfizer COVID-19 vaccine for emergency use", "image": "https://cdn.snapi.dev/images/v1/b/q/gettyimages-1229305401jpgw600.jpg", "site": "TechCrunch", "text": "The UK's medicines regulator has approved the BioNTech/Pfizer vaccine against\u00a0COVID-19 for emergency use, the companies said today. The UK is the first country to approve the vaccine for widespread use \u2014 paving the way for some of the most \u201chigh risk\u201d citizens, such as elderly care home residents, to get the jab before the end [\u2026]", "url": "https://techcrunch.com/2020/12/02/the-uk-approves-the-biontech-pfizer-covid-19-vaccine-for-emergency-use/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 03:25:02", "title": "U.K. Clears Pfizer-BioNTech Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/d/m/uk-clears-pfizer-biontech-covid-19-vaccine.jpg", "site": "Bloomberg Markets and Finance", "text": "Dec.02 -- The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing\u00a0Pfizer Inc.\u00a0and\u00a0BioNTech SE's shot ahead of decisions in the U.S. and European Union. Sam Fazeli, senior pharmaceutical analyst at Bloomberg Intelligence, has the details on \"Bloomberg Markets: European Open.", "url": "https://www.youtube.com/watch?v=Wo1jqhfedWs"}, {"symbol": "PFE", "publishedDate": "2020-12-02 02:57:41", "title": "Pfizer-BioNTech COVID-19 Vaccine Gets UK Approval For Emergency Use", "image": "https://cdn.snapi.dev/images/v1/w/r/dimitri-houtteman-qbhppxw3ess-unsplash-5.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Wednesday they have received regulatory approval\u00a0in the United Kingdom for their COVID-19 vaccine. What Happened: The go-ahead from the Medicines and Healthcare Products Regulatory Agency (MHRA) means the U.K. has become the first country to approve a COVID-19 vaccine on an emergency basis ahead of the United States and the European Union.", "url": "https://www.benzinga.com/general/biotech/20/12/18609434/pfizer-biontech-covid-19-vaccine-gets-uk-approval-for-emergency-use"}, {"symbol": "PFE", "publishedDate": "2020-12-02 02:16:09", "title": "Regulator says yes to Pfizer and BioNTech: UK becomes first Western country to have a coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/r/e/regulator-says-yes-to-pfizer-and-biontech-uk-becomes-first-western-country-to-have-a-coronavirus-vaccine.jpg", "site": "Business Insider", "text": "The UK has become the first Western country to officially have a new coronavirus vaccine, marking a potential exit route out of the pandemic. And it's happened in record time.\u00a0\u00a0 The vaccine developed by US drugmaker Pfizer and the small German biotech, BioNTech, can be used in the UK, after the independent regulatory body in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) signed off the vaccine.", "url": "https://www.businessinsider.com/pfizer-and-biontech-covid-19-vaccines-approved-by-uk-regulator-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-12-02 02:12:56", "title": "UK becomes first country to approve the Pfizer-BioNTech coronavirus vaccine for use", "image": "https://cdn.snapi.dev/images/v1/g/p/106800281-16058888822020-11-11t235006z-1966379303-rc2b1k9qa10w-rtrmadp-0-health-coronavirus-vaccines-pfizer.jpeg", "site": "CNBC", "text": "The U.K. has authorized the Pfizer/BioNtech coronavirus vaccine, making it the first country in the world to do so.", "url": "https://www.cnbc.com/2020/12/02/uk-approves-pfizer-biontech-coronavirus-vaccine-for-use.html"}, {"symbol": "PFE", "publishedDate": "2020-12-02 02:05:00", "title": "Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19", "image": "https://cdn.snapi.dev/images/v1/3/c/press16---uhgzyix2ws.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19. This constitutes the first Emergency Use Authorization following a worldwide Phase 3 trial of a vaccine to help fight the pandemic. Pfizer and BioNTech are anticipating further regulat", "url": "https://www.businesswire.com/news/home/20201201006304/en/Pfizer-and-BioNTech-Achieve-First-Authorization-in-the-World-for-a-Vaccine-to-Combat-COVID-19/"}, {"symbol": "PFE", "publishedDate": "2020-12-02 02:00:00", "title": "UK approves use of Pfizer's coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/c/b/m02d20201109t2i1540528426w940fhfwllplsqrlynxmpega80rr.jpg", "site": "Skynews", "text": "The UK's independent healthcare regulator has approved use of the Pfizer/BioNtech COVID-19 vaccine.", "url": "https://news.sky.com/story/covid-19-uk-approves-use-of-pfizers-coronavirus-vaccine-12148786"}, {"symbol": "PFE", "publishedDate": "2020-12-01 16:23:05", "title": "7 Safe Growth Stocks To Buy For 2021 Catalysts", "image": "https://cdn.snapi.dev/images/v1/s/s/ss02924---gm3vc03rrc.", "site": "InvestorPlace", "text": "Growth stocks to buy shouldn't mean pricey or risky. Here are 7 safe growth stocks that look set for a great 2021.", "url": "https://investorplace.com/2020/12/7-safe-growth-stocks-to-buy-for-2021-catalysts/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 14:19:07", "title": "European Drug Regulator Gives 6-Week Time Frame For Opinions On Pfizer-BioNTech, Moderna COVID-19 Vaccines", "image": "https://cdn.snapi.dev/images/v1/1/d/syringe-866550-1920-1-8.jpg", "site": "Benzinga", "text": "The European Medicines Agency said Tuesday it has received conditional marketing approval applications from Pfizer Inc. (NYSE: PFE)-BioNTech SE \u2013 ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA), the two frontrunners in the development of a\u00a0coronavirus vaccine.\u00a0 The decision isn't likely to come early, thereby pushing out the vaccine launch timeline.", "url": "https://www.benzinga.com/general/biotech/20/12/18598746/european-drug-regulator-gives-6-week-time-frame-for-opinions-on-pfizer-biontech-moderna-covid-19-"}, {"symbol": "PFE", "publishedDate": "2020-12-01 13:30:05", "title": "EARS Stock: Why Auris Medical Shares Are Soaring 450%", "image": "https://cdn.snapi.dev/images/v1/n/k/biotech23.jpg", "site": "InvestorPlace", "text": "EARS stock typically flies under the radar, but today it is getting a boost thanks to trial data from a Covid-19 treatment. The post EARS Stock: Why Auris Medical Shares Are Soaring 450% appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/12/ears-stock-why-auris-medical-shares-are-soaring-450/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 13:26:00", "title": "How United Airlines overcame one of the largest limitations to being transporting Pfizer's COVID-19 vaccine to the US", "image": "https://cdn.snapi.dev/images/v1/h/o/how-united-airlines-overcame-one-of-the-largest-limitations-to-being-transporting-pfizers-covid-19-vaccine-to-the-us.jpg", "site": "Business Insider", "text": "The COVID-19 vaccine has taken flight en route to the US.\u00a0 Pfizer has tasked United Airlines with transporting the first doses of its vaccine to the US, the Wall Street Journal reported on Friday, in preparation for an expected emergency authorization from the Food and Drug Administration scheduled to come in the upcoming weeks.", "url": "https://www.businessinsider.com/how-united-airlines-overcame-major-limitation-to-fly-pfizer-vaccine-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-12-01 13:01:43", "title": "4 Pharmaceutical Stocks That Aren't Worth Their Outsized 2020 Gains", "image": "https://cdn.snapi.dev/images/v1/w/s/drugs35.jpg", "site": "InvestorPlace", "text": "Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.", "url": "https://investorplace.com/2020/12/4-pharmaceutical-stocks-ino-regn-abbv-nvax-that-arent-worth-their-2020-gains/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 11:07:39", "title": "7 Warren Buffett Stocks That Belong On Your 2021 Watchlist", "image": "https://cdn.snapi.dev/images/v1/p/v/etf5-8.jpg", "site": "InvestorPlace", "text": "In the third quarter, Berkshire Hathaway made a number of changes. Here are seven Warren Buffett stocks that ought to be on your radar.", "url": "https://investorplace.com/2020/12/7-warren-buffett-stocks-that-belong-on-your-2021-watchlistthese-7-warren-buffett-stocks-ought-to-be-on-your-2021-watchlist/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 11:01:20", "title": "Buffett Buys Pharma: Two Out Of Four Seem Compelling", "image": "https://cdn.snapi.dev/images/v1/s/q/drugs32.jpg", "site": "Seeking Alpha", "text": "Berkshire's latest filing revealed the Oracle of Omaha and his team opening new positions in four pharma giants as of late. From a quality standpoint, all companies seem like a natural fit considering Buffett's reported preference for wide-moat businesses.", "url": "https://seekingalpha.com/article/4392293-buffett-buys-pharma-two-out-of-four-seem-compelling"}, {"symbol": "PFE", "publishedDate": "2020-12-01 09:21:11", "title": "Europe May Not Get Covid-19 Vaccine Before 2021, Earliest Approval Process Scheduled For December 29", "image": "https://cdn.snapi.dev/images/v1/e/u/europe-may-not-get-covid-19-vaccine-before-2021-earliest-approval-process-scheduled-for-december-29.jpg", "site": "Forbes", "text": "Moderna and Pfizer applied to the EU's vaccine regulator this week.", "url": "https://www.forbes.com/sites/siladityaray/2020/12/01/europe-may-not-get-covid-19-vaccine-before-2021-earliest-approval-process-scheduled-for-december-29/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 08:39:00", "title": "3 Pharma Stocks With Dividends Above 4% to Buy Now", "image": "https://cdn.snapi.dev/images/v1/a/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6022222fpharmaceutical-manufacturing-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Should you buy these drugmaker stocks for their juicy dividend yields?", "url": "https://www.fool.com/investing/2020/12/01/3-pharma-stocks-with-dividends-above-4-to-buy-now/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 08:25:00", "title": "Very Good News For REITs", "image": "https://cdn.snapi.dev/images/v1/g/q/catalog-mail7.jpg", "site": "Seeking Alpha", "text": "Most investors are focused on the bad news affecting REITs. But there has been a lot of very good news lately.", "url": "https://seekingalpha.com/article/4392082-good-news-for-reits"}, {"symbol": "PFE", "publishedDate": "2020-12-01 08:05:00", "title": "COVID-19 Vaccine Race Heats Up: Drugmarkers on Final Lap", "image": "https://cdn.snapi.dev/images/v1/r/l/drugs29.jpg", "site": "Zacks Investment Research", "text": "Shares of Moderna, Inc. (MRNA), Pfizer, Inc. (PFE) and AstraZeneca plc (AZN) are poised for substantial gains on encouraging final-stage trial results.", "url": "https://www.zacks.com/stock/news/1121020/covid-19-vaccine-race-heats-up-drugmarkers-on-final-lap"}, {"symbol": "PFE", "publishedDate": "2020-12-01 08:03:10", "title": "Regenerative Medicines: Universal Cell Therapy Gaining Momentum", "image": "https://cdn.snapi.dev/images/v1/9/y/biotech4.jpg", "site": "Seeking Alpha", "text": "Allogeneic cell therapies have a significant cost, convenience and efficiency advantage over autologous. Data from three of the leaders: Allogene, Atara and CRISPR are expected in the next 12-to-24 months to further elucidate safety and efficacy.", "url": "https://seekingalpha.com/article/4392250-regenerative-medicines-universal-cell-therapy-gaining-momentum"}, {"symbol": "PFE", "publishedDate": "2020-12-01 07:48:53", "title": "Pfizer, BioNTech seek COVID-19 vaccine approval in Europe", "image": "https://cdn.snapi.dev/images/v1/w/r/pfizer-51jpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer and BioNTech have asked European regulators for conditional approval of their experimental coronavirus vaccine \u2014 and officials say they could make a decision by the end of the month. The companies said they submitted an application to the European Medicines Agency on Monday for a conditional marketing authorization for their COVID-19 shot, which was.", "url": "https://nypost.com/2020/12/01/pfizer-biontech-seek-covid-vaccine-approval-in-europe/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 06:56:13", "title": "Pfizer and BioNTech have asked the EU to approve their vaccine \u2014 but first shots might not come until next year", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-and-biontech-have-asked-the-eu-to-approve-their-vaccine-but-first-shots-might-not-come-until-next-year.jpg", "site": "Business Insider", "text": "Pfizer and its German partner BioNTech said Tuesday they have asked the European Union to approve their COVID-19 vaccine, but that distribution is unlikely to start until January. After submitting an application on Monday to the European Medicines Agency (EMA), the drugmakers said the EU regulator accepted the application on Tuesday, per the Wall Street Journal.", "url": "https://www.businessinsider.com/pfizer-biontech-seek-clearance-for-covid-19-vaccine-in-europe-2020-12"}, {"symbol": "PFE", "publishedDate": "2020-12-01 06:31:41", "title": "Pfizer, BioNTech apply for CMA in Europe for COVID-19 vaccine candidate", "image": "https://cdn.snapi.dev/images/v1/p/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5642132fcoronavirus-vialsjpgw700opresize.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. rallied 2.8% while Germany-based BioNTech SE dropped 2.5% in premarket trading Tuesday, after the company said they submitted their COVID-19 vaccine candidate BNT162b2 for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA). If the EMA recommends granting a CMA, that could lead to use of BNT162b2 in Europe before the end of 2020.", "url": "https://www.marketwatch.com/story/pfizer-biontech-apply-for-cma-in-europe-for-covid-19-vaccine-candidate-2020-12-01"}, {"symbol": "PFE", "publishedDate": "2020-12-01 06:13:00", "title": "Pfizer-BioNTech apply for EU emergency authorization for COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/g/e/m02d20201201t2i1543038402w940fhfwllplsqrlynxmpegb02ex.jpg", "site": "Reuters", "text": "Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-biontech-apply-for-eu-emergency-authorization-for-covid-19-vaccine-idUSKBN28B4F3"}, {"symbol": "PFE", "publishedDate": "2020-12-01 06:06:00", "title": "4 Reasons the Stock Market Could Crash in the Next 3 Months", "image": "https://cdn.snapi.dev/images/v1/u/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026212fdollar-bill-stock-chart-plunge-correction-dow-sp-500-invest-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Big-time volatility may be right around the corner.", "url": "https://www.fool.com/investing/2020/12/01/4-reasons-the-stock-market-could-crash-in-3-months/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 06:05:00", "title": "This COVID Vaccine Is Already Shipping", "image": "https://cdn.snapi.dev/images/v1/v/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026422fjet-flying-over-airportjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Here's what it means -- and doesn't mean.", "url": "https://www.fool.com/investing/2020/12/01/this-covid-vaccine-is-already-shipping/"}, {"symbol": "PFE", "publishedDate": "2020-12-01 05:40:03", "title": "Pfizer, BioNTech apply for coronavirus vaccine approval in Europe", "image": "https://cdn.snapi.dev/images/v1/a/p/106717238-16010339862020-09-25t020720z-1743677146-rc2e5j97rka1-rtrmadp-0-health-coronavirus-usa.jpeg", "site": "CNBC", "text": "Pfizer and BioNTech said they have applied to the European Medicines Agency for the conditional marketing authorization of their coronavirus vaccine.", "url": "https://www.cnbc.com/2020/12/01/pfizer-biontech-apply-for-coronavirus-vaccine-approval-in-europe.html"}, {"symbol": "PFE", "publishedDate": "2020-11-30 12:12:24", "title": "Pfizer: A 'New' Growth Foundation In Genomic Medicine", "image": "https://cdn.snapi.dev/images/v1/v/z/drugs25.jpg", "site": "Seeking Alpha", "text": "Pfizer has been working on New Pfizer for almost a decade.\u00a0The spin offs of Consumer Health and Upjohn appear to be the last steps. Continuation of the policy of dividend growth is a stated priority.", "url": "https://seekingalpha.com/article/4392067-pfizer-new-growth-foundation-in-genomic-medicine"}, {"symbol": "PFE", "publishedDate": "2020-11-30 12:09:54", "title": "Eighth Review Of My Dividend Portfolio", "image": "https://cdn.snapi.dev/images/v1/f/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686502fgettyimage-stockchartjpgw700opresize.jpg", "site": "Seeking Alpha", "text": "Top five holdings add up to 50% of my portfolio. Portfolio currently yields approximately 3.91%.", "url": "https://seekingalpha.com/article/4392066-eighth-review-of-dividend-portfolio"}, {"symbol": "PFE", "publishedDate": "2020-11-30 12:04:14", "title": "First 'mass air shipment' of Pfizer's Covid vaccine arrives as airlines prepare for more", "image": "https://cdn.snapi.dev/images/v1/p/j/106099577-1595363154393-jet.jpg", "site": "CNBC", "text": "United's first flight carrying Pfizer's Covid-19 vaccines arrived in Chicago on Friday.", "url": "https://www.cnbc.com/2020/11/30/first-mass-air-shipment-of-pfizers-covid-vaccine-arrives-as-airlines-prepare-for-more.html"}, {"symbol": "PFE", "publishedDate": "2020-11-30 10:51:00", "title": "This could be the first country to distribute the Pfizer-BioNTech vaccine, as Moderna seeks FDA approval", "image": "https://cdn.snapi.dev/images/v1/j/g/im-265884width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K. government has told NHS hospitals to be ready to distribute the COVID-19 vaccine manufactured by Pfizer and BioNTech as soon as next Monday.", "url": "https://www.marketwatch.com/story/this-could-be-the-first-country-to-distribute-the-pfizer-biontech-vaccine-as-moderna-seeks-fda-approval-11606751481"}, {"symbol": "PFE", "publishedDate": "2020-11-30 08:06:00", "title": "Pfizer-BioNTech vaccine could be approved \u2018within days,' with U.K. set to be first to start COVID-19 shots", "image": "https://cdn.snapi.dev/images/v1/v/v/im-265863width620size15005861664712778.jpg", "site": "Market Watch", "text": "COVID-19 infections fall 30% across England in second lockdown, study finds.", "url": "https://www.marketwatch.com/story/pfizer-biontech-vaccine-could-be-approved-within-days-with-u-k-set-to-be-first-to-start-covid-19-shots-11606741593"}, {"symbol": "PFE", "publishedDate": "2020-11-30 06:05:00", "title": "Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna", "image": "https://cdn.snapi.dev/images/v1/k/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019532fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The small biotech's promising coronavirus vaccine candidate is only half of the reason.", "url": "https://www.fool.com/investing/2020/11/30/why-novavax-could-be-a-bigger-covid-vaccine-winner/"}, {"symbol": "PFE", "publishedDate": "2020-11-29 10:10:44", "title": "UK To Approve Pfizer-BioNTech Vaccine 'Within Days,' Secures 2M More Doses From Moderna", "image": "https://cdn.snapi.dev/images/v1/7/6/covidvaccinee.jpeg", "site": "Benzinga", "text": "The U.K. has secured two million more doses of COVID-19 vaccine from\u00a0Moderna Inc\u00a0(NASDAQ: MRNA) and is expected to approve the\u00a0vaccine made by\u00a0Pfizer Inc\u00a0(NYSE: PFE) and\u00a0BioNTech SE - ADR\u00a0(NASDAQ: BNTX) this week. What Happened:\u00a0Moderna\u00a0is to provide another two million vaccines to the U.K., in addition to a previous 5 million doses, Reuters\u00a0has reported.", "url": "https://www.benzinga.com/general/biotech/20/11/18564552/uk-to-approve-pfizer-biontech-vaccine-within-days-secures-2m-more-doses-from-moderna"}, {"symbol": "PFE", "publishedDate": "2020-11-29 09:06:00", "title": "3 Key Advantages Moderna Holds Over Pfizer and AstraZeneca", "image": "https://cdn.snapi.dev/images/v1/a/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019522fscientists-holding-vaccine-bottlejpgw700opresize.jpg", "site": "The Motley Fool", "text": "They could add up to make Moderna a much bigger winner for investors than either of the two big pharma stocks.", "url": "https://www.fool.com/investing/2020/11/29/3-key-advantages-moderna-holds-pfizer-and-astra-z/"}, {"symbol": "PFE", "publishedDate": "2020-11-29 08:25:10", "title": "Berkshire Hathaway Makes Big Bet on Pharma", "image": "https://cdn.snapi.dev/images/v1/b/g/asset-management33.jpg", "site": "GuruFocus", "text": "Despite solid gains in pharma sales and profits, Big Pharma's overall share value has pretty much stagnated over the past five years\u2014but better days appear to be ahead, in my opinion.", "url": "https://www.gurufocus.com/news/1298016/berkshire-hathaway-makes-big-bet-on-pharma"}, {"symbol": "PFE", "publishedDate": "2020-11-28 08:07:00", "title": "Pfizer's Vaccine Candidate Is Effective -- But It Has Issues", "image": "https://cdn.snapi.dev/images/v1/r/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018082fgettyimages-147091611jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The company's offering presents challenges at every step from the lab to the syringe.", "url": "https://www.fool.com/investing/2020/11/28/pfizers-vaccine-is-effective-but-it-has-issues/"}, {"symbol": "PFE", "publishedDate": "2020-11-28 07:03:09", "title": "Pfizer's COVID-19 vaccine is reportedly being flown by United Airlines chartered flights to distribution hubs, in anticipation of FDA approval", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizers-covid-19-vaccine-is-reportedly-being-flown-by-united-airlines-chartered-flights-to-distribution-hubs-in-anticipation-of-fda-approval.jpg", "site": "Business Insider", "text": "As drugmaker Pfizer seeks regulatory approval for its COVID-19 vaccine, shipments have already begun making their way to distribution centers via United Airlines charters, according to a Wall Street Journal report.\u00a0 The Federal Aviation Administration (FAA) approved the shipments, which require the vaccine candidate to be packed in dry ice, according to CNN.\u00a0", "url": "https://www.businessinsider.com/united-airlines-flying-pfizer-covid-19-vaccines-distribution-hubs-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-28 06:10:00", "title": "Where Will Pfizer Be in 5 Years?", "image": "https://cdn.snapi.dev/images/v1/n/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019482f2025-with-pushpinjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A prediction: In a much better position than it has been in during the last half a decade.", "url": "https://www.fool.com/investing/2020/11/28/where-will-pfizer-be-in-5-years/"}, {"symbol": "PFE", "publishedDate": "2020-11-27 16:38:29", "title": "United Airlines starts charter flights to distribute Pfizer's COVID-19 vaccine: WSJ", "image": "https://cdn.snapi.dev/images/v1/7/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009472ftwo-test-tubesjpgw700opresize.jpg", "site": "Market Watch", "text": "United Airlines Holdings Inc. on Friday started operating charter flights to get doses of Pfizer Inc.'s and BioNTech SE's COVID-19 vaccine ready for quick distribution if the vaccine candidate is approved by regulators, according to a Wall Street Journal report that cited people familiar with the matter. Pfizer and BioNTech last Friday submitted an application for the vaccine trial's emergency use authorization, making their vaccine candidate the first in line with U.S. regulators.", "url": "https://www.marketwatch.com/story/united-airlines-starts-charter-flights-to-distribute-pfizers-covid-19-vaccine-wsj-2020-11-27"}, {"symbol": "PFE", "publishedDate": "2020-11-27 15:01:08", "title": "Is Bitcoin Millenials' Alternative to Gold?", "image": "https://cdn.snapi.dev/images/v1/o/w/biotech16.jpg", "site": "GuruFocus", "text": "The price of gold this year rallied to new historical highs as the coronavirus pandemic sent equity markets plunging. The safe-haven asset has since pulled back significantly after several pharma companies announced good results from clinical trials for the Covid-19 vaccine.", "url": "https://www.gurufocus.com/news/1297901/is-bitcoin-millenials-alternative-to-gold"}, {"symbol": "PFE", "publishedDate": "2020-11-27 06:28:00", "title": "3 Dividend Stocks Ideal for Retirees", "image": "https://cdn.snapi.dev/images/v1/p/3/14dow.jpg", "site": "The Motley Fool", "text": "These buy-and-forget-about stocks offer above-average payouts and consistent profits.", "url": "https://www.fool.com/investing/2020/11/27/3-dividend-stocks-ideal-for-retirees/"}, {"symbol": "PFE", "publishedDate": "2020-11-27 05:33:20", "title": "Top 10 Stocks Warren Buffett Just Bought", "image": "https://cdn.snapi.dev/images/v1/e/r/gettyimages-957725692-6dbce81323da4b118e7f88b79dfdf468.jpg", "site": "Insider Monkey", "text": "In this article we'll run through the Top 10 Stocks Warren Buffett Just Bought. If you're in a hurry to see the hedge fund legend's highest conviction new stock purchases, you can jump straight to the Top 5 Stocks Warren Buffett Just Bought .", "url": "https://www.insidermonkey.com/blog/top-10-stocks-warren-buffett-just-bought-892035/"}, {"symbol": "PFE", "publishedDate": "2020-11-26 09:10:00", "title": "UPS Soars 71.1% in the Past 6 Months: More Room for Rally?", "image": "https://cdn.snapi.dev/images/v1/e/h/biotech9---gysic6fveo.jpg", "site": "Zacks Investment Research", "text": "The surge in e-commerce demand in the current pandemic scenario bodes well for the UPS stock.", "url": "https://www.zacks.com/stock/news/1113499/ups-soars-711-in-the-past-6-months-more-room-for-rally"}, {"symbol": "PFE", "publishedDate": "2020-11-26 08:21:00", "title": "Wall Street Set to Close the Year Higher: 5 Top Growth Picks", "image": "https://cdn.snapi.dev/images/v1/e/b/auto36.jpg", "site": "Zacks Investment Research", "text": "The stock market is poised to close the year positively, driven by a flurry of encouraging developments, making it a good time to invest in growth stocks like Beazer Homes (BZH) and Axcelis (ACLS).", "url": "https://www.zacks.com/stock/news/1113422/wall-street-set-to-close-the-year-higher-5-top-growth-picks"}, {"symbol": "PFE", "publishedDate": "2020-11-26 06:55:00", "title": "3 Cheap Stocks to Buy Before the Economy Makes a Full Recovery", "image": "https://cdn.snapi.dev/images/v1/j/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019702finvestor-looking-at-whether-to-buy-or-sell-a-stockjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They may be down this year, but don't count these stocks out for a rally in 2021.", "url": "https://www.fool.com/investing/2020/11/26/3-cheap-stocks-to-buy-before-the-economy-makes-a-f/"}, {"symbol": "PFE", "publishedDate": "2020-11-26 06:06:00", "title": "Who's Ready for a Stock Market Crash?", "image": "https://cdn.snapi.dev/images/v1/j/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019802fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A perfect storm could be brewing for equities.", "url": "https://www.fool.com/investing/2020/11/26/whos-ready-for-a-stock-market-crash/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 17:30:42", "title": "How to Invest in a Post-COVID World", "image": "https://cdn.snapi.dev/images/v1/l/t/drugs3---vorhrahhci.jpg", "site": "InvestorPlace", "text": "Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively. The post How to Invest in a Post-COVID World appeared first on InvestorPlace.", "url": "https://investorplace.com/moneywire/2020/11/post-covid-investing-where-to-invest-for-the-pandemics-end/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 13:56:35", "title": "Pfizer Stock Moved Markets This Month, But Can it Rally?", "image": "https://cdn.snapi.dev/images/v1/o/o/drug1.jpg", "site": "InvestorPlace", "text": "The company is a proven winner but Pfizer stock won't win any awards for excitement. Long term investors can reap strong dividend rewards; short term movement is murkier.", "url": "https://investorplace.com/2020/11/pfizer-stock-moved-markets-this-month-but-can-it-rally/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 11:25:33", "title": "The Top 5 Telehealth Stocks Disrupting the Healthcare Sector", "image": "https://cdn.snapi.dev/images/v1/8/d/insurance10.jpg", "site": "InvestorPlace", "text": "Don't count out telehealth stocks just yet. There's still plenty of demand as patients and providers become comfortable with virtual care.", "url": "https://investorplace.com/2020/11/the-top-5-telehealth-stocks-disrupting-the-healthcare-sector/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 09:40:00", "title": "Should Value Investors Pick Pfizer (PFE) Stock Right Now?", "image": "https://cdn.snapi.dev/images/v1/5/m/drugs45.jpg", "site": "Zacks Investment Research", "text": "Is Pfizer (PFE) a great pick from the value investor's perspective right now? Read on to know more.", "url": "https://www.zacks.com/stock/news/1111858/should-value-investors-pick-pfizer-pfe-stock-right-now"}, {"symbol": "PFE", "publishedDate": "2020-11-25 08:58:42", "title": "The challenges Pfizer faces distributing its Covid-19 vaccine to the masses", "image": "https://cdn.snapi.dev/images/v1/r/s/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg", "site": "CNBC", "text": "Pfizer's Covid-19 vaccine, made in partnership with BioNTech, needs to be stored at subzero temperatures and distribution challenges lie ahead.", "url": "https://www.cnbc.com/2020/11/25/challenges-pfizer-faces-distributing-covid-19-vaccine-to-the-masses-.html"}, {"symbol": "PFE", "publishedDate": "2020-11-25 08:38:00", "title": "Permian Producers in Focus as Crude Price Picks Up", "image": "https://cdn.snapi.dev/images/v1/t/4/oil42.jpg", "site": "Zacks Investment Research", "text": "Improving oil prices are definitely a boon for Permian explorers like Devon (DVN), Diamondback (FANG), Concho (CXO) and Matador (MTDR).", "url": "https://www.zacks.com/stock/news/1111716/permian-producers-in-focus-as-crude-price-picks-up"}, {"symbol": "PFE", "publishedDate": "2020-11-25 08:04:40", "title": "Forget the Vaccine, Buy Pfizer Stock for Its Impressive Cash Flow", "image": "https://cdn.snapi.dev/images/v1/n/j/pfizer-56a530e23df78cf77286d4a7.jpg", "site": "InvestorPlace", "text": "Vaccine news thrust Pfizer center stage this month. But it's PFE stock's beefy dividend that's the real story.", "url": "https://investorplace.com/2020/11/forget-the-vaccine-buy-pfizer-pfe-stock-for-cash-flow/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 07:43:00", "title": "Here's How the Top 3 Coronavirus Vaccine Candidates Stack Up", "image": "https://cdn.snapi.dev/images/v1/s/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019952fpreparting-injection-artsy-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which leading coronavirus vaccine candidate looks best so far?", "url": "https://www.fool.com/investing/2020/11/25/heres-how-the-top-3-coronavirus-vaccine-candidates/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 07:21:00", "title": "The Most Important Coronavirus Vaccine Questions Yet to Be Answered", "image": "https://cdn.snapi.dev/images/v1/k/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021422fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Despite exceptional clinical efficacy, it's far too early to declare victory over COVID-19.", "url": "https://www.fool.com/investing/2020/11/25/the-most-important-coronavirus-vaccine-questions-y/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 06:55:00", "title": "Could AstraZeneca's Coronavirus Vaccine Beat Pfizer and Moderna?", "image": "https://cdn.snapi.dev/images/v1/b/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021932fgettyimages-1247981297jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It depends on what you mean by \"beat.\"", "url": "https://www.fool.com/investing/2020/11/25/could-astrazenecas-coronavirus-vaccine-beat-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 06:45:00", "title": "Better Coronavirus Stock: Pfizer or Moderna?", "image": "https://cdn.snapi.dev/images/v1/5/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021622fgettyimages-842612564jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The companies might both win the coronavirus vaccine race -- but only one may dominate the market in the long term.", "url": "https://www.fool.com/investing/2020/11/25/better-coronavirus-stock-pfizer-or-moderna/"}, {"symbol": "PFE", "publishedDate": "2020-11-25 01:18:43", "title": "6.4M Pfizer COVID-19 Vaccine Doses To Be Distributed Across US Within 24 Hours Of FDA Approval: WaPo", "image": "https://cdn.snapi.dev/images/v1/z/t/hush-naidoo-zco-5y29s8k-unsplash.jpg", "site": "Benzinga", "text": "Over six million doses of Pfizer Inc's\u00a0 (NYSE: PFE) COVID-19 vaccine could be distributed within 24 hours of it being given the go-ahead by the United States Food And Drug Administration, The Washington Post reported Tuesday. What Happened: The vaccine's 6.4 million doses would be sent across communities and the first shots are expected to be given to front-line health-care workers, according to the Post.", "url": "https://www.benzinga.com/general/biotech/20/11/18525106/6-4m-pfizer-covid-19-vaccine-doses-to-be-distributed-across-us-within-24-hours-of-fda-approval-wa"}, {"symbol": "PFE", "publishedDate": "2020-11-24 12:37:18", "title": "Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield", "image": "https://cdn.snapi.dev/images/v1/j/r/isksk22.jpg", "site": "InvestorPlace", "text": "Pfizer looks like good value with its vaccine catalyst and dividend yield. PFE stock will be 60% higher within several years after the FDA grants EUA for its Covid-19 vaccine.", "url": "https://investorplace.com/2020/11/pfe-stock-could-be-worth-60-percent-more-once-vaccine-is-approved/"}, {"symbol": "PFE", "publishedDate": "2020-11-24 11:39:00", "title": "Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate", "image": "https://cdn.snapi.dev/images/v1/r/y/drugs33---cmgcfz29fw.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) doses the first participant in the late-stage BASIS study, currently investigating marstacimab to address severe hemophilia A or B with or without inhibitors.", "url": "https://www.zacks.com/stock/news/1111125/pfizer-pfe-begins-phase-iii-study-on-hemophilia-candidate"}, {"symbol": "PFE", "publishedDate": "2020-11-24 10:53:00", "title": "3 Coronavirus Vaccine Makers Near Finish Line in November", "image": "https://cdn.snapi.dev/images/v1/l/f/m02d20200625t2i1523586457w940fhfwllplsqrlynxmpeg5o16t.jpg", "site": "Zacks Investment Research", "text": "Positive developments related to coronavirus vaccine candidates have supported stock markets in November. Three leading coronavirus vaccine candidates achieve encouraging efficacy rate.", "url": "https://www.zacks.com/stock/news/1111005/3-coronavirus-vaccine-makers-near-finish-line-in-november"}, {"symbol": "PFE", "publishedDate": "2020-11-24 07:50:00", "title": "The Vaccines Are Almost Ready, but the Challenges Are Only Beginning", "image": "https://cdn.snapi.dev/images/v1/w/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015632fgettyimages-540123226jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Even when a coronavirus vaccine is ready, distribution could be a challenge -- but recent innovations in medical glass could benefit the public and investors alike.", "url": "https://www.fool.com/investing/2020/11/24/the-vaccines-are-almost-ready-but-the-challenges-a/"}, {"symbol": "PFE", "publishedDate": "2020-11-24 07:03:00", "title": "3 Long-Shot Coronavirus Vaccine Stocks to Watch in December", "image": "https://cdn.snapi.dev/images/v1/v/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015662fgettyimages-1242456322jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These dark horses are getting their second wind.", "url": "https://www.fool.com/investing/2020/11/24/3-long-shot-coronavirus-vaccine-stocks-to-watch-in/"}, {"symbol": "PFE", "publishedDate": "2020-11-24 06:37:00", "title": "What to Watch for Next in the Coronavirus Vaccine Race", "image": "https://cdn.snapi.dev/images/v1/x/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019882fgettyimages-1221407317jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Requests for Emergency Use Authorization and formal FDA approvals are next on the agenda.", "url": "https://www.fool.com/investing/2020/11/24/what-to-watch-for-next-in-the-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-11-24 06:05:00", "title": "Should Pfizer Shareholders Sell Their Viatris Stock?", "image": "https://cdn.snapi.dev/images/v1/2/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019422fbuysell-hold-paper-fortune-tellerjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There are several factors to consider.", "url": "https://www.fool.com/investing/2020/11/24/should-pfizer-shareholders-sell-their-viatris-stoc/"}, {"symbol": "PFE", "publishedDate": "2020-11-24 04:57:00", "title": "Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/e/f/biotech13.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is 95% effective in final analysis.", "url": "https://www.zacks.com/stock/news/1110610/pfizer-biontech-seek-nod-for-emergency-use-of-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-24 03:26:00", "title": "4 Sectors to Prosper in Thanksgiving Week", "image": "https://cdn.snapi.dev/images/v1/6/0/600petf-1.jpg", "site": "Zacks Investment Research", "text": "Back-to-back positive vaccine updates have offered sweet surprises to Wall Street from the start of the Thanksgiving month this year.", "url": "https://www.zacks.com/stock/news/1110596/4-sectors-to-prosper-in-thanksgiving-week"}, {"symbol": "PFE", "publishedDate": "2020-11-23 17:40:00", "title": "Markets Up on Sunny Holiday Outlook", "image": "https://cdn.snapi.dev/images/v1/7/h/airline7.jpg", "site": "Zacks Investment Research", "text": "The NRF announced it expects U.S. holiday shopping season to grow 5.2% year over year, based on pent-up demand and higher U.S. savings rates during the pandemic.", "url": "https://www.zacks.com/stock/news/1110490/markets-up-on-sunny-holiday-outlook"}, {"symbol": "PFE", "publishedDate": "2020-11-23 13:03:09", "title": "With Pfizer Partnership, BioNTech Stock Should Push Higher", "image": "https://cdn.snapi.dev/images/v1/o/v/biotech5.jpg", "site": "InvestorPlace", "text": "In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible. The post With Pfizer Partnership, BioNTech Stock Should Push Higher appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/with-pfizer-partnership-bntx-stock-should-push-higher/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 11:56:00", "title": "Can Coronavirus Vaccine Stocks Keep Lifting the Stock Market?", "image": "https://cdn.snapi.dev/images/v1/o/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6020232fcovid-gettyimages-1206790646jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The market woke up a little tired on Monday morning.", "url": "https://www.fool.com/investing/2020/11/23/can-coronavirus-vaccine-stocks-lift-stock-market/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 11:18:28", "title": "With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?", "image": "https://cdn.snapi.dev/images/v1/6/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5563602fpills-on-top-of-100-billjpgw700opresize.jpg", "site": "24/7 Wall Street", "text": "A COVID-19 vaccine appears to be just around the corner, and many of the companies developing drugs, cocktails, vaccines and treatments are very close to crossing the finish line.", "url": "https://247wallst.com/healthcare-business/2020/11/23/with-a-vaccine-coming-soon-where-do-these-covid-19-stocks-stand/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 10:15:00", "title": "With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?", "image": "https://cdn.snapi.dev/images/v1/k/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015622fgettyimages-1212506028jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It isn't as simple as buying stock in the most recent winners.", "url": "https://www.fool.com/investing/2020/11/23/with-2-effective-coronavirus-vaccine-candidates-ho/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 09:50:01", "title": "3 Dividend Stocks Gurus Like", "image": "https://cdn.snapi.dev/images/v1/a/y/3okjn333-4.jpg", "site": "GuruFocus", "text": "The Dividend Stocks screener at GuruFocus finds 616 dividend stocks held by the gurus as of the writing of this article. Another 19 are listed as over-the-counter stocks.", "url": "https://www.gurufocus.com/news/1294406/3-dividend-stocks-gurus-like"}, {"symbol": "PFE", "publishedDate": "2020-11-23 09:48:00", "title": "Decision on approving Pfizer-BioNTech vaccine to be made in \u2018shortest time possible,' U.K. regulator says", "image": "https://cdn.snapi.dev/images/v1/0/q/im-263561width620size15960099750623442.jpg", "site": "Market Watch", "text": "The U.K. has ordered 40 million vaccine doses from Pfizer and BioNTech \u2014 enough for up to a third of the population.", "url": "https://www.marketwatch.com/story/decision-on-approving-pfizer-biontech-vaccine-to-be-made-in-shortest-time-possible-u-k-regulator-says-11606142910"}, {"symbol": "PFE", "publishedDate": "2020-11-23 08:33:00", "title": "Could Late-Stage Coronavirus Vaccine Trials Fail?", "image": "https://cdn.snapi.dev/images/v1/d/z/podc2.jpg", "site": "The Motley Fool", "text": "Dr. Jeremy Brown says that historically, 90% of vaccine trials fail. Does this data still hold or has the game changed?", "url": "https://www.fool.com/investing/2020/11/23/could-late-stage-coronavirus-vaccine-trials-fail/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 08:18:00", "title": "Pandemic Expert Answers: 'Do You Foresee Challenges with Vaccine Distribution?'", "image": "https://cdn.snapi.dev/images/v1/z/d/podc1.jpg", "site": "The Motley Fool", "text": "Investors have questions about the cold chain, particularly for Pfizer's potential vaccine.", "url": "https://www.fool.com/investing/2020/11/23/pandemic-expert-answers-do-you-foresee-challenges/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 08:15:00", "title": "Key Tips for Buying COVID Vaccine Stocks", "image": "https://cdn.snapi.dev/images/v1/g/l/podc15.jpg", "site": "The Motley Fool", "text": "One principle is especially important.", "url": "https://www.fool.com/investing/2020/11/23/key-tips-for-buying-covid-vaccine-stocks/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 08:00:00", "title": "Ask A Virologist: What's The Timeline for Coronavirus Vaccine Distribution?", "image": "https://cdn.snapi.dev/images/v1/c/f/podc14.jpg", "site": "The Motley Fool", "text": "Dr. Angela Rasmussen answers the million-dollar question on everyone's mind.", "url": "https://www.fool.com/investing/2020/11/23/ask-a-virologist-whats-the-timeline-for-coronaviru/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 07:54:00", "title": "Thinking About Buying Coronavirus Vaccine Stocks? Watch This First", "image": "https://cdn.snapi.dev/images/v1/c/0/podc13.jpg", "site": "The Motley Fool", "text": "Dr. Jeremy Brown gives investors a helpful tip about valuation", "url": "https://www.fool.com/investing/2020/11/23/thinking-about-buying-coronavirus-vaccine-stocks-w/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 07:45:00", "title": "What Investors Need To Know About Companies Working on Coronavirus Vaccines", "image": "https://cdn.snapi.dev/images/v1/y/e/podc12.jpg", "site": "The Motley Fool", "text": "Dr. Leo Nissola shares 1 major thing investors should consider before buying coronavirus vaccine stocks.", "url": "https://www.fool.com/investing/2020/11/23/what-investors-need-to-know-about-companies-workin/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 07:11:00", "title": "Could The Coronavirus Pandemic Mean Fewer Flu Deaths This Year?", "image": "https://cdn.snapi.dev/images/v1/b/u/podc9.jpg", "site": "The Motley Fool", "text": "Dr. Jeremy Brown shares how COVID-19 will impact the seasonal flu.", "url": "https://www.fool.com/investing/2020/11/23/could-the-coronavirus-pandemic-mean-fewer-flu-deat/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 06:45:00", "title": "Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors", "image": "https://cdn.snapi.dev/images/v1/f/8/press7---iqhqj3g8pm.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (anti-TFPI) being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors. BASIS is a global Phase 3, open-label, multicenter study that will evaluate annualized bleed rate (ABR) through 12 months on prophylaxis treatment with marstacimab, an investigat", "url": "https://www.businesswire.com/news/home/20201123005602/en/Pfizer-Doses-First-Participant-in-Phase-3-Study-Evaluating-anti-TFPI-Investigational-Therapy-Marstacimab-for-People-With-Severe-Hemophilia-A-and-B-With-or-Without-Inhibitors/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 06:39:00", "title": "Is It Too Late to Get In on This Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/o/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017102fgettyimages-1179580489jpgw700opresize.jpg", "site": "The Motley Fool", "text": "This coronavirus vaccine maker started the year at $4. It's since gained more than 2,000%.", "url": "https://www.fool.com/investing/2020/11/23/is-it-too-late-to-get-in-on-this-millionaire-maker/"}, {"symbol": "PFE", "publishedDate": "2020-11-23 06:12:00", "title": "Better Buy: Gilead Sciences vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/a/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009472ftwo-test-tubesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both drugmakers are at critical crossroads with new COVID-19 programs. Which has the stronger prospects?", "url": "https://www.fool.com/investing/2020/11/23/better-buy-gilead-sciences-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 19:22:00", "title": "Americans could start receiving Pfizer vaccine 'as early as 11 December'", "image": "https://cdn.snapi.dev/images/v1/k/o/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg", "site": "Skynews", "text": "Americans could start receiving a COVID-19 vaccine as early as 11 December, according to the chief scientific adviser for the US government's vaccine programme.", "url": "https://news.sky.com/story/covid-19-americans-could-start-receiving-pfizer-vaccine-as-early-as-11-december-12139867"}, {"symbol": "PFE", "publishedDate": "2020-11-22 16:04:00", "title": "Unanswered Questions for the Top COVID Vaccines", "image": "https://cdn.snapi.dev/images/v1/n/m/podc2---k5ly8doidd.jpg", "site": "The Motley Fool", "text": "There's still a lot we don't yet know.", "url": "https://www.fool.com/investing/2020/11/22/unanswered-questions-for-the-top-covid-vaccines/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 14:01:00", "title": "Top COVID Vaccine Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/k/l/podc15.jpg", "site": "The Motley Fool", "text": "Here are ideas for both conservative and aggressive investors.", "url": "https://www.fool.com/investing/2020/11/22/top-covid-vaccine-stocks-to-buy-now/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 11:31:00", "title": "How Do Pfizer's and Moderna's COVID Vaccine Results Compare?", "image": "https://cdn.snapi.dev/images/v1/j/k/podc13.jpg", "site": "The Motley Fool", "text": "Hint: They stack up very closely.", "url": "https://www.fool.com/investing/2020/11/22/how-do-pfizers-and-modernas-covid-vaccine-results/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 09:31:00", "title": "Here's Why Moderna's Coronavirus Vaccine Could Outsell Pfizer's", "image": "https://cdn.snapi.dev/images/v1/w/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012002fgettyimages-1215061073jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Moderna's candidate is cool with being kept at warmer temperatures.", "url": "https://www.fool.com/investing/2020/11/22/heres-why-modernas-coronavirus-vaccine-could-outse/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 08:30:00", "title": "Is Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary?", "image": "https://cdn.snapi.dev/images/v1/v/v/podc10.jpg", "site": "The Motley Fool", "text": "Dr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.", "url": "https://www.fool.com/investing/2020/11/22/is-pfizer-and-biontechs-potential-mrna-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 07:46:00", "title": "Is Pfizer Stock A Good Bet On Coronavirus Vaccines?", "image": "https://cdn.snapi.dev/images/v1/8/j/podc7.jpg", "site": "The Motley Fool", "text": "Dr. Angela Rasmussen shares tips for investors thinking about buying stocks like Pfizer and Moderna.", "url": "https://www.fool.com/investing/2020/11/22/is-pfizer-stock-a-good-bet-on-coronavirus-vaccines/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 07:05:00", "title": "3 Best Pharma Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/q/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6005412fgettyimages-1214342283jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three stocks are ready to break out.", "url": "https://www.fool.com/investing/2020/11/22/3-best-pharma-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 06:53:00", "title": "Why Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for Pfizer", "image": "https://cdn.snapi.dev/images/v1/s/n/podc1.jpg", "site": "The Motley Fool", "text": "Pfizer's coronavirus vaccine candidate comes with two hurdles that might give its competitors an edge.", "url": "https://www.fool.com/investing/2020/11/22/why-ultra-cold-storage-and-two-dose-shots-could-sp/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 06:20:00", "title": "What This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19", "image": "https://cdn.snapi.dev/images/v1/k/h/podc15.jpg", "site": "The Motley Fool", "text": "Dr. Angela Rasmussen explains why news from Pfizer and Moderna's mRNA vaccine trials is so promising.", "url": "https://www.fool.com/investing/2020/11/22/what-this-virus-expert-thinks-about-mrna-vaccine-c/"}, {"symbol": "PFE", "publishedDate": "2020-11-22 06:11:00", "title": "How Big Of A Deal Is mRNA Vaccine Efficacy? Imagine If It Had Failed", "image": "https://cdn.snapi.dev/images/v1/w/u/podc14.jpg", "site": "The Motley Fool", "text": "Here's what a doctor and pandemic expert thinks about the exciting trial data coming from Pfizer and Moderna.", "url": "https://www.fool.com/investing/2020/11/22/how-big-of-a-deal-is-mrna-vaccine-efficacy-imagine/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 17:30:25", "title": "Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19", "image": "https://cdn.snapi.dev/images/v1/i/5/biotech10.jpg", "site": "InvestorPlace", "text": "Simply put, blockchain is the safest way to store and transfer information ever created, which makes it ideal for tracking vaccines. The post Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19 appeared first on InvestorPlace.", "url": "https://investorplace.com/moneywire/2020/11/the-blockchain-how-this-next-great-technology-platform-fight-covid-19/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 11:45:00", "title": "FDA to Discuss Pfizer's Coronavirus Vaccine Authorization Request in December", "image": "https://cdn.snapi.dev/images/v1/t/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018842fsales-rep-and-physician-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The group of independent experts will discuss Pfizer's request for emergency use authorization of its coronavirus vaccine candidate.", "url": "https://www.fool.com/investing/2020/11/21/fda-to-discuss-pfizers-coronavirus-vaccine-authori/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 11:30:00", "title": "Near-Term Catalysts to Watch for COVID Vaccine Stocks", "image": "https://cdn.snapi.dev/images/v1/w/h/podc9.jpg", "site": "The Motley Fool", "text": "More big news for leaders in the coronavirus vaccine race will be on the way soon.", "url": "https://www.fool.com/investing/2020/11/21/near-term-catalysts-to-watch-for-covid-vaccine-sto/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 10:00:00", "title": "A Doctor Explains: What Pfizer's Big Coronavirus Vaccine News Means", "image": "https://cdn.snapi.dev/images/v1/s/f/podc8.jpg", "site": "The Motley Fool", "text": "Here's what a pandemic expert thinks about the recent coronavirus vaccine trial data.", "url": "https://www.fool.com/investing/2020/11/21/a-doctor-explains-what-pfizers-big-coronavirus-vac/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 09:16:00", "title": "Moderna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine Winners", "image": "https://cdn.snapi.dev/images/v1/1/f/podc7.jpg", "site": "The Motley Fool", "text": "Dr. Leo Nissola explains why these two stocks are both likely winners.", "url": "https://www.fool.com/investing/2020/11/21/heres-how-this-doctor-thinks-a-covid-19-vaccine-wi/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 08:56:00", "title": "What Investors Should Look For In Vaccine Trials' Raw Data", "image": "https://cdn.snapi.dev/images/v1/b/u/podc6.jpg", "site": "The Motley Fool", "text": "Dr. Leo Nissola shares what more he wants to see from Pfizer and Moderna as they move toward submitting their potential vaccines to the FDA.", "url": "https://www.fool.com/investing/2020/11/21/what-investors-should-look-for-in-vaccine-trials-r/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 08:22:00", "title": "Ask A Virologist: How Do mRNA Vaccines Work?", "image": "https://cdn.snapi.dev/images/v1/j/r/podc5.jpg", "site": "The Motley Fool", "text": "Dr. Angela Rasmussen explains how this new class of vaccines can help prevent COVID-19.", "url": "https://www.fool.com/investing/2020/11/21/ask-a-virologist-how-do-mrna-vaccines-work/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 07:28:00", "title": "Is There Room for Latecomers to the COVID-19 Party?", "image": "https://cdn.snapi.dev/images/v1/q/f/podc3.jpg", "site": "The Motley Fool", "text": "Despite multiple treatments, vaccines, and tests for COVID-19 developed by leading competitors, Sorrento's CEO Henry Ji thinks the company still has an opportunity to thrive.", "url": "https://www.fool.com/investing/2020/11/21/is-there-room-for-latecomers-to-the-covid-19-party/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 07:03:00", "title": "3 Healthcare IPOs to Watch This Month", "image": "https://cdn.snapi.dev/images/v1/f/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6016682fipojpgw700opresize.jpg", "site": "The Motley Fool", "text": "Sotera Health, Maravai Life Sciences, and Olema Pharmaceuticals all have an Initial Public Offering with the NASDAQ this month. Are these healthcare companies worth getting excited about?", "url": "https://www.fool.com/investing/2020/11/21/3-healthcare-ipos-to-watch-this-month/"}, {"symbol": "PFE", "publishedDate": "2020-11-21 06:30:00", "title": "Ask A Doctor: What's A Realistic Prediction for When A Coronavirus Vaccine Will Be Available?", "image": "https://cdn.snapi.dev/images/v1/g/f/podc11.jpg", "site": "The Motley Fool", "text": "Dr. Jeremy Brown answers the question on everyone's mind: When will there be a COVID-19 vaccine on the market?", "url": "https://www.fool.com/investing/2020/11/21/ask-a-doctor-whats-a-realistic-prediction-for-when/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 19:41:31", "title": "Coronavirus vaccine: Pfizer and Biontech to submit emergency use authorization for vaccines", "image": "https://cdn.snapi.dev/images/v1/p/q/coronavirus-vaccine-pfizer-and-biontech-to-submit-emergency-use-authorization-for-vaccines.jpg", "site": "Yahoo Finance", "text": "Yahoo FInance's Anjalee Khemlani reports on the latest vaccine development, CDC recommends Americans avoid Thanksgiving. #coronavirus #COVID19 #vaccines Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=2vNfBb5IcK8"}, {"symbol": "PFE", "publishedDate": "2020-11-20 19:38:42", "title": "Pfizer applies for emergency use authorization for its vaccine", "image": "https://cdn.snapi.dev/images/v1/l/4/pfizer-applies-for-emergency-use-authorization-for-its-vaccine.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on the latest developments in the race to get a coronavirus vaccine to the American public. Dr. Ashish Jha, Brown University, weighs in.", "url": "https://www.youtube.com/watch?v=qIAZ8ZE3Ihk"}, {"symbol": "PFE", "publishedDate": "2020-11-20 18:08:43", "title": "Pfizer's 95% Efficacy Is Exciting, Says Ginkgo Bioworks CEO", "image": "https://cdn.snapi.dev/images/v1/k/z/pfizers-95-efficacy-is-exciting-says-ginkgo-bioworks-ceo.jpg", "site": "Bloomberg Technology", "text": "Nov.20 -- Jason Kelly, chief executive officer and co-founder at Ginkgo Bioworks Inc., discusses news of a potential vaccine to prevent Covid-19 on \"Bloomberg Technology.\"", "url": "https://www.youtube.com/watch?v=zKCBxTj0A78"}, {"symbol": "PFE", "publishedDate": "2020-11-20 17:07:22", "title": "Pfizer's Covid-19 vaccine should be relatively safe and could given to first patients in December", "image": "https://cdn.snapi.dev/images/v1/3/x/pfizers-covid-19-vaccine-should-be-relatively-safe-and-could-given-to-first-patients-in-december.jpg", "site": "CNBC Television", "text": "Dr. Scott Gottlieb says the application for Pfizer's Covid vaccine was sent today. It will take the FDA two to four weeks to review the application and the vaccine could be given to the first patients sometime in December.", "url": "https://www.youtube.com/watch?v=uWltWH42ywY"}, {"symbol": "PFE", "publishedDate": "2020-11-20 16:45:17", "title": "Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted", "image": "https://cdn.snapi.dev/images/v1/o/x/biotech5---wlgfv6mwhh.jpg", "site": "Market Watch", "text": "Pfizer Inc. and BioNTech on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine candidate, making their vaccine candidate the first in line with U.S. regulators. The two companies had said earlier Friday that the submission to the Food and Drug Administration was coming.", "url": "https://www.marketwatch.com/story/pfizer-biontech-make-it-official-covid-19-vaccine-eua-submitted-2020-11-20"}, {"symbol": "PFE", "publishedDate": "2020-11-20 15:54:19", "title": "Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst", "image": "https://cdn.snapi.dev/images/v1/m/1/syringe-866550-1920-1-7.jpg", "site": "Benzinga", "text": "The pharmaceutical industry has succeeded in doing its job in manufacturing multiple vaccines for the novel coronavirus, and it's \"now in the hands\" of government authorities to manage the distribution, Emily Field, head of European pharmaceutical research at Barclays,\u00a0Emily Field said Friday on CNBC's \"Squawk Box Europe.\" Price Not A Factor: Early indications suggest AstraZeneca plc (NASDAQ: AZN) and Johnson & Johnson's (NYSE: JNJ) vaccine will cost $3 to $5, while pricing for Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) could reach $40 on the high end.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18467156/pharma-sector-did-its-job-with-covid-19-vaccine-barclays-analyst"}, {"symbol": "PFE", "publishedDate": "2020-11-20 15:15:55", "title": "GOP senator in Pfizer trial urges trust in Covid vaccines: 'This is how we bring an end to this pandemic'", "image": "https://cdn.snapi.dev/images/v1/x/w/106666814-1597688425659-gettyimages-1225248702-gop-dc-state398-070120.jpeg", "site": "CNBC", "text": "\"It reminded me of getting the flu shot. It was virtually painless, the vaccine itself,\" Republican Sen.", "url": "https://www.cnbc.com/2020/11/20/covid-vaccine-pfizer-trial-participant-sen-steve-daines-urges-trust.html"}, {"symbol": "PFE", "publishedDate": "2020-11-20 13:11:00", "title": "Coronavirus: WHO advises against remdesivir for COVID-19, Pfizer and Biontech file EUA for vaccines", "image": "https://cdn.snapi.dev/images/v1/j/v/coronavirus-who-advises-against-remdesivir-for-covid-19-pfizer-and-biontech-file-eua-for-vaccines.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the World Health Organization advising against treating COVID-19 with remdesivir and Pfizer and Biontech filing for emergency use authorization. #coronavirus #COVID19 #coronavirusvaccine Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=XiAxtNX1VeE"}, {"symbol": "PFE", "publishedDate": "2020-11-20 12:52:10", "title": "BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA", "image": "https://cdn.snapi.dev/images/v1/n/j/biotech40.jpg", "site": "Investors Business Daily", "text": "Shares of BioNTech and Pfizer rose after the pharmaceutical companies announced they would submit their coronavirus vaccine to U.S. regulators Friday, the first drugmakers to seek approval. The post BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pfizer-stock-biontech-stock-rise-coronavirus-vaccine-submission-fda-approval/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 11:46:00", "title": "Why Pfizer and BioNTech Stocks Rose Today", "image": "https://cdn.snapi.dev/images/v1/c/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017452fcoronavirus-vaccine-gettyimages-1205966780jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Emergency Use Authorization could pave the way for a rapid rollout of their coronavirus vaccine.", "url": "https://www.fool.com/investing/2020/11/20/why-pfizer-and-biontech-stocks-rose-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 11:26:00", "title": "Capitol Report: Trump to announce rules to lower drug prices", "image": "https://cdn.snapi.dev/images/v1/i/m/im-262881width620size15005861664712778.jpg", "site": "Market Watch", "text": "President Donald Trump on Friday is expected to announce two rules intended to lower U.S. drug prices, as he continues to contest the results of the Nov. 3 election.", "url": "https://www.marketwatch.com/story/trump-to-announce-rules-to-lower-drug-prices-11605889605"}, {"symbol": "PFE", "publishedDate": "2020-11-20 11:24:00", "title": "Pfizer and BioNTech Will Ask the FDA to Authorize Their Coronavirus Vaccine Today", "image": "https://cdn.snapi.dev/images/v1/q/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017202fgettyimages-1210736764jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Emergency Use Authorization could enable shipments to high-risk populations in the U.S. in December.", "url": "https://www.fool.com/investing/2020/11/20/pfizer-and-biontech-will-ask-the-fda-to-authorize/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 10:57:14", "title": "University of Iowa Hospital & Clinics CEO on Pfizer vaccine authorization request", "image": "https://cdn.snapi.dev/images/v1/9/p/university-of-iowa-hospital-clinics-ceo-on-pfizer-vaccine-authorization-request.jpg", "site": "CNBC Television", "text": "Suresh Gunasekaran, University of Iowa Hospitals and Clinics CEO, joins CNBC's \"Squawk on the Street\" to discuss the coronavirus infection rate in Iowa and the state's plans to distribute Pfizer's Covid-19 vaccine, once approved.", "url": "https://www.youtube.com/watch?v=CajHrWRRpX8"}, {"symbol": "PFE", "publishedDate": "2020-11-20 10:28:03", "title": "Operation Warp Speed chief on Pfizer applying for emergency authorization for Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/7/w/operation-warp-speed-chief-on-pfizer-applying-for-emergency-authorization-for-covid-19-vaccine.jpg", "site": "CNBC Television", "text": "Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. Dr. Moncef Slaoui, Operation Warp Speed's chief science advisor, joins \"Squawk on the Street\" to discuss.", "url": "https://www.youtube.com/watch?v=98GvOadKJo8"}, {"symbol": "PFE", "publishedDate": "2020-11-20 09:18:23", "title": "Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval (PFE, BNTX)", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-biontech-gain-after-saying-theyll-submit-their-covid-19-vaccine-to-the-fda-for-emergency-approval.jpg", "site": "Business Insider", "text": "Pfizer and BioNTech gained on Friday after saying they would submit their COVID-19 vaccine candidate to the FDA today for Emergency Use Authorization. Phase III trial results released earlier this month were encouraging, with the vaccine demonstrating an efficacy rate of 95% in a trial with 44,000 participants.\u00a0", "url": "https://www.businessinsider.com/pfizer-biontech-stock-price-coronavirus-vaccine-fda-emergency-authorization-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-20 08:36:06", "title": "Pfizer, BioNTech File First For Emergency Use Authorization Of Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/u/y/medicine-5103043-1920-26.jpg", "site": "Benzinga", "text": "Signaling that Pfizer Inc. (NYSE: PFE) and BioNTech SE \u2013 ADR (NASDAQ: BNTX) are\u00a0nearing\u00a0the finish line, the companies announced plans Friday\u00a0to apply for emergency use authorization for the\u00a0coronavirus vaccine candidate BNT162b2. First To File: The filing means the vaccine could be available for high-risk populations in the U.S. by the middle or end of December.", "url": "https://www.benzinga.com/general/biotech/20/11/18464284/pfizer-biontech-file-first-for-emergency-use-authorization-of-coronavirus-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-20 08:13:49", "title": "What Emergency FDA Authorization Means for Covid-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/m/q/what-emergency-fda-authorization-means-for-covid-19-vaccine.jpg", "site": "Bloomberg Markets and Finance", "text": "Nov.20 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz offers insight into emergency authorization of a vaccine as Pfizer Inc. and BioNTech SE plan to file Friday for use of their coronavirus vaccine in December. He speaks with Bloomberg's Francine Lacqua on \u201cBloomberg Surveillance.", "url": "https://www.youtube.com/watch?v=vfEaapJk2hM"}, {"symbol": "PFE", "publishedDate": "2020-11-20 08:13:34", "title": "Pfizer, BioNTech To Seek Emergency Approval For Covid-19 Vaccine On Friday", "image": "https://cdn.snapi.dev/images/v1/m/v/pfizer-biontech-to-seek-emergency-approval-for-covid-19-vaccine-on-friday.jpg", "site": "Forbes", "text": "Clinical trials show the vaccine to be 95% effective at preventing Covid-19.", "url": "https://www.forbes.com/sites/roberthart/2020/11/20/pfizer-biontech-to-seek-emergency-approval-for-covid-19-vaccine-on-friday/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 08:01:00", "title": "Warren Buffett Just Bought These Stocks", "image": "https://cdn.snapi.dev/images/v1/d/h/dhdy22.jpg", "site": "The Motley Fool", "text": "Berkshire Hathaway's 13-F filing shows the Oracle of Omaha's bullish on healthcare.", "url": "https://www.fool.com/investing/2020/11/20/warren-buffett-just-bought-these-stocks/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:55:42", "title": "Pharma industry has 'done it's job' on Covid vaccine, Barclays says", "image": "https://cdn.snapi.dev/images/v1/i/l/pharma-industry-has-done-its-job-on-covid-vaccine-barclays-says.jpg", "site": "CNBC International TV", "text": "Barclays Head of European Pharmaceutical Research Emily Field speaks about the pharmaceutical industry's efforts to produce a Covid-19 vaccine.", "url": "https://www.youtube.com/watch?v=SqubFGjgj4s"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:46:35", "title": "Pfizer to request emergency FDA approval for its COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/4/p/pfizer-22jpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer and BioNTech said they will ask the feds for emergency approval of their experimental coronavirus vaccine on Friday.", "url": "https://nypost.com/2020/11/20/pfizer-to-request-emergency-fda-approval-for-its-covid-19-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:45:00", "title": "Pfizer/BioNTech to seek emergency authorization of Covid-19 vaccine Friday", "image": "https://cdn.snapi.dev/images/v1/m/x/im-262745width620size15005861664712778.jpg", "site": "Market Watch", "text": "Pfizer/BioNTech said they intend to submit applications to other regulatory agencies worldwide in coming days.", "url": "https://www.marketwatch.com/story/pfizer-biontech-to-seek-emergency-authorization-of-covid-19-vaccine-friday-11605876318"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:44:31", "title": "Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today", "image": "https://cdn.snapi.dev/images/v1/k/q/gettyimages-1229685402jpgw600.jpg", "site": "TechCrunch", "text": "Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. Pfizer and BioNTech, who revealed earlier this week that their vaccine was 95% effective based on Phase [\u2026]", "url": "https://techcrunch.com/2020/11/20/pfizer-and-biontech-to-submit-request-for-emergency-use-approval-of-their-covid-19-vaccine-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:40:29", "title": "Pfizer COVID-19 vaccine: The timeline now that FDA emergency use has been requested", "image": "https://cdn.snapi.dev/images/v1/6/a/p-1-pfizer-covid-19-vaccine-the-timeline-now-that-fda-emergency-use-requested.jpg", "site": "Fast Company", "text": "However, even if the EUA is granted, the chances of the average American receiving Pfizer's COVID-19 vaccine in 2020 is slim. Just days after announcing their COVID-19 vaccine has an efficacy rating of at least 95%, Pfizer has announced that they plan to ask the Food and Drug Administration for emergency use authorization (EUA) today, reports CNBC.", "url": "https://www.fastcompany.com/90578562/pfizer-covid-19-vaccine-the-timeline-now-that-fda-emergency-use-requested"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:19:45", "title": "BioNTech, Pfizer say they plan to submit COVID-19 vaccine application on Friday", "image": "https://cdn.snapi.dev/images/v1/g/2/biotech22---2dqgiilwn6.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. gained 1.4% in premarket trading on Friday after it announced plans with BioNTech to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine candidate. BioNTech's stock jumped 6.9% before the market opened.", "url": "https://www.marketwatch.com/story/biontech-pfizer-say-they-plan-to-submit-covid-19-vaccine-application-on-friday-2020-11-20"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:08:49", "title": "Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people", "image": "https://cdn.snapi.dev/images/v1/a/v/ave3---t3anm1u4uy.jpg", "site": "Business Insider", "text": "Pfizer and BioNTech will on Friday ask regulators to sign off on the emergency use of their coronavirus vaccine, a step that could allow the shot to be given more widely. Pfizer said Friday that it was preparing to file for an emergency use authorization with the US Food and Drug Administration, days after announcing that the vaccine was 95% effective at preventing COVID-19 in a late-stage trial.", "url": "https://www.businessinsider.com/pfizer-coronavirus-vaccine-filed-for-emergency-authorization-with-fda-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:05:00", "title": "Pfizer applies for U.S. emergency use for COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/y/1/m02d20201120t2i1541888667w940fhfwllplsqrlynxmpegaj0mm.jpg", "site": "Reuters", "text": "Pfizer Inc said on Friday it has applied to U.S. health regulators for emergency use authorization (EUA) of its COVID-19 vaccine, a major step toward providing protection against the new coronavirus for pandemic-weary Americans.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-applies-for-u-s-emergency-use-for-covid-19-vaccine-idUSKBN2801BT"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:03:04", "title": "Pfizer, Moderna COVID-19 Vaccines Could Get Limited EU Approval Before Year-End: Report", "image": "https://cdn.snapi.dev/images/v1/g/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5989662fgettyimages-1213501739jpgw700opresize.jpg", "site": "Benzinga", "text": "In an attempt to \u201csynchronize\u201d COVID-19 vaccine distribution at par with the U.S., the European Union is deliberating the idea of granting\u00a0\u00a0Pfizer Inc\u00a0(NYSE: PFE)-BioNTech SE\u00a0(NASDAQ:\u00a0BNTX) and\u00a0Moderna Inc\u00a0(NASDAQ:\u00a0MRNA), a conditional marketing authorization,\u00a0Bloomberg reports. What Happened: The European authority is holding constant talks with the U.S. Food and Drug Administration to evaluate and assess the vaccine's efficacy, Ursula von der Leyen, President of the European Commission, told Bloomberg.", "url": "https://www.benzinga.com/general/biotech/20/11/18460619/pfizer-moderna-covid-19-vaccines-could-get-limited-eu-approval-before-year-end-report"}, {"symbol": "PFE", "publishedDate": "2020-11-20 07:02:24", "title": "Pfizer and BioNTech to request emergency authorization from FDA for Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/l/m/pfizer-and-biontech-to-request-emergency-authorization-from-fda-for-covid-19-vaccine.jpg", "site": "CNBC Television", "text": "Pfizer and BioNTech will apply for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=aBcokz5fBN0"}, {"symbol": "PFE", "publishedDate": "2020-11-20 06:57:13", "title": "Pfizer and BioNTech to request emergency authorization from FDA for Covid-19 vaccine.", "image": "https://cdn.snapi.dev/images/v1/k/y/106788079-16049431642020-11-05t095723z-1430031187-rc2xwj91w57a-rtrmadp-0-china-trade-expo.jpeg", "site": "CNBC", "text": "The FDA process is expected to take a few weeks, and an advisory committee meeting to review the vaccine\u00a0has been tentatively scheduled\u00a0for early December.", "url": "https://www.cnbc.com/2020/11/20/covid-19-vaccine-pfizer-will-apply-for-fda-emergency-use-authorization.html"}, {"symbol": "PFE", "publishedDate": "2020-11-20 06:47:00", "title": "Doctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus Vaccines", "image": "https://cdn.snapi.dev/images/v1/u/z/podc14.jpg", "site": "The Motley Fool", "text": "Dr. Jeremy Brown knows a lot about pandemics. Here's what he thinks about the exciting trial data coming from Pfizer and BioNTech.", "url": "https://www.fool.com/investing/2020/11/20/doctor-and-pandemic-expert-shares-what-investors-n/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 06:45:00", "title": "Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/6/n/press3---o0ebskvavg.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end of December 2020. The submission is based on a vaccine efficacy rate of 95% (p", "url": "https://www.businesswire.com/news/home/20201120005370/en/Pfizer-and-BioNTech-to-Submit-Emergency-Use-Authorization-Request-Today-to-the-U.S.-FDA-for-COVID-19-Vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-11-20 06:14:00", "title": "Pfizer requests emergency authorisation for coronavirus vaccine in US", "image": "https://cdn.snapi.dev/images/v1/9/s/skynews-pfizer-coronavirus-5167467jpg20201110092122.jpg", "site": "Skynews", "text": "Pfizer and BioNTech are submitting an emergency authorisation request in the US which could allow its coronavirus vaccine to be used to treat high-risk populations in the country by mid-December.", "url": "https://news.sky.com/story/covid-19-pfizer-requests-emergency-authorisation-for-coronavirus-vaccine-in-us-12137091"}, {"symbol": "PFE", "publishedDate": "2020-11-20 01:04:00", "title": "Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - source", "image": "https://cdn.snapi.dev/images/v1/k/m/m02d20201120t2i1541856540w940fhfwllplsqrlynxmpegaj087.jpg", "site": "Reuters", "text": "The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.", "url": "https://www.reuters.com/article/us-health-coronavirus-eu-pfizer-exclusiv/exclusive-eu-could-pay-over-10-billion-for-pfizer-and-curevac-vaccines-source-idUSKBN2800IC"}, {"symbol": "PFE", "publishedDate": "2020-11-19 22:35:51", "title": "Pfizer, Moderna to file FDA COVID-19 vaccine emergency usage as soon as Friday", "image": "https://cdn.snapi.dev/images/v1/r/n/biotech19---w7s3ayfzbv.jpg", "site": "Fox Business", "text": "FDA approval for emergency usage is the first step to getting the COVID-19 vaccine to the public.", "url": "https://www.foxbusiness.com/markets/pfizer-covid-november-20-2020"}, {"symbol": "PFE", "publishedDate": "2020-11-19 18:12:49", "title": "Jefferies Jared Holz lays out why you should be cautious on vaccine stocks", "image": "https://cdn.snapi.dev/images/v1/m/q/jefferies-jared-holz-lays-out-why-you-should-be-cautious-on-vaccine-stocks.jpg", "site": "CNBC Television", "text": "Jared Holz from Jefferies on vaccine news and new risks for biotech. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Dan Nathan and Bonawyn Eison", "url": "https://www.youtube.com/watch?v=s4D8mxfUPJo"}, {"symbol": "PFE", "publishedDate": "2020-11-19 17:49:25", "title": "HHS Secretary Azar says Pfizer is expected to file FDA application for coronavirus vaccine Friday with Moderna soon to follow", "image": "https://cdn.snapi.dev/images/v1/n/e/106799927-1605825796975-gettyimages-1229686231-afp-8vj3nw.jpeg", "site": "CNBC", "text": "Health and Human Services Secretary Alex Azar said Thursday that Pfizer is expected to file an application to the FDA for emergency use of its coronavirus vaccine on Friday, with Moderna soon to follow.", "url": "https://www.cnbc.com/2020/11/19/hhs-chief-says-pfizer-is-expected-to-file-fda-application-for-coronavirus-vaccine-friday.html"}, {"symbol": "PFE", "publishedDate": "2020-11-19 16:51:20", "title": "Maravai IPO: What Investors Should Know About Pfizer/BioNTech COVID-19 Vaccine Partner", "image": "https://cdn.snapi.dev/images/v1/o/u/vaccine-4892017-1920-6.jpg", "site": "Benzinga", "text": "Maravai Life Sciences Holdings (NASDAQ:MRVI) will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on selling 50 million shares at a price point of $24 to $27.", "url": "https://www.benzinga.com/news/20/11/18456768/maravai-ipo-what-investors-should-know-about-pfizerbiontech-covid-19-vaccine-partner"}, {"symbol": "PFE", "publishedDate": "2020-11-19 15:09:55", "title": "4 Stocks To Sell If Covid-19 Hurts Oil Demand Again", "image": "https://cdn.snapi.dev/images/v1/d/2/d2efg3334---namxgnszr4.jpg", "site": "InvestorPlace", "text": "Another wave of Covid-19 could result in a double-dip recession, hurting leveraged oil companies. Put these on your list of stocks to sell.", "url": "https://investorplace.com/2020/11/4-stocks-to-sell-if-covid-19-hurts-oil-demand-again/"}, {"symbol": "PFE", "publishedDate": "2020-11-19 14:45:39", "title": "7 Growth Stocks to Buy as We Head Into 2021", "image": "https://cdn.snapi.dev/images/v1/d/y/software36.jpg", "site": "InvestorPlace", "text": "Growth stocks have been in favor since the lows in March. Let's look at a few that are worth buying on the latest pullback.", "url": "https://investorplace.com/2020/11/7-growth-stocks-to-buy-as-we-head-into-2021/"}, {"symbol": "PFE", "publishedDate": "2020-11-19 14:33:00", "title": "What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data", "image": "https://cdn.snapi.dev/images/v1/z/s/drugs37.jpg", "site": "Zacks Investment Research", "text": "Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in the coronavirus vaccine development.", "url": "https://www.zacks.com/stock/news/1105757/what-lies-ahead-for-pfizer-etfs-after-another-round-of-upbeat-vaccine-data"}, {"symbol": "PFE", "publishedDate": "2020-11-19 12:38:37", "title": "3 5G Stocks to Stream Profits into Your Portfolio in 2021", "image": "https://cdn.snapi.dev/images/v1/o/w/biotech10---ctt6cehgs0.jpg", "site": "InvestorPlace", "text": "Amidst the confusion in the world today, we know on fact for sure: Everyone wants 5G. Therefore 5G stocks belong in investor portfolios.", "url": "https://investorplace.com/2020/11/3-5g-stocks-to-stream-profits-into-your-portfolio-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-11-19 10:03:00", "title": "Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%", "image": "https://cdn.snapi.dev/images/v1/9/7/biotech5.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 95% effective in final analysis.", "url": "https://www.zacks.com/stock/news/1105322/pfizer-biontech-covid-19-vaccine-shows-final-efficacy-of-95"}, {"symbol": "PFE", "publishedDate": "2020-11-19 08:14:00", "title": "What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?", "image": "https://cdn.snapi.dev/images/v1/k/z/drugs30.jpg", "site": "Zacks Investment Research", "text": "Pfizer, Inc. (PFE), BioNTech SE (BNTX), Eli Lilly and Company (LLY), AstraZeneca plc (AZN), Moderna, Inc. (MRNA) and Gilead Sciences, Inc. (GILD) are leading the race to come up with a vaccine for coronavirus.", "url": "https://www.zacks.com/stock/news/1105044/what-awaits-pharma-giants-in-last-lap-of-covid-19-vaccine-race"}, {"symbol": "PFE", "publishedDate": "2020-11-19 07:00:00", "title": "Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China", "image": "https://cdn.snapi.dev/images/v1/o/s/press19---wl8czozvch.jpg", "site": "Business Wire", "text": "NEW YORK & SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--Pfizer, Inc. (NYSE: PFE) and LianBio announced today that they have entered into a collaboration aimed at developing and commercializing transformative pharmaceutical products in Greater China. LianBio, founded by Perceptive Advisors, forged a collaboration with Pfizer to pursue an innovative business development opportunity. Both companies will be dedicated to advancing best-in-class therapies for patients, leveraging both LianBio's and P", "url": "https://www.businesswire.com/news/home/20201119005290/en/Pfizer-and-LianBio-Announce-Strategic-Collaboration-to-Expand-Development-of-Novel-Therapeutics-in-Greater-China/"}, {"symbol": "PFE", "publishedDate": "2020-11-19 06:56:45", "title": "Morgan Stanley's Matthew Harrison on new vaccine data", "image": "https://cdn.snapi.dev/images/v1/m/q/morgan-stanleys-matthew-harrison-on-new-vaccine-data.jpg", "site": "CNBC Television", "text": "Matthew Harrison, Analyst at Morgan Stanley, joins Worldwide Exchange on the heels of vaccine data from Oxford, to discuss the space and the race for a cure.", "url": "https://www.youtube.com/watch?v=bW-LGpy-HOM"}, {"symbol": "PFE", "publishedDate": "2020-11-19 06:45:00", "title": "Results from Phase 3 CROWN Trial of Pfizer's LORBRENA\u00ae (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine", "image": "https://cdn.snapi.dev/images/v1/0/4/press4.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 CROWN trial of LORBRENA\u00ae (lorlatinib, available in Europe under the brand name LORVIQUA\u00ae) versus XALKORI\u00ae (crizotinib) in people with previously untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) were published online ahead of print in the New England Journal of Medicine. At a planned interim analysis, LORBRENA treatment resulted in statistically significant an", "url": "https://www.businesswire.com/news/home/20201119005392/en/Results-from-Phase-3-CROWN-Trial-of-Pfizer%E2%80%99s-LORBRENA%C2%AE-lorlatinib-in-Previously-Untreated-ALK-Positive-Lung-Cancer-Published-in-the-New-England-Journal-of-Medicine/"}, {"symbol": "PFE", "publishedDate": "2020-11-19 06:08:00", "title": "Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?", "image": "https://cdn.snapi.dev/images/v1/q/i/pfizer-covid-vaccine-457x274.jpg", "site": "The Motley Fool", "text": "For some investors, the answer is \"yes.\"", "url": "https://www.fool.com/investing/2020/11/19/is-pfizer-a-smart-coronavirus-stock-to-buy-after-m/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 15:45:40", "title": "Coronavirus vaccine: Pfizer to apply for emergency use authorization for vaccine", "image": "https://cdn.snapi.dev/images/v1/0/m/coronavirus-vaccine-pfizer-to-apply-for-emergency-use-authorization-for-vaccine.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the latest news in vaccine development. #Pfizer #Moderna #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=l_0uyLFzNsc"}, {"symbol": "PFE", "publishedDate": "2020-11-18 15:30:00", "title": "BioNTech says vaccine approval possible in mid-December under ideal conditions", "image": "https://cdn.snapi.dev/images/v1/4/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5965132fboy-receiving-a-vaccinejpgw700opresize.jpg", "site": "Reuters", "text": "U.S. and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of positive trial results.", "url": "https://www.reuters.com/article/us-health-coronavirus-biontech-approval/biontech-says-vaccine-approval-possible-in-mid-december-under-ideal-conditions-idUSKBN27Y2NB"}, {"symbol": "PFE", "publishedDate": "2020-11-18 15:17:58", "title": "Pfizer Provides More Details on Vaccine & Seeks FDA Emergency Authorization", "image": "https://cdn.snapi.dev/images/v1/r/m/pfizer-provides-more-details-on-vaccine-seeks-fda-emergency-authorization.jpg", "site": "Cheddar", "text": "Stocks moved higher on news that Pfizer is reporting its vaccine has 95 percent effectiveness in preventing the coronavirus and that it plans to submit to the FDA in days. Michael Jones, Chairman & CEO at Caravel Concepts, an investment planning software company, joined Cheddar to discuss.", "url": "https://www.youtube.com/watch?v=Z_C1aM37N0U"}, {"symbol": "PFE", "publishedDate": "2020-11-18 14:11:00", "title": "New Data Shows Higher Efficacy Rate for Pfizer and BioNTech Coronavirus Vaccine Candidate", "image": "https://cdn.snapi.dev/images/v1/1/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6014302fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The two companies plan to submit BNT162b2 for Emergency Use Authorization in the very near future.", "url": "https://www.fool.com/investing/2020/11/18/new-data-reveals-pfizer-and-biontechs-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 13:55:08", "title": "Pfizer Inc. (PFE) Management on 2nd Annual Wolfe Research Healthcare Conference (Transcript)", "image": "https://cdn.snapi.dev/images/v1/w/u/transcript18---vgtgifgztf.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) Management on 2nd Annual Wolfe Research Healthcare Conference (Transcript)", "url": "https://seekingalpha.com/article/4390083-pfizer-inc-pfe-management-on-2nd-annual-wolfe-research-healthcare-conference-transcript"}, {"symbol": "PFE", "publishedDate": "2020-11-18 13:43:59", "title": "Pfizer, BioNTech Filing Planned as Vaccine Proves 95% Effective", "image": "https://cdn.snapi.dev/images/v1/h/5/pfizer-biontech-filing-planned-as-vaccine-proves-95-effective.jpg", "site": "Bloomberg Markets and Finance", "text": "Nov.18 -- Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was 95% effective in a final-analysis trial. Bloomberg Intelligence's Sam Fazeli has the details on \u201cBloomberg Surveillance.", "url": "https://www.youtube.com/watch?v=2DVoO_pshF0"}, {"symbol": "PFE", "publishedDate": "2020-11-18 13:39:52", "title": "Mike Pence Falsely Gives Credit To Trump For Pfizer Vaccine Success", "image": "https://cdn.snapi.dev/images/v1/o/j/mike-pence-falsely-gives-credit-to-trump-for-pfizer-vaccine-success.jpg", "site": "Forbes", "text": "Pfizer has repeatedly said its vaccine research and development is \u201centirely self-funded.\u201d", "url": "https://www.forbes.com/sites/roberthart/2020/11/18/mike-pence-falsely-gives-credit-to-trump-for-pfizer-vaccine-success/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 12:14:16", "title": "BioNTech Will Apply in U.S. For Emergency Use of Covid Vaccine", "image": "https://cdn.snapi.dev/images/v1/g/y/biontech-will-apply-in-us-for-emergency-use-of-covid-vaccine.jpg", "site": "Bloomberg Markets and Finance", "text": "Nov.18 -- Pfizer and partner BioNTech SE say their Covid-19 vaccine was 95% effective in clinical trials. They will now apply for emergency use authorization in the U.S. BioNTech SE's Chief Executive Officer\u00a0Ugur Sahin\u00a0appears on \"Bloomberg Markets.", "url": "https://www.youtube.com/watch?v=NUlPue7Wd4k"}, {"symbol": "PFE", "publishedDate": "2020-11-18 11:35:00", "title": "Here's What's Bumping BioNTech Stock Higher Today", "image": "https://cdn.snapi.dev/images/v1/s/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6014162fphysician-holding-a-vaccine-shotjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There's more good news regarding the biotech's coronavirus vaccine candidate.", "url": "https://www.fool.com/investing/2020/11/18/heres-whats-bumping-biontech-stock-higher-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 10:56:04", "title": "Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial", "image": "https://cdn.snapi.dev/images/v1/3/3/biotech28.jpg", "site": "24/7 Wall Street", "text": "The COVID-19 vaccine duo, Pfizer Inc. (NYSE: PFE) and BioNTech S.E.", "url": "https://247wallst.com/healthcare-business/2020/11/18/pfizer-and-biontech-conclude-late-stage-covid-19-trial/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 10:36:59", "title": "Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?", "image": "https://cdn.snapi.dev/images/v1/v/4/biotech26.jpg", "site": "InvestorPlace", "text": "With a new Covid vaccine update today, how do the Moderna and Pfizer coronavirus vaccines compare? Dive in here.", "url": "https://investorplace.com/2020/11/covid-vaccine-update-moderna-and-pfizer-coronavirus-vaccines-compare/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 10:30:05", "title": "Coronavirus vaccine: Pfizer says vaccine is safe and 95% effective", "image": "https://cdn.snapi.dev/images/v1/g/s/coronavirus-vaccine-pfizer-says-vaccine-is-safe-and-95-effective.jpg", "site": "Yahoo Finance", "text": "Dr. C\u00e9line Gounder Clinical Assistant Professor of Infectious Diseases and member of President-elect Joe Biden's COVID-19 advisory board discusses vaccine development, and the importance taking measures to reduce the spread of COVID-19 with Yahoo Finance's Myles Udland. #Coronavirusvaccine #COVID19vaccine #Pfizer #Moderna Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=8ndW9cKr6lY"}, {"symbol": "PFE", "publishedDate": "2020-11-18 10:18:29", "title": "Pfizer, BioNTech Stocks Rise After Final Vaccine Update", "image": "https://cdn.snapi.dev/images/v1/j/0/biotech23.jpg", "site": "Schaeffers Research", "text": "Once again,\u00a0Pfizer Inc.\u00a0(NYSE:PFE) and\u00a0BioNTech SE (NASDAQ:BNTX)\u00a0are dominating headlines, after the two drugmakers announced their coronavirus vaccine candidate was 95% effective as its final result.", "url": "https://www.schaeffersresearch.com/content/news/2020/11/18/pfizer-biontech-stocks-rise-after-final-vaccine-update"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:52:08", "title": "LIVE | Boeing, Pfizer Fly Higher: Jim Cramer's Market Breakdown Nov. 18", "image": "https://cdn.snapi.dev/images/v1/l/g/live-boeing-pfizer-fly-higher-jim-cramers-market-breakdown-nov-18.jpg", "site": "The Street", "text": "In Wednesday's market, Jim Cramer talks Pfizer, Boeing, Lowe's and Apple and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet", "url": "https://www.youtube.com/watch?v=9-3lukWodRI"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:38:20", "title": "Target, Boeing, Pfizer Lead Stock Market Gains As Vaccine Rally Resumes", "image": "https://cdn.snapi.dev/images/v1/d/c/target-boeing-pfizer-lead-stock-market-gains-as-vaccine-rally-resumes.jpg", "site": "Forbes", "text": "Pfizer says it will apply for an emergency use authorization from the FDA within days.", "url": "https://www.forbes.com/sites/jonathanponciano/2020/11/18/stock-market-gains-target-boeing-pfizer-vaccine-rally/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:28:25", "title": "Pfizer, Moderna Vaccines Show Promise for mRNA: Johns Hopkins", "image": "https://cdn.snapi.dev/images/v1/a/2/pfizer-moderna-vaccines-show-promise-for-mrna-johns-hopkins.jpg", "site": "Bloomberg Markets and Finance", "text": "Nov.18 -- Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses fast authorization for coronavirus vaccines from Pfizer Inc. and Moderna Inc. She speaks on \"Bloomberg Surveillance.\" The Bloomberg School of Public Health is supported by Michael R.", "url": "https://www.youtube.com/watch?v=rt-9LgdDYek"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:13:00", "title": "Pfizer says analysis shows 3.8% of participants experienced fatigue", "image": "https://cdn.snapi.dev/images/v1/e/3/m02d20201118t2i1541637949w940fhfwllplsqrlynxmpegah149.jpg", "site": "Reuters", "text": "Pfizer Inc on Tuesday updated its analysis of the safety profile of its COVID-19 vaccine seen during its large, late-stage trial, saying that 3.8% of participants experienced fatigue after receiving a second dose of the shot.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-safety/pfizer-says-analysis-shows-3-8-of-participants-experienced-fatigue-idUSKBN27Y1XM"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:04:31", "title": "Pfizer's coronavirus shot is 95% effective", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizers-coronavirus-shot-is-95-effective.jpg", "site": "Business Insider", "text": "Hello, In an update Wednesday, Pfizer and its partner BioNTech said their coronavirus vaccine was 95% effective at preventing COVID-19, after a larger analysis of 170 cases of the disease seen in the study.", "url": "https://www.businessinsider.com/business-insider-biggest-healthcare-stories-for-november-1-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-18 09:00:00", "title": "Factbox: Development of Pfizer-BioNTech coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/g/g/m02d20201118t2i1541636034w940fhfwllplsqrlynxmpegah137.jpg", "site": "Reuters", "text": "Drugmaker Pfizer said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, and that it would apply for emergency U.S. authorization within days.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-fa/factbox-development-of-pfizer-biontech-coronavirus-vaccine-idUSKBN27Y1WA"}, {"symbol": "PFE", "publishedDate": "2020-11-18 08:45:46", "title": "Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-and-biontech-climb-as-95-vaccine-effectiveness-tees-up-application-for-fda-approval.jpg", "site": "Business Insider", "text": "Pfizer and BioNTech gained in early Wednesday trading after the companies announced their experimental coronavirus vaccine was 95% effective at protecting patients against COVID-19. The updated figure comes from final analysis of trial data. Preliminary results\u00a0released\u00a0on November 9 showed the drug to be 90% effective in the nearly 44,000-person trial. The newest information clears the way for Pfizer and BioNTech to apply for emergency-use authorization from the Food and Drug Administration in a matter of days.", "url": "https://www.businessinsider.com/pfizer-biontech-stock-price-coronavirus-vaccine-trial-effectiveness-fda-authorization-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-18 08:28:57", "title": "Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks last quarter. He's been teasing a bet on the sector for more than 20 years", "image": "https://cdn.snapi.dev/images/v1/w/a/warren-buffetts-berkshire-hathaway-plowed-more-than-5-billion-into-4-pharma-stocks-last-quarter-hes-been-teasing-a-bet-on-the-sector-for-more-than-20-years.jpg", "site": "Business Insider", "text": "Warren Buffett's Berkshire Hathaway plowed more than $5 billion in total into AbbVie, Bristol Myers Squibb, Merck, and Pfizer in the third quarter. Close followers of the company won't be surprised, as Buffett has been mulling a bet on the pharmaceutical sector for more than 20 years. \"You could've just bought the whole industry and done very well,\" the famed investor said at Berkshire's annual shareholder meeting in 1997. He was referring to the downturn in drug stocks in the early 1990s, sparked by President Bill Clinton's proposed healthcare reforms. \"We didn't do it. It was a mistake.\"", "url": "https://www.businessinsider.com/warren-buffett-berkshire-hathaway-buy-4-pharma-stocks-20-years-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-18 08:20:27", "title": "Pfizer-BioNTech Plan Vaccine Emergency Use Filing Within Days After Final Analysis Confirm Efficacy, Safety", "image": "https://cdn.snapi.dev/images/v1/a/c/vaccine-5074670-1920-17.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) andBioNTech SE \u2013 ADR (NASDAQ: BNTX) have managed to stay ahead in the vaccine race by a hair's breadth. Within days after\u00a0Moderna Inc (NASDAQ: MRNA) released its first interim analysis, the U.S.-German combo announced results from the final analysis of their late-stage study of their jointly-developed mRNA vaccine, codenamed BNT162b2.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18425383/pfizer-biontech-plan-vaccine-emergency-use-filing-within-days-after-final-analysis-"}, {"symbol": "PFE", "publishedDate": "2020-11-18 08:10:51", "title": "Barron's Daily: Are Pfizer and Boeing pointing a path back to normal?", "image": "https://cdn.snapi.dev/images/v1/e/i/im-261568width620size15.jpg", "site": "Market Watch", "text": "Barron's Daily: Are Pfizer and Boeing pointing a path back to normal?", "url": "https://www.marketwatch.com/articles/pfizers-covid-vaccine-boeings-737-max-and-signs-of-life-returning-to-normal-51605704033"}, {"symbol": "PFE", "publishedDate": "2020-11-18 08:07:00", "title": "Futures Movers: Oil surges on vaccine prospects after Pfizer says candidate is 95% effective", "image": "https://cdn.snapi.dev/images/v1/c/y/im-241658width620size15628815628815629.jpg", "site": "Market Watch", "text": "Oil futures add to gains Wednesday after Pfizer Inc. says its COVID-19 vaccine candidate was more than 95% effective.", "url": "https://www.marketwatch.com/story/oil-surges-on-vaccine-prospects-after-pfizer-says-candidate-is-95-effective-11605704841"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:57:59", "title": "Pfizer COVID-19 vaccine update: Final results shows it's 95% effective, too", "image": "https://cdn.snapi.dev/images/v1/u/d/p-1-pfizer-covid-19-vaccine-update-final-results-shows-itand8217s-95-effective-too.jpg", "site": "Fast Company", "text": "But don't let your COVID-19 guard down yet. There's still a long way to go before most people will receive the vaccine.", "url": "https://www.fastcompany.com/90577025/pfizer-covid-19-vaccine-update-final-results-shows-its-95-effective-too"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:54:00", "title": "Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizers-and-modernas-vaccines-likely-work-for-all-existing-coronavirus-strains-dont-worry-about-mutations-for-now-scientists-say.jpg", "site": "Business Insider", "text": "Don't worry about mutated strains of the coronavirus, experts say \u2014 the leading vaccine candidates should protect you against every version of the virus they've seen. Moderna and Pfizer each announced this month that their coronavirus vaccines prevent COVID-19 \u2014 the former's is 94.5% effective, while the latter's is 90%. Both companies hope to get approval from the FDA in the coming weeks.", "url": "https://www.businessinsider.com/coronavirus-vaccines-should-work-for-all-strains-mutations-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:37:07", "title": "Pfizer's COVID-19 vaccine 95% effective in final results, company to seek approval within days", "image": "https://cdn.snapi.dev/images/v1/s/t/104685035-m-740x416.jpg", "site": "Fox Business", "text": "The companies said they have collected the two months of safety data on about 19,000 study subjects requested by the U.S. Food and Drug Administration.", "url": "https://www.foxbusiness.com/markets/pfizers-covid-19-vaccine-95-effective-in-final-results-company-to-seek-approval-within-days"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:27:02", "title": "Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soon", "image": "https://cdn.snapi.dev/images/v1/q/l/im-261569width620size15005861664712778.jpg", "site": "Market Watch", "text": "Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soon", "url": "https://www.marketwatch.com/story/pfizer-says-it-will-seek-u-s-emergency-use-authorization-within-days-for-coronavirus-vaccine-01605702946"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:22:00", "title": "Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization", "image": "https://cdn.snapi.dev/images/v1/v/e/m02d20201118t2i1541623973w940fhfwllplsqrlynxmpegah0um.jpg", "site": "Reuters", "text": "Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-ends-covid-19-trial-with-95-efficacy-to-seek-emergency-use-authorization-idUSKBN27Y1GM"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:21:00", "title": "Moderna's and Pfizer's Vaccine News May Signal a Market Top", "image": "https://cdn.snapi.dev/images/v1/y/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011452fdoctor-giving-vaccine-flu-shot-to-senior-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Great news for humanity might not be such excellent news for Wall Street.", "url": "https://www.fool.com/investing/2020/11/18/moderna-and-pfizer-vaccine-may-signal-a-market-top/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:17:00", "title": "Instant View: Pfizer ends COVID-19 trial with 95% efficacy", "image": "https://cdn.snapi.dev/images/v1/g/z/m02d20201118t2i1541628501w940fhfwllplsqrlynxmpegah0wg.jpg", "site": "Reuters", "text": "Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-in/instant-view-pfizer-ends-covid-19-trial-with-95-efficacy-idUSKBN27Y1K4"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:13:09", "title": "Pfizer-BioNTech Says Covid-19 Vaccine Is 95% Effective, Will Seek Emergency Approval Within Days", "image": "https://cdn.snapi.dev/images/v1/s/n/pfizer-biontech-says-covid-19-vaccine-is-95-effective-will-seek-emergency-approval-within-days.jpg", "site": "Forbes", "text": "It comes after Moderna announced interim data from Phase 3 trials showed its vaccine candidate to be 94.5% effective.", "url": "https://www.forbes.com/sites/roberthart/2020/11/18/pfizer-biontech-says-covid-19-vaccine-is-95-effective-will-seek-emergency-approval-within-days/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:04:14", "title": "Pfizer says full vaccine results indicate its Covid-19 vaccine is 95% effective", "image": "https://cdn.snapi.dev/images/v1/3/d/pfizer-says-full-vaccine-results-indicate-its-covid-19-vaccine-is-95-effective.jpg", "site": "CNBC Television", "text": "Pfizer and BioNTech said Wednesday that a final data analysis found their coronavirus vaccine was 95% effective in preventing Covid-19 and, in addition, appeared to fend off severe disease. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=W9Xb61Ik7no"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:04:00", "title": "2 Reasons Why Moderna's Coronavirus Vaccine Candidate Just Took the Lead Away from Pfizer", "image": "https://cdn.snapi.dev/images/v1/w/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011732fgettyimages-1127763296jpgw700opresize.jpg", "site": "The Motley Fool", "text": "In this close race, Moderna offers a key data point -- and a logistical advantage.", "url": "https://www.fool.com/investing/2020/11/18/2-reasons-why-modernas-coronavirus-vaccine-candida/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 07:02:17", "title": "Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis", "image": "https://cdn.snapi.dev/images/v1/a/5/gettyimages-1229654222jpgw600.jpg", "site": "TechCrunch", "text": "Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a 90% effectiveness metric based on [\u2026]", "url": "https://techcrunch.com/2020/11/18/pfizer-says-its-covid-19-vaccine-is-95-effective-in-final-clinical-trial-results-analysis/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:59:00", "title": "Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints", "image": "https://cdn.snapi.dev/images/v1/a/k/press6---1xx5bhanxs.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study's primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p", "url": "https://www.businesswire.com/news/home/20201118005595/en/Pfizer-and-BioNTech-Conclude-Phase-3-Study-of-COVID-19-Vaccine-Candidate-Meeting-All-Primary-Efficacy-Endpoints/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:55:00", "title": "The Motley Fool Sits Down With A Doctor About Pfizer's Coronavirus Vaccine News", "image": "https://cdn.snapi.dev/images/v1/b/m/podc6.jpg", "site": "The Motley Fool", "text": "Dr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.", "url": "https://www.fool.com/investing/2020/11/18/the-motley-fool-sits-down-with-a-doctor-about-pfiz/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:46:08", "title": "Pfizer says final data analysis shows Covid vaccine is 95% effective \u2013 plans to submit to FDA in 'days'", "image": "https://cdn.snapi.dev/images/v1/k/x/106791886-1605096960804-gettyimages-1229031575.jpg", "site": "CNBC", "text": "Pfizer and BioNTech said final analysis found coronavirus vaccine was 95% effective in preventing Covid-19 and appeared to fend off severe disease.", "url": "https://www.cnbc.com/2020/11/18/coronavirus-pfizer-vaccine-is-95percent-effective-plans-to-submit-to-fda-in-days.html"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:45:00", "title": "Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorize the shot", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-says-its-coronavirus-vaccine-is-95-effective-as-it-gears-up-to-ask-the-fda-to-authorize-the-shot.jpg", "site": "Business Insider", "text": "On November 9, the world learned that Pfizer's coronavirus vaccine is highly effective.\u00a0 Even though details were sparse in that release, the news that the vaccine was highly protective against COVID-19 showed a potential exit path from this pandemic.\u00a0", "url": "https://www.businessinsider.com/pfizer-says-coronavirus-vaccine-effective-will-submit-to-fda-eua-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:23:00", "title": "Pfizer CEO says COVID-19 vaccine candidate has passed FDA safety milestone", "image": "https://cdn.snapi.dev/images/v1/n/a/drugs19.jpg", "site": "Market Watch", "text": "Pfizer Inc. Chief Executive Albert Bourla said the company and its partner BioNTech SE have passed the minimum two-month follow-up that the U.S. Food and Drug Administration requires as a safety milestone to obtain emergency use authorization for its COVID-19 vaccine candidate, according to media reports. Bourla made the comment at New York Times and STAT summits on Tuesday.", "url": "https://www.marketwatch.com/story/pfizer-ceo-says-covid-19-vaccine-candidate-has-passed-fda-safety-milestone-2020-11-18"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:08:00", "title": "Here's Exactly Why Warren Buffett Loaded Up on Big Pharma Stocks", "image": "https://cdn.snapi.dev/images/v1/e/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011112fwarren-buffett-tmfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Oracle of Omaha and his investing lieutenants knew what they were doing in buying AbbVie, BMS, Merck, and Pfizer.", "url": "https://www.fool.com/investing/2020/11/18/heres-exactly-why-warren-buffett-loaded-up-on-big/"}, {"symbol": "PFE", "publishedDate": "2020-11-18 06:00:00", "title": "Pfizer vaccine 95% effective and will be submitted for authorisation 'within days'", "image": "https://cdn.snapi.dev/images/v1/a/p/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg", "site": "Skynews", "text": "The Pfizer-BioNTech vaccine has now proved 95% effective in preventing coronavirus and has met the safety criteria needed for emergency authorisation, the firms have said.", "url": "https://news.sky.com/story/covid-19-pfizer-biontech-vaccine-now-95-effective-and-will-be-submitted-for-authorisation-within-days-12135473"}, {"symbol": "PFE", "publishedDate": "2020-11-17 18:57:04", "title": "Pfizer May File for Emergency Authorization of Coronavirus Vaccine Within the Week", "image": "https://cdn.snapi.dev/images/v1/3/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012992fcoronavirus-vaccine-gettyimages-1210736764jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The drugmaker is at the vanguard of the global battle against COVID-19.", "url": "https://www.fool.com/investing/2020/11/17/pfizer-may-file-for-emergency-authorization-of-cor/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 15:54:46", "title": "Pfizer's Pilot Program For Vaccine Distribution In 4 States: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/h/u/medicine-5103043-1920-25.jpg", "site": "Benzinga", "text": "Pfizer, Inc. (NYSE: PFE) shares, which came under selling pressure Monday in response to positive news on a rival vaccine candidate from Moderna, Inc. (NASDAQ: MRNA), were rebounding Tuesday after Pfizer unveiled an action plan to distribute its COVID-19 vaccine candidate upon successful regulatory clearance. What Happened: Pfizer announced the U.S. COVID-19 Immunization Pilot Program, which will facilitate delivery and deployment of BNT162b2, the investigational vaccine it is co-developing with German biopharma BioNTech SE \u2013 ADR (NASDAQ: BNTX).", "url": "https://www.benzinga.com/general/biotech/20/11/18405875/pfizers-pilot-program-for-vaccine-distribution-in-4-states-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2020-11-17 14:30:21", "title": "Pfizer Inc. initiates Covid-19 vaccine shipment trial", "image": "https://cdn.snapi.dev/images/v1/4/s/pfe2.jpg", "site": "The Dog of Wall Street", "text": "The company has selected Texas, New Mexico, Tennessee, and Rhode Island for the pilot program", "url": "https://thedogofwallstreet.com/pfe/pfizer-inc-initiates-covid-19-vaccine-shipment-trial"}, {"symbol": "PFE", "publishedDate": "2020-11-17 13:21:09", "title": "Warren Buffett makes big investment in US pharmaceutical firms", "image": "https://cdn.snapi.dev/images/v1/5/1/5173jpgwidth460quality85autoformatfitmaxse847f4895082da26e2565294d5ec2ea2.jpg", "site": "The Guardian", "text": "Berkshire Hathaway bought $5.7bn worth of shares in four companies in third quarter", "url": "https://www.theguardian.com/business/2020/nov/17/warren-buffett-makes-big-investment-in-us-pharmaceutical-firms"}, {"symbol": "PFE", "publishedDate": "2020-11-17 13:16:05", "title": "Pfizer To Test Covid-19 Vaccine Delivery Program In Four States", "image": "https://cdn.snapi.dev/images/v1/d/s/pfizer-to-test-covid-19-vaccine-delivery-program-in-four-states.jpg", "site": "Forbes", "text": "The company hopes to preemptively tackle any distribution problems caused by the ultra-cold storage requirements of the vaccine.", "url": "https://www.forbes.com/sites/roberthart/2020/11/17/pfizer-to-test-covid-19-vaccine-delivery-program-in-four-states/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 12:30:00", "title": "Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.'s (PFE) Directors and Officers for Breach of Fiduciary Duties", "image": "https://cdn.snapi.dev/images/v1/p/r/press17---uwebrwr7bw.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)-- #PFE--Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.'s (PFE) Directors and Officers for Breach of Fiduciary Duties", "url": "https://www.businesswire.com/news/home/20201117006048/en/ScottScott-Attorneys-at-Law-LLP-Investigates-Pfizer-Inc.%E2%80%99s-PFE-Directors-and-Officers-for-Breach-of-Fiduciary-Duties/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 12:28:00", "title": "Despite Buffett Bullishness, Stock Markets Are Falling", "image": "https://cdn.snapi.dev/images/v1/5/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012052fbuffett-image-biggerjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Find out what the Oracle of Omaha's company has been buying lately.", "url": "https://www.fool.com/investing/2020/11/17/despite-buffett-bullishness-stock-markets-are-fall/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 11:54:28", "title": "Has Buffett Become an Expert on Big Pharma?", "image": "https://cdn.snapi.dev/images/v1/d/n/drugs37.jpg", "site": "GuruFocus", "text": "Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) filed its 13F report for the third quarter on Monday this week. The announcement revealed that the Oracle of Omaha made some exciting changes to his portfolio during the reported period, including several investments in pharmaceutical companies.", "url": "https://www.gurufocus.com/news/1288599/has-buffett-become-an-expert-on-big-pharma"}, {"symbol": "PFE", "publishedDate": "2020-11-17 10:48:00", "title": "How two companies sprinted ahead in extraordinary race for a COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg", "site": "Reuters", "text": "Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission:", "url": "https://www.reuters.com/article/us-health-coronavirus-pfizer-vaccine-ins/how-two-companies-sprinted-ahead-in-extraordinary-race-for-a-covid-vaccine-idUSKBN27X25J"}, {"symbol": "PFE", "publishedDate": "2020-11-17 10:23:00", "title": "Moderna's (MRNA) Coronavirus Vaccine Progress Hurts Pfizer", "image": "https://cdn.snapi.dev/images/v1/m/c/biotech40.jpg", "site": "Zacks Investment Research", "text": "Moderna's (MRNA) coronavirus vaccine candidate seems to be more effective and its logistics less onerous than Pfizer and BioNTech's candidate.", "url": "https://www.zacks.com/stock/news/1102508/modernas-mrna-coronavirus-vaccine-progress-hurts-pfizer"}, {"symbol": "PFE", "publishedDate": "2020-11-17 10:16:00", "title": "Pfizer Launching Coronavirus Immunization Pilot Program in the U.S.", "image": "https://cdn.snapi.dev/images/v1/6/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011492fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg", "site": "The Motley Fool", "text": "The four states involved won't be getting COVID-19 vaccine doses early. They will be helping develop systems to ensure that the vaccine is distributed efficiently.", "url": "https://www.fool.com/investing/2020/11/17/pfizer-launching-coronavirus-immunization-pilot-pr/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 10:10:41", "title": "7 Pharmaceutical Stocks to Buy for 2021 and Beyond\u00a0", "image": "https://cdn.snapi.dev/images/v1/f/r/drugs13.jpg", "site": "InvestorPlace", "text": "Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives.", "url": "https://investorplace.com/2020/11/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 09:35:00", "title": "Pfizer (PFE), BioNTech Fall After Moderna COVID-19 Vaccine Data", "image": "https://cdn.snapi.dev/images/v1/r/m/biotech38.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech's (BNTX) stocks decline after Moderna COVID-19 vaccine candidate proves 94.5% effective and can be stored at standard refrigerator temperature.", "url": "https://www.zacks.com/stock/news/1102461/pfizer-pfe-biontech-fall-after-moderna-covid-19-vaccine-data"}, {"symbol": "PFE", "publishedDate": "2020-11-17 09:15:00", "title": "Better Coronavirus Vaccine: Moderna's mRNA-1273 or Pfizer and BioNTech's BNT162b2?", "image": "https://cdn.snapi.dev/images/v1/i/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011232fvaccination-syringejpgw700opresize.jpg", "site": "The Motley Fool", "text": "It's a two-horse race -- for now.", "url": "https://www.fool.com/investing/2020/11/17/better-coronavirus-vaccine-modernas-mrna-1273-or-p/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 08:00:00", "title": "3 Stocks to Win Big as Race for Coronavirus Vaccine Heats Up", "image": "https://cdn.snapi.dev/images/v1/m/b/biotech32.jpg", "site": "Zacks Investment Research", "text": "Coronavirus vaccine race is now at its peak following Moderna's (MRNA) 94.5% effective vaccine in Phase 3 trials. Pfizer (PFE) also bragged about the effectiveness of its vaccine to be more than 90%.", "url": "https://www.zacks.com/stock/news/1102330/3-stocks-to-win-big-as-race-for-coronavirus-vaccine-heats-up"}, {"symbol": "PFE", "publishedDate": "2020-11-17 07:53:00", "title": "The Huge Technology News That Went Totally Under the Radar on Monday", "image": "https://cdn.snapi.dev/images/v1/s/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010882fgettyimages-1256532426jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Moderna's vaccine data gobbled up headlines, but there was also big news for semiconductors.", "url": "https://www.fool.com/investing/2020/11/17/the-huge-technology-news-that-went-totally-under-t/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 07:18:00", "title": "Stocks Are Soaring. Here's What to Do as an Investor.", "image": "https://cdn.snapi.dev/images/v1/f/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010182fwoman-pointing-to-graphs-on-computer-screens-gettyimages-1170740969jpgw700opresize.jpg", "site": "The Motley Fool", "text": "High stock prices make for a challenge, but here's how to capitalize.", "url": "https://www.fool.com/investing/2020/11/17/stocks-are-soaring-heres-what-to-do-as-an-investor/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 07:13:00", "title": "AbbVie, Merck, and Pfizer shares jump after Warren Buffett's Berkshire Hathaway reveals it bought them last quarter", "image": "https://cdn.snapi.dev/images/v1/a/b/abbvie-merck-and-pfizer-shares-jump-after-warren-buffetts-berkshire-hathaway-reveals-it-bought-them-last-quarter.jpg", "site": "Business Insider", "text": "AbbVie, Merck, Bristol Myers Squibb, and Pfizer are the latest beneficiaries of the \"Buffett Effect.\" The quartet of pharmaceutical stocks jumped in pre-market trading on Tuesday after Warren Buffett's Berkshire Hathaway revealed on Monday that it invested in them last quarter. AbbVie, Merck, and Pfizer gained as much as 2%, and BMS rose as much as 3%, whereas benchmark S&P futures slid around 0.5%.", "url": "https://www.businessinsider.com/abbvie-merck-pfizer-stock-price-warren-buffett-berkshire-hathaway-pharmaceuticals-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-17 06:45:00", "title": "2 Top Coronavirus Stocks to Watch in November", "image": "https://cdn.snapi.dev/images/v1/v/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6008662fgettyimages-1221692768jpgw700opresize.jpg", "site": "The Motley Fool", "text": "As vaccine hype fades, Pfizer and BioNTech are on the cusp of a breakout -- but will they suceed?", "url": "https://www.fool.com/investing/2020/11/17/2-top-coronavirus-stocks-to-watch-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 06:15:00", "title": "This 1 Factor May Limit the Reach of Pfizer's Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/z/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6007542fgettyimages-1230863267jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Pfizer's vaccine candidate is on the path to being first to market. But one element may keep it from becoming a market leader.", "url": "https://www.fool.com/investing/2020/11/17/this-1-factor-may-limit-the-reach-of-pfizers-coron/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 06:04:00", "title": "3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or Moderna", "image": "https://cdn.snapi.dev/images/v1/i/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009362fmrna-vaccine-vial-on-palmjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Great efficacy results for mRNA COVID-19 vaccines so far could bode well for these three stocks.", "url": "https://www.fool.com/investing/2020/11/17/3-mrna-coronavirus-vaccine-stocks-to-check-out-tha/"}, {"symbol": "PFE", "publishedDate": "2020-11-17 05:41:52", "title": "Buffett's Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management27---v1uayxzxlp.jpg", "site": "InvestorPlace", "text": "Warren Buffett is ditching bank stocks and loading up on drug makers, according to Berkshire Hathaway's latest regulatory filing. The post Buffett's Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/buffets-berkshire-hathaway-stock-buys-new-stakes-in-vaccine-makers-cut-banks/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 22:06:00", "title": "Pfizer to start pilot program for COVID-19 immunization in four U.S. states", "image": "https://cdn.snapi.dev/images/v1/x/u/m02d20201117t2i1541441079w940fhfwllplsqrlynxmpegag04n.jpg", "site": "Reuters", "text": "Pfizer Inc said on Monday it was starting a pilot program for COVID-19 immunization in four U.S. states to help refine the plan for the delivery and deployment of its vaccine candidate.", "url": "https://www.reuters.com/article/us-health-coronavirus-usa-pfizer/pfizer-to-start-pilot-program-for-covid-19-immunization-in-four-u-s-states-idUSKBN27X09A"}, {"symbol": "PFE", "publishedDate": "2020-11-16 21:39:45", "title": "Warren Buffett's Berkshire Bets On These Four Drugmakers Amid Pandemic", "image": "https://cdn.snapi.dev/images/v1/x/x/6212237872-e74dd4f049-o.jpg", "site": "Benzinga", "text": "Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) Chairman Warren Buffett has invested in four large drugmakers as the world faces yet another wave of the raging COVID-19 pandemic. What Happened: Regulatory filings made with the United States Securities and Exchange Commission reveal that the legendary investor picked up shares worth nearly $136 million in drugmaker Pfizer Inc (NYSE: PFE) in the latest quarter.", "url": "https://www.benzinga.com/general/biotech/20/11/18398427/warren-buffetts-berkshire-bets-on-these-four-drugmakers-amid-pandemic"}, {"symbol": "PFE", "publishedDate": "2020-11-16 19:22:48", "title": "Both Moderna and Pfizer will file for FDA authorization as next step", "image": "https://cdn.snapi.dev/images/v1/z/b/both-moderna-and-pfizer-will-file-for-fda-authorization-as-next-step.jpg", "site": "CNBC Television", "text": "CNBC's senior health and science correspondent Meg Tirrell says it's very meaningful to have two Covid-19 vaccines, one from Pfizer and another one from Moderna that have well over 90 percent efficacy rates. She joins Shep Smith to discuss the next steps in accelerating these vaccines to the market.", "url": "https://www.youtube.com/watch?v=VLdKcf2BSAk"}, {"symbol": "PFE", "publishedDate": "2020-11-16 18:54:44", "title": "Warren Buffett Bought 4 Pharma Giants in Q3", "image": "https://cdn.snapi.dev/images/v1/9/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011182fwarren-buffett-4-tmf-may-2014jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Oracle of Omaha and his team opened new positions in the underperforming sector.", "url": "https://www.fool.com/investing/2020/11/16/warren-buffett-bought-4-pharma-giants-in-q3/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 18:27:33", "title": "Moderna Vaccine Had Decade Head Start Over Pfizer: Chairman", "image": "https://cdn.snapi.dev/images/v1/o/q/moderna-vaccine-had-decade-head-start-over-pfizer-chairman.jpg", "site": "Bloomberg Technology", "text": "Nov.16 -- Moderna Inc. reported its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial. Noubar Afeyan, Moderna co-founder and chairman, discusses the company's new data, distribution, plan for emergency use authorization and its advantage over a vaccine by Pfizer Inc. Afeyan spoke with Bloomberg's Emily Chang.", "url": "https://www.youtube.com/watch?v=DuJcMWwROZA"}, {"symbol": "PFE", "publishedDate": "2020-11-16 17:39:35", "title": "Warren Buffett Buys 6 Stocks in 3rd Quarter, Dumps Costco", "image": "https://cdn.snapi.dev/images/v1/z/y/st23-1.jpg", "site": "GuruFocus", "text": "Warren Buffett (Trades, Portfolio)'s $545.8 billion conglomerate, Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B), disclosed its equity portfolio for the third quarter of 2020 on Monday.", "url": "https://www.gurufocus.com/news/1287807/warren-buffett-buys-6-stocks-in-3rd-quarter-dumps-costco"}, {"symbol": "PFE", "publishedDate": "2020-11-16 17:28:14", "title": "Warren Buffett's Berkshire Hathaway makes big bets on drug stocks", "image": "https://cdn.snapi.dev/images/v1/j/w/200221091117-warren-buffett-1013-file-super-169.jpg", "site": "CNN Business", "text": "Warren Buffett's Berkshire Hathaway is making a big bet on the health care sector at a time when the Covid-19 pandemic continues to be a major crisis in the United States.", "url": "https://www.cnn.com/2020/11/16/investing/warren-buffett-berkshire-hathaway-drug-stocks/index.html"}, {"symbol": "PFE", "publishedDate": "2020-11-16 16:30:15", "title": "Warren Buffett's Berkshire Hathaway reveals stakes in AbbVie, Merck, Pfizer, and other 'big pharma' stocks", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs25---ifdb3um7ds.jpg", "site": "Business Insider", "text": "Warren Buffett's Berkshire Hathaway invested in AbbVie, Bristol-Myers Squibb, Merck, and Pfizer in the third quarter. The billionaire investor's company disclosed the new holdings in a regulatory filing on Monday. Berkshire boasted stakes worth more than $1.8 billion in each of AbbVie, Bristol Myers Squibb, and Merck as of September 30. It also owned $136 million of Pfizer stock. Buffett and his team also trimmed their Apple stake, which is easily the most valuable holding in their stock portfolio. Visit Business Insider's homepage for more stories. Warren Buffett's Berkshire Hathaway plowed billions of dollars into Pfizer, Merck, and other pharmaceutical stocks in the third quarter, a regulatory filing revealed on Monday.", "url": "https://www.businessinsider.com/warren-buffett-berkshire-hathaway-invests-pfizer-merck-abbvie-pharmaceutical-stocks-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-16 16:17:00", "title": "Buffett's Berkshire invests in several big drugmakers", "image": "https://cdn.snapi.dev/images/v1/t/2/m02d20201116t2i1541413016w940fhfwllplsqrlynxmpegaf1kl.jpg", "site": "Reuters", "text": "Warren Buffett's Berkshire Hathaway Inc said on Monday it has begun investing in four large drugmakers.", "url": "https://www.reuters.com/article/us-investment-funds-berkshire/buffetts-berkshire-invests-in-several-big-drugmakers-idUSKBN27W2TS"}, {"symbol": "PFE", "publishedDate": "2020-11-16 16:16:27", "title": "5 Bank Stocks to Buy for the Covid-19 Vaccine Recovery", "image": "https://cdn.snapi.dev/images/v1/d/z/bank12---0amclwtvww.jpg", "site": "InvestorPlace", "text": "Thanks to favorable Covid-19 vaccine developments, the stage is set for bank stocks to rebound in a big way in 2021. The post 5 Bank Stocks to Buy for the Covid-19 Vaccine Recovery appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/bank-stocks-to-buy-covid-19-vaccine-recovery/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 11:39:00", "title": "Pfizer shares drop as Moderna vaccine seen easier to distribute", "image": "https://cdn.snapi.dev/images/v1/a/m/m02d20201116t2i1541382658w940fhfwllplsqrlynxmpegaf171.jpg", "site": "Reuters", "text": "Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-ho/pfizer-shares-drop-as-moderna-vaccine-seen-easier-to-distribute-idUSKBN27W276"}, {"symbol": "PFE", "publishedDate": "2020-11-16 11:34:00", "title": "Why Pfizer, BioNTech, and Novavax Stocks Are Sinking Today", "image": "https://cdn.snapi.dev/images/v1/f/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010062fholding-coronavirus-vaccine-bottlesjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors are worried that Moderna's good news could be bad news for these coronavirus vaccine leaders.", "url": "https://www.fool.com/investing/2020/11/16/why-pfizer-biontech-and-novavax-stocks-are-sinking/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 10:59:13", "title": "Former FDA Commissioner Says Pandemic Could \u2018Effectively End In 2021' If Pfizer, Moderna Vaccines Live Up To Early Data", "image": "https://cdn.snapi.dev/images/v1/j/m/former-fda-commissioner-says-pandemic-could-effectively-end-in-2021-if-pfizer-moderna-vaccines-live-up-to-early-data.jpg", "site": "Forbes", "text": "Early data has indicated Pfizer's vaccine could be up to 90% effective and Moderna's could be more than 94% effective.", "url": "https://www.forbes.com/sites/elanagross/2020/11/16/former-fda-commissioner-says-pandemic-could-effectively-end-in-2021-if-pfizer-moderna-vaccines-live-up-to-early-data/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 09:29:20", "title": "WHO Chief Warns Vaccine Won't End Covid-19 Pandemic As Moderna, Pfizer Announce Early Successes", "image": "https://cdn.snapi.dev/images/v1/j/3/who-chief-warns-vaccine-wont-end-covid-19-pandemic-as-moderna-pfizer-announce-early-successes.jpg", "site": "Forbes", "text": "The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.", "url": "https://www.forbes.com/sites/roberthart/2020/11/16/who-chief-warns-vaccine-wont-end-covid-19-pandemic-as-moderna-pfizer-announce-early-successes/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 09:22:09", "title": "HHS Secretary Azar says the FDA will move 'as quickly as possible' to clear Moderna and Pfizer's Covid vaccines", "image": "https://cdn.snapi.dev/images/v1/g/j/106756463-1603370248431-gettyimages-1229208330-azar-redfield-cdc.jpeg", "site": "CNBC", "text": "HHS Secretary Alex Azar said Monday that the FDA will move \"as quickly as possible\" to issue an authorization for Covid-19 vaccines from Pfizer and Moderna.", "url": "https://www.cnbc.com/2020/11/16/coronavirus-hhs-secretary-azar-says-fda-will-move-as-quickly-as-possible-to-ok-moderna-and-pfizers-vaccines.html"}, {"symbol": "PFE", "publishedDate": "2020-11-16 09:21:49", "title": "Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-and-astrazeneca-slide-as-modernas-rival-covid-19-vaccine-shows-strong-efficacy.jpg", "site": "Business Insider", "text": "Another round of strong COVID-19 vaccine data, this time from Moderna, has put pressure on pharmaceutical companies developing their own vaccine, namely Pfizer, BioNTech, and AstraZeneca. On Monday, Moderna said its late-stage trial evaluating a COVID-19 vaccine candidate demonstrated efficacy of 94.5%, putting the company on track to receive emergency use authorization from the FDA by the end of this year.", "url": "https://www.businessinsider.com/pfizer-astrazeneca-stock-price-moderna-covid19-vaccine-shows-strong-efficacy-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-16 08:44:00", "title": "This Household Brand Name Just Tripled Profits and Raised Its Dividend. Time to Buy?", "image": "https://cdn.snapi.dev/images/v1/i/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009182fgettyimages-1209015108jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The video game vendor is firing on all cylinders, but will it last?", "url": "https://www.fool.com/investing/2020/11/16/this-household-brand-name-just-tripled-its-profits/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 08:31:31", "title": "BioNTech, Pfizer stocks fall after upbeat news on Moderna's COVID-19 vaccine candidate", "image": "https://cdn.snapi.dev/images/v1/4/x/biotech37.jpg", "site": "Market Watch", "text": "Shares of BioNTech SE dropped 5.9% in premarket trading Monday, and Pfizer Inc.'s stock fell 1.7%, after Moderna Inc. said its COVID-19 vaccine candidate can be stored at standard refrigerator temperatures for 30 days, while BioNTech's and Pfizer's vaccine needed to be stored at \"ultra-low\" temperatures. In addition, Moderna's candidate demonstrated an efficacy rate that may be higher than the BioNTech's and Pfizer's vaccine candidate.", "url": "https://www.marketwatch.com/story/biontech-pfizer-stocks-fall-after-upbeat-news-on-modernas-covid-19-vaccine-candidate-2020-11-16"}, {"symbol": "PFE", "publishedDate": "2020-11-16 08:18:29", "title": "Pfizer (PFE) and the Headline Effect", "image": "https://cdn.snapi.dev/images/v1/w/h/pfizer-56b002a05f9b58b7d01f655b.jpg", "site": "Investopedia", "text": "Pfizer's (PFE) vaccine announcement caused euphoria in the market, but sober second thoughts are now setting in.", "url": "https://www.investopedia.com/pfizer-and-the-headline-effect-5087757"}, {"symbol": "PFE", "publishedDate": "2020-11-16 07:30:00", "title": "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan", "image": "https://cdn.snapi.dev/images/v1/3/i/press9---e7pkcant6o.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, \u201cWe are proud to have completed the combination of Upjohn and Mylan to create Viatris and pleased to have delivered value to our shareholders through this transaction. I want to express my gratitude to our Upjohn colleagues for their dedicati", "url": "https://www.businesswire.com/news/home/20201116005378/en/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 07:06:00", "title": "Dangerous Coronavirus Vaccine Myths: Scientific Expert Explains The Truth", "image": "https://cdn.snapi.dev/images/v1/3/1/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "The Lancet's Richard Horton says we have to renegotiate our relationship with the virus and find a peaceful coexistence.", "url": "https://www.fool.com/investing/2020/11/16/dangerous-coronavirus-vaccine-myths-scientific-exp/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 06:31:00", "title": "Coronavirus Expert on mRNA Vaccines Versus The Old Fashioned Approach", "image": "https://cdn.snapi.dev/images/v1/g/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955382fsyringe-and-needle-on-top-of-calendarjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Editor-in-Chief of the British medical journal The Lancet explains why Pfizer and Moderna's approach is revolutionary.", "url": "https://www.fool.com/investing/2020/11/16/coronavirus-expert-on-mrna-vaccines-versus-the-old/"}, {"symbol": "PFE", "publishedDate": "2020-11-16 04:44:41", "title": "The creator of the Pfizer-BioNTech vaccine says life could return to normal by next winter", "image": "https://cdn.snapi.dev/images/v1/q/3/106797189-1605519286495-gettyimages-1188140352-urn-newsml-dpa-com-20090101-191213-99-123106-2.jpeg", "site": "CNBC", "text": "Professor Ugur Sahin, co-founder and chief executive of BioNTech, also suggested the coronavirus vaccine could halve transmission of the virus.", "url": "https://www.cnbc.com/2020/11/16/coronavirus-biontech-ceo-says-life-could-return-to-normal-next-winter.html"}, {"symbol": "PFE", "publishedDate": "2020-11-15 14:31:00", "title": "How Long Will It Take for Coronavirus Vaccines to Help the U.S. Move Past the Pandemic?", "image": "https://cdn.snapi.dev/images/v1/7/z/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "Vaccines probably won't be a quick fix.", "url": "https://www.fool.com/investing/2020/11/15/how-long-will-it-take-for-coronavirus-vaccines-to/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 12:33:16", "title": "Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO", "image": "https://cdn.snapi.dev/images/v1/d/e/dew2w3e3---ziqctr4yxo.jpg", "site": "Seeking Alpha", "text": "Innoforce, a Hangzhou company, formed a JV with Thermo Fisher Scientific to build a large biologics and steriles drug development and manufacturing facility in the Hangzhou Airport Economic Demonstration Area. Decheng Capital had good reason to be pleased when Merck paid $2.75 billion to acquire VelosBio, a company formed in 2017 to develop ROR1 ADCs for cancer.", "url": "https://seekingalpha.com/article/4389122-week-in-review-remegen-yantai-biologics-company-completes-515-million-hong-kong-ipo"}, {"symbol": "PFE", "publishedDate": "2020-11-15 09:04:12", "title": "Emirates working with Pfizer, others on vaccine transport \u2018challenge'", "image": "https://cdn.snapi.dev/images/v1/i/0/105715107-1549037812276gettyimages-1055511710.jpeg", "site": "CNBC", "text": "Emirates said it was working with Pfizer on the complex logistics of transporting its vaccine to the world.", "url": "https://www.cnbc.com/2020/11/15/emirates-working-with-pfizer-others-on-vaccine-transport-challenge-.html"}, {"symbol": "PFE", "publishedDate": "2020-11-15 09:00:00", "title": "Coronavirus Vaccine Stocks: How Long Will COVID-19 Immunity Last?", "image": "https://cdn.snapi.dev/images/v1/0/u/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "This big question will have significant impacts on dosing, reentering society, and how often people will need vaccinations.", "url": "https://www.fool.com/investing/2020/11/15/coronavirus-vaccine-stocks-how-long-will-covid-19/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 08:15:00", "title": "Coronavirus Expert: 'The Virus Is Bouncing Back'", "image": "https://cdn.snapi.dev/images/v1/p/1/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "New cases of COVID-19 are increasing rapidly as the winter months and holidays approach.", "url": "https://www.fool.com/investing/2020/11/15/coronavirus-expert-the-virus-is-bouncing-back/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 07:55:00", "title": "What Data This Coronavirus Expert Is Looking For In Pfizer and Moderna's Vaccine Trials", "image": "https://cdn.snapi.dev/images/v1/h/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5956072fgettyimages-1264722487jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It's important to look beyond the headlines and find out more about how effective coronavirus vaccine candidates are.", "url": "https://www.fool.com/investing/2020/11/15/what-data-this-coronavirus-expert-is-looking-for-i/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 07:08:00", "title": "5 Moves to Make if the Stock Market Soars Tomorrow", "image": "https://cdn.snapi.dev/images/v1/v/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5997562fstock-market-image-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "You know to stay calm if the stock market crashes. But can you control yourself when it surges?", "url": "https://www.fool.com/investing/2020/11/15/5-moves-to-make-if-the-stock-market-soars-tomorrow/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 06:57:00", "title": "3 Top Biotech Stocks to Watch in November", "image": "https://cdn.snapi.dev/images/v1/3/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6001802fgettyimages-1224223647jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These three stocks are loaded with potential, but need to be watched carefully over the next few weeks.", "url": "https://www.fool.com/investing/2020/11/15/3-top-biotech-stocks-to-watch-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 06:15:00", "title": "Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?", "image": "https://cdn.snapi.dev/images/v1/c/c/afdew1.jpg", "site": "The Motley Fool", "text": "It's a definite maybe.", "url": "https://www.fool.com/investing/2020/11/15/should-you-buy-a-basket-of-late-stage-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 06:11:00", "title": "Investors Wish They Could Vote These 2 Healthcare CEOs Out", "image": "https://cdn.snapi.dev/images/v1/q/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5964712fgettyimages-1147352097jpgw700opresize.jpg", "site": "The Motley Fool", "text": "With immobile stock prices and a hangover of legal issues, these CEOs might be glad Wall Street doesn't operate like a democracy.", "url": "https://www.fool.com/investing/2020/11/15/with-the-election-coming-investors-wish-they-could/"}, {"symbol": "PFE", "publishedDate": "2020-11-15 05:30:00", "title": "The Pandemic's Still Not Over: 3 Stay-at-Home Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/f/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6003702fwoman-in-isolation-during-covid-19jpgw700opresize.jpg", "site": "The Motley Fool", "text": "GoodRx, Nintendo, and Roku are all great growth investments to hang on to for the long term.", "url": "https://www.fool.com/investing/2020/11/15/the-pandemics-still-not-over-3-stay-at-home-stocks/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 11:01:00", "title": "The Biggest Takeaway From Pfizer's Coronavirus Vaccine Results", "image": "https://cdn.snapi.dev/images/v1/5/q/m02d20201111t2i1540854359w940fhfwllplsqrlynxmpegaa0s6.jpg", "site": "The Motley Fool", "text": "It could help Americans feel more confident about getting vaccinated for COVID-19.", "url": "https://www.fool.com/investing/2020/11/14/the-biggest-takeaway-from-pfizers-coronavirus-vacc/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 09:42:00", "title": "Which Coronavirus Vaccine Maker Is Poised to Be the Top Supplier?", "image": "https://cdn.snapi.dev/images/v1/p/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6003332fgettyimages-1205913548jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The numbers are close, but two players stand out at the moment.", "url": "https://www.fool.com/investing/2020/11/14/which-coronavirus-vaccine-maker-poised-to-be-top-s/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 09:15:30", "title": "Pfizer (PFE) Stock Price: $44 Target By Mizuho Securities", "image": "https://cdn.snapi.dev/images/v1/i/7/drugs47.jpg", "site": "Pulse2", "text": "Shares of Pfizer Inc. (NYSE: PFE) have received a price target increase from $43 to $44 by Mizuho Securities. These are the details.", "url": "https://pulse2.com/pfizer-nyse-pfe-stock-price-44-target-by-mizuho-securities/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 08:55:00", "title": "Here's Why Pfizer's Coronavirus Vaccine Would Be Revolutionary", "image": "https://cdn.snapi.dev/images/v1/q/a/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg", "site": "The Motley Fool", "text": "If approved and launched, an mRNA vaccine would disrupt the vaccine development landscape and go leaps and bounds toward helping the world recover from the pandemic.", "url": "https://www.fool.com/investing/2020/11/14/heres-why-pfizers-coronavirus-vaccine-would-be-rev/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 08:53:00", "title": "How To Invest In COVID-19 Vaccine Stocks: Bet On The Jockey", "image": "https://cdn.snapi.dev/images/v1/e/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5918892fvaccine-bottle-and-syringe-with-blue-backgroundjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The best way to pick coronavirus stocks is to make sure you trust the scientists running the company's COVID-19 program.", "url": "https://www.fool.com/investing/2020/11/14/how-to-invest-in-covid-19-vaccine-stocks-bet-on-th/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 07:30:00", "title": "3 Potentially Explosive Stocks for a Vaccine-Driven Bull Market", "image": "https://cdn.snapi.dev/images/v1/d/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998462fgettyimages-1210633307jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Find out why you might want to own these stocks in a post-vaccine world.", "url": "https://www.fool.com/investing/2020/11/14/3-potentially-explosive-stocks-for-a-vaccine-drive/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 07:15:00", "title": "Vaccine Hopes Sent These 3 Oil Stocks Up More Than 15%: Here's Why They're Still Cheap", "image": "https://cdn.snapi.dev/images/v1/i/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6004242fan-oil-pump-and-barrel-on-top-of-moneyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These oil stocks look like they have lots of room to run.", "url": "https://www.fool.com/investing/2020/11/14/vaccine-hopes-sent-these-3-oil-stocks-up-more-than/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 07:12:00", "title": "3 Top Coronavirus Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/f/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6005092fgettyimages-987070228jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Potential for emergency use authorizations and presidential promises are reasons to pick up these leaders today.", "url": "https://www.fool.com/investing/2020/11/14/3-top-coronavirus-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 06:48:00", "title": "How To Invest In Coronavirus Vaccines: Interview with The Lancet Editor-In-Chief", "image": "https://cdn.snapi.dev/images/v1/a/h/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "Here's why this top COVID-19 expert says trusting the scientists behind the stocks is the key to investing in companies developing coronavirus vaccines.", "url": "https://www.fool.com/investing/2020/11/14/how-to-invest-in-coronavirus-vaccines-interview-wi/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 05:43:00", "title": "Coronavirus Vaccine Stocks: Challenges With Manufacturing, Distribution, And the Cold Chain", "image": "https://cdn.snapi.dev/images/v1/8/c/podc11-moswiwvev7.jpg", "site": "The Motley Fool", "text": "Getting FDA authorization for a COVID-19 vaccine may be just the first hurdle of many.", "url": "https://www.fool.com/investing/2020/11/14/coronavirus-vaccine-stocks-challenges-with-manufac/"}, {"symbol": "PFE", "publishedDate": "2020-11-14 05:24:00", "title": "3 Best Biotech Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/t/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984552fgettyimages-1172482193jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Biotech is on every investor's mind as we move closer and closer to a successful vaccine for the coronavirus. Here are three contenders for your portfolio.", "url": "https://www.fool.com/investing/2020/11/14/3-best-biotech-stocks-to-buy-right-now/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 18:02:25", "title": "DGRW: Pfizer's Vaccine News Could Set This ETF Into Motion", "image": "https://cdn.snapi.dev/images/v1/g/b/etf38.jpg", "site": "Seeking Alpha", "text": "A re-opening rally could look like the opposite of how the market reacted at the beginning of the COVID outbreak and shift leadership back to cyclicals. In that case, DGRW is a dividend ETF that could be uniquely positioned to benefit in such an environment.", "url": "https://seekingalpha.com/article/4389018-dgrw-pfizers-vaccine-news-set-this-etf-motion"}, {"symbol": "PFE", "publishedDate": "2020-11-13 16:43:00", "title": "The Tell: Pfizer vaccine news sparks $44.5 billion flood into the stock market\u2014its biggest weekly inflow ever, says BofA", "image": "https://cdn.snapi.dev/images/v1/a/a/m02d20201109t2i1540528724w940fhfwllplsqrlynxmpega80ww.jpg", "site": "Market Watch", "text": "How seismic was the stock-market move that kicked off the week following news of an effective coronavirus vaccine candidate? It was the best week ever for inflows, according to BofA Global Research", "url": "https://www.marketwatch.com/story/pfizer-vaccine-news-sparks-44-5-billion-flood-into-the-stock-marketits-biggest-weekly-inflow-ever-says-bofa-11605287707"}, {"symbol": "PFE", "publishedDate": "2020-11-13 16:31:14", "title": "Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs", "image": "https://cdn.snapi.dev/images/v1/y/5/pfizer-has-a-head-start-but-the-covid-19-vaccine-market-is-still-up-for-grabs.jpg", "site": "Forbes", "text": "Any first-mover advantage won't last long, as some vaccine candidates may be easier to transport and administer than others.", "url": "https://www.forbes.com/sites/katiejennings/2020/11/13/pfizer-has-a-head-start-but-the-covid-19-vaccine-market-is-still-up-for-grabs/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 16:21:25", "title": "Pfizer COVID Vaccine Volunteer Describes Side Effects From Trial", "image": "https://cdn.snapi.dev/images/v1/1/5/pfizer-covid-vaccine-volunteer-describes-side-effects-from-trial.jpg", "site": "Cheddar", "text": "Giora Griffel, a participant in the Pfizer COVID-19 vaccine trial, joined Cheddar's Search for a Cure to explain the process of being selected for the trial and what it was like to be part of medical history. Subscribe to Cheddar Now on YouTube: https://chdr.tv/NowYT", "url": "https://www.youtube.com/watch?v=5Y1kghg1DRw"}, {"symbol": "PFE", "publishedDate": "2020-11-13 15:47:17", "title": "Global stock funds see record inflows on Pfizer's COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/x/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5954072fgettyimages-1210977583jpgw700opresize.jpg", "site": "Fox Business", "text": "The biggest catalyst for global equities: COVID-19 vaccine.", "url": "https://www.foxbusiness.com/markets/global-stock-funds-see-record-inflows-on-pfizers-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-13 15:22:19", "title": "Is Pfizer Stock A Buy After Its Coronavirus Vaccine Proved 90% Effective?", "image": "https://cdn.snapi.dev/images/v1/i/z/106599913-1593620338844ap-20183543531451.jpg", "site": "Investors Business Daily", "text": "Pfizer stock jumped in early November after the pharma company's coronavirus vaccine proved 90% effective in a final-phase study.\u00a0But if the pharmaceutical company's stock a buy now?", "url": "https://www.investors.com/news/technology/pfizer-stock-buy-now/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 15:12:27", "title": "BioNTech and Pfizer's COVID-19 vaccine is surprisingly effective, though experts question what effectiveness will look like in the real world", "image": "https://cdn.snapi.dev/images/v1/u/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984562fgettyimages-1203194637jpgw700opresize.jpg", "site": "Market Watch", "text": "BioNTech and Pfizer Inc.'s unexpectedly efficacious COVID-19 vaccine candidate caught Wall Street and the medical community by surprise this week, yet the same experts who are thrilled by the news caution that the effectiveness of the vaccine will likely be lower in the real world.", "url": "https://www.marketwatch.com/story/biontech-and-pfizers-covid-19-vaccine-is-surprisingly-effective-though-experts-question-what-effectiveness-will-look-like-in-the-real-world-2020-11-13"}, {"symbol": "PFE", "publishedDate": "2020-11-13 12:00:00", "title": "Pfizer's Covid-19 Vaccine News Is Pushing These 18 Stocks Up \u2013 Time To Invest?", "image": "https://cdn.snapi.dev/images/v1/q/h/pfizers-covid-19-vaccine-news-is-pushing-these-18-stocks-up-time-to-invest.jpg", "site": "Forbes", "text": "Amid some volatility, the S&P 500 has climbed nearly 2.5% in the past week. The triggers?", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/13/pfizers-covid-19-vaccine-news-is-pushing-these-18-stocks-up--time-to-invest/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 11:34:53", "title": "3 Pharmaceutical Stocks to Buy in November", "image": "https://cdn.snapi.dev/images/v1/9/t/drugs44.jpg", "site": "InvestorPlace", "text": "Here are pharmaceutical stocks for November 2020 with a focus on companies that are close to delivering a vaccine against Covid-19. The post 3 Pharmaceutical Stocks to Buy in November appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/pharmaceutical-stocks-to-buy-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 10:14:10", "title": "3 Dividend Stocks That Pay You Better Than Coca-Cola Does", "image": "https://cdn.snapi.dev/images/v1/b/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5167282fresized-iphone-rain-2.jpg", "site": "The Motley Fool", "text": "These companies are well-positioned to maintain leadership positions in their industries for years to come, and to keep rewarding shareholders with steadily rising payouts.", "url": "https://www.fool.com/investing/2020/11/13/3-dividend-stocks-that-pay-better-than-coca-cola/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 10:09:00", "title": "Pfizer's CEO sold $5.6 million worth of shares on the day of its big vaccine news. So what?", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs43.jpg", "site": "Market Watch", "text": "Pfizer said sale of shares by Albert Bourla was prearranged under plan set up in August", "url": "https://www.marketwatch.com/story/pfizers-ceo-sold-5-6-million-worth-of-shares-on-the-day-of-its-big-vaccine-news-so-what-11605280170"}, {"symbol": "PFE", "publishedDate": "2020-11-13 08:11:00", "title": "Coronavirus Fears to Boost Packaged Food Sales: 4 Picks", "image": "https://cdn.snapi.dev/images/v1/d/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5373772fyoung-man-comparing-bottles-grocery-shopping-cropjpgw700opresize.jpg", "site": "Zacks Investment Research", "text": "The Hain Celestial Group, Inc. (HAIN), United Natural Foods, Inc. (UNFI) and Tyson Foods, Inc. (TSN) may one again witness a surge in the demand for their products as surging coronavirus cases may once again compel people to confine themselves indoors.", "url": "https://www.zacks.com/stock/news/1101332/coronavirus-fears-to-boost-packaged-food-sales-4-picks"}, {"symbol": "PFE", "publishedDate": "2020-11-13 06:29:00", "title": "Should Coronavirus Vaccine Investors Worry About The Cold Chain?", "image": "https://cdn.snapi.dev/images/v1/v/l/stock-advisor-vs-sp-small.png", "site": "The Motley Fool", "text": "Do Pfizer and Moderna need to worry about keeping mRNA vaccines ultra-cold and could that hinder vaccine distribution?", "url": "https://www.fool.com/investing/2020/11/13/should-coronavirus-vaccine-investors-worry-about-t/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 06:24:00", "title": "Got $10,000? These 3 Top Growth Stocks Could Set You Up for Life", "image": "https://cdn.snapi.dev/images/v1/g/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6002112fgettyimages-925466034jpgw700opresize.jpg", "site": "The Motley Fool", "text": "If you're worried about another lockdown-fueled market crash, these three recession-proof stocks should be on your buy list.", "url": "https://www.fool.com/investing/2020/11/13/got-10000-these-3-top-growth-stocks-could-set-you/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 06:10:00", "title": "Why Regional Bank Stocks Will Benefit More From a COVID-19 Vaccine", "image": "https://cdn.snapi.dev/images/v1/x/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999622fgeneric-bank-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "All banks are anticipating loan losses due to the pandemic, but the regional players appear more exposed to those risks than both their larger and smaller peers.", "url": "https://www.fool.com/investing/2020/11/13/why-regional-bank-stocks-will-benefit-more-from-a/"}, {"symbol": "PFE", "publishedDate": "2020-11-13 05:01:25", "title": "5 Companies to Invest in for 2021 as Markets Price in Economy's Prospects", "image": "https://cdn.snapi.dev/images/v1/1/4/14mflfef-1.jpg", "site": "InvestorPlace", "text": "After the volatility of 2020, analysts see some calm in the offing. Here are 5 companies to invest in on those prospects.", "url": "https://investorplace.com/2020/11/5-companies-pfe-abl-nio-spwr-ccl-to-invest-in-for-2021/"}, {"symbol": "PFE", "publishedDate": "2020-11-12 21:09:41", "title": "Pfizer Negotiates COVID-19 Vaccine Supply With Brazil For Early Next Year", "image": "https://cdn.snapi.dev/images/v1/d/q/science-in-hd-9kstf9pvetm-unsplash-1-0.jpg", "site": "Benzinga", "text": "Pfizer Inc (NYSE: PFE) is in negotiations with the government of Brazil to supply its COVID-19 vaccine to the country, Reuters reported Thursday. What Happened: The negotiations are reportedly centered around supplying the vaccine in the first quarter of 2021.", "url": "https://www.benzinga.com/general/biotech/20/11/18353348/pfizer-negotiates-covid-19-vaccine-supply-with-brazil-for-early-next-year"}, {"symbol": "PFE", "publishedDate": "2020-11-12 16:31:59", "title": "With Pfizer Winning the Vaccine Race, Novavax Is a Strong Sell", "image": "https://cdn.snapi.dev/images/v1/w/v/biotech39.jpg", "site": "InvestorPlace", "text": "Novavax made a valiant effort at developing the leading Covid-19 vaccine, but it fell short. Now poor earnings will sink NVAX stock.", "url": "https://investorplace.com/2020/11/with-pfizer-winning-the-vaccine-race-nvax-stock-is-a-strong-sell/"}, {"symbol": "PFE", "publishedDate": "2020-11-12 15:55:32", "title": "7 Stocks That Could Benefit From Pfizer's COVID-19 Vaccine That Requires Cold Chain Storage", "image": "https://cdn.snapi.dev/images/v1/h/j/virus-4933201-1280-5.png", "site": "Benzinga", "text": "Pfizer Inc.'s (NYSE: PFE) coronavirus vaccine candidate may have turned in strong efficacy results, but the logistics it requires could impact the vaccine's eventual uptake.\u00a0 Opportunity In Adversity: The mRNA vaccine jointly developed by Pfizer and BioNTech SE \u2013 ADR (NASDAQ: BNTX) requires a storage temperature of negative 70 degrees Celsius.", "url": "https://www.benzinga.com/general/health-care/20/11/18324905/7-stocks-that-could-benefit-from-pfizers-covid-19-vaccine-that-requires-cold-chain-storage"}, {"symbol": "PFE", "publishedDate": "2020-11-12 12:20:00", "title": "Pfizer's CEO cashed out $5.6 million of stock after trumpeting its COVID-19 vaccine. That's 30% of his total compensation last year", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizers-ceo-cashed-out-56-million-of-stock-after-trumpeting-its-covid-19-vaccine-thats-30-of-his-total-compensation-last-year.jpg", "site": "Business Insider", "text": "Pfizer CEO Albert Bourla sold shares worth more than triple his base salary on Monday, hours after proclaiming that excellent results from the pharmaceutical company's COVID-19 vaccine in a late-stage trial made it a \"great day for science and humanity.\" Bourla described the results in a\u00a0press release as a \"critical milestone\" in the race to develop a vaccine, and a \"significant step\" towards ending the coronavirus pandemic. Pfizer's stock price jumped as much as 15% on the news.", "url": "https://www.businessinsider.com/pfizer-ceo-sold-stock-6-million-30-percent-compensation-vaccine-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-12 12:12:00", "title": "Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL\u00ae 80 mg/VYNDAMAX\u00ae 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg", "image": "https://cdn.snapi.dev/images/v1/j/c/press11---h8bqqkgttz.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the publication of an analysis showing that VYNDAQEL\u00ae (tafamidis meglumine) 80 mg/VYNDAMAX\u00ae (tafamidis) 61 mg were associated with a statistically significant improvement in long-term survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared to VYNDAQEL 20 mg, reaffirming optimal dosing for these patients. Results from the analysis of the Phase 3 Tafamidis in Transthyretin Amyloid Cardiomyopathy Clinical", "url": "https://www.businesswire.com/news/home/20201112005882/en/Analysis-from-Phase-3-ATTR-ACT-and-Its-Long-Term-Extension-Study-Demonstrates-VYNDAQEL%C2%AE-80-mgVYNDAMAX%C2%AE-61-mg-Significantly-Improved-Survival-in-Patients-with-Transthyretin-Amyloid-Cardiomyopathy-ATTR-CM-Compared-to-VYNDAQEL-20-mg/"}, {"symbol": "PFE", "publishedDate": "2020-11-12 08:48:00", "title": "Pfizer (PFE) to Supply 200M Doses of COVID-19 Vaccine to EU", "image": "https://cdn.snapi.dev/images/v1/k/t/drugs32---713l8xlqyf.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) and BioNTech sign a supply deal with the European Union for up to 300 million doses of their coronavirus vaccine.", "url": "https://www.zacks.com/stock/news/1100811/pfizer-pfe-to-supply-200m-doses-of-covid-19-vaccine-to-eu"}, {"symbol": "PFE", "publishedDate": "2020-11-12 08:30:03", "title": "BioNTech CEO discusses Pfizer coronavirus vaccine on 'Mornings with Maria'", "image": "https://cdn.snapi.dev/images/v1/r/m/biontech-ceo-discusses-pfizer-coronavirus-vaccine-on-mornings-with-maria.jpg", "site": "Fox Business", "text": "BioNTech co-founder and CEO Dr. Ugur Sahin provides insight into the vaccine progress with Pfizer. Subscribe to Fox Business!", "url": "https://www.youtube.com/watch?v=VBWbbq66JRU"}, {"symbol": "PFE", "publishedDate": "2020-11-12 07:56:43", "title": "Tracking stock sales of executives involved in Covid-19 drug developments", "image": "https://cdn.snapi.dev/images/v1/m/q/tracking-stock-sales-of-executives-involved-in-covid-19-drug-developments.jpg", "site": "CNBC Television", "text": "Pfizer CEO Albert Bourla sold almost $5.6 million worth of stock on Monday, the same day the drugmaker announced positive early data on its experimental coronavirus vaccine that sent shares soaring. But Bourla isn't the only executive officer of a pharmaceutical company involved in the race for Covid-19 vaccine and treatments who are selling stocks.", "url": "https://www.youtube.com/watch?v=k8I41B-foNM"}, {"symbol": "PFE", "publishedDate": "2020-11-12 07:56:00", "title": "What Investors Need To Know About Pfizer's Potential Coronavirus Vaccine", "image": "https://cdn.snapi.dev/images/v1/p/o/podc10---1gxdczglmu.jpg", "site": "The Motley Fool", "text": "Here's why The Lancet's editor-in-chief thinks an mRNA vaccine to prevent COVID-19 could be groundbreaking.", "url": "https://www.fool.com/investing/2020/11/12/what-investors-need-to-know-about-pfizers-potentia/"}, {"symbol": "PFE", "publishedDate": "2020-11-12 07:43:25", "title": "Pfizer coronavirus vaccine expected to protect patients for a year: BioNTech founder", "image": "https://cdn.snapi.dev/images/v1/s/g/biotech11.jpg", "site": "Fox Business", "text": "The Pfizer-BioNTech coronavirus vaccine could protect patients from the virus for a year, BioNTech\u00a0CEO Ugur Sahin told \"Mornings with Maria\" on Thursday.", "url": "https://www.foxbusiness.com/markets/pfizer-coronavirus-vaccine-reinfection-year-ugur-sahin"}, {"symbol": "PFE", "publishedDate": "2020-11-12 07:00:00", "title": "What The U.S. Election Results Likely Mean For Midstream Investors", "image": "https://cdn.snapi.dev/images/v1/l/z/oil3.jpg", "site": "Seeking Alpha", "text": "With a divided Congress, there are severe limitations to what a president-elect Biden could accomplish. This is the primary reason analysts believe the stock market has reacted with such a vigorous rally.", "url": "https://seekingalpha.com/article/4388226-what-u-s-election-results-likely-mean-for-midstream-investors"}, {"symbol": "PFE", "publishedDate": "2020-11-12 06:09:00", "title": "Pfizer CEO Sold Shares on Same Day as the Company's Coronavirus Vaccine News: Should You Be Outraged?", "image": "https://cdn.snapi.dev/images/v1/0/o/m02d20201109t2i1540533856w940fhfwllplsqrlynxmpega80yo.jpg", "site": "The Motley Fool", "text": "Hold your fire until you understand the full story.", "url": "https://www.fool.com/investing/2020/11/12/pfizer-ceo-sold-shares-on-same-day-as-the-companys/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 18:14:44", "title": "A securities lawyer breaks down the Pfizer CEO stock sale", "image": "https://cdn.snapi.dev/images/v1/s/w/a-securities-lawyer-breaks-down-the-pfizer-ceo-stock-sale.jpg", "site": "CNBC Television", "text": "Lisa Braganca, securities lawyer and former SEC branch chief, on Pfizer's CEO stock sale. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Dan Nathan.", "url": "https://www.youtube.com/watch?v=MO1IveRJ3KE"}, {"symbol": "PFE", "publishedDate": "2020-11-11 15:45:00", "title": "ETFs to Consider on Pfizer's Vaccine Announcement", "image": "https://cdn.snapi.dev/images/v1/n/p/drugs24---rrbmtzl2kk.jpg", "site": "Zacks Investment Research", "text": "ETFs with exposure to Pfizer (PFE) are beginning to look good after the results of BNT162b2's Phase 3 trial.", "url": "https://www.zacks.com/stock/news/1100428/etfs-to-consider-on-pfizers-vaccine-announcement"}, {"symbol": "PFE", "publishedDate": "2020-11-11 15:30:49", "title": "Pfizer CEO Sells Stock Same Day as Vaccine Announcement", "image": "https://cdn.snapi.dev/images/v1/i/5/pfizer-56a530e23df78cf77286d4a7.jpg", "site": "Investopedia", "text": "Pfizer CEO Albert Bourla sold nearly $5.6 million of the company's stock on Monday as the share price soared as much as 15% on the news that its COVID-19 vaccine candidate is 90% effective.", "url": "https://www.investopedia.com/pfizer-ceo-sells-stock-same-day-as-breakthrough-vaccine-announcement-5087140"}, {"symbol": "PFE", "publishedDate": "2020-11-11 15:11:32", "title": "Pfizer CEO sold $5.6 million worth of stock amid the pandemic", "image": "https://cdn.snapi.dev/images/v1/9/e/pfizer-ceo-sold-56-million-worth-of-stock-amid-the-pandemic.jpg", "site": "CNBC Television", "text": "Pfizer's CEO sold about $5.6 million worth of stock on Monday, according to a filing. CNBC's Meg Tirrell reports on the sale and the company's response.", "url": "https://www.youtube.com/watch?v=mjPlXMb4ZXQ"}, {"symbol": "PFE", "publishedDate": "2020-11-11 14:30:00", "title": "Bet Big on Industrial Metal ETFs on Vaccine Optimism", "image": "https://cdn.snapi.dev/images/v1/8/5/etf5.jpg", "site": "Zacks Investment Research", "text": "Wall Street has been on a rallying mode in recent sessions on upbeat vaccine data and recovering global manufacturing activities.", "url": "https://www.zacks.com/stock/news/1100425/bet-big-on-industrial-metal-etfs-on-vaccine-optimism"}, {"symbol": "PFE", "publishedDate": "2020-11-11 14:08:59", "title": "Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's", "image": "https://cdn.snapi.dev/images/v1/w/w/biotech39.jpg", "site": "Investors Business Daily", "text": "Moderna popped Wednesday after Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, predicted its coronavirus vaccine would be as effective as Pfizer's. The post Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/moderna-stock-pops-anthony-fauci-predicts-coronavirus-vaccine-effective-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 12:54:25", "title": "Pfizer Nabs Supply Deal For Covid-19 Vaccine; Executives Sell Stock", "image": "https://cdn.snapi.dev/images/v1/k/a/drugs23.jpg", "site": "Investors Business Daily", "text": "Pfizer and BioNTech reached a supply deal Wednesday with the European Union for up to 300 million doses of their coronavirus vaccine. The EU will initially buy 200 million doses.", "url": "https://www.investors.com/news/technology/coronavirus-vaccine-pfizer-inks-deal-eu-300-million-doses-branch/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 12:21:54", "title": "Why Investors Should Bank On Well Fargo", "image": "https://cdn.snapi.dev/images/v1/s/z/bank15---i2dz0yskn8.jpg", "site": "InvestorPlace", "text": "Yes, there are considerable problems at Wells Fargo. But WFC stock still looks very attractive at current levels.", "url": "https://investorplace.com/2020/11/why-investors-should-bank-on-well-fargo-wfc-stock/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 12:10:37", "title": "Pfizer CEO Bourla Offloads $5.6M In Stock In Preplanned Sale Amid Vaccine Rally", "image": "https://cdn.snapi.dev/images/v1/a/s/syringe-1884758-1920-76.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) shares rose to a 52-week high of $41.99 Monday thanks to strong late-stage interim readout for the mRNA vaccine candidate BNT162b2 the company is co-developing with its German partner BioNTech SE \u2013 ADR (NASDAQ: BNTX). Some insider stock sales\u00a0at the company are\u00a0coinciding with the strong upward move.", "url": "https://www.benzinga.com/general/biotech/20/11/18322660/pfizer-ceo-bourla-offloads-5-6m-in-stock-in-preplanned-sale-amid-vaccine-rally"}, {"symbol": "PFE", "publishedDate": "2020-11-11 11:38:39", "title": "Pfizer CEO sold $5.6 million of stock as company announced vaccine data that sent shares soaring", "image": "https://cdn.snapi.dev/images/v1/9/o/106635982-1604927371759-106635982-1595948992117-gettyimages-1132313750-wm2-7799-20190226114402859.jpg", "site": "CNBC", "text": "Bourla is not the first pharmaceutical or biotech executive to cash in on his company's stock gains during the pandemic.", "url": "https://www.cnbc.com/2020/11/11/coronavirus-vaccine-pfizer-ceo-sold-5point6-million-of-stock-as-company-announced-positive-data.html"}, {"symbol": "PFE", "publishedDate": "2020-11-11 11:11:25", "title": "What you need to know about BioNTech, the European company behind Pfizer's Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/a/w/106792254-1605109106759-gettyimages-1229548499-20090101201109-99-269063.jpeg", "site": "CNBC", "text": "Pfizer developed its coronavirus vaccine in partnership with BioNTech. CNBC takes a look at the company's history.", "url": "https://www.cnbc.com/2020/11/11/biontech-the-european-company-behind-pfizers-covid-19-vaccine.html"}, {"symbol": "PFE", "publishedDate": "2020-11-11 11:09:25", "title": "Pfizer, BioNTech Ink EU Deal For 300 Million Coronavirus Vaccine Doses", "image": "https://cdn.snapi.dev/images/v1/w/r/biotech34.jpg", "site": "Investors Business Daily", "text": "Pfizer and BioNTech reached a supply deal Wednesday with the European Union for up to 300 million doses of their coronavirus vaccine. The EU will initially buy 200 million doses.", "url": "https://www.investors.com/news/technology/coronavirus-vaccine-pfizer-inks-deal-eu-300-million-doses/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 11:00:00", "title": "Pfizer's Covid-19 Success Bodes Very Well For Moderna", "image": "https://cdn.snapi.dev/images/v1/g/r/pfizers-covid-19-success-bodes-very-well-for-moderna.jpg", "site": "Forbes", "text": "While Pfizer\u2018s surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn't mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong.", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/11/pfizers-covid-19-success-bodes-very-well-for-moderna/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 10:23:06", "title": "Could Pfizer Be a Millionaire-Maker Stock?", "image": "https://cdn.snapi.dev/images/v1/f/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5987982fgettyimages-1238772468jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Big news from the drugmaker on a coronavirus vaccine may be just the first in a string of successes.", "url": "https://www.fool.com/investing/2020/11/11/could-pfizer-be-a-millionaire-maker-stock/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 10:12:33", "title": "Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news", "image": "https://cdn.snapi.dev/images/v1/f/j/201111092154-albert-bourla-pfizer-file-restricted-super-169.jpg", "site": "CNN Business", "text": "Pfizer CEO Albert Bourla filed to sell millions of dollars of his company's stock Monday -- the day the pharmaceutical giant announced positive data about its coronnavirus vaccine.", "url": "https://www.cnn.com/2020/11/11/investing/pfizer-ceo-albert-bourla-stock-sale-vaccine/index.html"}, {"symbol": "PFE", "publishedDate": "2020-11-11 10:00:00", "title": "Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference", "image": "https://cdn.snapi.dev/images/v1/g/a/conf13.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Biopharmaceuticals Group, at the 2nd Annual Wolfe Research Healthcare Conference on Wednesday, November 18, 2020 at 9:50 a.m. EST. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Visitor", "url": "https://www.businesswire.com/news/home/20201111005209/en/Pfizer-Invites-Public-to-Listen-to-Webcast-of-Pfizer-Discussion-at-Healthcare-Conference/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 09:54:00", "title": "Exclusive: Europe to pay less than U.S. for Pfizer vaccine under initial deal: source", "image": "https://cdn.snapi.dev/images/v1/v/o/m02d20201111t2i1540854359w940fhfwllplsqrlynxmpegaa0s6.jpg", "site": "Reuters", "text": "The European Union has struck a deal to initially pay less for Pfizer's COVID-19 vaccine candidate than the United States, an EU official told Reuters as the bloc announced on Wednesday it had secured an agreement for up to 300 million doses.", "url": "https://www.reuters.com/article/us-health-coronavirus-eu-pfizer-exclusiv/exclusive-europe-to-pay-less-than-u-s-for-pfizer-vaccine-under-initial-deal-source-idUSKBN27R1F5"}, {"symbol": "PFE", "publishedDate": "2020-11-11 09:16:51", "title": "Pfizer CEO sold $5.6 million stock in pre-planned sale on day of vaccine news release", "image": "https://cdn.snapi.dev/images/v1/i/k/pfizer-ceo-sold-56-million-stock-in-pre-planned-sale-on-day-of-vaccine-news-release.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports the details of a stock sale by Pfizer CEO Albert Bourla on Monday, the same day the company announced its early vaccine trial results.", "url": "https://www.youtube.com/watch?v=4SCtZIYI4DQ"}, {"symbol": "PFE", "publishedDate": "2020-11-11 09:10:00", "title": "CEO sells stock worth $5.6 million on same day as Pfizer's COVID-19 vaccine update", "image": "https://cdn.snapi.dev/images/v1/m/l/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p.jpg", "site": "Reuters", "text": "Pfizer Inc Chief Executive Officer Albert Bourla has sold stake worth $5.56 million, according to a regulatory filing that showed the sale was made on Monday, the same day the drugmaker reported positive data on its experimental COVID-19 vaccine.", "url": "https://www.reuters.com/article/us-pfizer-albert-bourla-stake/ceo-sells-stock-worth-5-6-million-on-same-day-as-pfizers-covid-19-vaccine-update-idUSKBN27R1Z5"}, {"symbol": "PFE", "publishedDate": "2020-11-11 08:57:28", "title": "Pfizer-BioNTech Seals 200M Dose Vaccine Supply Deal With European Commission", "image": "https://cdn.snapi.dev/images/v1/c/d/vaccine-5074670-1920-16.jpg", "site": "Benzinga", "text": "After reporting stellar efficacy results for their vaccine candidate earlier this week, Pfizer Inc. (NYSE: PFE) and BioNTech SE \u2013 ADR (NASDAQ: BNTX) announced\u00a0a supply deal with the European Commission. What Happened: The U.S. pharma giant and its German partner said\u00a0have reached an agreement with the European Commission to supply 200 million doses of their investigational mRNA vaccine, codenamed BNT162b2, against SARS-CoV-2.", "url": "https://www.benzinga.com/general/biotech/20/11/18319375/pfizer-biontech-seals-200m-dose-vaccine-supply-deal-with-european-commission"}, {"symbol": "PFE", "publishedDate": "2020-11-11 08:40:00", "title": "Vaccine Hopes Rise as Pharma Giants Inch Closer Toward Success", "image": "https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5916012fhypodermic-needles-syringe-drug-pharmajpgw700opresize.jpg", "site": "Zacks Investment Research", "text": "Stocks of Eli Lilly and Company (LLY), Pfizer, Inc. (PFE) and Moderna, Inc. (MRNA) have been in focus since the coronavirus outbreak as they have been the frontrunners in the vaccine race.", "url": "https://www.zacks.com/stock/news/1100121/vaccine-hopes-rise-as-pharma-giants-inch-closer-toward-success"}, {"symbol": "PFE", "publishedDate": "2020-11-11 08:25:44", "title": "Pfizer CEO Albert Bourla sold millions in stock on same day of vaccine reveal", "image": "https://cdn.snapi.dev/images/v1/8/y/albert-bourlajpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer CEO Albert Bourla cashed in on his company's coronavirus vaccine breakthrough. The executive sold more than $5.5 million worth of Pfizer stock on Monday \u2014 the same day the drugmaker said its experimental COVID-19 shot was more than 90 percent effective, records show.", "url": "https://nypost.com/2020/11/11/pfizer-ceo-sold-5-5m-in-stock-amid-covid-19-vaccine-reveal/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 07:47:30", "title": "Pfizer CEO unloads $5.6M of stock as coronavirus vaccine hopes send shares soaring", "image": "https://cdn.snapi.dev/images/v1/n/j/106048558-1564499644537rtx71gap.jpg", "site": "Fox Business", "text": "Albert Bourla sold 132,508 Pfizer shares at a price of $41.94 apiece through a scheduled Rule 10b5-1 trading plan adopted on Aug. 19, one day after the company announced positive results from a Phase 1 study.", "url": "https://www.foxbusiness.com/markets/pfizer-ceo-stock-sale-coronavirus-vaccine-news"}, {"symbol": "PFE", "publishedDate": "2020-11-11 07:41:00", "title": "After Promising Coronavirus Vaccine Data, Is Pfizer a Buy?", "image": "https://cdn.snapi.dev/images/v1/i/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998512fvaccination-in-progress-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "An effective coronavirus vaccine candidate is just the tip of this gigantic pharmaceutical iceberg.", "url": "https://www.fool.com/investing/2020/11/11/after-promising-coronavirus-vaccine-data-is-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 06:53:00", "title": "How to Invest in the Coronavirus Vaccine Race Right Now", "image": "https://cdn.snapi.dev/images/v1/w/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998472fgettyimages-1213011325jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Pfizer grabbed the spotlight when it released efficacy data from its phase 3 study earlier this week. But is it too late to get in on the action?", "url": "https://www.fool.com/investing/2020/11/11/how-to-invest-in-the-coronavirus-vaccine-race-righ/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 06:45:00", "title": "Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens", "image": "https://cdn.snapi.dev/images/v1/4/a/press8---n9hbkegbtu.jpg", "site": "Business Wire", "text": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 and older with moderate to severe atopic dermatitis (AD) following response to initial open label induction treatment with abrocitinib 200mg. Patients were randomized into one of three arms: 200mg, 100mg, or placebo. Both doses of abrocitini", "url": "https://www.businesswire.com/news/home/20201111005237/en/Pfizer-Announces-Positive-Results-from-Fifth-Phase-3-Trial-of-Abrocitinib-Evaluating-Safety-and-Efficacy-Across-Different-Dosing-Regimens/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 06:26:29", "title": "Pfizer, BioNTech reach deal to supply EU with 200 million doses of its COVID-19 vaccine candidate", "image": "https://cdn.snapi.dev/images/v1/n/8/biotech18.jpg", "site": "Market Watch", "text": "Pfizer Inc. and BioNTech SE announced Wednesday a deal to provide a supply of 200 million doses of its COVID-19 vaccine candidate to the European Union, marking the largest order for the potential vaccine to date. As part of the deal, the EU has an option to request an additional 100 million doses.", "url": "https://www.marketwatch.com/story/pfizer-biontech-reach-deal-to-supply-eu-with-200-million-doses-of-its-covid-19-vaccine-candidate-2020-11-11"}, {"symbol": "PFE", "publishedDate": "2020-11-11 06:15:00", "title": "Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2", "image": "https://cdn.snapi.dev/images/v1/i/a/press9---awq9udxjup.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. Deliveries are anticipated to start by the end of 2020, subject to clinical success and r", "url": "https://www.businesswire.com/news/home/20201111005405/en/Pfizer-and-BioNTech-Reach-an-Agreement-to-Supply-the-EU-With-200-Million-Doses-of-Their-BNT162b2-mRNA-Based-Vaccine-Candidate-Against-SARS-CoV-2/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 06:06:00", "title": "5 Reasons Chasing COVID-19 Vaccine Stocks Is a Bad Idea", "image": "https://cdn.snapi.dev/images/v1/w/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6000002fdoctor-giving-vaccine-flu-shot-to-senior-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors are setting themselves up for disappointment.", "url": "https://www.fool.com/investing/2020/11/11/5-reasons-chasing-covid-19-vaccine-stocks-is-a-bad/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 05:21:00", "title": "Pfizer's Coronavirus Vaccine Data Is Better Than Meets the Eye", "image": "https://cdn.snapi.dev/images/v1/d/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998842fgettyimages-1219400893jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The probable winner of the vaccine race demonstrated that its candidate is at least 90% effective at preventing COVID-19 infection.", "url": "https://www.fool.com/investing/2020/11/11/pfizers-coronavirus-vaccine-data-is-better-than-me/"}, {"symbol": "PFE", "publishedDate": "2020-11-11 04:19:53", "title": "Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizers-ceo-cashed-out-60-of-his-stock-on-the-same-day-the-company-unveiled-the-results-of-its-covid-19-vaccine-trial.jpg", "site": "Business Insider", "text": "Pfizer CEO Albert Bourla sold 62% of his stock on the same day the company announced its experimental COVID-19 vaccine succeeded in clinical trials. The announcement sent Pfizer's shares soaring almost 15% on the day.", "url": "https://markets.businessinsider.com/news/stocks/pfizer-ceo-sold-stock-day-covid-19-vaccine-results-unveiled-2020-11-1029790705"}, {"symbol": "PFE", "publishedDate": "2020-11-11 03:11:57", "title": "Pfizer's vaccine news seems 'almost too good to be true': Standard Chartered", "image": "https://cdn.snapi.dev/images/v1/6/y/pfizers-vaccine-news-seems-almost-too-good-to-be-true-standard-chartered.jpg", "site": "CNBC International TV", "text": "Clive McDonnell of Standard Chartered Private Bank outlines risks and opportunities for the markets in light of the coronavirus pandemic and post-U.S. election.", "url": "https://www.youtube.com/watch?v=x3MFkfaSyOs"}, {"symbol": "PFE", "publishedDate": "2020-11-11 01:28:07", "title": "Freeze! Standex International And The Pfizer Vaccine", "image": "https://cdn.snapi.dev/images/v1/f/6/drugs15.jpg", "site": "Seeking Alpha", "text": "The Pfizer vaccine must be stored at -70 degrees Celsius. Anyone who wants to administer it will need an ultra low temp freezer. The market is mostly large companies like Thermo Fisher, but there is one public microcap, Standex International, that makes a limited line of these freezers.", "url": "https://seekingalpha.com/article/4387925-freeze-standex-international-and-pfizer-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-11 00:29:21", "title": "Pfizer's coronavirus vaccine faces 'huge' logistical challenges, says professor", "image": "https://cdn.snapi.dev/images/v1/8/z/pfizers-coronavirus-vaccine-faces-huge-logistical-challenges-says-professor.jpg", "site": "CNBC International TV", "text": "Maintaining optimal storage and shipping conditions for the coronavirus vaccine especially in low and middle-income countries will be a major challenge for Pfizer and its partners, says Paul Tambyah from the NUS Yong Loo Lin School of Medicine.", "url": "https://www.youtube.com/watch?v=cyMN13-pb5o"}, {"symbol": "PFE", "publishedDate": "2020-11-10 19:31:21", "title": "Pfizer vaccine results bode well for others in development: Biotech analyst", "image": "https://cdn.snapi.dev/images/v1/5/t/pfizer-vaccine-results-bode-well-for-others-in-development-biotech-analyst.jpg", "site": "CNBC Television", "text": "CNBC's Kelly Evans discusses the unknowns of Pfizer's vaccine effectiveness, including efficacy with older people and how long it may last, with Dr. Vincent Chen of Bernstein. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi \u00bb Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision \u00bb Subscribe to CNBC: https://cnb.cx/SubscribeCNBC \u00bb Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.", "url": "https://www.youtube.com/watch?v=10eAXfdcmPE"}, {"symbol": "PFE", "publishedDate": "2020-11-10 19:30:58", "title": "Why these biotech, pharma stocks have more upside: Analyst", "image": "https://cdn.snapi.dev/images/v1/m/q/why-these-biotech-pharma-stocks-have-more-upside-analyst.jpg", "site": "CNBC Television", "text": "CNBC's Kelly Evans talks with Ronny Gal of Bernstein to discuss how to invest in health care and pharma stocks right now. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi \u00bb Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision \u00bb Subscribe to CNBC: https://cnb.cx/SubscribeCNBC \u00bb Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.", "url": "https://www.youtube.com/watch?v=9t19zL3tjCU"}, {"symbol": "PFE", "publishedDate": "2020-11-10 18:07:51", "title": "Pfizer's Covid-19 vaccine candidate shows promise, but faces supply and distribution hurdles", "image": "https://cdn.snapi.dev/images/v1/f/h/pfizers-covid-19-vaccine-candidate-shows-promise-but-faces-supply-and-distribution-hurdles.jpg", "site": "CNBC Television", "text": "Dr. Kathleen Neuzil, University of Maryland School of Medicine director of the Center for Vaccine Development and Global Health, discusses the 90% efficacy of the Pfizer Covid-19 vaccine, and the supply and distribution challenges still ahead.", "url": "https://www.youtube.com/watch?v=a7pe6B0G7so"}, {"symbol": "PFE", "publishedDate": "2020-11-10 18:01:51", "title": "Gold Prices: Yesterday's Rally Put Our \u2018Trade of the Decade' on Sale", "image": "https://cdn.snapi.dev/images/v1/q/g/drugs13.jpg", "site": "InvestorPlace", "text": "I've been saying that I expect the\u00a0gold price to double over the next two or three years, and I've also told you that gold will win out over the dollar. Yesterday's news changes none of that.", "url": "https://investorplace.com/2020/11/gold-prices-yesterdays-rally-put-trade-of-decade-on-sale/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 17:35:33", "title": "\u2018I Trust Pfizer': Fauci Says He Would Take Coronavirus Vaccine Upon FDA Approval", "image": "https://cdn.snapi.dev/images/v1/s/k/i-trust-pfizer-fauci-says-he-would-take-coronavirus-vaccine-upon-fda-approval.jpg", "site": "Forbes", "text": "\u201cIf they look at this data, and they say this data is solid, let's go ahead and approve it.\u201d", "url": "https://www.forbes.com/sites/carlieporterfield/2020/11/10/i-trust-pfizer-fauci-says-he-would-take-coronavirus-vaccine-upon-fda-approval/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 17:32:33", "title": "Market Insight: What's Behind Monday's Huge Rally", "image": "https://cdn.snapi.dev/images/v1/b/w/drugs12.jpg", "site": "InvestorPlace", "text": "At first glance, this rally looks great. But if you dig underneath the surface, you'll see that this was actually a \u201cmean reversion\u201d rally and a big shift out of growth and into value.", "url": "https://investorplace.com/2020/11/market-insight-whats-behind-mondays-huge-rally/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 17:12:19", "title": "MoneyLine Podcast: The Best Sectors for a Biden Administration", "image": "https://cdn.snapi.dev/images/v1/g/z/biotech7---8r9txcronv.jpg", "site": "InvestorPlace", "text": "On this episode of MoneyLine, Matt McCall talks about what a Biden presidency would mean, as well as which sectors and stocks are set to blow. The post MoneyLine Podcast: The Best Sectors for a Biden Administration appeared first on InvestorPlace.", "url": "https://investorplace.com/moneywire/2020/11/moneyline-podcast-the-best-sectors-for-a-biden-administration/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 16:29:30", "title": "Causeway Capital Commentary- Update on Covid019 Vaccines: A Major Breakthrough for mRNA Technology", "image": "https://cdn.snapi.dev/images/v1/i/s/isksk22.jpg", "site": "GuruFocus", "text": "November 9, 2020", "url": "https://www.gurufocus.com/news/1282089/causeway-capital-commentary-update-on-covid019-vaccines-a-major-breakthrough-for-mrna-technology"}, {"symbol": "PFE", "publishedDate": "2020-11-10 16:20:52", "title": "Sales of Pfizer's Covid Vaccine Could Hit $4.6 Billion in 2021", "image": "https://cdn.snapi.dev/images/v1/4/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5811442fdoctor-holding-covid-19-vaccine-with-thumb-upjpgw700opresize.jpg", "site": "GuruFocus", "text": "Nearly four months ago I wrote that should the Covid-19 vaccine being developed by Pfizer Inc. (NYSE:PFE) prove successful, it could generate revenue of $15 billion. That expectation is moving closer to reality after the New York-based pharmaceutical leader and partner BioNTech SE (NASDAQ:BNTX) announced on Monday their leading candidate worked 90% of the time.", "url": "https://www.gurufocus.com/news/1282068/sales-of-pfizers-covid-vaccine-could-hit-46-billion-in-2021"}, {"symbol": "PFE", "publishedDate": "2020-11-10 16:00:50", "title": "Pfizer plans \u2018just-in-time' COVID-19 vaccine distribution in Canada", "image": "https://cdn.snapi.dev/images/v1/a/p/covid19vaccine1110.jpg", "site": "FreightWaves", "text": "Pfizer (NYSE:PFE) plans to distribute its potential COVID-19 vaccine directly to the locations where it will be administered in Canada in specialized, temperature-controlled containers filled with dry ice under a \u201cflexible just-in-time\u201d logistics scheme, the company said. The pharmaceutical giant is developing its Canadian distribution plan with federal and provincial government agencies to deploy the vaccine in the event it is approved for use.", "url": "https://www.freightwaves.com/news/pfizer-plans-just-in-time-covid-19-vaccine-distribution-in-canada"}, {"symbol": "PFE", "publishedDate": "2020-11-10 15:02:35", "title": "BioNTech CEO on vaccine progress with Pfizer", "image": "https://cdn.snapi.dev/images/v1/c/h/biontech-ceo-on-vaccine-progress-with-pfizer.jpg", "site": "CNBC Television", "text": "BioNTech CEO Dr. Ugur Sahin joins 'Power Lunch' to discuss the Covid-19 vaccine it is working on with Pfizer, the high efficiency rate and the storage of the vaccine.", "url": "https://www.youtube.com/watch?v=k9VNPMpfneA"}, {"symbol": "PFE", "publishedDate": "2020-11-10 14:45:22", "title": "Pfizer and BioNTech could make $13bn from coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/d/n/3500jpgwidth460quality85autoformatfitmaxs562e35b06414ab497c157f16bf2eac08.jpg", "site": "The Guardian", "text": "Johnson & Johnson and AstraZeneca pledged to make their vaccines available on a not-for-profit basis", "url": "https://www.theguardian.com/business/2020/nov/10/pfizer-and-biontech-could-make-13bn-from-coronavirus-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-10 13:00:00", "title": "Vaccine Hopes & Divided Government: Sector ETFs to Win", "image": "https://cdn.snapi.dev/images/v1/l/b/biotech2---kbdvltrcw4.jpg", "site": "Zacks Investment Research", "text": "News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.", "url": "https://www.zacks.com/stock/news/1099853/vaccine-hopes-divided-government-sector-etfs-to-win"}, {"symbol": "PFE", "publishedDate": "2020-11-10 12:11:30", "title": "Former FDA chief scientist on Pfizer vaccine", "image": "https://cdn.snapi.dev/images/v1/q/s/former-fda-chief-scientist-on-pfizer-vaccine.jpg", "site": "CNBC Television", "text": "The FDA has granted Eli Lilly's treatment emergency use authorization. Jesse Goodman, former FDA vaccine division chief, joins 'Squawk Alley' to discuss the Pfizer vaccine and the rise of coronavirus cases.", "url": "https://www.youtube.com/watch?v=EdVB0oy0oXw"}, {"symbol": "PFE", "publishedDate": "2020-11-10 12:00:00", "title": "Why Pfizer's Covid-19 Vaccine Is Unlikely To Move The Needle For The Stock", "image": "https://cdn.snapi.dev/images/v1/d/w/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock.jpg", "site": "Forbes", "text": "Pfizer (NYSE: PFE) and its German partner BioNTech indicated that their Coronavirus vaccine, dubbed BNT162b2, was over 90% effective at preventing Covid-19 infections among volunteers, based on early data from phase 3 trials.", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/10/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 11:59:52", "title": "Here's how millennials traded stocks on the Pfizer news", "image": "https://cdn.snapi.dev/images/v1/7/7/heres-how-millennials-traded-stocks-on-the-pfizer-news.jpg", "site": "CNBC Television", "text": "Millennials were taking profits on the travel stock rise while doubling down on the stay-at-home stocks. CNBC's Kate Rooney reports.", "url": "https://www.youtube.com/watch?v=kd-wio3VpFU"}, {"symbol": "PFE", "publishedDate": "2020-11-10 11:49:39", "title": "Pfizer Vaccine Puts a Return to Normal Within Reach in 2021", "image": "https://cdn.snapi.dev/images/v1/a/g/pfizer-vaccine-puts-a-return-to-normal-within-reach-in-2021-440x250.png", "site": "ETF Trends", "text": "Election Outcome Boosted Risk-On Theme Last Week One headline changes the narrative about the pandemic; or does it? Pfizer's vaccine study results Monday morning are shockingly good with over 90% effectiveness in preventing infection.", "url": "https://www.etftrends.com/etf-strategist-channel/pfizer-vaccine-puts-a-return-to-normal-within-reach-in-2021/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 11:43:22", "title": "Trump Falsely Takes Credit For Pfizer Vaccine Success, Accuses FDA And Democrats Of Stalling News Until After Election", "image": "https://cdn.snapi.dev/images/v1/a/k/trump-falsely-takes-credit-for-pfizer-vaccine-success-accuses-fda-and-democrats-of-stalling-news-until-after-election.jpg", "site": "Forbes", "text": "Trump's Operation Warp Speed didn't fund the Pfizer drug, though the government did agree to buy the vaccine when approved.", "url": "https://www.forbes.com/sites/roberthart/2020/11/10/trump-falsely-takes-credit-for-pfizer-vaccine-success-accuses-fda-and-democrats-of-stalling-news-until-after-election/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 11:11:25", "title": "Pfizer's Covid-19 vaccine has nothing to do with politics: Caret Group's Fred Hassan", "image": "https://cdn.snapi.dev/images/v1/i/x/pfizers-covid-19-vaccine-has-nothing-to-do-with-politics-caret-groups-fred-hassan.jpg", "site": "CNBC Television", "text": "Fred Hassan, The Caret Group chairman and Amgen board member, joins 'Squawk on the Street' to discuss how he would distribute the Pfizer Covid-19 vaccine and the money beyond Operation Warp Speed.", "url": "https://www.youtube.com/watch?v=vFMhE3WbQzk"}, {"symbol": "PFE", "publishedDate": "2020-11-10 11:04:00", "title": "Health secretary Alex Azar said Pfizer's coronavirus vaccine will be available to 'all Americans' by April", "image": "https://cdn.snapi.dev/images/v1/h/e/health-secretary-alex-azar-said-pfizers-coronavirus-vaccine-will-be-available-to-all-americans-by-april.jpg", "site": "Business Insider", "text": "When pharmaceutical company Pfizer announced Monday its experimental coronavirus vaccine may be 90% effective, many questions remained, including when it may be available and for whom. On Tuesday's episode of the Today Show, Secretary of Health and Human Services Alex Azar addressed those questions, saying the general public should have access to the vaccine and potentially others, like one in development by Moderna, by the end of March and early April 2021.", "url": "https://www.businessinsider.com/alex-azar-pfizer-vaccine-available-to-all-americans-by-april-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-10 10:49:43", "title": "Pfizer Analysts Raise Odds Of Success For Coronavirus Vaccine Candidate To 100%", "image": "https://cdn.snapi.dev/images/v1/e/d/virus-4030721-1920-0.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) reported Monday with strong Phase 3 interim efficacy data for its coronavirus vaccine candidate. The Pfizer Analysts: Morgan Stanley analyst David Risinger has an Equal-weight rating on Pfizer with a\u00a0$42 price target.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18299631/pfizer-analysts-raise-odds-of-success-for-coronavirus-vaccine-candidate-to-100"}, {"symbol": "PFE", "publishedDate": "2020-11-10 10:19:00", "title": "Blue Chips & Tech Going Separate Directions: PFE, GOOGL, FB, LLY & More", "image": "https://cdn.snapi.dev/images/v1/r/n/data-internet13.jpg", "site": "Zacks Investment Research", "text": "The last time we saw the Dow surge strongly ahead while the Nasdaq dipped into the red was back in 2000, when the tech bubble of the pre-Y2K market began to burst.", "url": "https://www.zacks.com/stock/news/1099621/blue-chips-tech-going-separate-directions-pfe-googl-fb-lly-more"}, {"symbol": "PFE", "publishedDate": "2020-11-10 09:37:00", "title": "Pfizer COVID-19 Vaccine Data Raises Hopes for Industry, Economy", "image": "https://cdn.snapi.dev/images/v1/1/5/drugs7---taxmwmtpoc.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 90% effective in phase III.", "url": "https://www.zacks.com/stock/news/1099561/pfizer-covid-19-vaccine-data-raises-hopes-for-industry-economy"}, {"symbol": "PFE", "publishedDate": "2020-11-10 09:33:49", "title": "Pfizer Covid-19 Vaccine's next big challenge: giving it to enough people", "image": "https://cdn.snapi.dev/images/v1/n/c/drugs4.jpg", "site": "Fox Business", "text": "Even for rich nations with developed vaccination programs, that presents a host of problems ranging including building new databases to track who is getting the shot, working out ways to encourage mass uptake among younger people, ensuring adequate supply and running large-scale inoculation centers where the shots can be safely and quickly administered.", "url": "https://www.foxbusiness.com/markets/pfizer-covid-19-vaccines-next-big-challenge-giving-it-to-enough-people"}, {"symbol": "PFE", "publishedDate": "2020-11-10 08:37:10", "title": "Pfizer Covid-19 Vaccine's Five Big Unknowns", "image": "https://cdn.snapi.dev/images/v1/g/w/pfizer-covid-19-vaccines-five-big-unknowns.jpg", "site": "Forbes", "text": "Pfizer's Covid-19 vaccine could grab $15 billion in profit from a $100 billion market -- if it can answer five big questions", "url": "https://www.forbes.com/sites/petercohan/2020/11/10/pfizer-covid-19-vaccines-five-big-unknowns/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 08:02:00", "title": "Novavax Steals Some of Pfizer's Thunder With Fast Track Designation", "image": "https://cdn.snapi.dev/images/v1/g/4/biotech17.jpg", "site": "InvestorPlace", "text": "Novavax delivered good news Nov. 9. It announced its Covid-19 vaccine's been fast-tracked by the FDA.", "url": "https://investorplace.com/2020/11/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 08:00:00", "title": "Vaccine Developments Knock Election News Off Front Page - Scott Martin Joins Alpha Trader", "image": "https://cdn.snapi.dev/images/v1/a/6/podc1.jpg", "site": "Seeking Alpha", "text": "Vaccine Developments Knock Election News Off Front Page - Scott Martin Joins Alpha Trader", "url": "https://seekingalpha.com/article/4387272-vaccine-developments-knock-election-news-off-front-page-scott-martin-joins-alpha-trader"}, {"symbol": "PFE", "publishedDate": "2020-11-10 07:42:40", "title": "Pfizer has a potential vaccine. Now what?", "image": "https://cdn.snapi.dev/images/v1/m/f/pfi1a.jpg", "site": "The Dog of Wall Street", "text": "Industries like entertainment, travel and hospitality, airlines, cruise ships, and casinos, were just a few of the sectors that reacted positively to the news.", "url": "https://thedogofwallstreet.com/pfe/pfizer-has-a-potential-vaccine-now-what"}, {"symbol": "PFE", "publishedDate": "2020-11-10 07:00:59", "title": "Meet Kathrin Jansen, the woman leading Pfizer's COVID-19 vaccine effort", "image": "https://cdn.snapi.dev/images/v1/z/p/poster-kathrin-jansen-pfizer.jpg", "site": "Fast Company", "text": "The rock star scientist has a track record of producing difficult vaccines against the odds. Pfizer has made an incredible announcement: Its COVID-19 vaccine looks like it is 90% effective at preventing the disease inside its clinical trial.", "url": "https://www.fastcompany.com/90573460/kathrin-jansen-pfizer-covid-19-vaccine-scientist"}, {"symbol": "PFE", "publishedDate": "2020-11-10 06:48:17", "title": "20 Million Doses Of Pfizer's Covid-19 Vaccine Headed To Spain In Early 2021", "image": "https://cdn.snapi.dev/images/v1/r/a/20-million-doses-of-pfizers-covid-19-vaccine-headed-to-spain-in-early-2021.jpg", "site": "Forbes", "text": "Early data from the vaccine's clinical trial shows it could be 90% effective at preventing the disease.", "url": "https://www.forbes.com/sites/roberthart/2020/11/10/20-million-doses-of-pfizers-covid-19-vaccine-headed-to-spain-in-early-2021/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 06:12:00", "title": "These are the non-pharma winners and losers from the Pfizer vaccine results", "image": "https://cdn.snapi.dev/images/v1/b/q/im-257642width620size15005861664712778.jpg", "site": "Market Watch", "text": "The 7 most important takeaways for investors.", "url": "https://www.marketwatch.com/story/these-are-the-non-pharma-winners-and-losers-from-the-pfizer-vaccine-results-11604970629"}, {"symbol": "PFE", "publishedDate": "2020-11-10 06:05:00", "title": "3 Stocks That Should Be Big Winners Under Joe Biden's Coronavirus Plan", "image": "https://cdn.snapi.dev/images/v1/j/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5997762fjoe-biden-whitehousegovjpgw700opresize.jpg", "site": "The Motley Fool", "text": "They check off the boxes for three of the President-elect's top COVID-19 priorities.", "url": "https://www.fool.com/investing/2020/11/10/3-stocks-that-should-be-big-winners-under-joe-bide/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 05:54:00", "title": "2 Best Pharma Stocks to Buy in November", "image": "https://cdn.snapi.dev/images/v1/q/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5987972fgettyimages-1205966780jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The two pharma stocks offer investors the upside of a coronavirus vaccine with the peace of mind of century-old businesses.", "url": "https://www.fool.com/investing/2020/11/10/2-best-pharma-stocks-to-buy-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-11-10 04:00:32", "title": "Health care researcher: Four questions to ask about Pfizer and BioNTech vaccine", "image": "https://cdn.snapi.dev/images/v1/o/d/health-care-researcher-four-questions-to-ask-about-pfizer-and-biontech-vaccine.jpg", "site": "CNBC International TV", "text": "Tara Raveendran, head of life sciences research at Shore Capital, analyzes the read-outs from the late-stage Pfizer and BioNTech Covid-19 vaccine trial.", "url": "https://www.youtube.com/watch?v=nejJ5mPxQF4"}, {"symbol": "PFE", "publishedDate": "2020-11-10 03:26:54", "title": "Regulatory agencies still need to review Pfizer's vaccine on safety: Professor", "image": "https://cdn.snapi.dev/images/v1/v/r/regulatory-agencies-still-need-to-review-pfizers-vaccine-on-safety-professor.jpg", "site": "CNBC International TV", "text": "Joshua Sharfstein from Johns Hopkins Bloomberg School of Public Health says Pfizer's coronavirus vaccine still needs to go through regulatory review for safety, and in the meantime, the public should continue practicing good hygience and social distancing.", "url": "https://www.youtube.com/watch?v=mpgDyEW3Xq8"}, {"symbol": "PFE", "publishedDate": "2020-11-10 03:15:00", "title": "Spain to get first Pfizer vaccines in early 2021, Health Minister says", "image": "https://cdn.snapi.dev/images/v1/s/y/m02d20201110t2i1540664257w940fhfwllplsqrlynxmpega90iq.jpg", "site": "Reuters", "text": "Spain would get the first vaccines developed by U.S. pharmaceutical giant Pfizer in early 2021, Health Minister Salvador Illa said on Tuesday.", "url": "https://www.reuters.com/article/us-health-coronavirus-spain-vaccine/spain-to-get-first-pfizer-vaccines-in-early-2021-health-minister-says-idUSKBN27Q0Y3"}, {"symbol": "PFE", "publishedDate": "2020-11-10 02:52:56", "title": "Pfizer's COVID-19 Vaccine News Throws Bitcoin Rally Off Course", "image": "https://cdn.snapi.dev/images/v1/p/g/dmitry-demidko-og3a-ilg8ay-unsplash-2.jpg", "site": "Benzinga", "text": "Bitcoin traded nearly flat but above the $15,000 level at press-time after going as low as $14,865.33 in a 24-hour period. What Happened: Bitcoin's price fell by nearly $1,000 on Monday as stocks rallied after Pfizer Inc (NYSE: PFE) said its coronavirus vaccine was 90% effective in preventing COVID-19.", "url": "https://www.benzinga.com/markets/cryptocurrency/20/11/18290619/pfizers-covid-19-vaccine-news-throws-bitcoin-rally-off-course"}, {"symbol": "PFE", "publishedDate": "2020-11-10 02:47:00", "title": "The New York Post: Pfizer COVID-19 vaccine could be given by the end of the year: Fauci", "image": "https://cdn.snapi.dev/images/v1/k/f/im-257683width620size14988290398126465.jpg", "site": "Market Watch", "text": "Dr. Anthony Fauci said Monday that Pfizer's coronavirus vaccine could be administered to people by the end of the year.", "url": "https://www.marketwatch.com/story/pfizer-covid-19-vaccine-could-be-given-by-the-end-of-the-year-fauci-11604994465"}, {"symbol": "PFE", "publishedDate": "2020-11-10 00:41:24", "title": "Coronavirus vaccine: Pfizer's vaccine trials show a vaccine is 90% effective", "image": "https://cdn.snapi.dev/images/v1/r/z/coronavirus-vaccine-pfizers-vaccine-trials-show-a-vaccine-is-90-effective.jpg", "site": "Yahoo Finance", "text": "Yahoo Lifestyle writer and editor Abby Haglage breaks down Pfizer's news of a vaccine that shows 90% effective rate in trials. In long-awaited good news Monday, drugmaker Pfizer announced that its vaccine candidate \u2014 created with German biotechnology company BioNTech SE \u2014 was 90 percent effective in preventing COVID-19 in phase III clinical trials.", "url": "https://www.youtube.com/watch?v=xOmAcVEbEps"}, {"symbol": "PFE", "publishedDate": "2020-11-09 19:51:00", "title": "Why Video Game and Streaming Stocks Plunged Today", "image": "https://cdn.snapi.dev/images/v1/q/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999262fgame-controller-on-a-tablejpgw700opresize.jpg", "site": "The Motley Fool", "text": "If people go back to work, will they really stop playing video games?", "url": "https://www.fool.com/investing/2020/11/09/why-video-game-stocks-plunged-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 19:32:44", "title": "Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'", "image": "https://cdn.snapi.dev/images/v1/f/k/jim-cramer-pfizer-vaccine-news-is-a-new-chapter-for-the-market.jpg", "site": "CNBC Television", "text": "\"I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week,\" the \"Mad Money\" host said.", "url": "https://www.youtube.com/watch?v=Y6aIEtO4T_s"}, {"symbol": "PFE", "publishedDate": "2020-11-09 19:21:13", "title": "Who will be first to get the Pfizer Covid vaccine?", "image": "https://cdn.snapi.dev/images/v1/8/d/who-will-be-first-to-get-the-pfizer-covid-vaccine.jpg", "site": "CNBC Television", "text": "There are limited dosages available for Pfizer's Covid vaccine. Former FDA Commissioner Dr. Scott Gottlieb discusses who is likely to get the vaccine first in the United States.", "url": "https://www.youtube.com/watch?v=lEZgMvNZ26s"}, {"symbol": "PFE", "publishedDate": "2020-11-09 19:17:52", "title": "Pfizer's Covid vaccine is more than 90% effective, but there is low supply", "image": "https://cdn.snapi.dev/images/v1/q/q/pfizers-covid-vaccine-is-more-than-90-effective-but-there-is-low-supply.jpg", "site": "CNBC Television", "text": "Stocks rallied today on news of Pfizer's Covid vaccine, which has proven to be more than 90% effective in trials. There will be 50 million doses of it available this year and about 1.3 billion in 2021.", "url": "https://www.youtube.com/watch?v=H0p5I0SH_u4"}, {"symbol": "PFE", "publishedDate": "2020-11-09 18:15:00", "title": "Brazil in talks with Pfizer to buy promising COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/q/0/m02d20201109t2i1540615121w940fhfwllplsqrlynxmpega81l9.jpg", "site": "Reuters", "text": "The Brazilian federal government is in talks with Pfizer Inc in Brazil to buy its experimental COVID-19 vaccine for inclusion in its national vaccination program, a spokesman for the company said on Monday.", "url": "https://www.reuters.com/article/us-health-coronavirus-pfizer-brazil/brazil-in-talks-with-pfizer-to-buy-promising-covid-19-vaccine-idUSKBN27P2LD"}, {"symbol": "PFE", "publishedDate": "2020-11-09 17:47:00", "title": "As S&P 500 Roars to Near-Highs, Here's One Mindblowing Stat About Today's 100 Best- Performing Stocks", "image": "https://cdn.snapi.dev/images/v1/c/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999472fman-with-rocketsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Despite a bad day for some of 2020's best stocks, news of what looks like an effective coronavirus vaccine has investors buying big today.", "url": "https://www.fool.com/investing/2020/11/09/as-sp-500-roars-to-near-highs-heres-one-mindblowin/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 17:13:56", "title": "Pfizer's \u201890% Effective' Vaccine News Doesn't Mean Stimulus Is Dead", "image": "https://cdn.snapi.dev/images/v1/7/u/pfizers-90-effective-vaccine-news-doesnt-mean-stimulus-is-dead.jpg", "site": "Forbes", "text": "Investors cheered the long-awaited good news, but we're not out of the woods yet.", "url": "https://www.forbes.com/sites/sarahhansen/2020/11/09/pfizers-90-effective-vaccine-news-doesnt-mean-stimulus-is-dead/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 17:04:05", "title": "Market Insight: 3 Takeaways From Today's Massive Rally", "image": "https://cdn.snapi.dev/images/v1/z/c/data-internet5.jpg", "site": "InvestorPlace", "text": "While Matt McCall hopes some of your stocks were up big today, he also suggests keeping an even keel. Here are his three key takeaways to today's market action.", "url": "https://investorplace.com/moneywire/2020/11/market-insight-3-takeaways-from-todays-massive-rally/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 16:37:00", "title": "Vaccine Hope Sent These Retailers Soaring Monday", "image": "https://cdn.snapi.dev/images/v1/z/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5597632fbusy-retail-mall-closing-slide-source-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These four retailers are soaring today as an effective vaccine would help return the world, and shopping, to near-normal.", "url": "https://www.fool.com/investing/2020/11/09/vaccine-hope-sent-these-retailers-soaring-monday/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 16:22:00", "title": "Stocks Are Crushing It Today: Here's Why These 4 Stocks Fell", "image": "https://cdn.snapi.dev/images/v1/y/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999162farrows-up-and-downjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The likelihood of a coronavirus vaccine has investors looking away from these companies, despite their great prospects.", "url": "https://www.fool.com/investing/2020/11/09/stocks-are-crushing-it-today-heres-why-these-5-sto/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 16:15:00", "title": "Why a COVID-19 Vaccine in 2021 Would Be Such a Boost for Bank Stocks", "image": "https://cdn.snapi.dev/images/v1/8/b/103334235-gettyimages-498338509.jpg", "site": "The Motley Fool", "text": "An effective vaccine in 2021 could get the economy churning at a more normal level and effectively help banks avoid some of the loan losses they are currently projecting.", "url": "https://www.fool.com/investing/2020/11/09/why-a-covid-19-vaccine-in-2021-would-be-such-a-boo/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 16:14:57", "title": "Pfizer's vaccine trial 'raises the bar' for other pharmaceutical companies: Jefferies' Jared Holz", "image": "https://cdn.snapi.dev/images/v1/x/j/pfizers-vaccine-trial-raises-the-bar-for-other-pharmaceutical-companies-jefferies-jared-holz.jpg", "site": "CNBC Television", "text": "Jared Holz, Jefferies, healthcare equity strategist, joins 'Closing Bell' to talk about his thoughts on Pfizer's 90 percent effective vaccine trial that's driving the markets today. He says the result pushes other pharmaceutical companies to produce effective, low-cost vaccines.", "url": "https://www.youtube.com/watch?v=icdUkJkMEnw"}, {"symbol": "PFE", "publishedDate": "2020-11-09 16:11:36", "title": "This is great news, but it's too soon to be certain: Fmr. CDC director on Pfizer's vaccine trial", "image": "https://cdn.snapi.dev/images/v1/d/n/this-is-great-news-but-its-too-soon-to-be-certain-fmr-cdc-director-on-pfizers-vaccine-trial.jpg", "site": "CNBC Television", "text": "Dr. Tom Frieden, former CDC director under President Obama, says he is encouraged by the data from Pfizer's vaccine trials that showed it would be 90 percent effective. But he also warned it's too soon to tell if it will work for everyone.", "url": "https://www.youtube.com/watch?v=VkIBD6EnF4Y"}, {"symbol": "PFE", "publishedDate": "2020-11-09 15:42:17", "title": "Pfizer vaccine is going to be great for the U.S. economy: Trian Partners CEO Nelson Peltz", "image": "https://cdn.snapi.dev/images/v1/t/b/pfizer-vaccine-is-going-to-be-great-for-the-us-economy-trian-partners-ceo-nelson-peltz.jpg", "site": "CNBC Television", "text": "Nelson Peltz, Trian Partners CEO, joins 'Closing Bell' to discuss his take on the Pfizer vaccine and what it means for the U.S. economy. He also discusses the outcome of the 2020 presidential election and its impact on the market.", "url": "https://www.youtube.com/watch?v=yusQ-obBXb8"}, {"symbol": "PFE", "publishedDate": "2020-11-09 15:41:23", "title": "What Pfizer's Coronavirus Vaccine Data Means For Moderna", "image": "https://cdn.snapi.dev/images/v1/p/j/dna-24559-1280-21.png", "site": "Benzinga", "text": "Moderna Inc (NASDAQ: MRNA) shares were advancing strongly Monday after a rival vaccine developed by Pfizer Inc. (NYSE: PFE) and\u00a0BioNTech SE \u2013 ADR (NASDAQ: BNTX) showed efficacy in a late-stage study. High Bar For Moderna To Clear: The 90% vaccine efficacy demonstrated by Pfizer and BioNTech sets an extremely high bar for Moderna, SVB Leerink analyst Mani Foroohar said in a Monday note.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18279366/what-pfizers-coronavirus-vaccine-data-means-for-moderna"}, {"symbol": "PFE", "publishedDate": "2020-11-09 15:29:03", "title": "What You Need To Know In Options This Week: SPY, Disney, Cisco, Draft Kings, Pfizer And More", "image": "https://cdn.snapi.dev/images/v1/1/j/chart-5222700-1920-39.png", "site": "Benzinga", "text": "The DJIA and S&P 500 are soaring this morning following a promising Covid vaccine announcement from Pfizer\u00a0(NYSE: PFE). The more tech heavy Nasdaq is mixed.", "url": "https://www.benzinga.com/markets/options/20/11/18283410/what-you-need-to-know-in-options-this-week-spy-disney-cisco-draft-kings-pfizer-and-more"}, {"symbol": "PFE", "publishedDate": "2020-11-09 15:26:37", "title": "Here's what to know about how Pfizer and BioNTech's Covid-19 vaccine will be transported", "image": "https://cdn.snapi.dev/images/v1/5/u/heres-what-to-know-about-how-pfizer-and-biontechs-covid-19-vaccine-will-be-transported.jpg", "site": "CNBC Television", "text": "Pfizer and BioNTech have announced a Covid-19 vaccine that is more than 90 percent effective. Lori Ann LaRocco, CNBC senior editor, joins 'Power Lunch' to discuss how the vaccine will be transported and how quickly will there be mass production.", "url": "https://www.youtube.com/watch?v=V-a3D-bHLro"}, {"symbol": "PFE", "publishedDate": "2020-11-09 15:05:32", "title": "Travel companies cheer Pfizer Covid vaccine news as 'welcomed step' toward return in demand", "image": "https://cdn.snapi.dev/images/v1/p/u/106723726-1601478306430-gettyimages-1220515510-1006-08-fl200415019.jpeg", "site": "CNBC", "text": "\"Today's Pfizer news is a welcomed step in the right direction,\" TripAdvisor CEO Steve Kaufer told CNBC.", "url": "https://www.cnbc.com/2020/11/09/pfizer-covid-vaccine-travel-companies-see-it-as-welcomed-step-.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:53:09", "title": "ETF Edge: Impact of the election and Pfizer's vaccine news", "image": "https://cdn.snapi.dev/images/v1/y/b/etf-edge-impact-of-the-election-and-pfizers-vaccine-news.jpg", "site": "CNBC Television", "text": "Matt Bartolini, State Stree; Nick Colas, DataTrek; and Brendan Ahern, KranShares, discuss the election results and Pfizer's big vaccine news, and what it means for the ETF market.", "url": "https://www.youtube.com/watch?v=DEINt6gLU7Q"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:51:19", "title": "Jefferies analyst makes the case for Moderna after Pfizer and BioNTech rise on Covid-19 vaccine news", "image": "https://cdn.snapi.dev/images/v1/p/d/jefferies-analyst-makes-the-case-for-moderna-after-pfizer-and-biontech-rise-on-covid-19-vaccine-news.jpg", "site": "CNBC Television", "text": "Michael Yee, Jefferies health care and biotech analyst, joins 'Power Lunch' to discuss the news that Pfizer and BioNtech have announced a Covid-19 vaccine is more than 90 percent effective and what it means for biotech sector.", "url": "https://www.youtube.com/watch?v=zf7fYIF-0X4"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:42:00", "title": "Pfizer vaccine is not a \u2018slam dunk,' warns U.K. prime minister", "image": "https://cdn.snapi.dev/images/v1/v/n/im-257343width620size14988290398126465.jpg", "site": "Market Watch", "text": "Boris Johnson said: \u201cI just don't want to let people run away with the idea that this . . . is necessarily a home run, a slam dunk, a shot to the back of the net yet.", "url": "https://www.marketwatch.com/story/pfizer-vaccine-is-not-a-slam-dunk-warns-u-k-prime-minister-11604950947"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:27:00", "title": "Why These Fast Food Stocks Popped Monday Morning", "image": "https://cdn.snapi.dev/images/v1/p/r/sk22-2.jpg", "site": "The Motley Fool", "text": "Pfizer's vaccine data was welcome news for many restaurant stocks.", "url": "https://www.fool.com/investing/2020/11/09/why-these-fast-food-stocks-popped-monday-morning/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:25:48", "title": "Pfizer's promising COVID-19 vaccine trials is good news for Moderna's tests, Fauci says", "image": "https://cdn.snapi.dev/images/v1/k/n/200512-moderna-768x504.jpg", "site": "GeekWire", "text": "Pharmaceutical giant Pfizer on Monday announced promising results from its COVID-19 vaccine trials, showing that it was more than 90% effective in preventing the disease.", "url": "https://www.geekwire.com/2020/pfizers-promising-covid-19-vaccine-trials-good-news-modernas-tests-fauci-says/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:24:00", "title": "Pfizer Vaccine News Pumps Up Oil Prices", "image": "https://cdn.snapi.dev/images/v1/v/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998682fstock-market-arrow-rising-above-a-stack-of-oil-barrelsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Demand for oil could rise, and OPEC says it can meet the demand.", "url": "https://www.fool.com/investing/2020/11/09/pfizer-vaccine-news-pumps-up-oil-prices/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:20:23", "title": "U.S. health officials 'very optimistic' Pfizer coronavirus vaccine and others 'could effectively end the pandemic'", "image": "https://cdn.snapi.dev/images/v1/g/p/106588987-15929301292020-06-23t162754z-374314806-rc24fh98j533-rtrmadp-0-health-coronavirus-usa-congress.jpeg", "site": "CNBC", "text": "A senior administration official said Monday that U.S. health officials are \u201cextremely encouraged\u201d by the announcement that Pfizer's coronavirus vaccine is highly effective in preventing Covid-19.", "url": "https://www.cnbc.com/2020/11/09/pfizer-coronavirus-vaccine-us-officials-optimistic-pandemic-could-end.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:15:04", "title": "How Pfizer's COVID-19 vaccine works: mRNA", "image": "https://cdn.snapi.dev/images/v1/d/i/p-1-90573488-mrna-vaccines.jpg", "site": "Fast Company", "text": "The vaccine uses a new, innovative form of biotechnology to make the body produce antibodies to protect itself against the virus. In January, as cases of the new, mysterious coronavirus were growing in China\u2014but two months before the World Health Organization declared the disease a pandemic\u2014a handful of small biotech companies began scrambling to develop vaccines using an as-yet-unproven technology platform that relies on something called messenger RNA, usually shortened to mRNA.", "url": "https://www.fastcompany.com/90573488/how-pfizers-covid-19-vaccine-works-mrna"}, {"symbol": "PFE", "publishedDate": "2020-11-09 14:01:39", "title": "Pfizer CEO wants to be \u2018among the first' to take COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/g/c/pfizer-ceo-covid-vaccinejpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer will likely have millions of coronavirus vaccine doses ready by the end of 2020 \u2014 and the company's CEO is willing to be one of the first to take it. The Manhattan-based drugmaker expects to churn out up to 50 million doses of the shot globally this year and is in \u201ca very, very.", "url": "https://nypost.com/2020/11/09/pfizer-covid-19-vaccine-nearly-50m-doses-will-be-ready-in-2020/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:56:00", "title": "Dow Jones Rockets 1,300 Points on Pfizer Vaccine News; Boeing Stock Soars; McDonald's Stock Drops Despite Earnings Beat", "image": "https://cdn.snapi.dev/images/v1/s/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5867412fgettyimages-1138898580jpgw700opresize.jpg", "site": "The Motley Fool", "text": "An effective vaccine could start rolling out this year, marking the beginning of the end of the pandemic.", "url": "https://www.fool.com/investing/2020/11/09/dow-jones-rockets-1300-points-on-pfizer-vaccine-ne/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:52:00", "title": "Pfizer COVID-19 vaccine news delivers hope around the globe", "image": "https://cdn.snapi.dev/images/v1/h/u/m02d20201109t2i1540583537w940fhfwllplsqrlynxmpega81mt.jpg", "site": "Reuters", "text": "News that Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results renewed hope on Monday among world leaders, scientists and global investors that the battle against a pandemic that has killed over a million people could be won.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccine-highlights/pfizer-covid-19-vaccine-news-delivers-hope-around-the-globe-idUSKBN27P2MO"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:51:58", "title": "PreMarket Prep Stock Of The Day: Pfizer", "image": "https://cdn.snapi.dev/images/v1/o/u/microscope-3184432-1920-109.jpg", "site": "Benzinga", "text": "Benzinga's\u00a0PreMarket Prep\u00a0airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.", "url": "https://www.benzinga.com/news/20/11/18280051/premarket-prep-stock-of-the-day-pfizer"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:45:00", "title": "Why Casual-Dining Stocks Are Soaring Today", "image": "https://cdn.snapi.dev/images/v1/0/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998632fcasual-dining-restaurantjpgw700opresize.jpg", "site": "The Motley Fool", "text": "News that Pfizer has an effective vaccine sent the sector surging.", "url": "https://www.fool.com/investing/2020/11/09/why-casual-dining-stocks-are-soaring-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:21:21", "title": "Trump Allies Are Rushing To Falsely Claim Government Credit For Pfizer Vaccine Success", "image": "https://cdn.snapi.dev/images/v1/w/0/trump-allies-are-rushing-to-falsely-claim-government-credit-for-pfizer-vaccine-success.jpg", "site": "Forbes", "text": "Trump's Operation Warp Speed didn't fund the Pfizer drug, though the government did agree to buy the vaccine.", "url": "https://www.forbes.com/sites/roberthart/2020/11/09/trump-allies-are-rushing-to-falsely-claim-government-credit-for-pfizer-vaccine-success/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 13:10:53", "title": "Options Traders Swarm PFE, BNTX After Vaccine News", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5820542fscientists-looking-through-microscopesjpgw700opresize.jpg", "site": "Schaeffers Research", "text": "This morning, we covered two pharmaceutical stocks that exploded after announcing some more-than-optimistic coronavirus vaccine news.", "url": "https://www.schaeffersresearch.com/content/options/2020/11/09/options-traders-swarm-pfe-bntx-after-vaccine-news"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:51:37", "title": "Pfizer CEO: Our vaccine timing had nothing to do with politics", "image": "https://cdn.snapi.dev/images/v1/4/t/201109095425-pfizer-covid-19-vaccine-clinical-trial-0909-restricted-super-169.jpg", "site": "CNN Business", "text": "Pfizer's encouraging news about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day. But Pfizer CEO Albert Bourla says the timing had nothing to do with politics.", "url": "https://www.cnn.com/2020/11/09/business/pfizer-covid-vaccine/index.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:29:18", "title": "Pfizer Analyst: Coronavirus Vaccine Moving Closer To Emergency Use Authorization", "image": "https://cdn.snapi.dev/images/v1/w/6/medicine-5103043-1920-24.jpg", "site": "Benzinga", "text": "Although the details of interim data from the Phase 3 trials of Pfizer Inc's (NYSE: PFE) COVID-19 vaccine study rea unclear, the results represent\u00a0\u201ca solid win\u201d for the company, according to BofA Securities. The Pfizer Analyst: Geoff Meacham maintained a Neutral rating on Pfizer with an unchanged $39 price target.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18275529/pfizer-analyst-coronavirus-vaccine-moving-closer-to-emergency-use-authorization"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:25:21", "title": "Pfizer Vaccine Prevents 90% of Infections in Large Study", "image": "https://cdn.snapi.dev/images/v1/0/8/pfizer-vaccine-prevents-90-of-infections-in-large-study.jpg", "site": "Bloomberg Markets and Finance", "text": "Nov.09 -- The Covid-19 vaccine under development by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a trial involving tens of thousands of volunteers. Bloomberg Intelligence's Sam Fazeli has the details on \u201cBloomberg Surveillance.", "url": "https://www.youtube.com/watch?v=41Yx96DOwrM"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:21:32", "title": "Walter Isaacson on being a Pfizer vaccine trial participant", "image": "https://cdn.snapi.dev/images/v1/k/o/walter-isaacson-on-being-a-pfizer-vaccine-trial-participant.jpg", "site": "CNBC Television", "text": "CNBC contributor Walter Isaacson and Dr. Purvi Parikh of NYU Langone join \"Squawk Alley\" to discuss Pfizer's developments on a coronavirus vaccine.", "url": "https://www.youtube.com/watch?v=x5WhwHuyJYg"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:17:00", "title": "Potential approval of Pfizer vaccine still several weeks away: U.S. official", "image": "https://cdn.snapi.dev/images/v1/y/o/m02d20201109t2i1540567184w940fhfwllplsqrlynxmpega81f5.jpg", "site": "Reuters", "text": "U.S. Health and Human Services Secretary Alex Azar said on Monday it would take several weeks for U.S. regulators to receive and then process data on Pfizer Inc's vaccine for the coronavirus before the government could potentially approve it.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-az/potential-approval-of-pfizer-vaccine-still-several-weeks-away-u-s-official-idUSKBN27P2CF"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:11:05", "title": "Is the Stock Market Getting Ahead of Itself on COVID-19 Vaccine News?", "image": "https://cdn.snapi.dev/images/v1/o/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998782fcovid-19-vaccine-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The stock market soared Monday morning, but some wonder if it'll last.", "url": "https://www.fool.com/investing/2020/11/09/is-stock-market-ahead-of-itself-covid-19-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:10:56", "title": "Pfizer Inc. (PFE) shares hit new 52-week high after positive results of Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/7/8/pfi1a.jpg", "site": "The Dog of Wall Street", "text": "Pfizer says its experimental coronavirus vaccine more than 90 percent effective in trials", "url": "https://thedogofwallstreet.com/bntx/pfizer-inc-pfe-shares-hit-new-52-week-high-after-positive-results-of-covid-19-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:06:13", "title": "Ivanka Trump Falsely Gives Credit To Government For Pfizer Vaccine Success", "image": "https://cdn.snapi.dev/images/v1/d/c/ivanka-trump-falsely-gives-credit-to-government-for-pfizer-vaccine-success.jpg", "site": "Forbes", "text": "Trump praised Pfizer's partnership with Operation Warp Speed, despite the government scheme only agreeing to buy the vaccine, while it has not funded the vaccine's development.", "url": "https://www.forbes.com/sites/roberthart/2020/11/09/ivanka-trump-falsely-gives-credit-to-government-for-pfizer-vaccine-success/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:05:00", "title": "Israel asks for U.S. help in getting potential Pfizer COVID-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/q/a/m02d20201109t2i1540565445w940fhfwllplsqrlynxmpega81et.jpg", "site": "Reuters", "text": "Israel said it asked the U.S. government on Monday to help it get access to Pfizer's potential COVID-19 vaccine.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-is/israel-asks-for-u-s-help-in-getting-potential-pfizer-covid-19-vaccine-idUSKBN27P2C0"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:01:51", "title": "Zoom, Peloton, Netflix: Stay-At-Home Stocks Are Getting Smoked By Pfizer's Latest Vaccine Prospects", "image": "https://cdn.snapi.dev/images/v1/p/q/zoom-peloton-netflix-stay-at-home-stocks-are-getting-smoked-by-pfizers-latest-vaccine-prospects.jpg", "site": "Forbes", "text": "Stocks that have posted massive gains this year are among the few\u2013and biggest\u2013losers in Monday's rally.", "url": "https://www.forbes.com/sites/jonathanponciano/2020/11/09/zoom-peloton-netflix-stay-at-home-stocks-are-getting-smoked-by-pfizers-latest-vaccine-prospects/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 12:01:27", "title": "Election, Pfizer vaccine give a lot more clarity: Matrix Asset Advisors CIO", "image": "https://cdn.snapi.dev/images/v1/f/i/election-pfizer-vaccine-give-a-lot-more-clarity-matrix-asset-advisors-cio.jpg", "site": "CNBC Television", "text": "David Katz, CIO of Matrix Asset Advisors, and Tony Roth, CIO of Wilmington Trust, join \"Squawk Alley\" to discuss the markets and the coronavirus vaccine.", "url": "https://www.youtube.com/watch?v=_eJmOf0MPXw"}, {"symbol": "PFE", "publishedDate": "2020-11-09 11:47:00", "title": "Restaurant Stocks Soar on Phenomenal Vaccine News", "image": "https://cdn.snapi.dev/images/v1/p/y/11abe1139b6397174ee3b87b18c83f55.png", "site": "The Motley Fool", "text": "Pfizer delivered an early holiday gift to restaurant investors Monday.", "url": "https://www.fool.com/investing/2020/11/09/restaurant-stocks-soar-on-phenomenal-vaccine-news/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 11:30:26", "title": "Walter Isaacson, a participant in Pfizer's Covid vaccine trial, describes what it's like", "image": "https://cdn.snapi.dev/images/v1/t/n/106717236-16010339452020-09-25t020718z-880456934-rc2e5j9xpzyt-rtrmadp-0-health-coronavirus-usa.jpeg", "site": "CNBC", "text": "\"I had zero worry\" going into the trial whether the vaccine was going to be safe, Isaacson told CNBC. But he does not know if he got the vaccine or the placebo.", "url": "https://www.cnbc.com/2020/11/09/walter-isaacson-part-of-the-pfizer-covid-vaccine-trial-describes-it.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 11:15:24", "title": "Coronavirus vaccine frontrunner Pfizer delivers key trial data \u2013 here's where the other vaccines stand", "image": "https://cdn.snapi.dev/images/v1/i/k/106600031-15936247142020-07-01t122821z-536695232-rc2ckh9zm6kb-rtrmadp-0-health-coronavirus-biontech-pfizer.jpeg", "site": "CNBC", "text": "A safe and effective Covid-19 vaccine is seen by investors and policymakers as a solution to get the global economy back on track.", "url": "https://www.cnbc.com/2020/11/09/coronavirus-vaccine-where-the-frontrunners-including-pfizer-stand.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 11:02:37", "title": "WWE, Vail Resorts, MSG Among Soaring Sports Stocks After Pfizer Vaccine News", "image": "https://cdn.snapi.dev/images/v1/r/t/wwe-vail-resorts-msg-among-soaring-sports-stocks-after-pfizer-vaccine-news.jpg", "site": "Forbes", "text": "Global stock markets shot up Monday morning after Pfizer released early results from their promising vaccine trial. Publicly-traded sports companies were among the biggest winners.", "url": "https://www.forbes.com/sites/kurtbadenhausen/2020/11/09/wwe-vail-resorts-msg-among-soaring-sports-stocks-after-pfizer-vaccine-news/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 11:00:06", "title": "Dr. Siegel breaks down Pfizer coronavirus vaccine, distribution", "image": "https://cdn.snapi.dev/images/v1/e/o/dr-siegel-breaks-down-pfizer-coronavirus-vaccine-distribution.jpg", "site": "Fox Business", "text": "Fox News medical contributor Dr. Marc Siegel provides insight into Pfizer's coronavirus vaccine and vaccine distribution. Subscribe to Fox Business!", "url": "https://www.youtube.com/watch?v=UXkEHliT7X8"}, {"symbol": "PFE", "publishedDate": "2020-11-09 10:39:34", "title": "Cramer on how investors should handle stay-at-home stock slump on Pfizer vaccine news", "image": "https://cdn.snapi.dev/images/v1/x/q/cramer-on-how-investors-should-handle-stay-at-home-stock-slump-on-pfizer-vaccine-news.jpg", "site": "CNBC Television", "text": "Dow futures surged on the news that data from the coronavirus vaccine trial out of Pfizer and German biotech firm BioNTech shows the vaccine is more than 90% effective in preventing Covid-19 among those without evidence of prior infection. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss what this means for technology stocks that have risen during the pandemic.", "url": "https://www.youtube.com/watch?v=NQTrKyKiDwA"}, {"symbol": "PFE", "publishedDate": "2020-11-09 10:36:18", "title": "Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal", "image": "https://cdn.snapi.dev/images/v1/o/r/biotech17.jpg", "site": "InvestorPlace", "text": "Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE) The post Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company Daily Picks: Stocks to Buy Ahead of the Election", "url": "https://investorplace.com/2020/11/homology-medicines-pfizer-news/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 10:04:55", "title": "Coronavirus: Pfizer, Biontech say COVID-19 vaccine is 90% effective", "image": "https://cdn.snapi.dev/images/v1/w/o/coronavirus-pfizer-biontech-say-covid-19-vaccine-is-90-effective.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance medical contributor Dr. Dara Kass breaks down the latest news on vaccine development and the spread of coronavirus. #coronavirus #COVID19 #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.", "url": "https://www.youtube.com/watch?v=WcIelYWAHEg"}, {"symbol": "PFE", "publishedDate": "2020-11-09 10:01:59", "title": "Irrational Exuberance? Stocks Surging, Markets At All-Time Highs On Pfizer's COVID-19 Vaccine News", "image": "https://cdn.snapi.dev/images/v1/u/z/businessman-2365538-1920-3.jpg", "site": "Benzinga", "text": "The S&P 500 skyrocketed 3.2% on Monday morning following news from Pfizer Inc. (NYSE: PFE) that its coronavirus vaccine candidate is more than 90% effective. While the news triggered a broad market rally, stocks that have been hit hardest during the pandemic were some of the market's biggest movers.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18274798/irrational-exuberance-stocks-surging-markets-at-all-time-highs-on-pfizers-covid-19-"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:58:00", "title": "Why BioNTech Stock Is Skyrocketing\u00a0Today After Gaining 23% Last Month", "image": "https://cdn.snapi.dev/images/v1/v/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "On Monday, the German biotech and its partner Pfizer\u00a0announced that initial data shows their COVID-19 vaccine candidate is more than 90% effective.", "url": "https://www.fool.com/investing/2020/11/09/why-biontech-stock-is-skyrocketing-today-after-gai/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:49:00", "title": "Why Pfizer and BioNTech Stocks Are Soaring Today", "image": "https://cdn.snapi.dev/images/v1/m/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998292fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The two companies reported great news for COVID-19 vaccine candidate BNT162b2.", "url": "https://www.fool.com/investing/2020/11/09/why-pfizer-and-biontech-stocks-are-soaring-today/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:48:42", "title": "Stocks Surge Worldwide To New All-Time Highs After Pfizer Says Covid-19 Vaccine Candidate 90% Effective", "image": "https://cdn.snapi.dev/images/v1/w/4/stocks-surge-worldwide-to-new-all-time-highs-after-pfizer-says-covid-19-vaccine-candidate-90-effective.jpg", "site": "Forbes", "text": "Industries hardest hit by the pandemic are among those rallying the most on Monday morning.", "url": "https://www.forbes.com/sites/jonathanponciano/2020/11/09/stocks-surge-worldwide-to-new-all-time-highs-after-pfizer-says-covid-19-vaccine-candidate-90-effective/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:46:26", "title": "Trump Applauds Pfizer Vaccine News, While Biden Expresses Cautious Optimism", "image": "https://cdn.snapi.dev/images/v1/2/u/trump-applauds-pfizer-vaccine-news-while-biden-expresses-cautious-optimism.jpg", "site": "Forbes", "text": "It's a sign of the differing leadership approaches the two leaders have taken during the pandemic.", "url": "https://www.forbes.com/sites/jackbrewster/2020/11/09/trump-applauds-pfizer-vaccine-news-while-biden-expresses-cautious-optimism/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:46:00", "title": "EU drug regulator says it is assessing early data from Pfizer COVID vaccine", "image": "https://cdn.snapi.dev/images/v1/a/w/m02d20201109t2i1540543723w940fhfwllplsqrlynxmpega8133.jpg", "site": "Reuters", "text": "The European Union drug regulator said on Monday it had not yet received results from large-scale trials on the COVID vaccines being developed by Pfizer and BioNTech and that it was currently assessing earlier data on the quality of the shot.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-em/eu-drug-regulator-says-it-is-assessing-early-data-from-pfizer-covid-vaccine-idUSKBN27P1X5"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:45:34", "title": "Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market", "image": "https://cdn.snapi.dev/images/v1/e/j/biotech13.jpg", "site": "24/7 Wall Street", "text": "Shares of both Pfizer Inc. (NYSE: PFE) and BioNTech S.E.", "url": "https://247wallst.com/healthcare-business/2020/11/09/efficacy-in-pfizer-and-biontech-covid-19-study-rocks-the-market/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:39:26", "title": "Zoom Video Stock Plunges On Pfizer Vaccine News, Possible Business Travel Rebound", "image": "https://cdn.snapi.dev/images/v1/x/i/drugs31.jpg", "site": "Investors Business Daily", "text": "Zoom Video stock plunged on Monday amid positive coronavirus vaccine news from Pfizer. Shares in Zoom Video had soared some 635% in 2020 as businesses told employees to work from home.", "url": "https://www.investors.com/news/technology/zoom-video-stock-plunges-vaccine-news-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:39:08", "title": "Walter Isaacson on being part of the Pfizer coronavirus vaccine trial", "image": "https://cdn.snapi.dev/images/v1/o/v/walter-isaacson-on-being-part-of-the-pfizer-coronavirus-vaccine-trial.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Walter Isaacson, Tulane professor and an advisory partner at Perella Weinberg Partners, was part of the trial and he joins \"Squawk Box\" to discuss his experience as well as the promise of the mRNA technology the vaccine utilizes.", "url": "https://www.youtube.com/watch?v=XnDmIhY25nQ"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:38:36", "title": "BioNTech and Pfizer say their COVID-19 vaccine candidate is 90% effective", "image": "https://cdn.snapi.dev/images/v1/t/0/biotech5---mf19apak5n.jpg", "site": "Market Watch", "text": "BioNTech and Pfizer Inc.'s COVID-19 vaccine candidate is the first to demonstrate it can protect most people from contracting symptomatic infections with the virus in a Phase 3 clinical trial \u2014 an announcement that puts the companies in the lead to bring to market the first COVID-19 vaccine in the U.S.", "url": "https://www.marketwatch.com/story/biontech-and-pfizer-say-their-covid-19-vaccine-candidate-is-90-effective-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:38:28", "title": "Two Drugmakers Surging After COVID-19 Vaccine Announcement", "image": "https://cdn.snapi.dev/images/v1/9/-/9-pharmaceutical-companies-racing-for-a-covid-19-vaccine---scrdkjp0pt.jpg", "site": "Schaeffers Research", "text": "Two drug makers making waves on Wall Street this morning are\u00a0Pfizer Inc.\u00a0(NYSE:PFE) and\u00a0BioNTech SE (NASDAQ:BNTX).", "url": "https://www.schaeffersresearch.com/content/news/2020/11/09/two-drugmakers-surging-after-covid-19-vaccine-announcement"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:33:18", "title": "Dow soars to first intaday record in 9 months on upbeat report on coronavirus Pfizer-BioNtech candidate, Biden presidency", "image": "https://cdn.snapi.dev/images/v1/6/a/biotech6---xfpkejkeyc.jpg", "site": "Market Watch", "text": "U.S. stock benchmarks notched record highs early Monday after a Pfizer Inc. and BioNTech coronavirus vaccine candidate showed a 90% efficacy in Phase 3 trials. The news on the experimental drug comes as Democrat Joe Biden's electoral victory, projected on Saturday, laid the groundwork for a powerful rally.", "url": "https://www.marketwatch.com/story/dow-soars-to-first-intaday-record-in-9-months-on-upbeat-report-on-coronavirus-pfizer-biontech-candidate-biden-presidency-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:32:30", "title": "Dr. Scott Gottlieb, a Pfizer director and ex-FDA chief, says Covid vaccine won't help immediately", "image": "https://cdn.snapi.dev/images/v1/b/g/105764883-1551291628734gettyimages-664917690.jpeg", "site": "CNBC", "text": "\"I think we need to remember that we have perhaps a brief, but very hard stretch, ahead of us\" without a widely available Covid-19 vaccine, Gottlieb told CNBC.", "url": "https://www.cnbc.com/2020/11/09/dr-scott-gottlieb-pfizer-covid-vaccine-wont-help-immediately.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:31:08", "title": "Pfizer board member Scott Gottlieb: States will manage distribution of coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/9/r/pfizer-board-member-scott-gottlieb-states-will-manage-distribution-of-coronavirus-vaccine.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins \"Squawk Box\" to discuss.", "url": "https://www.youtube.com/watch?v=IX9b7FUPxBw"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:31:00", "title": "EU about to sign supply deal for Pfizer COVID vaccine: lawmaker", "image": "https://cdn.snapi.dev/images/v1/4/v/m02d20201109t2i1540540985w940fhfwllplsqrlynxmpega811u.jpg", "site": "Reuters", "text": "The European Union is about to sign a contract for millions of doses of the COVID-19 vaccine being developed by Pfizer and BioNTech , a prominent EU lawmaker said on Monday.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccine-pfizer-eu/eu-about-to-sign-supply-deal-for-pfizer-covid-vaccine-lawmaker-idUSKBN27P1VQ"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:28:24", "title": "Why BET founder says the Pfizer vaccine is particularly great for Black Americans", "image": "https://cdn.snapi.dev/images/v1/z/j/why-bet-founder-says-the-pfizer-vaccine-is-particularly-great-for-black-americans.jpg", "site": "CNBC Television", "text": "Robert Johnson, founder of RLJ Companies and BET, joins CNBC's \"Squawk Box\" to discuss the impact of Pfizer's vaccine trial showing over 90% effectiveness and what it means for the U.S. economy.", "url": "https://www.youtube.com/watch?v=3ZFfBXLufKY"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:27:20", "title": "Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results", "image": "https://cdn.snapi.dev/images/v1/5/e/m02d20201027t2i1538994505w940fhfwllplsqrlynxmpeg9q1fx.jpg", "site": "InvestorPlace", "text": "Pfizer stock is rallying higher Monday on coronavirus vaccine results, and it's taking the rest of the stock market with it. The post Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/vaccine-news-pfizer-stock-soars-15-on-coronavirus-trial-results/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:25:40", "title": "U.S. Futures Poised for Records on Joe Biden Victory, Positive Coronavius Vaccine News from Pfizer", "image": "https://cdn.snapi.dev/images/v1/8/m/us-futures-poised-for-records-on-joe-biden-victory-positive-coronavius-vaccine-news-from-pfizer.jpg", "site": "Cheddar", "text": "U.S. futures were poised to open at record highs as investors react to a Biden victory in the presidential election, as well as positive coronavirus vaccine news from Pfizer and BioNTech. Chris Konstantinos, Chief Investment Strategist at RiverFront Investment Group, joined Wake Up With Cheddar for more on the markets.", "url": "https://www.youtube.com/watch?v=FKDL7ak_HrA"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:23:48", "title": "Pfizer board member Scott Gottlieb: '2021 will look very different from 2020'", "image": "https://cdn.snapi.dev/images/v1/b/5/pfizer-board-member-scott-gottlieb-2021-will-look-very-different-from-2020.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins \"Squawk Box\" to discuss.", "url": "https://www.youtube.com/watch?v=lH4NiohKqho"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:13:03", "title": "Pfizer CEO says he wants to be among the first to take coronavirus vaccine to allay concerns", "image": "https://cdn.snapi.dev/images/v1/o/t/pfizer-ceo-says-he-wants-to-be-among-the-first-to-take-coronavirus-vaccine-to-allay-concerns.jpg", "site": "CNBC Television", "text": "Pfizer CEO Albert Bourla said Monday that he would like to be among the first to take a coronavirus vaccine to ease public concerns about vaccine safety. But there are ethical considerations for that, Bourla said during an interview on CNBC's \"Squawk Box.", "url": "https://www.youtube.com/watch?v=-VHJiV8o63E"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:13:00", "title": "Tech Stocks: Zoom, Peloton lead stay-home tech selloff after upbeat Pfizer vaccine announcement", "image": "https://cdn.snapi.dev/images/v1/1/z/im-243914width620size14780600461893765.jpg", "site": "Market Watch", "text": "Shares of technology stocks that saw big benefits from stay-at-home trends due to the pandemic are falling in premarket trading Monday given upbeat vaccine news from Pfizer Inc. and BioNTech SE.", "url": "https://www.marketwatch.com/story/zoom-peloton-lead-stay-home-tech-selloff-after-upbeat-pfizer-vaccine-announcement-11604931225"}, {"symbol": "PFE", "publishedDate": "2020-11-09 09:08:58", "title": "Airline, hotel, and travel stocks poised for Monday rally on Pfizer vaccine news", "image": "https://cdn.snapi.dev/images/v1/t/d/poster-travel-stock-boost.jpg", "site": "Fast Company", "text": "Everything's up in the air right now. Health experts have long warned us not to get too excited about vaccine trials before the full range of data can be examined, but investors in the travel industry are doing just that.", "url": "https://www.fastcompany.com/90573370/airline-hotel-and-travel-stocks-poised-for-monday-rally-on-pfizer-vaccine-news"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:58:00", "title": "Here are the winners and losers in Europe from the Pfizer vaccine news", "image": "https://cdn.snapi.dev/images/v1/t/x/im-257140width620size15005861664712778.jpg", "site": "Market Watch", "text": "Here's the list of Stoxx Europe 600 components that have gained at least 20%. They are predominately in the travel sector, such as airlines and hotel operators.", "url": "https://www.marketwatch.com/story/here-are-the-winners-and-losers-in-europe-from-the-pfizer-vaccine-news-11604930298"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:55:00", "title": "Coronavirus Vaccine Candidate From Pfizer and BioNTech Leaps Over Efficacy Hurdle", "image": "https://cdn.snapi.dev/images/v1/o/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998162fgettyimages-1236470093-5be3ipfjpgw700opresize.jpg", "site": "The Motley Fool", "text": "A phase 3 clinical trial found BNT162b2 more than 90% effective at preventing COVID-19 at the first interim analysis.", "url": "https://www.fool.com/investing/2020/11/09/coronavirus-vaccine-candidate-from-pfizer-and-bion/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:54:10", "title": "Pfizer Stock Rockets As Coronavirus Vaccine Proves 90% Effective", "image": "https://cdn.snapi.dev/images/v1/j/o/drugs29.jpg", "site": "Investors Business Daily", "text": "Pfizer stock rocketed early Monday after the pharma giant said its coronavirus vaccine was more than 90% effective in a Phase 3 study. The post Pfizer Stock Rockets As Coronavirus Vaccine Proves 90% Effective appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/coronavirus-vaccine-succeeds-phase-3-test-pfizer-stock-rockets/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:54:05", "title": "Biden And Trump React To Pfizer's Vaccine Update, Stock Market Rally: 'Great News!'", "image": "https://cdn.snapi.dev/images/v1/p/y/the-white-house-1623005-1920-4.jpg", "site": "Benzinga", "text": "Pifzer Inc (NYSE: PFE) and partner BioTech SE (NASDAQ: BNTX) reported interim analysis of a Phase 3 study on coronavirus candidate BNT 162b2. The trial showed a 90% efficacy rate at the seven-day mark after a second dose of the vaccine was applied.", "url": "https://www.benzinga.com/news/20/11/18272147/biden-and-trump-react-to-pfizers-vaccine-update-stock-market-rally-great-news"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:48:00", "title": "Factbox: Development of Pfizer-BioNTech coronavirus vaccine", "image": "https://cdn.snapi.dev/images/v1/v/h/m02d20201109t2i1540533856w940fhfwllplsqrlynxmpega80yo.jpg", "site": "Reuters", "text": "U.S. drugmaker Pfizer and German partner BioNTech on Monday became the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-fa/factbox-development-of-pfizer-biontech-coronavirus-vaccine-idUSKBN27P1QX"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:47:00", "title": "Bond Report: 10-year Treasury yield pops above 0.90% on positive BioNTech, Pfizer vaccine news", "image": "https://cdn.snapi.dev/images/v1/7/o/biotech21---otnj8hkde0.jpg", "site": "Market Watch", "text": "U.S. Treasury yields surge higher early Monday after BioNTech and Pfizer said their COVID-19 vaccine candidate was 90% effective.", "url": "https://www.marketwatch.com/story/10-year-treasury-yield-pops-above-0-90-on-positive-biontech-pfizer-vaccine-news-11604929625"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:36:32", "title": "American Express leads financial-sector rally in wake of Pfizer news", "image": "https://cdn.snapi.dev/images/v1/u/9/bank2.jpg", "site": "Market Watch", "text": "American Express leads financial-sector rally in wake of Pfizer news", "url": "https://www.marketwatch.com/story/financial-stocks-soar-led-by-american-express-after-upbeat-news-on-potential-covid-19-vaccine-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:35:36", "title": "Pfizer/BioNTech COVID-19 vaccine is effective in more than 90% of cases", "image": "https://cdn.snapi.dev/images/v1/l/o/104685035-m-740x416.jpg", "site": "Invezz", "text": "In a statement on Monday, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said that their jointly developed COVID-19 vaccine is effective in more than 90% of the patients. The two drug manufacturers are the first ones to publish successful trial data, taking the world a step closer to winning the battle against the Coronavirus pandemic that has so far infected more than 50 million people worldwide and caused over 1.2 million deaths.", "url": "https://invezz.com/news/2020/11/09/pfizer-biontech-covid-19-vaccine-is-effective-in-more-than-90-of-cases/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:35:13", "title": "Pfizer CEO on manufacturing and distributing Covid-19 vaccine", "image": "https://cdn.snapi.dev/images/v1/m/g/pfizer-ceo-on-manufacturing-and-distributing-covid-19-vaccine.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Pfizer CEO Albert Bourla explains the company's plan to roll out the vaccine to meet the high demand.", "url": "https://www.youtube.com/watch?v=V2cntEzIAf0"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:32:11", "title": "Pfizer CEO says he would take coronavirus vaccine first to ease public concern", "image": "https://cdn.snapi.dev/images/v1/h/j/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg", "site": "CNBC", "text": "Pfizer CEO Albert Bourla said Monday that he would like to be among the first to take a coronavirus vaccine to ease public concerns about vaccine safety.", "url": "https://www.cnbc.com/2020/11/09/coronavirus-vaccine-pfizer-ceo-says-he-would-take-it-first-to-ease-public-concern.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:29:33", "title": "Pfizer CEO on formulating Covid-19 vaccine for younger and older populations", "image": "https://cdn.snapi.dev/images/v1/x/b/pfizer-ceo-on-formulating-covid-19-vaccine-for-younger-and-older-populations.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Pfizer CEO Albert Bourla joins \"Squawk Box\" to discuss.", "url": "https://www.youtube.com/watch?v=2gia2yGcSnk"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:23:00", "title": "Biden welcomes Pfizer coronavirus vaccine news, says safety measures still needed", "image": "https://cdn.snapi.dev/images/v1/g/b/m02d20201109t2i1540529367w940fhfwllplsqrlynxmpega80x1.jpg", "site": "Reuters", "text": "U.S. president-elect Joe Biden greeted Pfizer Inc's experimental COVID-19 vaccine as excellent news on Monday, but warned that widespread vaccination remains months away and Americans need to continue wearing masks and maintain social distancing.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccine-biden/biden-welcomes-pfizer-coronavirus-vaccine-news-says-safety-measures-still-needed-idUSKBN27P1OX"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:22:56", "title": "Pfizer vaccine news is exactly what investors were craving", "image": "https://cdn.snapi.dev/images/v1/8/p/201109080717-pfizer-covid-19-vaccine-trial-restricted-super-169.jpg", "site": "CNN Business", "text": "Markets spent weeks obsessing over the outcome of the US election. Now that it's clear Joe Biden will be the next president, Wall Street is moving on.", "url": "https://www.cnn.com/2020/11/09/investing/premarket-stocks-trading/index.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:20:00", "title": "UK says expects to receive 10 million doses of Pfizer/BioNTech vaccine this year", "image": "https://cdn.snapi.dev/images/v1/i/g/m02d20201109t2i1540528724w940fhfwllplsqrlynxmpega80ww.jpg", "site": "Reuters", "text": "Britain expects to have 10 million doses of Pfizer/BioNTech's candidate COVID-19 vaccine available by the end of the year if regulators approve it, Prime Minister Boris Johnson's spokesman said on Monday, following positive clinical trial results.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-br/uk-says-expects-to-receive-10-million-doses-of-pfizer-biontech-vaccine-this-year-idUSKBN27P1OR"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:19:00", "title": "German health minister encouraged by Pfizer COVID-19 vaccine data", "image": "https://cdn.snapi.dev/images/v1/l/l/m02d20201109t2i1540528419w940fhfwllplsqrlynxmpega80vg.jpg", "site": "Reuters", "text": "Data from Pfizer and its partner BioNTech on their experimental COVID-19 vaccine are encouraging, Germany's health minister said on Monday.", "url": "https://www.reuters.com/article/us-health-coronavirus-germany-spahn/german-health-minister-encouraged-by-pfizer-covid-19-vaccine-data-idUSKBN27P1LB"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:17:00", "title": "Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'", "image": "https://cdn.snapi.dev/images/v1/9/a/m02d20201109t2i1540528152w940fhfwllplsqrlynxmpega80wq.jpg", "site": "Reuters", "text": "Positive data on BioNTech and U.S. partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.", "url": "https://www.reuters.com/article/us-health-coronavirus-biontech-ceo-newsm/behind-pfizers-vaccine-an-understated-husband-and-wife-dream-team-idUSKBN27P1ON"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:14:52", "title": "Cruise stocks charge up more than 20% after upbeat news on Pfizer, BioNTech COVID-9 vaccine candidate", "image": "https://cdn.snapi.dev/images/v1/e/u/biotech14.jpg", "site": "Market Watch", "text": "Shares of cruise operators soared Monday, as investors cheered news that Pfizer Inc.'s and BioNTech Inc.'s COVID-19 vaccine candidate achieved \"success\" in an interim analysis from a Phase 3 study. Carnival Corp.'s stock rocketed 29.5% in active premarket trading, Royal Caribbean Group shares soared 21.1% and Norwegian Cruise Line Holdings Ltd.", "url": "https://www.marketwatch.com/story/cruise-stocks-charge-up-more-than-20-after-upbeat-news-on-pfizer-biontech-covid-9-vaccine-candidate-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 08:01:39", "title": "Pfizer CEO on Covid vaccine efficacy: 'It is a great day for humanity'", "image": "https://cdn.snapi.dev/images/v1/u/x/pfizer-ceo-on-covid-vaccine-efficacy-it-is-a-great-day-for-humanity.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. \"It is a great day for science,\" Pfizer CEO Albert Bourla told CNBC's \"Squawk Box\" Monday morning.", "url": "https://www.youtube.com/watch?v=3yRsIL7s5eU"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:57:42", "title": "Dow futures soar 1,200 points after Pfizer says its Covid-19 vaccine is 90% effective", "image": "https://cdn.snapi.dev/images/v1/b/y/201109120517-02-covid-19-vaccine-trial-florida-file-super-169.jpg", "site": "CNN Business", "text": "US stock futures surged Monday morning after Pfizer said its Covid-19 vaccine is 90% effective.", "url": "https://www.cnn.com/2020/11/09/investing/dow-stock-market-today/index.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:54:42", "title": "Pfizer Says Covid-19 Vaccine Is 90% Effective, Although Trials Are Ongoing", "image": "https://cdn.snapi.dev/images/v1/j/n/pfizer-says-covid-19-vaccine-is-90-effective-although-trials-are-ongoing.jpg", "site": "Forbes", "text": "Early analysis of trial data suggests the vaccine Pfizer is producing with BioNTech could be 90% effective at preventing Covid-19 infection.", "url": "https://www.forbes.com/sites/roberthart/2020/11/09/pfizer-says-covid-19-vaccine-is-90-effective-although-trials-are-ongoing/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:50:37", "title": "Cinema stock AMC soars 59% premarket, Live Nation up 14% as Pfizer vaccine news sparks rally in event stocks", "image": "https://cdn.snapi.dev/images/v1/x/y/entertainment-diversified6---zm014lleyu.jpg", "site": "Market Watch", "text": "AMC Entertainment Holdings Inc.'s beaten-down shares soared a staggering 59% in premarket trade Monday, after Pfizer Inc. and BioNTech SE said their COVID-19 vaccine candidatewas found to be more than 90% effectiive in preventing the virus in trial participants without previous evidence of SARS-CoV-2 infection. The companies said they are planning to submit for Emergency Use Authorization (EUA) to the Food and Drug Administration soon after the safety milestones are met, which is currently expected in the third week of November.", "url": "https://www.marketwatch.com/story/cinema-stock-amc-soars-59-premarket-live-nation-up-14-as-pfizer-vaccine-news-sparks-rally-in-event-stocks-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:46:40", "title": "Pfizer CEO calls Covid vaccine a 'great day for humanity' and a 'light at the end of the tunnel'", "image": "https://cdn.snapi.dev/images/v1/n/y/106635982-1595948992117-gettyimages-1132313750-wm2-7799-20190226114402859.jpeg", "site": "CNBC", "text": "\"I think we can see light at the end of the tunnel\" on the pandemic, Pfizer's Albert Bourla told CNBC on Monday.", "url": "https://www.cnbc.com/2020/11/09/pfizer-ceo-albert-bourla-covid-vaccine-a-light-at-the-end-of-the-tunnel.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:45:08", "title": "Trump celebrates Pfizer announcing a successful COVID-19 vaccine, days after he lost the US election", "image": "https://cdn.snapi.dev/images/v1/5/6/56848336-s-740x416-2.jpg", "site": "Business Insider", "text": "President Donald Trump celebrated Pfizer announcing a successful COVID-19 vaccine, news which broke on the first business day after he lost the US presidential election. Trump tweeted on Monday morning: \"STOCK MARKET UP BIG, VACCINE COMING SOON. REPORT 90% EFFECTIVE. SUCH GREAT NEWS!\"", "url": "https://www.businessinsider.com/trump-celebrates-pfizer-covid-19-vaccine-announcement-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:42:43", "title": "Pfizer's COVID-19 vaccine is more than 90 percent effective, company says", "image": "https://cdn.snapi.dev/images/v1/u/e/pfizer-63jpgquality90stripall.jpg", "site": "New York Post", "text": "The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic. The Manhattan-based drugmaker and the German biotech firm became the first pharmaceutical outfits to reveal successful data from a large, late-stage study of a COVID-19.", "url": "https://nypost.com/2020/11/09/pfizers-covid-19-vaccine-is-more-than-90-percent-effective-company/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:37:00", "title": "European banks, airlines surge after Pfizer COVID-19 vaccine news", "image": "https://cdn.snapi.dev/images/v1/p/s/m02d20201109t2i1540522210w940fhfwllplsqrlynxmpega80um.jpg", "site": "Reuters", "text": "Shares in European banks and in the travel and leisure industries surged about 10% on Monday after Pfizer announced that its experimental COVID-19 vaccine was more than 90% effective, which prompted a major rally across the continent's bourses.", "url": "https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-st/european-banks-airlines-surge-after-pfizer-covid-19-vaccine-news-idUSKBN27P1JT"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:36:32", "title": "Cramer reacts to Dow futures soaring on news Pfizer vaccine is 90% effective", "image": "https://cdn.snapi.dev/images/v1/2/w/cramer-reacts-to-dow-futures-soaring-on-news-pfizer-vaccine-is-90-effective.jpg", "site": "CNBC Television", "text": "Stock futures surged after Pfizer and BioNTech said trial data indicated their Covid-19 vaccine is 90% effective in preventing Covid-19 among those without evidence of prior infection. CNBC's Jim Cramer discusses what this means for the markets.", "url": "https://www.youtube.com/watch?v=0iJ0BsXjwSQ"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:30:10", "title": "Treasury yields jump, gold suffers, tech stocks lag after Pfizer COVID-19 trial news", "image": "https://cdn.snapi.dev/images/v1/o/8/drugs23.jpg", "site": "Market Watch", "text": "A Phase 3 trial showing the COVID-19 vaccine being developed by Pfizer and BioNTech was more than 90% effective hit several asset classes, as well as boosting stock futures . The yield on the 10-year Treasury jumped 9 basis points to 0.91%, and gold futures sunk $33 an ounce.", "url": "https://www.marketwatch.com/story/treasury-yields-jump-gold-suffers-tech-stocks-lag-after-pfizer-covid-19-trial-news-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:29:56", "title": "Dow futures surge 1,500 points on Pfizer's COVID-19 vaccine news", "image": "https://cdn.snapi.dev/images/v1/h/q/drugs24.jpg", "site": "Fox Business", "text": "Stock futures resumed their march higher on Monday on Pfizer's vaccine news and a Biden-Harris win.", "url": "https://www.foxbusiness.com/markets/us-stocks-november-9-2020"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:27:00", "title": "Instant View: Global stocks soar on Pfizer, Biontech vaccine news", "image": "https://cdn.snapi.dev/images/v1/q/g/m02d20201109t2i1540520604w940fhfwllplsqrlynxmpega80tr.jpg", "site": "Reuters", "text": "Global stocks surged to record highs after Pfizer on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19, based on initial data from a large study.", "url": "https://www.reuters.com/article/us-health-coronavirus-global-markets/instant-view-global-stocks-soar-on-pfizer-biontech-vaccine-news-idUSKBN27P1IF"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:23:00", "title": "Market Snapshot: Dow futures soar 1,500 points after Pfizer, BioNTech say coronavirus vaccine candidate 90% effective", "image": "https://cdn.snapi.dev/images/v1/m/g/im-257119width620size15005861664712778.jpg", "site": "Market Watch", "text": "U.S. stock-index futures on Monday were soaring after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine candidate achieved \"success\" in the first interim analysis of from a Phase 3 study.", "url": "https://www.marketwatch.com/story/dow-futures-soar-1-500-points-after-pfizer-biontech-say-coronavirus-vaccine-candidate-90-effective-11604924582"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:22:38", "title": "Pfizer leaps 13% on news that its COVID-19 vaccine is over 90% effective in preventing illness", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-leaps-13-on-news-that-its-covid-19-vaccine-is-over-90-effective-in-preventing-illness.jpg", "site": "Business Insider", "text": "Pfizer leapt 13% in pre-market trading on Monday after the drugmaker announced that its experimental COVID-19 vaccine succeeded in late-stage trials. The US pharma firm said its vaccine, developed with German biotech partner BioNTech, is over 90% effective in preventing COVID-19 infection.", "url": "https://www.businessinsider.com/pfizer-stock-price-biontech-successful-covid-19-vaccine-emergency-approval-2020-11"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:13:56", "title": "Pfizer, BioNTech announce Covid-19 vaccine candidate is 90% effective", "image": "https://cdn.snapi.dev/images/v1/s/8/pfizer-biontech-announce-covid-19-vaccine-candidate-is-90-effective.jpg", "site": "CNBC Television", "text": "U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. CNBC's Meg Tirrell reports.", "url": "https://www.youtube.com/watch?v=mMrJSllDoPc"}, {"symbol": "PFE", "publishedDate": "2020-11-09 07:12:16", "title": "Pfizer's COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial", "image": "https://cdn.snapi.dev/images/v1/i/q/gettyimages-1208040947jpgw600.jpg", "site": "TechCrunch", "text": "The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That's based on data analyzed by an external, independent committee assigned to check the results of the trial, and reflects only [\u2026]", "url": "https://techcrunch.com/2020/11/09/pfizers-covid-19-vaccine-proves-90-effective-in-first-results-from-phase-3-clinical-trial/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:57:00", "title": "COVID-19 vaccine found to be 90% effective in 'great day for science and humanity'", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5911572fgettyimages-1131003745jpgw700opresize.jpg", "site": "Skynews", "text": "The coronavirus vaccine being developed by Pfizer and BioNTech has been found to be 90% effective in preventing people from getting the virus, it has been confirmed.", "url": "https://news.sky.com/story/coronavirus-pfizer-vaccine-found-to-be-90-effective-in-great-day-for-science-and-humanity-12128452"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:56:02", "title": "BioNTech, Pfizer stocks soar after COVID-19 vaccine candidate achieves 'success' in first analysis", "image": "https://cdn.snapi.dev/images/v1/g/u/biotech8---mwxrayewnc.jpg", "site": "Market Watch", "text": "Shares of Germany-based BioNTech SE shot up 17.9% and Pfizer Inc. jumped 8.6% in premarket trading Monday, after the company's said their COVID-19 vaccine candidate achieved \"success\" in the first interim analysis of from a Phase 3 study. The companies said BNT162b2 vaccine candidate was found to be more than 90% effective in preventing COVID-19 in trial participants without previous evidence of SARS-CoV-2 infection.", "url": "https://www.marketwatch.com/story/biontech-pfizer-stocks-soar-after-covid-19-vaccine-candidate-achieves-success-in-first-analysis-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:55:14", "title": "Stock futures surge, with Dow futures up 1100 points, after Pfizer vaccine news", "image": "https://cdn.snapi.dev/images/v1/h/r/drugs22.jpg", "site": "Market Watch", "text": "U.S. stock futures extended what already were strong gains, following the news that the vaccine being developed by Pfizer and BioNTech was more than 90% effective in preventing COVID-19. Futures on the Dow Jones Industrial Average leapt 1,116 points, and those on the S&P 500 rose more than 3%.", "url": "https://www.marketwatch.com/story/stock-futures-surge-with-dow-futures-up-1100-points-after-pfizer-vaccine-news-2020-11-09"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:51:26", "title": "Pfizer says its coronavirus vaccine helps prevent COVID-19, marking a milestone in the fight against the pandemic", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-says-its-coronavirus-vaccine-helps-prevent-covid-19-marking-a-milestone-in-the-fight-against-the-pandemic.jpg", "site": "Business Insider", "text": "A leading coronavirus vaccine candidate worked to prevent people from developing COVID-19, a milestone in society's war against the pandemic. The pharmaceutical company Pfizer said Monday that its vaccine succeeded in the final stage of clinical trials, which compared tens of thousands of volunteers who received two doses of the experimental vaccine against a group receiving a saltwater placebo.", "url": "https://www.businessinsider.com/pfizer-coronavirus-vaccine-success-plans-for-emergency-approval-fda-2020-9"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:48:44", "title": "Pfizer trial: Vaccine more than 90% effective in preventing COVID-19", "image": "https://cdn.snapi.dev/images/v1/h/j/drugs21.jpg", "site": "Market Watch", "text": "Pfizer trial: Vaccine more than 90% effective in preventing COVID-19", "url": "https://www.marketwatch.com/investing/stock/PFE"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:45:05", "title": "Pfizer, BioNTech say late-stage trial data shows Covid vaccine is more than 90% effective in preventing infection", "image": "https://cdn.snapi.dev/images/v1/z/p/106599913-1593620338844ap-20183543531451.jpg", "site": "CNBC", "text": "Albert Bourla, chairman and CEO of Pfizer, hailed the development as a \"great day for science and humanity.\"", "url": "https://www.cnbc.com/2020/11/09/covid-vaccine-pfizer-drug-is-more-than-90percent-effective-in-preventing-infection.html"}, {"symbol": "PFE", "publishedDate": "2020-11-09 06:45:00", "title": "\u00a0Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study", "image": "https://cdn.snapi.dev/images/v1/d/7/press2---fa6niiwpg0.jpg", "site": "Business Wire", "text": "NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study. After discussion with the FDA, t", "url": "https://www.businesswire.com/news/home/20201109005539/en/%C2%A0Pfizer-and-BioNTech-Announce-Vaccine-Candidate-Against-COVID-19-Achieved-Success-in-First-Interim-Analysis-from-Phase-3-Study/"}, {"symbol": "PFE", "publishedDate": "2020-11-09 05:16:03", "title": "4 Strong Value Stocks for Savvy Investors Seeking 2021 Winners", "image": "https://cdn.snapi.dev/images/v1/q/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5901022fgettyimages-1170740969jpgw700opresize.jpg", "site": "InvestorPlace", "text": "Take a look at four value stocks from sectors that have underperformed lately. In addition to valuations, these stocks have robust dividend yield.", "url": "https://investorplace.com/2020/11/4-strong-value-stocks-pfe-lmt-jpm-f-for-savvy-investors-seeking-2021-winners/"}, {"symbol": "PFE", "publishedDate": "2020-11-08 13:15:22", "title": "Pfizer: SEC Foreign-Bribery Unit Has Formally Asked Company For Info", "image": "https://cdn.snapi.dev/images/v1/7/t/new-york-city-pfizer-world-headquarters-01-0.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) has\u00a0disclosed\u00a0in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall Street Journal. What Happened: The pharmaceutical company received formal requests regarding its operations in China and Russia from the SEC's foreign-bribery unit and the U.S. Justice Department in August and June.", "url": "https://www.benzinga.com/news/earnings/20/11/18264260/pfizer-sec-foreign-bribery-unit-has-formally-asked-company-for-info"}, {"symbol": "PFE", "publishedDate": "2020-11-08 07:55:00", "title": "Here's Why This Laggard in the Coronavirus Vaccine Race Could Still Win", "image": "https://cdn.snapi.dev/images/v1/v/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5989402fgettyimages-1210040522jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The combination vaccine could save massive amounts of resources.", "url": "https://www.fool.com/investing/2020/11/08/heres-why-this-laggard-in-the-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-11-08 07:12:00", "title": "November Is a Crucial Month for this Coronavirus Vaccine Stock", "image": "https://cdn.snapi.dev/images/v1/f/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984402fgettyimages-1183175188jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The fate of this company's late-stage trial is now in the hands of the FDA.", "url": "https://www.fool.com/investing/2020/11/08/november-is-a-crucial-month-for-this-coronvirus-va/"}, {"symbol": "PFE", "publishedDate": "2020-11-08 06:25:00", "title": "Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks", "image": "https://cdn.snapi.dev/images/v1/t/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5988902fgettyimages-1210040522jpgw700opresize.jpg", "site": "The Motley Fool", "text": "These top players may reach the finish line first -- and offer the world a new kind of vaccine.", "url": "https://www.fool.com/investing/2020/11/08/moderna-and-pfizer-a-tale-of-two-mrna-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-11-08 06:12:00", "title": "What Are Your Chances of Getting a Coronavirus Vaccine by Year-End?", "image": "https://cdn.snapi.dev/images/v1/p/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981152fperson-getting-a-vaccine-shotjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Hint: They're not great.", "url": "https://www.fool.com/investing/2020/11/08/what-are-chances-of-getting-a-coronavirus-vaccine-/"}, {"symbol": "PFE", "publishedDate": "2020-11-07 06:14:00", "title": "Better Coronavirus Stock: AstraZeneca vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/r/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5983032fcovid-vaccine-with-microscopejpgw700opresize.jpg", "site": "The Motley Fool", "text": "Both big drugmakers could have blockbuster COVID-19 vaccines on the way soon.", "url": "https://www.fool.com/investing/2020/11/07/better-coronavirus-stock-astrazeneca-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2020-11-06 06:16:00", "title": "3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors", "image": "https://cdn.snapi.dev/images/v1/w/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981132fpushing-giant-jigsaw-pieces-togetherjpgw700opresize.jpg", "site": "The Motley Fool", "text": "There really isn't a downside to this deal.", "url": "https://www.fool.com/investing/2020/11/06/3-reasons-pfizers-imminent-upjohn-mylan-merger-is/"}, {"symbol": "PFE", "publishedDate": "2020-11-06 06:08:23", "title": "US Regulators Seek Information On Pfizer's China Operations", "image": "https://cdn.snapi.dev/images/v1/u/k/pfizer-finland-hq-february-13-2009.jpg", "site": "Benzinga", "text": "Pfizer Inc\u00a0(NYSE:\u00a0PFE) in the\u00a0SEC filing, disclosed that the U.S. stock market regulator and the Justice Department have informally sought information related to its operations in China. What Happened: The initial request for information was made in June by the U.S. Department of Justice's Foreign Corrupt Practices Act (FCPA) Unit.", "url": "https://www.benzinga.com/general/biotech/20/11/18244288/us-regulators-seek-information-on-pfizers-china-operations"}, {"symbol": "PFE", "publishedDate": "2020-11-05 19:11:00", "title": "U.S. government looking into Pfizer's operations in China", "image": "https://cdn.snapi.dev/images/v1/y/z/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg", "site": "Reuters", "text": "Pfizer Inc received informal requests relating to its operations in China from the U.S. Department of Justice and the U.S. Securities and Exchange Commission (SEC) in June and August, respectively, its regulatory filing https://bit.ly/38geoz2 showed on Thursday.", "url": "https://www.reuters.com/article/us-pfizer-fcpa/u-s-government-looking-into-pfizers-operations-in-china-idUSKBN27M00Z"}, {"symbol": "PFE", "publishedDate": "2020-11-05 09:50:00", "title": "Moderna, Novavax, Pfizer: How Are Coronavirus Vaccine Stocks Faring?", "image": "https://cdn.snapi.dev/images/v1/j/f/moderna-novavax-pfizer-how-are-coronavirus-vaccine-stocks-faring.jpg", "site": "Forbes", "text": "Our indicative theme of Coronavirus Vaccine stocks \u2013 which includes a diverse set of U.S.-based pharma and biotech companies developing Covid vaccines \u2013 is up by about 560% year-to-date, on an equally weighted basis, compared to the S&P 500 which has gained just about 4% over the same period.", "url": "https://www.forbes.com/sites/greatspeculations/2020/11/05/moderna-novavax-pfizer-how-are-coronavirus-vaccine-stocks-faring/"}, {"symbol": "PFE", "publishedDate": "2020-11-05 07:27:00", "title": "Need to Know: These 7 unloved stocks are for the long haul, says contrarian manager", "image": "https://cdn.snapi.dev/images/v1/e/t/etf28---gan7oyd3pn.jpg", "site": "Market Watch", "text": "Our call of the day offers up several stocks that busy, distracted investors have been overlooking. Smead Capital Management's CIO says they are stocks to hold for the long run.", "url": "https://www.marketwatch.com/story/these-7-unloved-stocks-are-for-the-long-haul-says-contrarian-manager-11604579260"}, {"symbol": "PFE", "publishedDate": "2020-11-04 21:22:00", "title": "Australia signs two more COVID-19 vaccine deals", "image": "https://cdn.snapi.dev/images/v1/c/d/cdc-xlhdvfz0sum-unsplash-0.jpg", "site": "Reuters", "text": "Australia has agreed to purchase another 50 million doses of two more COVID-19 vaccines, Prime Minister Scott Morrison said on Thursday, as Canberra aims to complete a mass inoculation programme within months.", "url": "https://www.reuters.com/article/us-health-coronavirus-australia/australia-signs-two-more-covid-19-vaccine-deals-idUSKBN27K2WI"}, {"symbol": "PFE", "publishedDate": "2020-11-04 08:53:53", "title": "Republican Hold On Senate Seen As Plus For Drug Companies", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs30---bbzw9njnud.jpg", "site": "Investors Business Daily", "text": "While the presidential race is undecided awaiting final results from key states, it appears Republicans could retain control of the Senate, and AbbVie stock and other biotech stocks rose. The post Republican Hold On Senate Seen As Plus For Drug Companies appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/abbvie-stock-leasd-pack-biotech-stock-gains-republicans-could-retain-senate-majority/"}, {"symbol": "PFE", "publishedDate": "2020-11-03 18:00:00", "title": "Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx)", "image": "https://cdn.snapi.dev/images/v1/t/6/press6---grqyxwtjm9.jpg", "site": "PRNewsWire", "text": "CARLSBAD, Calif. and BOSTON, Nov. 3, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and its wholly owned subsidiary Akcea Therapeutics, Inc., today announced that Pfizer Inc. (NYSE: PFE) has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated...", "url": "https://www.prnewswire.com/news-releases/ionis-and-akcea-announce-that-pfizer-has-initiated-a-phase-2b-clinical-study-of-vupanorsen-akcea-angptl3-lrx-301166067.html"}, {"symbol": "PFE", "publishedDate": "2020-11-03 14:35:23", "title": "7 Top Stocks to Buy for November", "image": "https://cdn.snapi.dev/images/v1/p/o/software21.jpg", "site": "InvestorPlace", "text": "As we near the end of 2020, it's time to safeguard your portfolio before we enter the new year. Here are the top stocks to buy in November.", "url": "https://investorplace.com/2020/11/7-top-stocks-to-buy-in-november/"}, {"symbol": "PFE", "publishedDate": "2020-11-03 09:56:53", "title": "Which Biotech Stocks Are a Buy on Earnings?", "image": "https://cdn.snapi.dev/images/v1/q/n/medical19.jpg", "site": "InvestorPlace", "text": "If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?", "url": "https://investorplace.com/2020/11/which-biotech-stocks-are-a-buy-on-earnings/"}, {"symbol": "PFE", "publishedDate": "2020-11-02 11:11:03", "title": "5 Industries Biden Would Destroy as President", "image": "https://cdn.snapi.dev/images/v1/s/w/swqdff---mi8uxzqxwn.jpg", "site": "InvestorPlace", "text": "If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times. Tread carefully as voters head to the polls.", "url": "https://investorplace.com/2020/11/election-stocks-sell-5-industries-threatened-biden-victory/"}, {"symbol": "PFE", "publishedDate": "2020-11-02 06:05:35", "title": "3 Biotech Stocks With Eye-Catching Pipelines", "image": "https://cdn.snapi.dev/images/v1/c/q/biotech1.jpg", "site": "InvestorPlace", "text": "Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorPlace.", "url": "https://investorplace.com/2020/11/3-biotech-stocks-with-eye-catching-pipelines/"}, {"symbol": "PFE", "publishedDate": "2020-11-01 14:28:01", "title": "Week In Review: CStone Out-Licenses Ex-China Rights To 2 Immunotherapies In $1.3 Billion Deal", "image": "https://cdn.snapi.dev/images/v1/m/x/biotech7.jpg", "site": "Seeking Alpha", "text": "CStone Pharma out-licensed global rights (ex-China) for two immuno-oncology assets to US-based EQRx in a $1.3 billion agreement. CASI Pharma in-licensed China rights to a novel antibody checkpoint receptor inhibitor from Sweden's BioInvent in a $95 million deal.", "url": "https://seekingalpha.com/article/4383861-week-in-review-cstone-out-licenses-ex-china-rights-to-2-immunotherapies-in-1_3-billion-deal"}, {"symbol": "PFE", "publishedDate": "2020-11-01 12:11:00", "title": "3 Reasons Pfizer and BioNTech's Coronavirus Vaccine Might Fail Even If It Works", "image": "https://cdn.snapi.dev/images/v1/e/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5980812fvaccination-4jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Clinical trials are tricky business.", "url": "https://www.fool.com/investing/2020/11/01/3-reasons-pfizer-and-biontechs-coronavirus-vaccine/"}, {"symbol": "PFE", "publishedDate": "2020-10-30 15:39:00", "title": "Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit", "image": "https://cdn.snapi.dev/images/v1/s/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5978422facquisition-dealjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The Federal Trade Commission has signed off on the deal.", "url": "https://www.fool.com/investing/2020/10/30/pfizer-and-mylan-set-merger-date/"}, {"symbol": "PFE", "publishedDate": "2020-10-30 15:01:00", "title": "Regulators are accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report", "image": "https://cdn.snapi.dev/images/v1/a/3/im-252333width620size15005861664712778.jpg", "site": "Market Watch", "text": "The U.K. drug regulator is accelerating reviews of the coronavirus vaccines being developed by Pfizer and AstraZeneca, according to a report.", "url": "https://www.marketwatch.com/story/regulators-are-accelerating-reviews-of-covid-19-vaccines-from-pfizer-and-astrazeneca-according-to-a-report-11604084483"}, {"symbol": "PFE", "publishedDate": "2020-10-30 13:39:00", "title": "Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn", "image": "https://cdn.snapi.dev/images/v1/4/0/press1---4piiqnf0mp.jpg", "site": "PRNewsWire", "text": "HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the \"FTC\") accepted a proposed consent order, which concludes the FTC's review of the proposed...", "url": "https://www.prnewswire.com/news-releases/mylan-and-pfizer-receive-clearance-from-the-us-federal-trade-commission-for-proposed-combination-of-mylan-and-upjohn-301164021.html"}, {"symbol": "PFE", "publishedDate": "2020-10-30 13:22:00", "title": "Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn", "image": "https://cdn.snapi.dev/images/v1/j/5/press20.jpg", "site": "Business Wire", "text": "HERTFORDSHIRE, England & PITTSBURGH & NEW YORK--(BUSINESS WIRE)--Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the \u201cFTC\u201d) accepted a proposed consent order, which concludes the FTC's review of the proposed combination of Mylan and Pfizer's Upjohn Business. The parties have now obtained all required antitrust clearances for the proposed transaction. The combination will be effected through a Reverse Morris Trust transaction, pursuant", "url": "https://www.businesswire.com/news/home/20201030005641/en/Mylan-and-Pfizer-Receive-Clearance-from-the-U.S.-Federal-Trade-Commission-for-Proposed-Combination-of-Mylan-and-Upjohn/"}, {"symbol": "PFE", "publishedDate": "2020-10-29 23:14:15", "title": "Vaccine expectations baked into Pfizer's stock price: Analyst", "image": "https://cdn.snapi.dev/images/v1/3/d/vaccine-expectations-baked-into-pfizers-stock-price-analyst.jpg", "site": "CNBC International TV", "text": "Vamil Divan of Mizuho Americas explains how much upside there is for Pfizer stock if the company becomes a front runner in the race for a coronavirus vaccine.", "url": "https://www.youtube.com/watch?v=NSb03kdONJI"}, {"symbol": "PFE", "publishedDate": "2020-10-29 15:25:48", "title": "Judgement Day Approaches For COVID-19 Vaccine Names", "image": "https://cdn.snapi.dev/images/v1/f/r/drugs25.jpg", "site": "Seeking Alpha", "text": "PFE/BNTX and MRNA remain the front-runners in the race to develop a COVID-19 vaccine. PFE has seen some delays but at least, we haven't passed an interim analysis without success.", "url": "https://seekingalpha.com/article/4382733-judgement-day-approaches-for-covidminus-19-vaccine-names"}, {"symbol": "PFE", "publishedDate": "2020-10-29 06:39:14", "title": "5 Best Stocks To Buy: Our Recent Dividend Stocks Purchases", "image": "https://cdn.snapi.dev/images/v1/5/r/data-internet21.jpg", "site": "Seeking Alpha", "text": "Despite volatility, we continue to put our hard-earned cash to work. In total, we purchased 4 companies and one ETF over the last week. Three of the companies are Dividend Aristocrats, and one is an exchange-traded fund that invests in dividend growth stocks!", "url": "https://seekingalpha.com/article/4382466-5-best-stocks-to-buy-recent-dividend-stocks-purchases"}, {"symbol": "PFE", "publishedDate": "2020-10-29 06:25:07", "title": "U.K. Government Expects Pfizer's Vaccine Verdict Before Christmas", "image": "https://cdn.snapi.dev/images/v1/w/n/syringe-417786-1920-6.jpg", "site": "Benzinga", "text": "Reuters\u00a0reports that senior sources in the British government expect a verdict on\u00a0Pfizer Inc's\u00a0(NYSE:\u00a0PFE) COVID-19 vaccine results, before\u00a0AstraZeneca Plc's\u00a0(NASDAQ:\u00a0AZN) trials, according to the\u00a0Financial Times.\u00a0 What Happened: Pfizer's vaccine is being developed in collaboration with German company\u00a0BioNTech SE\u00a0(NASDAQ:\u00a0BNTX).", "url": "https://www.benzinga.com/general/biotech/20/10/18112056/u-k-government-expects-pfizers-vaccine-verdict-before-christmas"}, {"symbol": "PFE", "publishedDate": "2020-10-29 06:25:00", "title": "Got $1,000? These 2 Top Stocks Are Great Buys Right Now", "image": "https://cdn.snapi.dev/images/v1/w/p/e474f9657d2d7e1dcf6fe2d45822714c.png", "site": "The Motley Fool", "text": "These leaders in the coronavirus vaccine race have other things to offer investors.", "url": "https://www.fool.com/investing/2020/10/29/got-1000-these-2-top-stocks-are-great-buys-right-n/"}, {"symbol": "PFE", "publishedDate": "2020-10-29 06:08:00", "title": "Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids", "image": "https://cdn.snapi.dev/images/v1/p/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5965132fboy-receiving-a-vaccinejpgw700opresize.jpg", "site": "The Motley Fool", "text": "So far, only one late-stage study evaluating a COVID-19 vaccine candidate includes children.", "url": "https://www.fool.com/investing/2020/10/29/heres-the-clear-leader-in-developing-a-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-10-28 16:56:26", "title": "Why Pfizer Stock Dropped Today", "image": "https://cdn.snapi.dev/images/v1/c/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5971602fgettyimages-1154450279jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Investors are still waiting on data from Pfizer's ongoing clinical trial for its coronavirus vaccine candidate.", "url": "https://www.fool.com/investing/2020/10/28/why-pfizer-stock-dropped-today/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 18:57:23", "title": "Pfizer Vaccine Data Delayed; Fed Halts Clinical Trial", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer-covid-vaccine-457x274.jpg", "site": "PYMNTS", "text": "Any remaining hope for an end to the coronavirus crisis within the next few months appears to be fading, with two more setbacks on the research front emerging on Tuesday (Oct. 27). Pfizer CEO Albert Bourla told investors on Tuesday that the pharma giant won't be releasing coronavirus vaccine data before the Nov. 3 election, [\u2026]", "url": "https://www.pymnts.com/coronavirus/2020/pfizer-vaccine-data-delayed-fed-halts-clinical-trial/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 17:10:05", "title": "Don't Be Fazed by the Recent Market Volatility", "image": "https://cdn.snapi.dev/images/v1/g/a/drugs33.jpg", "site": "InvestorPlace", "text": "Don't be misled by worrisome headlines by the fearmongering media. The market should only get better from here.", "url": "https://investorplace.com/2020/10/why-im-not-fazed-by-the-recent-market-volatility/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 16:13:06", "title": "Pfizer Inc. (PFE) CEO Albert Bourla on Q3 2020 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/u/o/transcript49.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla on Q3 2020 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4381823-pfizer-inc-pfe-ceo-albert-bourla-on-q3-2020-results-earnings-call-transcript"}, {"symbol": "PFE", "publishedDate": "2020-10-27 13:00:00", "title": "How Pfizer Missed an Opportunity With Its Q3 Results", "image": "https://cdn.snapi.dev/images/v1/v/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5967582fscientist-in-labjpgw700opresize.jpg", "site": "The Motley Fool", "text": "The big drugmaker posted mixed third-quarter numbers. However, several key catalysts should be right around the corner.", "url": "https://www.fool.com/investing/2020/10/27/how-pfizer-missed-an-opportunity-in-q3/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 10:59:31", "title": "Crucial Covid vaccine data expected from Pfizer this week now unlikely to come before U.S. election", "image": "https://cdn.snapi.dev/images/v1/t/a/106696363-1599690402216-gettyimages-1228428304-364547128-1-9.jpeg", "site": "CNBC", "text": "", "url": "https://www.cnbc.com/2020/10/27/crucial-covid-vaccine-data-expected-from-pfizer-this-week-now-unlikely-to-come-before-us-election.html"}, {"symbol": "PFE", "publishedDate": "2020-10-27 10:54:00", "title": "Pfizer CEO: may be a week between conclusive vaccine data, public notification", "image": "https://cdn.snapi.dev/images/v1/y/y/m02d20201027t2i1538994505w940fhfwllplsqrlynxmpeg9q1fx.jpg", "site": "Reuters", "text": "Pfizer Inc's Chief Executive Albert Bourla said on Tuesday that once it knows whether the vaccine candidate it is developing with Germany's BioNTech SE works, it could be a week before it lets the public know, making it unlikely it will release data before the Nov. 3 presidential election.", "url": "https://www.reuters.com/article/us-pfizer-results-vaccine/pfizer-ceo-may-be-a-week-between-conclusive-vaccine-data-public-notification-idUSKBN27C27G"}, {"symbol": "PFE", "publishedDate": "2020-10-27 10:49:57", "title": "Do Merck and Pfizer Earnings Signal a Pullback in Health Care?", "image": "https://cdn.snapi.dev/images/v1/a/c/drugs21---tiwmnwzmmh.jpg", "site": "24/7 Wall Street", "text": "Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc.", "url": "https://247wallst.com/healthcare-business/2020/10/27/do-merck-and-pfizer-earnings-signal-a-pullback-in-health-care/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 08:52:44", "title": "Pfizer earnings report touts coronavirus vaccine progress in 42,000-participant clinical trial", "image": "https://cdn.snapi.dev/images/v1/c/y/health-coronavirus-pfizerjpgquality90stripall.jpg", "site": "Fox Business", "text": "Pfizer Inc. (PFE) on Tuesday reported third-quarter profit of $2.19 billion.", "url": "https://www.foxbusiness.com/markets/pfizer-earnings-share-price-stock-vaccine"}, {"symbol": "PFE", "publishedDate": "2020-10-27 08:08:00", "title": "Could Some Coronavirus Vaccines Be Left Out in the Cold?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc1---kjeo5ltffr.jpg", "site": "The Motley Fool", "text": "Some coronavirus vaccines must be stored at extremely low temperatures. Could this limit their market potential?", "url": "https://www.fool.com/investing/2020/10/27/could-some-coronavirus-vaccines-be-left-out-in-the/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 07:34:38", "title": "Pfizer Earnings Mixed; Drug Giant Steady", "image": "https://cdn.snapi.dev/images/v1/h/q/drugs12---6zvyie1tli.jpg", "site": "Investors Business Daily", "text": "Pfizer earnings narrowly beat third-quarter views but revenue came in short. PFE stock was little changed before Tuesday's open.", "url": "https://www.investors.com/news/technology/pfizer-earnings-pfe-stock/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 07:14:03", "title": "Pfizer posts light EPS beat but misses on revenue in Q3", "image": "https://cdn.snapi.dev/images/v1/i/5/pfizer-posts-light-eps-beat-but-misses-on-revenue-in-q3.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell breaks down Pfizer's quarterly earnings results as well as the latest developments out of the company's Phase 3 coronavirus vaccine trial.", "url": "https://www.youtube.com/watch?v=LoA9RlzPXS4"}, {"symbol": "PFE", "publishedDate": "2020-10-27 07:07:00", "title": "Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact", "image": "https://cdn.snapi.dev/images/v1/p/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5956622fgettyimages-1210040522jpgw700opresize.jpg", "site": "The Motley Fool", "text": "The World Health Organization is managing a global vaccine program without U.S. participation, and it could have a big impact for investors.", "url": "https://www.fool.com/investing/2020/10/27/investors-betting-on-a-coronavirus-vaccine-better/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 06:59:07", "title": "Pfizer's late-stage coronavirus vaccine trial is near complete enrollment with 42,000 volunteers", "image": "https://cdn.snapi.dev/images/v1/t/u/106599913-1593620338844ap-20183543531451.jpg", "site": "CNBC", "text": "", "url": "https://www.cnbc.com/2020/10/27/pfizers-late-stage-coronavirus-vaccine-trial-is-near-complete-enrollment-with-42000-volunteers.html"}, {"symbol": "PFE", "publishedDate": "2020-10-27 06:50:00", "title": "3 Dirt-Cheap Dividend Stocks to Buy Today", "image": "https://cdn.snapi.dev/images/v1/w/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5962152fsuitcase-full-of-cashjpgw700opresize.jpg", "site": "The Motley Fool", "text": "These giants show no signs of letting up on their regular payments to investors.", "url": "https://www.fool.com/investing/2020/10/27/3-dirt-cheap-dividend-stocks-to-buy-today/"}, {"symbol": "PFE", "publishedDate": "2020-10-27 06:02:00", "title": "Will the Coronavirus Vaccine Market Be Winner-Take-All?", "image": "https://cdn.snapi.dev/images/v1/r/v/syringe-1884779-1920-7.jpg", "site": "The Motley Fool", "text": "The answer boils down to simple math.", "url": "https://www.fool.com/investing/2020/10/27/will-the-coronavirus-vaccine-market-be-winner-take/"}, {"symbol": "PFE", "publishedDate": "2020-10-26 20:54:24", "title": "This analyst has concerns about the Pfizer and BioNTech vaccine", "image": "https://cdn.snapi.dev/images/v1/p/3/this-analyst-has-concerns-about-the-pfizer-and-biontech-vaccine.jpg", "site": "CNBC Television", "text": "CNBC's Kelly Evans discusses vaccine stocks, and why there are concerns about vaccine effectiveness, with Dr. Vincent Chen, biotech analyst at Bernstein. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi \u00bb Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision \u00bb Subscribe to CNBC: https://cnb.cx/SubscribeCNBC \u00bb Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.", "url": "https://www.youtube.com/watch?v=3kej0uS5B1c"}, {"symbol": "PFE", "publishedDate": "2020-10-26 08:14:00", "title": "What's the Best Way to Invest in Coronavirus Vaccine Stocks?", "image": "https://cdn.snapi.dev/images/v1/p/o/podc9---ajlptxtusp.jpg", "site": "The Motley Fool", "text": "Here are three potential strategies.", "url": "https://www.fool.com/investing/2020/10/26/whats-the-best-way-to-invest-in-coronavirus-vaccin/"}, {"symbol": "PFE", "publishedDate": "2020-10-25 09:02:00", "title": "Here's the Biggest Misconception About Coronavirus Vaccines", "image": "https://cdn.snapi.dev/images/v1/n/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5845132fgettyimages-1225481435jpgw700opresize.jpg", "site": "The Motley Fool", "text": "It could translate to good news for biotechs with COVID-19 therapies.", "url": "https://www.fool.com/investing/2020/10/25/heres-the-biggest-misconception-about-coronavirus/"}, {"symbol": "PFE", "publishedDate": "2020-10-25 06:14:00", "title": "Better Coronavirus Stock: Moderna vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/m/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955472fvaccine-shotjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Which stock wins between this up-and-coming biotech and a longtime pharma giant?", "url": "https://www.fool.com/investing/2020/10/25/better-coronavirus-stock-moderna-vs-pfizer/"}, {"symbol": "PFE", "publishedDate": "2019-08-22 10:20:00", "title": "Pfizer's Xtandi Label Expansion Filing Gets Priority Review", "image": "https://cdn.snapi.dev/images/v1/b/g/drugs24.jpg", "site": "Zacks Investment Research", "text": "If data from ARCHES study is approved to be included in the label of Pfizer's (PFE) Xtandi, it can treat a broader prostate cancer patient population.", "url": "https://www.zacks.com/stock/news/482846/pfizers-xtandi-label-expansion-filing-gets-priority-review"}, {"symbol": "PFE", "publishedDate": "2019-08-22 07:30:00", "title": "3 Dividend Stocks That Pay Better Than Coca-Cola.", "image": "https://cdn.snapi.dev/images/v1/n/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5373342f18-08-21-a-jar-of-coins-with-the-word-dividends-on-it-gettyimages-545379302jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Coke's yield is a juicy 3% or so. But you can do better!", "url": "https://www.fool.com/investing/2019/08/22/3-dividend-stocks-that-pay-better-than-coca-cola.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-21 13:39:31", "title": "Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/f/w/drugs18.jpg", "site": "Investors Business Daily", "text": "Pfizer stock jumped Wednesday after the Dow Jones giant announced a big push into gene therapy manufacturing as it tackles Duchenne muscular dystrophy and hemophilia B.", "url": "https://www.investors.com/news/technology/pfizer-stock-rises-investment-gene-therapy-manufacturing/"}, {"symbol": "PFE", "publishedDate": "2019-08-21 09:20:24", "title": "Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals", "image": "https://cdn.snapi.dev/images/v1/r/v/pf9-3.jpg", "site": "InvestorPlace", "text": "PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.", "url": "https://investorplace.com/2019/08/trade-of-the-day-pfizer-stock-is-flashing-attractive-buy-signals/"}, {"symbol": "PFE", "publishedDate": "2019-08-20 15:11:01", "title": "3 Healthcare Stocks to Trade: UNH, JNJ and PFE", "image": "https://cdn.snapi.dev/images/v1/a/l/etf24-51.jpg", "site": "InvestorPlace", "text": "Even though they are prone to headlines during elections, here are 3 healthcare stocks to buy: PFE, UNH and JNJ.\r\nThe post 3 Healthcare Stocks to Trade: UNH, JNJ and PFE appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/08/3-healthcare-stocks-to-trade-unh-jnj-and-pfe/"}, {"symbol": "PFE", "publishedDate": "2019-08-15 13:26:42", "title": "Pfizer recalls two lots of migraine drug due to potential bacterial contamination", "image": "https://cdn.snapi.dev/images/v1/f/z/drugs9.jpg", "site": "Market Watch", "text": "Pfizer Inc. PFE, +0.23% is recalling two lots of its migraine medication Relpax, the U.S. Food and Drug Administration said Thursday.", "url": "https://www.marketwatch.com/story/pfizer-recalls-two-lots-of-migraine-drug-due-to-potential-bacterial-contamination-2019-08-15"}, {"symbol": "PFE", "publishedDate": "2019-08-13 09:30:33", "title": "Tuesday\u2019s Vital Data: Uber, Pfizer and Roku", "image": "https://cdn.snapi.dev/images/v1/5/c/stocks1600-768x432.jpg", "site": "InvestorPlace", "text": "Options trading was buzzing in Uber, Pfizer and Roku on Monday. Here are the metrics that matter moving forward.", "url": "https://investorplace.com/2019/08/tuesdays-vital-data-uber-pfizer-and-roku/"}, {"symbol": "PFE", "publishedDate": "2019-08-13 06:00:00", "title": "5 Biggest New Drugs Approved in 2019 So Far", "image": "https://cdn.snapi.dev/images/v1/c/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5366262fwhite-pill-with-dollar-symboljpgw700opresize.jpg", "site": "The Motley Fool", "text": "And the one big pharma most likely to benefit the most.", "url": "https://www.fool.com/investing/2019/08/13/5-biggest-new-drugs-approved-in-2019-so-far.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-12 13:57:31", "title": "Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers", "image": "https://cdn.snapi.dev/images/v1/p/v/drugs14.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -3.52% dropped 3.6% in afternoon grading Monday, putting them on track to close at a 14-month low, as the drugmaker extends the rough patch in the wake of its second-quarter earnings report and announcement to merge its Upjohn business with Mylan Inc.", "url": "https://www.marketwatch.com/story/pfizers-stock-sinks-again-toward-14-month-low-to-pace-dows-losers-2019-08-12"}, {"symbol": "PFE", "publishedDate": "2019-08-12 06:35:20", "title": "Pfizer Once Again the Most Shorted Dow Stock", "image": "https://cdn.snapi.dev/images/v1/5/g/chemicals15.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/08/12/pfizer-once-again-the-most-shorted-dow-stock/"}, {"symbol": "PFE", "publishedDate": "2019-08-06 09:30:13", "title": "SNY vs. PFE: Which Stock Is the Better Value Option?", "image": "https://cdn.snapi.dev/images/v1/z/u/drugs10.jpg", "site": "Zacks Investment Research", "text": "SNY vs. PFE: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/459725/sny-vs-pfe-which-stock-is-the-better-value-option"}, {"symbol": "PFE", "publishedDate": "2019-08-06 08:19:40", "title": "3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink", "image": "https://cdn.snapi.dev/images/v1/i/o/etf13-35.jpg", "site": "InvestorPlace", "text": "The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.\r\nThe post 3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/08/3-big-stock-charts-for-tuesday-pfizer-aes-and-centurylink/"}, {"symbol": "PFE", "publishedDate": "2019-08-04 09:00:00", "title": "These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024", "image": "https://cdn.snapi.dev/images/v1/s/9/385.jpg", "site": "The Motley Fool", "text": "These five-star medicines should continue to push the industry higher in the next decade, despite the political blowback surrounding U.S. prescription drug prices.", "url": "https://www.fool.com/investing/2019/08/04/the-top-5-best-selling-prescription-drugs.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-02 09:32:53", "title": "Fitch Ratings downgrades Pfizer to A vs. A-plus with negative outlook", "image": "https://cdn.snapi.dev/images/v1/n/7/drugs40.jpg", "site": "Market Watch", "text": "Fitch Ratings downgraded Pfizer Inc.'s long-term issuer default rating by one notch to A from A-plus on Friday, after the closing of the acquisition of Array BioPharma earlier this week.", "url": "https://www.marketwatch.com/story/fitch-ratings-downgrades-pfizer-to-a-vs-a-plus-with-negative-outlook-2019-08-02-9913253"}, {"symbol": "PFE", "publishedDate": "2019-08-02 09:06:00", "title": "The 'Dogs Of The Dow' For 2019 Stalled In July", "image": "https://cdn.snapi.dev/images/v1/e/t/etf48-33.jpg", "site": "Forbes", "text": "The eight \u201cDogs of the Dow\u201d have an aggregate year-to-date gain of 12.2%, lagging the Dow Jones Industrial Average, which is up 15.2%.", "url": "https://www.forbes.com/sites/investor/2019/08/02/the-dogs-of-the-dow-for-2019-stalled-in-july/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 14:00:08", "title": "5 Stocks to Buy and Keep an Eye on Come Fall", "image": "https://cdn.snapi.dev/images/v1/e/t/etf13-59.jpg", "site": "InvestorPlace", "text": "Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks.", "url": "https://investorplace.com/2019/07/5-stocks-to-buy-and-keep-an-eye-on-come-fall/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 13:50:20", "title": "Square ahead of earnings, plus the Boeing trade in #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/y/w/square-ahead-of-earnings-plus-the-boeing-trade-in-askhalftime.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Square, Boeing, Pfizer, & Nokia.", "url": "https://www.youtube.com/watch?v=dGUpSqSmCD4"}, {"symbol": "PFE", "publishedDate": "2019-07-31 10:01:27", "title": "Wednesday\u2019s Vital Data: Pfizer, Advanced Micro Devices and Apple", "image": "https://cdn.snapi.dev/images/v1/r/q/4srj-7.jpg", "site": "InvestorPlace", "text": "Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.", "url": "https://investorplace.com/2019/07/wednesdays-vital-data-pfizer-advanced-micro-devices-and-apple/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 05:01:52", "title": "Here\u2019s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal", "image": "https://cdn.snapi.dev/images/v1/k/p/drugs2.jpg", "site": "InvestorPlace", "text": "The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.\r\nThe post Here\u2019s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/07/heres-how-pfizer-stock-and-pharma-stand-to-benefit-from-mylan-deal/"}, {"symbol": "PFE", "publishedDate": "2019-07-30 16:32:00", "title": "Why Beyond Meat, McDermott International, and Pfizer Slumped Today", "image": "https://cdn.snapi.dev/images/v1/e/l/sto2934.jpg", "site": "The Motley Fool", "text": "Sometimes even solid growth isn't enough to lift a stock's price.", "url": "https://www.fool.com/investing/2019/07/30/why-beyond-meat-mcdermott-international-and-pfizer.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-30 15:51:17", "title": "5 Top Stock Trades for Wednesday (July 31)", "image": "https://cdn.snapi.dev/images/v1/8/b/8b-10.jpg", "site": "InvestorPlace", "text": "Under Armour, PepsiCo, Invitae, Capital One and Pfizer are our top stock trades for Wednesday. Here's how to trade them.", "url": "https://investorplace.com/2019/07/5-top-stock-trades-for-wednesday-uaa-pep-nvta/"}, {"symbol": "PFE", "publishedDate": "2019-07-30 13:41:23", "title": "Pfizer Becomes a Falling Knife After Monday's Earnings", "image": "https://cdn.snapi.dev/images/v1/d/n/pfizer5.jpg", "site": "Investopedia", "text": "The pharma giant beat EPS estimates but missed on revenue, with sales suffering from major drugs that are now offered as generics.", "url": "https://www.investopedia.com/pfizer-became-a-falling-knife-after-mondays-earnings-4707595"}, {"symbol": "PFE", "publishedDate": "2019-07-30 12:14:41", "title": "Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger", "image": "https://cdn.snapi.dev/images/v1/w/3/pfi88.jpg", "site": "Benzinga", "text": "Morgan Stanley downgraded Pfizer Inc (NYSE: PFE)\u00a0Tuesday after the drug company announced the\u00a0spinoff of its Upjohn division\u00a0on Monday, sending its stock downward.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14160768/morgan-stanley-downgrades-pfizer-in-wake-of-upjohn-mylan-merger"}, {"symbol": "PFE", "publishedDate": "2019-07-30 10:15:56", "title": "Pfizer's stock tumbles toward worst 2-day stretch in 10 1/2-years", "image": "https://cdn.snapi.dev/images/v1/l/w/pfi9.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -5.30% tumbled 5.2% to pace the Dow Jones Industrial Average's DJIA, -0.18% decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the deal in which the company's Upjohn business will merge with generic drugmaker Mylan N.V.", "url": "https://www.marketwatch.com/story/pfizers-stock-tumbles-toward-worst-2-day-stretch-in-10-12-years-2019-07-30"}, {"symbol": "PFE", "publishedDate": "2019-07-30 07:58:00", "title": "Morgan Stanley downgrades Pfizer, says Mylan sale this week revealed some bad news", "image": "https://cdn.snapi.dev/images/v1/n/c/103890274-gettyimages-537929536.jpg", "site": "CNBC", "text": "Morgan Stanley downgraded Pfizer to equal-weight from overweight and slashed it price target to $40 per share from $48 per share.", "url": "https://www.cnbc.com/2019/07/30/morgan-stanley-downgrades-pfizer-says-mylan-sale-this-week-revealed-some-bad-news.html"}, {"symbol": "PFE", "publishedDate": "2019-07-30 06:00:00", "title": "3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders", "image": "https://cdn.snapi.dev/images/v1/h/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5241922fpills-with-some-in-shape-of-dollar-dignjpgampw700ampopresize.jpg", "site": "The Motley Fool", "text": "Pfizer's proposed deal with Mylan is complicated. But if you're a Pfizer shareholder, here's what you need to know.", "url": "https://www.fool.com/investing/2019/07/30/3-key-things-to-know-about-how-the-mylan-upjohn-me.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 18:23:47", "title": "Jefferies' Holz: Pfizer, Mylan deal not seen as defensive, both business in 'tight spaces'", "image": "https://cdn.snapi.dev/images/v1/s/x/jefferies-holz-pfizer-mylan-deal-not-seen-as-defensive-both-business-in-tight-spaces.jpg", "site": "CNBC Television", "text": "Jared Holz, health care sector strategist at Jefferies, and Chris Meekins, research analyst at Raymond James, join CNBC's \"Closing Bell\" to discuss the new deal between Pfizer and Mylan, as well as presidential hopeful Sen.", "url": "https://www.youtube.com/watch?v=h-jMerEtae8"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:58:58", "title": "Health-Care M&A Takes Center Stage With Mylan-Pfizer, Exact-Genomic Deals", "image": "https://cdn.snapi.dev/images/v1/t/4/health-care-ma-takes-center-stage-with-mylan-pfizer-exact-genomic-deals.jpg", "site": "Bloomberg Markets and Finance", "text": "Bloomberg's Nabila Ahmed takes a look at the latest M&A activity in the health-care industry. She speaks on \"Bloomberg Markets: The Close.\"", "url": "https://www.youtube.com/watch?v=IIJWnr20HFc"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:35:06", "title": "Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/m/n/transcript40.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4278771-pfizer-inc-pfe-ceo-albert-bourla-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:24:00", "title": "How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?", "image": "https://cdn.snapi.dev/images/v1/1/g/drugs20.jpg", "site": "Forbes", "text": "Pfizer (NYSE:PFE) today announced its plan to combine its generic drugs business with Mylan in a Reverse Morris Trust transaction. The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest.", "url": "https://www.forbes.com/sites/greatspeculations/2019/07/29/how-big-is-pfizers-generic-drugs-business-that-it-plans-to-merge-with-mylan/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 15:31:56", "title": "Mylan, Pfizer combined could generate more than $19 billion in annual sales: Analyst", "image": "https://cdn.snapi.dev/images/v1/m/b/mylan-pfizer-combined-could-generate-more-than-19-billion-in-annual-sales-analyst.jpg", "site": "CNBC Television", "text": "CNBC's \"Power Lunch\" team and Meg Tirrell discuss generic drug makers with Irina Koffler of Mizuho Securities.", "url": "https://www.youtube.com/watch?v=zZ_XFHmbFvc"}, {"symbol": "PFE", "publishedDate": "2019-07-29 14:00:00", "title": "What You'll Want to Know About Pfizer's Q2 Earnings Results", "image": "https://cdn.snapi.dev/images/v1/0/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5331082fpills-with-some-in-shape-of-dollar-dignjpgw700opresize.jpg", "site": "The Motley Fool", "text": "No big surprises with Pfizer's Q2 earnings results. The big surprise was a major deal with Mylan that caused the results to be announced earlier than expected.", "url": "https://www.fool.com/investing/2019/07/29/what-youll-want-to-know-about-pfizers-q2-earnings.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 13:05:00", "title": "Pfizer Inc to Combine Off-Patent Drug Business With Mylan NV", "image": "https://cdn.snapi.dev/images/v1/x/h/drugs15.jpg", "site": "GuruFocus", "text": "Drugmaker Pfizer Inc. (NYSE:PFE) announced on Monday it is combining its off-patent drug business, which is called Upjohn, with Pittsburgh-based generic pharmaceutical giant Mylan NV (NASDAQ:MYL) in an all-stock deal, creating a new company.", "url": "https://www.gurufocus.com/news/917420/pfizer-to-combine-offpatent-drug-business-with-mylan"}, {"symbol": "PFE", "publishedDate": "2019-07-29 13:03:28", "title": "Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger", "image": "https://cdn.snapi.dev/images/v1/t/v/drugs13.jpg", "site": "InvestorPlace", "text": "A new Mylan-Pfizer deal that will have the companies taking part in a merger agreement has MYL stock heading higher on Monday.\nThe post Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/07/mylan-pfizer-deal-has-myl-stock-up/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:38:56", "title": "Pfizer to merge off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/e/n/pfizer-to-merge-off-patent-drug-business-with-mylan.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the Pharmaceutical Giants Pfizer and Mylan have reached.", "url": "https://www.youtube.com/watch?v=86KbecWWBAg"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:31:18", "title": "Pfizer to spinoff, merge off-patent drugs unit with Mylan", "image": "https://cdn.snapi.dev/images/v1/f/f/drugs16jpg.jpg", "site": "Reuters", "text": "Pfizer Inc  has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar.", "url": "https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-spinoff-merge-off-patent-drugs-unit-with-mylan-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:05:22", "title": "What to Watch When Merck and Pfizer Report Early on Tuesday", "image": "https://cdn.snapi.dev/images/v1/f/j/drugs11.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) are each scheduled to release their second-quarter financial results before the markets open on Tuesday.", "url": "https://247wallst.com/healthcare-business/2019/07/29/what-to-watch-when-merck-and-pfizer-report-early-on-tuesday/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:44:26", "title": "Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-5.jpg", "site": "Reuters", "text": "Pfizer Inc. is in talks to merge its contract manufacturer that produces Mylan\u2019s EpiPen emergency allergy treatment into the new generics business it is creating by combining its older off-patent medicines unit with Mylan NV (MYL.O), a Pfizer spokeswoman said.", "url": "https://www.reuters.com/article/us-mylan-pfizer-epipen/pfizer-in-talks-to-transition-epipen-maker-into-generics-spinoff-spokeswoman-idUSKCN1UO1SG"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:40:53", "title": "Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty", "image": "https://cdn.snapi.dev/images/v1/a/2/stocks1600-768x432.jpg", "site": "The Motley Fool", "text": "Stocks were mixed on Wall Street Monday morning.", "url": "https://www.fool.com/investing/2019/07/29/stock-market-news-pfizer-mylan-make-a-deal-chipotl.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:16:29", "title": "Mylan CEO to depart as part of deal with Pfizer's off-patent drug business", "image": "https://cdn.snapi.dev/images/v1/o/o/ook92-1.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Pfizer's move to combine its off-patent drug business with Mylan, whose CEO Heather Bresch will depart as part of the deal.", "url": "https://www.youtube.com/watch?v=Kp8vDagElNQ"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:04:00", "title": "Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan", "image": "https://cdn.snapi.dev/images/v1/k/s/drugs10.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) beats estimates for second-quarter earnings but misses on sales. The company also lowers 2019 earnings and sales guidance.", "url": "https://www.zacks.com/stock/news/452910/pfizer-pfe-beats-on-q2-earnings-to-merge-upjohn-with-mylan"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:59:49", "title": "It's Market Madness: Jim Cramer on Earnings Season, Pfizer and Mylan, Starbucks", "image": "https://cdn.snapi.dev/images/v1/r/z/its-market-madness-jim-cramer-on-earnings-season-pfizer-and-mylan-starbucks.jpg", "site": "The Street", "text": "Jim weighs in on Pfizer and Mylan, Starbucks and, of course, the causes for a week of market madness.", "url": "https://www.youtube.com/watch?v=huoAr0MFBeE"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:52:59", "title": "Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup", "image": "https://cdn.snapi.dev/images/v1/m/y/mypf92-1.jpg", "site": "Investors Business Daily", "text": "Pfizer announced an all-stock plan Monday to combine its off-patent and generic drugs unit, Upjohn, with pharmaceutical company Mylan\u00a0\u2014 sending Mylan stock flying as Pfizer stock stumbled.\r\nThe post Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pharmaceutical-companies-pfizer-upjohn-combine-mylan-generic-drugs/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:19:54", "title": "S&P downgrades Pfizer by one notch to AA-minus after Upjohn/Mylan deal", "image": "https://cdn.snapi.dev/images/v1/p/f/pfz-2.jpg", "site": "Market Watch", "text": "S&P Global Ratings downgraded Pfizer Inc.'s ratings by one notch to AA-minus Monday, after the company said it is divesting its Upjohn generics business and merging it with Mylan Plc.", "url": "https://www.marketwatch.com/story/sp-downgrades-pfizer-by-one-notch-to-aa-minus-after-upjohnmylan-deal-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:12:00", "title": "What's in Store for Array BioPharma (ARRY) in Q4 Earnings?", "image": "https://cdn.snapi.dev/images/v1/e/8/biotech3.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma's (ARRY) Braftovi-Mektovi combination therapy is likely to drive fourth-quarter sales.", "url": "https://www.zacks.com/stock/news/452742/whats-in-store-for-array-biopharma-arry-in-q4-earnings"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:41:54", "title": "Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus", "image": "https://cdn.snapi.dev/images/v1/v/o/drugs29.jpg", "site": "Reuters", "text": "Drugmaker Pfizer Inc  has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar.", "url": "https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-merge-generics-unit-with-mylan-seeks-to-sharpen-cancer-focus-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:25:24", "title": "What This Mylan-Pfizer Pharma Juggernaut Will Look Like", "image": "https://cdn.snapi.dev/images/v1/l/n/drugs50.jpg", "site": "24/7 Wall Street", "text": "Mylan N.V. (NASDAQ: MYL) released its second-quarter financial results before the markets opened on Monday.", "url": "https://247wallst.com/healthcare-business/2019/07/29/what-this-mylan-pfizer-pharma-juggernaut-will-look-like/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:07:00", "title": "Pfizer Closes in on a Major Spinoff", "image": "https://cdn.snapi.dev/images/v1/m/x/pfi88.jpg", "site": "The Motley Fool", "text": "The pharmaceutical giant will reportedly combine its legacy products business with generic drug major Mylan.", "url": "https://www.fool.com/investing/2019/07/29/pfizer-closes-in-on-a-major-spinoff.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:56:18", "title": "Pfizer stock down after revenue miss, merger announcement", "image": "https://cdn.snapi.dev/images/v1/4/o/pfi9.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, +0.98% fell 3% in premarket trade Monday after the company announced a deal to merge its Upjohn business with Mylan and reported second-quarter earnings that topped profit expectations, though the drugmaker fell short of revenue estimates.", "url": "https://www.marketwatch.com/story/pfizer-stock-down-after-revenue-miss-merger-announcement-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:23:15", "title": "Pfizer to Merge Off-Patent Unit With Mylan in All-Stock Deal", "image": "https://cdn.snapi.dev/images/v1/x/z/pfizer-to-merge-off-patent-unit-with-mylan-in-all-stock-deal.jpg", "site": "Bloomberg Markets and Finance", "text": "Pfizer Inc. will combine its business line of older blockbuster medicines in an all-stock deal with generic drugmaker Mylan NV. Bloomberg Intelligence's Sam Fazeli has the details on \"Bloomberg Daybreak: Americas.\"", "url": "https://www.youtube.com/watch?v=OsfX0od-x4I"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:05:04", "title": "Pfizer (PFE) Q2 Earnings Top Estimates", "image": "https://cdn.snapi.dev/images/v1/e/q/drugs47.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) delivered earnings and revenue surprises of 3.90% and -0.44%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/452520/pfizer-pfe-q2-earnings-top-estimates"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:01:01", "title": "Mylan, Pfizer's Upjohn To Merge And Create New Company", "image": "https://cdn.snapi.dev/images/v1/c/p/medications-257336-1920-50.jpg", "site": "Benzinga", "text": "Mylan (NASDAQ: MYL) shares are trading higher after it announced the launch of a new company with Pfizer's (NYSE: PFE) Upjohn division.", "url": "https://www.benzinga.com/m-a/19/07/14149338/mylan-pfizers-upjohn-to-merge-and-create-new-company"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:56:40", "title": "Pfizer Reports Mixed Q2 Earnings, Lowers Guidance", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech23-10.jpg", "site": "Benzinga", "text": "Pfizer (NYSE: PFE) reported quarterly earnings of 80 cents per share, which beat the analyst consensus estimate of 75 cents by 6.67%.", "url": "https://www.benzinga.com/news/earnings/19/07/14149282/pfizer-reports-mixed-q2-earnings-lowers-guidance"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:40:25", "title": "Buy Pfizer Stock Before this Week\u2019s Earnings Report Gives It a Bump Up", "image": "https://cdn.snapi.dev/images/v1/s/7/drugs41.jpg", "site": "InvestorPlace", "text": "As it prepares to report its second-quarter earnings, Pfizer Stock is set to make some big moves. Now is the time to get in.", "url": "https://investorplace.com/2019/07/buy-pfizer-stock-before-this-weeks-earnings-report-gives-it-a-bump-up/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:35:12", "title": "Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes", "image": "https://cdn.snapi.dev/images/v1/r/y/drugs40.jpg", "site": "Market Watch", "text": "Mylan N.V. MYL, +0.11% said that in connection with the deal to merge with Pfizer Inc.", "url": "https://www.marketwatch.com/story/mylan-ceo-heather-bresch-to-retire-after-deal-to-merge-with-pfizers-upjohn-closes-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:08:27", "title": "Pfizer to combine off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/i/i/ii292-1.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on a new Pharma deal between Pfizer and Mylan.", "url": "https://www.youtube.com/watch?v=BqzZYdPOI7g"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:06:05", "title": "Pfizer posts 30% rise in quarterly profit", "image": "https://cdn.snapi.dev/images/v1/l/m/m02d20190729t2i1413211723rlynxnpef6s0ucw640.jpg", "site": "Reuters", "text": "Pfizer Inc  on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.", "url": "https://www.reuters.com/article/us-pfizer-results/pfizer-posts-30-rise-in-quarterly-profit-idUSKCN1UO18S"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:03:56", "title": "Mylan to combine with Pfizer's off-patent medicines unit", "image": "https://cdn.snapi.dev/images/v1/l/y/my723-2.jpg", "site": "Reuters", "text": "Mylan NV  said on Monday it would combine with Pfizer Inc's  off-patent branded and generic established medicines business to form a global generic drugmaker.", "url": "https://www.reuters.com/article/us-mylan-pfizer/mylan-to-combine-with-pfizers-off-patent-medicines-unit-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 06:59:17", "title": "Mylan's stock soars after deal to merger with Pfizer's Upjohn", "image": "https://cdn.snapi.dev/images/v1/6/9/drugs38.jpg", "site": "Market Watch", "text": "Shares of Mylan N.V. MYL, +0.11% soared 24% in premarket trading Monday, after the generic drug maker confirmed it was merging with Pfizer Inc.", "url": "https://www.marketwatch.com/story/mylans-stock-soars-after-deal-to-merger-with-pfizers-upjohn-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 06:30:00", "title": "3 Things to Look For in Pfizer's Q2 Earnings Update", "image": "https://cdn.snapi.dev/images/v1/8/k/pfizer5.jpg", "site": "The Motley Fool", "text": "The big drugmaker announces its Q2 results on July 30. Here's what you can expect.", "url": "https://www.fool.com/investing/2019/07/29/3-things-to-look-for-in-pfizers-q2-earnings-update.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-28 17:33:00", "title": "Pfizer plans combination of off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/0/a/103606723-rtx2cq0n.jpg", "site": "CNBC", "text": "The deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.", "url": "https://www.cnbc.com/2019/07/28/pfizer-plans-combination-of-off-patent-drug-business-with-mylan.html"}, {"symbol": "PFE", "publishedDate": "2019-07-27 12:20:00", "title": "10 Biggest Cancer-Fighting Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg", "site": "The Motley Fool", "text": "The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.", "url": "https://www.fool.com/investing/2019/07/27/10-biggest-cancer-fighting-stocks.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-27 09:04:02", "title": "Pfizer in talks to merge off-patent drugs business with Mylan", "image": "https://cdn.snapi.dev/images/v1/j/z/m02d20190727t2i1412584697rlynxnpef6q0b3w640.jpg", "site": "Reuters", "text": "Pfizer Inc  is in talks to merge its off-patent drugs business with Mylan NV  in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.", "url": "https://www.reuters.com/article/us-mylan-nl-m-a-pfizer/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idUSKCN1UM0DP"}, {"symbol": "PFE", "publishedDate": "2019-07-25 09:00:08", "title": "Array BioPharma (ARRY) Moves to Buy: Rationale Behind the Upgrade", "image": "https://cdn.snapi.dev/images/v1/w/e/biotech5.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "url": "https://www.zacks.com/stock/news/449331/array-biopharma-arry-moves-to-buy-rationale-behind-the-upgrade"}, {"symbol": "PFE", "publishedDate": "2019-07-25 06:40:09", "title": "Intel Overtakes Pfizer as Most Shorted Dow Stock", "image": "https://cdn.snapi.dev/images/v1/e/t/etf30-54.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/07/25/intel-overtakes-pfizer-as-most-shorted-dow-stock/"}, {"symbol": "PFE", "publishedDate": "2019-07-24 18:41:00", "title": "Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?", "image": "https://cdn.snapi.dev/images/v1/t/c/drugs39.jpg", "site": "Zacks Investment Research", "text": "Pfizer Inc. (PFE) is set to report its Q2 earnings results on Tuesday, July 30.", "url": "https://www.zacks.com/stock/news/448975/can-pfizers-q2-earnings-help-boost-pfe-stock-in-a-struggling-pharma-market"}, {"symbol": "PFE", "publishedDate": "2019-07-23 10:32:19", "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for", "image": "https://cdn.snapi.dev/images/v1/j/f/drugs3.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/447566/analysts-estimate-pfizer-pfe-to-report-a-decline-in-earnings-what-to-look-out-for"}, {"symbol": "PFE", "publishedDate": "2019-07-21 09:00:00", "title": "Better Buy:  Pfizer vs.  AbbVie", "image": "https://cdn.snapi.dev/images/v1/x/a/top23.jpg", "site": "The Motley Fool", "text": "Which stock wins in a head-to-head matchup between these two big drugmakers?", "url": "https://www.fool.com/investing/2019/07/21/better-buy-pfizer-vs-abbvie.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-20 09:00:00", "title": "3 Stocks to Build Your Portfolio Around: Google, Pfizer & W.P. Carey", "image": "https://cdn.snapi.dev/images/v1/l/w/sto23-3.jpg", "site": "The Motley Fool", "text": "It needs a solid foundation, and Alphabet, Pfizer, and W.P. Carey have proven their worth over time.", "url": "https://www.fool.com/investing/2019/07/20/3-stocks-to-build-your-portfolio-around.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-16 21:00:12", "title": "Sangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's Hands", "image": "https://cdn.snapi.dev/images/v1/b/l/drugs3.jpg", "site": "Seeking Alpha", "text": "Sangamo Therapeutics reports positive results from its phase 1/2 open-label study using SB-525 to treat patients with Hemophilia A.", "url": "https://seekingalpha.com/article/4275320-sangamos-hemophilia-results-light-spark-push-program-pfizers-hands?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-07-12 11:35:00", "title": "Drug Pricing Woes Linger on Repealing Drug Rebate Proposal", "image": "https://cdn.snapi.dev/images/v1/u/n/drugs41.jpg", "site": "Zacks Investment Research", "text": "Investors' skepticism runs rife as Trump drops the drug rebate proposal, pushing drugmakers to take center stage with regard to the controversial drug pricing issue.", "url": "https://www.zacks.com/stock/news/441711/drug-pricing-woes-linger-on-repealing-drug-rebate-proposal"}, {"symbol": "PFE", "publishedDate": "2019-07-12 09:30:17", "title": "SNY or PFE: Which Is the Better Value Stock Right Now?", "image": "https://cdn.snapi.dev/images/v1/r/a/drugs34.jpg", "site": "Zacks Investment Research", "text": "SNY vs. PFE: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/441539/sny-or-pfe-which-is-the-better-value-stock-right-now"}, {"symbol": "PFE", "publishedDate": "2019-07-11 15:19:00", "title": "These are the stocks that have powered the Dow's rally to 27,000", "image": "https://cdn.snapi.dev/images/v1/1/0-3/105981729-15611309300202019-06-05t145625z-1590043122-rc11ed42bf00-rtrmadp-3-usa-stocks.jpg", "site": "CNBC", "text": "The Dow Jones Industrial Average surged above 27,000 for the first time ever on Thursday, just a day after the S&P 500 topped 3,000. Here's a look at the stocks that drove the rally.", "url": "https://www.cnbc.com/2019/07/11/these-are-the-stocks-that-have-powered-the-dows-rally-to-27000.html"}, {"symbol": "PFE", "publishedDate": "2019-07-11 15:00:51", "title": "4 Drug Stocks Getting Smashed", "image": "https://cdn.snapi.dev/images/v1/e/x/exv2-2.jpg", "site": "InvestorPlace", "text": "Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.", "url": "https://investorplace.com/2019/07/4-drug-stocks-getting-smashed/"}, {"symbol": "PFE", "publishedDate": "2019-07-11 09:45:31", "title": "Big Pharma Sees Rising Tide in Short Interest", "image": "https://cdn.snapi.dev/images/v1/1/1/11bpha-1.jpg", "site": "24/7 Wall Street", "text": "Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.", "url": "https://247wallst.com/healthcare-business/2019/07/11/big-pharma-sees-rising-tide-in-short-interest/"}, {"symbol": "PFE", "publishedDate": "2019-07-11 06:35:50", "title": "The 5 Most Shorted Dow Stocks.", "image": "https://cdn.snapi.dev/images/v1/7/s/7shst-1.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/07/11/5-most-shorted-dow-stocks-microsoft-on-the-rise/"}, {"symbol": "PFE", "publishedDate": "2019-07-10 13:16:00", "title": "The 10 Biggest Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5301712fbusinessman-pointing-to-healthcare-iconsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "How big does a company's market cap need to be to make the top 10 list of healthcare stocks? $111 billion.", "url": "https://www.fool.com/investing/2019/07/10/the-10-biggest-healthcare-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-10 08:19:00", "title": "Here's Why Array BioPharma Soared 75.4% in June", "image": "https://cdn.snapi.dev/images/v1/z/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5305882fprescription-drug-pills-stacked-on-hundred-dollar-bill-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "It looks like Novartis let a big one get away.", "url": "https://www.fool.com/investing/2019/07/10/heres-why-array-biopharma-soared-754-in-june.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-10 08:00:14", "title": "Megadeals Enter Biotech Realm \u2014 And 3 Other Trends To Watch In 2019", "image": "https://cdn.snapi.dev/images/v1/c/b/cbm-2.jpg", "site": "Investors Business Daily", "text": "Biotech companies exploded with \"megadeals\" in the first half of 2019 as pharmaceutical companies Bristol-Myers Squibb and AbbVie announced acquisitions worth a combined $137 billion.\r\nThe post Megadeals Enter Biotech Realm \u2014 And 3 Other Trends To Watch In 2019 appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/biotech-companies-megadeals-political-pressure-china-trends-2019/"}, {"symbol": "PFE", "publishedDate": "2019-07-10 06:35:51", "title": "Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/e/t/etf25-30.jpg", "site": "24/7 Wall Street", "text": "The ongoing trade and tariff issues most likely will have the greatest impact when companies report second-quarter earnings.", "url": "https://247wallst.com/investing/2019/07/10/merrill-lynch-has-5-stocks-to-buy-that-could-beat-q2-earnings-estimates/"}, {"symbol": "PFE", "publishedDate": "2019-07-09 16:45:22", "title": "Many Top Pharma & Biotechs Rise As Drug Price Disclosure Thrown Out", "image": "https://cdn.snapi.dev/images/v1/e/t-2/etf14-52.jpg", "site": "24/7 Wall Street", "text": "While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more affordable.", "url": "https://247wallst.com/healthcare-business/2019/07/09/many-top-pharma-biotechs-rise-as-drug-price-disclosure-thrown-out/"}, {"symbol": "PFE", "publishedDate": "2019-07-08 15:49:16", "title": "Will Sangamo and Pfizer\u2019s Hemophilia Gene Therapy Keep Building Momentum?", "image": "https://cdn.snapi.dev/images/v1/e/m/drugs31.jpg", "site": "24/7 Wall Street", "text": "Sangamo Therapeutics, Inc. (NASDAQ: SGMO) made a handy gain to start out the week after the firm, in conjunction with Pfizer Inc.", "url": "https://247wallst.com/healthcare-business/2019/07/08/will-sangamo-and-pfizers-hemophilia-gene-therapy-keep-building-momentum/"}, {"symbol": "PFE", "publishedDate": "2019-07-08 13:56:11", "title": "Buy Pfizer or Merck?", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi823-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer vs. Merck.", "url": "https://www.youtube.com/watch?v=ADrx5gbf-fY&t=111s"}, {"symbol": "PFE", "publishedDate": "2019-07-08 12:59:24", "title": "Trump targets big pharma with new drug price executive order", "image": "https://cdn.snapi.dev/images/v1/g/o/gox9-1.jpg", "site": "Fox Business", "text": "Former Celgene CEO Bob Hugin on President Trump's efforts to rein in drug prices and reform the U.S. health-care system.", "url": "https://www.youtube.com/watch?v=iT1u1-19m5I"}, {"symbol": "PFE", "publishedDate": "2019-07-07 11:17:00", "title": "Better Buy: Pfizer vs. Johnson & Johnson", "image": "https://cdn.snapi.dev/images/v1/9/i/jnj-1.jpg", "site": "The Motley Fool", "text": "Which of these pharmaceutical giants is best positioned to help your portfolio grow?", "url": "https://www.fool.com/investing/2019/07/07/better-buy-pfizer-vs-johnson-johnson.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-05 20:25:28", "title": "Pfizer Remains A Strong Hold In Our Portfolio", "image": "https://cdn.snapi.dev/images/v1/5/r/drugs12.jpg", "site": "Seeking Alpha", "text": "Shares have had a strong few months.", "url": "https://seekingalpha.com/article/4273635-pfizer-remains-strong-hold-portfolio?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-07-05 20:09:15", "title": "The Top 10 Biotechnology Companies (JNJ, ROG.VX)", "image": "https://cdn.snapi.dev/images/v1/k/t/drugs11.jpg", "site": "Investopedia", "text": "Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational biotechnology corporations.", "url": "https://www.investopedia.com/articles/markets/122215/worlds-top-10-biotechnology-companies-jnj-rogvx.asp"}, {"symbol": "PFE", "publishedDate": "2019-07-05 14:15:22", "title": "The \"Halftime Report\": Can Pfizer hold its gains?", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi882-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer.", "url": "https://www.youtube.com/watch?v=W0ks4lUsGtU&t=155s"}, {"symbol": "PFE", "publishedDate": "2019-07-05 11:49:00", "title": "Trump says administration preparing an executive order on drug prices", "image": "https://cdn.snapi.dev/images/v1/1/0-3/106004366-1562340818732gettyimages-1153940064.jpeg", "site": "CNBC", "text": "\"We're working on it right now a favored nations clause where we pay the lower nation's price is, like Canada,\" President Donald Trump tells reporters.", "url": "https://www.cnbc.com/2019/07/05/trump-administration-preparing-drug-price-executive-order.html"}, {"symbol": "PFE", "publishedDate": "2019-07-03 13:13:01", "title": "Bloomberg Turnaround: How to Take Advantage of a $117 Billion Takeover Bid", "image": "https://cdn.snapi.dev/images/v1/a/s/astra-03-07.jpg", "site": "Bloomberg Markets and Finance", "text": "In 2014, Pfizer Inc. made four attempts to buy AstraZeneca Plc in less than six months. AstraZeneca Chief Executive Officer Pascal Soriot used the situation to galvanize his staff.", "url": "https://www.youtube.com/watch?v=hZzoC8dUw9s"}, {"symbol": "PFE", "publishedDate": "2019-07-03 09:34:00", "title": "Will the Pharma Space Witness More Mega-Merger Deals in 2H?", "image": "https://cdn.snapi.dev/images/v1/3/8/385.jpg", "site": "Zacks Investment Research", "text": "After two mega-mergers, Bristol-Myers/Celgene and AbbVie/Allergan, in first half of 2019, it remains to be seen if more such deals are in store for the second half.", "url": "https://www.zacks.com/stock/news/437588/will-the-pharma-space-witness-more-mega-merger-deals-in-2h"}, {"symbol": "PFE", "publishedDate": "2019-07-03 07:58:31", "title": "3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser", "image": "https://cdn.snapi.dev/images/v1/e/t/etf27-36.jpg", "site": "InvestorPlace", "text": "The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.", "url": "https://investorplace.com/2019/07/3-big-stock-charts-for-wednesday-cvs-pfe-wy/"}, {"symbol": "PFE", "publishedDate": "2019-07-02 16:56:00", "title": "Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis", "image": "https://cdn.snapi.dev/images/v1/g/a/drugs47.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) Eucrisa ointment is found safe in a late-stage label expansion study for treating mild to moderate atopic dermatitis in minors aged 3 months to 2 years.", "url": "https://www.zacks.com/stock/news/437327/pfizers-eucrisa-proves-safety-in-kids-with-atopic-dermatitis"}, {"symbol": "PFE", "publishedDate": "2019-07-02 15:38:28", "title": "3 Dow Jones Stocks to Buy for the Second Half", "image": "https://cdn.snapi.dev/images/v1/e/t/etf35-47.jpg", "site": "InvestorPlace", "text": "As we head into the second half of the year, here are three Dow Jones stocks to buy for a long-term portfolio.", "url": "https://investorplace.com/2019/07/3-dow-jones-stocks-to-buy-for-the-second-half/"}, {"symbol": "PFE", "publishedDate": "2019-07-02 15:04:26", "title": "Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation", "image": "https://cdn.snapi.dev/images/v1/1/1/11-5.jpg", "site": "Benzinga", "text": "It didn't take long for ex-FDA Commissioner Scott Gottlieb to land a new gig: he joined Pfizer Inc.'s board of directors and signed on as a partner at the venture capital firm NEA.", "url": "https://www.benzinga.com/news/19/07/14020031/ex-fda-chief-scott-gottlieb-defends-return-to-private-sector-warren-calls-for-resignation"}, {"symbol": "PFE", "publishedDate": "2019-07-02 10:06:00", "title": "Warren calls on ex-FDA chief Gottlieb to resign from Pfizer board, says it 'smacks of corruption'", "image": "https://cdn.snapi.dev/images/v1/f/u/105830370-1554293317973gettyimages-1134332168.jpeg", "site": "CNBC", "text": "'This kind of revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful,' Warren said in a July 1 letter to Gottlieb.", "url": "https://www.cnbc.com/2019/07/02/sen-warren-calls-on-ex-fda-chief-gottlieb-to-resign-from-pfizer-board.html"}, {"symbol": "PFE", "publishedDate": "2019-07-02 10:03:35", "title": "Scott Gottlieb defends his decision to join Pfizer's board", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi923.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.", "url": "https://www.youtube.com/watch?v=nFERazuvc3k"}, {"symbol": "PFE", "publishedDate": "2019-07-02 09:43:15", "title": "Scott Gottlieb on joining Pfizer's board, drug prices, and 'Medicare for All'", "image": "https://cdn.snapi.dev/images/v1/w/n/scott-gottlieb-on-joining-pfizers-board-drug-prices-and-medicare-for-all.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.", "url": "https://www.youtube.com/watch?v=gGqaYXJZJ4E"}, {"symbol": "PFE", "publishedDate": "2019-07-02 09:15:00", "title": "Former FDA Commissioner Gottlieb defends decision to join Pfizer board", "image": "https://cdn.snapi.dev/images/v1/7/k/105050631-gettyimages-866274606.jpg", "site": "CNBC", "text": "Pfizer last week announced Gottlieb would join its board of directors \u2014 a job that paid a minimum of $335,000 in stock and cash in 2018.", "url": "https://www.cnbc.com/2019/07/02/former-fda-commissioner-gottlieb-defends-decision-to-join-pfizer-board.html"}, {"symbol": "PFE", "publishedDate": "2019-07-01 10:00:12", "title": "How Pfizer Is Looking to Expand Its Eczema Treatment", "image": "https://cdn.snapi.dev/images/v1/i/j/pfi9.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) has announced topline results from its most recent late-stage study in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis (AD), also known as eczema, a chronic skin disease characterized by inflammation of the skin and skin barrier defects.", "url": "https://247wallst.com/healthcare-business/2019/07/01/how-pfizer-is-looking-to-expand-its-eczema-treatment/"}, {"symbol": "PFE", "publishedDate": "2019-07-01 09:43:00", "title": "Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval", "image": "https://cdn.snapi.dev/images/v1/f/c/drugs23.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) gets FDA approval for biosimilar Avastin, Zirabev. This is Pfizer's second oncology biosimilar to be approved in United States.", "url": "https://www.zacks.com/stock/news/436385/pfizers-pfe-avastin-biosimilar-zirabev-gets-fda-approval"}, {"symbol": "PFE", "publishedDate": "2019-07-01 09:21:00", "title": "Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study", "image": "https://cdn.snapi.dev/images/v1/3/7/drugs25.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) presents early data from a study on its investigational gene therapy for DMD. However, the study highlighted some serious side effects in two out of the six participants.", "url": "https://www.zacks.com/stock/news/436331/pfizers-dmd-gene-therapy-shows-severe-side-effects-in-study"}, {"symbol": "PFE", "publishedDate": "2019-07-01 08:27:10", "title": "Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study", "image": "https://cdn.snapi.dev/images/v1/w/g/drugs19.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -0.25% ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a period of four weeks.", "url": "https://www.marketwatch.com/story/pfizer-stock-up-12-premarket-after-drugmaker-announces-positive-results-from-phase-4-eczema-study-2019-07-01"}, {"symbol": "PFE", "publishedDate": "2019-07-01 06:38:04", "title": "Acquisition Improves the Outlook of Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/a/c/drugs17.jpg", "site": "InvestorPlace", "text": "Array's cancer drug pipeline, which has many advanced, high-potential treatments, can boost Pfizer stock price over the long-term.", "url": "https://investorplace.com/2019/07/acquiring-array-biopharma-improves-pfizers-prospects/"}, {"symbol": "PFE", "publishedDate": "2019-06-30 12:15:00", "title": "Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway", "image": "https://cdn.snapi.dev/images/v1/l/i/pfz.jpg", "site": "The Motley Fool", "text": "Don't ignore the fallout from Lyrica's loss of patent exclusivity. But do look beyond it.", "url": "https://www.fool.com/investing/2019/06/30/pfizers-about-to-enter-a-sales-slump-heres-why-you.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-29 08:48:02", "title": "Pfizer\u2019s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King", "image": "https://cdn.snapi.dev/images/v1/b/p/15pha.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) has released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy (DMD).", "url": "https://247wallst.com/healthcare-business/2019/06/29/pfizers-duchenne-muscular-dystrophy-pain-could-make-sarepta-the-dmd-king/"}, {"symbol": "PFE", "publishedDate": "2019-06-28 18:07:38", "title": "These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019", "image": "https://cdn.snapi.dev/images/v1/d/o/dowdow2.jpg", "site": "Investors Business Daily", "text": "Health-related stocks were among the worst-performing Dow Jones stocks during the first half of 2019, led by Walgreens Boots Alliance.", "url": "https://www.investors.com/news/dow-jones-stocks-walgreens-3m-unitedhealth-pfizer-verizon-worst-in-1h-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-28 10:55:43", "title": "Former FDA Commissioner has joined the board of directors at Pfizer Inc.", "image": "https://cdn.snapi.dev/images/v1/d/j/drugs1.jpg", "site": "Market Watch", "text": "Former U.S. Food and Drug Administration Commissioner Scott Gottlieb has joined the board of directors at Pfizer Inc.", "url": "https://www.marketwatch.com/story/former-fda-commissioner-scott-gottlieb-joins-pfizers-board-of-directors-2019-06-28"}, {"symbol": "PFE", "publishedDate": "2019-06-28 07:49:12", "title": "Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer", "image": "https://cdn.snapi.dev/images/v1/e/t-2/drugs46.jpg", "site": "Market Watch", "text": "Pfizer Inc. PFE, +1.02% said Friday the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer.", "url": "https://www.marketwatch.com/story/pfizer-says-fda-has-approved-its-oncology-biosimilar-zirabev-to-treat-5-types-of-cancer-2019-06-28"}, {"symbol": "PFE", "publishedDate": "2019-06-27 17:17:59", "title": "Pfizer names former FDA chief Scott Gottlieb to its board", "image": "https://cdn.snapi.dev/images/v1/d/r/m02d20190627t2i1402189472rlynxnpef5q21jw640.jpg", "site": "Reuters", "text": "Pfizer Inc  said on Thursday it has named former U.S. Food and Drug Administration Commissioner Scott Gottlieb to its board of directors, effective immediately.", "url": "https://www.reuters.com/article/us-pfizer-board/pfizer-names-former-fda-chief-scott-gottlieb-to-its-board-idUSKCN1TS36L"}, {"symbol": "PFE", "publishedDate": "2019-06-27 16:50:54", "title": "Former FDA Chief Scott Gottlieb joins Pfizer's board", "image": "https://cdn.snapi.dev/images/v1/o/g/former-fda-chief-scott-gottlieb-joins-pfizers-board.jpg", "site": "CNBC Television", "text": "CNBC's Seema Mody reports on news that Pfiezer has named former FDA Chief Scott Gottlieb to its board.", "url": "https://www.youtube.com/watch?v=Onie7VJnX2U"}, {"symbol": "PFE", "publishedDate": "2019-06-27 16:26:00", "title": "Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directors", "image": "https://cdn.snapi.dev/images/v1/6/3/105925105-1558449878026nup-187141-0485cr.jpg", "site": "CNBC", "text": "Scott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer's board of directors, the company announced Thursday.", "url": "https://www.cnbc.com/2019/06/27/former-fda-commissioner-scott-gottlieb-joins-pfizers-board.html"}, {"symbol": "PFE", "publishedDate": "2019-06-27 11:08:01", "title": "The 7 Top Small-Cap Stocks Of 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf33-27.jpg", "site": "InvestorPlace", "text": "Small-cap stocks have under-performed their large cap peers in 2019, but these 7 small-cap stocks have each more than tripled this year.", "url": "https://investorplace.com/2019/06/the-7-top-small-cap-stocks-of-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-27 07:21:00", "title": "UnitedHealth and one other Dow stock could be on the cusp of a comeback", "image": "https://cdn.snapi.dev/images/v1/u/n/unip55.jpg", "site": "CNBC", "text": "As the Dow closes in on records, just four stocks have been shut out of the rally. Some could be on the verge of a major breakout.", "url": "https://www.cnbc.com/2019/06/27/unitedhealth-and-pfizer-could-be-on-the-cusp-of-a-comeback.html"}, {"symbol": "PFE", "publishedDate": "2019-06-25 20:07:00", "title": "3 Dividend Stocks That Could Pay You the Rest of Your Life", "image": "https://cdn.snapi.dev/images/v1/a/s/asset-management24-13.jpg", "site": "The Motley Fool", "text": "This drug company, renewable power generator, and candymaker should provide investors with a steady stream of income in the decades to come.", "url": "https://www.fool.com/investing/2019/06/25/3-dividend-stocks-that-could-pay-you-the-rest-of-y.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-25 17:45:23", "title": "Pfizer (PFE) Flat As Market Sinks: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/q/x/drugs50.jpg", "site": "Zacks Investment Research", "text": "In the latest trading session, Pfizer (PFE) closed at $43.76, marking no change from the previous day.", "url": "https://www.zacks.com/stock/news/434254/pfizer-pfe-flat-as-market-sinks-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2019-06-25 12:46:38", "title": "3 Healthcare Stocks to Buy With the Market Near All-Time Highs", "image": "https://cdn.snapi.dev/images/v1/h/e/healthcaremsn4-2.jpg", "site": "InvestorPlace", "text": "PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.", "url": "https://investorplace.com/2019/06/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs/"}, {"symbol": "PFE", "publishedDate": "2019-06-24 15:33:11", "title": "The 7 Best Acquisitions of 2019", "image": "https://cdn.snapi.dev/images/v1/m/e/mergermsn.jpg", "site": "InvestorPlace", "text": "The $28 billion acquisition is the eighth-largest bank deal of all time. It\u2019s expected to close in the fourth quarter.", "url": "https://investorplace.com/2019/06/the-7-best-acquisitions-of-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-24 09:43:00", "title": "Read This Before You Buy Any New Cancer Drug Stocks", "image": "https://cdn.snapi.dev/images/v1/d/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5294672flaboratory-technician-pipeting-bloodjpgw700opresize.jpg", "site": "The Motley Fool", "text": "Around $36 billion worth of biopharma acquisitions over the past few years suggests smaller might be better.", "url": "https://www.fool.com/investing/2019/06/24/read-this-before-you-buy-any-new-cancer-drug-stock.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-24 08:33:00", "title": "Pfizer's Talzenna Gets Approval in Europe for Breast Cancer", "image": "https://cdn.snapi.dev/images/v1/0/y/drugs7.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) PARP inhibitor, Talzenna, receives approval in Europe for treating BRCA-mutated locally advanced or metastatic breast cancer.", "url": "https://www.zacks.com/stock/news/433383/pfizers-talzenna-gets-approval-in-europe-for-breast-cancer"}, {"symbol": "PFE", "publishedDate": "2019-06-23 09:00:00", "title": "These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?", "image": "https://cdn.snapi.dev/images/v1/z/q/biotech38-6.jpg", "site": "The Motley Fool", "text": "These stocks were huge winners last week. But can their momentum continue?", "url": "https://www.fool.com/investing/2019/06/23/these-3-biotech-stocks-skyrocketed-last-week-are-t.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-21 14:40:15", "title": "5 Dow Stocks Not Allowing the DJIA a Proper Rally", "image": "https://cdn.snapi.dev/images/v1/e/t/etf7-22.jpg", "site": "24/7 Wall Street", "text": "The markets have been on a wild ride in this year. The seasonal theme of \u201cSell in May and go away\u201d passed and seemingly has turned into \u201cHold your nose and buy in June.", "url": "https://247wallst.com/investing/2019/06/21/5-dow-stocks-not-allowing-the-djia-a-proper-rally/"}, {"symbol": "PFE", "publishedDate": "2019-06-21 11:57:54", "title": "Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA", "image": "https://cdn.snapi.dev/images/v1/y/c/medic-563423-1920-1-2.jpg", "site": "Benzinga", "text": "Pfizer (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug.", "url": "https://www.benzinga.com/news/19/06/13957440/pfizer-receives-european-commission-approval-for-breast-cancer-drug-talzenna"}, {"symbol": "PFE", "publishedDate": "2019-06-20 04:18:09", "title": "GSK offers concessions to address EU concerns over Pfizer deal", "image": "https://cdn.snapi.dev/images/v1/i/k/m02d20190620t2i1399681607rlynxnpef5j0juw640.jpg", "site": "Reuters", "text": "GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.", "url": "https://www.reuters.com/article/us-pfizer-m-a-gsk-eu/gsk-offers-concessions-to-address-eu-concerns-over-pfizer-deal-idUSKCN1TL0R0"}, {"symbol": "PFE", "publishedDate": "2019-06-19 11:47:14", "title": "Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years", "image": "https://cdn.snapi.dev/images/v1/b/p/drugs4.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer could become a leader in colon cancer treatment with its looming $11.4 billion acquisition of biotech company Array BioPharma, an analyst said Wednesday.", "url": "https://www.investors.com/news/technology/cancer-treatment-pfizer-buying-biotech-company-array/"}, {"symbol": "PFE", "publishedDate": "2019-06-19 09:06:00", "title": "Big Drugmakers That May Tread the M&A Path After Pfizer", "image": "https://cdn.snapi.dev/images/v1/3/8/383-3.jpg", "site": "Zacks Investment Research", "text": "There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.", "url": "https://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer"}, {"symbol": "PFE", "publishedDate": "2019-06-19 07:56:15", "title": "3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company", "image": "https://cdn.snapi.dev/images/v1/e/t/etf26-39.jpg", "site": "InvestorPlace", "text": "The stock charts of MKC, FMC and PFE are at major turning points here at the midpoint of the trading week.", "url": "https://investorplace.com/2019/06/3-big-stock-charts-for-wednesday-pfe-mkc-fmc/"}, {"symbol": "PFE", "publishedDate": "2019-06-18 09:51:00", "title": "Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio", "image": "https://cdn.snapi.dev/images/v1/b/a/biotech23.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) offers $48 per share to buy Array BioPharma and strengthen its cancer portfolio.", "url": "https://www.zacks.com/stock/news/431106/pfizer-to-buy-array-biopharma-broaden-cancer-portfolio"}, {"symbol": "PFE", "publishedDate": "2019-06-18 07:57:29", "title": "5 Dividend Leaders To Buy From Merrill Lynch\u2019s Large Cap Defensive Portfolio", "image": "https://cdn.snapi.dev/images/v1/e/t/etf5-24.jpg", "site": "24/7 Wall Street", "text": "With summer starting on Friday, we could be in for a hot three months in more ways than one.", "url": "https://247wallst.com/investing/2019/06/18/5-dividend-leaders-to-buy-from-merrill-lynchs-large-cap-defensive-portfolio/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 18:48:58", "title": "Biotech M&A Boom: 4 trades", "image": "https://cdn.snapi.dev/images/v1/t/f/tfs72.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 4 trades in Biotech as the deal space heats up in the sector.", "url": "https://www.youtube.com/watch?v=AfpX7f4Uy_Y"}, {"symbol": "PFE", "publishedDate": "2019-06-17 18:36:07", "title": "Fmr. FDA commissioner on biotech", "image": "https://cdn.snapi.dev/images/v1/m/q-5/fmr-fda-commissioner-on-biotech.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb on biotech", "url": "https://www.youtube.com/watch?v=YqJDCmWU2Lg"}, {"symbol": "PFE", "publishedDate": "2019-06-17 17:06:21", "title": "Pfizer strengthens its position in cancer", "image": "https://cdn.snapi.dev/images/v1/u/g/biotech3.jpg", "site": "The Motley Fool", "text": "Acquisitions made headlines, with Pfizer buying Array BioPharma.", "url": "https://www.fool.com/investing/2019/06/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 17:00:00", "title": "Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon", "image": "https://cdn.snapi.dev/images/v1/e/s/esuq7.jpg", "site": "The Motley Fool", "text": "The big drugmaker is spending more than $11 billion for the cancer-drug specialist.", "url": "https://www.fool.com/investing/2019/06/17/why-pfizers-acquisition-of-array-biopharma-wont-pa.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 16:05:26", "title": "Five Top Stock Trades for Tuesday June 18", "image": "https://cdn.snapi.dev/images/v1/s/t/stoc99.jpg", "site": "InvestorPlace", "text": "Gilead Sciences, Pfizer, Tesla, Netflx and Facebook are our top stock trades for Tuesday. Here's a look at the charts.", "url": "https://investorplace.com/2019/06/5-top-stock-trades-for-tuesday-fb-nflx-gild-tsla/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 12:11:58", "title": "Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal", "image": "https://cdn.snapi.dev/images/v1/q/i/biotech11.jpg", "site": "InvestorPlace", "text": "Array BioPharma news for Monday concerning a deal with Pfizer (PFE) that will have the two companies coming together has ARRY stock soaring.", "url": "https://investorplace.com/2019/06/array-biopharma-news-boosts-arry-stock/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 11:56:07", "title": "How Much Is Pfizer Overpaying For Array Bio?", "image": "https://cdn.snapi.dev/images/v1/g/o/pf9-3.jpg", "site": "24/7 Wall Street", "text": "Array BioPharma Inc. shares shot up on Monday after the firm announced that it would be acquired by Pfizer Inc. in an all cash transaction.", "url": "https://247wallst.com/healthcare-business/2019/06/17/how-much-is-pfizer-overpaying-for-array-bio/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 11:32:21", "title": "Stock Market News: Array Get Winning Bids on a Big Deal Day", "image": "https://cdn.snapi.dev/images/v1/4/6/biotech17.jpg", "site": "The Motley Fool", "text": "Wall Street was in an optimistic mood on Monday morning.", "url": "https://www.fool.com/investing/2019/06/17/stock-market-news-sothebys-array-get-winning-bids.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 10:33:00", "title": "\"Merger Monday\" Returns: Pfizer Buying Array", "image": "https://cdn.snapi.dev/images/v1/o/8/biotech10.jpg", "site": "Zacks Investment Research", "text": "News on two major mergers in their respective industries are taking headlines, along with a fresh regional economic read.", "url": "https://www.zacks.com/stock/news/430565/merger-monday-returns-pfizer-buying-array-t-mobile-sprint-on-ice"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:58:02", "title": "Pfizer will access Array's approved cancer drugs in $11 billion deal", "image": "https://cdn.snapi.dev/images/v1/y/2/pfizer-will-access-arrays-approved-cancer-drugs-in-11-billion-deal.jpg", "site": "CNBC Television", "text": "Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.", "url": "https://www.youtube.com/watch?v=0E2mWA269PQ"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:49:44", "title": "Pfizer acquires array biopharma in $10.64B deal", "image": "https://cdn.snapi.dev/images/v1/f/p/pfizer-acquires-array-biopharma-in-1064b-deal.jpg", "site": "Yahoo Finance", "text": "Pfizer is buying Array BioPharma in a deal valued at $10.6 billion.", "url": "https://www.youtube.com/watch?v=pW7KVOjEILc"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:34:37", "title": "How An $11.4 Billion Takeover Will Deepen Pfizer's Efforts In Cancer", "image": "https://cdn.snapi.dev/images/v1/r/b/drugs9.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer announced Monday an $11.4 billion plan to acquire biotech company Array BioPharma, which is working on cancer treatments.", "url": "https://www.investors.com/news/technology/biotech-company-array-acquired-pfizer-deal-cancer-treatments/"}, {"symbol": "PFE", "publishedDate": "2019-06-17 09:22:00", "title": "Why Array BioPharma Stock Is on Fire Today", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech18-6.jpg", "site": "The Motley Fool", "text": "Pfizer moves to acquire the cancer specialist in a deal valued at $11.4 billion.", "url": "https://www.fool.com/investing/2019/06/17/why-array-biopharma-inc-is-on-fire-today.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-17 08:44:00", "title": "S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal", "image": "https://cdn.snapi.dev/images/v1/g/v/pf9.jpg", "site": "Market Watch", "text": "S&P Global Ratings placed Pfizer Inc.'s ratings on CreditWatch negative on Monday, after the drug company announced that it is acquiring Array BioPharma Inc.", "url": "https://www.marketwatch.com/story/sp-places-pfizer-ratings-on-creditwatch-negative-after-114-billion-array-deal-2019-06-17"}, {"symbol": "PFE", "publishedDate": "2019-06-17 07:55:36", "title": "Pfizer To Buy Array BioPharma For $48/Share", "image": "https://cdn.snapi.dev/images/v1/c/j/medicine-2520463-1920-20.jpg", "site": "Benzinga", "text": "Array BioPharma (NASDAQ: ARRY) shares are trading sharply higher after the company announced it will be acquired by Pfizer (NYSE: PFE) for $48 per share in cash for a total value of around $11.4 billion.", "url": "https://www.benzinga.com/general/biotech/19/06/13928334/pfizer-to-buy-array-biopharma-for-48share"}, {"symbol": "PFE", "publishedDate": "2019-06-17 07:35:22", "title": "Pfizer buys Array Biopharma for $48/share in cash", "image": "https://cdn.snapi.dev/images/v1/p/a/pah82.jpg", "site": "CNBC Television", "text": "Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.", "url": "https://www.youtube.com/watch?v=2wDGoXrrMPk"}, {"symbol": "PFE", "publishedDate": "2019-06-17 06:56:59", "title": "Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer", "image": "https://cdn.snapi.dev/images/v1/q/k/biotech4.jpg", "site": "Market Watch", "text": "Shares of Array BioPharma Inc. ARRY, +0.58% rocketed 56% toward a record high in premarket trading Monday, after biopharmaceutical company developing cancer treatments agreed to be acquired by Pfizer Inc.", "url": "https://www.marketwatch.com/story/array-biopharmas-stock-rockets-after-114-billion-buyout-deal-with-pfizer-2019-06-17"}, {"symbol": "PFE", "publishedDate": "2019-06-17 06:56:16", "title": "Pfizer to buy Array for $10.64 billion", "image": "https://cdn.snapi.dev/images/v1/4/c/m02d20190617t2i1398681146rlynxnpef5g0nmw640.jpg", "site": "Reuters", "text": "Pfizer Inc said on Monday it had agreed to acquire Array Biopharma Inc for $10.64 billion, which will grant it access to its cancer drugs.", "url": "https://www.reuters.com/article/us-array-biopharma-m-a-pfizer/pfizer-to-buy-array-for-10-64-billion-idUSKCN1TI15T"}, {"symbol": "PFE", "publishedDate": "2019-06-15 08:00:00", "title": "5 Biggest Blockbuster Drugs of the Future", "image": "https://cdn.snapi.dev/images/v1/d/r/drugs50.jpg", "site": "The Motley Fool", "text": "Each of these drugs is forecast to rake in at least $9.5 billion in 2024. Investors looking to profit should pay attention to the pharmaceutical giants that sell them.", "url": "https://www.fool.com/investing/2019/06/15/5-biggest-blockbuster-drugs-of-the-future.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-14 06:25:34", "title": "7 Stocks Not Enjoying the Bull Market and Holding Down the Dow in 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf16-38.jpg", "site": "24/7 Wall Street", "text": "It\u2019s been a wild ride in 2019. The seasonal theme of \u201csell in May and go away\u201d passed and seemingly has turned into \u201cHold your nose and buy in June.", "url": "https://247wallst.com/investing/2019/06/14/7-stocks-not-enjoying-the-bull-market-and-holding-down-the-dow-in-2019/"}, {"symbol": "PFE", "publishedDate": "2019-06-13 08:24:00", "title": "Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study", "image": "https://cdn.snapi.dev/images/v1/f/b/drugs33.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) study on JAK inhibitor Xeljanz XR demonstrates the efficacy of the medicine when used as a monotherapy without methotrexate.", "url": "https://www.zacks.com/stock/news/428916/pfizers-pfe-xeljanz-effective-as-monotherapy-in-ra-study"}, {"symbol": "PFE", "publishedDate": "2019-06-12 16:58:48", "title": "6 Large-Cap Stocks Outperforming the Benchmark", "image": "https://cdn.snapi.dev/images/v1/e/t/etf45-15.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the last 12 months.", "url": "https://www.gurufocus.com/news/893322/6-largecap-stocks-outperforming-the-benchmark"}, {"symbol": "PFE", "publishedDate": "2019-06-12 10:36:00", "title": "Top Ranked Income Stocks to Buy for June 12th 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf20-24.jpg", "site": "Zacks Investment Research", "text": "Top Ranked Income Stocks to Buy for June 12th", "url": "https://www.zacks.com/commentary/428514/top-ranked-income-stocks-to-buy-for-june-12th"}, {"symbol": "PFE", "publishedDate": "2019-06-12 08:30:17", "title": "Big Pharma Sees a Rising Tide in Short Interest", "image": "https://cdn.snapi.dev/images/v1/1/5/15pha.jpg", "site": "24/7 Wall Street", "text": "Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.", "url": "https://247wallst.com/healthcare-business/2019/06/12/big-pharma-sees-a-rising-tide-in-short-interest/"}, {"symbol": "PFE", "publishedDate": "2019-06-12 08:28:00", "title": "Boost Your Portfolio's Health With These 3 Big Drug Stocks", "image": "https://cdn.snapi.dev/images/v1/2/8/287-4.jpg", "site": "Zacks Investment Research", "text": "The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.", "url": "https://www.zacks.com/stock/news/428332/boost-your-portfolios-health-with-these-3-big-drug-stocks"}, {"symbol": "PFE", "publishedDate": "2019-06-12 07:35:40", "title": "4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners", "image": "https://cdn.snapi.dev/images/v1/8/h/8hed.jpg", "site": "24/7 Wall Street", "text": "We have noted that hedge fund performance over the past couple of years, especially by some of the bigger funds, has trailed the overall market performance.", "url": "https://247wallst.com/investing/2019/06/12/4-price-momentum-stocks-hedge-funds-love-could-be-big-summer-winners/"}, {"symbol": "PFE", "publishedDate": "2019-06-12 07:15:18", "title": "6 Most Shorted Dow Stocks", "image": "https://cdn.snapi.dev/images/v1/7/s/7sho-1.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/06/12/6-most-shorted-dow-stocks-pfizer-still-on-top/"}, {"symbol": "PFE", "publishedDate": "2019-06-10 16:20:34", "title": "Five Health Care Stocks Gurus Are Buying", "image": "https://cdn.snapi.dev/images/v1/2/0/20heal.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.", "url": "https://www.gurufocus.com/news/891970/5-health-care-stocks-gurus-are-buying"}, {"symbol": "PFE", "publishedDate": "2019-06-10 10:33:00", "title": "These 3 Biotech Stocks Doubled in the First Half of 2019", "image": "https://cdn.snapi.dev/images/v1/e/t/etf24-23.jpg", "site": "The Motley Fool", "text": "Could the second half of the year be as much fun as the first?", "url": "https://www.fool.com/investing/2019/06/10/these-3-biotech-stocks-doubled-in-first-half-2019.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-07 07:45:00", "title": "Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far", "image": "https://cdn.snapi.dev/images/v1/u/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg", "site": "The Motley Fool", "text": "They might be this year's Bad News Bears, but I think these three stocks will be long-term winners.", "url": "https://www.fool.com/investing/2019/06/07/why-im-sticking-with-my-3-worst-performing-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-06 09:31:26", "title": "Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?", "image": "https://cdn.snapi.dev/images/v1/b/n/biotech8.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/425534/why-is-array-biopharma-arry-up-271-since-last-earnings-report"}, {"symbol": "PFE", "publishedDate": "2019-06-06 09:05:00", "title": "5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug", "image": "https://cdn.snapi.dev/images/v1/n/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5278612fhealthcare-provider-helping-a-patient-stand-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.", "url": "https://www.fool.com/investing/2019/06/06/5-reasons-pfizer-sat-on-a-potential-new-alzheimers.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-06 08:50:45", "title": "3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies", "image": "https://cdn.snapi.dev/images/v1/e/t/etf14-30.jpg", "site": "InvestorPlace", "text": "The stock charts of WMT, FLT and PFE are headed into the latter half of the week at inflection points. Here's what you can expect from each.", "url": "https://investorplace.com/2019/06/3-big-stock-charts-for-thursday-pfizer-walmart-and-fleetcor-technologies/"}, {"symbol": "PFE", "publishedDate": "2019-06-05 13:31:45", "title": "Pfizer denies report it hid possible Alzheimer\u2019s breakthrough", "image": "https://cdn.snapi.dev/images/v1/q/8/pfizer-alzheimers-reportjpgquality90stripall.jpg", "site": "New York Post", "text": "Pfizer is fighting back against a report that it hid the potential of a blockbuster drug to prevent Alzheimer\u2019s disease in order to avoid shelling out for a \u201ccostly clinical trial.\u201d Researchers at Pfizer in 2015 found that Enbrel, an anti-inflammatory drug used to treat rheumatioid arthritis, seemed to reduce the risk of Alzheimer\u2019s disease.", "url": "https://nypost.com/2019/06/05/pfizer-denies-report-it-hid-possible-alzheimers-breakthrough/"}, {"symbol": "PFE", "publishedDate": "2019-06-05 09:05:00", "title": "Pfizer to Launch Several Drugs Despite Generic Headwinds", "image": "https://cdn.snapi.dev/images/v1/s/z/drugs16.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) looks well positioned to launch several breakthrough innovative medicines in the next five years amid loss of exclusivity headwinds.", "url": "https://www.zacks.com/stock/news/424912/pfizer-to-launch-several-drugs-despite-generic-headwinds"}, {"symbol": "PFE", "publishedDate": "2019-06-05 07:06:00", "title": "The Four Most Oversold Dow Stocks", "image": "https://cdn.snapi.dev/images/v1/1/1/11over.jpg", "site": "Forbes", "text": "Many of the stocks in the Dow Industrial Average dropped sharply in May as fears over the deepening trade war made them less attractive to investors. In his regular monthly scan, Viper Report\u2019s Tom Aspray discusses the four most oversold Dow stocks.", "url": "https://www.forbes.com/sites/tomaspray/2019/06/05/the-four-most-oversold-dow-stocks/"}, {"symbol": "PFE", "publishedDate": "2019-06-04 15:18:11", "title": "The 10 Best Stocks for 2019 \u2014 So Far", "image": "https://cdn.snapi.dev/images/v1/b/u/bul23.jpg", "site": "InvestorPlace", "text": "Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019. The post The 10 Best Stocks for 2019 \u2014 So Far appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/06/the-10-best-stocks-for-2019-so-far/"}, {"symbol": "PFE", "publishedDate": "2019-06-04 13:57:00", "title": "Top Research Reports for Pfizer, Coca-Cola & VMware", "image": "https://cdn.snapi.dev/images/v1/r/l/asset-management19.jpg", "site": "Zacks Investment Research", "text": "Top Research Reports for Pfizer, Coca-Cola & VMware", "url": "https://www.zacks.com/research-daily/424605/top-research-reports-for-pfizer-coca-cola-vmware"}, {"symbol": "PFE", "publishedDate": "2019-06-04 09:21:00", "title": "3 Cancer Stocks Given a Lift by Amgen", "image": "https://cdn.snapi.dev/images/v1/n/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5183412fbiotech-stocks-to-own.jpg", "site": "The Motley Fool", "text": "Success with an experimental new oncology treatment that scratches a 35-year itch is good news for more than one biotech stock.", "url": "https://www.fool.com/investing/2019/06/04/3-cancer-stocks-given-a-lift-by-amgen.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-06-03 16:05:11", "title": "6 High-Yield Stocks", "image": "https://cdn.snapi.dev/images/v1/e/t/etf14-29.jpg", "site": "GuruFocus", "text": "According to the GuruFocus All-in-One Screener, the following companies have high dividend yields but performed poorly over the last 12 months.", "url": "https://www.gurufocus.com/news/888731/6-highyield-stocks"}, {"symbol": "PFE", "publishedDate": "2019-06-03 08:42:00", "title": "'Dogs Of The Dow' Slump, Here's How To Trade Them Now", "image": "https://cdn.snapi.dev/images/v1/1/4/14dow.jpg", "site": "Forbes", "text": "The eight \u201cDogs of the Dow\u201d for 2019 have an aggregate year-to-date gain of 5.5% at the end of May, down from 12.2% at the end of April. Here's how to buy and sell them now.", "url": "https://www.forbes.com/sites/investor/2019/06/03/dogs-of-the-dow-slump-heres-how-to-trade-them-now/"}, {"symbol": "PFE", "publishedDate": "2019-05-30 12:59:00", "title": "Only five Dow stocks have gained in May as trade war drags on", "image": "https://cdn.snapi.dev/images/v1/1/0-2/103310522-gettyimages-479184028.jpg", "site": "CNBC", "text": "Just five Dow components were poised for May gains Thursday afternoon, a reflection of the effect the trade war is having on Wall Street.", "url": "https://www.cnbc.com/2019/05/30/only-five-dow-stocks-have-gained-in-may-as-trade-war-drags-on.html"}, {"symbol": "PFE", "publishedDate": "2019-05-30 10:34:00", "title": "2 Ultra-High-Growth Biotech Stocks to Buy Now", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech38-6.jpg", "site": "The Motley Fool", "text": "Amicus Therapeutics and Array BioPharma are two top growth stocks to consider buying now.", "url": "https://www.fool.com/investing/2019/05/30/2-ultra-high-growth-biotech-stocks-to-buy-now.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-30 09:31:52", "title": "Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/i/b/pfi92.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?", "url": "https://www.zacks.com/stock/news/422183/pfizer-pfe-up-23-since-last-earnings-report-can-it-continue"}, {"symbol": "PFE", "publishedDate": "2019-05-29 22:07:38", "title": "Array's Positive Phase 3 Results Make The Case For Revenue Growth For BRAFTOVI And METKOVI", "image": "https://cdn.snapi.dev/images/v1/d/m/biotech27.jpg", "site": "Seeking Alpha", "text": "Array obtained positive results for its phase 3 BEACON CRC study using BRAFTOVI, METKOVI, and ERBITUX to treat patients with BRAF mutant metastatic colorectal cancer.", "url": "https://seekingalpha.com/article/4267182-arrays-positive-phase-3-results-make-case-revenue-growth-braftovi-metkovi?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-05-28 15:36:50", "title": "This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5270562fdrugs-pharmaceuticals-pill-box-pills-2018-05-10-12-39-51-utcjpgw700opresize.jpg", "site": "The Motley Fool", "text": "And the analyst really likes one in particular.", "url": "https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-28 14:39:44", "title": "4 Drug and Health Stocks Pushing Higher \u00a0", "image": "https://cdn.snapi.dev/images/v1/b/i/biotechmsn-compressed.jpg", "site": "InvestorPlace", "text": "U.S. equities are mostly higher in post-holiday trading on Tuesday, as investors are looking for stocks to buy.", "url": "https://feedproxy.google.com/~r/InvestorPlace/~3/71FlC3SQO_c/"}, {"symbol": "PFE", "publishedDate": "2019-05-27 09:22:00", "title": "Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study", "image": "https://cdn.snapi.dev/images/v1/l/s/pf9-3.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) announces failure of a phase III study evaluating Lyrica in patients with primary generalized tonic-clonic seizures, a form of epilepsy.", "url": "https://www.zacks.com/stock/news/420063/pfizers-pfe-epilepsy-drug-lyrica-fails-in-phase-iii-study"}, {"symbol": "PFE", "publishedDate": "2019-05-24 16:20:20", "title": "Pfizer's Lyrica doesn't meet endpoint in epilepsy study", "image": "https://cdn.snapi.dev/images/v1/l/y/ly7dr.jpg", "site": "Market Watch", "text": "Pfizer Inc. said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/gmEaZnwq7Fw/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-05-23 18:58:51", "title": "Pfizer Has Limited Downside", "image": "https://cdn.snapi.dev/images/v1/o/s/11-2.jpg", "site": "Seeking Alpha", "text": "10-year chart shows strong support for shares.", "url": "https://seekingalpha.com/article/4266229-pfizer-limited-downside?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-05-23 14:21:02", "title": "Pfizer or Johnson & Johnson? The viewers #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/p/f/pfzj7.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer & J&J.", "url": "https://www.youtube.com/watch?v=RtaOeJqeP8c&t=36s"}, {"symbol": "PFE", "publishedDate": "2019-05-23 14:14:00", "title": "Mr. Wonderful's Top 10 Dividend Stocks", "image": "https://cdn.snapi.dev/images/v1/0/x/0x600-149.jpg", "site": "Forbes", "text": "Kevin O\u2019Leary is Chairman of O\u2019Shares Investments, but you probably know him as \u201cMr. Wonderful\u201d from Shark Tank, assertsBen Reynolds, editor ofSure Dividendand contributor toMoneyShow.comin a special report that analyzes some of the shark\u2019s top high quality, dividend paying ideas.", "url": "https://www.forbes.com/sites/moneyshow/2019/05/23/mr-wonderfuls-top-10-dividend-stocks/"}, {"symbol": "PFE", "publishedDate": "2019-05-23 08:54:00", "title": "Array BioPharma Inc. (ARRY) Shares March Higher, Can It Continue?", "image": "https://cdn.snapi.dev/images/v1/j/i/biotech6.jpg", "site": "Zacks Investment Research", "text": "As of late, it has definitely been a great time to be an investor in Array BioPharma Inc. (ARRY).", "url": "https://www.zacks.com/stock/news/418486/array-biopharma-inc-arry-shares-march-higher-can-it-continue"}, {"symbol": "PFE", "publishedDate": "2019-05-21 09:00:00", "title": "Better Buy: AbbVie vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/k/5/hcs2.jpg", "site": "The Motley Fool", "text": "AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?", "url": "https://www.fool.com/investing/2019/05/21/better-buy-abbvie-vs-pfizer.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-20 12:04:42", "title": "Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/p/f/pfemsn-300x165.jpg", "site": "InvestorPlace", "text": "Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.", "url": "https://feedproxy.google.com/~r/InvestorPlace/~3/30572ZveJNQ/"}, {"symbol": "PFE", "publishedDate": "2019-05-15 08:00:19", "title": "Pfizer Stock Is The Biggest Pharma \u2014 But Should You Buy It?", "image": "https://cdn.snapi.dev/images/v1/d/a/drugs11.jpg", "site": "Investors Business Daily", "text": "Pfizer stock has fallen 7.1% this year, behind pharma stocks. Recent news has been upbeat with a drug approval and earnings beat.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/ciWE76f27MY/"}, {"symbol": "PFE", "publishedDate": "2019-05-14 07:39:05", "title": "Shark Tank's Kevin O'Leary: Keep your stock picks boring during trade turmoil", "image": "https://cdn.snapi.dev/images/v1/m/q-4/shark-tanks-kevin-oleary-keep-your-stock-picks-boring-during-trade-turmoil.jpg", "site": "CNBC Television", "text": "Guest Host Kevin O'Leary of Shark Tank joins \"Squawk Box\" to give his top stock picks amid the market sell-off and what he thinks investors should do about Boeing.", "url": "https://www.youtube.com/watch?v=7DoVpIJT2qQ"}, {"symbol": "PFE", "publishedDate": "2019-05-12 11:00:00", "title": "Top vaccine makers Merck and Pfizer target China and older adults next", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi22.jpg", "site": "CNBC", "text": "The four companies that now dominate global vaccine sales are Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.", "url": "https://www.cnbc.com/2019/05/10/merck-pfizer-sanofi-pasteur-and-glaxosmithkline-make-billions-from-shingrix-and-gardasil-vaccines.html"}, {"symbol": "PFE", "publishedDate": "2019-05-10 09:00:07", "title": "All You Need to Know About Array BioPharma (ARRY) Rating Upgrade to Buy", "image": "https://cdn.snapi.dev/images/v1/r/e/biotech3.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "url": "https://www.zacks.com/stock/news/412542/all-you-need-to-know-about-array-biopharma-arry-rating-upgrade-to-buy"}, {"symbol": "PFE", "publishedDate": "2019-05-09 14:10:45", "title": "2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure", "image": "https://cdn.snapi.dev/images/v1/6/e/6el.jpg", "site": "24/7 Wall Street", "text": "Thursday market saw two very successful IPOs in the emerging biotech sector.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/viMU8PpZeNU/"}, {"symbol": "PFE", "publishedDate": "2019-05-08 11:17:51", "title": "Pfizer Buys Rare Disease Biotech Therachon For $340M", "image": "https://cdn.snapi.dev/images/v1/s/9/syringe-1884758-1920-7-4.jpg", "site": "Benzinga", "text": "Pfizer Inc. (NYSE: PFE) said Wednesday that it reached a definitive agreement to acquire all the shares of Therachon Holding AG, a privately held clinical-stage biotech\u00a0focused on rare diseases.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/WV6qRuusYTc/pfizer-buys-rare-disease-biotech-therachon-for-340m"}, {"symbol": "PFE", "publishedDate": "2019-05-08 09:56:00", "title": "Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates", "image": "https://cdn.snapi.dev/images/v1/y/c/biotech17.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma's (ARRY) top and bottom lines beat estimates in the third quarter of fiscal 2019. Momentum in uptake of Braftovi-Mektovi combination therapy continues.", "url": "https://www.zacks.com/stock/news/411124/array-biopharma-arry-q3-earnings-and-sales-beat-estimates"}, {"symbol": "PFE", "publishedDate": "2019-05-07 20:21:00", "title": "Can Pfizer Leap Over the Competition With This Potential Blockbuster?", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-ojpg.jpg", "site": "The Motley Fool", "text": "It's been nearly seven years since the FDA refused to approve tafamidis's first new drug application, and the field is a lot more crowded now.", "url": "https://www.fool.com/investing/2019/05/07/can-pfizer-leap-over-competition-with-tafamidis.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-07 16:48:05", "title": "Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/n/s/transcript6jpg.jpg", "site": "Seeking Alpha", "text": "Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4261149-array-biopharma-inc-arry-ceo-ron-squarer-q3-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-05-07 09:15:03", "title": "Array BioPharma (ARRY) Reports Q3 Loss, Tops Revenue Estimates", "image": "https://cdn.snapi.dev/images/v1/o/z/biotech2jpg.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) delivered earnings and revenue surprises of 19.05% and 25.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/410143/array-biopharma-arry-reports-q3-loss-tops-revenue-estimates"}, {"symbol": "PFE", "publishedDate": "2019-05-06 13:16:03", "title": "How Dow Jones' Pfizer Could Take On New Drugs From 2 Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/e/l/pfz.jpg", "site": "Investors Business Daily", "text": "Dow Jones component Pfizer gained approval Monday for a drug that treats a rare heart disease\u00a0\u2014 potentially rivaling new drugs from Alnylam Pharmaceuticals and Ionis Pharmaceuticals.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/dVL5agWqXzw/"}, {"symbol": "PFE", "publishedDate": "2019-05-05 07:30:00", "title": "5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term", "image": "https://cdn.snapi.dev/images/v1/a/h/pd2.jpg", "site": "The Motley Fool", "text": "A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.", "url": "https://www.fool.com/investing/2019/05/05/5-reasons-why-pfizer-is-a-great-stock-to-buy-and-h.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-05-03 14:16:00", "title": "Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth", "image": "https://cdn.snapi.dev/images/v1/l/o/pf9.jpg", "site": "Forbes", "text": "Pfizer recently reported its Q1 2019 results, which were above our estimates. This note details the company\u2019s Q1 performance, and Trefis\u2019 forecast for the full year 2019.", "url": "https://www.forbes.com/sites/greatspeculations/2019/05/03/pfizer-beats-in-q1-but-lyrica-headwinds-will-likely-weigh-on-near-term-growth/"}, {"symbol": "PFE", "publishedDate": "2019-05-02 14:18:22", "title": "Pfizer Stock Rebounds Under Cloud of Negative Charts", "image": "https://cdn.snapi.dev/images/v1/2/b/drugs48jpg.jpg", "site": "Investopedia", "text": "Pfizer reported better-then-expected earnings on April 30, but the stock is under a \"death cross\" and a negative weekly chart.", "url": "https://www.investopedia.com/pfizer-stock-rebounds-under-cloud-of-negative-charts-4686156"}, {"symbol": "PFE", "publishedDate": "2019-05-01 18:26:42", "title": "The top 2 health care names to play for a catch-up: Technician", "image": "https://cdn.snapi.dev/images/v1/h/e/he2l3.jpg", "site": "CNBC Television", "text": "Mark Newton, Newton Advisors, on playing catch-up with health care stocks.", "url": "https://www.youtube.com/watch?v=20YklDG_jUo"}, {"symbol": "PFE", "publishedDate": "2019-05-01 14:54:36", "title": "How Viagra Made Pfizer Billions Despite Generics", "image": "https://cdn.snapi.dev/images/v1/a/q/how-viagra-made-pfizer-billions-despite-generics.jpg", "site": "CNBC", "text": "Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter.", "url": "https://www.youtube.com/watch?v=8f8ldl8-3AQ"}, {"symbol": "PFE", "publishedDate": "2019-04-30 14:11:21", "title": "Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/j/v/transcript46.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4258082-pfizer-inc-pfe-ceo-albert-bourla-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-04-30 13:28:47", "title": "Pfizer CEO: Drug prices will not be a growth driver", "image": "https://cdn.snapi.dev/images/v1/m/q-3/pfizer-ceo-drug-prices-will-not-be-a-growth-driver.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Pfizer's CEO claiming drug volume will drive growth for the company, not drug prices.", "url": "https://www.youtube.com/watch?v=An2kHegfIb8"}, {"symbol": "PFE", "publishedDate": "2019-04-30 13:00:00", "title": "What You Need to Know About Pfizer's Q1 Earnings Beat", "image": "https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5217742fpfizer-earnings-04302019.jpg", "site": "The Motley Fool", "text": "The big drugmaker exceeded expectations in Q1 on both the top and bottom lines.", "url": "https://www.fool.com/investing/2019/04/30/what-you-need-to-know-about-pfizers-q1-earnings-be.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-30 12:15:31", "title": "Why Pfizer Shareholders Are Smiling After Earnings", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-4.jpg", "site": "24/7 Wall Street", "text": "When Pfizer Inc. reported first-quarter 2019 results before markets opened Tuesday, the drugmaker posted adjusted diluted earnings per share (EPS) of $0.85 on revenues of $13.12 billion.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/mvJQvAx9tVk/"}, {"symbol": "PFE", "publishedDate": "2019-04-30 09:33:00", "title": "Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi92.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) beat estimates for first-quarter earnings and sales and raised the mid-point of its earnings expectations for 2019 by a penny and confirmed its previous outlook for full-year sales.", "url": "https://www.zacks.com/stock/news/405867/pfizer-pfe-beats-on-q1-earnings-sales-raises-eps-view"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:35:42", "title": "Pfizer stock up 1.7% after earnings and revenue beat", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer5-2.jpg", "site": "Market Watch", "text": "Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its full-year guidance.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ubFp54YYhLU/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:27:10", "title": "Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly", "image": "https://cdn.snapi.dev/images/v1/m/q-3/heres-a-breakdown-of-big-pharma-earnings-from-merck-pfizer-eli-lilly.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell joins \"Squawk Box\" to discuss how earnings results from Pfizer, Merck and Eli Lilly compare.", "url": "https://www.youtube.com/watch?v=Fb9sFhR7yXE"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:20:00", "title": "Three major pharmaceutical companies just reported earnings \u2014 here\u2019s how they did", "image": "https://cdn.snapi.dev/images/v1/m/j/mjb6-2.jpg", "site": "CNBC", "text": "Shares of Pfizer and Merck rose after reporting financial results that beat expectations.", "url": "https://www.cnbc.com/2019/04/30/3-major-pharma-companies-just-reported-earning-heres-how-they-did.html"}, {"symbol": "PFE", "publishedDate": "2019-04-30 07:13:33", "title": "Pfizer, Merck both post earnings beats", "image": "https://cdn.snapi.dev/images/v1/m/q-3/pfizer-merck-both-post-earnings-beats.jpg", "site": "CNBC Television", "text": "\"Squawk Box\" reports on Pfizer's and Merck's earnings results and 2019 outlook.", "url": "https://www.youtube.com/watch?v=zwMShmxlZts"}, {"symbol": "PFE", "publishedDate": "2019-04-30 06:00:00", "title": "Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/4/h/4hc.jpg", "site": "The Motley Fool", "text": "There's a clear and present danger to many healthcare stocks that's more serious than anything ever before.", "url": "https://www.fool.com/investing/2019/04/30/why-this-could-be-the-most-dangerous-time-ever-for.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-28 09:00:00", "title": "AbbVie vs. Pfizer", "image": "https://cdn.snapi.dev/images/v1/i/c/391.jpg", "site": "The Motley Fool", "text": "Which big pharma stock is more likely to be the bigger winner over the long run?", "url": "https://www.fool.com/investing/2019/04/28/better-buy-pfizer-vs-abbvie.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-26 06:45:37", "title": "Pfizer & Apple: The Most Shorted Dow Stocks in April", "image": "https://cdn.snapi.dev/images/v1/p/a/pa22.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or at least for their share prices to fall handily.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/cGKNLHWlzrg/"}, {"symbol": "PFE", "publishedDate": "2019-04-24 21:06:55", "title": "Merck Maintains Status In Front-Line Cancer Space", "image": "https://cdn.snapi.dev/images/v1/f/d/fda3.jpg", "site": "Seeking Alpha", "text": "Merck announced FDA approval for Keytruda given in combination with Pfizer's Inlyta to treat front-line advanced kidney cancer patients.", "url": "https://seekingalpha.com/article/4256488-merck-maintains-status-front-line-cancer-space?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-24 16:29:00", "title": "Pfizer to Report Q1 Earnings: Will It Beat Estimates?", "image": "https://cdn.snapi.dev/images/v1/r/d/pfi88.jpg", "site": "Zacks Investment Research", "text": "While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.", "url": "https://www.zacks.com/stock/news/398971/pfizer-pfe-to-report-q1-earnings-will-it-beat-estimates"}, {"symbol": "PFE", "publishedDate": "2019-04-23 15:54:00", "title": "Kidney-Cancer Market: Good for Patients, Hard for Investors", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5201622fdoctor-patient-2.jpg", "site": "The Motley Fool", "text": "Drugmakers battle for patients.", "url": "https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-23 10:32:35", "title": "Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release", "image": "https://cdn.snapi.dev/images/v1/v/3/pf9.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/391530/pfizer-pfe-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release"}, {"symbol": "PFE", "publishedDate": "2019-04-22 17:34:00", "title": "Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher", "image": "https://cdn.snapi.dev/images/v1/e/x/exv2.jpg", "site": "The Motley Fool", "text": "Here's why Cologuard's popularity will continue to climb for a long time.", "url": "https://www.fool.com/investing/2019/04/22/exact-sciences-is-near-an-all-time-high-heres-why.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-22 10:24:22", "title": "Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns", "image": "https://cdn.snapi.dev/images/v1/t/j/syringe-1884758-1920-7-2.jpg", "site": "Benzinga", "text": "Eli Lilly And Co (NYSE: LLY)\u00a0faced a setback following the  release of top-line results from a late-stage study of its pain medication candidate.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/2Mn0g6Uelic/eli-lilly-pfizers-non-opioid-painkiller-faces-safety-efficacy-concerns"}, {"symbol": "PFE", "publishedDate": "2019-04-19 14:12:00", "title": "5 Top Pharmaceutical Stocks to Buy in 2019", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg", "site": "The Motley Fool", "text": "Some are really big, while others are relatively small. But all these pharmaceutical stocks look like promising picks for 2019.", "url": "https://www.fool.com/investing/2019/04/19/5-top-pharmaceutical-stocks-to-buy-in-2019.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-18 18:37:16", "title": "Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech33-2.jpg", "site": "Market Watch", "text": "Shares of drug makers Pfizer Inc. and Eli Lilly & Co. declined in the extended session Thursday after the companies said a clinical study of an osteoarthritis drug didn't meet certain goals.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/kLsbz4SWgaE/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-04-14 07:00:00", "title": "The 3 Greatest Risks Pfizer Faces", "image": "https://cdn.snapi.dev/images/v1/p/d/pd2.jpg", "site": "The Motley Fool", "text": "Here's what could get in the way of the big pharma company's future success.", "url": "https://www.fool.com/investing/2019/04/14/the-3-greatest-risks-pfizer-faces.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-04-11 03:05:59", "title": "Pfizer: A Better Prospect", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-o-2.jpg", "site": "Seeking Alpha", "text": "Historical and projected rates of return for Johnson & Johnson are compared to similar data for Pfizer - with Pfizer, perhaps surprisingly, coming out a clear winner.", "url": "https://seekingalpha.com/article/4253889-johnson-and-johnson-solid-stable-returns-pfizer-better-prospect?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-10 17:45:21", "title": "Pfizer Stock Sinks As Market Gains: What You Should Know", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi9.jpg", "site": "Zacks Investment Research", "text": "Pfizer closed the most recent trading day at $42.73, moving -0.26% from the previous trading session.", "url": "https://www.zacks.com/stock/news/378063/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know"}, {"symbol": "PFE", "publishedDate": "2019-04-10 10:19:02", "title": "Pfizer: Solid, Stable Returns", "image": "https://cdn.snapi.dev/images/v1/1/1/11-2.jpg", "site": "Seeking Alpha", "text": "Supported by large share repurchases, Pfizer share price has shown steady growth, from ~$25 in 2012 to the current level.", "url": "https://seekingalpha.com/article/4253754-pfizer-solid-stable-returns?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-04-10 07:30:39", "title": "The 5 Most Shorted Dow Stocks: Pfizer", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-3.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/vPJVvbrTkfI/"}, {"symbol": "PFE", "publishedDate": "2019-04-09 08:20:49", "title": "Brand-name drugs cost 18 times more than generics: AARP", "image": "https://cdn.snapi.dev/images/v1/m/q-2/brand-name-drugs-cost-18-times-more-than-generics-aarp.jpg", "site": "Fox Business", "text": "AARP Health Services Research Director Leigh Purvis discusses why drug prices are so high.", "url": "https://www.youtube.com/watch?v=5QOl-0NeTBM"}, {"symbol": "PFE", "publishedDate": "2019-04-05 21:26:00", "title": "Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men", "image": "https://cdn.snapi.dev/images/v1/5/4/547-3.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) blockbuster breast cancer medicine gets FDA approval to treat men. The approval for the expanded indication is based predominately on real-world data.", "url": "https://www.zacks.com/stock/news/371728/pfizers-ibrance-gets-fda-approval-for-breast-cancer-in-men"}, {"symbol": "PFE", "publishedDate": "2019-04-02 10:54:24", "title": "Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia A", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech39.jpg", "site": "Investors Business Daily", "text": "Sangamo Therapeutics popped to a five-month high Tuesday after its gene-editing therapy showed promise as a hemophilia A treatment. Sangamo stock jumped by double digits in high volume.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/tAUmjaSwIZ0/"}, {"symbol": "PFE", "publishedDate": "2019-04-01 13:03:24", "title": "Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9.jpg", "site": "Benzinga", "text": "Large-cap pharma stocks have seen a mixed performance in year to date, and among this group, Pfizer Inc.  is poised to benefit from some key second-half catalysts, according to an analyst at Bank of America Merrill Lynch.", "url": "https://feeds.benzinga.com/~r/benzinga/~3/IXoj1Kd4e9w/bank-of-america-hikes-pfizer-price-target-estimates-cit"}, {"symbol": "PFE", "publishedDate": "2019-03-29 18:04:00", "title": "This Dow stock could be a way to play catch-up to the rally", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi2.jpg", "site": "CNBC", "text": "The Dow is having its best start to the year since 2013. Now, two market watchers agree that one of the Dow components is a compelling name to own if you want to play catch-up: Pfizer.", "url": "https://www.cnbc.com/2019/03/29/pfizer-is-the-name-to-buy-to-catch-up-to-the-dows-rally-say-two-experts.html"}, {"symbol": "PFE", "publishedDate": "2019-03-27 15:55:08", "title": "Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi88.jpg", "site": "24/7 Wall Street", "text": "Shares of drug giant Pfizer Inc.have been lagging rival Merck & Co., Inc.. The gain of 23% for Pfizer from this time a year ago is an impressive 23% return, but Merck\u2019s gain has been 55% in the same period", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/w-hVpgWnnBI/"}, {"symbol": "PFE", "publishedDate": "2019-03-25 07:25:02", "title": "5 Must-Own Merrill Lynch Income Portfolio High-Dividend Stocks", "image": "https://cdn.snapi.dev/images/v1/d/i/dividend1.jpg", "site": "24/7 Wall Street", "text": "24/7 Wall St. screened the portfolio looking for the highest yielding Buy rated companies and found five from different sectors that are solid plays now.", "url": "https://feedproxy.google.com/~r/typepad/RyNm/~3/Bzzb1JK-r4w/"}, {"symbol": "PFE", "publishedDate": "2019-03-22 13:32:58", "title": "Final Trades: Verizon, XPO, Pfizer, Alphabet and BB&T", "image": "https://cdn.snapi.dev/images/v1/m/q/final-trades-verizon-xpo-pfizer-alphabet-and-bbt.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=GOzdkOjGEqw"}, {"symbol": "PFE", "publishedDate": "2019-03-21 18:18:04", "title": "Diving for Dividends: PFIZER", "image": "https://cdn.snapi.dev/images/v1/p/f/pfe-21-03.png", "site": "CNBC Television", "text": "Robert Sluymer, Fundstrat Technician, outlines his top stock to buy for investors searching for yield.", "url": "https://www.youtube.com/watch?v=PXUF2FmSj68&t=132s"}, {"symbol": "PFE", "publishedDate": "2019-03-20 10:24:02", "title": "Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million", "image": "https://cdn.snapi.dev/images/v1/p/f/pfz.jpg", "site": "Market Watch", "text": "Pfizer Inc. said Wednesday it has paid 45 million euro, or the equivalent of $51 million to acquire a 15% equity stake in privately held gene therapy company Vivet Therapeutics.", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/MJC6DQPgwmw/story.aspx"}, {"symbol": "PFE", "publishedDate": "2019-03-20 07:58:00", "title": "Pfizer buys stake in French gene therapy firm Vivet", "image": "https://cdn.snapi.dev/images/v1/1/0/105761925-1551198899700gettyimages-1127566854530x298.jpeg", "site": "CNBC", "text": "Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver disorders.", "url": "https://www.cnbc.com/2019/03/20/pfizer-buys-stake-in-french-gene-therapy-firm-vivet.html"}, {"symbol": "PFE", "publishedDate": "2019-03-19 13:04:27", "title": "Stocks to Build Your Portfolio Around", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5164712ftrust.jpg", "site": "The Motley Fool", "text": "The first stock you ever buy could be the most important. These three names won't disappoint.", "url": "https://www.fool.com/investing/2019/03/19/3-stocks-to-build-your-portfolio-around.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-03-18 21:36:25", "title": "How Important Is Oncology For Pfizer?", "image": "https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-o.jpg", "site": "Forbes", "text": "Pfizer\u2019s oncology business contributes more than 10% to its overall top line. This can be attributed to its breast cancer drug ~ Ibrance ~ which has been doing well of late, and it has a large addressable market.", "url": "https://www.forbes.com/sites/greatspeculations/2019/03/18/how-important-is-oncology-for-pfizer/"}, {"symbol": "PFE", "publishedDate": "2019-03-13 14:19:47", "title": "Forget About Dogs Of The Dow In 2019, Upgrade To Dobermans", "image": "https://cdn.snapi.dev/images/v1/d/o/doberman-1177935-1280-1200x800.jpg", "site": "Forbes", "text": "A year ago, I introduced to Forbes readers my Dobermans of the Dow screen. It's simple to employ, and the historical returns far exceed the traditional Dogs of the Dow.", "url": "https://www.forbes.com/sites/michaelcannivet/2019/01/03/forget-about-dogs-of-the-dow-in-2019-upgrade-to-dobermans/"}, {"symbol": "PFE", "publishedDate": "2019-03-12 15:06:00", "title": "Option trading opportunities in Pfizer", "image": "https://cdn.snapi.dev/images/v1/p/f/pfizer.jpg", "site": "CNBC Television", "text": "\"Halftime Report\" trader Jon Najarian spots unusual options activity in shares of Pfizer.", "url": "https://www.youtube.com/watch?v=TCpC0dl0wI0&t=0s"}, {"symbol": "PFE", "publishedDate": "2019-03-12 14:46:47", "title": "Final trades: Array Biopharma, Alphabet, KKR & XLK tech", "image": "https://cdn.snapi.dev/images/v1/f/i/finaltrades-4.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=Y9NBB_L2Kd0"}, {"symbol": "PFE", "publishedDate": "2019-03-11 13:03:03", "title": "2 Undervalued Stocks With Strong, Secure Dividends", "image": "https://cdn.snapi.dev/images/v1/q/p/qpdvzfgckcw.jpg", "site": "Morningstar", "text": "Both Bristol-Myers Squibb and Pfizer are well-positioned for growth.", "url": "https://www.youtube.com/watch?v=QPdvzfgckcw"}, {"symbol": "PFE", "publishedDate": "2019-02-27 19:00:00", "title": "Top technician says charts point to healthy gains ahead for this stock", "image": "https://cdn.snapi.dev/images/v1/c/j/cj7s4ylolgq.jpg", "site": "CNBC Television", "text": "Robert Sluymer, Fundstrat, looks at the best stocks in health care space. With CNBC's Dominic Chu and Melissa Lee, and the Fast Money traders, Tim Seymour, Steve Grasso, Dan Nathan and Guy Adami.", "url": "https://www.youtube.com/watch?v=cj7s4yLoLgQ"}, {"symbol": "PFE", "publishedDate": "2019-02-26 19:00:00", "title": "High U.S. drug prices fuel outrage", "image": "https://cdn.snapi.dev/images/v1/d/r/drugprices.jpg", "site": "Bloomberg Markets and Finance", "text": "Lara Rhame, FS Investments chief U.S. economist, and Mike Liss, American Century portfolio manager, discuss drug pricing on \"Bloomberg Daybreak: Americas.\"", "url": "https://www.bloomberg.com/news/videos/2019-02-27/high-u-s-drug-prices-fuel-outrage-video"}, {"symbol": "PFE", "publishedDate": "2019-02-25 19:00:00", "title": "We need more drug price transparency, says Senator Chuck Grassley", "image": "https://cdn.snapi.dev/images/v1/m/y/mysh5f9wirm.jpg", "site": "CNBC Television", "text": "Senator Chuck Grassley (R-IA), head of the Senate Finance Committee, joins \"Squawk Box\" before the committee hears testimony from seven major pharmaceutical CEOs about drug pricing.", "url": "https://www.youtube.com/watch?v=MYSh5F9WIrM"}, {"symbol": "PFE", "publishedDate": "2019-02-24 19:00:00", "title": "There will be continued interest in gene therapy, says biotech analyst", "image": "https://cdn.snapi.dev/images/v1/r/o/roche-1.jpg", "site": "CNBC Television", "text": "CNBC's \"Power Lunch\" team discusses whether there's more biotech buyouts ahead with Michael Yee of Jefferies.", "url": "https://www.youtube.com/watch?v=g4Wg0qvTJ0I"}, {"symbol": "PFE", "publishedDate": "2019-02-10 19:00:00", "title": "Even if there's no trade deal, here's what traders think is still safe to buy", "image": "https://cdn.snapi.dev/images/v1/1/0/10jaziai56m.jpg", "site": "CNBC Television", "text": "Are all the market risks priced in? The biggest risks to the New Year rally. With CNBC's Brian Sullivan and the Fast Money traders, Pete Najarian, Tim Seymour, Dan Nathan and Guy Adami.", "url": "https://www.youtube.com/watch?v=10jAziAI56M"}, {"symbol": "PFE", "publishedDate": "2019-02-05 19:00:00", "title": "Final Trades: Array BioPharma", "image": "https://cdn.snapi.dev/images/v1/t/2/t23uhmjw51ev-1.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day including Advanced Micro, Array Biopharma & more.", "url": "https://www.youtube.com/watch?v=T23UhMjW51E&t=0s"}, {"symbol": "PFE", "publishedDate": "2019-02-04 19:00:00", "title": "Trade Update: Array BioPharma", "image": "https://cdn.snapi.dev/images/v1/l/0/l0384w3hvzcv-4.jpg", "site": "CNBC Television", "text": "\"Halftime Report\" traders Jon and Pete Najarian spots unusual options activity in Square and Cars.com. Plus: trade updates on Intel and Array BioPharma.", "url": "https://www.youtube.com/watch?v=l0384W3hVzc&t=128s"}, {"symbol": "PFE", "publishedDate": "2019-02-03 19:00:00", "title": "The traders answer your questions about: Pfizer", "image": "https://cdn.snapi.dev/images/v1/a/b/abf4ziklvq4.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Boeing, Paypal, Pfizer, Verizon, Visa & Gilead.", "url": "https://www.youtube.com/watch?v=abf4ZIKlVq4&t=68s"}, {"symbol": "PFE", "publishedDate": "2019-01-29 19:00:00", "title": "What Boeing's Report Means for U.S. Companies With China Exposure", "image": "https://cdn.snapi.dev/images/v1/u/1/u13kumvf7pi.jpg", "site": "The Street", "text": "Kate Warne, investment strategist at Edward Jones, spoke to TheStreet about what the Boeing earnings mean for companies with exposure to China, how the tech sector is doing after Apple's AAPLearnings and how healthcare is looking now that Amgen, Pfizer and Allergan have reported.", "url": "https://www.youtube.com/watch?v=u13kUMVf7pI"}, {"symbol": "PFE", "publishedDate": "2019-01-28 19:00:00", "title": "Stocks Mixed: Apple Earnings Due, Pfizer Reports, Pinduoduo Strong", "image": "https://cdn.snapi.dev/images/v1/w/8/w8mkcxl9dnc.jpg", "site": "Investors Business Daily", "text": "Investor's Business Daily's MARKET UPDATE, with Alissa Coram and Ken Shreve.", "url": "https://www.youtube.com/watch?v=W8mKcXL9Dnc"}, {"symbol": "PFE", "publishedDate": "2019-01-24 19:00:00", "title": "Earnings Thirteen: 4 buys", "image": "https://cdn.snapi.dev/images/v1/1/c/1cqx0bznin8.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 4 buys ahead of the big 13 Dow stocks reporting next week.", "url": "https://www.youtube.com/watch?v=1CQx0BZnin8"}, {"symbol": "PFE", "publishedDate": "2019-01-17 19:00:00", "title": "Bulls bet on this biopharma company. Plus, the update on Freeport-McMoRan", "image": "https://cdn.snapi.dev/images/v1/q/4/q4dbuoj6xfy.jpg", "site": "CNBC Television", "text": "\"Halftime Report\" traders Jon and Pete Najarian spot unusual options activity in shares of Macy's and Pfizer.", "url": "https://www.youtube.com/watch?v=Q4dBUoJ6XfY"}, {"symbol": "PFE", "publishedDate": "2019-01-02 19:00:00", "title": "Is now a good time to buy tech? Is 3M poised to move higher? What about Fortinet? Your questions ans", "image": "https://cdn.snapi.dev/images/v1/v/o/vo4hb-ts9dg.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on 3M, Fortinet, Pfizer, Weatherford International, and if now's the time to buy tech.", "url": "https://www.youtube.com/watch?v=VO4hb_Ts9dg"}, {"symbol": "PFE", "publishedDate": "2019-01-01 19:00:00", "title": "Final Trades: FDX, PFE, & Bitcoin", "image": "https://cdn.snapi.dev/images/v1/o/i/oivdoec0swc.jpg", "site": "CNBC Television", "text": "The \u201cFast Money\u201d traders discuss how to trade FedEx, Pfizer and Bitcoin.", "url": "https://www.youtube.com/watch?v=OiVDoeC0swc"}, {"symbol": "PFE", "publishedDate": "2018-12-27 19:00:00", "title": "Tech stock picks from two investing experts", "image": "https://cdn.snapi.dev/images/v1/v/i/viu4uxkd-qc.jpg", "site": "CNBC Television", "text": "CNBC's \"Power Lunch\" team talks about the state of the markets with Ernesto Ramos of BMO and Kim Forrest of Fort Pitt Capital.", "url": "https://www.youtube.com/watch?v=vIU4uXKd_qc"}, {"symbol": "PFE", "publishedDate": "2018-12-10 19:00:00", "title": "Clients trust Apple stock despite its recent dip, says TD Ameritrade's JJ Kinahan", "image": "https://cdn.snapi.dev/images/v1/g/d/gdonwdlosok.jpg", "site": "CNBC Television", "text": "JJ Kinahan, chief market strategist at TD Ameritrade, breaks down his clients' stock picks.", "url": "https://www.youtube.com/watch?v=gDONwDlosOk"}, {"symbol": "PFE", "publishedDate": "2018-11-29 19:00:00", "title": "Bulls shop for TJX. Plus, the trade on Pfizer", "image": "https://cdn.snapi.dev/images/v1/b/8/b8pkzdn8xwm.jpg", "site": "CNBC Television", "text": "\"Halftime Report\" trader Jon Najarian spots bullish option buying in TJX Companies and Pfizer.", "url": "https://www.youtube.com/watch?v=B8pkZdn8xWM"}, {"symbol": "PFE", "publishedDate": "2018-11-20 19:00:00", "title": "BMO portfolio manager breaks down top dividend picks", "image": "https://cdn.snapi.dev/images/v1/i/a/iajx4j2hhw0.jpg", "site": "CNBC Television", "text": "Ernesto Ramos, portfolio manager with BMO Global Asset Management, discusses his top dividend choices.", "url": "https://www.youtube.com/watch?v=iAJx4J2hHw0"}, {"symbol": "PFE", "publishedDate": "2018-11-19 19:00:00", "title": "Pfizer to raise drug prices despite Trump's complaints", "image": "https://cdn.snapi.dev/images/v1/s/o/soc8igt3vca.jpg", "site": "Fox Business", "text": "Association for Accessible Medicines CEO Chip Davis discusses the Trump administration's fight to lower prescription drug prices.", "url": "https://www.youtube.com/watch?v=SOC8Igt3vCA"}, {"symbol": "PFE", "publishedDate": "2018-11-15 19:00:00", "title": "Final Trades: Virtu, JPMorgan & Pfizer", "image": "https://cdn.snapi.dev/images/v1/i/v/ivyeaofonea.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders give their top stocks to watch for the second half.", "url": "https://www.youtube.com/watch?v=IvyeAoFOneA"}, {"symbol": "PFE", "publishedDate": "2018-11-09 19:00:00", "title": "Final Trades: CSCO, PFE & more", "image": "https://cdn.snapi.dev/images/v1/b/m/bmcip-ysegy.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day, including Cisco, Pfizer, Tesla and General Electric.", "url": "https://www.youtube.com/watch?v=bMciP-YseGY"}, {"symbol": "PFE", "publishedDate": "2018-11-07 19:00:00", "title": "The future of the health-care industry", "image": "https://cdn.snapi.dev/images/v1/u/6/u6rlgkkgeoe.jpg", "site": "CNBC Television", "text": "Fred Hassan, former Shering-Plough CEO, and Bill George, former Medtronic CEO, join 'Squawk on the Street' to discuss the impact on health-care stocks after news that the sector was the top issue for midterm voters.", "url": "https://www.youtube.com/watch?v=U6rLgKKgeOE"}, {"symbol": "PFE", "publishedDate": "2018-11-06 19:00:00", "title": "Elections is more about the health care sector, and less drug prices, says pro", "image": "https://cdn.snapi.dev/images/v1/q/h/qhp0-wnd4ci.jpg", "site": "CNBC Television", "text": "Ipsita Smolinski of Capitol Street and Jared Holz of Jefferies join 'Closing Bell' to discuss the health care sector and how drug pricing could be changed following the midterm elections.", "url": "https://www.youtube.com/watch?v=qhp0_wnd4cI"}, {"symbol": "PFE", "publishedDate": "2018-11-05 19:00:00", "title": "How health care could be impacted by the midterms", "image": "https://cdn.snapi.dev/images/v1/n/f/nfjcujynh9s.jpg", "site": "CNBC Television", "text": "Umer Raffat of Evercore ISI, Institutional Investors number one biotech analyst, joins 'Power Lunch' to discuss how health care stocks could be impacted by the midterm elections.", "url": "https://www.youtube.com/watch?v=NfJcujyNH9s"}, {"symbol": "PFE", "publishedDate": "2018-10-31 20:00:00", "title": "Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine", "image": "https://cdn.snapi.dev/images/v1/r/f/rflx3ewmkyc.jpg", "site": "Zacks Investment Research", "text": "After a volatile October, Ryan McQueeney highlights two income companies that fared better than the broader markets during the selloff\u2014Pfizer and Coca-Cola\u2014and explains why earnings and defensive posturing might have helped the stocks.", "url": "https://www.youtube.com/watch?v=rFlX3eWmKyc"}, {"symbol": "PFE", "publishedDate": "2018-10-29 20:00:00", "title": "Pfizer posts mixed quarter", "image": "https://cdn.snapi.dev/images/v1/f/j/fjfpdkzpity.jpg", "site": "CNBC Television", "text": "Pfizer reports quarterly earnings of $0.78 per share, revenues of $13.298 billion.", "url": "https://www.youtube.com/watch?v=fjFPDKzPITY"}, {"symbol": "PFE", "publishedDate": "2018-10-28 20:00:00", "title": "Where should investors go to sit out the sell-off? Traders give their picks", "image": "https://cdn.snapi.dev/images/v1/u/g/ug74bftptak.jpg", "site": "CNBC Television", "text": "Sitting out the sell-off. Where investors are running to for cover. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Guy Adami.", "url": "https://www.youtube.com/watch?v=Ug74BftPTak"}, {"symbol": "PFE", "publishedDate": "2018-10-23 20:00:00", "title": "Pfizer & Eli Lilly's Opioid Alternative Shows Promise", "image": "https://cdn.snapi.dev/images/v1/b/n/bn-c0aexou.jpg", "site": "Zacks Investment Research", "text": "In a large clinical trial, Pfizer (PFE) and Eli Lilly (LLY) have been testing a pain medication, tanezumab, for the treatment of osteoarthritis.", "url": "https://www.youtube.com/watch?v=-bn_c0aexOU"}, {"symbol": "PFE", "publishedDate": "2018-10-17 20:00:00", "title": "Will Pfizer hit $50? Is Cleveland-Cliffs a safe bet ahead of earnings? The desk takes viewer quest", "image": "https://cdn.snapi.dev/images/v1/1/u/1uvohfmupuw.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders take viewer questions on Pfizer, Mosaic and Cleveland-Cliffs", "url": "https://www.youtube.com/watch?v=1UvOHFMupUw"}, {"symbol": "PFE", "publishedDate": "2018-10-11 20:00:00", "title": "Final Trades: HD, DIS & more", "image": "https://cdn.snapi.dev/images/v1/r/q/rqxrhtskl7g.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day, including Home Depot, Disney, Pfizer and JPMorgan.", "url": "https://www.youtube.com/watch?v=rQxRhTSkL7g"}, {"symbol": "PFE", "publishedDate": "2018-10-10 20:00:00", "title": "S&P 500 having worst month since September 2011", "image": "https://cdn.snapi.dev/images/v1/y/k/ykpndjxdlku.jpg", "site": "CNBC Television", "text": "CNBC's Bob Pisani breaks down Thursday's market sell-off after the closing bell.", "url": "https://www.youtube.com/watch?v=YKPNDJxDlkU"}, {"symbol": "PFE", "publishedDate": "2018-10-02 20:00:00", "title": "Stocks and rates are stuck in a game of chicken, so which will blink first", "image": "https://cdn.snapi.dev/images/v1/l/n/lnb08d4n-pi.jpg", "site": "CNBC Television", "text": "The Dow closes at a record high. Will rates derail the rally? With CNBC's Melissa Lee and the Fast Money traders, Pete Najarian, Tim Seymour, Karen Finerman and Guy Adami.", "url": "https://www.youtube.com/watch?v=LNB08D4n_PI"}, {"symbol": "PFE", "publishedDate": "2018-09-30 20:00:00", "title": "Pfizer says CEO Ian Read will retire at the end of the year", "image": "https://cdn.snapi.dev/images/v1/k/w/kwv92li02ao.jpg", "site": "Fox Business", "text": "Pfizer announced that CEO Ian Read will step-down by the end of the year and be replaced by the company's current chief operating officer Albert Bourla.", "url": "https://www.youtube.com/watch?v=KwV92lI02Ao"}, {"symbol": "PFE", "publishedDate": "2018-09-28 20:00:00", "title": "Final Trades: T, DIS & more", "image": "https://cdn.snapi.dev/images/v1/1/w/1ww7jldtru.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day, including AT&T, Disney, Pfizer and Celgene.", "url": "https://www.youtube.com/watch?v=_1wW7jlDTRU"}, {"symbol": "PFE", "publishedDate": "2018-09-05 20:00:00", "title": "The Final Call: STZ, PFE & more", "image": "https://cdn.snapi.dev/images/v1/x/9/x9uknhmxqgg.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders share their final trades of the day, including Constellation Brands, Pfizer, Taiwan Semiconductor and CBS.", "url": "https://www.youtube.com/watch?v=X9uKNHMxqgg"}, {"symbol": "PFE", "publishedDate": "2018-08-28 20:00:00", "title": "Must own stocks: 5 buys", "image": "https://cdn.snapi.dev/images/v1/p/i/pira-eli9ha.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you their 5 picks for must own stocks.", "url": "https://www.youtube.com/watch?v=PirA_ELI9hA"}, {"symbol": "PFE", "publishedDate": "2018-08-26 20:00:00", "title": "Stocks rally following US-Mexico trade deal", "image": "https://cdn.snapi.dev/images/v1/s/j/sjohopkl400.jpg", "site": "CNBC Television", "text": "Traders Joe Terranova, Jim Lebenthal, Stephen Weiss and Josh Brown discuss that the U.S.-Mexico trade deal is good news for certain sectors of the economy and that the surging stocks signal that the market sees an eventual trade resolution with China.", "url": "https://www.youtube.com/watch?v=sJOhoPkl400"}, {"symbol": "PFE", "publishedDate": "2018-08-22 20:00:00", "title": "Exact Sciences CEO: Pfizer partnership | Mad Money | CNBC", "image": "https://cdn.snapi.dev/images/v1/f/n/fn2h0ndnhl4.jpg", "site": "CNBC Television", "text": "Jim Cramer sits down with Exact Sciences CEO Kevin Conroy to find out what's next for the company, including its partnership with Pfizer.", "url": "https://www.youtube.com/watch?v=FN2H0NDnhL4"}, {"symbol": "PFE", "publishedDate": "2018-08-21 20:00:00", "title": "Jim Cramer on Target, Lowe's, Toll Brothers and Tariffs", "image": "https://cdn.snapi.dev/images/v1/t/o/to1oq-l2yog.jpg", "site": "Zacks Investment Research", "text": "heStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks from the floor of the New York Stock Exchange including Target, Lowe's, Toll Brother's, and tariffs.", "url": "https://www.youtube.com/watch?v=tO1OQ_l2Yog"}, {"symbol": "PFE", "publishedDate": "2018-08-15 20:00:00", "title": "Trading a huge rally: 6 picks", "image": "https://cdn.snapi.dev/images/v1/c/m/cmtp78cvfww.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 6 ways to trade a big up day in the market.", "url": "https://www.youtube.com/watch?v=CMTp78cvFWw"}, {"symbol": "PFE", "publishedDate": "2018-08-07 20:00:00", "title": "Stocks to buy at market highs: 5 picks", "image": "https://cdn.snapi.dev/images/v1/7/t/7tpdnpsrhgm.jpg", "site": "CNBC Television", "text": "The \"Fast Money\" traders give you 5 stocks to buy as the S&P 500 hits its highest level since January.", "url": "https://www.youtube.com/watch?v=7tPDNPsRHgM"}, {"symbol": "PFE", "publishedDate": "2018-08-02 20:00:00", "title": "Trade it or fade it: This week's winners", "image": "https://cdn.snapi.dev/images/v1/m/-/m-3mbnyhb84.jpg", "site": "CNBC Television", "text": "Trading this week's winners. Should investors keep betting on them? With CNBC's Michelle Caruso-Cabrera and the Fast Money traders, Tim Seymour, Steve Grasso, Brian Kelly and Dan Nathan.", "url": "https://www.youtube.com/watch?v=M-3MbNyhb84"}]